Citrus Sinensis ID: 030211

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-
Protein Sequence
MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQG
Secondary Structure (PSIPRED)
cccEEEEEEEccccEEEEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHcccccEEEEEEEEEcccEEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEEccccccccccccccccccccccccHHHHccccccccccc
Secondary Structure Prediction (SSPRO)
cccEEEEEEccccccEEEEEEEEcccccEEEEEEEEcccccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccccEEEEcccccccccccccccccccccccccHHHHcccccccccc
Coil and Loop (DISEMBL)
MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINhrslrhpniirfkevvltpTHLAIVMEYAAGGELFDRIcnagrfsedeGRYFFQQLISGvnychsmqICHRDLKLentlldgsaaprlkicdfgyskssvlhsrpkstvgtpayiapevlsrreydgkqg
Flexible Loop (DISEMBL)
mekyelvkdlgagnfgvarllrhketkelvavkyiergrkidenVAREIinhrslrhpniirFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSsvlhsrpkstvgtpayiapevlsrreydgkqg
Low Complexity Region (SEG)
MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQG
Disordered region (IsUnstruct)
*****LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS*V******************************
Disordered Region (DISOPRED)
*EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD****
Disordered Region (DISEMBL)
MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR********
Disordered Region (DISPRO)
MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQG
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	181	2.2.26 [Sep-21-2011]
Q9FFP9	360	Serine/threonine-protein	yes	no	1.0	0.502	0.911	6e-96
P43292	353	Serine/threonine-protein	no	no	1.0	0.512	0.895	2e-95
Q7XQP4	359	Serine/threonine-protein	yes	no	1.0	0.504	0.900	3e-95
P43291	363	Serine/threonine-protein	no	no	1.0	0.498	0.895	5e-95
Q6ZI44	365	Serine/threonine-protein	no	no	1.0	0.495	0.895	1e-94
Q9C958	361	Serine/threonine-protein	no	no	1.0	0.501	0.883	5e-93
Q940H6	362	Serine/threonine-protein	no	no	0.983	0.491	0.859	2e-91
A2YNT8	339	Serine/threonine-protein	N/A	no	0.988	0.528	0.860	3e-91
Q39193	361	Serine/threonine-protein	no	no	0.983	0.493	0.859	4e-91
Q0D4J7	339	Serine/threonine-protein	no	no	0.988	0.528	0.854	7e-91

>sp|Q9FFP9|SRK2H_ARATH Serine/threonine-protein kinase SRK2H OS=Arabidopsis thaliana GN=SRK2H PE=1 SV=1

 Score =  349 bits (895), Expect = 6e-96,   Method: Compositional matrix adjust.
 Identities = 165/181 (91%), Positives = 174/181 (96%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYE+VKDLGAGNFGVARLLRHKETKELVA+KYIERGRKIDENVAREIINHRSLRHPNI
Sbjct: 1   MDKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSE E RYFFQQLI GV+YCHS+QIC
Sbjct: 61  IRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLKLENTLLDGS AP LKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK 
Sbjct: 121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKH 180

Query: 181 G 181
            
Sbjct: 181 A 181

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P43292|SRK2G_ARATH Serine/threonine-protein kinase SRK2G OS=Arabidopsis thaliana GN=SRK2G PE=1 SV=2

 Score =  347 bits (891), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 162/181 (89%), Positives = 173/181 (95%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KY++VKDLGAGNFGVARLLRHK+TKELVA+KYIERGRKIDENVAREIINHRSL+HPNI
Sbjct: 1   MDKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEV+LTPTHLAIVMEYA+GGELFDRIC AGRFSE E RYFFQQLI GV+YCHS+QIC
Sbjct: 61  IRFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLKLENTLLDGS AP LKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK 
Sbjct: 121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKH 180

Query: 181 G 181
            
Sbjct: 181 A 181

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7XQP4|SAPK7_ORYSJ Serine/threonine-protein kinase SAPK7 OS=Oryza sativa subsp. japonica GN=SAPK7 PE=2 SV=2

 Score =  347 bits (889), Expect = 3e-95,   Method: Compositional matrix adjust.
 Identities = 163/181 (90%), Positives = 173/181 (95%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           ME+YEL+KD+GAGNFGVARL+R+KETKELVA+KYI RG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MERYELLKDIGAGNFGVARLMRNKETKELVAMKYIPRGLKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVV+TPTHLAIVMEYAAGGELFDRICNAGRFSEDE RYFFQQLI GV+YCH MQIC
Sbjct: 61  IRFKEVVVTPTHLAIVMEYAAGGELFDRICNAGRFSEDEARYFFQQLICGVSYCHFMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVLSRREYDGK 
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYDGKT 180

Query: 181 G 181
            
Sbjct: 181 A 181

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43291|SRK2A_ARATH Serine/threonine-protein kinase SRK2A OS=Arabidopsis thaliana GN=SRK2A PE=1 SV=1

 Score =  346 bits (887), Expect = 5e-95,   Method: Compositional matrix adjust.
 Identities = 162/181 (89%), Positives = 173/181 (95%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYELVKD+GAGNFGVARL++ K +KELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MDKYELVKDIGAGNFGVARLMKVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAI MEYAAGGELF+RIC+AGRFSEDE RYFFQQLISGV+YCH+MQIC
Sbjct: 61  IRFKEVVLTPTHLAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK 
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 181 G 181
            
Sbjct: 181 A 181

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6ZI44|SAPK6_ORYSJ Serine/threonine-protein kinase SAPK6 OS=Oryza sativa subsp. japonica GN=SAPK6 PE=2 SV=1

 Score =  344 bits (883), Expect = 1e-94,   Method: Compositional matrix adjust.
 Identities = 162/181 (89%), Positives = 173/181 (95%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           MEKYEL+KD+G+GNFGVARL+R++ETKELVA+KYI RG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MEKYELLKDIGSGNFGVARLMRNRETKELVAMKYIPRGLKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELFDRIC+AGRFSEDE RYFFQQLI GV+YCH MQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICSAGRFSEDESRYFFQQLICGVSYCHFMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVLSRREYDGK 
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 181 G 181
            
Sbjct: 181 A 181

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C958|SRK2B_ARATH Serine/threonine-protein kinase SRK2B OS=Arabidopsis thaliana GN=SRK2B PE=1 SV=1

 Score =  339 bits (870), Expect = 5e-93,   Method: Compositional matrix adjust.
 Identities = 160/181 (88%), Positives = 171/181 (94%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYELVKD+GAGNFGVARL+R K +KELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MDKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTH+AI MEYAAGGELF+RIC+AGRFSEDE RYFFQQLISGV+YCH+MQIC
Sbjct: 61  IRFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVLSR EYDGK 
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKM 180

Query: 181 G 181
            
Sbjct: 181 A 181

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1

 Score =  334 bits (856), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 153/178 (85%), Positives = 171/178 (96%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++YELVKD+G+GNFGVARL+R K++ ELVAVKYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSEDE R+FFQQLISGV+YCH+MQ+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           RDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL ++EYDGK
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196

Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2

 Score =  333 bits (855), Expect = 3e-91,   Method: Compositional matrix adjust.
 Identities = 154/179 (86%), Positives = 172/179 (96%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           ME+YE++KD+G+GNFGVA+L+R   TKEL AVK+IERG+KIDENV REI+NHRSLRHPNI
Sbjct: 1   MERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +RFKEVVLTPTHLAIVMEYAAGGELF+RIC+AGRFSEDE R+FFQQLISGV+YCHSMQIC
Sbjct: 61  VRFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL+R+EYDGK
Sbjct: 121 HRDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGK 179

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1

 Score =  333 bits (853), Expect = 4e-91,   Method: Compositional matrix adjust.
 Identities = 153/178 (85%), Positives = 170/178 (95%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++Y+ VKD+G+GNFGVARL+R K TKELVAVKYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 79

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           RFKEV+LTPTHLAI+MEYA+GGEL++RICNAGRFSEDE R+FFQQL+SGV+YCHSMQICH
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           RDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL R+EYDGK
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK 197

Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1

 Score =  332 bits (852), Expect = 7e-91,   Method: Compositional matrix adjust.
 Identities = 153/179 (85%), Positives = 172/179 (96%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           ME+YE++KD+G+GNFGVA+L+R   TKEL AVK+IERG+KIDENV REI+NHRSLRHPNI
Sbjct: 1   MERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +RFKEVVLTPTHLAIVMEYAAGGELF+RIC+AGRFSEDE R+FFQQLISGV+YCHSMQIC
Sbjct: 61  VRFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL+R+EYDGK
Sbjct: 121 HRDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGK 179

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	181
449480851	355	PREDICTED: LOW QUALITY PROTEIN: serine/t	1.0	0.509	0.950	4e-98
449457283	355	PREDICTED: serine/threonine-protein kina	1.0	0.509	0.950	4e-98
449480931	337	PREDICTED: serine/threonine-protein kina	1.0	0.537	0.939	2e-97
224144496	204	predicted protein [Populus trichocarpa]	0.988	0.877	0.960	4e-97
449453216	355	PREDICTED: serine/threonine-protein kina	1.0	0.509	0.939	5e-97
404435149	360	sucrose non-fermenting 1-related protein	0.988	0.497	0.932	4e-96
225448215	356	PREDICTED: serine/threonine-protein kina	0.988	0.502	0.938	4e-96
147864363	357	hypothetical protein VITISV_028464 [Viti	0.988	0.501	0.938	4e-96
297739581	335	unnamed protein product [Vitis vinifera]	0.988	0.534	0.938	4e-96
38228677	359	serine/threonine-protein kinase [Fagus s	0.988	0.498	0.944	5e-96

>gi|449480851|ref|XP_004156012.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase SRK2H-like [Cucumis sativus]

 Score =  362 bits (929), Expect = 4e-98,   Method: Compositional matrix adjust.
 Identities = 172/181 (95%), Positives = 177/181 (97%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYE+VKDLGAGNFGVARLLRHKETKELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MDKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGVNYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVNYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLKLENTLLDGSAAPRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK 
Sbjct: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 181 G 181
            
Sbjct: 181 A 181

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449457283|ref|XP_004146378.1| PREDICTED: serine/threonine-protein kinase SRK2H-like [Cucumis sativus]

 Score =  362 bits (929), Expect = 4e-98,   Method: Compositional matrix adjust.
 Identities = 172/181 (95%), Positives = 177/181 (97%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYE+VKDLGAGNFGVARLLRHKETKELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MDKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGVNYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVNYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLKLENTLLDGSAAPRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK 
Sbjct: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 181 G 181
            
Sbjct: 181 A 181

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449480931|ref|XP_004156033.1| PREDICTED: serine/threonine-protein kinase SRK2H-like [Cucumis sativus]

 Score =  360 bits (923), Expect = 2e-97,   Method: Compositional matrix adjust.
 Identities = 170/181 (93%), Positives = 176/181 (97%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYE+VKDLGAGNFGVARLLRHK+TKELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MDKYEVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGVNYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVNYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK 
Sbjct: 121 HRDLKLENTLLDGSTAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 181 G 181
            
Sbjct: 181 A 181

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224144496|ref|XP_002325309.1| predicted protein [Populus trichocarpa] gi|222862184|gb|EEE99690.1| predicted protein [Populus trichocarpa]

 Score =  358 bits (920), Expect = 4e-97,   Method: Compositional matrix adjust.
 Identities = 172/179 (96%), Positives = 176/179 (98%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           MEKYELVKDLGAGNFGVARLLRHKETKELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGVNYCH+MQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVNYCHNMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449453216|ref|XP_004144354.1| PREDICTED: serine/threonine-protein kinase SRK2A-like [Cucumis sativus]

 Score =  358 bits (919), Expect = 5e-97,   Method: Compositional matrix adjust.
 Identities = 170/181 (93%), Positives = 176/181 (97%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYE+VKDLGAGNFGVARLLRHK+TKELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MDKYEVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGVNYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVNYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK 
Sbjct: 121 HRDLKLENTLLDGSTAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 181 G 181
            
Sbjct: 181 A 181

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|404435149|gb|AFR68941.1| sucrose non-fermenting 1-related protein kinase 2 family member [Solanum tuberosum]

 Score =  355 bits (911), Expect = 4e-96,   Method: Compositional matrix adjust.
 Identities = 167/179 (93%), Positives = 177/179 (98%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           MEKYELVKD+G+GNFGVARL+R+KETKELVA+KYIERG KIDENVAREIINH+SLRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRNKETKELVAMKYIERGHKIDENVAREIINHKSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGV+YCH+MQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVHYCHNMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRDLKLENTLLDGSAAPRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK
Sbjct: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179

Source: Solanum tuberosum

Species: Solanum tuberosum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225448215|ref|XP_002269221.1| PREDICTED: serine/threonine-protein kinase SRK2B isoform 1 [Vitis vinifera]

 Score =  355 bits (911), Expect = 4e-96,   Method: Compositional matrix adjust.
 Identities = 168/179 (93%), Positives = 177/179 (98%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           MEKYELVKD+G+GNFGVARL+R+KETKELVA+KYIERG+KIDENVAREIINHRSLRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRNKETKELVAMKYIERGQKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGV+YCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147864363|emb|CAN78793.1| hypothetical protein VITISV_028464 [Vitis vinifera]

 Score =  355 bits (911), Expect = 4e-96,   Method: Compositional matrix adjust.
 Identities = 168/179 (93%), Positives = 177/179 (98%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           MEKYELVKD+G+GNFGVARL+R+KETKELVA+KYIERG+KIDENVAREIINHRSLRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRNKETKELVAMKYIERGQKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGV+YCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297739581|emb|CBI29763.3| unnamed protein product [Vitis vinifera]

 Score =  355 bits (911), Expect = 4e-96,   Method: Compositional matrix adjust.
 Identities = 168/179 (93%), Positives = 177/179 (98%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           MEKYELVKD+G+GNFGVARL+R+KETKELVA+KYIERG+KIDENVAREIINHRSLRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRNKETKELVAMKYIERGQKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RICNAGRFSEDE RYFFQQLISGV+YCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|38228677|emb|CAE54075.1| serine/threonine-protein kinase [Fagus sylvatica]

 Score =  355 bits (911), Expect = 5e-96,   Method: Compositional matrix adjust.
 Identities = 169/179 (94%), Positives = 175/179 (97%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+KYE+VKDLGAGNFGVARLLRHKETKELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct: 1   MDKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGLKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RIC AG+FSEDE RYFFQQLISGVNYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICTAGKFSEDEARYFFQQLISGVNYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRDLKLENTLLDGS APRLKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179

Source: Fagus sylvatica

Species: Fagus sylvatica

Genus: Fagus

Family: Fagaceae

Order: Fagales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	181
TAIR|locus:2160559	360	SNRK2.5 "SNF1-related protein	0.988	0.497	0.921	2.9e-87
TAIR|locus:2159597	353	SNRK2.1 "SNF1-related protein	0.988	0.507	0.905	2.6e-86
TAIR|locus:2206046	361	SNRK2.10 "SNF1-related protein	0.988	0.495	0.893	2.7e-84
TAIR|locus:2118929	362	OST1 "OPEN STOMATA 1" [Arabido	0.983	0.491	0.859	3.9e-83
TAIR|locus:2174999	361	SNRK2.3 "sucrose nonfermenting	0.983	0.493	0.859	1.3e-82
TAIR|locus:2032075	343	SNRK2-8 "SNF1-RELATED PROTEIN	0.988	0.521	0.826	5.4e-79
TAIR|locus:2045319	339	SNRK2.9 "SNF1-related protein	0.988	0.528	0.832	2.3e-78
TAIR|locus:2140104	350	SNRK2.7 "SNF1-related protein	0.988	0.511	0.810	2.3e-78
TAIR|locus:2059279	451	CIPK3 "CBL-interacting protein	0.939	0.376	0.449	5.7e-36
TAIR|locus:2090537	444	CIPK1 "CBL-interacting protein	0.955	0.389	0.467	7.2e-36

TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)]

 Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
 Identities = 165/179 (92%), Positives = 174/179 (97%)

Query:     1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
             M+KYE+VKDLGAGNFGVARLLRHKETKELVA+KYIERGRKIDENVAREIINHRSLRHPNI
Sbjct:     1 MDKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
             IRFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSE E RYFFQQLI GV+YCHS+QIC
Sbjct:    61 IRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query:   121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
             HRDLKLENTLLDGS AP LKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK
Sbjct:   121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)]

 Score = 863 (308.9 bits), Expect = 2.6e-86, P = 2.6e-86
 Identities = 162/179 (90%), Positives = 173/179 (96%)

Query:     1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
             M+KY++VKDLGAGNFGVARLLRHK+TKELVA+KYIERGRKIDENVAREIINHRSL+HPNI
Sbjct:     1 MDKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
             IRFKEV+LTPTHLAIVMEYA+GGELFDRIC AGRFSE E RYFFQQLI GV+YCHS+QIC
Sbjct:    61 IRFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query:   121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
             HRDLKLENTLLDGS AP LKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK
Sbjct:   121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGK 179

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)]

 Score = 844 (302.2 bits), Expect = 2.7e-84, P = 2.7e-84
 Identities = 160/179 (89%), Positives = 171/179 (95%)

Query:     1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
             M+KYELVKD+GAGNFGVARL+R K +KELVA+KYIERG KIDENVAREIINHRSLRHPNI
Sbjct:     1 MDKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
             IRFKEVVLTPTH+AI MEYAAGGELF+RIC+AGRFSEDE RYFFQQLISGV+YCH+MQIC
Sbjct:    61 IRFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQIC 120

Query:   121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
             HRDLKLENTLLDGS APRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVLSR EYDGK
Sbjct:   121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGK 179

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005829 "cytosol" evidence=IDA;RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0048527 "lateral root development" evidence=IMP

GO:0070300 "phosphatidic acid binding" evidence=IDA

TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 833 (298.3 bits), Expect = 3.9e-83, P = 3.9e-83
 Identities = 153/178 (85%), Positives = 171/178 (96%)

Query:     2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
             ++YELVKD+G+GNFGVARL+R K++ ELVAVKYIERG KIDENV REIINHRSLRHPNI+
Sbjct:    19 DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78

Query:    62 RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
             RFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSEDE R+FFQQLISGV+YCH+MQ+CH
Sbjct:    79 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138

Query:   122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
             RDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL ++EYDGK
Sbjct:   139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196

GO:0004672 "protein kinase activity" evidence=IEA;IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009414 "response to water deprivation" evidence=IGI;IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IDA;IMP

GO:0010119 "regulation of stomatal movement" evidence=IMP

GO:0009931 "calcium-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:2000377 "regulation of reactive oxygen species metabolic process" evidence=IMP

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010118 "stomatal movement" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005985 "sucrose metabolic process" evidence=IMP

GO:0006636 "unsaturated fatty acid biosynthetic process" evidence=IMP

GO:0019432 "triglyceride biosynthetic process" evidence=IMP

GO:0040007 "growth" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

GO:0042744 "hydrogen peroxide catabolic process" evidence=RCA

TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)]

 Score = 828 (296.5 bits), Expect = 1.3e-82, P = 1.3e-82
 Identities = 153/178 (85%), Positives = 170/178 (95%)

Query:     2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
             ++Y+ VKD+G+GNFGVARL+R K TKELVAVKYIERG KIDENV REIINHRSLRHPNI+
Sbjct:    20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 79

Query:    62 RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
             RFKEV+LTPTHLAI+MEYA+GGEL++RICNAGRFSEDE R+FFQQL+SGV+YCHSMQICH
Sbjct:    80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139

Query:   122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
             RDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL R+EYDGK
Sbjct:   140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK 197

GO:0004672 "protein kinase activity" evidence=IEA;IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0009789 "positive regulation of abscisic acid mediated signaling pathway" evidence=IGI

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0009739 "response to gibberellin stimulus" evidence=IGI

GO:0010029 "regulation of seed germination" evidence=IGI;RCA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0009414 "response to water deprivation" evidence=IGI

TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)]

 Score = 794 (284.6 bits), Expect = 5.4e-79, P = 5.4e-79
 Identities = 148/179 (82%), Positives = 168/179 (93%)

Query:     1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
             ME+YE+VKD+G+GNFGVA+L+R K +KEL AVK+IERG+KIDE+V REI+NHRSL HPNI
Sbjct:     1 MERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
             IRFKEV+LT THLA+VMEYAAGGELF RIC+AGRFSEDE R+FFQQLISGVNYCHS+QIC
Sbjct:    61 IRFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQIC 120

Query:   121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
             HRDLKLENTLLDGS APR+KICDFGYSKS VLHS+PK+TVGTPAYIAPEVLS +EYDGK
Sbjct:   121 HRDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGK 179

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0080167 "response to karrikin" evidence=IEP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=IGI

TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)]

 Score = 788 (282.4 bits), Expect = 2.3e-78, P = 2.3e-78
 Identities = 149/179 (83%), Positives = 163/179 (91%)

Query:     1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
             MEKYE+VKDLG GNFG+ARL+R+K+T ELVAVK+I+RG KIDENVAREIINHR+L HPNI
Sbjct:     1 MEKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
             +RFKEVVLTPTHL IVMEYAAGGELF+RI + GRFSE E RYFFQQLI GV+Y H++QIC
Sbjct:    61 VRFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQIC 120

Query:   121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
             HRDLKLENTLLDGS APRLKICDFGYSKSSVLHS PKSTVGTPAYIAPEV  R EYDGK
Sbjct:   121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGK 179

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=IGI

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)]

 Score = 788 (282.4 bits), Expect = 2.3e-78, P = 2.3e-78
 Identities = 145/179 (81%), Positives = 166/179 (92%)

Query:     1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
             ME+Y++++DLG+GNFGVA+L+R K   E  AVKYIERG KIDE+V REIINHR L+HPNI
Sbjct:     1 MERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
             IRFKEV +TPTHLAIVMEYAAGGELF+RICNAGRFSEDEGRY+F+QLISGV+YCH+MQIC
Sbjct:    61 IRFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQIC 120

Query:   121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
             HRDLKLENTLLDGS +  LKICDFGYSKSSVLHS+PKSTVGTPAY+APEVLSR+EY+GK
Sbjct:   121 HRDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGK 179

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 388 (141.6 bits), Expect = 5.7e-36, P = 5.7e-36
 Identities = 84/187 (44%), Positives = 116/187 (62%)

Query:     3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHP 58
             KYE+ + +G G F   +  R+ ET E VA+K +++ +    K+ E + REI   + ++HP
Sbjct:    23 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMKLIKHP 82

Query:    59 NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
             N+++  EV+ + T + I++EY  GGELFD+I N GR  EDE R +FQQLI  V+YCHS  
Sbjct:    83 NVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDYCHSRG 142

Query:   119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-------VLHSRPKSTVGTPAYIAPEVL 171
             + HRDLK EN LLD      LKI DFG S  S       +LH+    + GTP Y+APEVL
Sbjct:   143 VYHRDLKPENLLLDSYG--NLKISDFGLSALSQQVRDDGLLHT----SCGTPNYVAPEVL 196

Query:   172 SRREYDG 178
             + R YDG
Sbjct:   197 NDRGYDG 203

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0009735 "response to cytokinin stimulus" evidence=IEP

TAIR|locus:2090537 CIPK1 "CBL-interacting protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 387 (141.3 bits), Expect = 7.2e-36, P = 7.2e-36
 Identities = 86/184 (46%), Positives = 114/184 (61%)

Query:     3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRHP 58
             KYEL + LG GNFG  +  +   +    AVK I++ R  D N    + REI   + L+HP
Sbjct:    19 KYELGRTLGEGNFGKVKFAKDTVSGHSFAVKIIDKSRIADLNFSLQIKREIRTLKMLKHP 78

Query:    59 NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
             +I+R  EV+ + T + +VME   GGELFDRI + G+ +E +GR  FQQLI G++YCHS  
Sbjct:    79 HIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQLIDGISYCHSKG 138

Query:   119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK----STVGTPAYIAPEVLSRR 174
             + HRDLKLEN LLD  A   +KI DFG S +   H R      +T G+P Y+APEVL+ R
Sbjct:   139 VFHRDLKLENVLLD--AKGHIKITDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLANR 195

Query:   175 EYDG 178
              YDG
Sbjct:   196 GYDG 199

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0006970 "response to osmotic stress" evidence=IMP

GO:0009651 "response to salt stress" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IMP

GO:0010118 "stomatal movement" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FFP9	SRK2H_ARATH	2, ., 7, ., 1, 1, ., 1	0.9116	1.0	0.5027	yes	no
Q7XQP4	SAPK7_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.9005	1.0	0.5041	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	grail3.0141004801	hypothetical protein (204 aa)
		(Populus trichocarpa)
Predicted Functional Partners:
	eugene3.00020801	hypothetical protein (277 aa)			•						0.432
	gw1.57.100.1	hypothetical protein (187 aa)			•						0.420
	gw1.X.6334.1	hypothetical protein (321 aa)			•						0.406

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	181
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-70
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-62
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-54
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-51
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-43
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-40
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-40
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-39
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-37
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-36
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-35
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-34
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-34
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-34
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-33
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-33
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-32
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-32
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-32
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-32
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-32
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-31
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-31
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-31
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-31
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-31
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-30
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-30
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-30
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-30
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-29
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-29
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-29
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-28
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-28
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-28
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-28
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-28
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-27
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-27
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-27
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-27
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-27
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-26
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-26
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-26
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-26
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-26
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-26
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-25
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-25
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-25
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-25
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-25
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-24
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-24
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-24
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-24
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-24
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-24
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-24
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-24
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-24
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-24
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-24
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-24
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-24
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-24
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-24
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-24
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-23
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-23
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-23
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-22
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-22
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-22
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-22
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-22
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-22
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-22
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-22
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-22
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-21
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-21
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-21
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-21
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-21
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-21
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-21
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-21
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-21
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-21
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-21
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-21
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-21
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-20
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-20
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-20
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-20
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-20
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-20
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-20
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-19
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-19
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-19
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-19
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-18
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-18
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-18
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-18
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-18
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-18
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-17
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-17
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-17
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-16
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-16
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-16
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	9e-16
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-15
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-15
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-15
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-15
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-14
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-14
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-14
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-14
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-14
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-13
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-13
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-13
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-13
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-12
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-11
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-10
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-09
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-08
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-08
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-08
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-07
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-07
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-06
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-06
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-06
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-05
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-05
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-05
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-05
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-05
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-05
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.001
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	0.002
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	0.002
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	0.002
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	0.002
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.002
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.003
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.004
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  213 bits (546), Expect = 1e-70
 Identities = 76/178 (42%), Positives = 108/178 (60%), Gaps = 4/178 (2%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNII 61
           YE+++ LG G+FG   L R K+T +LVA+K I  ++ +K  E + REI   + L+HPNI+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           R  +V      L +VMEY  GG+LFD +   GR SEDE R++ +Q++S + Y HS  I H
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           RDLK EN LLD      +K+ DFG ++      +  + VGTP Y+APEVL  + Y   
Sbjct: 121 RDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  194 bits (494), Expect = 1e-62
 Identities = 78/180 (43%), Positives = 102/180 (56%), Gaps = 6/180 (3%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRHPNI 60
           YEL++ LG+G+FG     +HK T ++VAVK +       K D+   REI   R L HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +R  +      HL +VMEY  GG+LFD +   G  SEDE +    Q++ G+ Y HS  I 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGK 179
           HRDLK EN LLD +    +KI DFG +K  +  S   +T VGTP Y+APEVL      G 
Sbjct: 121 HRDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  171 bits (436), Expect = 2e-54
 Identities = 77/175 (44%), Positives = 100/175 (57%), Gaps = 5/175 (2%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNIIRFKEVV 67
           LG G FG   L R K+T + VA+K I  E    + E + REI   + L HPNI++   V 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 68  LTPTHLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKL 126
               HL +VMEY  GG L D +  N G+ SEDE      Q++ G+ Y HS  I HRDLK 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120

Query: 127 ENTLLDGSAAPRLKICDFGYSK-SSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           EN LLD S   ++K+ DFG SK  +   S  K+ VGTPAY+APEVL  + Y  ++
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  164 bits (418), Expect = 3e-51
 Identities = 68/187 (36%), Positives = 101/187 (54%), Gaps = 14/187 (7%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRHPN 59
           KYE++K +G G+FG   L+R K   +L  +K I       K  E+   E+   + L HPN
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNYCH 115
           II++ E       L IVMEYA GG+L  +I    +    F E++   +F QL   + Y H
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLS 172
           S +I HRD+K +N  L   +   +K+ DFG SK   S+V  +  K+ VGTP Y++PE+  
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQ 176

Query: 173 RREYDGK 179
            + Y+ K
Sbjct: 177 NKPYNYK 183

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  143 bits (364), Expect = 5e-43
 Identities = 64/183 (34%), Positives = 93/183 (50%), Gaps = 10/183 (5%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPN 59
           ++   + LG G+FG   L   K+T EL+AVK +E     +E +    REI    SL+HPN
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 60  IIRFK--EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           I+R+   E       L I +EY +GG L   +   G+  E   R + +Q++ G+ Y HS 
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRD+K  N L+D      +K+ DFG +K            S  GTP ++APEV+   
Sbjct: 121 GIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 175 EYD 177
           EY 
Sbjct: 179 EYG 181

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  137 bits (347), Expect = 1e-40
 Identities = 63/181 (34%), Positives = 98/181 (54%), Gaps = 8/181 (4%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPNII 61
            +E+++ +G G FG     RHK T + VA+K I    ++  E +  EI   +  +HPNI+
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++    L    L IVME+ +GG L D + +  +  +E +  Y  ++L+ G+ Y HS  I 
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGII 120

Query: 121 HRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           HRD+K  N LL  DG     +K+ DFG S          + VGTP ++APEV++ + YD 
Sbjct: 121 HRDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176

Query: 179 K 179
           K
Sbjct: 177 K 177

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 5e-40
 Identities = 64/173 (36%), Positives = 96/173 (55%), Gaps = 7/173 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS----LRHPNIIRFKE 65
           LG G+FG   L+R K+T +L A+K +++ + I        +  R+    + HP I++   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
              T   L +V+EYA GGELF  +   GRFSE+  R++  +++  + Y HS+ I +RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 126 LENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRREYD 177
            EN LLD      +K+ DFG +K      SR  +  GTP Y+APEVL  + Y 
Sbjct: 121 PENILLDADG--HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  135 bits (343), Expect = 1e-39
 Identities = 66/184 (35%), Positives = 105/184 (57%), Gaps = 20/184 (10%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPN 59
           +E +K LG G+FG   L+RHK + +  A+K + + + +     E+V  E    +S+RHP 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 60  IIR----FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           ++     F++     ++L +VMEY  GGELF  +  +GRF E   R++  Q++  + Y H
Sbjct: 63  LVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118

Query: 116 SMQICHRDLKLENTLLD--GSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
           S+ I +RDLK EN LLD  G     +KI DFG++K   +  R  +  GTP Y+APE++  
Sbjct: 119 SLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEIILS 172

Query: 174 REYD 177
           + Y 
Sbjct: 173 KGYG 176

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  129 bits (326), Expect = 4e-37
 Identities = 62/182 (34%), Positives = 102/182 (56%), Gaps = 8/182 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E Y+ ++ +G G  G       + T + VA+K +   ++  E +  EI+  +  +HPNI+
Sbjct: 19  ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIV 78

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
            + +  L    L +VMEY  GG L D I  N  R +E +  Y  ++++ G+ Y HS  + 
Sbjct: 79  DYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI 138

Query: 121 HRDLKLENTLL--DGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HRD+K +N LL  DGS    +K+ DFG++ + +   S+  S VGTP ++APEV+ R++Y 
Sbjct: 139 HRDIKSDNILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG 194

Query: 178 GK 179
            K
Sbjct: 195 PK 196

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  125 bits (317), Expect = 8e-36
 Identities = 57/183 (31%), Positives = 90/183 (49%), Gaps = 10/183 (5%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPN 59
           +Y+++  +G G  G+    + +ET E VA+K +   R    I     REI   ++ +HP 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQ 118
           +++  +V    +   +VMEY     L + + +  R   E + + + + L+ GV Y H+  
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEVL-SRRE 175
           I HRDLK  N L+  SA   LKI DFG ++  S          V T  Y APE+L   R+
Sbjct: 120 IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 176 YDG 178
           YD 
Sbjct: 178 YDP 180

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  123 bits (310), Expect = 9e-35
 Identities = 61/180 (33%), Positives = 96/180 (53%), Gaps = 8/180 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRH 57
           +  E +K +G G FG   L+R + ++   A+K +     I     ++V  E    + + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P IIR          L ++MEY  GGELF  + N+GRFS   G ++  +++  + Y HS 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +I +RDLK EN LLD      +K+ DFG++K   L  R  +  GTP Y+APEV+  + ++
Sbjct: 121 EIVYRDLKPENILLDKEG--HIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGHN 176

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  120 bits (303), Expect = 4e-34
 Identities = 70/182 (38%), Positives = 98/182 (53%), Gaps = 6/182 (3%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIIN-HRSLRHPN 59
           KYE ++ +G G FG+  L R K  ++LV +K I  E+  K +   A+      + L HPN
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSM 117
           II + E  L    L IVMEYA GG L + I         ED   +FF Q++  +++ H+ 
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            I HRDLK +N LLD      +KI DFG SK     S+  + VGTP YI+PE+   + Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179

Query: 178 GK 179
            K
Sbjct: 180 QK 181

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  121 bits (306), Expect = 4e-34
 Identities = 62/174 (35%), Positives = 94/174 (54%), Gaps = 10/174 (5%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRHPN 59
           YE ++ LG G +GV    R K+T E+VA+K I R    +E +     REI   + L+HPN
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I++  +V+ T   L +V EY    +L   +    G  S +  +    QL+ G+ YCHS +
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           I HRDLK +N L++      LK+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 119 ILHRDLKPQNILINRD--GVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEIL 170

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  120 bits (303), Expect = 6e-34
 Identities = 61/195 (31%), Positives = 97/195 (49%), Gaps = 23/195 (11%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRHP 58
            YE+++ +G G+FG  R +R K   +++  K I+ G  + E   +++++     R L+HP
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHP 59

Query: 59  NIIRF--KEVVLTPTHLAIVMEYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGVN 112
           NI+R+  + +  +   L IVMEY  GG+L   I           E+       QL+  + 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 113 YCH-----SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPA 164
            CH        + HRDLK  N  LD +    +K+ DFG +K  +L       K+ VGTP 
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDAN--NNVKLGDFGLAK--ILGHDSSFAKTYVGTPY 175

Query: 165 YIAPEVLSRREYDGK 179
           Y++PE L+   YD K
Sbjct: 176 YMSPEQLNHMSYDEK 190

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  120 bits (302), Expect = 2e-33
 Identities = 68/174 (39%), Positives = 91/174 (52%), Gaps = 7/174 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---RHPNIIRF 63
           K LG G FG   L+R K T +  A+K +++   I  + VA  +   R L   RHP +   
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           K    T   L  VMEYA GGELF  +     FSED  R++  +++S + Y HS  + +RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 124 LKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREY 176
           LKLEN +LD      +KI DFG  K  +       T  GTP Y+APEVL   +Y
Sbjct: 121 LKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  117 bits (295), Expect = 9e-33
 Identities = 60/182 (32%), Positives = 94/182 (51%), Gaps = 14/182 (7%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYI--ERGR-KIDENVAREIINHRSLRHPNIIRFKEV 66
           +G G FG      + +T EL+AVK I  +    K  + +A E+     L+HPN++++  V
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 67  VLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEG--RYFFQQLISGVNYCHSMQICHRDL 124
            +    + I MEY +GG L + +   GR   DE   R +  QL+ G+ Y HS  I HRD+
Sbjct: 68  EVHREKVYIFMEYCSGGTLEE-LLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125

Query: 125 KLENTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           K  N  LD +    +K+ DFG +      ++ +    +S  GTPAY+APEV++  +  G 
Sbjct: 126 KPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183

Query: 180 QG 181
             
Sbjct: 184 GR 185

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 1e-32
 Identities = 69/183 (37%), Positives = 95/183 (51%), Gaps = 18/183 (9%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG-RKIDENVA-REIINHRSLR----H 57
           Y+++K LG G FG   L R+KET ELVA+K +++     +E +  RE+   +SLR    H
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC--NAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++ KEV      L  V EY   G L+  +       FSE   R    Q++ G+ + H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVLSR 173
                HRDLK EN L+ G     +KI DFG ++   + SRP  T  V T  Y APE+L R
Sbjct: 117 KHGFFHRDLKPENLLVSGPE--VVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172

Query: 174 REY 176
              
Sbjct: 173 STS 175

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 2e-32
 Identities = 56/178 (31%), Positives = 93/178 (52%), Gaps = 8/178 (4%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPN 59
           ++++  +G G +G   L + K+T E+VA+K +++      N  R ++  R +    +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +++         +L + MEY  GG+    + N G  SED  R++  ++   V+  H +  
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDLK EN L+D S    +K+ DFG SK  V  +   S VG+P Y+APEVL  + YD
Sbjct: 123 IHRDLKPENFLIDASG--HIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYD 176

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 3e-32
 Identities = 59/174 (33%), Positives = 85/174 (48%), Gaps = 10/174 (5%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVA-REIINHRSLRHPNI 60
           Y+ +  +G G +GV    R K T E+VA+K I+     +     A REI   + L HPNI
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I+  +V      L +V E+      +L           E   + +  QL+ G+ +CHS  
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           I HRDLK EN L++      LK+ DFG ++S     RP +  V T  Y APE+L
Sbjct: 119 ILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  118 bits (296), Expect = 3e-32
 Identities = 67/185 (36%), Positives = 95/185 (51%), Gaps = 19/185 (10%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHP 58
            Y +++ LG G+FG   L R ++    VA+K + +      K  E   REI    SL HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 59  -NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN---AGRFSEDEGRYFFQQLISGVNYC 114
            NI++  +       L +VMEY  GG L D +      G  SE E  +   Q++S + Y 
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK-------SSVLHSRPKSTVGTPAYIA 167
           HS  I HRD+K EN LLD      +K+ DFG +K       +S + + P ++VGTP Y+A
Sbjct: 118 HSKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 168 PEVLS 172
           PEVL 
Sbjct: 177 PEVLL 181

Length = 384

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  116 bits (292), Expect = 4e-32
 Identities = 61/200 (30%), Positives = 90/200 (45%), Gaps = 36/200 (18%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VARE-IINHRSLRHP 58
           ++  K +G G+F    L + KET +  A+K +++ + I E     V  E  +  R   HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 59  NIIR----FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
            II+    F++      +L  V+EYA  GEL   I   G   E   R++  +++  + Y 
Sbjct: 63  GIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYL 118

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---------------------SSVLH 153
           HS  I HRDLK EN LLD      +KI DFG +K                          
Sbjct: 119 HSKGIIHRDLKPENILLDKDM--HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 154 SRPKSTVGTPAYIAPEVLSR 173
            R  S VGT  Y++PE+L+ 
Sbjct: 177 RRFASFVGTAEYVSPELLNE 196

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  116 bits (292), Expect = 6e-32
 Identities = 66/174 (37%), Positives = 92/174 (52%), Gaps = 8/174 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHPNIIRFK 64
           LG G+FG   L   K T EL AVK +++   + D++V   +   R L    +HP + +  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               T   L  VMEY  GG+L   I  +GRF E   R++  +++ G+ + H   I +RDL
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYD 177
           KL+N LLD      +KI DFG  K  +L     ST  GTP YIAPE+LS + Y 
Sbjct: 123 KLDNVLLDSEG--HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 1e-31
 Identities = 68/180 (37%), Positives = 95/180 (52%), Gaps = 17/180 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLRH 57
            KYE++  +G G +GV    R+K T E+VA+K   +  + DE+V     RE+   R LRH
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRH 59

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            NI+  KE       L +V EY      EL +   + G    D  R +  QL+  + YCH
Sbjct: 60  ENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCH 117

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST----VGTPAYIAPEVL 171
           S  I HRD+K EN L+  S    LK+CDFG++++  L +RP S     V T  Y APE+L
Sbjct: 118 SHNIIHRDIKPENILVSESGV--LKLCDFGFARA--LRARPASPLTDYVATRWYRAPELL 173

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  115 bits (290), Expect = 1e-31
 Identities = 61/176 (34%), Positives = 92/176 (52%), Gaps = 8/176 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS-----LRHPNIIR 62
           K +G G+FG   L +HK   +  AVK +++   + +   + I+  R+     ++HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                 T   L  V++Y  GGELF  +     F E   R++  ++ S + Y HS+ I +R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYD 177
           DLK EN LLD      L   DFG  K  + HS+  ST  GTP Y+APEVL ++ YD
Sbjct: 121 DLKPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 2e-31
 Identities = 61/176 (34%), Positives = 90/176 (51%), Gaps = 12/176 (6%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPN 59
            Y+L   +G G FGV     + ET + VA+K I   +  +E +    +EI   ++L+HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE-GRYFFQQLISGVNYCHSMQ 118
           I+++   + T   L I++EYA  G L   I   G F E     Y +Q L  G+ Y H   
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL-QGLAYLHEQG 119

Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVL 171
           + HRD+K  N L   DG      K+ DFG + K + +     S VGTP ++APEV+
Sbjct: 120 VIHRDIKAANILTTKDGVV----KLADFGVATKLNDVSKDDASVVGTPYWMAPEVI 171

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  113 bits (285), Expect = 2e-31
 Identities = 51/180 (28%), Positives = 99/180 (55%), Gaps = 10/180 (5%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLRHPN 59
           +EL++ +G G FG   +++ ++TK++ A+KY+ + + +++   R ++N R     L HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           ++          ++ +V++   GG+L   +    +FSE++ +++  +++  + Y HS  I
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVLSRREYD 177
            HRD+K +N LLD      + I DF    ++ +     +T   GTP Y+APEVL R+ Y 
Sbjct: 122 IHRDIKPDNILLDEQG--HVHITDFNI--ATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS 177

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 3e-31
 Identities = 58/181 (32%), Positives = 92/181 (50%), Gaps = 6/181 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHPN 59
           E + L++ +G G+FG       K T ++VA+K I+     D  E++ +EI      R P 
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I ++    L  + L I+MEY  GG   D +   G+  E    +  ++++ G+ Y H    
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGK 119

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG S   +   S+  + VGTP ++APEV+ +  YD 
Sbjct: 120 IHRDIKAANILL--SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177

Query: 179 K 179
           K
Sbjct: 178 K 178

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  113 bits (284), Expect = 4e-31
 Identities = 57/181 (31%), Positives = 92/181 (50%), Gaps = 7/181 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E +++++ LG G++G      HKET ++VA+K +     + + + +EI   +    P I+
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYIV 61

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           ++       T L IVMEY   G + D  +I N    +E+E      Q + G+ Y HS + 
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNKK 120

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLSRREYDG 178
            HRD+K  N LL+       K+ DFG S         ++TV GTP ++APEV+    Y+ 
Sbjct: 121 IHRDIKAGNILLNEEGQA--KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178

Query: 179 K 179
           K
Sbjct: 179 K 179

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 1e-30
 Identities = 68/192 (35%), Positives = 98/192 (51%), Gaps = 24/192 (12%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-----VAREIINHRSLR 56
           E YEL++ +G+G +G     R   T ELVA+K I    K++       + +EI   +  R
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVI----KLEPGDDFEIIQQEISMLKECR 58

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCH 115
           HPNI+ +    L    L IVMEY  GG L D      G  SE +  Y  ++ + G+ Y H
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118

Query: 116 SMQICHRDLKLENTLL--DGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTPAYIAPEV 170
                HRD+K  N LL  DG     +K+ DFG S    +++  ++ KS +GTP ++APEV
Sbjct: 119 ETGKIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEV 172

Query: 171 L---SRREYDGK 179
                +  YDGK
Sbjct: 173 AAVERKGGYDGK 184

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  111 bits (279), Expect = 2e-30
 Identities = 56/180 (31%), Positives = 89/180 (49%), Gaps = 15/180 (8%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLRHPNIIRFKE 65
           +  G +G   L + K T ++ A+K I++   I +N   +++  R      + P +++   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                 +L +VMEY  GG+L   + N G   ED  R +  +++  + Y HS  I HRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 126 LENTLLDGSAAPRLKICDFGYSK------SSVLHSRPKST---VGTPAYIAPEVLSRREY 176
            +N L+D +    LK+ DFG SK         L+   K     VGTP YIAPEV+  + +
Sbjct: 121 PDNILIDSNG--HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  110 bits (276), Expect = 4e-30
 Identities = 65/185 (35%), Positives = 94/185 (50%), Gaps = 14/185 (7%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS----LRHPN 59
           Y  ++ LG G FG A L R  E   LV  K +   R + E   R+ +N       L+HPN
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRIC--NAGRFSEDEGRYFFQQLISGVNYCHSM 117
           II +    +    L I MEYA GG L+D+I       F E+   ++  Q++S V+Y H  
Sbjct: 61  IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRD+K  N  L  + A  +K+ DFG SK   S    +  ++ VGTP Y++PE+    
Sbjct: 121 GILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMA--ETVVGTPYYMSPELCQGV 176

Query: 175 EYDGK 179
           +Y+ K
Sbjct: 177 KYNFK 181

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  110 bits (277), Expect = 4e-30
 Identities = 50/172 (29%), Positives = 86/172 (50%), Gaps = 6/172 (3%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS----LRHPNIIRFKE 65
           LG G FG   L++ K      A+K +++   ++      I + +       HP I++   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                 ++ ++MEY  GGEL+  + + G F E   R++   ++    Y H+  I +RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 126 LENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            EN LLD +    +K+ DFG++K      +  +  GTP Y+APE++  + YD
Sbjct: 121 PENLLLDSNG--YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD 170

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  108 bits (271), Expect = 2e-29
 Identities = 63/186 (33%), Positives = 104/186 (55%), Gaps = 14/186 (7%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPN 59
           KY  VK +G G+FG A L++ KE  +   +K I   +   K  E   +E+    +++HPN
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR---FSEDEGRYFFQQLISGVNYCHS 116
           I++++E      +L IVM+Y  GG+L+ +I NA R   F ED+   +F Q+   + + H 
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSR 173
            +I HRD+K +N  L       +K+ DFG ++  VL+S     ++ +GTP Y++PE+   
Sbjct: 120 RKILHRDIKSQNIFLTKDGT--IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICEN 175

Query: 174 REYDGK 179
           R Y+ K
Sbjct: 176 RPYNNK 181

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  109 bits (273), Expect = 3e-29
 Identities = 65/174 (37%), Positives = 91/174 (52%), Gaps = 7/174 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---RHPNIIRF 63
           K LG G FG   L+R K T    A+K + +   I  + VA  +   R L   RHP +   
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS  + +RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 124 LKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRREY 176
           +KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +Y
Sbjct: 121 IKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  107 bits (270), Expect = 4e-29
 Identities = 68/184 (36%), Positives = 93/184 (50%), Gaps = 12/184 (6%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNI 60
           ++++K LG G++G    ++     +  A+K ++ G   +K  E+   EI    S+ HPNI
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNYCHS 116
           I +KE  L    L IVMEYA  G+L   I    +      E E    F QL+ G+   H 
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKSTVGTPAYIAPEVLSRRE 175
            +I HRDLK  N LL   A   +KI D G SK  VL     K+ +GTP Y+APEV   R 
Sbjct: 122 QKILHRDLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGRP 177

Query: 176 YDGK 179
           Y  K
Sbjct: 178 YSYK 181

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  106 bits (267), Expect = 1e-28
 Identities = 66/188 (35%), Positives = 98/188 (52%), Gaps = 21/188 (11%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE----------RGRKIDENVAREIINHRSLRHPN 59
           +G+G+FG   L  +  + EL+AVK +E          R R + + +AREI   + L+H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I+++    L   HL I +EY  GG +   + N G F E   R F +Q++ G+NY H+  I
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--------RPKSTVGTPAYIAPEVL 171
            HRD+K  N L+D      +KI DFG SK    +S        RP S  G+  ++APEV+
Sbjct: 128 IHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARP-SLQGSVFWMAPEVV 184

Query: 172 SRREYDGK 179
            +  Y  K
Sbjct: 185 KQTSYTRK 192

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  107 bits (270), Expect = 1e-28
 Identities = 60/178 (33%), Positives = 95/178 (53%), Gaps = 8/178 (4%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPN 59
           +E+ + LG G+FG  R+ +HK T E  A+K +++      K  ++VA+E      L HP 
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I+           +  ++E+  GGELF  +  AGRF  D  +++  +L+    Y HS  I
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            +RDLK EN LLD      +K+ DFG++K   +  R  +  GTP Y+APEV+  + + 
Sbjct: 140 IYRDLKPENLLLDNKG--HVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKGHG 193

Length = 329

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  107 bits (269), Expect = 1e-28
 Identities = 67/174 (38%), Positives = 94/174 (54%), Gaps = 7/174 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---RHPNIIRF 63
           K LG G FG   L+R K + +  A+K +++   I  + VA  +   R L   RHP +   
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           K    T   L  VMEY  GGELF  +     FSED  R++  +++S ++Y HS +I +RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 124 LKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVLSRREY 176
           LKLEN +LD      +KI DFG  K  +  +   K+  GTP Y+APEVL   +Y
Sbjct: 121 LKLENLMLDKDG--HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY 172

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  105 bits (265), Expect = 2e-28
 Identities = 58/178 (32%), Positives = 87/178 (48%), Gaps = 10/178 (5%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHPNIIR 62
           E VK LG G+ GV   +RHK T ++ A+K I      +  + + RE+   RS   P +++
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-QICH 121
                     ++IV+EY  GG L D +   G+  E    Y  +Q++ G++Y H+   I H
Sbjct: 64  CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123

Query: 122 RDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREY 176
           RD+K  N L+   G      KI DFG SK         +T VGT  Y++PE +    Y
Sbjct: 124 RDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY 177

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  106 bits (267), Expect = 3e-28
 Identities = 66/178 (37%), Positives = 91/178 (51%), Gaps = 15/178 (8%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID---------ENVAREIINHRSLRHPNI 60
           LG G+FG   L  +K+T EL A+K +++G  I          E    E  N  S RHP +
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN--SERHPFL 64

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +       T  H+  VMEYAAGG+L   I +   FSE    ++   ++ G+ Y H  +I 
Sbjct: 65  VNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIV 123

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYD 177
           +RDLKL+N LLD      +KI DFG  K  +      ST  GTP ++APEVL+   Y 
Sbjct: 124 YRDLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  105 bits (263), Expect = 9e-28
 Identities = 65/175 (37%), Positives = 92/175 (52%), Gaps = 8/175 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSL----RHPNIIR 62
           K LG G+FG   L   K T E  A+K +++     D++V   ++  R L     HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                 T  HL  VMEY  GG+L   I ++GRF E   R++  ++I G+ + H   I +R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREY 176
           DLKL+N LLD      +KI DFG  K ++      ST  GTP YIAPE+L  ++Y
Sbjct: 121 DLKLDNVLLDKDG--HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  105 bits (262), Expect = 1e-27
 Identities = 59/176 (33%), Positives = 86/176 (48%), Gaps = 8/176 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR-----SLRHPNIIR 62
           K +G G+FG   L + K      AVK +++   + +     I+  R     +L+HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                 T   L  V++Y  GGELF  +     F E   R++  ++ S + Y HS+ I +R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYD 177
           DLK EN LLD      + + DFG  K  V      ST  GTP Y+APEVL +  YD
Sbjct: 121 DLKPENILLDSQG--HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  103 bits (259), Expect = 1e-27
 Identities = 62/185 (33%), Positives = 100/185 (54%), Gaps = 13/185 (7%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHPNI 60
           +Y +++ +G G+FG A L++H  + +  A+K I   +     E+  +E +    ++HPNI
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGR-FSEDEGRYFFQQLISGVNYCHSMQ 118
           + FKE      HL IVMEY  GG+L  +I    G+ F ED    +F Q+  GV + H  +
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS----TVGTPAYIAPEVLSRR 174
           + HRD+K +N  L  +   ++K+ DFG   S+ L + P +     VGTP Y+ PE+    
Sbjct: 121 VLHRDIKSKNIFLTQNG--KVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175

Query: 175 EYDGK 179
            Y+ K
Sbjct: 176 PYNNK 180

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  102 bits (257), Expect = 3e-27
 Identities = 55/184 (29%), Positives = 76/184 (41%), Gaps = 17/184 (9%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKE-TKELVAVKYI--ERGRKIDENVAREIINHRSLRHP 58
            L K LG G FG     +L       K  VAVK +  +   +  E   RE    R L HP
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           N+++   V      L IVMEY  GG+L   +  N  + S  +   F  Q+  G+ Y  S 
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFG-----YSKSSVLHSRPKSTVGTPAYIAPEVLS 172
              HRDL   N L+  +    +KI DFG     Y          K  +    ++APE L 
Sbjct: 122 NFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESLK 176

Query: 173 RREY 176
             ++
Sbjct: 177 EGKF 180

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  102 bits (256), Expect = 5e-27
 Identities = 55/185 (29%), Positives = 73/185 (39%), Gaps = 18/185 (9%)

Query: 5   ELVKDLGAGNFGV---ARLLRHK-ETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
            L K LG G FG      L       +  VAVK ++        E   RE    R L HP
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NI++   V      L IVMEY  GG+L  + R       S  +   F  Q+  G+ Y  S
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFG-----YSKSSVLHSRPKSTVGTPAYIAPEVL 171
               HRDL   N L+  +    +KI DFG     Y          K  +    ++APE L
Sbjct: 122 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPESL 176

Query: 172 SRREY 176
              ++
Sbjct: 177 KEGKF 181

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 7e-27
 Identities = 63/182 (34%), Positives = 91/182 (50%), Gaps = 23/182 (12%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN------VAREIINHRSLRH 57
           YE +  +G G +G     R+K+T ELVA+K I   R  +E         REI   + LRH
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRH 57

Query: 58  PNIIRFKEVVLTPTHLAI--VMEYA----AGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
           PNI+R KE+V +    +I  V EY      G  L D      +F+E + + + +QL+ G+
Sbjct: 58  PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGL 113

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPE 169
            Y HS  I HRD+K  N L++      LK+ DFG ++     +    T  V T  Y  PE
Sbjct: 114 QYLHSNGILHRDIKGSNILINNDG--VLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171

Query: 170 VL 171
           +L
Sbjct: 172 LL 173

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  102 bits (256), Expect = 9e-27
 Identities = 60/176 (34%), Positives = 95/176 (53%), Gaps = 8/176 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-----RHPNIIR 62
           K +G G+FG   L RHK  ++  AVK +++   + +   + I++ R++     +HP ++ 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                 T   L  V++Y  GGELF  +     F E   R++  ++ S + Y HS+ I +R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYD 177
           DLK EN LLD      + + DFG  K ++ H+   ST  GTP Y+APEVL ++ YD
Sbjct: 121 DLKPENILLDSQG--HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 2e-26
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 50/219 (22%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR----- 56
           + +E++K +G G FG   L+R K+T ++ A+K +   RK D     +I + R+ R     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL---RKSDMIKRNQIAHVRAERDILAD 57

Query: 57  --HPNIIR----FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
              P I++    F++      HL +VMEY  GG+L + +     F E+  R++  +L+  
Sbjct: 58  ADSPWIVKLYYSFQDE----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--------------------- 149
           ++  H +   HRD+K +N L+D      +K+ DFG  K                      
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADG--HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 150 ---------SVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
                         R  STVGTP YIAPEVL    Y  +
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE 210

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  101 bits (254), Expect = 2e-26
 Identities = 60/176 (34%), Positives = 90/176 (51%), Gaps = 8/176 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHPNIIR 62
           K LG G+FG   L   K T E+ A+K +++   + D++V   +   R L    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                 T   L  VMEY  GG+L  +I  + +F E   R++  ++   + + H   + +R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYD 177
           DLKL+N LLD  A    K+ DFG  K  +L+    +T  GTP YIAPE+L   EY 
Sbjct: 121 DLKLDNILLD--AEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYG 174

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  101 bits (253), Expect = 3e-26
 Identities = 66/175 (37%), Positives = 94/175 (53%), Gaps = 8/175 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---RHPNIIRF 63
           K LG G FG   L++ K T    A+K +++   +  + VA  +  +R L   RHP +   
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHR 122
           K    T   L  VMEYA GGELF  +     FSED  R++  +++S ++Y HS   + +R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRREY 176
           DLKLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +Y
Sbjct: 121 DLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY 173

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  101 bits (253), Expect = 3e-26
 Identities = 62/173 (35%), Positives = 89/173 (51%), Gaps = 8/173 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHPNIIRFK 64
           LG G+FG   L R KE+  L AVK +++   + D++V   +   R L     HP + +  
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               TP  L  VME+  GG+L   I  + RF E   R++  ++ S + + H   I +RDL
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREY 176
           KL+N LLD       K+ DFG  K  + + +  ST  GTP YIAPE+L    Y
Sbjct: 123 KLDNVLLDHEG--HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY 173

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  101 bits (252), Expect = 4e-26
 Identities = 59/179 (32%), Positives = 95/179 (53%), Gaps = 10/179 (5%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-----RGRKIDENVAREIINHRSLRH--PNIIR 62
           +G G FG    +R K+T+ + A+K +        +++   +    I  R+L    P I+ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
            K    T + L +V +Y +GGELF  +   GRFSED  +++  +L+  + + H   I +R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGKQ 180
           DLK EN LLD  A   + +CDFG SK+++  ++  +T  GT  Y+APEVL   +   K 
Sbjct: 121 DLKPENILLD--ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 99.4 bits (248), Expect = 9e-26
 Identities = 58/184 (31%), Positives = 94/184 (51%), Gaps = 13/184 (7%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRH--- 57
           + EL+   G G +G     +H  T  +VA+K I      D+  ++ RE+     LR    
Sbjct: 5   RLELI---GRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI ++    L    L I+MEYA GG +   +  AG  +E       ++++  + Y H +
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSR-RE 175
            + HRD+K  N L+  +    +K+CDFG +     +S  +ST VGTP ++APEV++  + 
Sbjct: 121 GVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178

Query: 176 YDGK 179
           YD K
Sbjct: 179 YDTK 182

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 99.0 bits (247), Expect = 1e-25
 Identities = 61/188 (32%), Positives = 95/188 (50%), Gaps = 14/188 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           + +E++ +LG G FG     +HKET    A K I+   + + E+   EI      +HPNI
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNI 64

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQI 119
           +   E       L I++E+  GG L   +    R  +E + RY  +Q++  +N+ HS ++
Sbjct: 65  VGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKV 124

Query: 120 CHRDLKLENTLL--DGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVL----- 171
            HRDLK  N LL  DG     +K+ DFG S K+     +  + +GTP ++APEV+     
Sbjct: 125 IHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180

Query: 172 SRREYDGK 179
               YD K
Sbjct: 181 KDNPYDYK 188

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 99.2 bits (247), Expect = 2e-25
 Identities = 61/175 (34%), Positives = 90/175 (51%), Gaps = 8/175 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSL----RHPNIIR 62
           K LG G+FG   L   K   E  AVK +++    ID++V   ++  R L     +P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                 T  HL  VME+  GG+L   I + GRF      ++  +++ G+ + HS  I +R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVGTPAYIAPEVLSRREY 176
           DLKL+N +LD      +KI DFG  K +V   +R  +  GTP YIAPE+L   +Y
Sbjct: 121 DLKLDNVMLDRDG--HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 98.3 bits (245), Expect = 2e-25
 Identities = 60/186 (32%), Positives = 89/186 (47%), Gaps = 18/186 (9%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-----------VAREIINHRSLRHP 58
           +G G +G   L  +  T E++AVK +E    I              +  EI   + L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+++     T  +L+I +EY  GG +   +   GRF E   R+F +Q++ G+ Y HS  
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSS---VLHSRPKSTVGTPAYIAPEV--LSR 173
           I HRDLK +N L+D       KI DFG SK S     + +  S  G+  ++APEV     
Sbjct: 129 ILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186

Query: 174 REYDGK 179
           + Y  K
Sbjct: 187 QGYSAK 192

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 97.9 bits (244), Expect = 4e-25
 Identities = 58/172 (33%), Positives = 94/172 (54%), Gaps = 9/172 (5%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   K T   VAVK ++ R ++  E +  E++  R  +HPNI+      L
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  +++ H+  + HRD+K ++
Sbjct: 87  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDS 145

Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            LL  DG    R+K+ DFG+ ++ S    R KS VGTP ++APEV+SR  Y 
Sbjct: 146 ILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYG 193

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 97.0 bits (242), Expect = 6e-25
 Identities = 62/181 (34%), Positives = 93/181 (51%), Gaps = 11/181 (6%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDENVAREI-INHRSLRHPNII 61
           E + +LGAGN GV   + H+ T +++AVK I       I + + RE+ I H+    P I+
Sbjct: 4   EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIV 62

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHS-MQ 118
            F         ++I MEY  GG L D+I     GR  E         ++ G+ Y H   +
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           I HRD+K  N L++     ++K+CDFG S   V +S  K+ VGT +Y+APE +   +Y  
Sbjct: 122 IIHRDVKPSNILVNSRG--QIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDYSV 178

Query: 179 K 179
           K
Sbjct: 179 K 179

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 97.3 bits (243), Expect = 7e-25
 Identities = 63/182 (34%), Positives = 91/182 (50%), Gaps = 20/182 (10%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA-------REIINHRS 54
           ++YE +  +  G +GV    R K+T E+VA+K +    K+++          REI     
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREINILLK 60

Query: 55  LRHPNIIRFKEVVL--TPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGV 111
           L+HPNI+  KEVV+      + +VMEY    +L   +      F + E +    QL+SGV
Sbjct: 61  LQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGV 119

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPE 169
            + H   I HRDLK  N LL+      LKICDFG ++   S L    +  V T  Y APE
Sbjct: 120 AHLHDNWILHRDLKTSNLLLNNRG--ILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPE 176

Query: 170 VL 171
           +L
Sbjct: 177 LL 178

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 96.3 bits (240), Expect = 9e-25
 Identities = 52/170 (30%), Positives = 88/170 (51%), Gaps = 8/170 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYI------ERGRKIDENVAREIINHRSLRHPNIIRF 63
           LG+G+FG      + +  +  AVK +      + G++  + + +EI     L+HPNI+++
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
                   +L I +E   GG L   +   G F E   R + +Q++ G+ Y H     HRD
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127

Query: 124 LKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
           +K  N L+D +    +K+ DFG +K  V  S  KS  G+P ++APEV+++
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ 175

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 96.6 bits (241), Expect = 9e-25
 Identities = 60/194 (30%), Positives = 94/194 (48%), Gaps = 26/194 (13%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR----H 57
             +ELV+ +G G +G     RHK+T +LVA+K ++     +E +  E      LR    H
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY---NILRKYSNH 62

Query: 58  PNIIRFKEVVLTPTH------LAIVMEYAAGGELFD-----RICNAGRFSEDEGRYFFQQ 106
           PNI  F    +          L +VME   GG + D     R     R  E+   Y  ++
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-KRLKEEWIAYILRE 121

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTP 163
            + G+ Y H  ++ HRD+K +N LL  +A   +K+ DFG S    S++   R  + +GTP
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNA--EVKLVDFGVSAQLDSTL--GRRNTFIGTP 177

Query: 164 AYIAPEVLSRREYD 177
            ++APEV++  E  
Sbjct: 178 YWMAPEVIACDEQP 191

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 97.2 bits (242), Expect = 1e-24
 Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 23/198 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RH 57
           E +E +K +  G +G   L+RHKET++  A+K I +   I  N  +++   R +     +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P ++       T  HL +VMEY  GG+    + N G    D  R +F + +  + Y H+ 
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP----------------KSTVG 161
            I HRDLK +N L+  ++   +K+ DFG SK  ++                    K   G
Sbjct: 121 GIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178

Query: 162 TPAYIAPEVLSRREYDGK 179
           TP YIAPEV+ R+ Y GK
Sbjct: 179 TPEYIAPEVILRQGY-GK 195

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 97.2 bits (242), Expect = 1e-24
 Identities = 59/180 (32%), Positives = 92/180 (51%), Gaps = 8/180 (4%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHP 58
           +  +  LG G+FG   L   K T EL A+K +++   I D++V   ++  R L    + P
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
            + +      T   L  VMEY  GG+L   I   G+F E    ++  ++  G+ + HS  
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYD 177
           I +RDLKL+N +LD      +KI DFG  K ++   +   T  GTP YIAPE+++ + Y 
Sbjct: 122 IIYRDLKLDNVMLDAEG--HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYG 179

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 96.6 bits (240), Expect = 1e-24
 Identities = 62/176 (35%), Positives = 93/176 (52%), Gaps = 11/176 (6%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRHPN 59
           K+E++  +G G +GV    RHKETKE+VA+K     E   ++ E   RE+   R+L+  N
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           I+  KE       L +V EY      EL + + N      ++ R +  QLI  +++CH  
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHKN 119

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            I HRD+K EN L+  S    LK+CDFG++++    S    T  V T  Y +PE+L
Sbjct: 120 DIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 95.7 bits (238), Expect = 2e-24
 Identities = 61/182 (33%), Positives = 90/182 (49%), Gaps = 8/182 (4%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIE---RGRKIDENVAREIINHRSLRHPNI 60
           +E++  +G G+FGV   +  K  K + A+K I+     R+  E    E      L    I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRI--CNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR+ E  L    L IVMEYA  G+L   +         ED+   FF Q++ G+ + HS +
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRD+K  N  LD  A   +KI D G +K  S   +   + VGTP Y++PE+   + Y+
Sbjct: 122 ILHRDIKSLNLFLD--AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN 179

Query: 178 GK 179
            K
Sbjct: 180 EK 181

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 96.2 bits (239), Expect = 3e-24
 Identities = 60/179 (33%), Positives = 93/179 (51%), Gaps = 8/179 (4%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHP 58
           +  +  LG G+FG   L   K T EL A+K +++   I D++V   ++  R L    + P
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
            + +      T   L  VMEY  GG+L  +I   GRF E    ++  ++  G+ + HS  
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTVGTPAYIAPEVLSRREY 176
           I +RDLKL+N +LD      +KI DFG  K ++      K+  GTP YIAPE+++ + Y
Sbjct: 122 IIYRDLKLDNVMLDSEG--HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY 178

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 96.4 bits (241), Expect = 3e-24
 Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 32/196 (16%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN------VAREIINHRSLR 56
           +YEL+K +G+G +GV      K T   VA+K I     + ++      + REI   R LR
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN---VFDDLIDAKRILREIKLLRHLR 57

Query: 57  HPNIIRFKEVVLTPT-----HLAIVMEYAAGGELFD----RICNAGRF-SEDEGRYFFQQ 106
           H NII   +++  P+      + IV E      L +    ++  + +  ++D  +YF  Q
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTE------LMETDLHKVIKSPQPLTDDHIQYFLYQ 111

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST----VGT 162
           ++ G+ Y HS  + HRDLK  N L++ +    LKICDFG ++        K      V T
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVVT 169

Query: 163 PAYIAPEV-LSRREYD 177
             Y APE+ LS   Y 
Sbjct: 170 RWYRAPELLLSSSRYT 185

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 95.8 bits (238), Expect = 3e-24
 Identities = 59/176 (33%), Positives = 93/176 (52%), Gaps = 8/176 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHPNIIR 62
           K LG G+FG   L   K T +  A+K +++   + D++V   ++  R L     HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                 T  +L  VMEY  GG+L   I +  +F      ++  ++I G+ + HS  I +R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVGTPAYIAPEVLSRREYD 177
           DLKL+N LLD      +KI DFG  K ++L  ++  +  GTP YIAPE+L  ++Y+
Sbjct: 121 DLKLDNILLDTDG--HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 94.9 bits (237), Expect = 3e-24
 Identities = 54/184 (29%), Positives = 77/184 (41%), Gaps = 16/184 (8%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKE-TKELVAVKYIERGRKIDENVA--REIINHRSLRHP 58
           EL K LG G FG      L    E T+  VAVK ++ G   +E      E    + L HP
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           NI+R   V      L IV EY  GG+L D +  +  + +  +      Q+  G+ Y  S 
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI-----APEVLS 172
              HRDL   N L+  +    +KI DFG S+   ++            +     APE L 
Sbjct: 122 NFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESLK 177

Query: 173 RREY 176
             ++
Sbjct: 178 DGKF 181

Length = 258

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 95.3 bits (237), Expect = 4e-24
 Identities = 60/178 (33%), Positives = 100/178 (56%), Gaps = 10/178 (5%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLR 56
           M++YE V+ +G G +GV    R + T E +A+K I R  + DE V     REI   + ++
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQ 59

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEG--RYFFQQLISGVNYC 114
           H NI+R ++VV +   L +V EY    +L   + ++  F+++    + +  Q++ G+ YC
Sbjct: 60  HGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           HS ++ HRDLK +N L+D      LK+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL 175

Length = 294

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 95.3 bits (238), Expect = 4e-24
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 13/178 (7%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK------IDENVAREIINHRSLR 56
           +YE  K LG G + V    R KET  +VA+K I+ G +      I+    REI   + L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           HPNII   +V    +++ +V E+      ++      +   +  + + +    + G+ Y 
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYL 118

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           HS  I HRDLK  N L+       LK+ DFG ++S    +R  +  V T  Y APE+L
Sbjct: 119 HSNWILHRDLKPNNLLIASDG--VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELL 174

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 94.3 bits (234), Expect = 5e-24
 Identities = 66/188 (35%), Positives = 99/188 (52%), Gaps = 17/188 (9%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPN 59
           +YE++K +G G+FG   L + K   E   +K I+  +   K  E   +E+I    ++HPN
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR---FSEDEGRYFFQQLISGVNYCHS 116
           I+ F         L IVMEY  GG+L  RI N  R   FSED+   +F Q+  G+ + H 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 117 MQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVL 171
            +I HRD+K +N  L  +G  A   K+ DFG ++   L+       + VGTP Y++PE+ 
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC 174

Query: 172 SRREYDGK 179
             R Y+ K
Sbjct: 175 QNRPYNNK 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 94.7 bits (235), Expect = 5e-24
 Identities = 60/172 (34%), Positives = 89/172 (51%), Gaps = 6/172 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           E +EL++ +G+G +G     R+  T EL A+K I  E G      V +EII  +  +H N
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSN 67

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I+ +    L    L I ME+  GG L D     G  SE +  Y  ++ + G+ Y HS   
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEV 170
            HRD+K  N LL  +    +K+ DFG S   +   ++ KS +GTP ++APEV
Sbjct: 128 MHRDIKGANILLTDNG--HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 96.0 bits (239), Expect = 6e-24
 Identities = 60/190 (31%), Positives = 100/190 (52%), Gaps = 17/190 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE-NVA-----REIINHRSL 55
           E ++++K +G G FG  +L+RHK +K++ A+K + +   I   + A     R+I+ H + 
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN- 101

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
               I++         +L +VMEY  GG+L + + N     E   R++  +++  ++  H
Sbjct: 102 -SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIH 159

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRPKSTVGTPAYIAPEVL 171
           SM   HRD+K +N LLD S    LK+ DFG       + ++     + VGTP YI+PEVL
Sbjct: 160 SMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMDANGMVRC--DTAVGTPDYISPEVL 215

Query: 172 SRREYDGKQG 181
             +  DG  G
Sbjct: 216 KSQGGDGYYG 225

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 95.0 bits (237), Expect = 6e-24
 Identities = 63/205 (30%), Positives = 92/205 (44%), Gaps = 38/205 (18%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA------REIINHRSLRH 57
           ++ +K LG G+ G   L+R K T +L A+K +++   I  N        +EI+   +L H
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATLDH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCH 115
           P +        T T+L +VM+Y  GGELF   +       SE+  R++  +++  + Y H
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 116 SMQICHRDLKLENTLLDGSA-----------------APRLKICDFGYSKSSVLHS---- 154
            + I +RDLK EN LL  S                   P  K    G  +SSV       
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180

Query: 155 -------RPKSTVGTPAYIAPEVLS 172
                  R  S VGT  YIAPEV+S
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVIS 205

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 95.1 bits (236), Expect = 7e-24
 Identities = 58/173 (33%), Positives = 89/173 (51%), Gaps = 8/173 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL----RHPNIIRFK 64
           LG G+FG   L   K T EL A+K +++   I D++V   ++  R L    + P + +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               T   L  VMEY  GG+L   I   G+F E +  ++  ++  G+ + H   I +RDL
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREY 176
           KL+N +LD      +KI DFG  K  ++      T  GTP YIAPE+++ + Y
Sbjct: 128 KLDNVMLDSEG--HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY 178

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 95.4 bits (237), Expect = 8e-24
 Identities = 57/175 (32%), Positives = 90/175 (51%), Gaps = 9/175 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHK-ETKELVAVKYIERGRKIDENVAREIINHRSL----R 56
           E +  ++ LG G+FG   L  +K E    VA+K  E+ + I +     + + R +     
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP  +         ++L +V+E+  GGE F  +    RF  D G ++  Q++    Y  S
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           + I +RDLK EN LLD      +K+ DFG++K  V+ +R  +  GTP YIAPE+L
Sbjct: 150 LNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEIL 200

Length = 340

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 94.7 bits (236), Expect = 9e-24
 Identities = 64/177 (36%), Positives = 91/177 (51%), Gaps = 14/177 (7%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRK-IDENVAREIINHRSLRHPNI 60
           +E +  +G G +G+    R   + E+VA+K +  +  R  I  +  REI    +LRHPNI
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 61  IRFKEVVLTPTHLA---IVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           +  KEVV    HL    +VMEY       L D +     FSE + +    QL+ G+ Y H
Sbjct: 69  VELKEVV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLH 125

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
              I HRDLK+ N LL       LKI DFG +++  L ++P +  V T  Y APE+L
Sbjct: 126 ENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELL 180

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.7 bits (233), Expect = 1e-23
 Identities = 61/182 (33%), Positives = 90/182 (49%), Gaps = 12/182 (6%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE------NVAREIINHRSLRHPNII 61
           K LG G FG   L    +T   +AVK +       E       +  EI   ++L+H  I+
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           ++   +     L+I MEY  GG + D++   G  +E   R + +Q++ GV Y HS  I H
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSR---PKSTVGTPAYIAPEVLSRREYD 177
           RD+K  N L D  +A  +K+ DFG SK    + S     KS  GTP +++PEV+S   Y 
Sbjct: 128 RDIKGANILRD--SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185

Query: 178 GK 179
            K
Sbjct: 186 RK 187

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 94.5 bits (235), Expect = 1e-23
 Identities = 58/180 (32%), Positives = 101/180 (56%), Gaps = 13/180 (7%)

Query: 7   VKDLGAGNFGVARLLRH---KETKELVAVKYIERGR-KIDENV----AREIINHRSLRHP 58
           +K LG G+FG   L+R     +  +L A+K +++   K+ + V     R+I+    + HP
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHP 58

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
            I++      T   L +++++  GG+LF R+     F+E++ +++  +L   +++ HS+ 
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRREYD 177
           I +RDLK EN LLD      +K+ DFG SK S+ H  +  S  GT  Y+APEV++RR + 
Sbjct: 119 IIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 93.9 bits (233), Expect = 2e-23
 Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 8/176 (4%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-----RHPNIIR 62
           K +G G+FG   L + K   +  AVK +++   ++    + I+  R++     +HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                 T   L  V+++  GGELF  +     F E   R++  ++ S + Y HS+ I +R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYD 177
           DLK EN LLD      + + DFG  K  +  S   +T  GTP Y+APEV+ ++ YD
Sbjct: 121 DLKPENILLDSQG--HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 92.4 bits (229), Expect = 1e-22
 Identities = 62/188 (32%), Positives = 99/188 (52%), Gaps = 13/188 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RH 57
           E YE+VK +G G FG  +L+RHK T+++ A+K + +   I  + +      R +      
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P +++         +L +VMEY  GG+L + + N     E   R++  +++  ++  HSM
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 161

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
              HRD+K +N LLD S    LK+ DFG     +K  ++  R  + VGTP YI+PEVL  
Sbjct: 162 GFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKS 217

Query: 174 REYDGKQG 181
           +  DG  G
Sbjct: 218 QGGDGYYG 225

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 90.5 bits (225), Expect = 2e-22
 Identities = 59/191 (30%), Positives = 88/191 (46%), Gaps = 17/191 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + YEL++ +G G   V          E VA+K I  E+ +   + + +E+       HPN
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFD---RICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           ++++    +    L +VM Y +GG L D        G   E       ++++ G+ Y HS
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120

Query: 117 MQICHRDLKLENTLL--DGSAAPRLKICDFGYSKS-----SVLHSRPKSTVGTPAYIAPE 169
               HRD+K  N LL  DGS    +KI DFG S S            K+ VGTP ++APE
Sbjct: 121 NGQIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 170 VLS-RREYDGK 179
           V+     YD K
Sbjct: 177 VMEQVHGYDFK 187

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 92.0 bits (228), Expect = 2e-22
 Identities = 56/188 (29%), Positives = 98/188 (52%), Gaps = 13/188 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RH 57
           E Y++VK +G G FG  +L+RHK ++++ A+K + +   I  + +      R +      
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P +++         +L +VMEY  GG+L + + N     E   +++  +++  ++  HSM
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSM 161

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            + HRD+K +N LLD      LK+ DFG      ++ ++     + VGTP YI+PEVL  
Sbjct: 162 GLIHRDVKPDNMLLDKHG--HLKLADFGTCMKMDETGMVRC--DTAVGTPDYISPEVLKS 217

Query: 174 REYDGKQG 181
           +  DG  G
Sbjct: 218 QGGDGYYG 225

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 90.7 bits (225), Expect = 2e-22
 Identities = 61/184 (33%), Positives = 95/184 (51%), Gaps = 13/184 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA+K +  + +   E +  EI+  R  +HPNI
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ 118
           + + +  L    L +VMEY AGG L D +        DEG+     ++ +  + + HS Q
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ 135

Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRRE 175
           + HRD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV++R+ 
Sbjct: 136 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 176 YDGK 179
           Y  K
Sbjct: 192 YGPK 195

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 90.8 bits (225), Expect = 3e-22
 Identities = 51/172 (29%), Positives = 85/172 (49%), Gaps = 7/172 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPNIIRFKE 65
           +G G+FG    +R ++T+ + A+K I +   +  +     +  R++      P I+  K 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
              +P  L +V+ +  GGELF  +   GRF     R++  +L+  +   H   + +RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 126 LENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREY 176
            EN LLD      + +CDFG  K ++      +T  GTP Y+APE+L    Y
Sbjct: 121 PENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGY 170

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 91.0 bits (226), Expect = 3e-22
 Identities = 56/185 (30%), Positives = 99/185 (53%), Gaps = 13/185 (7%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVA-----REIINHRSLRH 57
           +++   +G G+FG  +++R K T ++ A+K +++   +  E V+     R+I++  +   
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN--S 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHS 116
           P I + +       +L +VMEY  GG+L   +     +F ED  +++  +L+  ++  H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEVLSRR 174
           M   HRD+K EN L+D +    +K+ DFG +   ++      K  VGTP YIAPEVL+  
Sbjct: 121 MGYVHRDIKPENVLIDRTG--HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178

Query: 175 EYDGK 179
             DGK
Sbjct: 179 NGDGK 183

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 89.1 bits (222), Expect = 4e-22
 Identities = 52/189 (27%), Positives = 75/189 (39%), Gaps = 19/189 (10%)

Query: 8   KDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPNIIR 62
           K LG G FG     +L         VAVK ++     +E     +E    + L HPN++R
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLIS-------GVNY 113
              V      L +V+EY  GG+L  + R       S ++     + L+S       G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI---APEV 170
             S +  HRDL   N L+       +KI DFG S+        +   G    I   APE 
Sbjct: 121 LASKKFVHRDLAARNCLVG--EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178

Query: 171 LSRREYDGK 179
           L    +  K
Sbjct: 179 LKDGIFTSK 187

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 4e-22
 Identities = 63/175 (36%), Positives = 91/175 (52%), Gaps = 11/175 (6%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRHPN 59
           Y+ V+ +G G +GV    R K T E+VA+K I R    DE V     REI   + L HPN
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           I+R  +VV +   L +V E+      +  D     G       + +  QL+ G+ YCHS 
Sbjct: 60  IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSH 118

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           ++ HRDLK +N L+D   A  LK+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 119 RVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 89.8 bits (223), Expect = 4e-22
 Identities = 61/176 (34%), Positives = 95/176 (53%), Gaps = 12/176 (6%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRHP 58
           KYE ++ +G G +G     +++ET E+VA+K + R    DE V     REI   + L+H 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 59

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NI+R  +V+ +   L +V EY      + FD  CN G    +  + F  QL+ G+ +CHS
Sbjct: 60  NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDS-CN-GDIDPEIVKSFMFQLLKGLAFCHS 117

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
             + HRDLK +N L++ +    LK+ DFG +++  +  R  S  V T  Y  P+VL
Sbjct: 118 HNVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 89.4 bits (222), Expect = 7e-22
 Identities = 57/184 (30%), Positives = 85/184 (46%), Gaps = 13/184 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKIDENVAREIINHRSLRHPN 59
           EK   +  LG G  G     R K T  + A+K I       + + + RE+  ++S + P 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRI-----CNAGRFSEDEGRYFFQQLISGVN 112
           I+++    L    + + I MEY  GG L D I        GR  E       + ++ G++
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           Y HS +I HRD+K  N LL       +K+CDFG S   V  S   +  GT  Y+APE + 
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQ 176

Query: 173 RREY 176
            + Y
Sbjct: 177 GKPY 180

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 9e-22
 Identities = 58/190 (30%), Positives = 87/190 (45%), Gaps = 24/190 (12%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSLR-- 56
           YE + ++G G +G     R   T   VA+K +     E G  I  +  REI   + L   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58

Query: 57  -HPNIIRFKEVVLTP-----THLAIVMEYA----AGGELFDRICNAGRFSEDEGRYFFQQ 106
            HPNI+R  +V   P       L +V E+     A    +   C       +  +   +Q
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLAT---YLSKCPKPGLPPETIKDLMRQ 115

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI 166
           L+ GV++ HS +I HRDLK +N L+  ++  ++KI DFG ++         S V T  Y 
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILV--TSDGQVKIADFGLARIYSFEMALTSVVVTLWYR 173

Query: 167 APEVLSRREY 176
           APEVL +  Y
Sbjct: 174 APEVLLQSSY 183

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 88.7 bits (220), Expect = 1e-21
 Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 7/173 (4%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIE---RGRKIDENVAREIINHRSLRHPNI 60
           ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L HPNI
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGG-ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           ++  +V+ T   L +V E+     + F              + +  QL+ G+ +CHS ++
Sbjct: 62  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
            HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 122 LHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 88.0 bits (219), Expect = 1e-21
 Identities = 60/181 (33%), Positives = 90/181 (49%), Gaps = 15/181 (8%)

Query: 2   EKYELVKDLGA--GNFGVARLLRHKETKELVAVKYIERGRKIDENV-AREIINHRSLR-H 57
           +  E+VK L    G FG   +L+HK T++L   K I+      +N  A E + H+ ++ +
Sbjct: 14  KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIK-----AKNFNAIEPMVHQLMKDN 68

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PN I+    V T     ++M+Y   G+LFD +   G+ SE E +   +QL+  +N  H  
Sbjct: 69  PNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH 128

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLSRREY 176
            I H D+KLEN L D  A  R+ +CD+G  K         S   GT  Y +PE +    Y
Sbjct: 129 NIIHNDIKLENVLYDR-AKDRIYLCDYGLCK----IIGTPSCYDGTLDYFSPEKIKGHNY 183

Query: 177 D 177
           D
Sbjct: 184 D 184

Length = 267

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 88.3 bits (219), Expect = 2e-21
 Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 13/183 (7%)

Query: 4   YELVKDLGAGNFGVARLLRH---KETKELVAVKYIERGR-----KIDENVARE-IINHRS 54
           +EL++ LG G +G   L+R     +  +L A+K +++       K  E+   E  +    
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
            R P ++       T T L ++++Y  GGELF  +     F+E E R +  +++  +++ 
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPKSTVGTPAYIAPEVLS 172
           H + I +RD+KLEN LLD      + + DFG SK  +     R  S  GT  Y+APEV+ 
Sbjct: 122 HQLGIIYRDIKLENILLDSEG--HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179

Query: 173 RRE 175
              
Sbjct: 180 GGS 182

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 88.2 bits (218), Expect = 2e-21
 Identities = 65/188 (34%), Positives = 98/188 (52%), Gaps = 14/188 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           E +E++ +LG G FG     ++KET  L A K I+   + + E+   EI    S  HPNI
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQI 119
           ++  +      +L I++E+ AGG +   +    R  +E + R   +Q +  +NY H  +I
Sbjct: 65  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124

Query: 120 CHRDLKLENTL--LDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVL----- 171
            HRDLK  N L  LDG     +K+ DFG S K++    R  S +GTP ++APEV+     
Sbjct: 125 IHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 172 SRREYDGK 179
             R YD K
Sbjct: 181 KDRPYDYK 188

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 87.8 bits (218), Expect = 2e-21
 Identities = 58/180 (32%), Positives = 91/180 (50%), Gaps = 18/180 (10%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVK-YIERG-----RKIDENVAREIINHRSL 55
           EKYE +  +G G++GV    R++ET ++VA+K ++E       +KI     REI   + L
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI---ALREIRMLKQL 57

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           +HPN++   EV      L +V EY     L +   N     E   +    Q +  VN+CH
Sbjct: 58  KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST----VGTPAYIAPEVL 171
                HRD+K EN L+  +   ++K+CDFG+++   + + P       V T  Y APE+L
Sbjct: 118 KHNCIHRDVKPENILI--TKQGQIKLCDFGFAR---ILTGPGDDYTDYVATRWYRAPELL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 87.5 bits (217), Expect = 3e-21
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 11/175 (6%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI----ERGRKIDENVAREIINHRSLRHPN 59
           ++ ++ LG G +      R++ T E+VA+K I    E G        REI   + L+H N
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHEN 59

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           I+R  +V+ T   L +V EY      +  D     G    +  + F  QL+ G+ +CH  
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVL 171
           ++ HRDLK +N L++      LK+ DFG +++  +  +   + V T  Y AP+VL
Sbjct: 120 RVLHRDLKPQNLLINKRG--ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVL 172

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 87.0 bits (215), Expect = 3e-21
 Identities = 59/169 (34%), Positives = 90/169 (53%), Gaps = 4/169 (2%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-VAREIINHRSLRHPNIIR 62
           YEL++ +G+G +G     R+  T EL AVK I+     D + + +EI   +  +H NI+ 
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
           +    L+   L I MEY  GG L D     G  SE +  Y  ++ + G+ Y HS    HR
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130

Query: 123 DLKLENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEV 170
           D+K  N LL  +    +K+ DFG  +K +   ++ KS +GTP ++APEV
Sbjct: 131 DIKGANILLTDNG--DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 87.4 bits (217), Expect = 4e-21
 Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 25/194 (12%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSLRH 57
           KYE +  +G G FG     RHK+TK++VA+K +     + G  I     REI   + L+H
Sbjct: 13  KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPI--TALREIKILQLLKH 70

Query: 58  PNIIRFKEVVLTPT--------HLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLI 108
            N++   E+  T             +V E+    +L   + N   +F+  E +   + L+
Sbjct: 71  ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLL 129

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-----VGTP 163
           +G+ Y H  +I HRD+K  N L+       LK+ DFG +++  L    K       V T 
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGI--LKLADFGLARAFSLSKNSKPNRYTNRVVTL 187

Query: 164 AYIAPEV-LSRREY 176
            Y  PE+ L  R+Y
Sbjct: 188 WYRPPELLLGERDY 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 87.8 bits (218), Expect = 4e-21
 Identities = 56/189 (29%), Positives = 88/189 (46%), Gaps = 16/189 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR---EIINHRSLRHP 58
            +Y+ ++++G+G +GV        + + VA+K I     +     R   E+   R  +H 
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64

Query: 59  NIIRFKEVVLTP----THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           NII  ++++  P      + +VM+     +L   I +    +E+  RYF  QL+ G+ Y 
Sbjct: 65  NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSR-PKSTVGTPAYIAPE 169
           HS  + HRDLK  N L++      L+I DFG     S S   H       V T  Y APE
Sbjct: 124 HSANVIHRDLKPSNLLVNEDC--ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181

Query: 170 VL-SRREYD 177
           +L S  EY 
Sbjct: 182 LLLSLPEYT 190

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 86.4 bits (214), Expect = 6e-21
 Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 10/170 (5%)

Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH-----PNII 61
           +K +  G FG   L + + T +  A+K +++   I +N    +   R++       P + 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           +      +  +L +VMEY  GG+    I   G   ED  + +  +++ GV   H   I H
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           RD+K EN L+D      LK+ DFG S++ +     K  VGTP Y+APE +
Sbjct: 121 RDIKPENLLID--QTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETI 165

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 86.7 bits (214), Expect = 7e-21
 Identities = 60/184 (32%), Positives = 96/184 (52%), Gaps = 13/184 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA+K +  + +   E +  EI+  R  ++PNI
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ 118
           + + +  L    L +VMEY AGG L D +        DEG+     ++ +  +++ HS Q
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ 135

Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRRE 175
           + HRD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV++R+ 
Sbjct: 136 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 176 YDGK 179
           Y  K
Sbjct: 192 YGPK 195

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 86.6 bits (214), Expect = 8e-21
 Identities = 56/171 (32%), Positives = 96/171 (56%), Gaps = 9/171 (5%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  + R K +   VAVK ++ R ++  E +  E++  R  +H N++   +  L
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L ++ME+  GG L D I +  R +E++     + ++  + Y HS  + HRD+K ++
Sbjct: 89  VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147

Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            LL  DG    R+K+ DFG+ ++ S    + KS VGTP ++APEV+SR  Y
Sbjct: 148 ILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY 194

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 86.0 bits (213), Expect = 8e-21
 Identities = 61/194 (31%), Positives = 93/194 (47%), Gaps = 20/194 (10%)

Query: 4   YELVKDLGAGNFG-VARLLRHKETKELVAVKYI------------ERGRKIDENVAREII 50
           Y +++ LG+G FG V ++ +    + L+A+K I            ER + I + V+   I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 51  NHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG---GELFDRICNAG-RFSEDEGRYFFQQ 106
               LRHPNI+R+ +  L    L IVM+   G   GE F+ +     RF+E+     F Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 107 LISGVNYCH-SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAY 165
           ++  + Y H   +I HRDL   N +L      ++ I DFG +K     S+  S VGT  Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 166 IAPEVLSRREYDGK 179
             PE++    Y  K
Sbjct: 180 SCPEIVKNEPYGEK 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 86.7 bits (215), Expect = 1e-20
 Identities = 64/178 (35%), Positives = 90/178 (50%), Gaps = 12/178 (6%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKID-ENVAREIINHRSLRHPN 59
           KY  +K +G G +G+    ++ ET E VA+K I      +ID +   REI   R L H N
Sbjct: 6   KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDR-----ICNAGRFSEDEGRYFFQQLISGVNYC 114
           +I  K+++  P H     +     EL D      I ++   S+D  +YF  QL+ G+ Y 
Sbjct: 66  VIAIKDIM-PPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRPKSTVGTPAYIAPEVL 171
           HS  + HRDLK  N LL+  A   LKICDFG ++ +S         V T  Y APE+L
Sbjct: 125 HSANVLHRDLKPSNLLLN--ANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 85.4 bits (211), Expect = 1e-20
 Identities = 60/190 (31%), Positives = 92/190 (48%), Gaps = 18/190 (9%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETK---ELVAVKYIERG-----RKIDENVAREIINHRS 54
           +Y L + LG G+FG   L++ K+      L  +K I  G       +  N   ++++   
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLS--K 58

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI----CNAGRFSEDEGRYFFQQLISG 110
           L HP I++F    L      I+ EY  G +L  ++          SE++   +F QL+ G
Sbjct: 59  LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPE 169
           V+Y H  +I HRDLK +N  L  +    LKI DFG S+  +      +T  GTP Y++PE
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL---LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175

Query: 170 VLSRREYDGK 179
            L  + YD K
Sbjct: 176 ALKHQGYDSK 185

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 86.4 bits (214), Expect = 1e-20
 Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIER-----GRKIDENVAREIINHRSLRHPNIIRFK 64
           +G G++    L+  K+T+ + A+K I++        ID     + +   +  HP ++   
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               T + L  V+E+ +GG+L   +    +  E+  R++  ++   +N+ H   I +RDL
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYD 177
           KL+N LLD  A   +K+ D+G  K  +      ST  GTP YIAPE+L   +Y 
Sbjct: 123 KLDNVLLD--AEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYG 174

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 85.3 bits (211), Expect = 2e-20
 Identities = 59/181 (32%), Positives = 89/181 (49%), Gaps = 17/181 (9%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR-------KIDENVAREIINHRSLRHPNIIR 62
           LG G F      R  +T  L+AVK +   R       ++ E + +EI     L HP+IIR
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                   +H  + +E+ AGG +   +   G F E     + +QL+ G++Y H  QI HR
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-------VGTPAYIAPEVLSRRE 175
           D+K  N L+D S   RL+I DFG   ++ L ++           +GT A++APEVL   +
Sbjct: 128 DVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184

Query: 176 Y 176
           Y
Sbjct: 185 Y 185

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 85.6 bits (212), Expect = 3e-20
 Identities = 58/184 (31%), Positives = 90/184 (48%), Gaps = 13/184 (7%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVK--YIERGRKIDENVAREIINHRSLRHPNIIR 62
           E V  +G+G  G    + H+ T  L A+K  Y      +   + REI   R + HPN+++
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
             ++      + +++E+  GG L        +F  D  R    Q++SG+ Y H   I HR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHR 192

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEV----LSRREYD 177
           D+K  N L++  +A  +KI DFG S+       P  S+VGT AY++PE     L+   YD
Sbjct: 193 DIKPSNLLIN--SAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250

Query: 178 GKQG 181
           G  G
Sbjct: 251 GYAG 254

Length = 353

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 84.1 bits (208), Expect = 4e-20
 Identities = 51/169 (30%), Positives = 88/169 (52%), Gaps = 6/169 (3%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           LG G +G+    R   T+  +A+K I ER  +  + +  EI  H  L+H NI+++     
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 69  TPTHLAIVMEYAAGGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                 I ME   GG L   + +     + +E    ++ +Q++ G+ Y H  QI HRD+K
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135

Query: 126 LENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSR 173
            +N L++ + +  +KI DFG SK  + ++   ++  GT  Y+APEV+ +
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 84.8 bits (209), Expect = 4e-20
 Identities = 58/184 (31%), Positives = 98/184 (53%), Gaps = 13/184 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA++ +  + +   E +  EI+  R  ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ 118
           + + +  L    L +VMEY AGG L D +        DEG+     ++ +  + + HS Q
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           + HRD+K +N LL  DGS    +K+ DFG+ ++ +   S+  + VGTP ++APEV++R+ 
Sbjct: 137 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 176 YDGK 179
           Y  K
Sbjct: 193 YGPK 196

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 84.4 bits (209), Expect = 5e-20
 Identities = 60/179 (33%), Positives = 93/179 (51%), Gaps = 16/179 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVK-YIERG-----RKIDENVAREIINHRSL 55
           EKYE +  +G G++G+    +HKET ++VA+K ++E       +KI     REI   + L
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKI---AMREIRMLKQL 57

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           RH N++   EV      L +V E+     L D         E   R +  Q++ G+ +CH
Sbjct: 58  RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST---VGTPAYIAPEVL 171
           S  I HRD+K EN L+  S    +K+CDFG++++  L +  +     V T  Y APE+L
Sbjct: 118 SHNIIHRDIKPENILVSQSGV--VKLCDFGFART--LAAPGEVYTDYVATRWYRAPELL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 83.9 bits (208), Expect = 7e-20
 Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 14/176 (7%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKY-IERGRKIDE-NVAREIINHRSLR-HPNI 60
           Y+++  +G G F      + ++T +  A+K   +  + +++ N  REI   R L  HPNI
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60

Query: 61  IRFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSM 117
           +R  EV+       LA+V E      L++ I    R   E   + +  QL+  +++ H  
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            I HRD+K EN L+       LK+ DFG  +   ++S+P  T  + T  Y APE L
Sbjct: 120 GIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECL 170

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 84.3 bits (208), Expect = 7e-20
 Identities = 52/176 (29%), Positives = 88/176 (50%), Gaps = 14/176 (7%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIER-----GRKIDENVAREIINHRSLRHPNIIRFK 64
           +G G++    L+R K+T+ + A+K +++        ID     + +  ++  HP ++   
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               T + L  V+EY  GG+L   +    +  E+  R++  ++   +NY H   I +RDL
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV----GTPAYIAPEVLSRREY 176
           KL+N LLD      +K+ D+G  K  +   RP  T     GTP YIAPE+L   +Y
Sbjct: 123 KLDNVLLDSEG--HIKLTDYGMCKEGL---RPGDTTSTFCGTPNYIAPEILRGEDY 173

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 83.6 bits (206), Expect = 1e-19
 Identities = 59/182 (32%), Positives = 94/182 (51%), Gaps = 9/182 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA+K I   ++   E +  EI+  + L++PNI
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           + F +  L    L +VMEY AGG L D +       E +     ++ +  + + H+ Q+ 
Sbjct: 79  VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQALEFLHANQVI 137

Query: 121 HRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYD 177
           HRD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV++R+ Y 
Sbjct: 138 HRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193

Query: 178 GK 179
            K
Sbjct: 194 PK 195

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 83.2 bits (205), Expect = 1e-19
 Identities = 56/181 (30%), Positives = 94/181 (51%), Gaps = 6/181 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPN 59
           E +  ++ +G G+FG         T+++VA+K I+     DE  ++ +EI        P 
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + ++    L  T L I+MEY  GG   D +  AG F E +     ++++ G++Y HS + 
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKK 122

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG + + +    +  + VGTP ++APEV+ +  YD 
Sbjct: 123 IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180

Query: 179 K 179
           K
Sbjct: 181 K 181

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 83.2 bits (206), Expect = 1e-19
 Identities = 53/176 (30%), Positives = 95/176 (53%), Gaps = 10/176 (5%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRHP 58
            Y  ++ +G G +GV    R+K+T ++VA+K I R    +E V     REI   + L+HP
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHP 59

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NI+  ++V++  + L ++ E+ +    +  D +        +  + +  Q++ G+ +CHS
Sbjct: 60  NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
            ++ HRDLK +N L+D      +K+ DFG +++  +  R  +  V T  Y APEVL
Sbjct: 120 RRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL 173

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 82.9 bits (205), Expect = 1e-19
 Identities = 58/176 (32%), Positives = 82/176 (46%), Gaps = 12/176 (6%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVA---REIINHRSLRHPNIIRF 63
           LG G FG     + K T ++ A K +++ R   +  E +A   ++I+   S R   I+  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSL 58

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICH 121
                T   L +VM    GG+L   I N G   F E    ++  Q+I G+ + H  +I +
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           RDLK EN LLD     R  I D G +       + K   GTP Y+APEVL    YD
Sbjct: 119 RDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 83.3 bits (206), Expect = 1e-19
 Identities = 59/187 (31%), Positives = 94/187 (50%), Gaps = 16/187 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDE---NVAREIINHRSLRH 57
           + +  ++++G G+FG     R   T E+VA+K +   G++ +E   ++ +E+   + LRH
Sbjct: 15  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PN I +K   L      +VMEY  G   ++ +   +     E E        + G+ Y H
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV---LS 172
           S +  HRD+K  N LL       +K+ DFG   S+ L S   S VGTP ++APEV   + 
Sbjct: 133 SHERIHRDIKAGNILLTEPGT--VKLADFG---SASLVSPANSFVGTPYWMAPEVILAMD 187

Query: 173 RREYDGK 179
             +YDGK
Sbjct: 188 EGQYDGK 194

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 82.8 bits (204), Expect = 2e-19
 Identities = 59/175 (33%), Positives = 91/175 (52%), Gaps = 9/175 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           E +E++ +LG G FG     ++KET  L A K IE   + + E+   EI    +  HP I
Sbjct: 12  EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI 71

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQI 119
           ++          L I++E+  GG +   +    R  +E + +   +Q++  + Y HSM+I
Sbjct: 72  VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKI 131

Query: 120 CHRDLKLENTLL--DGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVL 171
            HRDLK  N LL  DG     +K+ DFG S K+     R  S +GTP ++APEV+
Sbjct: 132 IHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV 182

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.4 bits (203), Expect = 2e-19
 Identities = 63/191 (32%), Positives = 100/191 (52%), Gaps = 16/191 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-------ERGRKIDENVAREIINHRS 54
             + L K LG G FG   L    +T   +AVK +       E  ++++  +  EI   ++
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNA-LECEIQLLKN 60

Query: 55  LRHPNIIRFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           LRH  I+++   +  P    L+I +EY  GG + D++   G  +E+  R + +Q++ GV+
Sbjct: 61  LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRP--KSTVGTPAYIAP 168
           Y HS  I HRD+K  N L D  +A  +K+ DFG SK   ++  S    KS  GTP +++P
Sbjct: 121 YLHSNMIVHRDIKGANILRD--SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 169 EVLSRREYDGK 179
           EV+S   Y  K
Sbjct: 179 EVISGEGYGRK 189

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 83.2 bits (206), Expect = 2e-19
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 53/222 (23%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-RSLR---- 56
           + +E +K +G G FG  RL++ K+T  + A+K +   RK  E + +E + H R+ R    
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL---RK-SEMLEKEQVAHVRAERDILA 56

Query: 57  ---HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
              +P +++         +L ++MEY  GG++   +     F+E+E R++  + I  ++ 
Sbjct: 57  EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---------------------SSVL 152
            H +   HRD+K +N LLD      +K+ DFG                            
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174

Query: 153 HSRPK------------------STVGTPAYIAPEVLSRREY 176
            S+P                   STVGTP YIAPEV  +  Y
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY 216

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 81.9 bits (202), Expect = 6e-19
 Identities = 57/188 (30%), Positives = 96/188 (51%), Gaps = 15/188 (7%)

Query: 4   YELVKDLGAGNFGVARLLRH---KETKELVAVKYIERGRKIDE-------NVAREIINHR 53
           +EL+K LG G +G   L+R     +T +L A+K +++   + +          R ++ H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
             + P ++       T   L ++++Y +GGE+F  +     FSEDE R++  ++I  + +
Sbjct: 62  R-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--SVLHSRPKSTVGTPAYIAPEVL 171
            H + I +RD+KLEN LLD      + + DFG SK   S    R  S  GT  Y+APE++
Sbjct: 121 LHKLGIVYRDIKLENILLDSEG--HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 172 SRREYDGK 179
             +   GK
Sbjct: 179 RGKGGHGK 186

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 81.2 bits (200), Expect = 8e-19
 Identities = 54/169 (31%), Positives = 93/169 (55%), Gaps = 5/169 (2%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   K T + VAVK ++ R ++  E +  E++  R   H N++      L
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++Y H+  + HRD+K ++
Sbjct: 90  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148

Query: 129 TLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            LL  ++  R+K+ DFG+ ++ S    + KS VGTP ++APEV+SR  Y
Sbjct: 149 ILL--TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY 195

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 80.9 bits (199), Expect = 9e-19
 Identities = 58/173 (33%), Positives = 86/173 (49%), Gaps = 6/173 (3%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFKEVV 67
           +G G+FG         TKE+VA+K I+     DE  ++ +EI        P I R+    
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 68  LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
           L  T L I+MEY  GG   D +   G   E       ++++ G++Y HS +  HRD+K  
Sbjct: 72  LKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 130

Query: 128 NTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGK 179
           N LL  S    +K+ DFG +         ++T VGTP ++APEV+ +  YD K
Sbjct: 131 NVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 82.5 bits (203), Expect = 1e-18
 Identities = 68/212 (32%), Positives = 101/212 (47%), Gaps = 33/212 (15%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDE--NVAREIINHRSLRH 57
           + +YE++K +G G FG   L++HK T+E    K I  RG K  E   +  E+   R L+H
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71

Query: 58  PNIIRFKEVVLTPTH--LAIVMEYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGV 111
            NI+R+ +  L   +  L I+ME+   G+L   I       G+  E       +QL+  +
Sbjct: 72  KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 112 NYCHSMQ-------ICHRDLKLENTLLDG---------------SAAPRLKICDFGYSKS 149
            YCH+++       + HRDLK +N  L                 +  P  KI DFG SK+
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 150 SVLHSRPKSTVGTPAYIAPEVL--SRREYDGK 179
             + S   S VGTP Y +PE+L    + YD K
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDK 223

Length = 1021

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 81.0 bits (200), Expect = 1e-18
 Identities = 54/181 (29%), Positives = 91/181 (50%), Gaps = 11/181 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHP 58
            +Y  ++ +G G FG+    R + T + VA+K I +      + +   RE+   + LRH 
Sbjct: 10  NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69

Query: 59  NIIRFKEVVLTP-THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           NII   ++ ++P   +  V E    G    R+  +    +   +YF  Q++ G+ Y HS 
Sbjct: 70  NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV-LSRREY 176
            + HRDLK  N L++ +    LKICDFG ++  +   +    V T  Y APE+ L+ ++Y
Sbjct: 128 GVVHRDLKPSNILINENC--DLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQKY 183

Query: 177 D 177
           D
Sbjct: 184 D 184

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 80.1 bits (197), Expect = 1e-18
 Identities = 60/188 (31%), Positives = 95/188 (50%), Gaps = 14/188 (7%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR------EIINHRSLRH 57
           + L K LG G FG   L    +T   +AVK ++   +  E          EI   ++L H
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 58  PNIIRFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
             I+++   +  P    L+I ME+  GG + D++ + G  +E+  R + +Q++ GV+Y H
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS----SVLHSRPKSTVGTPAYIAPEVL 171
           S  I HRD+K  N L D  +   +K+ DFG SK      +  +  KS  GTP +++PEV+
Sbjct: 124 SNMIVHRDIKGANILRD--SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181

Query: 172 SRREYDGK 179
           S   Y  K
Sbjct: 182 SGEGYGRK 189

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 80.8 bits (199), Expect = 1e-18
 Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 8/173 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIER-----GRKIDENVAREIINHRSLRHPNIIRFK 64
           +G G++    L+R K+  ++ A+K +++        ID     + +  ++  +P ++   
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               T + L +V+EY  GG+L   +    +  E+  R++  ++   +N+ H   I +RDL
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREY 176
           KL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L   EY
Sbjct: 123 KLDNVLLDADG--HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 80.4 bits (198), Expect = 1e-18
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 15/180 (8%)

Query: 4   YELVKDLGAGNFGVARLLRH---KETKELVAVKYIERGRKIDE-------NVAREIINHR 53
           +EL+K LG G +G   L+R     ++ +L A+K +++   + +          R+++ H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
             + P ++       T T L ++++Y  GGELF  +    RF E E + +  +++  + +
Sbjct: 62  R-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPKSTVGTPAYIAPEVL 171
            H + I +RD+KLEN LLD +    + + DFG SK        R  S  GT  Y+AP+++
Sbjct: 121 LHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 80.1 bits (197), Expect = 2e-18
 Identities = 55/171 (32%), Positives = 94/171 (54%), Gaps = 9/171 (5%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   K + +LVAVK ++ R ++  E +  E++  R  +H N++      L
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++  H+  + HRD+K ++
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146

Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            LL  DG    R+K+ DFG+ ++ S    R KS VGTP ++APE++SR  Y
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY 193

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 79.7 bits (196), Expect = 2e-18
 Identities = 54/181 (29%), Positives = 92/181 (50%), Gaps = 6/181 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPN 59
           E +  ++ +G G+FG         T+++VA+K I+     DE  ++ +EI        P 
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + ++    L  T L I+MEY  GG   D +   G   E +     ++++ G++Y HS + 
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 122

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG + + +    +  + VGTP ++APEV+ +  YD 
Sbjct: 123 IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180

Query: 179 K 179
           K
Sbjct: 181 K 181

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 79.4 bits (196), Expect = 2e-18
 Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 19/192 (9%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE----RGRKIDENVAREIINHRSLR 56
           +  +++ K +G G F V           +VA+K ++       K  ++  +EI   + L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVN 112
           HPN+I++    +    L IV+E A  G+L   I +  +      E     +F QL S + 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYIA 167
           + HS +I HRD+K  N  +  +    +K+ D G      SK++  HS     VGTP Y++
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMS 174

Query: 168 PEVLSRREYDGK 179
           PE +    Y+ K
Sbjct: 175 PERIHENGYNFK 186

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 78.9 bits (194), Expect = 5e-18
 Identities = 55/186 (29%), Positives = 94/186 (50%), Gaps = 14/186 (7%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIR 62
           +E+++ +G G +G    + +K+   L AVK ++    +DE +  E    +SL  HPN+++
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVK 83

Query: 63  FKEVVLTPTHLA-----IVMEYAAGG---ELFDRICNAG-RFSEDEGRYFFQQLISGVNY 113
           F  +      L      +V+E   GG   EL   +   G R  E    Y     + G+ +
Sbjct: 84  FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQH 143

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLS 172
            H+ +I HRD+K  N LL  +    +K+ DFG S   +    R  ++VGTP ++APEV++
Sbjct: 144 LHNNRIIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201

Query: 173 -RREYD 177
             ++YD
Sbjct: 202 CEQQYD 207

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 79.5 bits (196), Expect = 7e-18
 Identities = 58/221 (26%), Positives = 88/221 (39%), Gaps = 50/221 (22%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPN 59
           +  +K +G G FG   L+R  +T  L A+K + +   +  N A  +   R +     +  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +++         +L  VM+Y  GG++   +   G F ED  R++  +L   +   H M  
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFG-------------YSK---------------SSV 151
            HRD+K +N L+D      +K+ DFG             Y K               S +
Sbjct: 123 IHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180

Query: 152 LHSRPK----------------STVGTPAYIAPEVLSRREY 176
              R K                S VGTP YIAPEVL R  Y
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY 221

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 7e-18
 Identities = 56/190 (29%), Positives = 86/190 (45%), Gaps = 22/190 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV-----AREIINHRSLR 56
            +Y+ +  +G G +G+     HK T   VA+K I      +         REI   R  +
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS---PFEHQTFCQRTLREIKILRRFK 61

Query: 57  HPNIIRFKEVVLTPT-----HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
           H NII   +++  P+      + IV E     +L+ ++      S D  +YF  Q++ G+
Sbjct: 62  HENIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYFLYQILRGL 119

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST----VGTPAYIA 167
            Y HS  + HRDLK  N LL+      LKICDFG ++ +             V T  Y A
Sbjct: 120 KYIHSANVLHRDLKPSNLLLN--TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 168 PEV-LSRREY 176
           PE+ L+ + Y
Sbjct: 178 PEIMLNSKGY 187

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 78.2 bits (193), Expect = 8e-18
 Identities = 49/152 (32%), Positives = 73/152 (48%), Gaps = 11/152 (7%)

Query: 6   LVKDLGAGNFGVARLLRHK----ETKELVAVKYIER--GRKIDENVAREIINHRSLRHPN 59
            +K LG G+FG   L R+      T E VAVK +      +   +  REI   R+L H N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V   P    L ++MEY   G L D +  +  + +      F  Q+  G++Y  S
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            +  HRDL   N L++      +KI DFG +K
Sbjct: 128 QRYIHRDLAARNILVESED--LVKISDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 78.5 bits (193), Expect = 9e-18
 Identities = 57/178 (32%), Positives = 88/178 (49%), Gaps = 12/178 (6%)

Query: 9   DLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDE---NVAREIINHRSLRHPNIIRFK 64
           ++G G+FG      +  T E+VAVK +   G++ +E   ++ +E+   + L+HPN I +K
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
              L      +VMEY  G        +     E E        + G+ Y HS  + HRD+
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV---LSRREYDGK 179
           K  N LL  +   ++K+ DFG   S+   S   S VGTP ++APEV   +   +YDGK
Sbjct: 148 KAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGK 200

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 77.5 bits (191), Expect = 2e-17
 Identities = 63/194 (32%), Positives = 92/194 (47%), Gaps = 33/194 (17%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSL 55
           ++K++++  +G G +G     R K+T ELVA+K +     + G  I     REI   R L
Sbjct: 6   VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPI--TAIREIKILRQL 63

Query: 56  RHPNIIRFKEVVLTPTH----------LAIVMEYAAG---GELFDRICNAGRFSEDEGRY 102
            H NI+  KE+V                 +V EY      G L   + +   FSED  + 
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKS 120

Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRPKS 158
           F +QL+ G+NYCH     HRD+K  N LL+     ++K+ DFG    Y+      SRP +
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG--QIKLADFGLARLYNSEE---SRPYT 175

Query: 159 T-VGTPAYIAPEVL 171
             V T  Y  PE+L
Sbjct: 176 NKVITLWYRPPELL 189

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 77.5 bits (191), Expect = 3e-17
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 21/183 (11%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA------REIINHRSLR 56
           +Y++ + +G G++GV        T E VA+K I     + E+V+      REI   R LR
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLR 57

Query: 57  HPNIIRFKEVVLTPTH-----LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
           HP+I+  K ++L P+      + +V E     +L   I      + +  ++F  QL+  +
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK----STVGTPAYIA 167
            Y H+  + HRDLK +N L   +A  +LKICDFG ++ +   +         V T  Y A
Sbjct: 117 KYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 168 PEV 170
           PE+
Sbjct: 175 PEL 177

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 76.6 bits (188), Expect = 4e-17
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 12/180 (6%)

Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDE---NVAREIINHRSLRHPNIIR 62
           ++++G G+FG     R     E+VA+K +   G++ +E   ++ +E+   + LRHPN I+
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
           ++   L      +VMEY  G        +     E E        + G+ Y HS  + HR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV---LSRREYDGK 179
           D+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV   +   +YDGK
Sbjct: 140 DVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 194

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 76.8 bits (189), Expect = 4e-17
 Identities = 56/179 (31%), Positives = 88/179 (49%), Gaps = 17/179 (9%)

Query: 7   VKDLGAGNFG---VARLLRHKETKELVAVKYIERGRKIDEN--------VAREIINHRSL 55
           +K LG G +G     R +   +T ++ A+K +++   I  N          R I+   ++
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKA-TIVRNQKDTAHTKAERNIL--EAV 57

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           +HP I+       T   L +++EY +GGELF  +   G F ED   ++  ++   + + H
Sbjct: 58  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSR 173
              I +RDLK EN LLD  A   +K+ DFG  K S+       T  GT  Y+APE+L R
Sbjct: 118 QQGIIYRDLKPENILLD--AQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR 174

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 76.7 bits (188), Expect = 4e-17
 Identities = 56/180 (31%), Positives = 91/180 (50%), Gaps = 12/180 (6%)

Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDE---NVAREIINHRSLRHPNIIR 62
           ++++G G+FG     R   T E+VA+K +   G++ +E   ++ +E+   + ++HPN I 
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
           +K   L      +VMEY  G        +     E E        + G+ Y HS  + HR
Sbjct: 90  YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV---LSRREYDGK 179
           D+K  N LL  +   ++K+ DFG   S+ + S   S VGTP ++APEV   +   +YDGK
Sbjct: 150 DIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQYDGK 204

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.0 bits (184), Expect = 8e-17
 Identities = 54/186 (29%), Positives = 91/186 (48%), Gaps = 15/186 (8%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI------ERGRKIDENVAREIINHRSLRH 57
           Y  V+ +G G++G   L+RH+   +   +K +       R RK  E  A+ +     L+H
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLL---SQLKH 58

Query: 58  PNIIRFKEVVL-TPTHLAIVMEYAAGGELFDRI--CNAGRFSEDEGRYFFQQLISGVNYC 114
           PNI+ ++E        L IVM +  GG+L+ ++         E++   +F Q+   + Y 
Sbjct: 59  PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSR 173
           H   I HRDLK +N  L  +    +K+ D G ++         ST +GTP Y++PE+ S 
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176

Query: 174 REYDGK 179
           + Y+ K
Sbjct: 177 KPYNYK 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 75.5 bits (186), Expect = 1e-16
 Identities = 51/183 (27%), Positives = 82/183 (44%), Gaps = 19/183 (10%)

Query: 5   ELVKDLGAGNFG--VARLLRHKETKELVAVKYIERGRKIDENVAR---EIINHRSLRHPN 59
           EL+  +G       +  L +HK T  LVAVK I       E++     EII  R L+HPN
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGG---ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+ +    +  + L +V    A G   +L       G   E    +  + +++ ++Y HS
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYS--------KSSVLHSRPKSTVGTPAYIAP 168
               HR +K  + LL G    ++ +    YS        +  V+H  PKS+V    +++P
Sbjct: 120 KGFIHRSVKASHILLSGDG--KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177

Query: 169 EVL 171
           EVL
Sbjct: 178 EVL 180

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 75.0 bits (184), Expect = 1e-16
 Identities = 52/183 (28%), Positives = 90/183 (49%), Gaps = 15/183 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNI 60
           + +E+++ +G G +G    + +K+     AVK ++    IDE +  E    ++L  HPN+
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77

Query: 61  IRF-----KEVVLTPTHLAIVMEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGV 111
           ++F     K+ V     L +V+E   GG + D +        R  E    Y   + + G+
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPE 169
            + H  +  HRD+K  N LL       +K+ DFG S   +S    R  ++VGTP ++APE
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAPE 194

Query: 170 VLS 172
           V++
Sbjct: 195 VIA 197

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 74.8 bits (184), Expect = 2e-16
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 8/182 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVK--YIERGRKIDENVAREIINHRSLRHPN 59
           E  E + DLGAGN G    ++H  T  ++A K  +I     + + + RE+      R P 
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSM- 117
           I+ F    L   ++ + ME+   G L DRI    G    +        ++ G+ Y +++ 
Sbjct: 65  IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +I HRD+K  N L++     ++K+CDFG S   +++S   + VGT  Y++PE +   +Y 
Sbjct: 124 RIMHRDIKPSNILVNSRG--QIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGGKYT 180

Query: 178 GK 179
            K
Sbjct: 181 VK 182

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 74.3 bits (182), Expect = 2e-16
 Identities = 54/182 (29%), Positives = 93/182 (51%), Gaps = 12/182 (6%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPNIIR 62
           +ELV+ +G G +G     RH +T +L A+K ++     +E +  EI +  +   H NI  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 63  FKEVVLT---PTH---LAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYC 114
           +    +    P H   L +VME+   G + D + N       ED   Y  ++++ G+ + 
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSR 173
           H+ ++ HRD+K +N LL  +A   +K+ DFG S        R  + +GTP ++APEV++ 
Sbjct: 138 HAHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195

Query: 174 RE 175
            E
Sbjct: 196 DE 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 75.7 bits (186), Expect = 2e-16
 Identities = 44/152 (28%), Positives = 78/152 (51%), Gaps = 6/152 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----R 56
           +E++ +VK +  G FG   L R K   +L AVK +++   I++N+  ++   R      +
Sbjct: 3   IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P I+     + +  ++ +VMEY  GG++   +   G F E+    +  ++   ++Y H 
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             I HRDLK +N L+  S    +K+ DFG SK
Sbjct: 123 HGIIHRDLKPDNMLI--SNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 74.7 bits (183), Expect = 2e-16
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 6/178 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVK--YIERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   ++HK +  ++A K  ++E    I   + RE+        P 
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-Q 118
           I+ F     +   ++I ME+  GG L   +  A R  E+        ++ G+ Y     Q
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 125 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 73.4 bits (180), Expect = 4e-16
 Identities = 53/184 (28%), Positives = 86/184 (46%), Gaps = 17/184 (9%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-------RGRKIDENVAREIINHRSLRHPNIIR 62
           LG G +G           +L+AVK +E          K  E +  E+   +SL+H NI++
Sbjct: 8   LGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
           +    L    ++I ME+  GG +   +   G   E     + +Q++ GV Y H+  + HR
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRP-KSTVGTPAYIAPEVLSRRE 175
           D+K  N +L  +    +K+ DFG ++          HS   KS  GTP ++APEV++   
Sbjct: 127 DIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184

Query: 176 YDGK 179
           Y  K
Sbjct: 185 YGRK 188

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 73.6 bits (180), Expect = 4e-16
 Identities = 58/184 (31%), Positives = 91/184 (49%), Gaps = 14/184 (7%)

Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR------EIINHRSLRHPNII 61
           K LG G FG   L    +T   +A K ++   +  E          EI   ++L+H  I+
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 62  RFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           ++   +       L I MEY  GG + D++   G  +E   R + +Q++ G++Y HS  I
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRP--KSTVGTPAYIAPEVLSRRE 175
            HRD+K  N L D  +A  +K+ DFG SK   ++  S    +S  GTP +++PEV+S   
Sbjct: 128 VHRDIKGANILRD--SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185

Query: 176 YDGK 179
           Y  K
Sbjct: 186 YGRK 189

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 73.5 bits (180), Expect = 5e-16
 Identities = 56/175 (32%), Positives = 88/175 (50%), Gaps = 7/175 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHP 58
           +E Y  +  LG G +      R K T+ LVA+K I  E          RE+   ++L+H 
Sbjct: 4   LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRF-SEDEGRYFFQQLISGVNYCHSM 117
           NI+   +++ T   L +V EY    +L   + N G   S    + F  QL+ G++YCH  
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           +I HRDLK +N L++      LK+ DFG +++  + ++  S  V T  Y  P+VL
Sbjct: 123 KILHRDLKPQNLLINEKG--ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 175

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 73.1 bits (179), Expect = 7e-16
 Identities = 54/178 (30%), Positives = 85/178 (47%), Gaps = 24/178 (13%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRH-------PN 59
           +G G FG     R  +T ++ A+K +++ R   K  E +A   +N R +         P 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNERIMLSLVSTGDCPF 58

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I+       TP  L  +++   GG+L   +   G FSE E R++  ++I G+ + H+  +
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFV 118

Query: 120 CHRDLKLENTLLDGSAAPRLK----ICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQK 169

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 73.4 bits (181), Expect = 9e-16
 Identities = 63/188 (33%), Positives = 89/188 (47%), Gaps = 18/188 (9%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE---RGRKIDENVAREIINHRSLR- 56
           + KYE+++ LG G +G+      + TKE+VA+K I    R     +   REI+  + L  
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD 65

Query: 57  HPNIIRFKEVVLTPTHLAI--VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           HPNI++   V+       I  V EY    +L   I  A    +   RY   QL+  + Y 
Sbjct: 66  HPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-RANILEDVHKRYIMYQLLKALKYI 123

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS----SVLHSRPKST--VGTPAYIAP 168
           HS  + HRDLK  N LL+     R+K+ DFG ++S          P  T  V T  Y AP
Sbjct: 124 HSGNVIHRDLKPSNILLNSDC--RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181

Query: 169 EVL--SRR 174
           E+L  S R
Sbjct: 182 EILLGSTR 189

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 73.1 bits (179), Expect = 9e-16
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-Q 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 125 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 72.7 bits (178), Expect = 1e-15
 Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 24/178 (13%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRH-------PN 59
           +G G FG     R  +T ++ A+K +++ R   K  E +A   +N R +         P 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNERIMLSLVSTGDCPF 58

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I+       TP  L+ +++   GG+L   +   G FSE E R++  ++I G+ + H+  +
Sbjct: 59  IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFV 118

Query: 120 CHRDLKLENTLLDGSAAPRLK----ICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQK 169

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.4 bits (177), Expect = 1e-15
 Identities = 51/179 (28%), Positives = 91/179 (50%), Gaps = 12/179 (6%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPNIIR 62
           +ELV+ +G G +G     RH +T +L A+K ++     +E + +EI +  +   H NI  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 63  FKEVVLTPT------HLAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYC 114
           +    +          L +VME+   G + D I N       E+   Y  ++++ G+++ 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLS 172
           H  ++ HRD+K +N LL  +A   +K+ DFG S        R  + +GTP ++APEV++
Sbjct: 128 HQHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 2e-15
 Identities = 59/178 (33%), Positives = 87/178 (48%), Gaps = 13/178 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----ERGRKIDENVAREIINHRSLR 56
           +E Y+ +  LG G++      R K T +LVA+K I    E G        RE    + L+
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLK 61

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           H NI+   +++ T   L +V EY      +  D  C  G  S    R F  QL+ G+ YC
Sbjct: 62  HANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDD-CGGG-LSMHNVRLFLFQLLRGLAYC 119

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           H  ++ HRDLK +N L+  S    LK+ DFG +++  + S+  S  V T  Y  P+VL
Sbjct: 120 HQRRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVL 175

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 71.5 bits (175), Expect = 2e-15
 Identities = 55/175 (31%), Positives = 81/175 (46%), Gaps = 12/175 (6%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVA---REIINHRSLRHPNIIRF 63
           LG G FG    ++ K T ++ A K +++ R   K  E +A   +EI+    +  P I+  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGR--YFFQQLISGVNYCHSMQICH 121
                + THL +VM    GG+L   I N G    +  R  ++  Q+  G+ + HSM I +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           RD+K EN LLD     RL   D G +             GT  Y+APE+L    Y
Sbjct: 119 RDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPY 171

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 71.4 bits (175), Expect = 3e-15
 Identities = 49/173 (28%), Positives = 85/173 (49%), Gaps = 13/173 (7%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH----PNI 60
           E++ +LG GN+G    + H+ T   +A+K I    ++DE+   +II    + H    P I
Sbjct: 4   EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIR--LELDESKFNQIIMELDILHKAVSPYI 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGG---ELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HS 116
           + F         + + MEY   G   +L+          ED  R     ++ G+ +    
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
             I HRD+K  N L++G+   ++K+CDFG S  +++ S  K+ +G  +Y+APE
Sbjct: 122 HNIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPE 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 71.5 bits (176), Expect = 3e-15
 Identities = 50/189 (26%), Positives = 82/189 (43%), Gaps = 22/189 (11%)

Query: 3   KYELVKDLGAGNFGVARLLRHKE--TKELVAVKYIE----RGRKIDENVAREIINHRSLR 56
           KYE+   +G G +G     + K     +  A+K  +    +   I ++  REI   R L+
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 57  HPNIIRFKEVVLTPTHLAIVM--EYAAGGEL----FDRICNAGRFSEDEGRYFFQQLISG 110
           H N++   EV L     ++ +  +YA         F R            +    Q+++G
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 111 VNYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKS------TVGT 162
           V+Y HS  + HRDLK  N L+  +G     +KI D G ++  + ++  K        V T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVT 178

Query: 163 PAYIAPEVL 171
             Y APE+L
Sbjct: 179 IWYRAPELL 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 71.6 bits (175), Expect = 4e-15
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 44/201 (21%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVARE----IIN--- 51
           + +E++K +G G FG   +++ K T+ + A+K +   E  ++ +    RE    ++N   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 52  ------HRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFF 104
                 H + +  N            +L +VM+Y  GG+L   +     R  ED  R++ 
Sbjct: 61  QWITTLHYAFQDEN------------YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYI 108

Query: 105 QQLISGVNYCHSMQICHRDLKLENTLLDGSAAPR-------LKICDFGYSKSSVLHSRPK 157
            +++  ++  H +   HRD+K +N LLD +   R       LK+   G  +SSV      
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV------ 162

Query: 158 STVGTPAYIAPEVLSRREYDG 178
             VGTP YI+PE+L   E DG
Sbjct: 163 -AVGTPDYISPEILQAME-DG 181

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 71.2 bits (174), Expect = 4e-15
 Identities = 55/175 (31%), Positives = 87/175 (49%), Gaps = 7/175 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHP 58
           ME Y  ++ LG G +      R K T+ LVA+K I  E          RE+   + L+H 
Sbjct: 5   METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSM 117
           NI+   ++V T   L +V EY    +L   + + G   S    + F  Q++ G+ YCH  
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           ++ HRDLK +N L++      LK+ DFG +++  + ++  S  V T  Y  P+VL
Sbjct: 124 KVLHRDLKPQNLLINERG--ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 71.2 bits (174), Expect = 6e-15
 Identities = 58/225 (25%), Positives = 86/225 (38%), Gaps = 54/225 (24%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPN 59
           +  +K LG G FG   L R  +TK L A+K + +   +  N    +   R +     +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           ++R         +L  VM+Y  GG++   +   G F ED  R++  +L   V   H M  
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYS-------------------------------- 147
            HRD+K +N L+D      +K+ DFG                                  
Sbjct: 123 IHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180

Query: 148 --------------KSSVLHSR--PKSTVGTPAYIAPEVLSRREY 176
                         +++  H R    S VGTP YIAPEVL R  Y
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY 225

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 70.6 bits (173), Expect = 6e-15
 Identities = 50/150 (33%), Positives = 75/150 (50%), Gaps = 10/150 (6%)

Query: 7   VKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNII 61
           ++ LG GNFG   L R+      T E+VAVK ++        +  REI   +SL+H NI+
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 62  RFKEVVLTP--THLAIVMEYAAGGELFDR-ICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           ++K V  +    +L +VMEY   G L D    +  R    +   +  Q+  G+ Y  S +
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL   N L++     R+KI DFG +K
Sbjct: 129 YVHRDLATRNILVESEN--RVKIGDFGLTK 156

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 70.5 bits (173), Expect = 7e-15
 Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 6/178 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + H+ +  ++A K I  E    I   + RE+        P 
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E+        ++ G+ Y     +
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK 120

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 121 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 175

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 69.7 bits (171), Expect = 8e-15
 Identities = 61/183 (33%), Positives = 86/183 (46%), Gaps = 20/183 (10%)

Query: 8   KDLGAGNFGVARLLRHKETKEL-----VAVKYIERGR--KIDENVAREIINHRSLRHPNI 60
           K LG G+FGV R  R + +        VAVK ++  +   I ++  +E     SL H N+
Sbjct: 1   KKLGDGSFGVVR--RGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNA-GRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR   VVLT   L +V E A  G L DR+  +A G F       +  Q+ +G+ Y  S +
Sbjct: 59  IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 119 ICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVL---HSRPKSTVGTP-AYIAPEVLSR 173
             HRDL   N LL   A+    KI DFG  ++      H   +  +  P A+ APE L  
Sbjct: 118 FIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174

Query: 174 REY 176
           R +
Sbjct: 175 RTF 177

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 9e-15
 Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 22/191 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVK------YIERGRKIDENVAREIINHRSL 55
           + +E++K +G G FG   +++ K T ++ A+K       ++R         R+++ +   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYC 114
           R   I           +L +VM+Y  GG+L   +     R  ED  R++  +++  ++  
Sbjct: 61  RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST------VGTPAYIAP 168
           H +   HRD+K +N LLD +   RL   DFG    S L      T      VGTP YI+P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISP 172

Query: 169 EVLSRREYDGK 179
           E+L   E DGK
Sbjct: 173 EILQAME-DGK 182

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.9 bits (171), Expect = 9e-15
 Identities = 54/175 (30%), Positives = 86/175 (49%), Gaps = 21/175 (12%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH----PNIIRFKE 65
           LG GN G      H  T+ ++AVK I     I   + ++I++   + +    P II F  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 66  VVLTPTHLAIVMEYAAGGEL--FDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICH 121
                  ++I  E+  GG L  + +I     GR +          ++ G+ Y  S++I H
Sbjct: 67  AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA--------VAVVKGLTYLWSLKILH 118

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           RD+K  N L++     ++K+CDFG S   V +S  K+ VGT AY+APE +S  +Y
Sbjct: 119 RDVKPSNMLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQY 170

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.0 bits (171), Expect = 1e-14
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 21/182 (11%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHP 58
           +E Y  +  LG G +      R K T  LVA+K I  E          RE+   + L+H 
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEG--------RYFFQQLISG 110
           NI+   +++ T   L +V EY       D+  +  ++ +D G        + F  QL+ G
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEY------LDK--DLKQYLDDCGNSINMHNVKLFLFQLLRG 116

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPE 169
           +NYCH  ++ HRDLK +N L++      LK+ DFG +++  + ++  S  V T  Y  P+
Sbjct: 117 LNYCHRRKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPD 174

Query: 170 VL 171
           +L
Sbjct: 175 IL 176

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 70.1 bits (171), Expect = 1e-14
 Identities = 51/189 (26%), Positives = 89/189 (47%), Gaps = 18/189 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E +E++K +G G FG   +++ K   ++ A+K + +   +           R +    ++
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV----LV 56

Query: 62  RFKEVVLTPTHLA--------IVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVN 112
                 +T  H A        +VM+Y  GG+L   +     R  ED  R++  +++  ++
Sbjct: 57  NGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
             H +   HRD+K +N L+D +   RL   DFG     +     +S+  VGTP YI+PE+
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174

Query: 171 LSRREYDGK 179
           L   E DGK
Sbjct: 175 LQAME-DGK 182

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 69.3 bits (170), Expect = 1e-14
 Identities = 47/153 (30%), Positives = 65/153 (42%), Gaps = 19/153 (12%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +L + LGAG FG V     +  TK  VAVK ++ G    E   +E    + LRH  +
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF-FQQLI-------SGVN 112
           ++   V      + IV EY + G L D +         EG+     QL+        G+ 
Sbjct: 64  VQLYAVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMA 117

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
           Y  S    HRDL   N L+  +     KI DFG
Sbjct: 118 YLESRNYIHRDLAARNILVGENLV--CKIADFG 148

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 69.7 bits (170), Expect = 2e-14
 Identities = 51/216 (23%), Positives = 93/216 (43%), Gaps = 42/216 (19%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN-- 59
           E +E +K +G G FG  RL++ K+T  + A+K + +   +++     I   R +      
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 60  --IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             +++         +L ++ME+  GG++   +      +E+E +++  + +  ++  H +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKS-----------SVLHSRPK--------- 157
              HRD+K +N LLD      +K+ DFG               ++ HS P          
Sbjct: 121 GFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 158 ----------------STVGTPAYIAPEVLSRREYD 177
                           STVGTP YIAPEV  +  Y+
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN 214

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 68.9 bits (168), Expect = 2e-14
 Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 21/193 (10%)

Query: 1   MEKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSL 55
           +  +++ K +G G F  V R     + K  VA+K ++    +D    ++  +EI   + L
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKP-VALKKVQIFEMMDAKARQDCVKEIDLLKQL 59

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGV 111
            HPN+I++ +  +    L IV+E A  G+L   I    +      E     +F QL S V
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYI 166
            + HS ++ HRD+K  N  +  +A   +K+ D G      SK++  H    S VGTP Y+
Sbjct: 120 EHMHSRRVMHRDIKPANVFI--TATGVVKLGDLGLGRFFSSKTTAAH----SLVGTPYYM 173

Query: 167 APEVLSRREYDGK 179
           +PE +    Y+ K
Sbjct: 174 SPERIHENGYNFK 186

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 69.3 bits (170), Expect = 2e-14
 Identities = 48/159 (30%), Positives = 74/159 (46%), Gaps = 25/159 (15%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI----ER-GRKIDENVAREIINHRSLRHP 58
           YE++  LG G FG     R  +T  +VA+K I    E+ G  I     REI   + L+HP
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPI--TALREIKILKKLKHP 67

Query: 59  NIIRFKEVVL--------TPTHLAIVMEYAA---GGELFD-RICNAGRFSEDEGRYFFQQ 106
           N++   ++ +            + +V  Y      G L +  +    + +E + + +  Q
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV----KLTESQIKCYMLQ 123

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
           L+ G+NY H   I HRD+K  N L+D      LKI DFG
Sbjct: 124 LLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFG 160

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 68.7 bits (168), Expect = 2e-14
 Identities = 56/177 (31%), Positives = 83/177 (46%), Gaps = 11/177 (6%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPN---IIRFKE 65
           LG G FG     + + T +L A K + + R K  +     ++  R L   +   I+    
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNYCHSMQICH 121
              T T L +VM    GG+L   I N       F E    ++  Q+ISG+ + H  +I +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           RDLK EN LLD      ++I D G + +     S+ K   GTP ++APE+L   EYD
Sbjct: 121 RDLKPENVLLDNDG--NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 69.3 bits (169), Expect = 2e-14
 Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 42/216 (19%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN-- 59
           + +E +K +G G FG  RL++ K+T  + A+K + +   +++     I   R +      
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 60  --IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             +++         +L ++ME+  GG++   +      SE+  +++  + +  ++  H +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKS-----------SVLHSRPK--------- 157
              HRD+K +N LLD  A   +K+ DFG               ++ H+ P          
Sbjct: 121 GFIHRDIKPDNLLLD--AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 158 ----------------STVGTPAYIAPEVLSRREYD 177
                           STVGTP YIAPEV  +  Y+
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN 214

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 69.0 bits (168), Expect = 3e-14
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 13/177 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----ERGRKIDENVAREIINHRSLRH 57
           + YE ++ LG G++      + K   +LVA+K I    E G        RE    + L+H
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLKH 62

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            NI+   +++ T   L +V EY      +  D+  + G    +  + F  QL+ G++Y H
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
              I HRDLK +N L+  +    LK+ DFG +++  + S   S  V T  Y  P+VL
Sbjct: 121 QRYILHRDLKPQNLLISDTG--ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 68.8 bits (168), Expect = 3e-14
 Identities = 49/153 (32%), Positives = 76/153 (49%), Gaps = 11/153 (7%)

Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIER--GRKIDENVAREIINHRSLRHP 58
           + ++ LG G+FG   L  +      T E+VAVK ++R  G++      +EI   ++L H 
Sbjct: 7   KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66

Query: 59  NIIRFKEVVLTP--THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NI+++K          L ++MEY   G L D +    + +  +   F QQ+  G+ Y HS
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
               HRDL   N LLD      +KI DFG +K+
Sbjct: 126 QHYIHRDLAARNVLLDNDRL--VKIGDFGLAKA 156

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 68.0 bits (166), Expect = 4e-14
 Identities = 52/184 (28%), Positives = 82/184 (44%), Gaps = 20/184 (10%)

Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG G FGV +  + +   + VA+K I+ G   ++    E      L H  +++   
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVNYCHSMQ 118
           V      + IV EY + G L + +   G+      R+   QL+        G+ Y  S Q
Sbjct: 67  VCTKQRPIYIVTEYMSNGCLLNYLREHGK------RFQPSQLLEMCKDVCEGMAYLESKQ 120

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRRE 175
             HRDL   N L+D      +K+ DFG S+  VL     S+VG+     +  PEVL   +
Sbjct: 121 FIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177

Query: 176 YDGK 179
           +  K
Sbjct: 178 FSSK 181

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 69.1 bits (169), Expect = 4e-14
 Identities = 40/114 (35%), Positives = 63/114 (55%), Gaps = 9/114 (7%)

Query: 73  LAIVMEYAAGGELFDRICN---AGR-FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
           +A+V++YA  G+L   I +     R F E E    F Q++  V++ HS  + HRD+K  N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173

Query: 129 TLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            LL  +    +K+ DFG+SK   ++V     ++  GTP Y+APE+  R+ Y  K
Sbjct: 174 ILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK 225

Length = 496

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 67.7 bits (165), Expect = 1e-13
 Identities = 51/167 (30%), Positives = 80/167 (47%), Gaps = 10/167 (5%)

Query: 21  LRHKETKELVAVKYIERGRKIDENVAR-EIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY 79
            R  + KE V  K++    +     AR E+    +  H  I++  +   +   L ++MEY
Sbjct: 87  TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146

Query: 80  AAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA 135
            +GG+L  +I    +    F E E    F Q++  ++  HS ++ HRDLK  N  L  + 
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG 206

Query: 136 APRLKICDFGYSKS---SVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
              +K+ DFG+SK    SV      S  GTP Y+APE+  R+ Y  K
Sbjct: 207 I--IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK 251

Length = 478

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 67.6 bits (165), Expect = 1e-13
 Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 54/227 (23%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RH 57
           E +  VK +G G FG  RL++ K+T ++ A+K + +     ++    +   R +      
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P ++          +L ++ME+  GG+L   +     FSED  R++  + +  +   H +
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK----------------------------- 148
              HRD+K +N L+D      +K+ DFG S                              
Sbjct: 121 GFIHRDIKPDNILID--RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178

Query: 149 ------SSVLHSRPK-------------STVGTPAYIAPEVLSRREY 176
                 +  + S+ +             STVGTP YIAPE+  ++ Y
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 66.2 bits (162), Expect = 1e-13
 Identities = 49/153 (32%), Positives = 65/153 (42%), Gaps = 20/153 (13%)

Query: 8   KDLGAGNFGVAR--LLRHKETKEL-VAVKYIERGRKIDENVA--REIINHRS----LRHP 58
           K+LG GNFG     +   K  KE+ VAVK +    K +   A  +E +   S    L HP
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTL----KQEHIAAGKKEFLREASVMAQLDHP 56

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
            I+R   V      L +VME A  G L   +         + +    Q+  G+ Y  S  
Sbjct: 57  CIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH 115

Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGYSKS 149
             HRDL   N LL     A    KI DFG S++
Sbjct: 116 FVHRDLAARNVLLVNRHQA----KISDFGMSRA 144

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 65.9 bits (161), Expect = 2e-13
 Identities = 54/184 (29%), Positives = 81/184 (44%), Gaps = 14/184 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
            ++ +L   +G G FG   L  ++  K  VAVK ++      +    E     +LRHPN+
Sbjct: 5   SKELKLGATIGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAAQAFLAEASVMTTLRHPNL 62

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQ 118
           ++   VVL    L IV EY A G L D + + GR   +  +   F   +  G+ Y     
Sbjct: 63  VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122

Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVL-HSRPKSTVGTPAYIAPEVLSRRE 175
             HRDL   N L+  D  A    K+ DFG +K +       K  V    + APE L  ++
Sbjct: 123 FVHRDLAARNVLVSEDLVA----KVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKK 175

Query: 176 YDGK 179
           +  K
Sbjct: 176 FSTK 179

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 66.7 bits (163), Expect = 2e-13
 Identities = 62/204 (30%), Positives = 90/204 (44%), Gaps = 49/204 (24%)

Query: 4   YELVKDLGAGNFGVARLLRHKETK--ELVAVKYIERGRKIDENVAREIINHRSLR----- 56
           YEL+K+LG G +G+    R+ ET   E VA+K      KI    +++I+  R+LR     
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIK------KITNVFSKKILAKRALRELKLL 55

Query: 57  -----HPNII-----------RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEG 100
                H NI             F E+ L       +ME     +L   I +    ++   
Sbjct: 56  RHFRGHKNITCLYDMDIVFPGNFNELYLYEE----LMEA----DLHQIIRSGQPLTDAHF 107

Query: 101 RYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST- 159
           + F  Q++ G+ Y HS  + HRDLK  N L++  A   LKICDFG ++       P    
Sbjct: 108 QSFIYQILCGLKYIHSANVLHRDLKPGNLLVN--ADCELKICDFGLARG--FSENPGENA 163

Query: 160 ------VGTPAYIAPEV-LSRREY 176
                 V T  Y APE+ LS + Y
Sbjct: 164 GFMTEYVATRWYRAPEIMLSFQSY 187

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 66.2 bits (162), Expect = 3e-13
 Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 20/187 (10%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLRHP 58
           ++Y+ +  +G+G +G        +T   VA+K + R     I  +   RE+   + + H 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V    + L       +V     G +L + I    + S+D  ++   Q++ G+ 
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRGLK 132

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 186

Query: 171 -LSRREY 176
            L+   Y
Sbjct: 187 MLNWMHY 193

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.7 bits (160), Expect = 3e-13
 Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 11/152 (7%)

Query: 7   VKDLGAGNFGVARLLRHK----ETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNI 60
           ++DLG G+FG   L R+      T E VAVK +  E G     ++ +EI   R+L H NI
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 61  IRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSM 117
           +++K +        + ++ME+   G L + +  N  + +  +   +  Q+  G++Y  S 
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
           Q  HRDL   N L++     ++KI DFG +K+
Sbjct: 129 QYVHRDLAARNVLVESEH--QVKIGDFGLTKA 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 66.2 bits (161), Expect = 4e-13
 Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 54/222 (24%)

Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPNIIR 62
           +K LG G FG   L    +T  L A+K + +   ++ N    +   R +     +  +++
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
                    +L  VM+Y  GG++   +     F E   R++  +L   +   H M   HR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125

Query: 123 DLKLENTLLDGSAAPRLKICDFG-------------YSKSS------------------- 150
           D+K +N L+D      +K+ DFG             Y K S                   
Sbjct: 126 DIKPDNILIDLDG--HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNC 183

Query: 151 -------VLHSRPK---------STVGTPAYIAPEVLSRREY 176
                   L  R           S VGTP YIAPEVL R+ Y
Sbjct: 184 RCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY 225

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 65.4 bits (159), Expect = 4e-13
 Identities = 52/189 (27%), Positives = 87/189 (46%), Gaps = 20/189 (10%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSLR- 56
           +YE V ++G G +G     R   +   VA+K +     E G  +  +  RE+   + L  
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPL--STVREVALLKRLEA 58

Query: 57  --HPNIIRFKEVVLT-----PTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQL 107
             HPNI+R  +V  T      T + +V E+         D++   G    +  +   +Q 
Sbjct: 59  FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQF 117

Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           + G+++ H+  I HRDLK EN L+  ++  ++K+ DFG ++           V T  Y A
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 168 PEVLSRREY 176
           PEVL +  Y
Sbjct: 176 PEVLLQSTY 184

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 65.2 bits (159), Expect = 6e-13
 Identities = 59/198 (29%), Positives = 83/198 (41%), Gaps = 31/198 (15%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNII 61
           +Y  ++ LG G+ G+       +  + VAVK I     +  ++  REI   R L H NI+
Sbjct: 6   RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65

Query: 62  RFKEV-----------VLTPTHLA---IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQL 107
           +  EV           V + T L    IV EY         +   G  SE+  R F  QL
Sbjct: 66  KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMYQL 123

Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG--------YSKSSVLHSRPKST 159
           + G+ Y HS  + HRDLK  N  ++ +    LKI DFG        YS    L       
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYL----SEG 178

Query: 160 VGTPAYIAPE-VLSRREY 176
           + T  Y +P  +LS   Y
Sbjct: 179 LVTKWYRSPRLLLSPNNY 196

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.9 bits (158), Expect = 8e-13
 Identities = 43/177 (24%), Positives = 87/177 (49%), Gaps = 9/177 (5%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y ++K L  G+ G   +       + V +K  ++G  + E +  + +NH     P++IR 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNH-----PSVIRM 122

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
           K+ +++     +V+ + +  +L+  +   +     D+     +Q++ G+ Y H+ +I HR
Sbjct: 123 KDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           D+K EN  ++     ++ I D G ++  V+        GT    APEVL+R +Y+ K
Sbjct: 182 DVKTENIFIN--DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK 236

Length = 357

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 63.2 bits (154), Expect = 2e-12
 Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 8/178 (4%)

Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG+G FGV  L + +  K  VA+K I  G   +++   E      L HPN+++   
Sbjct: 8   FLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V      + IV EY A G L + +    G+   +        +   + Y  S    HRDL
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI---APEVLSRREYDGK 179
              N L+       +K+ DFG ++  VL  +  S+ GT   +    PEV     +  K
Sbjct: 127 AARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 63.1 bits (153), Expect = 2e-12
 Identities = 52/192 (27%), Positives = 86/192 (44%), Gaps = 19/192 (9%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE----RGRKIDENVAREIINHRSLR 56
           +  + + K +G G F              VA+K ++       K   +  +EI   + L 
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVN 112
           HPN+I++    +    L IV+E A  G+L   I +  +      E     +F QL S + 
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYIA 167
           + HS ++ HRD+K  N  +  +A   +K+ D G      SK++  H    S VGTP Y++
Sbjct: 121 HMHSRRVMHRDIKPANVFI--TATGVVKLGDLGLGRFFSSKTTAAH----SLVGTPYYMS 174

Query: 168 PEVLSRREYDGK 179
           PE +    Y+ K
Sbjct: 175 PERIHENGYNFK 186

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 63.5 bits (154), Expect = 3e-12
 Identities = 56/184 (30%), Positives = 86/184 (46%), Gaps = 25/184 (13%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y+L   +G G+FGV       +T E VA+K + +  +      RE++  ++L H NII  
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN---RELLIMKNLNHINIIFL 124

Query: 64  KEVVLTPT--------HLAIVMEYAAGG-----ELFDRICNAGRFSEDEGRYFFQQLISG 110
           K+   T           L +VME+         + + R  N         + +  QL   
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNHALPLFLVKLYSYQLCRA 182

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPR---LKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           + Y HS  ICHRDLK +N L+D    P    LK+CDFG +K+ +   R  S + +  Y A
Sbjct: 183 LAYIHSKFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRA 238

Query: 168 PEVL 171
           PE++
Sbjct: 239 PELM 242

Length = 440

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 62.3 bits (151), Expect = 5e-12
 Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 8/178 (4%)

Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
           LV+++G+G FG+  L    E ++ VA+K I  G   +E+   E      L HP +++   
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V    + + +V E+   G L D +    G+FS++        +  G+ Y  S  + HRDL
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126

Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGK 179
              N L+  +    +K+ DFG ++  VL  +  S+ GT     + +PEV S  +Y  K
Sbjct: 127 AARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 62.3 bits (151), Expect = 5e-12
 Identities = 56/178 (31%), Positives = 84/178 (47%), Gaps = 19/178 (10%)

Query: 4   YELVKDLGAGNF-----GVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRS 54
           Y  ++ LG G++     G++R+        LVA+K I    K +E V     RE    + 
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQ-----LVALKVISM--KTEEGVPFTAIREASLLKG 59

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           L+H NI+   +++ T   L  V EY         I + G       R F  QL+ G+ Y 
Sbjct: 60  LKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           H   I HRDLK +N L+  S    LK+ DFG +++  + S+  S+ V T  Y  P+VL
Sbjct: 120 HGQHILHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL 175

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 61.7 bits (150), Expect = 9e-12
 Identities = 56/186 (30%), Positives = 82/186 (44%), Gaps = 19/186 (10%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRH 57
           + YE ++ +G G +G     R K T +LVA+K   R    +E +     REI   + L  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSE 59

Query: 58  -PNIIRFKEVVLTPTH-----LAIVMEYAAGGELFDRICNAGR-----FSEDEGRYFFQQ 106
              I+R  +V           L +V EY    +L   + + GR           + F  Q
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAY 165
           L+ GV +CH   + HRDLK +N L+D      LKI D G  ++ S+        + T  Y
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWY 177

Query: 166 IAPEVL 171
            APEVL
Sbjct: 178 RAPEVL 183

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 61.6 bits (149), Expect = 1e-11
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 17/189 (8%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINH-RS 54
           ++YE V ++G G +G V +    K     VA+K +     E G  +       ++ H  +
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 55  LRHPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQL 107
             HPN++R  +V         T L +V E+         D++   G  +E      FQ L
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 119

Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           + G+++ HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y A
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRA 177

Query: 168 PEVLSRREY 176
           PEVL +  Y
Sbjct: 178 PEVLLQSSY 186

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 61.1 bits (148), Expect = 2e-11
 Identities = 52/179 (29%), Positives = 83/179 (46%), Gaps = 16/179 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           E+Y  +K +G+G +G       K T E VA+K + R  + +   +   RE+   + ++H 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  +           +VM Y        +I      SED+ +Y   Q++ G+ 
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLK 131

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y HS  I HRDLK  N  ++      LKI DFG ++ +   +     V T  Y APEV+
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDC--ELKILDFGLARHA--DAEMTGYVVTRWYRAPEVI 186

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 59.9 bits (145), Expect = 3e-11
 Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 8/177 (4%)

Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEV 66
           +K+LG+G FGV  L + +   + VA+K I  G   +E+   E      L HP +++   V
Sbjct: 9   MKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 67  VLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                 L IV E+   G L + +    G+ S+D      Q +  G+ Y       HRDL 
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127

Query: 126 LENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGK 179
             N L+  S+   +K+ DFG ++  VL     S+ G      +  PEV +  +Y  K
Sbjct: 128 ARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 60.6 bits (147), Expect = 3e-11
 Identities = 43/161 (26%), Positives = 59/161 (36%), Gaps = 14/161 (8%)

Query: 25  ETKELVAVKYIE----RGRKIDENVAREIINHRSLRHPNIIRF-KEVVLTPTHLAIVMEY 79
            T   VA+K +               RE      L HPNI+         P  L  V EY
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 80  AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APR 138
             G  L + +   G     E      Q++  +   H+  I HRDLK +N ++  +   P 
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 139 LKICDFGYS--------KSSVLHSRPKSTVGTPAYIAPEVL 171
            K+ DFG                +R    +GTP Y APE L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 59.6 bits (144), Expect = 4e-11
 Identities = 56/182 (30%), Positives = 85/182 (46%), Gaps = 18/182 (9%)

Query: 8   KDLGAGNFG-VAR-LLRHKETKEL-VAVKYIERG--RKIDENVAREIINHRSLRHPNIIR 62
           K +GAG FG V R +L+    KE+ VA+K ++ G   K  ++   E        H NIIR
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRIC--NAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
            + VV       I+ EY   G L D+    + G FS  +     + + +G+ Y   M   
Sbjct: 71  LEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  VL   P+ T  T        + APE ++ R
Sbjct: 130 HRDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185

Query: 175 EY 176
           ++
Sbjct: 186 KF 187

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.8 bits (145), Expect = 5e-11
 Identities = 42/134 (31%), Positives = 61/134 (45%), Gaps = 10/134 (7%)

Query: 45  VAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDR-----ICNAGRFSEDE 99
           V RE+      +H N++   ++ L P H+    E     EL        I +    S D 
Sbjct: 46  VFRELKMLCFFKHDNVLSALDI-LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDH 104

Query: 100 GRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST 159
            + F  Q++ G+ Y HS  I HRD+K  N L++ +    LKICDFG ++          T
Sbjct: 105 VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC--VLKICDFGLARVEEPDESKHMT 162

Query: 160 --VGTPAYIAPEVL 171
             V T  Y APE+L
Sbjct: 163 QEVVTQYYRAPEIL 176

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 59.3 bits (144), Expect = 6e-11
 Identities = 55/191 (28%), Positives = 84/191 (43%), Gaps = 33/191 (17%)

Query: 6   LVKDLGAGNFG---VARLLRHKETKELVAVKYIERG--RKIDENVAREIINHRSLRHPNI 60
           + K +G G FG     RL    + +  VA+K ++ G   K   +   E        HPNI
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLI-------SGV 111
           IR + VV     + I+ EY   G L  F R        E++G++   QL+       SG+
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASGM 119

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT-----PA-Y 165
            Y   M   HRDL   N L++ +     K+ DFG S+   L    ++T  T     P  +
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSR--RLED-SEATYTTKGGKIPIRW 174

Query: 166 IAPEVLSRREY 176
            APE ++ R++
Sbjct: 175 TAPEAIAYRKF 185

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.6 bits (144), Expect = 6e-11
 Identities = 49/180 (27%), Positives = 84/180 (46%), Gaps = 17/180 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           ++Y  +K +G+G +G       + T   VA+K + R  + +   +   RE+   + ++H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 59  NIIRFKEVVLTP-------THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
           N+I   +V  TP           +VM +   G    ++    + SED  ++   Q++ G+
Sbjct: 75  NVIGLLDV-FTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            Y H+  I HRDLK  N  ++      LKI DFG ++ +   S     V T  Y APEV+
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQT--DSEMTGYVVTRWYRAPEVI 187

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 59.3 bits (143), Expect = 6e-11
 Identities = 50/156 (32%), Positives = 70/156 (44%), Gaps = 19/156 (12%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LVK LGAG FG V     +  TK  VAVK ++ G    +    E    ++L+H  +
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--------FFQQLISGVN 112
           +R   VV     + I+ EY A G L D +        DEG          F  Q+  G+ 
Sbjct: 64  VRLYAVVTKEEPIYIITEYMAKGSLLDFL------KSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           Y       HRDL+  N L+  S +   KI DFG ++
Sbjct: 118 YIERKNYIHRDLRAANVLV--SESLMCKIADFGLAR 151

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 58.9 bits (143), Expect = 8e-11
 Identities = 42/166 (25%), Positives = 68/166 (40%), Gaps = 27/166 (16%)

Query: 1   MEKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS- 54
            EK  L+++LG G+FG     +A+ +   E +  VA+K +     + E    E +N  S 
Sbjct: 5   REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASV 62

Query: 55  ---LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ------ 105
                  +++R   VV T     +VME  A G+L   +    R  E E            
Sbjct: 63  MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQK 120

Query: 106 ------QLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
                 ++  G+ Y  + +  HRDL   N ++       +KI DFG
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFG 164

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 58.5 bits (142), Expect = 1e-10
 Identities = 48/181 (26%), Positives = 67/181 (37%), Gaps = 39/181 (21%)

Query: 2   EKYELVKDLGAGNFGVARL-----------LRHKETKE-----LVAVKYIERGRKIDENV 45
           +    V+ LG G FG   L               E        LVAVK +    + D + 
Sbjct: 5   QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL----RPDASD 60

Query: 46  A------REIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------FDR 88
                  +E+     L  PNI R   V      L ++MEY   G+L              
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120

Query: 89  ICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            CN+   S     Y   Q+ SG+ Y  S+   HRDL   N L+  +    +KI DFG S+
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY--TIKIADFGMSR 178

Query: 149 S 149
           +
Sbjct: 179 N 179

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 58.5 bits (141), Expect = 1e-10
 Identities = 53/183 (28%), Positives = 83/183 (45%), Gaps = 12/183 (6%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M++ +L++ +G G FG   L  ++  K  VAVK I+        +A   +    LRH N+
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASV-MTQLRHSNL 61

Query: 61  IRFKEVVLTP-THLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSM 117
           ++   V++     L IV EY A G L D + + GR     D    F   +   + Y  + 
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-YIAPEVLSRREY 176
              HRDL   N L+  S     K+ DFG +K +   S  + T   P  + APE L  +++
Sbjct: 122 NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKF 176

Query: 177 DGK 179
             K
Sbjct: 177 STK 179

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 58.2 bits (141), Expect = 2e-10
 Identities = 44/201 (21%), Positives = 78/201 (38%), Gaps = 34/201 (16%)

Query: 2   EKYELV-KDLGAGNFGVARLLRHKETKELVAVKYI----------ERGRKIDE-----NV 45
           E+Y      LG G +G         T ++VA+K +          +  + +         
Sbjct: 8   ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67

Query: 46  AREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ 105
            RE+     ++H NI+   +V +    + +VM+  A  +L   +    R +E + +    
Sbjct: 68  LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILL 126

Query: 106 QLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-----------HS 154
           Q+++G+N  H     HRDL   N  ++       KI DFG ++                 
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 155 RPK----STVGTPAYIAPEVL 171
           + +    S V T  Y APE+L
Sbjct: 185 QRREEMTSKVVTLWYRAPELL 205

Length = 335

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 58.2 bits (140), Expect = 2e-10
 Identities = 55/187 (29%), Positives = 90/187 (48%), Gaps = 20/187 (10%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKEL--VAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           +YE  K +G G +G     + K+ K+    A+K IE G  I  +  REI   R L+HPN+
Sbjct: 3   EYEGCK-VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACREIALLRELKHPNV 60

Query: 61  IRFKEVVLTPT--HLAIVMEYAAGGEL----FDRICNAGR----FSEDEGRYFFQQLISG 110
           I  ++V L+ +   + ++ +YA         F R   A +          +    Q++ G
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 111 VNYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKS----TVGTPA 164
           ++Y H+  + HRDLK  N L+  +G    R+KI D G+++      +P +     V T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 165 YIAPEVL 171
           Y APE+L
Sbjct: 181 YRAPELL 187

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 57.7 bits (139), Expect = 2e-10
 Identities = 52/173 (30%), Positives = 77/173 (44%), Gaps = 8/173 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPN---IIRFKE 65
           LG G FG     + + T ++ A K +E+ R K  +  A  +   R L   N   ++    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF--QQLISGVNYCHSMQICHRD 123
              T   L +V+    GG+L   I N G    DE R  F   +L  G+      +I +RD
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRD 127

Query: 124 LKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           LK EN LLD      ++I D G +         +  VGT  Y+APEV++  +Y
Sbjct: 128 LKPENILLDDRG--HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 57.6 bits (139), Expect = 2e-10
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 24/184 (13%)

Query: 10  LGAGNFG-VAR-LLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSL----RHPNIIR 62
           +GAG FG V R  L+    +E+ VA+K ++ G    E   R+ ++  S+     HPNII 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
            + VV     + I+ E+   G L  F R  N G+F+  +     + + +G+ Y   M   
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA--------YIAPEVLS 172
           HRDL   N L++ +     K+ DFG S+   L         T +        + APE ++
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 173 RREY 176
            R++
Sbjct: 185 YRKF 188

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 57.3 bits (138), Expect = 3e-10
 Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 18/178 (10%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR---------KIDENVAREIINHRSLRHPNI 60
           LG G FG     + + T ++ A K +E+ R          ++E    E +N +      +
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF-----V 62

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQ 118
           +       T   L +V+    GG+L   I N G   F E+   ++  +++ G+   H   
Sbjct: 63  VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
             +RDLK EN LLD      ++I D G +         +  VGT  Y+APEVL+ + Y
Sbjct: 123 TVYRDLKPENILLDDYG--HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 57.7 bits (139), Expect = 3e-10
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 8/177 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 57.4 bits (138), Expect = 3e-10
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 8/177 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 57.0 bits (138), Expect = 3e-10
 Identities = 48/188 (25%), Positives = 79/188 (42%), Gaps = 31/188 (16%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRHPNIIRFKE 65
           +G G FG    + HK +  ++AVK I R    ++   R +++     RS   P I++F  
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 66  VVLTPTHLAIVMEYAAGG-ELFDRICNAGRFSEDEGRYFFQQLISGVNYC---------H 115
            +       I ME      + F +        E       ++++  +             
Sbjct: 71  ALFREGDCWICMELMDISLDKFYKYVY-----EVLKSVIPEEILGKIAVATVKALNYLKE 125

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTPAYIAPEVL- 171
            ++I HRD+K  N LLD +    +K+CDFG S     S+  +R     G   Y+APE + 
Sbjct: 126 ELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVDSIAKTR---DAGCRPYMAPERID 180

Query: 172 -SRRE-YD 177
            S R+ YD
Sbjct: 181 PSARDGYD 188

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 57.3 bits (138), Expect = 3e-10
 Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 8/182 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VAVK + R    +   +   RE++  + + H
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C       D  R  Y   Q++ G+ + 
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 139

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV+   
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM 197

Query: 175 EY 176
            Y
Sbjct: 198 GY 199

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 57.3 bits (138), Expect = 4e-10
 Identities = 55/202 (27%), Positives = 85/202 (42%), Gaps = 39/202 (19%)

Query: 5   ELVKDLGAG--NFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIIN------HRS- 54
           EL+  +G G  +     L R+K T E V V      R+I+ E    E++       H S 
Sbjct: 1   ELLTVIGRGFEDLMTVNLARYKPTGEYVTV------RRINLEACTNEMVTFLQGELHVSK 54

Query: 55  -LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGV 111
              HPNI+ ++   +    L +V  + A G   D IC       SE    Y  Q ++  +
Sbjct: 55  LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKAL 114

Query: 112 NYCHSMQICHRDLKLENTL--LDGSAAPRLKICDFGY----------SKSSVLHSRPKST 159
           +Y H M   HR +K  + L  +DG      K+   G            +  V+H  PK +
Sbjct: 115 DYIHHMGYVHRSVKASHILISVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYS 168

Query: 160 VGTPAYIAPEVLSR--REYDGK 179
           V    +++PEVL +  + YD K
Sbjct: 169 VKVLPWLSPEVLQQNLQGYDAK 190

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 56.6 bits (136), Expect = 5e-10
 Identities = 51/178 (28%), Positives = 77/178 (43%), Gaps = 18/178 (10%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGR---------KIDENVAREIINHRSLRHPNI 60
           LG G FG     + + T ++ A K +E+ R          ++E    E +N R      +
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF-----V 62

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF--QQLISGVNYCHSMQ 118
           +       T   L +V+    GG+L   I + G    +EGR  F   ++  G+   H  +
Sbjct: 63  VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I +RDLK EN LLD      ++I D G +         K  VGT  Y+APEV+    Y
Sbjct: 123 IVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 56.4 bits (136), Expect = 6e-10
 Identities = 46/173 (26%), Positives = 74/173 (42%), Gaps = 8/173 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPNIIRFKE 65
           LG G FG     + + T ++ A K +E+ R          +N + +        ++    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRD 123
              T   L +V+    GG+L   I N G   F E+   ++  ++  G+   H  +I +RD
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRD 127

Query: 124 LKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           LK EN LLD      ++I D G +         +  VGT  Y+APEV+    Y
Sbjct: 128 LKPENILLDDYG--HIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 56.4 bits (136), Expect = 6e-10
 Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 22/184 (11%)

Query: 8   KDLGAGNFG---VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +GAG FG     RL    + +  VA+K ++ G    E   R+ ++  S+     HPNI
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNI 67

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I  + VV     + IV EY   G L  F R  + G+F+  +     + + SG+ Y   M 
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDMG 126

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + APE ++
Sbjct: 127 YVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIA 182

Query: 173 RREY 176
            R++
Sbjct: 183 YRKF 186

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 56.6 bits (136), Expect = 6e-10
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 33/204 (16%)

Query: 1   MEKYELVKDLGAGNFG---VARLLRHKE-----------------TKELVAVKYIERGRK 40
           +  + ++ DL AG FG   +  L    E                  + L+A K ++ G +
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIA-KRVKAGSR 205

Query: 41  IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM---EYAAGGELFDRICN-AGRFS 96
               +  EI+    L H NI++ +E++ +  +  ++    ++     ++D   +   R  
Sbjct: 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPL 265

Query: 97  EDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVL 152
             + R   +QL+  V Y H  ++ HRD+KLEN  L+      L   DFG    + K    
Sbjct: 266 LKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLG--DFGTAMPFEKERE- 322

Query: 153 HSRPKSTVGTPAYIAPEVLSRREY 176
            +     VGT A  +PE+L+   Y
Sbjct: 323 -AFDYGWVGTVATNSPEILAGDGY 345

Length = 501

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 56.0 bits (135), Expect = 8e-10
 Identities = 45/155 (29%), Positives = 67/155 (43%), Gaps = 18/155 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E  +LVK LGAG FG   +  +    + VA+K +++G    E    E    + L+HP ++
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLV 64

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           R   VV T   + I+ EY   G L D +         EG             Q+  G+ +
Sbjct: 65  RLYAVV-TQEPIYIITEYMENGSLVDFL------KTPEGIKLTINKLIDMAAQIAEGMAF 117

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
                  HRDL+  N L+  S     KI DFG ++
Sbjct: 118 IERKNYIHRDLRAANILV--SETLCCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 55.9 bits (135), Expect = 1e-09
 Identities = 54/185 (29%), Positives = 83/185 (44%), Gaps = 28/185 (15%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA------REIINHRSLR 56
           +Y+ +K +G+G  G+        T + VA+K + R     +NV       RE++  + + 
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVN 73

Query: 57  HPNIIRFKEVVLTP-------THLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQ 106
           H NII    V  TP         + +VME      L D  +C   +   D  R  Y   Q
Sbjct: 74  HKNIIGLLNV-FTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMSYLLYQ 126

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI 166
           ++ G+ + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y 
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYR 184

Query: 167 APEVL 171
           APEV+
Sbjct: 185 APEVI 189

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.8 bits (134), Expect = 1e-09
 Identities = 44/177 (24%), Positives = 79/177 (44%), Gaps = 11/177 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G          ++ VAVK + R  +         RE+   + ++H 
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74

Query: 59  NIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           N+I   +V    T +     + +     G   + I    + S++  ++   QL+ G+ Y 
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N  ++      L+I DFG ++ +         V T  Y APE++
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDC--ELRILDFGLARQA--DDEMTGYVATRWYRAPEIM 187

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.8 bits (134), Expect = 1e-09
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.5 bits (134), Expect = 1e-09
 Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 12/178 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN--VAREI-INHRSLRHP 58
              E + ++G+G  G    +R K+T  ++AVK + R    +EN  +  ++ +  +S   P
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC-H 115
            I++     +T + + I ME  +    +L  RI   G   ED        ++  ++Y   
Sbjct: 75  YIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE 132

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVLS 172
              + HRD+K  N LLD S    +K+CDFG S   V  S+ K+ + G  AY+APE + 
Sbjct: 133 KHGVIHRDVKPSNILLDASG--NVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPERID 187

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 55.8 bits (134), Expect = 1e-09
 Identities = 55/187 (29%), Positives = 89/187 (47%), Gaps = 20/187 (10%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKEL--VAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           +YE  K +G G +G     + K+ K+    A+K IE G  I  +  REI   R L+HPN+
Sbjct: 3   EYEGCK-VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNV 60

Query: 61  IRFKEVVLTPT--HLAIVMEYAAGGEL----FDRICNAGR----FSEDEGRYFFQQLISG 110
           I  ++V L+     + ++ +YA         F R   A +          +    Q++ G
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 111 VNYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKS----TVGTPA 164
           ++Y H+  + HRDLK  N L+  +G    R+KI D G+++      +P +     V T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 165 YIAPEVL 171
           Y APE+L
Sbjct: 181 YRAPELL 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.0 bits (132), Expect = 2e-09
 Identities = 48/176 (27%), Positives = 71/176 (40%), Gaps = 30/176 (17%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKE--------------LVAVKYI--ERGRKIDENV 45
           ++  L + LG G FG   L   +   E              LVAVK +  +  +    + 
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 46  AREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL------------FDRICNAG 93
            +EI     L++PNIIR   V ++   L ++ EY   G+L            F    N  
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124

Query: 94  RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
             S     Y   Q+ SG+ Y  S+   HRDL   N L+       +KI DFG S++
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRN 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 53.6 bits (129), Expect = 5e-09
 Identities = 46/191 (24%), Positives = 73/191 (38%), Gaps = 25/191 (13%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           E++ L + LG+G FG       K     VA+K ++    +  ++  +E+   + LRH ++
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGR--------YFFQQLISGVN 112
           I    V      + I+ E    G L   + +       EG+            Q+  G+ 
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKGSLLAFLRSP------EGQVLPVASLIDMACQVAEGMA 118

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS---KSSV-LHSRPKSTVGTPAYIAP 168
           Y       HRDL   N L+        K+ DFG +   K  V L S  K       + AP
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY---KWTAP 173

Query: 169 EVLSRREYDGK 179
           E  S   +  K
Sbjct: 174 EAASHGTFSTK 184

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 53.5 bits (128), Expect = 6e-09
 Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 20/156 (12%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +L K LGAG FG V     +K TK  VAVK ++ G    E    E    ++L+H  +
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--------FFQQLISGVN 112
           ++   VV T   + I+ E+ A G L D +        DEG          F  Q+  G+ 
Sbjct: 64  VKLHAVV-TKEPIYIITEFMAKGSLLDFL------KSDEGSKQPLPKLIDFSAQIAEGMA 116

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           +       HRDL+  N L+  SA+   KI DFG ++
Sbjct: 117 FIEQRNYIHRDLRAANILV--SASLVCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 52.8 bits (127), Expect = 1e-08
 Identities = 45/164 (27%), Positives = 67/164 (40%), Gaps = 23/164 (14%)

Query: 6   LVKDLGAGNFGVARL-----LRHKETKELVAVKYIERG--RKIDENVAREIINHRSLRHP 58
           L ++LG G FG   L     L  +  KELVAVK ++        ++  RE     + +H 
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGEL----------FDRICNA----GRFSEDEGRYFF 104
           NI++F  V        +V EY   G+L             + +     G  +  +     
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 105 QQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            Q+ SG+ Y  S    HRDL   N L+       +KI DFG S+
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 52.4 bits (126), Expect = 1e-08
 Identities = 45/153 (29%), Positives = 66/153 (43%), Gaps = 19/153 (12%)

Query: 5   ELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           +L++ LGAG FG V   L +  T   VAVK ++ G    ++   E    + LRHP +I+ 
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL 66

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF-FQQLI-------SGVNYCH 115
             V      + IV E    G L + +          GR     QLI       SG+ Y  
Sbjct: 67  YAVCTLEEPIYIVTELMKYGSLLEYLQG------GAGRALKLPQLIDMAAQVASGMAYLE 120

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           +    HRDL   N L+  +     K+ DFG ++
Sbjct: 121 AQNYIHRDLAARNVLVGENNI--CKVADFGLAR 151

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 52.4 bits (126), Expect = 2e-08
 Identities = 48/179 (26%), Positives = 86/179 (48%), Gaps = 23/179 (12%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYI-------ERGRKI-DENVAREIINHRSLR 56
           E++++LG G +GV   +RH  T  ++AVK I       E+ R + D +++      RS+ 
Sbjct: 4   EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISM-----RSVD 58

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDE--GRYFFQQLISGVN 112
            P  + F   +     + I ME       + + ++ + G    ++  G+     ++  + 
Sbjct: 59  CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS-IVKALE 117

Query: 113 YCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPE 169
           Y HS + + HRD+K  N L++     ++K+CDFG S   V  S  K+   G   Y+APE
Sbjct: 118 YLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPE 173

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 52.2 bits (125), Expect = 2e-08
 Identities = 38/134 (28%), Positives = 59/134 (44%), Gaps = 15/134 (11%)

Query: 29  LVAVKYI--ERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELF 86
           LVAVK +  +  +    +  +EI     L+ PNIIR   V +T   L ++ EY   G+L 
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 87  DRIC-----------NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA 135
             +            +    S     +   Q+ SG+ Y  S+   HRDL   N L+  + 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY 167

Query: 136 APRLKICDFGYSKS 149
              +KI DFG S++
Sbjct: 168 T--IKIADFGMSRN 179

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 52.0 bits (125), Expect = 2e-08
 Identities = 50/191 (26%), Positives = 81/191 (42%), Gaps = 27/191 (14%)

Query: 2   EKYELVKDLGAGNFG---VARLLRHKETKELVAVKY--IERGRKIDENVAREIINHRSLR 56
           E   L + +G G FG       +  +  K  VAVK         + E   +E    R   
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--------FFQQLI 108
           HP+I++   V+ T   + IVME A  GEL         + +             +  QL 
Sbjct: 66  HPHIVKLIGVI-TENPVWIVMELAPLGEL-------RSYLQVNKYSLDLASLILYSYQLS 117

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPR-LKICDFGYSKSSVLHSRPKSTVGT-P-AY 165
           + + Y  S +  HRD+   N L+   ++P  +K+ DFG S+     S  K++ G  P  +
Sbjct: 118 TALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKW 174

Query: 166 IAPEVLSRREY 176
           +APE ++ R +
Sbjct: 175 MAPESINFRRF 185

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.5 bits (123), Expect = 3e-08
 Identities = 50/157 (31%), Positives = 71/157 (45%), Gaps = 22/157 (14%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +L+K LG G FG V     +  TK  VAVK ++ G    E+   E    + LRH  +
Sbjct: 6   ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSED-EGRYF--------FQQLISGV 111
           ++   VV +   + IV EY + G L D       F +D EGR            Q+ +G+
Sbjct: 64  VQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKDGEGRALKLPNLVDMAAQVAAGM 115

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            Y   M   HRDL+  N L+        KI DFG ++
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLV--CKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 51.1 bits (122), Expect = 4e-08
 Identities = 55/187 (29%), Positives = 84/187 (44%), Gaps = 22/187 (11%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRH 57
           ++K  L + +G G FG   +L+ + T + VAVK I    K D   +    E      L H
Sbjct: 5   LQKLTLGEIIGEGEFGA--VLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHH 58

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCH 115
            N++R   V+L    L IVME  + G L + +   GR      +   F   +  G+ Y  
Sbjct: 59  KNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117

Query: 116 SMQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-YIAPEVLS 172
           S ++ HRDL   N L+  DG A    K+ DFG ++   + S        P  + APE L 
Sbjct: 118 SKKLVHRDLAARNILVSEDGVA----KVSDFGLAR---VGSMGVDNSKLPVKWTAPEALK 170

Query: 173 RREYDGK 179
            +++  K
Sbjct: 171 HKKFSSK 177

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 50.8 bits (121), Expect = 5e-08
 Identities = 45/143 (31%), Positives = 59/143 (41%), Gaps = 7/143 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR---HPNIIRFKEV 66
           +G GNFG     R +     VAVK        D   A+ +   R L+   HPNI+R   V
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK-AKFLQEARILKQYSHPNIVRLIGV 61

Query: 67  VLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                 + IVME   GG+    +   G R    E     +   +G+ Y  S    HRDL 
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121

Query: 126 LENTLLDGSAAPRLKICDFGYSK 148
             N L+       LKI DFG S+
Sbjct: 122 ARNCLVTEKNV--LKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 49.8 bits (119), Expect = 1e-07
 Identities = 41/143 (28%), Positives = 57/143 (39%), Gaps = 8/143 (5%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL---RHPNIIRFKEV 66
           +G GNFG       K     VAVK   R     +   + +     L    HPNI++   V
Sbjct: 3   IGKGNFGDVYKGVLK-GNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 67  VLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
            +    + IVME   GG L   +     R +  +         +G+ Y  S    HRDL 
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120

Query: 126 LENTLLDGSAAPRLKICDFGYSK 148
             N L+  +    LKI DFG S+
Sbjct: 121 ARNCLVGENNV--LKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 49.7 bits (119), Expect = 1e-07
 Identities = 45/163 (27%), Positives = 63/163 (38%), Gaps = 23/163 (14%)

Query: 5   ELVKDLGAGNFG-----VARLLRHKETKELVAVKYI-ERGRKIDE-NVAREIINHRSLRH 57
            L++ LG G FG     + R       +  VAVK + E   + DE +   E +      H
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGEL--FDRIC--NAGRFSEDEGRYFFQQLI----- 108
            NI+R   V        I++E  AGG+L  F R       R S        + L+     
Sbjct: 69  QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSS----LTMKDLLFCARD 124

Query: 109 --SGVNYCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSK 148
              G  Y       HRD+   N LL      R+ KI DFG ++
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 49.4 bits (118), Expect = 2e-07
 Identities = 41/173 (23%), Positives = 68/173 (39%), Gaps = 29/173 (16%)

Query: 1   MEKYELVKDLGAGNFG-VAR----LLRHKETKELVAVKYIERGR--KIDENVAREIINHR 53
           +     +++LG G FG V +        + +   VA+K ++     K+ +   +E     
Sbjct: 4   LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS 63

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSEDEGRY------- 102
            L+HPNI+    V        ++ EY A G+L +       ++   +E            
Sbjct: 64  DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123

Query: 103 --FFQ---QLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL--KICDFGYSK 148
             F     Q+ +G+ Y  S    HRDL   N L+       L  KI DFG S+
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV----GEGLTVKISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 48.7 bits (116), Expect = 2e-07
 Identities = 38/141 (26%), Positives = 58/141 (41%), Gaps = 4/141 (2%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 74  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 133

Query: 128 NTLLDGSAAPRLKICDFGYSK 148
           N L+       +K+ DFG S+
Sbjct: 134 NCLV--GENHLVKVADFGLSR 152

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 48.3 bits (115), Expect = 4e-07
 Identities = 47/175 (26%), Positives = 69/175 (39%), Gaps = 31/175 (17%)

Query: 3   KYELVKDLGAGNFGV---ARL--LRHKETKELVAVKYIERGRKID--ENVAREIINHRSL 55
             E V+D+G G FG    AR   L   E   +VAVK ++     D   +  RE       
Sbjct: 6   NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD--------------------RICNAGR- 94
            HPNI++   V      + ++ EY A G+L +                    R C     
Sbjct: 66  DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125

Query: 95  -FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             S  E     +Q+ +G+ Y    +  HRDL   N L+  +    +KI DFG S+
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 47.6 bits (113), Expect = 7e-07
 Identities = 42/148 (28%), Positives = 65/148 (43%), Gaps = 10/148 (6%)

Query: 8   KDLGAGNFGVAR--LLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRHPNII 61
            +LG+GNFG  +  + + K++++ VAVK I +    D  +  E++      + L +P I+
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIV 59

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           R   +        +VME A  G L   +      +E        Q+  G+ Y       H
Sbjct: 60  RMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKS 149
           RDL   N LL        KI DFG SK+
Sbjct: 119 RDLAARNVLL--VTQHYAKISDFGLSKA 144

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 47.4 bits (113), Expect = 9e-07
 Identities = 55/205 (26%), Positives = 85/205 (41%), Gaps = 35/205 (17%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRS 54
           ++  L K LG G FG      A  L +      VAVK ++      +  ++  E+   + 
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI---------CNAGRFSEDEGRYFF 104
           + +H NII    V      L +V+EYAA G L D +          +       E     
Sbjct: 72  IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 105 QQLIS-------GVNYCHSMQICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRP 156
           + L+S       G+ +  S +  HRDL   N L+ +      +KI DFG ++   +H   
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV---MKIADFGLARD--IHHID 186

Query: 157 ---KSTVG-TPA-YIAPEVLSRREY 176
              K+T G  P  ++APE L  R Y
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVY 211

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.5 bits (113), Expect = 1e-06
 Identities = 28/85 (32%), Positives = 40/85 (47%), Gaps = 17/85 (20%)

Query: 104 FQQLISGVNYCHSMQICHRDLKLENTLL---------DGSAAPRLK-----ICDFGYSKS 149
           F ++ + + Y HS  + HRDLK +N LL         D  AA   K     + D    + 
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 150 SVLHSR---PKSTVGTPAYIAPEVL 171
           ++ +S    P   VGTP Y+APE L
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERL 203

Length = 932

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 46.6 bits (111), Expect = 1e-06
 Identities = 46/192 (23%), Positives = 79/192 (41%), Gaps = 27/192 (14%)

Query: 5   ELVKDLGAGNFGVARLLRHK--------ETKELVAVKYI--ERGRKIDENVAREIINHRS 54
           E +K LG+G FG      +K        + K  VA+K +  E   K ++ +  E     S
Sbjct: 10  EKIKVLGSGAFGTV----YKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS 65

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNY 113
           + HP+++R   + L+     ++ +    G L D +  +           +  Q+  G++Y
Sbjct: 66  VDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPA-----YIA 167
               ++ HRDL   N L+     P+  KI DFG +K  +L    K            ++A
Sbjct: 125 LEEKRLVHRDLAARNVLVK---TPQHVKITDFGLAK--LLDVDEKEYHAEGGKVPIKWMA 179

Query: 168 PEVLSRREYDGK 179
            E +  R Y  K
Sbjct: 180 LESILHRIYTHK 191

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 46.5 bits (110), Expect = 2e-06
 Identities = 46/181 (25%), Positives = 75/181 (41%), Gaps = 15/181 (8%)

Query: 5   ELVKDLGAG--NFGVARLLRHKETKELVAVKYIERGRKIDENV---AREIINHRSLRHPN 59
           EL  ++G G  N     L RH  T  LV V+  +     +E++     E++     RHPN
Sbjct: 1   ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60

Query: 60  IIRFKEVVLTPTHLAIV---MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+    V  T + L ++   M Y +   L       G  SE          + G+NY H 
Sbjct: 61  IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQ 119

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYS------KSSVLHSRPKSTVGTPAYIAPEV 170
               HR++K  + L+ G     L      YS      K+ V++  P+ +     +++PE+
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179

Query: 171 L 171
           L
Sbjct: 180 L 180

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 46.1 bits (109), Expect = 2e-06
 Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 10/147 (6%)

Query: 9   DLGAGNFGVAR--LLRHKETKELVAVKYIERG--RKIDENVAREIINHRSLRHPNIIRFK 64
           +LG+GNFG  +  + + ++ +  VA+K ++    + + + + RE      L +P I+R  
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHR 122
            V      L +VME A+GG L ++  +  +   +         Q+  G+ Y       HR
Sbjct: 62  GVC-EAEALMLVMEMASGGPL-NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKS 149
           DL   N LL        KI DFG SK+
Sbjct: 120 DLAARNVLLVNQHYA--KISDFGLSKA 144

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 46.1 bits (109), Expect = 3e-06
 Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 18/157 (11%)

Query: 3   KYELVKDLGAGNFG-VARLLRHKETKEL---VAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG V + L   E +++   VA+K +      K ++ +  E     S+ 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 68  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 122

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 123 NYLEERRLVHRDLAARNVLVKTPQ--HVKITDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 45.6 bits (108), Expect = 3e-06
 Identities = 43/159 (27%), Positives = 61/159 (38%), Gaps = 22/159 (13%)

Query: 10  LGAGNFG------VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPN 59
           LG+G FG         +L        VAVK + +G    E    E +    L     HPN
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLIS-------GVN 112
           I++   V L      I+ME   GG+L   + +A            ++L+        G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 113 YCHSMQICHRDLKLENTLL---DGSAAPRLKICDFGYSK 148
           Y   M   HRDL   N L+      A   +KI DFG ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 45.1 bits (106), Expect = 6e-06
 Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 21/162 (12%)

Query: 6   LVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPN 59
           L ++LG G FG   L     L  ++ K LVAVK ++       ++  RE     +L+H +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-------------RFSEDEGRYFFQQ 106
           I++F  V +    L +V EY   G+L   +   G               ++ +  +  QQ
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           + +G+ Y  S    HRDL   N L+  +    +KI DFG S+
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 44.9 bits (106), Expect = 7e-06
 Identities = 44/180 (24%), Positives = 74/180 (41%), Gaps = 45/180 (25%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKY---IERGRKIDENVAREII------NHRS------ 54
           LG G FG   L      ++L  +++   + +GR +   VA +I+      N R+      
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPL--LVAVKILRPDANKNARNDFLKEV 70

Query: 55  -----LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGR-------- 101
                L+ PNIIR   V +    L ++ EY   G+L ++  ++    + E          
Sbjct: 71  KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPA 129

Query: 102 ------------YFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
                       +   Q+ SG+ Y  S+   HRDL   N L+  +    +KI DFG S++
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSRN 187

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 44.3 bits (104), Expect = 9e-06
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T + VA+K ++ G  + E   +E    + LRH  ++
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLV 64

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
               VV +   + IV E+   G L D +       E +G+Y           Q+  G+ Y
Sbjct: 65  PLYAVV-SEEPIYIVTEFMGKGSLLDFL------KEGDGKYLKLPQLVDMAAQIADGMAY 117

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     KI DFG ++
Sbjct: 118 IERMNYIHRDLRAANILVGDNLV--CKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 43.9 bits (103), Expect = 1e-05
 Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 10/151 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 64

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSE----DEGRYFFQQLISGVNYCHSM 117
           +   VV +   + IV EY + G L D +   G   +     +      Q+ SG+ Y   M
Sbjct: 65  QLYAVV-SEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERM 121

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              HRDL+  N L+  +     K+ DFG ++
Sbjct: 122 NYVHRDLRAANILVGENLV--CKVADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 43.8 bits (103), Expect = 1e-05
 Identities = 56/188 (29%), Positives = 78/188 (41%), Gaps = 40/188 (21%)

Query: 10  LGAGNFGVARLLRHKET---KELVAVKYIERGRKIDENVAREIINHRSLR---HPNIIRF 63
           LG GNFG       K T   K  VAVK  +     +  + + +   R L+   HPNI++ 
Sbjct: 3   LGKGNFGEV----FKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKL 57

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVNYCHS 116
             V      + IVME   GG+    +    R  +DE +   +QL+       +G+ Y  S
Sbjct: 58  IGVCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLES 111

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK--------SSVLHSRPKSTVGTPAYIAP 168
               HRDL   N L+  +    LKI DFG S+        SS L   P        + AP
Sbjct: 112 KNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAP 163

Query: 169 EVLSRREY 176
           E L+   Y
Sbjct: 164 EALNYGRY 171

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 43.8 bits (103), Expect = 1e-05
 Identities = 52/168 (30%), Positives = 74/168 (44%), Gaps = 30/168 (17%)

Query: 6   LVKDLGAGNFGVARL-----LRHKETKELVAVKYIE----RGRKIDENVAREIINHRSLR 56
           L ++LG G FG   L     L   + K LVAVK ++      RK  +  A  + N   L+
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN---LQ 65

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FDR-------ICNAGRFSEDEGRYFFQQL 107
           H +I++F  V      L +V EY   G+L  F R       I   G+  + +G     Q+
Sbjct: 66  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 108 I-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           +       SG+ Y  S    HRDL   N L+   A   +KI DFG S+
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 43.4 bits (102), Expect = 2e-05
 Identities = 47/162 (29%), Positives = 69/162 (42%), Gaps = 25/162 (15%)

Query: 9   DLGAGNFGVARL-----LRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPNIIR 62
           +LG G FG   L     L  ++ K LVAVK + E      ++  RE      L+H +I+R
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQ 106
           F  V      L +V EY   G+L +R   +                G+ +  +      Q
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           + SG+ Y  S+   HRDL   N L+       +KI DFG S+
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.3 bits (102), Expect = 2e-05
 Identities = 31/80 (38%), Positives = 40/80 (50%), Gaps = 15/80 (18%)

Query: 105 QQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKIC--DFGY------SKSSVLHSRP 156
           +QL+S ++Y H   I HRD+K EN L++G       IC  DFG       S S+  H   
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322

Query: 157 KSTVGTPAYIAPEVLSRREY 176
             TV T    APEVL+   Y
Sbjct: 323 AGTVDTN---APEVLAGDPY 339

Length = 461

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 43.1 bits (101), Expect = 2e-05
 Identities = 46/175 (26%), Positives = 70/175 (40%), Gaps = 29/175 (16%)

Query: 10  LGAGNFG--VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-----RHPNIIR 62
           +G GNFG  +  +++    K   A+K ++      EN  R+      +      HPNII 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFD-----RIC-----------NAGRFSEDEGRYFFQQ 106
                    +L I +EYA  G L D     R+             A   +  +   F   
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG 161
           + +G+ Y    Q  HRDL   N L+  + A   KI DFG S+   ++   K T+G
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMG 178

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 43.0 bits (101), Expect = 3e-05
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 37/207 (17%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKE------LVAVKYIERGRKIDENVAREIINHRS 54
           ++  L K LG G FG V R   +   K        VAVK + +    D+++A ++I+   
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLA-DLISEME 69

Query: 55  L-----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-----FSED-----E 99
           L     +H NII    V      L +++EYAA G L + +  A R     ++ D     E
Sbjct: 70  LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPE 128

Query: 100 GRYFFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--S 150
            +  F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++    
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV--TEDNVMKIADFGLARGVHD 186

Query: 151 VLHSRPKSTVGTPA-YIAPEVLSRREY 176
           + + +  S    P  ++APE L  R Y
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVY 213

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 43.0 bits (101), Expect = 3e-05
 Identities = 52/214 (24%), Positives = 80/214 (37%), Gaps = 42/214 (19%)

Query: 3   KYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSL 55
              L K LG G FG      A  L+ +     VAVK ++      E  ++  E    + +
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----FDRICNAGRFSEDEGRY-------- 102
            HP++I+          L +++EYA  G L       R         D  R         
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 103 -----------FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--- 148
                      F  Q+  G+ Y   M++ HRDL   N L+  +   ++KI DFG S+   
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVY 178

Query: 149 ---SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
              S V  S+ +  V    ++A E L    Y  +
Sbjct: 179 EEDSYVKRSKGRIPV---KWMAIESLFDHIYTTQ 209

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 42.3 bits (99), Expect = 4e-05
 Identities = 49/194 (25%), Positives = 81/194 (41%), Gaps = 22/194 (11%)

Query: 6   LVKDLGAGNFG--VARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNI 60
           L K LG G FG  +   L   ++   VAVK ++     R   E+   E +  +   HPN+
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 61  IRFKEVVLTPTHL------AIVMEYAAGGEL-----FDRICNAGRFSEDEGRY-FFQQLI 108
           +R   V L            +++ +   G+L     + R+ +  ++   +    F   + 
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--SVLHSRPKSTVGTPA-Y 165
           SG+ Y  S    HRDL   N +L+ +    + + DFG SK   +  + R       P  +
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180

Query: 166 IAPEVLSRREYDGK 179
           IA E L+ R Y  K
Sbjct: 181 IAIESLADRVYTTK 194

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 42.6 bits (100), Expect = 4e-05
 Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 33/196 (16%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN-- 59
           ++++++  LG G FG       ++ KE  AVK +    K   +   EI     +R  +  
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPA 188

Query: 60  ----IIRFKEVVLTPT-HLAIVM-EYAAGGELFDRICNAGRFSEDEGRYFFQ---QLISG 110
               +++ +      T H+ IVM +Y  G  L D I   G FS    R+  Q   Q    
Sbjct: 189 DRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSH---RHLAQIIFQTGVA 243

Query: 111 VNYCHS-MQICHRDLKLENTLLDGS----------AAP----RLKICDFGYSKSSVLHSR 155
           ++Y H+ + + H DLK EN L++ S          A P    R++ICD G       HSR
Sbjct: 244 LDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSR 302

Query: 156 PKSTVGTPAYIAPEVL 171
             + V T  Y +PEV+
Sbjct: 303 -TAIVSTRHYRSPEVV 317

Length = 467

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 42.0 bits (98), Expect = 5e-05
 Identities = 42/175 (24%), Positives = 69/175 (39%), Gaps = 29/175 (16%)

Query: 10  LGAGNFG--VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-----RHPNIIR 62
           +G GNFG  +   ++    +   A+K ++      ++  R+      +      HPNII 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFD-----RIC-----------NAGRFSEDEGRYFFQQ 106
                    +L + +EYA  G L D     R+             A   S  +  +F   
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG 161
           +  G++Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMG 171

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 41.6 bits (97), Expect = 7e-05
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 16/152 (10%)

Query: 7   VKDLGAGNFGVAR---LLRHKETKEL-VAVKYIER--GRKIDENVAREIINHRSLRHPNI 60
           VK LG+G FG       +   ET ++ VA+K +    G K +     E +   S+ HP++
Sbjct: 12  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQ----QLISGVNYCHS 116
           +R   V L+PT + +V +    G L D +       ++ G         Q+  G+ Y   
Sbjct: 72  VRLLGVCLSPT-IQLVTQLMPHGCLLDYV---HEHKDNIGSQLLLNWCVQIAKGMMYLEE 127

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            ++ HRDL   N L+   +   +KI DFG ++
Sbjct: 128 RRLVHRDLAARNVLV--KSPNHVKITDFGLAR 157

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 41.4 bits (97), Expect = 8e-05
 Identities = 37/152 (24%), Positives = 64/152 (42%), Gaps = 21/152 (13%)

Query: 8   KDLGAGNFG------VARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPN 59
            ++G G FG        R +     K  V VK +      DE +   +E+  +R L HPN
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMS----KARVVVKELRASATPDEQLLFLQEVQPYRELNHPN 56

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQL----ISGVNY 113
           +++     +      +V+E+   G+L  + R    G  ++   +   Q++     SG+ +
Sbjct: 57  VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNR-GMVAQMAQKDVLQRMACEVASGLLW 115

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
            H     H DL L N  L    +  +KI D+G
Sbjct: 116 LHQADFIHSDLALRNCQLTADLS--VKIGDYG 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 41.3 bits (97), Expect = 9e-05
 Identities = 40/168 (23%), Positives = 64/168 (38%), Gaps = 34/168 (20%)

Query: 6   LVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           L K LG G FG     +L +   ++  VAVK +    K+D       E    E    +  
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDF 58

Query: 56  RHPNIIRFKEVVLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI- 108
            HPN+++   V    + L       +++ +   G+L   +    R      +   Q L+ 
Sbjct: 59  DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLK 117

Query: 109 ------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKIC--DFGYSK 148
                  G+ Y  +    HRDL   N +L       + +C  DFG SK
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 41.3 bits (97), Expect = 1e-04
 Identities = 42/158 (26%), Positives = 64/158 (40%), Gaps = 14/158 (8%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVAR----EIINH 52
                 K LGAG FG      A  L   +    VAVK ++      E  A     +I++H
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSE-DEGRYFFQQLISG 110
               H NI+           + ++ EY   G+L + +      F   ++   F  Q+  G
Sbjct: 95  LG-NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           + +  S    HRDL   N LL  +    +KICDFG ++
Sbjct: 154 MAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 41.0 bits (96), Expect = 1e-04
 Identities = 35/133 (26%), Positives = 61/133 (45%), Gaps = 9/133 (6%)

Query: 3   KYELVKDLGAGNFG-VARLLRH-KETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           +Y ++  L  G+ G V    +H  E ++ V VK +  G+       REI   +++ H  I
Sbjct: 93  QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAI 148

Query: 61  IRFKEVVLTPTHLAIVM-EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I         + + +VM +Y    +LF  +  +G    ++     ++L+  + Y H   I
Sbjct: 149 INLIHAYRWKSTVCMVMPKYKC--DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGI 206

Query: 120 CHRDLKLENTLLD 132
            HRD+K EN  LD
Sbjct: 207 IHRDVKTENIFLD 219

Length = 392

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 40.4 bits (94), Expect = 2e-04
 Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 33/205 (16%)

Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--------- 102
               +H NII           L +++EYA+ G L + +  A R    E  Y         
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIARVPDEQ 133

Query: 103 -FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVL 152
             F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  +++ 
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNNID 191

Query: 153 HSRPKSTVGTPA-YIAPEVLSRREY 176
           + +  +    P  ++APE L  R Y
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVY 216

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 40.1 bits (94), Expect = 2e-04
 Identities = 39/146 (26%), Positives = 64/146 (43%), Gaps = 9/146 (6%)

Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      L+     K   AVK + R   ++E     +E I  +   HPN++   
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 65  EVVLTPTHLA-IVMEYAAGGELFDRICNAGRFSEDEGRYFFQ-QLISGVNYCHSMQICHR 122
            + L       +V+ Y   G+L + I +       +    F  Q+  G+ Y  S +  HR
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR 122

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK 148
           DL   N +LD S    +K+ DFG ++
Sbjct: 123 DLAARNCMLDESFT--VKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 39.2 bits (91), Expect = 5e-04
 Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 23/166 (13%)

Query: 2   EKYELVKDLGAGNF-----GVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+F     G AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 6   EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63

Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELF--------DRICNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L         +   N GR      E   
Sbjct: 64  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123

Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 38.0 bits (88), Expect = 0.001
 Identities = 40/149 (26%), Positives = 64/149 (42%), Gaps = 11/149 (7%)

Query: 8   KDLGAGNFGVARL--LRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPNIIRF 63
           K++G G FG   L  +    T   V VK +     + E +    E   +RSL+H N+++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 64  KEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQ---QLISGVNYCHSMQ 118
                  T   +VME+   G+L  + R C        +     +   ++  G+ + H   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYS 147
             H DL L N LL  +A   +KI D+G S
Sbjct: 121 FIHSDLALRNCLL--TADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 37.6 bits (87), Expect = 0.002
 Identities = 39/143 (27%), Positives = 57/143 (39%), Gaps = 10/143 (6%)

Query: 10  LGAGNFG-VAR-LLRHKETKEL-VAVKYIERG--RKIDENVAREIINHRSLRHPNIIRFK 64
           LG G FG + R  L+    +EL VA+  +  G   K       E +      H NI+R +
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 65  EVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
            V+     + IV EY + G L  F R  + G+    +       L SG+ Y   M   H+
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEMGYVHK 131

Query: 123 DLKLENTLLDGSAAPRLKICDFG 145
            L     L++       KI  F 
Sbjct: 132 GLAAHKVLVNSDLV--CKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 37.7 bits (87), Expect = 0.002
 Identities = 43/173 (24%), Positives = 71/173 (41%), Gaps = 25/173 (14%)

Query: 10  LGAGNFG--VARLLRHKETKELVAVKYIERGRKIDE--NVAREI-INHRSLRHPNIIRFK 64
           +G GNFG  +   ++    +   A+K ++     D+  + A E+ +  +   HPNII   
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 65  EVVLTPTHLAIVMEYAAGGELFDRI----------------CNAGRFSEDEGRYFFQQLI 108
                  +L + +EYA  G L D +                  A   S  +  +F   + 
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG 161
            G++Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMG 183

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 37.6 bits (87), Expect = 0.002
 Identities = 38/150 (25%), Positives = 64/150 (42%), Gaps = 18/150 (12%)

Query: 7   VKDLGAGNFGVARLLRHK--------ETKELVAVKYIE--RGRKIDENVAREIINHRSLR 56
           +K LG+G FG      HK          K  VA+K I+   GR+  + +   ++   SL 
Sbjct: 12  LKLLGSGVFGTV----HKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCH 115
           H  I+R   +    + L +V + +  G L D +  +           +  Q+  G+ Y  
Sbjct: 68  HAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFG 145
             ++ HR+L   N LL   +   ++I DFG
Sbjct: 127 EHRMVHRNLAARNILLKSDS--IVQIADFG 154

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 37.3 bits (86), Expect = 0.002
 Identities = 39/142 (27%), Positives = 60/142 (42%), Gaps = 25/142 (17%)

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------FDRICNAGRFSEDEGRYFF 104
           +H NII           L +++EYA+ G L            D   +  +  E++    F
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ--LTF 133

Query: 105 QQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRP 156
           + L+S       G+ Y  S +  HRDL   N L+       +KI DFG ++    +    
Sbjct: 134 KDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDYYK 191

Query: 157 KSTVGT-PA-YIAPEVLSRREY 176
           K+T G  P  ++APE L  R Y
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVY 213

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 37.3 bits (86), Expect = 0.002
 Identities = 41/178 (23%), Positives = 75/178 (42%), Gaps = 16/178 (8%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           + +++    G  G A      +T E V +K  +RG       A E    R++ HP+II+ 
Sbjct: 94  FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG-----GTATEAHILRAINHPSIIQL 148

Query: 64  KEVVLTPTHLAIVM-EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
           K          +++  Y    +L+  +      +  +     + ++  + Y H  +I HR
Sbjct: 149 KGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHR 206

Query: 123 DLKLENTLLDGSAAPRLKIC--DFGYS--KSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           D+K EN  ++        +C  DFG +     +  ++     GT A  APE+L+R  Y
Sbjct: 207 DIKAENIFINHPG----DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY 260

Length = 391

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 36.9 bits (85), Expect = 0.003
 Identities = 31/139 (22%), Positives = 58/139 (41%), Gaps = 20/139 (14%)

Query: 25  ETKELVAVKYIERGRKID--ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG 82
           E  + VA+K ++   +    E    E +    L+HPNI+    VV     L+++  Y + 
Sbjct: 33  EQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSH 92

Query: 83  GELFD----RICNAGRFSEDEGR------------YFFQQLISGVNYCHSMQICHRDLKL 126
            +L +    R  ++   S D+ +            +   Q+ +G+ +  S  + H+DL  
Sbjct: 93  SDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLAT 152

Query: 127 ENTLLDGSAAPRLKICDFG 145
            N L+       +KI D G
Sbjct: 153 RNVLVFDKLN--VKISDLG 169

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 37.0 bits (85), Expect = 0.004
 Identities = 24/71 (33%), Positives = 39/71 (54%), Gaps = 8/71 (11%)

Query: 105 QQLISGVNYCHSMQICHRDLKLENTL--LDGSAAPRLKICDFGYS--KSSVLHSRPKSTV 160
           +Q+++G+   H + I HRD+K EN L  +DG    ++KI DFG +    + ++  P   +
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDG----QVKIIDFGAAVDMCTGINFNPLYGM 371

Query: 161 GTPAYIAPEVL 171
             P Y  PE L
Sbjct: 372 LDPRYSPPEEL 382

Length = 507

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 36.4 bits (84), Expect = 0.004
 Identities = 47/168 (27%), Positives = 66/168 (39%), Gaps = 30/168 (17%)

Query: 4   YELVKDLGAGNFGVAR---LLRHKETKELVAVKYIERGRKID-------ENVAREIINHR 53
           + L + LG G FG  R   L     + + VAVK +    K D       E   RE    +
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML----KADIFSSSDIEEFLREAACMK 56

Query: 54  SLRHPNIIRFKEVVL---TPTHLAIVM---EYAAGGELFDRICNAGRFSEDEGRYFFQQL 107
              HPN+I+   V L       L I M    +   G+L   +    R  E+      Q L
Sbjct: 57  EFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTL 115

Query: 108 I-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           +       SG+ Y  S    HRDL   N +L+ +    + + DFG SK
Sbjct: 116 VRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	181
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.98
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.98
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.98
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.98
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.98
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.98
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.98
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.98
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.98
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.98
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.98
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.98
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.98
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.98
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.98
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.98
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.98
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.98
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.98
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.98
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.98
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.98
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.98
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.98
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.98
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.98
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.98
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.98
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.98
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.98
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.98
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.98
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.98
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.98
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.98
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.98
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.98
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.97
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
PHA02988	283	hypothetical protein; Provisional	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
PRK09188	365	serine/threonine protein kinase; Provisional	99.96
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.96
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.96
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.96
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.96
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.95
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.93
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.93
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.92
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.92
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.92
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
smart00090	237	RIO RIO-like kinase.	99.9
PRK10345	210	hypothetical protein; Provisional	99.9
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.88
PRK14879	211	serine/threonine protein kinase; Provisional	99.88
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.87
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.86
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.85
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.82
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.8
PLN00181	793	protein SPA1-RELATED; Provisional	99.8
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.8
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.72
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.7
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.67
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.67
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.66
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.66
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.65
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.64
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.64
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.62
KOG3087	229	consensus Serine/threonine protein kinase [General	99.57
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.56
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.56
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.53
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.52
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.5
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.46
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.41
KOG1243	690	consensus Protein kinase [General function predict	99.37
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.35
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.32
PRK09902	216	hypothetical protein; Provisional	99.3
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.28
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.28
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.27
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.27
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	99.15
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	99.14
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.01
COG0661	517	AarF Predicted unusual protein kinase [General fun	99.0
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.93
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.91
PLN02876	822	acyl-CoA dehydrogenase	98.89
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.79
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.74
PF01636	239	APH: Phosphotransferase enzyme family This family	98.73
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.69
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.69
KOG2270	520	consensus Serine/threonine protein kinase involved	98.66
COG4248	637	Uncharacterized protein with protein kinase and he	98.64
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.54
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.45
PRK10593	297	hypothetical protein; Provisional	98.45
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.36
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.24
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.22
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.2
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.18
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.16
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	98.1
PRK05231	319	homoserine kinase; Provisional	98.1
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.08
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.06
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	98.01
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.95
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.89
KOG2137	700	consensus Protein kinase [Signal transduction mech	97.79
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.79
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.7
PLN02236	344	choline kinase	97.7
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.7
COG2334	331	Putative homoserine kinase type II (protein kinase	97.59
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.57
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.55
PLN02756	418	S-methyl-5-thioribose kinase	97.54
PRK11768	325	serine/threonine protein kinase; Provisional	97.52
PRK12396	409	5-methylribose kinase; Reviewed	97.36
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.3
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	97.29
PTZ00384	383	choline kinase; Provisional	97.27
PRK06148	1013	hypothetical protein; Provisional	97.17
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.14
PTZ00296	442	choline kinase; Provisional	96.92
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.88
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.64
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	96.56
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.05

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-47  Score=273.49  Aligned_cols=180  Identities=39%  Similarity=0.648  Sum_probs=166.6

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc---ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +++|.+.+.||+|.|++||+|.+++++..||||.+...   ++..+.+..|+.+++.++|||||.++++...++++|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            46899999999999999999999999999999998764   233466788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccC-CC---CcEEEeecCCcccccCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-AA---PRLKICDFGYSKSSVLH  153 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~-~~---~~v~l~dfg~a~~~~~~  153 (181)
                      |||.+|+|.+++...+.+++.+++.++.|++.||++||+++|+||||||+||+++.. ..   ..+||.|||+|+...+.
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            999999999999999999999999999999999999999999999999999999643 22   57999999999999988


Q ss_pred             CCCCcccCCCCccCcccccCCccCCCC
Q 030211          154 SRPKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ....+.+|+|-|||||++..+.|+.|.
T Consensus       169 ~~a~tlcGSplYMAPEV~~~~~YdAKA  195 (429)
T KOG0595|consen  169 SMAETLCGSPLYMAPEVIMSQQYDAKA  195 (429)
T ss_pred             hHHHHhhCCccccCHHHHHhccccchh
Confidence            888999999999999999999999874

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-44  Score=258.57  Aligned_cols=177  Identities=41%  Similarity=0.647  Sum_probs=161.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccccc--------HHHHHHHHHHhhCCCCCeeEEEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--------ENVAREIINHRSLRHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~--------~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~   73 (181)
                      +.|.+.+.+|+|+||.|-+|..+.+++.||+|++.+.+...        ..+.+|+.+++++.|||||++.++|..+++.
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            56899999999999999999999999999999997643221        2357999999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccC-CCCcEEEeecCCcccccC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-AAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~-~~~~v~l~dfg~a~~~~~  152 (181)
                      |+||||++||.|.+.+-.+..+.+.....+++|++.|+.|||++||+||||||+||++..+ ....+||.|||+|+....
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~  331 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE  331 (475)
T ss_pred             EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence            9999999999999999999999999999999999999999999999999999999999655 445799999999998888


Q ss_pred             CCCCCcccCCCCccCcccccCCccCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      .....+++|||.|.|||++.++.++.
T Consensus       332 ~sfm~TlCGTpsYvAPEVl~~kg~~~  357 (475)
T KOG0615|consen  332 GSFMKTLCGTPSYVAPEVLASKGVEY  357 (475)
T ss_pred             ceehhhhcCCccccChhheecCCeec
Confidence            88899999999999999999876543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-44  Score=255.62  Aligned_cols=177  Identities=33%  Similarity=0.594  Sum_probs=160.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +.|++++.||+|+||.||.++.+++++.+|+|++++....    .+...+|..++..++||.||.+...|++...+|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            6799999999999999999999999999999999876432    356788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc-cCCCCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-VLHSRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~-~~~~~~  156 (181)
                      ||+.||.|...+..++.|++.+++.++..|+.||.|||++||+||||||+||+++.+++  ++|+|||+|+.. ..+...
T Consensus       105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~~~~t  182 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKDGDAT  182 (357)
T ss_pred             eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccCCCcc
Confidence            99999999999999999999999999999999999999999999999999999976665  999999999854 444455


Q ss_pred             CcccCCCCccCcccccCCccCCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      .+++||++|||||++.+.+|+..+
T Consensus       183 ~tfcGT~eYmAPEil~~~gy~~~v  206 (357)
T KOG0598|consen  183 RTFCGTPEYMAPEILLGKGYDKAV  206 (357)
T ss_pred             ccccCCccccChHHHhcCCCCccc
Confidence            567999999999999999998653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-43  Score=263.76  Aligned_cols=175  Identities=38%  Similarity=0.590  Sum_probs=163.0

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccc----cccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIER----GRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~----~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      +|..++.||+|||+.+|++++.++|..||+|++.+    .....+.+.+|+.+++++.|||||+++++|++++++|++.|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE   98 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence            69999999999999999999999999999999987    44556788999999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCCCCC
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSRPK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~~~~  157 (181)
                      +|..++|..++....++++.+++.++.||+.||.|||+++|+|||||..|+|++++.+  |||+|||+|.... +++...
T Consensus        99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk~  176 (592)
T KOG0575|consen   99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERKK  176 (592)
T ss_pred             ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCcccccc
Confidence            9999999999988889999999999999999999999999999999999999986666  9999999998775 558889


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +.+|||.|.|||++.+..++..
T Consensus       177 TlCGTPNYIAPEVl~k~gHsfE  198 (592)
T KOG0575|consen  177 TLCGTPNYIAPEVLNKSGHSFE  198 (592)
T ss_pred             eecCCCcccChhHhccCCCCCc
Confidence            9999999999999998877654

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-42  Score=240.19  Aligned_cols=175  Identities=34%  Similarity=0.637  Sum_probs=160.3

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++++.+|.|+||+|.+++.+.++..+|+|++.+.+-.    .+...+|..+++.+.||.++++.+.+.+.+++|++
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            47899999999999999999999999999999999876432    35677899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |||.+|+.|.+++.+.++|++..++.++.|++.|++|||+++|++|||||+||++|.++.  ++++|||+|+.....  .
T Consensus       123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~r--T  198 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSGR--T  198 (355)
T ss_pred             EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecCc--E
Confidence            999999999999999999999999999999999999999999999999999999976655  999999999865443  6


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+.+|||+|+|||.+...+|+-.
T Consensus       199 ~TlCGTPeYLAPEii~sk~ynka  221 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYNKA  221 (355)
T ss_pred             EEecCCccccChHHhhcCCCCcc
Confidence            67899999999999999999864

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=237.38  Aligned_cols=175  Identities=34%  Similarity=0.503  Sum_probs=158.1

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccc--cccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCe-EEEEEee
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTH-LAIVMEY   79 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~--~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~-~~~v~e~   79 (181)
                      +.+.++.||+|..|+||++.++-+++.+|+|.+.-  .+...+++.+|+.++...+||+||.+++.|..++. +.++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            56678899999999999999999999999999843  34446889999999999999999999999999994 9999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      |.+++|...+...+.+++.....++.+++++|.|||+ .+|+||||||+||+++..+.  |||+|||.+...... ...+
T Consensus       160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~a~t  236 (364)
T KOG0581|consen  160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-IANT  236 (364)
T ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-hccc
Confidence            9999999999888899999999999999999999996 89999999999999976555  999999998755444 7788


Q ss_pred             ccCCCCccCcccccCCccCCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      +.||..|||||-+.++.|+.++
T Consensus       237 fvGT~~YMsPERi~g~~Ys~~s  258 (364)
T KOG0581|consen  237 FVGTSAYMSPERISGESYSVKS  258 (364)
T ss_pred             ccccccccChhhhcCCcCCccc
Confidence            9999999999999999998764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=242.51  Aligned_cols=178  Identities=56%  Similarity=0.857  Sum_probs=161.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc----c--cccHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----R--KIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++++.||+|.||.|+.+.+..++..||+|++.+.    .  ...+.+.+|+.+++.++ ||||+++++++..+..++
T Consensus        17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~   96 (370)
T KOG0583|consen   17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY   96 (370)
T ss_pred             CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence            6899999999999999999999999999999987664    1  23456778999999999 999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc-cCC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-VLH  153 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~-~~~  153 (181)
                      +||||+.++.|.+++.+..++++..++.+++|++.|++|||++||+||||||+||+++.+. ..+||+|||++... ...
T Consensus        97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~~~~  175 (370)
T KOG0583|consen   97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISPGED  175 (370)
T ss_pred             EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccCCCC
Confidence            9999999999999998888999999999999999999999999999999999999997662 45999999999877 567


Q ss_pred             CCCCcccCCCCccCcccccCCc-cCCCC
Q 030211          154 SRPKSTVGTPAYIAPEVLSRRE-YDGKQ  180 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~  180 (181)
                      ......+|++.|+|||++.+.. |+++.
T Consensus       176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~  203 (370)
T KOG0583|consen  176 GLLKTFCGSPAYAAPEVLSGKGTYSGKA  203 (370)
T ss_pred             CcccCCCCCcccCCHHHhCCCCCcCCch
Confidence            7888899999999999999988 88654

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5e-41  Score=235.18  Aligned_cols=176  Identities=29%  Similarity=0.496  Sum_probs=156.2

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      |++|+.+.++|+|++|+||+++++++|+.||+|.|..++..   .+..++|++++++++|+|+|.++++|.....+++|+
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            78999999999999999999999999999999999876543   478899999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCCC
Q 030211           78 EYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSR  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~~  155 (181)
                      |||.. ++.+.+...+ -++.+.+..+.+|++.|+.|+|+++++||||||+||+|+  .++.+||+|||+|+... ++..
T Consensus        81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit--~~gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT--QNGVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe--cCCcEEeccchhhHhhcCCcch
Confidence            99966 5555554443 689999999999999999999999999999999999996  44559999999998776 7777


Q ss_pred             CCcccCCCCccCcccccC-CccCCC
Q 030211          156 PKSTVGTPAYIAPEVLSR-REYDGK  179 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~-~~~~~~  179 (181)
                      ...+..|..|.|||.+.+ -+|++.
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~p  182 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKP  182 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCc
Confidence            888999999999999998 556554

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.1e-39  Score=242.62  Aligned_cols=177  Identities=31%  Similarity=0.534  Sum_probs=154.9

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++.|+++++||+|+||.||+|+.+++|..+|+|+++++.-.    .+.+..|-.+|....++.+|+++..|++..++||+
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            47899999999999999999999999999999999886533    35677788889889999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-----
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-----  151 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-----  151 (181)
                      |||++||++..++.+.+.+++..++.++.+++.|++.||+.|++|+||||+|++||..++  +||.|||+|....     
T Consensus       220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhhhhh
Confidence            999999999999999999999999999999999999999999999999999999975555  9999999984211     


Q ss_pred             ------------------CCCCC-------------------------CcccCCCCccCcccccCCccCCC
Q 030211          152 ------------------LHSRP-------------------------KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       152 ------------------~~~~~-------------------------~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                                        +....                         .+++|||.|||||++.+..|+..
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~  368 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE  368 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence                              00000                         12459999999999999988753

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-40  Score=243.68  Aligned_cols=176  Identities=33%  Similarity=0.502  Sum_probs=154.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      .+|.+++.||.|.|++|++|+++++++.+|+|++.+.-.    ..+-+..|-..+.++ .||++++++..|++...+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            579999999999999999999999999999999876422    123455566667767 899999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-  155 (181)
                      +||.++|.|.+++++-+.|++..++.++.+|+.||+|||++|||||||||+||+++.|+.  ++|.|||.|+...+... 
T Consensus       153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPSQKS  230 (604)
T ss_pred             EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChhhcc
Confidence            999999999999999999999999999999999999999999999999999999976665  99999999976443222 


Q ss_pred             -------------CCcccCCCCccCcccccCCccCCC
Q 030211          156 -------------PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 -------------~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                                   ..+++||-+|++||++.++..++.
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~  267 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS  267 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCCcc
Confidence                         145789999999999999887765

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=243.97  Aligned_cols=174  Identities=36%  Similarity=0.526  Sum_probs=155.8

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccccc--HHHHHHHHHHhhCC-CCCeeEEEEeEEcCC-eEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLR-HPNIIRFKEVVLTPT-HLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~--~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~-~~~~v   76 (181)
                      ++||.+.+++|.|.||.||+|+.++++..||||.+++....-  -.-++|+..++++. ||||+++.+++.+++ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            579999999999999999999999999999999998754332  34567999999997 999999999999988 89999


Q ss_pred             EeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      |||| ...|.+.+... ..|+++.++.|+.||+++|+++|.+|+.|||+||+||+|..  ...|||+|||+|+.......
T Consensus        89 fE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~--~~~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   89 FEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG--NDVIKIADFGLAREVRSKPP  165 (538)
T ss_pred             HHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc--cceeEecccccccccccCCC
Confidence            9999 45899888654 47999999999999999999999999999999999999963  33499999999999999999


Q ss_pred             CCcccCCCCccCcccccCCccC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYD  177 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~  177 (181)
                      ...+..|..|.|||++.+..+-
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Y  187 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYY  187 (538)
T ss_pred             cchhhhcccccchHHhhhcccc
Confidence            9999999999999999876543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-41  Score=234.42  Aligned_cols=177  Identities=31%  Similarity=0.508  Sum_probs=152.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEE-eEEcCCe-EEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKE-VVLTPTH-LAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~-~~~~~~~-~~~v   76 (181)
                      +.|++.++||+|.||.||+|.+..+|..+|.|.++-+.   +..+....|+.++++++||||+++++ -|.+++. ++++
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            46999999999999999999999999999999887432   33467889999999999999999988 4545554 8999


Q ss_pred             EeecCCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh--cC--eeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211           77 MEYAAGGELFDRIC----NAGRFSEDEGRYFFQQLISGVNYCHS--MQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus        77 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~--~g--i~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      ||+|..|+|.+.+.    ....+++.++|.++.|++.||..+|.  ..  +.||||||.|||++.++  .+||+|||+++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g--vvKLGDfGL~r  176 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG--VVKLGDFGLGR  176 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC--ceeeccchhHh
Confidence            99999999987763    24579999999999999999999999  44  89999999999996544  59999999998


Q ss_pred             cccCCCC-CCcccCCCCccCcccccCCccCCCC
Q 030211          149 SSVLHSR-PKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       149 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ....... ..++.|||.|||||.+.+.+|++|+
T Consensus       177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kS  209 (375)
T KOG0591|consen  177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKS  209 (375)
T ss_pred             HhcchhHHHHhhcCCCcccCHHHHhcCCCCcch
Confidence            7654443 4567899999999999999999986

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=235.03  Aligned_cols=174  Identities=34%  Similarity=0.477  Sum_probs=151.7

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcE-EEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCC-eEEEEEe
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKEL-VAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPT-HLAIVME   78 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~-v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-~~~~v~e   78 (181)
                      ..+.+.+|+|+||+||++.+.  |.. ||+|++......   .+.+.+|+.++..++|||||++++++.++. ...+|||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            456677999999999999998  445 999999875433   358999999999999999999999999988 7999999


Q ss_pred             ecCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC-eeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-C
Q 030211           79 YAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQ-ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-S  154 (181)
Q Consensus        79 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~g-i~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~  154 (181)
                      |+++|+|.+++.+  ...++...+..++.||+.|++|||+++ |+|+||||+||+++.+. ..+||+|||+++..... .
T Consensus       121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~~~  199 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSREKVISKT  199 (362)
T ss_pred             eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccceeeccccc
Confidence            9999999999987  568999999999999999999999999 99999999999997554 25999999999765444 4


Q ss_pred             CCCcccCCCCccCccccc--CCccCCCC
Q 030211          155 RPKSTVGTPAYIAPEVLS--RREYDGKQ  180 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~--~~~~~~~~  180 (181)
                      ......||+.|||||+++  +.+|+.|+
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~  227 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKS  227 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccc
Confidence            444478999999999999  67888875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-38  Score=232.39  Aligned_cols=170  Identities=33%  Similarity=0.547  Sum_probs=147.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcC--CeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v   76 (181)
                      +.|+..++||+|+||.||+|++..+|+.||+|.+....   .......+|+.+|+++.||||+++.+...+.  +.+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            46888999999999999999999999999999887543   2246788999999999999999999998876  789999


Q ss_pred             EeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-
Q 030211           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-  154 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-  154 (181)
                      +|||+. +|..++.... .|++..+..++.|++.+|+|||.+|+.|||||.+||+||+++.  +||+|||+|....+.. 
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGS  273 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCCCC
Confidence            999965 8887776543 7999999999999999999999999999999999999975555  9999999998655444 


Q ss_pred             -CCCcccCCCCccCcccccCC
Q 030211          155 -RPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       155 -~~~~~~~~~~~~aPE~~~~~  174 (181)
                       .....+-|+.|.|||.+.+.
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~  294 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGA  294 (560)
T ss_pred             cccccceEEeeccChHHhcCC
Confidence             35566789999999998864

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.8e-37  Score=230.47  Aligned_cols=176  Identities=27%  Similarity=0.471  Sum_probs=152.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||+||+|.+..+++.+|+|++....    .....+.+|..++..++|++++++++.+.+.+.++++|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            57999999999999999999999999999999987532    12245777889999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC---
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~---  154 (181)
                      ||+++++|.+.+.+...+++..++.++.|++.||+|||++||+|+||||+||+++.++  .++|+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~--~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC--CEEEeeccCccccccccccc
Confidence            9999999999998888999999999999999999999999999999999999997655  49999999986432211   


Q ss_pred             ---------------------------------CCCcccCCCCccCcccccCCccCCC
Q 030211          155 ---------------------------------RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                                                       ......||+.|+|||++.+..++.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~  216 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL  216 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc
Confidence                                             0123468999999999998888765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=236.02  Aligned_cols=177  Identities=34%  Similarity=0.581  Sum_probs=156.9

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +++|++.+++|+|.||.|+++..+.++..+|||++++....    .+..+.|.+++... +||.+++++..|+...++|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            57899999999999999999999999999999999986432    35677788888766 59999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCC
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~  154 (181)
                      ||||+.|+++.. +...+.|++..++.++..++.||.|||++||++||||.+||++|.+++  +||+|||+|+..- .+.
T Consensus       447 vmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  447 VMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCCCCC
Confidence            999999999443 334468999999999999999999999999999999999999976666  9999999998654 666


Q ss_pred             CCCcccCCCCccCcccccCCccCCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ...+++|||+|||||++.+..|+..+
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~aV  549 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRAV  549 (694)
T ss_pred             ccccccCChhhcChhhhccCcccchh
Confidence            77888999999999999999998754

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.9e-37  Score=226.85  Aligned_cols=175  Identities=34%  Similarity=0.586  Sum_probs=154.5

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|+||.||++.+..+++.+|+|++....    ...+.+.+|+.++..++|||++++++.+.+.+..+++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            468999999999999999999999999999999987542    2235678899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |||+.+++|.+.+.+...+++..+..++.|++.||.|||++|++|+||+|+||++++++.  ++|+|||++......  .
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~--~  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPDR--T  172 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCCC--c
Confidence            999999999999988888999999999999999999999999999999999999976554  999999998754322  2


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....|++.|+|||++.+..++.+
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~  195 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHGKA  195 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCCCc
Confidence            34578999999999998887765

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.7e-37  Score=233.84  Aligned_cols=174  Identities=32%  Similarity=0.436  Sum_probs=157.1

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC-C-----CCeeEEEEeEEcCCeEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-H-----PNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~-~-----~~i~~~~~~~~~~~~~~~v   76 (181)
                      +|++.+.||+|.||+|-+|.+..+++.||||+++..+....+...|+.+|..++ |     -|+|+++++|...++.|+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            799999999999999999999999999999999988877788888999998886 3     3899999999999999999


Q ss_pred             EeecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           77 MEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +|.+ ..+|.+++..+.  .++...++.++.||+.+|..||+.|||||||||+|||+.+.....||++|||.++.....-
T Consensus       267 fELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v  345 (586)
T KOG0667|consen  267 FELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV  345 (586)
T ss_pred             ehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc
Confidence            9998 559999997665  6889999999999999999999999999999999999987777789999999997533332


Q ss_pred             CCCcccCCCCccCcccccCCccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .  ++..+..|.|||+|.+.+|+.+
T Consensus       346 y--tYiQSRfYRAPEVILGlpY~~~  368 (586)
T KOG0667|consen  346 Y--TYIQSRFYRAPEVILGLPYDTA  368 (586)
T ss_pred             e--eeeeccccccchhhccCCCCCc
Confidence            2  7889999999999999999875

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-37  Score=229.67  Aligned_cols=177  Identities=30%  Similarity=0.530  Sum_probs=153.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.++..++|+|++++++.+.+++.++++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            57999999999999999999999999999999987542    22345678999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--  155 (181)
                      ||+++++|.+++.....+++..++.++.|++.||+|||++|++|+||||+||+++.++.  ++|+|||++........  
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence            99999999999988888999999999999999999999999999999999999976554  99999999864322110  


Q ss_pred             -------------------------------------CCcccCCCCccCcccccCCccCCCC
Q 030211          156 -------------------------------------PKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       156 -------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                                                           .....||+.|+|||++.+..+++++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  220 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC  220 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCee
Confidence                                                 1123589999999999988887653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=225.70  Aligned_cols=175  Identities=31%  Similarity=0.528  Sum_probs=154.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++....    .....+..|+.++..++|||++++++.+.+.+..+++|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999987542    12356778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      ||+++++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||++++++.  ++|+|||++.....  ...
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~  156 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YAN  156 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccC
Confidence            99999999999988888999999999999999999999999999999999999976554  99999999875433  334


Q ss_pred             cccCCCCccCcccccCCccCCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ...|++.|+|||++.+..++.++
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~  179 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGYDFTV  179 (333)
T ss_pred             CcccCccccChhHhcCCCCCCcc
Confidence            46789999999999988877653

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.7e-38  Score=235.83  Aligned_cols=176  Identities=38%  Similarity=0.638  Sum_probs=158.4

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      |++|-+.+.||+|.||.||+++.+.+.+.||+|.+.+..+.   .+.+.+|+++++.++||||+.+++.|+....+|+|+
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            68999999999999999999999999999999999765433   456888999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC-
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~-  156 (181)
                      ||+.+ +|..++.....++++.++.++.+++.||.|||+++|.|+|+||.||+++..+  .+||+|||+|+........ 
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~--~~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG--TLKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC--ceeechhhhhhhcccCceee
Confidence            99977 9999998888999999999999999999999999999999999999996555  4999999999876554333 


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+..|||-|||||.+++++|+-.
T Consensus       158 tsikGtPlYmAPElv~e~pyd~~  180 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQPYDHT  180 (808)
T ss_pred             eeccCcccccCHHHHcCCCccch
Confidence            34579999999999999999754

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=228.93  Aligned_cols=176  Identities=30%  Similarity=0.502  Sum_probs=151.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+..    ...+.+.+|+.+++.++|||++++++++.+++.++++|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            57999999999999999999999999999999886532    12346778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC---
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~---  154 (181)
                      ||+++++|.+++.....+++..++.++.|++.||+|||++|++|+||||+||+++.++  .++|+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~--~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC--CEEEeecccccccccccccc
Confidence            9999999999998888899999999999999999999999999999999999997555  49999999985321100   


Q ss_pred             ---------------------------------------------CCCcccCCCCccCcccccCCccCCC
Q 030211          155 ---------------------------------------------RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                                                                   ......|++.|+|||++.+..++.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  228 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE  228 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc
Confidence                                                         0012468999999999998888765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-37  Score=227.02  Aligned_cols=176  Identities=27%  Similarity=0.377  Sum_probs=152.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEEEEeEEcCC-eEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPT-HLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-~~~~v~e~   79 (181)
                      ++|.-...||+|+||.||++.-.++ +.||+|.+...... ..+|.+|+.++..++|||+++++++|.+.+ ..++|+||
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy  153 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY  153 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence            3566678999999999999998764 88999988776554 567999999999999999999999999999 49999999


Q ss_pred             cCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---eeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-C
Q 030211           80 AAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQ---ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-H  153 (181)
Q Consensus        80 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~g---i~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~  153 (181)
                      ++.|+|.+.+....  +++|.....|+.++++||+|||...   |+|+||||+||++|.+.+  .||+|||+|+.... .
T Consensus       154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~~  231 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEGD  231 (361)
T ss_pred             cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCccc
Confidence            99999999887655  8999999999999999999999853   999999999999987776  99999999965444 3


Q ss_pred             CCCCcc-cCCCCccCcccccCCccCCCC
Q 030211          154 SRPKST-VGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       154 ~~~~~~-~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ...... .||.+|+|||++..+..+.|+
T Consensus       232 ~~~~~~~~gt~gY~~PEy~~~g~lt~Ks  259 (361)
T KOG1187|consen  232 TSVSTTVMGTFGYLAPEYASTGKLTEKS  259 (361)
T ss_pred             cceeeecCCCCccCChhhhccCCcCccc
Confidence            333333 899999999999998888775

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=226.35  Aligned_cols=178  Identities=43%  Similarity=0.682  Sum_probs=161.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +.|++.+.||+|.||.||++.++.+|+.+|+|.+.+...    ..+.+.+|+.+++.+. |||++.+.++|++.+.+++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            469999999999999999999999999999999987544    2368999999999998 99999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC--CCcEEEeecCCcccccCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA--APRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~--~~~v~l~dfg~a~~~~~~~  154 (181)
                      ||++.|+.|.+.+... .+++..+..++.|++.++.|||+.|++|+|+||+|+++....  ...++++|||++.......
T Consensus       115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~  193 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE  193 (382)
T ss_pred             EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence            9999999999988766 499999999999999999999999999999999999995443  3579999999999877766


Q ss_pred             CCCcccCCCCccCcccccCCccCCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      .....+||+.|+|||++...+|+...
T Consensus       194 ~~~~~~Gtp~y~APEvl~~~~y~~~~  219 (382)
T KOG0032|consen  194 RLHTIVGTPEYVAPEVLGGRPYGDEV  219 (382)
T ss_pred             eEeeecCCccccCchhhcCCCCCccc
Confidence            77788999999999999998888753

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=232.14  Aligned_cols=176  Identities=34%  Similarity=0.556  Sum_probs=158.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      .+|...++||+|+.|.||.|....+++.||+|.+...... .+-+.+|+.+++..+|+|+|.+++.|...+.+|+||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4688899999999999999999999999999999765444 467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-CCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~~~~  159 (181)
                      ++++|.+... +..+++..+..+.+.++.||++||.+||+|+|||.+||++..++.  +||+|||+|........ -...
T Consensus       353 ~ggsLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~Tm  429 (550)
T KOG0578|consen  353 EGGSLTDVVT-KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRSTM  429 (550)
T ss_pred             CCCchhhhhh-cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCccccc
Confidence            9999888774 446999999999999999999999999999999999999976666  99999999987766664 4456


Q ss_pred             cCCCCccCcccccCCccCCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      +|||.|||||++.+.+|++|+
T Consensus       430 VGTPYWMAPEVvtrk~YG~KV  450 (550)
T KOG0578|consen  430 VGTPYWMAPEVVTRKPYGPKV  450 (550)
T ss_pred             cCCCCccchhhhhhcccCccc
Confidence            899999999999999999985

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.7e-37  Score=211.59  Aligned_cols=171  Identities=35%  Similarity=0.511  Sum_probs=150.9

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +++|...+.+|+|.||.||+|.+.++|+.||+|.++.+...   .....+|++.++.++|+||+.++++|...+.+.+|+
T Consensus         1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            46899999999999999999999999999999999876543   468899999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           78 EYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      ||+ ..+|...+..+. .++...+..++.+++++++|||++.|.||||||.|++|++++.  +||+|||+|+...+....
T Consensus        81 Efm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   81 EFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRI  157 (318)
T ss_pred             Eec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCcc
Confidence            999 458888886554 7899999999999999999999999999999999999976665  999999999876555444


Q ss_pred             Cc-ccCCCCccCcccccCC
Q 030211          157 KS-TVGTPAYIAPEVLSRR  174 (181)
Q Consensus       157 ~~-~~~~~~~~aPE~~~~~  174 (181)
                      .. ..-|..|.|||.+-+.
T Consensus       158 ~~~~V~TRWYRAPELLfGs  176 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGS  176 (318)
T ss_pred             cccceeeeeccChHHhccc
Confidence            33 3678999999988654

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=218.18  Aligned_cols=174  Identities=38%  Similarity=0.541  Sum_probs=148.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC--eEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPT--HLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~e   78 (181)
                      .+|...+.||+|.||+||++.+.++|...|+|.+..... ..+.+.+|+.++..++||+||+.++......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            358889999999999999999998899999998765421 1456889999999999999999999744433  6999999


Q ss_pred             ecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC----C
Q 030211           79 YAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL----H  153 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~----~  153 (181)
                      |+++++|.+++.+.+ .+++..++.+.+|++.+|+|||++|++||||||+||++++. ++.+||.|||+++....    .
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~-~~~~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS-NGDVKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC-CCeEEeccCccccccccccccc
Confidence            999999999998876 79999999999999999999999999999999999999762 33599999999986653    2


Q ss_pred             CCCCcccCCCCccCcccccCCcc
Q 030211          154 SRPKSTVGTPAYIAPEVLSRREY  176 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~  176 (181)
                      .......||+.|||||++..+..
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~  198 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEV  198 (313)
T ss_pred             cccccccCCccccCchhhcCCCc
Confidence            33445789999999999996433

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.9e-36  Score=226.51  Aligned_cols=176  Identities=30%  Similarity=0.494  Sum_probs=151.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|++.+..    .....+.+|+.++..++|++++++++.+.+++.++++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999986532    22356778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC----
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH----  153 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~----  153 (181)
                      ||+++++|.+++.+...+++..++.++.|++.||+|||++||+|+||||+||+++.++.  ++|+|||+|......    
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccc
Confidence            99999999999988888999999999999999999999999999999999999975554  999999987422100    


Q ss_pred             ----------------------------------------CCCCcccCCCCccCcccccCCccCCC
Q 030211          154 ----------------------------------------SRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ----------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                                                              .......|++.|+|||++.+..++.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  224 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL  224 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc
Confidence                                                    00112468999999999998888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-36  Score=217.10  Aligned_cols=175  Identities=33%  Similarity=0.463  Sum_probs=152.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCC-eeEEEEeEEcCC------
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPN-IIRFKEVVLTPT------   71 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~-i~~~~~~~~~~~------   71 (181)
                      ..|+.+++||+|++|+||+|..+.+|+.||+|.+....+   ......+|+.+++.++|+| ++++++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            468888999999999999999999999999999876644   4577899999999999999 999999998877      


Q ss_pred             eEEEEEeecCCCChHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCc
Q 030211           72 HLAIVMEYAAGGELFDRICNAG----RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a  147 (181)
                      .+++++|+. ..+|..++...+    .++...+..+++||+.||+|||++||+||||||.||+|++++  .+||+|||+|
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G--~lKlaDFGlA  167 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG--VLKLADFGLA  167 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC--cEeeeccchH
Confidence            789999998 559999887654    477789999999999999999999999999999999997644  5999999999


Q ss_pred             cccc-CCCCCCcccCCCCccCcccccCC-ccCCC
Q 030211          148 KSSV-LHSRPKSTVGTPAYIAPEVLSRR-EYDGK  179 (181)
Q Consensus       148 ~~~~-~~~~~~~~~~~~~~~aPE~~~~~-~~~~~  179 (181)
                      +... +.....+-..|..|.|||++.+. .|++.
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~  201 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTS  201 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCC
Confidence            8665 45556666789999999999887 55543

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-38  Score=213.39  Aligned_cols=177  Identities=33%  Similarity=0.598  Sum_probs=159.2

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++++.+|.|.||.||.|..+.++..||+|++.+++.    ..+++.+|+.+...++||||++++++|.++...|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            5789999999999999999999999999999999987642    346788899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           77 MEYAAGGELFDRIC--NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        77 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +||.+.+.+...+.  ....+++...+.+..|++.|+.|+|.++++|||++|+|++++..+  .++++|||++... +..
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~--~lkiAdfGwsV~~-p~~  177 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG--ELKIADFGWSVHA-PSN  177 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC--CeeccCCCceeec-CCC
Confidence            99999999998887  556899999999999999999999999999999999999996544  4999999999744 466


Q ss_pred             CCCcccCCCCccCcccccCCccCCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      .-...+||..|.+||+..+.+++..+
T Consensus       178 kR~tlcgt~dyl~pEmv~~~~hd~~V  203 (281)
T KOG0580|consen  178 KRKTLCGTLDYLPPEMVEGRGHDKFV  203 (281)
T ss_pred             CceeeecccccCCHhhcCCCCccchh
Confidence            67778999999999999999887653

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-37  Score=222.75  Aligned_cols=174  Identities=34%  Similarity=0.589  Sum_probs=152.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|++....    ...+.+.+|+.+++.++|||++++++++.+.+.++++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            57999999999999999999999899999999986532    22356778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      ||+++++|.+++.....+++..+..++.|++.||.+||++|++|+||+|+||++++++  .++|+|||++.....  ...
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~--~~kl~Dfg~~~~~~~--~~~  156 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG--HIKLTDFGFAKKLRD--RTW  156 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEEEecCcchhccC--Ccc
Confidence            9999999999998888899999999999999999999999999999999999997554  499999999875432  223


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...|++.|+|||++.+..++.+
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~  178 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHNKA  178 (291)
T ss_pred             cccCChhhcCHHHHcCCCCCch
Confidence            3568999999999998877654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.9e-36  Score=226.85  Aligned_cols=177  Identities=28%  Similarity=0.434  Sum_probs=151.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +.|++++.||+|+||+||+|.+..+++.+|+|++....    .....+.+|+.++..++|++++++++.+.+.+.++++|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            46999999999999999999999999999999987532    22346788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC----
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH----  153 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~----  153 (181)
                      ||+++++|.+++.....+++..++.++.|++.||.+||+.||+|+||||+||+++.++  .++|+|||++......    
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~--~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG--HIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC--CEEEeeCcCCcccccccccc
Confidence            9999999999998888899999999999999999999999999999999999996554  5999999987532100    


Q ss_pred             --------------------------------------------CCCCcccCCCCccCcccccCCccCCCC
Q 030211          154 --------------------------------------------SRPKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       154 --------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                                                                  .......||+.|+|||++.+..++.++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  229 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC  229 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence                                                        001234689999999999988887653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.6e-36  Score=224.50  Aligned_cols=177  Identities=26%  Similarity=0.466  Sum_probs=152.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++....    .....+.+|..++..++|++++++++.+.+.+.++++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999986532    22356777899999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC---
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~---  154 (181)
                      ||+++++|.+++.+...+++..++.++.|++.+|++||++|++|+||||+||+++.++  .++|+|||++.......   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~--~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEeeccCCcccccccccc
Confidence            9999999999998888899999999999999999999999999999999999997555  49999999986432110   


Q ss_pred             ---------------------------------CCCcccCCCCccCcccccCCccCCCC
Q 030211          155 ---------------------------------RPKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       155 ---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                                                       ......|++.|+|||++.+..++.++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~  217 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC  217 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcc
Confidence                                             01134689999999999988887653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-37  Score=225.58  Aligned_cols=174  Identities=41%  Similarity=0.713  Sum_probs=162.0

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccccc----HHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ||++.+.+|.|.+|.|-+|.....|+.||+|.+++.+...    -.+.+|++++.++.||||..++.+|++.+.+.+|||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            7999999999999999999999999999999998876443    247889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      |..+|.|.+++...+.+++.+++.+++||..|+.|+|.++++|+|||.+||++|.+++  +||.|||++-.+.....-.+
T Consensus       134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfLqT  211 (668)
T KOG0611|consen  134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFLQT  211 (668)
T ss_pred             ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHHHH
Confidence            9999999999999999999999999999999999999999999999999999976666  99999999987777777888


Q ss_pred             ccCCCCccCcccccCCccCC
Q 030211          159 TVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ++|+|-|.+||.+.+.+|..
T Consensus       212 FCGSPLYASPEIvNG~PY~G  231 (668)
T KOG0611|consen  212 FCGSPLYASPEIVNGTPYKG  231 (668)
T ss_pred             hcCCcccCCccccCCCCCCC
Confidence            99999999999999999864

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.6e-36  Score=227.13  Aligned_cols=176  Identities=32%  Similarity=0.493  Sum_probs=151.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++++.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++.+.|++++++++.+.+.+.+++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            47999999999999999999999999999999987542    12356778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC----
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH----  153 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~----  153 (181)
                      ||+++++|.+.+.....+++..++.++.|++.||++||++||+|+||||+||+++.++.  ++|+|||+|......    
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCcccccccccc
Confidence            99999999999887778999999999999999999999999999999999999976554  999999987422100    


Q ss_pred             --------------------------------------------CCCCcccCCCCccCcccccCCccCCC
Q 030211          154 --------------------------------------------SRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 --------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                                                                  .......|++.|+|||++.+..++.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~  228 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL  228 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence                                                        00112468999999999998888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=225.83  Aligned_cols=176  Identities=32%  Similarity=0.564  Sum_probs=154.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++....    .....+.+|..++..++|++++++++.+.+.+..+++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            58999999999999999999999999999999987542    23356788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC---
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~---  154 (181)
                      ||+++++|.+++.+...+++..++.++.|++.||++||++|++|+||+|+||+++.++.  ++|+|||++.......   
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence            99999999999988788999999999999999999999999999999999999976554  9999999987554333   


Q ss_pred             ---------------------------CCCcccCCCCccCcccccCCccCCC
Q 030211          155 ---------------------------RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                                                 ......|++.|+|||++.+..++++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  210 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE  210 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc
Confidence                                       2334568999999999998877765

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.9e-36  Score=223.64  Aligned_cols=175  Identities=32%  Similarity=0.506  Sum_probs=151.5

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCC-cEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETK-ELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~-~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +++|++.+.||+|+||.||+|.+..++ ..||+|.+....    ...+.+.+|..++..++|||++++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            367999999999999999999876554 689999886532    223567789999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      +|||+.+++|.+++..+..+++..+..++.|++.||.|||++|++|+||+|+||++++++  .++|+|||++.....  .
T Consensus       109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~--~ikL~DFG~a~~~~~--~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG--FIKMTDFGFAKVVDT--R  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEecCCCCeecCC--C
Confidence            999999999999998888899999999999999999999999999999999999997555  499999999875432  2


Q ss_pred             CCcccCCCCccCcccccCCccCCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .....|++.|+|||++.+..++.+
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~  208 (340)
T PTZ00426        185 TYTLCGTPEYIAPEILLNVGHGKA  208 (340)
T ss_pred             cceecCChhhcCHHHHhCCCCCcc
Confidence            334578999999999988777654

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.1e-36  Score=221.29  Aligned_cols=170  Identities=38%  Similarity=0.581  Sum_probs=147.6

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (181)
                      +.||+|+||.||++.+..+++.+|+|++....    .....+.+|+.+++.++|||++++.+.+...+..+++|||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999987532    12245677899999999999999999999999999999999999


Q ss_pred             ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-CCCCCcccCC
Q 030211           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVGT  162 (181)
Q Consensus        84 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~~~~~~~~~~  162 (181)
                      +|...+..+..+++..++.++.|++.||+|||++||+|+||||+||++++++.  ++|+|||++..... ........|+
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecC
Confidence            99999888888999999999999999999999999999999999999975554  99999999875322 2333445799


Q ss_pred             CCccCcccccCCccCCC
Q 030211          163 PAYIAPEVLSRREYDGK  179 (181)
Q Consensus       163 ~~~~aPE~~~~~~~~~~  179 (181)
                      +.|+|||++.+..++.+
T Consensus       159 ~~y~aPE~~~~~~~~~~  175 (323)
T cd05571         159 PEYLAPEVLEDNDYGRA  175 (323)
T ss_pred             ccccChhhhcCCCCCcc
Confidence            99999999998887765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-37  Score=227.79  Aligned_cols=179  Identities=35%  Similarity=0.569  Sum_probs=162.2

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCe-EEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTH-LAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~-~~~v   76 (181)
                      +++|.+++++|+|+||.++.+.++.+++.+++|.+.-..   +..+....|+.++++++|||++.+.+.|.+++. .+++
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            579999999999999999999999999999999886533   334578899999999999999999999998887 9999


Q ss_pred             EeecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           77 MEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      |+|++|+++.+.+...  ..|+++.+..++.|++.|+.|||++.|+|+|||+.|||++.+..  |+|+|||+|+...+..
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED  160 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCch
Confidence            9999999999888654  37999999999999999999999999999999999999976665  8999999999887776


Q ss_pred             -CCCcccCCCCccCcccccCCccCCCCC
Q 030211          155 -RPKSTVGTPAYIAPEVLSRREYDGKQG  181 (181)
Q Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~  181 (181)
                       ...+..||+.||+||++.+.+|+.|+.
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn~KSD  188 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYNEKSD  188 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCCccCc
Confidence             777789999999999999999999873

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2e-35  Score=215.07  Aligned_cols=176  Identities=26%  Similarity=0.365  Sum_probs=151.6

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.....    ....+.+|+.++..++|++++.+.+.+.+.+..++++|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            48899999999999999999999999999998865321    12457789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           79 YAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        79 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |+++++|...+..  ...+++..+..++.|++.||++||++|++|+||+|+||+++++..  ++|+|||++.........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETV  158 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCee
Confidence            9999999877643  336899999999999999999999999999999999999975554  999999998765444444


Q ss_pred             CcccCCCCccCcccccCCccCCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ....|++.|+|||++.+..+++++
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~  182 (285)
T cd05631         159 RGRVGTVGYMAPEVINNEKYTFSP  182 (285)
T ss_pred             cCCCCCCCccCHhhhcCCCCCccc
Confidence            556789999999999988887763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-36  Score=229.30  Aligned_cols=176  Identities=42%  Similarity=0.757  Sum_probs=164.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +=|++++.+|.|+.|.|-.|++.++|+..|||++.+...    ....+.+|+.+++.+.|||++++++++++..++|++.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            458999999999999999999999999999999976522    2457889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      ||+++|-|.+++...+++++.++..+++||+.|+.|+|..+|.|+|+||+|++++...+  |||+|||+|....++..-+
T Consensus        92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklLe  169 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLLE  169 (786)
T ss_pred             EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCcccc
Confidence            99999999999999999999999999999999999999999999999999999976665  9999999999888888889


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +.+|+|-|.|||++.+.+|...
T Consensus       170 TSCGSPHYA~PEIV~G~pYdG~  191 (786)
T KOG0588|consen  170 TSCGSPHYAAPEIVSGRPYDGR  191 (786)
T ss_pred             ccCCCcccCCchhhcCCCCCCC
Confidence            9999999999999999999754

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.7e-35  Score=222.48  Aligned_cols=171  Identities=30%  Similarity=0.474  Sum_probs=147.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++.+..    .....+.+|..+++.++|||++++++.+.+++.++++|
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999986532    12345778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--  155 (181)
                      ||+++++|.+++.. ..+++..+..++.|++.||++||++||+|+||||+||++++++.  ++|+|||+|........  
T Consensus       123 Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         123 EYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCcee
Confidence            99999999998854 46899999999999999999999999999999999999975554  99999999876533222  


Q ss_pred             CCcccCCCCccCcccccCCc
Q 030211          156 PKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~  175 (181)
                      .....|++.|+|||++.+..
T Consensus       200 ~~~~~gt~~Y~aPE~~~~~~  219 (370)
T cd05621         200 CDTAVGTPDYISPEVLKSQG  219 (370)
T ss_pred             cccCCCCcccCCHHHHhccC
Confidence            23456999999999997654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.6e-35  Score=219.08  Aligned_cols=170  Identities=36%  Similarity=0.578  Sum_probs=146.9

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (181)
                      +.||+|+||.||++.+..+++.||+|++....    .....+.+|+.+++.++|||++++++.+...+.++++|||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47899999999999999999999999987532    12345667899999999999999999999999999999999999


Q ss_pred             ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCCCcccCC
Q 030211           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGT  162 (181)
Q Consensus        84 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~~  162 (181)
                      +|...+..+..+++..++.++.|++.||.|||++|++|+||+|+||++++++.  ++|+|||++...... .......|+
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCC
Confidence            99988887788999999999999999999999999999999999999976554  999999998653222 223345689


Q ss_pred             CCccCcccccCCccCCC
Q 030211          163 PAYIAPEVLSRREYDGK  179 (181)
Q Consensus       163 ~~~~aPE~~~~~~~~~~  179 (181)
                      +.|+|||++.+..++.+
T Consensus       159 ~~y~aPE~~~~~~~~~~  175 (323)
T cd05595         159 PEYLAPEVLEDNDYGRA  175 (323)
T ss_pred             cCcCCcccccCCCCCch
Confidence            99999999998887765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.6e-37  Score=212.74  Aligned_cols=177  Identities=37%  Similarity=0.547  Sum_probs=159.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc-----c----ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-----K----IDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-----~----~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~   71 (181)
                      ++|...+.+|+|..++|.++.++.+++.+++|++....     +    ..+.-..|+.+++++ .||+|.++.++|+.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            57889999999999999999999999999999986421     1    124556688888877 7999999999999999


Q ss_pred             eEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      .+++|+|.++-|.|.+++.+.-+++++..+++++|++.+++|||.++|+|+||||+||+++++.+  ++|.|||+|+...
T Consensus        97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~  174 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLE  174 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccC
Confidence            99999999999999999988889999999999999999999999999999999999999986666  9999999999998


Q ss_pred             CCCCCCcccCCCCccCcccccCCccCCCC
Q 030211          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ++..-...+|||+|+|||.++...+...-
T Consensus       175 ~GekLrelCGTPgYLAPEtikC~m~e~~p  203 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAPETIKCSMYENHP  203 (411)
T ss_pred             CchhHHHhcCCCcccChhheeeecccCCC
Confidence            98888889999999999999988876543

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.1e-35  Score=217.91  Aligned_cols=170  Identities=37%  Similarity=0.579  Sum_probs=147.1

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (181)
                      +.||+|+||.||++.+..+++.+|+|++....    .....+.+|+.+++.++||+++++.+.+...+.+++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999987532    22346778899999999999999999999999999999999999


Q ss_pred             ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-CCCCCcccCC
Q 030211           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVGT  162 (181)
Q Consensus        84 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~~~~~~~~~~  162 (181)
                      +|...+.....+++..++.++.|++.||+|||++|++|+||||+||++++++.  ++|+|||++..... ........|+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCC
Confidence            99988887778999999999999999999999999999999999999975554  99999999865322 2223345689


Q ss_pred             CCccCcccccCCccCCC
Q 030211          163 PAYIAPEVLSRREYDGK  179 (181)
Q Consensus       163 ~~~~aPE~~~~~~~~~~  179 (181)
                      +.|+|||++.+..++.+
T Consensus       159 ~~y~aPE~~~~~~~~~~  175 (328)
T cd05593         159 PEYLAPEVLEDNDYGRA  175 (328)
T ss_pred             cCccChhhhcCCCCCcc
Confidence            99999999998877765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=215.41  Aligned_cols=179  Identities=34%  Similarity=0.552  Sum_probs=159.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      +.|++.+.||+|.|+.|+++.+..+|+.+++|++...+   ...+.+.+|.++-..++||||+++.+.+.+.++.|+|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            57899999999999999999999999999999886543   234788999999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEe-ccCCCCcEEEeecCCcccccCCCCCC
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i-~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      ++.|+.|-.-+-...-+++..+..+++||+.||.|+|.+||+|+|++|+|+++ ..+....+||+|||+|.....+..-.
T Consensus        91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~  170 (355)
T KOG0033|consen   91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWH  170 (355)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccc
Confidence            99999987666555668899999999999999999999999999999999999 33444579999999999888666677


Q ss_pred             cccCCCCccCcccccCCccCCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      .+.|+|.|||||++++++|+-.+
T Consensus       171 G~~GtP~fmaPEvvrkdpy~kpv  193 (355)
T KOG0033|consen  171 GFAGTPGYLSPEVLKKDPYSKPV  193 (355)
T ss_pred             cccCCCcccCHHHhhcCCCCCcc
Confidence            78999999999999999998654

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-35  Score=216.17  Aligned_cols=168  Identities=30%  Similarity=0.553  Sum_probs=146.1

Q ss_pred             eCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCCh
Q 030211           10 LGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (181)
Q Consensus        10 i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   85 (181)
                      ||+|+||.||++.+..+++.||+|.+....    .....+..|+.++..++|||++++++.+.+++..+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            689999999999999999999999987532    2234567899999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCCCcccCCCC
Q 030211           86 FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPA  164 (181)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~~~~  164 (181)
                      .+.+.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++...... .......|++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcc
Confidence            999988888999999999999999999999999999999999999975554  999999998753222 22334568999


Q ss_pred             ccCcccccCCccCCC
Q 030211          165 YIAPEVLSRREYDGK  179 (181)
Q Consensus       165 ~~aPE~~~~~~~~~~  179 (181)
                      |+|||++.+..++.+
T Consensus       159 y~aPE~~~~~~~~~~  173 (312)
T cd05585         159 YLAPELLLGHGYTKA  173 (312)
T ss_pred             cCCHHHHcCCCCCCc
Confidence            999999998888765

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.1e-35  Score=216.46  Aligned_cols=175  Identities=31%  Similarity=0.511  Sum_probs=149.6

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCC-CCeeEEEEeEEcCCeEEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRH-PNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~-~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....    ...+.+..|..++..+.| ++++.+++++.+.+.+|++|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5899999999999999999999999999999987532    223456778888888876 56888999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCCCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~~~  156 (181)
                      ||+++++|.+.+.....+++..+..++.|++.||+|||++|++|+||+|+||++++++.  ++|+|||++.... .....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCce
Confidence            99999999999888888999999999999999999999999999999999999976554  9999999986432 22333


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....|++.|+|||++.+.+++.+
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~  181 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQPYGKS  181 (324)
T ss_pred             eeecCCccccChhhhcCCCCCcc
Confidence            34568999999999998888765

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-36  Score=220.08  Aligned_cols=173  Identities=35%  Similarity=0.584  Sum_probs=147.1

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----------c-----cHHHHHHHHHHhhCCCCCeeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----------I-----DENVAREIINHRSLRHPNIIRFKE   65 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----------~-----~~~~~~e~~~~~~~~~~~i~~~~~   65 (181)
                      ++.|++.+.||+|.||.|-+|.+..+++.||+|++.+.+.          .     .+.+.+|+.+++++.|+|+|++++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            5789999999999999999999999999999999875321          1     147889999999999999999999


Q ss_pred             eEEcC--CeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEee
Q 030211           66 VVLTP--THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICD  143 (181)
Q Consensus        66 ~~~~~--~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~d  143 (181)
                      +.-++  +.+|+|+|||..+.+.+.-.....+++.+++.++++++.+|+|||.+||+||||||+|+++++++  .+||.|
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g--~VKIsD  253 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG--TVKISD  253 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC--cEEeec
Confidence            99775  56999999999988877655554599999999999999999999999999999999999997665  599999


Q ss_pred             cCCcccccCCC------CCCcccCCCCccCcccccCCc
Q 030211          144 FGYSKSSVLHS------RPKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       144 fg~a~~~~~~~------~~~~~~~~~~~~aPE~~~~~~  175 (181)
                      ||.+...+...      .-..+.|||.|+|||....+.
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~  291 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN  291 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCC
Confidence            99986442221      122367999999999998744

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.9e-35  Score=217.58  Aligned_cols=170  Identities=29%  Similarity=0.505  Sum_probs=147.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++.....    ..+.+.+|+.++..++|++++++++.+.+.+..+++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            579999999999999999999999999999999876432    2356778889999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           78 EYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      ||+++++|.+++.+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++  .++|+|||++.........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG--HIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC--CEEeccCCCCeECCCCCce
Confidence            999999999998776 5799999999999999999999999999999999999997555  4999999998754433322


Q ss_pred             --CcccCCCCccCcccccC
Q 030211          157 --KSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       157 --~~~~~~~~~~aPE~~~~  173 (181)
                        ....+++.|+|||++..
T Consensus       159 ~~~~~~gt~~y~aPE~~~~  177 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTT  177 (330)
T ss_pred             eeecccCCccccCHHHhcc
Confidence              23468999999999873

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.8e-35  Score=215.87  Aligned_cols=170  Identities=37%  Similarity=0.574  Sum_probs=146.3

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (181)
                      +.||+|+||.||++.+..+++.+|+|++....    .....+..|+.++..++||+++++.+.+...+.+++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999987532    12245677888999999999999999999999999999999999


Q ss_pred             ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-CCCCCcccC
Q 030211           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVG  161 (181)
Q Consensus        84 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~~~~~~~~~  161 (181)
                      +|...+.....+++..+..++.|++.||.|||+ +|++|+||||+||++++++.  ++|+|||++..... ........|
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccC
Confidence            999888877789999999999999999999997 79999999999999975554  99999999865332 222334568


Q ss_pred             CCCccCcccccCCccCCC
Q 030211          162 TPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.|+|||++.+..++.+
T Consensus       159 t~~y~aPE~~~~~~~~~~  176 (325)
T cd05594         159 TPEYLAPEVLEDNDYGRA  176 (325)
T ss_pred             CcccCCHHHHccCCCCCc
Confidence            999999999998887765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.4e-35  Score=216.19  Aligned_cols=170  Identities=26%  Similarity=0.473  Sum_probs=146.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++.+..    .....+.+|..++....|++++.+++++.+.+..|++|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999986532    12244677888888999999999999999999999999


Q ss_pred             eecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      ||+.+++|.+++.. ...+++..+..++.|++.+|++||++|++|+||||+||+++.++  .++|+|||++.........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG--HIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC--CEEEEeccceeeccCCCce
Confidence            99999999999876 45789999999999999999999999999999999999997555  4999999998755433322


Q ss_pred             --CcccCCCCccCcccccC
Q 030211          157 --KSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       157 --~~~~~~~~~~aPE~~~~  173 (181)
                        ....|++.|+|||++.+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~  177 (331)
T cd05624         159 QSSVAVGTPDYISPEILQA  177 (331)
T ss_pred             eeccccCCcccCCHHHHhc
Confidence              23468999999999875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-35  Score=216.81  Aligned_cols=170  Identities=26%  Similarity=0.490  Sum_probs=146.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++.+..    ...+.+.+|..++..++|++++++++++.+++.++++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999987532    12345778888999999999999999999999999999


Q ss_pred             eecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      ||+++++|.+++.+ ...+++..+..++.|++.||++||++|++|+||+|+||+++.++  .++|+|||++.........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG--HIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC--CEEEEECCceeecCCCCCc
Confidence            99999999998865 45799999999999999999999999999999999999996555  4999999998654433322


Q ss_pred             --CcccCCCCccCcccccC
Q 030211          157 --KSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       157 --~~~~~~~~~~aPE~~~~  173 (181)
                        ....|++.|+|||++..
T Consensus       159 ~~~~~~gt~~y~aPE~~~~  177 (331)
T cd05597         159 QSNVAVGTPDYISPEILQA  177 (331)
T ss_pred             cccceeccccccCHHHHhh
Confidence              22468999999999873

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.4e-35  Score=219.09  Aligned_cols=171  Identities=33%  Similarity=0.489  Sum_probs=147.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++....    .....+.+|..+++.++|||++++++.+.+++..+++|
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            68999999999999999999999999999999986432    12245678889999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--  155 (181)
                      ||+++++|.+++.. ..+++..+..++.|++.||.+||++||+|+||+|+||++++++.  ++|+|||++........  
T Consensus       123 Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~~~~  199 (371)
T cd05622         123 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVR  199 (371)
T ss_pred             cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCCccc
Confidence            99999999988754 46899999999999999999999999999999999999976554  99999999876543322  


Q ss_pred             CCcccCCCCccCcccccCCc
Q 030211          156 PKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~  175 (181)
                      .....|++.|+|||++.+..
T Consensus       200 ~~~~~gt~~y~aPE~l~~~~  219 (371)
T cd05622         200 CDTAVGTPDYISPEVLKSQG  219 (371)
T ss_pred             ccCcccCccccCHHHHhccC
Confidence            23456899999999997643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.8e-35  Score=219.26  Aligned_cols=170  Identities=31%  Similarity=0.489  Sum_probs=146.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++....    .....+.+|+.+++.++||+++++++++.+++.++++|
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            57999999999999999999999999999999986532    12245678899999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--  155 (181)
                      ||+++++|.+++.. ..+++..+..++.|++.||+|||++|++|+||+|+||++++++.  ++|+|||++........  
T Consensus       123 Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         123 EYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCccc
Confidence            99999999987754 46889999999999999999999999999999999999976554  99999999875543322  


Q ss_pred             CCcccCCCCccCcccccCC
Q 030211          156 PKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~  174 (181)
                      .....|++.|+|||++.+.
T Consensus       200 ~~~~~gt~~y~aPE~~~~~  218 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQ  218 (370)
T ss_pred             CCCCCCCcCeECHHHhccC
Confidence            2345689999999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.7e-35  Score=215.92  Aligned_cols=170  Identities=28%  Similarity=0.485  Sum_probs=146.0

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|+||.||++.+..+++.||+|++.+...    ..+.+..|..++..+ +|||++++++++.+.+.++++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            468999999999999999999999999875321    224466788888777 799999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc-cCCCCCCcccC
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-VLHSRPKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~-~~~~~~~~~~~  161 (181)
                      ++|...+.....+++..++.++.|++.||.|||++|++|+||+|+||++++++.  ++|+|||++... ..........|
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccC
Confidence            999988877788999999999999999999999999999999999999976554  999999998643 22333444578


Q ss_pred             CCCccCcccccCCccCCC
Q 030211          162 TPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.|+|||++.+..++.+
T Consensus       159 t~~y~aPE~~~~~~~~~~  176 (329)
T cd05588         159 TPNYIAPEILRGEDYGFS  176 (329)
T ss_pred             CccccCHHHHcCCCCCCc
Confidence            999999999998887765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-35  Score=210.84  Aligned_cols=172  Identities=33%  Similarity=0.437  Sum_probs=147.3

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcC--CeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTP--THLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~   75 (181)
                      ++.|+.+..|++|.||.||+|+++.++..||+|.++-.+..   .-..++|+.++.+.+|||||.+-.+..-.  +.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            46799999999999999999999999999999998755432   24678999999999999999998877644  57999


Q ss_pred             EEeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           76 VMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      ||||++. +|.+.+.+-+ +|...++..++.|+++|++|||.+.|+||||||+|+++++.+.  +|++|||+|+.+....
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPL  231 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhhhcCCc
Confidence            9999965 8888886654 8999999999999999999999999999999999999975555  9999999998765443


Q ss_pred             C-CCcccCCCCccCcccccCCc
Q 030211          155 R-PKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       155 ~-~~~~~~~~~~~aPE~~~~~~  175 (181)
                      . .....-|+.|.|||.+.+.+
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~  253 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAK  253 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCc
Confidence            3 34456799999999998654

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.5e-34  Score=213.90  Aligned_cols=176  Identities=32%  Similarity=0.514  Sum_probs=149.2

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +|++.+.||+|+||.||++.+..+++.+|+|++.+...    .......|..++..+ .|++++.+++++.+.+.++++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            58999999999999999999999999999999875421    123445566666655 5789999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-CCCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~~~~  156 (181)
                      ||+++++|...+.....+++..+..++.|++.||++||++|++|+||+|+||++++++.  ++|+|||++..... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCcc
Confidence            99999999998888788999999999999999999999999999999999999976554  99999999875332 2333


Q ss_pred             CcccCCCCccCcccccCCccCCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ....|++.|+|||++.+.+++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~  182 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQPYGKSV  182 (323)
T ss_pred             ccCCCChhhcCHHHhcCCCCCCcc
Confidence            445789999999999998888764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1e-34  Score=211.38  Aligned_cols=176  Identities=33%  Similarity=0.514  Sum_probs=149.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++.+.||+|++|.||++.+..+++.+++|++.....   ..+.+.+|+.+++.++|+|++++++++...+..+++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            589999999999999999999999999999999875432   23567889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--C
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--P  156 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--~  156 (181)
                      |++++.+.........+++..++.++.|++.||.+||+.|++|+||+|+||+++.++  .++|+|||++........  .
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND--VLKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--cEEEeeccCcccccccccccc
Confidence            998876655544445799999999999999999999999999999999999997555  499999999876533222  2


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+++.|+|||++.+..++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~  181 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPYGKA  181 (287)
T ss_pred             cccccccccCCcHHHcCCCCCCc
Confidence            33468999999999988887664

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=219.54  Aligned_cols=171  Identities=36%  Similarity=0.604  Sum_probs=152.6

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEcccc---ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGE   84 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   84 (181)
                      +++|+|-||+||-++++.+|+.||+|++.+.   .+....+.+|+.++..+.||++|.+..-|+.++.+|+|||-+ .++
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence            6799999999999999999999999998764   334467889999999999999999999999999999999998 557


Q ss_pred             hHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEec-cCCCCcEEEeecCCcccccCCCCCCcccC
Q 030211           85 LFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD-GSAAPRLKICDFGYSKSSVLHSRPKSTVG  161 (181)
Q Consensus        85 l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~-~~~~~~v~l~dfg~a~~~~~~~~~~~~~~  161 (181)
                      .++.+.+  .+++++.....+..||+.||.|||.++|+||||||+|+++. .+..+.+||+|||+|+.+.......+..|
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG  728 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG  728 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence            7776654  34799999999999999999999999999999999999994 44557899999999998877777778899


Q ss_pred             CCCccCcccccCCccCCC
Q 030211          162 TPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~  179 (181)
                      ||.|+|||+++++.|+.+
T Consensus       729 TPAYLaPEVLrnkGyNrS  746 (888)
T KOG4236|consen  729 TPAYLAPEVLRNKGYNRS  746 (888)
T ss_pred             CccccCHHHHhhcccccc
Confidence            999999999999999864

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.4e-34  Score=210.91  Aligned_cols=175  Identities=32%  Similarity=0.513  Sum_probs=147.0

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      +++|++.+.||+|+||.||++.+..+++.||+|.+.....  ....+.+|+.+++.++|||++++++++.+.+..+++||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            5789999999999999999999999999999999865422  23567789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCC
Q 030211           79 YAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRP  156 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~  156 (181)
                      ++++ +|.+++.... .+++..+..++.|++.||++||++|++|+||+|+||++++++.  ++|+|||++...... ...
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCccc
Confidence            9975 8888776543 5789999999999999999999999999999999999975554  999999998653322 223


Q ss_pred             CcccCCCCccCcccccC-CccCC
Q 030211          157 KSTVGTPAYIAPEVLSR-REYDG  178 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~-~~~~~  178 (181)
                      ....+++.|+|||++.+ ..++.
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~  183 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYST  183 (288)
T ss_pred             cCceecccccChHHhcCCcccCc
Confidence            34567899999999875 33443

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1e-34  Score=214.91  Aligned_cols=171  Identities=30%  Similarity=0.535  Sum_probs=144.0

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHH-HHhhCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREII-NHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~-~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|+||.||+|.+..+++.+|+|++.....    ....+..|.. +++.++|||++++++.+...+..+++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            468999999999999999999999999865321    1233444443 46778999999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCCCCCcccC
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSRPKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~~~~~~~~  161 (181)
                      ++|...+.+...+++..++.++.|++.||.|||++|++|+||+|+||++++++.  ++|+|||++.... .........|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccC
Confidence            999988888888999999999999999999999999999999999999976554  9999999986432 2233344578


Q ss_pred             CCCccCcccccCCccCCCC
Q 030211          162 TPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~  180 (181)
                      ++.|+|||++.+..++.++
T Consensus       159 t~~y~aPE~~~~~~~~~~~  177 (325)
T cd05604         159 TPEYLAPEVIRKQPYDNTV  177 (325)
T ss_pred             ChhhCCHHHHcCCCCCCcC
Confidence            9999999999988887653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-34  Score=214.56  Aligned_cols=171  Identities=33%  Similarity=0.588  Sum_probs=143.2

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHH-HHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREI-INHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~-~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|+||.||+|.+..+++.+|+|++.....    ....+..+. .+++.++|+|++++++.+.+.+..+++|||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            478999999999999999999999999875321    122333333 356778999999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCCCCCcccC
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSRPKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~~~~~~~~  161 (181)
                      ++|.+.+.....+++..++.++.|++.||.+||++|++|+||||+||++++++  .++|+|||++.... .........|
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~--~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEEccCCCCcccccCCCCcccccC
Confidence            99999998888899999999999999999999999999999999999997555  49999999986532 2233444578


Q ss_pred             CCCccCcccccCCccCCCC
Q 030211          162 TPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~  180 (181)
                      ++.|+|||++.+..++.++
T Consensus       159 t~~y~aPE~~~~~~~~~~~  177 (325)
T cd05602         159 TPEYLAPEVLHKQPYDRTV  177 (325)
T ss_pred             CccccCHHHHcCCCCCCcc
Confidence            9999999999988877653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.4e-34  Score=214.00  Aligned_cols=170  Identities=32%  Similarity=0.572  Sum_probs=143.0

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHH-HHhhCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREII-NHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~-~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|+||.||++.+..+++.||+|++.....    ....+..|.. +++.++|||++++++.+.+.+..+++|||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            468999999999999999999999999875321    1223334433 55778999999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCCCCCcccC
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSRPKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~~~~~~~~  161 (181)
                      ++|...+..+..+++..+..++.|++.||.|||++|++|+||+|+||++++++  .++|+|||++.... .........|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC--cEEEeccCCCcccccCCCccccccC
Confidence            99999888888899999999999999999999999999999999999997655  49999999986532 2233344568


Q ss_pred             CCCccCcccccCCccCCC
Q 030211          162 TPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.|+|||++.+..++.+
T Consensus       159 t~~y~aPE~~~~~~~~~~  176 (323)
T cd05575         159 TPEYLAPEVLRKQPYDRT  176 (323)
T ss_pred             ChhhcChhhhcCCCCCcc
Confidence            999999999998887765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.6e-34  Score=214.22  Aligned_cols=171  Identities=29%  Similarity=0.501  Sum_probs=145.5

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|+||.||++.+..+++.+|+|++.+..    .....+..|..++..+ +|||++++++++...+..+++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46899999999999999999999999987542    1224566777777665 899999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCCCCCcccC
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSRPKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~~~~~~~~  161 (181)
                      ++|...+.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++.... .........|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccC
Confidence            999988877788999999999999999999999999999999999999976554  9999999986532 2223344578


Q ss_pred             CCCccCcccccCCccCCCC
Q 030211          162 TPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~  180 (181)
                      ++.|+|||++.+..++.++
T Consensus       159 t~~y~aPE~~~~~~~~~~~  177 (329)
T cd05618         159 TPNYIAPEILRGEDYGFSV  177 (329)
T ss_pred             CccccCHHHHcCCCCCCcc
Confidence            9999999999988887653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.3e-34  Score=214.00  Aligned_cols=170  Identities=34%  Similarity=0.520  Sum_probs=144.8

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|+||.||+|.++.+++.||+|++.+..    ...+.+..|..++... .||+++++++++.+.+.++++|||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999999999999999987532    2234556677777655 699999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-CCCCCcccC
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~~~~~~~~~  161 (181)
                      ++|...+.+...+++..+..++.|++.||+|||++|++|+||+|+||++++++.  ++|+|||++..... ........|
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence            999998888888999999999999999999999999999999999999976554  99999999875322 223344568


Q ss_pred             CCCccCcccccCCccCCC
Q 030211          162 TPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.|+|||++.+..++++
T Consensus       159 t~~y~aPE~~~~~~~~~~  176 (320)
T cd05590         159 TPDYIAPEILQEMLYGPS  176 (320)
T ss_pred             CccccCHHHHcCCCCCCc
Confidence            999999999998887765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.3e-34  Score=212.80  Aligned_cols=169  Identities=25%  Similarity=0.493  Sum_probs=145.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||++.++.+++.+|+|++.+..    .....+.+|..++..++|++++++++.+.+.+.++++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            57999999999999999999999999999999986422    11234677888889999999999999999999999999


Q ss_pred             eecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-
Q 030211           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-  155 (181)
                      ||+++++|.+++.+ ...+++..++.++.|++.||.+||++|++|+||||+||+++.++  .++|+|||++........ 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~--~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC--CEEEeecchheecccCCcc
Confidence            99999999999876 45789999999999999999999999999999999999997555  499999999865433322 


Q ss_pred             -CCcccCCCCccCccccc
Q 030211          156 -PKSTVGTPAYIAPEVLS  172 (181)
Q Consensus       156 -~~~~~~~~~~~aPE~~~  172 (181)
                       .....|++.|+|||++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~  176 (332)
T cd05623         159 QSSVAVGTPDYISPEILQ  176 (332)
T ss_pred             eecccccCccccCHHHHh
Confidence             22346899999999986

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.9e-34  Score=213.19  Aligned_cols=170  Identities=32%  Similarity=0.491  Sum_probs=144.7

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|+||.||+|.+..+++.+|+|++.+..    ...+.+..|..++..+ +||+++++++++.+.+.++++|||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46899999999999999999999999987532    1224456677777654 799999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCCCCCcccC
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSRPKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~~~~~~~~  161 (181)
                      ++|...+.....+++..+..++.|++.||.+||++|++|+||+|+||++++++  .++|+|||++.... .........|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG--HCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEeecccceecccCCcccccccc
Confidence            99998888888899999999999999999999999999999999999997655  49999999986532 2223344568


Q ss_pred             CCCccCcccccCCccCCC
Q 030211          162 TPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.|+|||++.+..++++
T Consensus       159 t~~y~aPE~~~~~~~~~~  176 (321)
T cd05591         159 TPDYIAPEILQELEYGPS  176 (321)
T ss_pred             CccccCHHHHcCCCCCCc
Confidence            999999999998888765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.9e-34  Score=213.11  Aligned_cols=170  Identities=32%  Similarity=0.556  Sum_probs=143.2

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHH-HHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREI-INHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~-~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|+||.||+|.+..+++.+|+|++.+...    ....+..|. .+++.++|||++++++.+.+.+..+++|||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            478999999999999999999999999865321    123344444 457788999999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc-cCCCCCCcccC
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-VLHSRPKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~-~~~~~~~~~~~  161 (181)
                      ++|...+.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++... ..........+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC--CEEEccCCCCccCCCCCCccccccC
Confidence            99988887777899999999999999999999999999999999999997555  4999999998653 23333444578


Q ss_pred             CCCccCcccccCCccCCC
Q 030211          162 TPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.|+|||.+.+..++.+
T Consensus       159 t~~y~aPE~~~~~~~~~~  176 (321)
T cd05603         159 TPEYLAPEVLRKEPYDRT  176 (321)
T ss_pred             CcccCCHHHhcCCCCCCc
Confidence            999999999998887765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-34  Score=217.40  Aligned_cols=170  Identities=23%  Similarity=0.303  Sum_probs=147.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|+||.||++.+..+++.||+|....     ..+.+|+.+++.++||||+++++++......++++|++.
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  166 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK  166 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence            479999999999999999999999999999996542     456789999999999999999999999999999999985


Q ss_pred             CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC--CCCCcc
Q 030211           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH--SRPKST  159 (181)
Q Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~--~~~~~~  159 (181)
                       ++|..++.....+++..++.++.|++.||.|||++||+|+||||+||+++.++  .++|+|||+|......  ......
T Consensus       167 -~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~--~vkL~DFG~a~~~~~~~~~~~~~~  243 (391)
T PHA03212        167 -TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG--DVCLGDFGAACFPVDINANKYYGW  243 (391)
T ss_pred             -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC--CEEEEeCCcccccccccccccccc
Confidence             58888887777899999999999999999999999999999999999997555  4999999998643221  222345


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .||+.|+|||++.+..++++
T Consensus       244 ~gt~~y~aPE~~~~~~~~~~  263 (391)
T PHA03212        244 AGTIATNAPELLARDPYGPA  263 (391)
T ss_pred             cCccCCCChhhhcCCCCCcH
Confidence            78999999999998888765

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.3e-34  Score=212.88  Aligned_cols=175  Identities=31%  Similarity=0.517  Sum_probs=148.6

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCeEEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....    ...+.+..|..++..+. |++++++.+++.+.+.++++|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4789999999999999999999999999999987532    12245666777777775 577888999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~  156 (181)
                      ||+++++|.+.+.....+++..+..++.|++.||.+||++|++|+||+|+||++++++.  ++|+|||++...... ...
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccc
Confidence            99999999999888788999999999999999999999999999999999999976554  999999998753322 223


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....|++.|+|||++.+..++.+
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~  181 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQPYGKS  181 (323)
T ss_pred             cCccCCccccCHHHHcCCCCCCc
Confidence            34568999999999998888765

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.4e-34  Score=212.04  Aligned_cols=175  Identities=31%  Similarity=0.468  Sum_probs=153.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|++|.||++.+..++..+++|.+....  ...+.+.+|+.+++.++|||++++++++...+..+++|||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            68999999999999999999999999999999887542  2235788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      +++++|.+++.....+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.  ++|+|||++..... .....
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~~  161 (331)
T cd06649          85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  161 (331)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCcccccccc-ccccc
Confidence            99999999998877899999999999999999999986 6999999999999976554  99999999865432 23344


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..+++.|+|||++.+..++.+
T Consensus       162 ~~g~~~y~aPE~~~~~~~~~~  182 (331)
T cd06649         162 FVGTRSYMSPERLQGTHYSVQ  182 (331)
T ss_pred             CCCCcCcCCHhHhcCCCCCch
Confidence            578999999999998887765

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.8e-35  Score=211.62  Aligned_cols=168  Identities=36%  Similarity=0.534  Sum_probs=146.1

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC-----eEEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPT-----HLAIVM   77 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-----~~~~v~   77 (181)
                      +|+..+++|+|.||.||++...+++..||+|..-..+.   -.-+|+.+++.+.||||+++..+|....     +..+||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            47888999999999999999999999999998765543   2346889999999999999998887532     356999


Q ss_pred             eecCCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           78 EYAAGGELFDRIC----NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        78 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      ||++. +|...+.    .+..++...+.-+++||++||+|||+.||.||||||.|+++|. .++.+||+|||.|+...+.
T Consensus       102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~-~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP-DTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC-CCCeEEeccCCcceeeccC
Confidence            99955 7877765    3568999999999999999999999999999999999999985 4468999999999999999


Q ss_pred             CCCCcccCCCCccCcccccCCc
Q 030211          154 SRPKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~  175 (181)
                      +...++..|..|.|||.+.+..
T Consensus       180 epniSYicSRyYRaPELifga~  201 (364)
T KOG0658|consen  180 EPNISYICSRYYRAPELIFGAT  201 (364)
T ss_pred             CCceeEEEeccccCHHHHcCcc
Confidence            9999999999999999998653

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.2e-34  Score=212.20  Aligned_cols=171  Identities=32%  Similarity=0.555  Sum_probs=145.5

Q ss_pred             cceeeeeeCCccceeEEEEEEc---cCCcEEEEEEccccc-----cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeE
Q 030211            3 KYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR-----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~-----~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~   73 (181)
                      +|++.+.||+|+||.||++.+.   .+++.+|+|++.+..     ...+.+..|+.++..+ .|++++.+++.+...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999864   468899999986532     1234567788889888 589999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      +++|||+.+++|.+.+.....+++..+..++.|++.||.+||++|++|+||||+||++++++  .++|+|||++......
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~--~~kl~DfG~~~~~~~~  158 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG--HVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC--CEEEeeCcCCcccccc
Confidence            99999999999999998888899999999999999999999999999999999999997655  4999999998754332


Q ss_pred             CC--CCcccCCCCccCcccccCCc
Q 030211          154 SR--PKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       154 ~~--~~~~~~~~~~~aPE~~~~~~  175 (181)
                      ..  .....|++.|+|||++.+..
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~  182 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKG  182 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCC
Confidence            22  23456899999999997643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.2e-34  Score=211.52  Aligned_cols=171  Identities=36%  Similarity=0.566  Sum_probs=143.0

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHh-hCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHR-SLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~-~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|+||.||+|.+..+++.||+|++....    ...+....|..++. ..+||+++++++++...+.++++|||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999999999999999987542    11233444555554 44899999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-CCCCCcccC
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~~~~~~~~~  161 (181)
                      ++|...+.....+++..+..++.|++.||.|||++|++|+||+|+||++++++.  ++|+|||++..... ........|
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccC
Confidence            999998887788999999999999999999999999999999999999975554  99999999875432 233344578


Q ss_pred             CCCccCcccccCCccCCCC
Q 030211          162 TPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~  180 (181)
                      ++.|+|||++.+..++.++
T Consensus       159 t~~y~aPE~~~~~~~~~~~  177 (316)
T cd05592         159 TPDYIAPEILKGQKYNESV  177 (316)
T ss_pred             CccccCHHHHcCCCCCCcc
Confidence            9999999999988877653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.3e-34  Score=212.11  Aligned_cols=173  Identities=36%  Similarity=0.567  Sum_probs=145.0

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHH---hhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINH---RSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~---~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      |++.+.||+|++|.||++.+..+++.||+|++....    ...+.+..|.+++   ..++|||++++++++.+.+..+++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            789999999999999999999999999999987542    1223455555544   566899999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-CCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~~~  155 (181)
                      |||+++++|...+. ...+++..++.++.|++.||.|||++|++|+||+|+||++++++  .++|+|||++..... ...
T Consensus        81 ~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          81 MEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG--FVKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC--cEEeCcccCCccCCCCCCc
Confidence            99999999987764 35799999999999999999999999999999999999997655  499999999864332 233


Q ss_pred             CCcccCCCCccCcccccCCccCCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .....|++.|+|||.+.+..++.+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~  181 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTETSYTRA  181 (324)
T ss_pred             ccccccCccccCHhHhcCCCCCcc
Confidence            344578999999999998887754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-34  Score=209.97  Aligned_cols=146  Identities=28%  Similarity=0.439  Sum_probs=132.0

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++++.||.|.-|+||+|....++..+|+|++.+....    ......|-.+|..++||.+++++..|+.+++.+++
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            35789999999999999999999999999999999875432    34667788999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211           77 MEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      ||||+|++|....++++  .|+++.++.++..++.||+|||-.|||.|||||+||+|.++++  |+|.||.++.
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~  227 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSL  227 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccc
Confidence            99999999988876654  7999999999999999999999999999999999999976776  9999999863

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.9e-34  Score=211.15  Aligned_cols=171  Identities=30%  Similarity=0.485  Sum_probs=145.2

Q ss_pred             eeeeCCccceeEEEEEEc---cCCcEEEEEEccccc-----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            7 VKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR-----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~-----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++.||+|+||.||++.+.   ..++.+|+|++....     .....+.+|+.++..++|||++++++.+..++.++++||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999863   468899999987532     222456789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCC
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~  157 (181)
                      |+++++|.+.+.....+++..+..++.|++.||.+||++|++|+||+|+||++++++  .++|+|||++....... ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEeeCcCCeecccCCCccc
Confidence            999999999998888899999999999999999999999999999999999997555  49999999986433222 233


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...|++.|+|||++.+..++.+
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~  180 (323)
T cd05584         159 TFCGTIEYMAPEILMRSGHGKA  180 (323)
T ss_pred             ccCCCccccChhhccCCCCCCc
Confidence            4568999999999988777654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-34  Score=206.70  Aligned_cols=175  Identities=26%  Similarity=0.374  Sum_probs=150.0

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      .|++.+.||+|++|.||++.+..+++.||+|.+.....    ....+.+|+.+++.++|++++++++.+.+++..+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            58999999999999999999998899999999865321    12456789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           79 YAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        79 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |+++++|...+...  ..+++..+..++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG--HIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC--CEEEeeCCCceecCCCCcc
Confidence            99999998776543  4689999999999999999999999999999999999997554  4999999998765433333


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+++.|+|||++.+..++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~  181 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERYTFS  181 (285)
T ss_pred             ccccCCCCccCcHHhcCCCCCcc
Confidence            44578999999999988877765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.8e-34  Score=211.50  Aligned_cols=170  Identities=28%  Similarity=0.493  Sum_probs=145.9

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|+||.||++.+..+++.+|+|++.+...    ..+.+..|..++..+ +|++++.+++++.+.+.++++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999876421    224567788887777 689999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCCCCCcccC
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSRPKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~~~~~~~~  161 (181)
                      ++|...+.....+++..+..++.|++.||+|||++|++|+||+|+||++++++.  ++|+|||++.... .........|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence            999988877778999999999999999999999999999999999999976655  9999999987432 2233344578


Q ss_pred             CCCccCcccccCCccCCC
Q 030211          162 TPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.|+|||++.+..++.+
T Consensus       159 t~~y~aPE~~~~~~~~~~  176 (327)
T cd05617         159 TPNYIAPEILRGEEYGFS  176 (327)
T ss_pred             CcccCCHHHHCCCCCCch
Confidence            999999999998888765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.9e-34  Score=212.81  Aligned_cols=175  Identities=27%  Similarity=0.394  Sum_probs=147.1

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC------
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPT------   71 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~------   71 (181)
                      +++|++.+.||+|+||.||++.+..+++.+|+|.+....   .....+.+|+.+++.++|||++++++++...+      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            468999999999999999999999999999999986532   22356778999999999999999999986543      


Q ss_pred             eEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      ..+++|||+.+ ++.+.+..  .+++..+..++.|++.||.|||++|++|+||+|+||++++++.  ++|+|||++....
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~  174 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAC  174 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccc
Confidence            57999999965 56555533  4889999999999999999999999999999999999976554  9999999987554


Q ss_pred             CCCCCCcccCCCCccCcccccCCccCCCC
Q 030211          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      .........+++.|+|||++.+..+++++
T Consensus       175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  203 (359)
T cd07876         175 TNFMMTPYVVTRYYRAPEVILGMGYKENV  203 (359)
T ss_pred             cCccCCCCcccCCCCCchhccCCCCCcch
Confidence            44444556789999999999988887653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.5e-34  Score=210.74  Aligned_cols=170  Identities=34%  Similarity=0.516  Sum_probs=143.7

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhh-CCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRS-LRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~-~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|+||.||++.++.++..||+|.+....    ...+....|..++.. .+|++++++++++.+.+.++++|||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999999999999999987542    122345556666654 4899999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-CCCCCcccC
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~~~~~~~~~  161 (181)
                      ++|...+.....+++..+..++.|++.||+|||++|++|+||+|+||++++++  .++|+|||++..... ........|
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG--HIKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEeCccCCCeecccCCCceeccCC
Confidence            99999888878899999999999999999999999999999999999997555  499999999864322 222344568


Q ss_pred             CCCccCcccccCCccCCC
Q 030211          162 TPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.|+|||++.+..++++
T Consensus       159 t~~y~aPE~~~~~~~~~~  176 (316)
T cd05620         159 TPDYIAPEILQGLKYTFS  176 (316)
T ss_pred             CcCccCHHHHcCCCCCcc
Confidence            999999999998888765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.7e-34  Score=210.82  Aligned_cols=171  Identities=32%  Similarity=0.527  Sum_probs=145.8

Q ss_pred             eeeeCCccceeEEEEEE---ccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            7 VKDLGAGNFGVARLLRH---KETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~---~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++.||+|+||.||++.+   ..+++.+|+|++.....   .......|+.++..++|||++++++++.+++.++++|||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            36799999999999986   35788999999875432   2245667899999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCCCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~~~~  159 (181)
                      ++++|.+.+.+...+++..++.++.|++.||.|||++|++|+||+|+||++++++.  ++|+|||++...... ......
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecc
Confidence            99999999988788999999999999999999999999999999999999975554  999999998754333 233345


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .|++.|+|||.+.+..++.+
T Consensus       159 ~g~~~y~aPE~~~~~~~~~~  178 (318)
T cd05582         159 CGTVEYMAPEVVNRRGHTQS  178 (318)
T ss_pred             cCChhhcCHHHHcCCCCCCc
Confidence            78999999999988777654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.8e-34  Score=212.16  Aligned_cols=174  Identities=30%  Similarity=0.521  Sum_probs=145.2

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcC-----CeEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTP-----THLA   74 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~   74 (181)
                      +|++.+.||+|++|.||++.+..++..||+|.+.....   ....+.+|+.+++.++|||++++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            69999999999999999999999999999998864321   234578899999999999999999988654     2489


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      ++|||++ ++|.+.+.....+++..+..++.|++.||.|||++|++|+||+|+||++++++  .++|+|||++.......
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--cEEEccCcccccccccc
Confidence            9999995 58888888777899999999999999999999999999999999999997555  49999999987542222


Q ss_pred             C----CCcccCCCCccCcccccC--CccCCC
Q 030211          155 R----PKSTVGTPAYIAPEVLSR--REYDGK  179 (181)
Q Consensus       155 ~----~~~~~~~~~~~aPE~~~~--~~~~~~  179 (181)
                      .    .....+++.|+|||++.+  ..++++
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~  188 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPA  188 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCch
Confidence            1    133568999999999876  455544

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9.5e-34  Score=207.86  Aligned_cols=170  Identities=29%  Similarity=0.464  Sum_probs=143.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|++......  ...+.+|+.+++.++|||++++++++.+....+++|||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            6899999999999999999999988999999998754322  34677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCCC
Q 030211           80 AAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPK  157 (181)
Q Consensus        80 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~~  157 (181)
                      +. ++|.+.+..+ ..++++.++.++.|++.||++||++|++|+||||+||++++++  .++|+|||++...... ....
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG--ELKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECCCCcceeccCCCccCC
Confidence            95 5777766554 4689999999999999999999999999999999999997555  4999999998643222 2233


Q ss_pred             cccCCCCccCcccccCC
Q 030211          158 STVGTPAYIAPEVLSRR  174 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~  174 (181)
                      ...+++.|+|||++.+.
T Consensus       162 ~~~~~~~y~aPE~~~~~  178 (303)
T cd07869         162 NEVVTLWYRPPDVLLGS  178 (303)
T ss_pred             CCcccCCCCChHHHcCC
Confidence            45678999999998654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.3e-34  Score=212.12  Aligned_cols=177  Identities=23%  Similarity=0.356  Sum_probs=143.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEcccccc--ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCC-e
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPT-H   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~-~   72 (181)
                      ++|++.+.||+|+||.||+|.+.     .+++.||+|.+.....  ....+.+|+.++..+ +|||++++++++...+ .
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            58999999999999999999752     3456799999875432  235688899999999 8999999999887654 5


Q ss_pred             EEEEEeecCCCChHHHHhhc------------------------------------------------------------
Q 030211           73 LAIVMEYAAGGELFDRICNA------------------------------------------------------------   92 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~------------------------------------------------------------   92 (181)
                      ++++|||+++++|.+++...                                                            
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            89999999999998887542                                                            


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC---CCcccCCCCccC
Q 030211           93 --GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIA  167 (181)
Q Consensus        93 --~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~a  167 (181)
                        .++++..+..++.|++.||+|||++|++|+||||+||+++.+.  .++|+|||++........   .....+++.|+|
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC--cEEEeecccccccccCcchhcccCCCCCccccC
Confidence              2377888999999999999999999999999999999997554  599999999875432221   122345678999


Q ss_pred             cccccCCccCCCC
Q 030211          168 PEVLSRREYDGKQ  180 (181)
Q Consensus       168 PE~~~~~~~~~~~  180 (181)
                      ||++.+..++.++
T Consensus       245 PE~~~~~~~~~~s  257 (338)
T cd05102         245 PESIFDKVYTTQS  257 (338)
T ss_pred             cHHhhcCCCCccc
Confidence            9999988887764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.6e-34  Score=210.62  Aligned_cols=175  Identities=32%  Similarity=0.480  Sum_probs=151.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|+||.||++.+..++..+++|.+.....  ....+.+|+.+++.++|+|++++++++.+.+..+++|||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            689999999999999999999998899999998775422  235688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      +.+++|.+++.....+++..+..++.|++.++.|||+. +++|+||+|+||++++++.  ++|+|||++..... .....
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~~~~  161 (333)
T cd06650          85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  161 (333)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hcccc
Confidence            99999999998877899999999999999999999975 7999999999999975554  99999999864322 22334


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..+++.|+|||.+.+..++.+
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~  182 (333)
T cd06650         162 FVGTRSYMSPERLQGTHYSVQ  182 (333)
T ss_pred             CCCCccccCHHHhcCCCCCcH
Confidence            568999999999988777654

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.1e-34  Score=228.22  Aligned_cols=177  Identities=27%  Similarity=0.370  Sum_probs=148.9

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      |++|++.+.||+|+||.||+|.+..+++.||+|++.....    ..+.+.+|+.+++.++|||++++++++.+++..+++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            6899999999999999999999999999999999875322    235688899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecC
Q 030211           77 MEYAAGGELFDRICNA-----------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG  145 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg  145 (181)
                      |||+++++|.+++...           ...+...+..++.|++.||++||++|++||||||+||+++.++.  ++|+|||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFG  158 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWG  158 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecC
Confidence            9999999998877531           23456678899999999999999999999999999999975554  9999999


Q ss_pred             CcccccCC-------------------CCCCcccCCCCccCcccccCCccCCC
Q 030211          146 YSKSSVLH-------------------SRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       146 ~a~~~~~~-------------------~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ++......                   .......|++.|+|||.+.+.+++.+
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k  211 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES  211 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH
Confidence            98754111                   01112458999999999998887765

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.9e-34  Score=209.77  Aligned_cols=170  Identities=34%  Similarity=0.519  Sum_probs=143.5

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhh-CCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRS-LRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~-~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|+||.||++.+..+++.||+|.+....    ........|..++.. .+||+++++++++.+.+.++++|||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            47899999999999999999999999987642    222345556666664 5899999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-CCCCCcccC
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~~~~~~~~~  161 (181)
                      ++|...+.....+++..+..++.|++.||.|||++|++|+||+|+||++++++.  ++|+|||++..... ........|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecC
Confidence            999998887778999999999999999999999999999999999999976554  99999999864322 223344568


Q ss_pred             CCCccCcccccCCccCCC
Q 030211          162 TPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.|+|||++.+..++.+
T Consensus       159 t~~y~aPE~~~~~~~~~~  176 (316)
T cd05619         159 TPDYIAPEILLGQKYNTS  176 (316)
T ss_pred             CccccCHHHHcCCCCCch
Confidence            999999999998887765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.9e-34  Score=208.35  Aligned_cols=176  Identities=26%  Similarity=0.354  Sum_probs=144.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc----------------CCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE----------------TKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRF   63 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~----------------~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~   63 (181)
                      ++|++.+.||+|+||.||+|.+.+                ++..||+|.+.....  ....+.+|+.++..++|||++++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            589999999999999999998643                334699998875422  23568889999999999999999


Q ss_pred             EEeEEcCCeEEEEEeecCCCChHHHHhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCC
Q 030211           64 KEVVLTPTHLAIVMEYAAGGELFDRICNA-------------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDL  124 (181)
Q Consensus        64 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-------------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl  124 (181)
                      ++++.+.+..+++|||+++++|.+++...                   ..+++..++.++.|++.||.+||++|++|+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl  164 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL  164 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence            99999999999999999999998887542                   13677889999999999999999999999999


Q ss_pred             CCCCEEeccCCCCcEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       125 ~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +|+||+++++.  .++|+|||++........   .....++..|+|||++..+.++++
T Consensus       165 kp~Nill~~~~--~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  220 (304)
T cd05096         165 ATRNCLVGENL--TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA  220 (304)
T ss_pred             chhheEEcCCc--cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch
Confidence            99999997554  499999999875433221   122345778999999988887765

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-33  Score=217.69  Aligned_cols=175  Identities=29%  Similarity=0.400  Sum_probs=148.2

Q ss_pred             cceeeeeeCCccceeEEEEEEccC-CcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            3 KYELVKDLGAGNFGVARLLRHKET-KELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      .|.+.+.||+|++|.||.|.+..+ +..|++|.+...... ...+.+|+.+++.++|||++++++.+...+..+++|||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            499999999999999999998876 778899976543322 345677999999999999999999999999999999999


Q ss_pred             CCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC--
Q 030211           81 AGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--  154 (181)
Q Consensus        81 ~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~--  154 (181)
                      ++++|.+.+..    ..++++..+..++.|++.||.+||++||+|+||||+||++++++  .++|+|||++.......  
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~--~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG--IIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC--cEEEEeCcCceecCCcccc
Confidence            99999876643    34689999999999999999999999999999999999997555  49999999997543322  


Q ss_pred             -CCCcccCCCCccCcccccCCccCCC
Q 030211          155 -RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                       ......|++.|+|||++.+..++.+
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~  251 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKK  251 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcH
Confidence             2334568999999999998887765

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.1e-34  Score=214.29  Aligned_cols=176  Identities=43%  Similarity=0.706  Sum_probs=163.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ..|.+.+.||+|.|+.|..+++..++..||+|.+.+..-.   .+...+|+.+++.+.|||+++++.+.+.+..+|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            5799999999999999999999999999999999875422   2457889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      |..++.+.+++.+++...+.+++.++.|++.|++|||++.|+|+|||++|++++.+.+  ++|+|||++..........+
T Consensus       136 ya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~lqt  213 (596)
T KOG0586|consen  136 YASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLMLQT  213 (596)
T ss_pred             eccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccccccc
Confidence            9999999999999999999999999999999999999999999999999999976666  99999999998888888999


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+|++.|.|||++.+..|+..
T Consensus       214 ~cgsppyAaPEl~~g~~y~gp  234 (596)
T KOG0586|consen  214 FCGSPPYAAPELFNGKKYDGP  234 (596)
T ss_pred             cCCCCCccChHhhcCcccCCc
Confidence            999999999999999888754

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=207.08  Aligned_cols=169  Identities=31%  Similarity=0.493  Sum_probs=147.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +.|++.+.||.|..++||+|...-.+..||||++.-.+-  ..+.+.+|+..++.+.||||++.+..|....++|+||+|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            579999999999999999999998899999999875432  246788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-C
Q 030211           80 AAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-P  156 (181)
Q Consensus        80 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~  156 (181)
                      |.+|++.+.+...  .-+++..+..+++++++||.|||.+|-+|||||+.||+|++++.  |+|.|||.+-.....+. .
T Consensus       106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G~R~  183 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSGDRQ  183 (516)
T ss_pred             hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeeeeecccCcee
Confidence            9999999988653  35999999999999999999999999999999999999987776  99999998654333322 1


Q ss_pred             ----CcccCCCCccCccccc
Q 030211          157 ----KSTVGTPAYIAPEVLS  172 (181)
Q Consensus       157 ----~~~~~~~~~~aPE~~~  172 (181)
                          ..+.|++.|||||++.
T Consensus       184 ~~rf~tfvgtp~wmAPEvl~  203 (516)
T KOG0582|consen  184 VTRFNTFVGTPCWMAPEVLM  203 (516)
T ss_pred             eEeeccccCcccccChHHhh
Confidence                3457999999999954

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.4e-34  Score=205.53  Aligned_cols=173  Identities=40%  Similarity=0.591  Sum_probs=149.7

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccH---HHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE---NVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~---~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      |++++.||+|++|+||++.+..+++.+|+|++........   ....|+..+..++|++++++++++.+.+..+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            8999999999999999999999999999999987654332   2345889999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc-cCCCCCCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-VLHSRPKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~-~~~~~~~~~  159 (181)
                      .+++|.+++.....++...+..++.|++.+|.+||++|++|+||+|+||++++++  .++|+|||.+... .........
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~  158 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG--EVKLIDFGSSVKLSENNENFNPF  158 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS--EEEESSGTTTEESTSTTSEBSSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccc
Confidence            9999999998778899999999999999999999999999999999999997444  5999999998753 333344456


Q ss_pred             cCCCCccCccccc-CCccCC
Q 030211          160 VGTPAYIAPEVLS-RREYDG  178 (181)
Q Consensus       160 ~~~~~~~aPE~~~-~~~~~~  178 (181)
                      .+++.|+|||++. ...++.
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~  178 (260)
T PF00069_consen  159 VGTPEYMAPEVLQQGKKYTR  178 (260)
T ss_dssp             SSSGGGSCHHHHTTTSSBST
T ss_pred             cccccccccccccccccccc
Confidence            7899999999998 555443

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.3e-33  Score=203.80  Aligned_cols=174  Identities=37%  Similarity=0.654  Sum_probs=152.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+....    ...+.+.+|+.+++.+.|||++++++++.+++..+++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            57999999999999999999999889999999987543    22356778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      ||+++++|.+++.....++...+..++.|++.+|.+||++|++|+||+|+||++++++  .++|+|||++......  ..
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~--~~  156 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG--YIKITDFGFAKRVKGR--TY  156 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC--CEEEeeCCCccccCCC--CC
Confidence            9999999999998888899999999999999999999999999999999999997655  4999999998754333  33


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...+++.|+|||.+.+...+.+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~  178 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGYGKA  178 (290)
T ss_pred             CCCCCccccChhhhcCCCCCcc
Confidence            4568899999999987766554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.2e-33  Score=208.66  Aligned_cols=170  Identities=36%  Similarity=0.561  Sum_probs=144.5

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|+||.||++.+..+++.+|+|++.+..    .....+..|..++..+ +|||++++++++.+.+.++++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999999899999999987542    1224456677777766 799999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCCCCCcccC
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSRPKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~~~~~~~~  161 (181)
                      ++|...+.+...+++..+..++.|++.||.|||++|++|+||+|+||++++++  .++|+|||++.... .........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG--HIKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC--cEEecccCCCeecCcCCCcccceec
Confidence            99998888777899999999999999999999999999999999999997655  49999999986432 2222334568


Q ss_pred             CCCccCcccccCCccCCC
Q 030211          162 TPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.|+|||++.+..++.+
T Consensus       159 ~~~y~aPE~~~~~~~~~~  176 (318)
T cd05570         159 TPDYIAPEILSYQPYGPA  176 (318)
T ss_pred             CccccCHHHhcCCCCCcc
Confidence            999999999998888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.2e-33  Score=201.97  Aligned_cols=175  Identities=26%  Similarity=0.375  Sum_probs=150.4

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      .|+..+.||+|+||.||++.+..+++.+++|.+......    ...+.+|+.+++.++|++++.+.+.+.+.+..+++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            488899999999999999999999999999988654322    2346779999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           79 YAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        79 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |+++++|.+.+...  ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++.  ++|+|||++.........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccc
Confidence            99999998877543  35899999999999999999999999999999999999975554  999999998755444444


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+++.|+|||++.+..++.+
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~  181 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYTFS  181 (285)
T ss_pred             cCCCCCccccChHHHcCCCCCCc
Confidence            45578999999999998888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6e-33  Score=202.04  Aligned_cols=176  Identities=26%  Similarity=0.379  Sum_probs=150.4

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      .|+..+.||+|+||+||++.+..+++.+|+|.+.....    ....+.+|+.++..++|++++.+.+.+.+.+..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            47889999999999999999998999999999865422    12346789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           79 YAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        79 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |+.+++|...+..  ...+++..+..++.|++.+|.+||++|++|+||+|+||+++++.  .++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG--HIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC--CEEEecCCcceecCCCCcc
Confidence            9999999877654  33699999999999999999999999999999999999997555  4999999998654433334


Q ss_pred             CcccCCCCccCcccccCCccCCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ....+++.|+|||++.+..++.++
T Consensus       159 ~~~~g~~~~~aPE~~~~~~~~~~~  182 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQRYTLSP  182 (285)
T ss_pred             cCCCCCcCccChHHhcCCCCCccc
Confidence            455789999999999888877653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=235.52  Aligned_cols=172  Identities=31%  Similarity=0.496  Sum_probs=152.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc----ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +.|+++++||+|+||.|..++++++++.+|+|++.+-    .....-|.+|-.++.--..+=|++++..|++++++|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            5799999999999999999999999999999999872    222355777777777777788999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC-
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~-  156 (181)
                      ||++||+|...+.+...++++.++.++..|+.||..||+.|+|||||||+||+++..++  |+|+|||.|-.....+.- 
T Consensus       155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG~V~  232 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADGTVR  232 (1317)
T ss_pred             ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCCcEE
Confidence            99999999999988889999999999999999999999999999999999999975555  999999999877766663 


Q ss_pred             -CcccCCCCccCcccccCCc
Q 030211          157 -KSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       157 -~~~~~~~~~~aPE~~~~~~  175 (181)
                       ...+|||.|.|||++....
T Consensus       233 s~~aVGTPDYISPEvLqs~~  252 (1317)
T KOG0612|consen  233 SSVAVGTPDYISPEVLQSQG  252 (1317)
T ss_pred             eccccCCCCccCHHHHHhhc
Confidence             4468999999999998543

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.8e-33  Score=210.57  Aligned_cols=174  Identities=27%  Similarity=0.399  Sum_probs=146.9

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcC------C
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTP------T   71 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~------~   71 (181)
                      +++|++.+.||+|+||.||++.+..+++.+|+|.+.....   ....+.+|+.+++.++|||++++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            4789999999999999999999998999999999875432   235677899999999999999999988654      3


Q ss_pred             eEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      ..+++|||+.+ ++.+.+..  .++...+..++.|++.||.+||++|++|+||+|+||++++++.  ++|+|||++....
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~  170 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  170 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccCC
Confidence            57999999965 66665543  4889999999999999999999999999999999999976554  9999999997655


Q ss_pred             CCCCCCcccCCCCccCcccccCCccCCC
Q 030211          152 LHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .........+++.|+|||++.+..++++
T Consensus       171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~  198 (355)
T cd07874         171 TSFMMTPYVVTRYYRAPEVILGMGYKEN  198 (355)
T ss_pred             CccccCCccccCCccCHHHHcCCCCCch
Confidence            5444555678999999999998887765

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.6e-33  Score=202.46  Aligned_cols=175  Identities=29%  Similarity=0.452  Sum_probs=141.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-cCCcEEEEEEcccccc---ccHHHHHHHHHHhhC---CCCCeeEEEEeEEc-----
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-ETKELVAVKYIERGRK---IDENVAREIINHRSL---RHPNIIRFKEVVLT-----   69 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~---~~~~i~~~~~~~~~-----   69 (181)
                      ++|++.+.||+|+||.||+|.+. .+++.||+|.+.....   ....+.+|+..++.+   .|||++++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            58999999999999999999985 4567899998865322   123455666666554   79999999998853     


Q ss_pred             CCeEEEEEeecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCc
Q 030211           70 PTHLAIVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (181)
Q Consensus        70 ~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a  147 (181)
                      ...++++||++. ++|.+++...  ..+++..+..++.|++.||.+||++|++|+||+|+||++++++.  ++|+|||++
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~  157 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA  157 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccce
Confidence            356899999996 5888877543  35899999999999999999999999999999999999976554  999999998


Q ss_pred             ccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          148 KSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .............+++.|+|||.+.+..++.+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  189 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP  189 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCCCCCCc
Confidence            76554444455678999999999988877765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-33  Score=206.79  Aligned_cols=167  Identities=33%  Similarity=0.571  Sum_probs=137.4

Q ss_pred             eCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhC---CCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211           10 LGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSL---RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus        10 i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~---~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      ||+|+||+||+|.+..+++.||+|++.+....    ......|..++...   .||+++.+++.+.+++..+++|||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            68999999999999999999999998653221    12233344444433   699999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-CCCCCcccC
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~~~~~~~~~  161 (181)
                      ++|...+.....+++..++.++.|++.||+|||++|++|+||+|+||++++++  .++|+|||++..... ........|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG--HIALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC--CEEEecCCcCcCCCCCCCCccCccC
Confidence            99998888888899999999999999999999999999999999999997555  499999999865332 233344578


Q ss_pred             CCCccCcccccCCc-cCC
Q 030211          162 TPAYIAPEVLSRRE-YDG  178 (181)
Q Consensus       162 ~~~~~aPE~~~~~~-~~~  178 (181)
                      ++.|+|||++.+.. ++.
T Consensus       159 t~~y~aPE~~~~~~~~~~  176 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTK  176 (330)
T ss_pred             CccccCHHHHcCCCCCCC
Confidence            99999999987543 444

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5e-33  Score=201.98  Aligned_cols=168  Identities=32%  Similarity=0.435  Sum_probs=142.0

Q ss_pred             eCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCCh
Q 030211           10 LGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (181)
Q Consensus        10 i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   85 (181)
                      ||+|+||+||++.+..+++.+|+|.+......    .+.+..|+.+++.++|++++++.+++...+..+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            68999999999999999999999998653221    24567789999999999999999999999999999999999999


Q ss_pred             HHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-CCccc
Q 030211           86 FDRIC----NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKSTV  160 (181)
Q Consensus        86 ~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~~~~~  160 (181)
                      ...+.    .+..+++..+..++.|++.||.|||++|++|+||+|+||+++++.  .++|+|||++........ .....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG--NVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCccceecCCCCccccccC
Confidence            87663    234689999999999999999999999999999999999997554  499999999865433322 23356


Q ss_pred             CCCCccCcccccCCccCCC
Q 030211          161 GTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       161 ~~~~~~aPE~~~~~~~~~~  179 (181)
                      +++.|+|||++.+..++.+
T Consensus       159 g~~~y~aPE~~~~~~~~~~  177 (280)
T cd05608         159 GTPGFMAPELLQGEEYDFS  177 (280)
T ss_pred             CCcCccCHHHhcCCCCCcc
Confidence            8999999999998887754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-33  Score=208.99  Aligned_cols=170  Identities=25%  Similarity=0.417  Sum_probs=145.7

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +|++.+.||+|+||.||+|.+..+++.|++|+....     ....|+.+++.++|+|++++++++...+..++++|++. 
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  140 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-  140 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-
Confidence            699999999999999999999988999999975432     33568899999999999999999999999999999995 


Q ss_pred             CChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccC
Q 030211           83 GELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~  161 (181)
                      ++|.+++.. ...+++..+..++.|++.||.|||++||+|+||||+||+++++..  ++|+|||.+.............|
T Consensus       141 ~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~g  218 (357)
T PHA03209        141 SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGLAG  218 (357)
T ss_pred             CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCcccccccc
Confidence            477777654 457999999999999999999999999999999999999975554  99999999875444444445678


Q ss_pred             CCCccCcccccCCccCCCC
Q 030211          162 TPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~  180 (181)
                      ++.|+|||++.+..++.++
T Consensus       219 t~~y~aPE~~~~~~~~~~~  237 (357)
T PHA03209        219 TVETNAPEVLARDKYNSKA  237 (357)
T ss_pred             cccccCCeecCCCCCCchh
Confidence            9999999999988887653

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.5e-33  Score=209.08  Aligned_cols=174  Identities=28%  Similarity=0.397  Sum_probs=146.8

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcC------C
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP------T   71 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~------~   71 (181)
                      +++|++.+.||+|+||.||++.+..+++.+|+|.+....   .....+.+|+.+++.++|||++++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            478999999999999999999999999999999987532   2235677899999999999999999987643      3


Q ss_pred             eEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      ..+++|||+++ ++...+..  .++...+..++.|++.||.+||++|++|+||+|+||++++++.  ++|+|||++....
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~  177 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  177 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccccC
Confidence            57999999965 66666643  4888999999999999999999999999999999999976554  9999999997655


Q ss_pred             CCCCCCcccCCCCccCcccccCCccCCC
Q 030211          152 LHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .........+++.|+|||++.+..++++
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~  205 (364)
T cd07875         178 TSFMMTPYVVTRYYRAPEVILGMGYKEN  205 (364)
T ss_pred             CCCcccCCcccCCcCCHHHHhCCCCCch
Confidence            4444455678999999999998887765

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.1e-32  Score=200.66  Aligned_cols=175  Identities=28%  Similarity=0.449  Sum_probs=143.1

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhC---CCCCeeEEEEeEEcC-----C
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSL---RHPNIIRFKEVVLTP-----T   71 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~---~~~~i~~~~~~~~~~-----~   71 (181)
                      +|++.+.||+|++|.||+|.+..+++.+|+|.+.....   ......+|+.+++.+   .|||++++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            69999999999999999999999999999998875322   123455666666554   799999999988653     4


Q ss_pred             eEEEEEeecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           72 HLAIVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      ..++++|++.+ +|.+++...  ..+++..++.++.|++.||.|||++|++|+||+|+||++++++.  ++|+|||++..
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI  157 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence            58999999975 787777553  35899999999999999999999999999999999999976554  99999999876


Q ss_pred             ccCCCCCCcccCCCCccCcccccCCccCCCC
Q 030211          150 SVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       150 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ...........+++.|+|||++.+..++.++
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  188 (288)
T cd07863         158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPV  188 (288)
T ss_pred             ccCcccCCCccccccccCchHhhCCCCCCcc
Confidence            5444444456788999999999888777653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-34  Score=203.32  Aligned_cols=170  Identities=34%  Similarity=0.508  Sum_probs=147.1

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc---ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcC-----CeEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTP-----THLA   74 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~   74 (181)
                      +|...+.||+|++|.|+.|.++.++..||+|.+...   ....+..++|+++++.++|+|++.+.+++..+     +.+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            466678999999999999999999999999988743   23347889999999999999999999998762     4699


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC--
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL--  152 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~--  152 (181)
                      +|+|+| +.+|...+..+..++.+.+..+++|++.||.|+|+.+++||||||.|++++.+  +.+|++|||+|+....  
T Consensus       103 iV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~--c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  103 LVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD--CDLKICDFGLARYLDKFF  179 (359)
T ss_pred             EehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC--CCEEeccccceeeccccC
Confidence            999999 66888888877789999999999999999999999999999999999999644  4599999999986654  


Q ss_pred             -CCCCCcccCCCCccCcccccCCc
Q 030211          153 -HSRPKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       153 -~~~~~~~~~~~~~~aPE~~~~~~  175 (181)
                       .+....+..|..|.|||.+.+..
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~  203 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSS  203 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccc
Confidence             44456678899999999987543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=209.97  Aligned_cols=175  Identities=29%  Similarity=0.410  Sum_probs=151.3

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      .+++.+.||+|-||.||.+.+.. ...|++|.+.......+.+.+|+.++++++|++||++++++..+..+++||||++.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            35677889999999999999974 34699999998777778999999999999999999999999998899999999999


Q ss_pred             CChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc--
Q 030211           83 GELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS--  158 (181)
Q Consensus        83 ~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~--  158 (181)
                      |+|.+++..  ...+.......++.||+.+++||.++++|||||.+.||+++++.  .+|++|||+|+......-...  
T Consensus       286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~--~vKIsDFGLAr~~~d~~Y~~~~~  363 (468)
T KOG0197|consen  286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL--VVKISDFGLARLIGDDEYTASEG  363 (468)
T ss_pred             CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc--eEEEcccccccccCCCceeecCC
Confidence            999999986  45799999999999999999999999999999999999997555  599999999984332222222  


Q ss_pred             ccCCCCccCcccccCCccCCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ..-...|.|||.+..+.++.||
T Consensus       364 ~kfPIkWtAPEa~~~~~FS~kS  385 (468)
T KOG0197|consen  364 GKFPIKWTAPEALNYGKFSSKS  385 (468)
T ss_pred             CCCCceecCHHHHhhCCccccc
Confidence            2235679999999999999876

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.6e-33  Score=213.38  Aligned_cols=173  Identities=32%  Similarity=0.460  Sum_probs=142.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcC--------CeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTP--------THL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--------~~~   73 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+....   ....+|+.+++.++|+|++++.+++...        ..+
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            47999999999999999999999899999999876432   2345789999999999999998887532        247


Q ss_pred             EEEEeecCCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           74 AIVMEYAAGGELFDRIC----NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      +++|||+++ ++..++.    ....+++..++.++.|++.||.|||++||+||||||+||+++.+. ..++|+|||+|+.
T Consensus       143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~-~~vkL~DFGla~~  220 (440)
T PTZ00036        143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT-HTLKLCDFGSAKN  220 (440)
T ss_pred             EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC-Cceeeeccccchh
Confidence            799999975 6655543    345799999999999999999999999999999999999996432 3599999999987


Q ss_pred             ccCCCCCCcccCCCCccCcccccCC-ccCCC
Q 030211          150 SVLHSRPKSTVGTPAYIAPEVLSRR-EYDGK  179 (181)
Q Consensus       150 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~  179 (181)
                      ...........+++.|+|||++.+. .++.+
T Consensus       221 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  251 (440)
T PTZ00036        221 LLAGQRSVSYICSRFYRAPELMLGATNYTTH  251 (440)
T ss_pred             ccCCCCcccCCCCcCccCHHHhcCCCCCCcH
Confidence            6555555567889999999998754 45543

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=196.91  Aligned_cols=176  Identities=33%  Similarity=0.477  Sum_probs=151.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+.....      ....+.+|+.+++.++|||++++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            579999999999999999999998899999998865321      12457789999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      ++|++++++|.+.+.+...+++..+..++.|++.++.+||+.|++|+||+|+||+++++.  .++|+|||.+........
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~--~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeecccceecccccc
Confidence            999999999999988877899999999999999999999999999999999999997554  499999999865433222


Q ss_pred             C----CcccCCCCccCcccccCCccCCC
Q 030211          156 P----KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~----~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .    ....++..|+|||.+.+..++.+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~  187 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRK  187 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCch
Confidence            1    23457789999999988776654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.7e-32  Score=198.97  Aligned_cols=168  Identities=29%  Similarity=0.401  Sum_probs=142.5

Q ss_pred             eCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCCh
Q 030211           10 LGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (181)
Q Consensus        10 i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   85 (181)
                      ||+|+||.||++.++.+++.+++|.+.....    .......|+.++..++|||++++.+.+.+....+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            6899999999999999999999998864321    123456688999999999999999999999999999999999999


Q ss_pred             HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccCCC
Q 030211           86 FDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP  163 (181)
Q Consensus        86 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~  163 (181)
                      .+.+....  .+++..+..++.|++.||++||+.|++|+||+|+||+++++..  ++|+|||++.............+++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCC
Confidence            87775433  5888899999999999999999999999999999999976554  9999999987654443334457899


Q ss_pred             CccCcccccCCccCCC
Q 030211          164 AYIAPEVLSRREYDGK  179 (181)
Q Consensus       164 ~~~aPE~~~~~~~~~~  179 (181)
                      .|+|||++.+..++.+
T Consensus       159 ~y~aPE~~~~~~~~~~  174 (277)
T cd05607         159 GYMAPEILKEEPYSYP  174 (277)
T ss_pred             CccCHHHHccCCCCCc
Confidence            9999999998887754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6e-33  Score=209.06  Aligned_cols=177  Identities=24%  Similarity=0.313  Sum_probs=144.8

Q ss_pred             ccceeeeeeCCccceeEEEEEE-----ccCCcEEEEEEcccccc--ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRH-----KETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~-----~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~   73 (181)
                      ++|++.+.||+|+||.||+|++     .+++..||+|++.....  ..+.+.+|+.++..+ +|||++++++++.+.+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4799999999999999999974     34566899999875432  235678899999999 899999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhc-------------------------------------------------------------
Q 030211           74 AIVMEYAAGGELFDRICNA-------------------------------------------------------------   92 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~-------------------------------------------------------------   92 (181)
                      +++|||+++++|.+++...                                                             
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            9999999999998877532                                                             


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC--
Q 030211           93 --------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--  156 (181)
Q Consensus        93 --------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~--  156 (181)
                                    ..++++.+..++.|++.||.|||++|++|+||+|+||+++++.  .++|+|||++.........  
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~  272 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIRNDSNYVV  272 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC--cEEEecCccceeccCcccccc
Confidence                          1467888999999999999999999999999999999997544  4999999998754332221  


Q ss_pred             -CcccCCCCccCcccccCCccCCCC
Q 030211          157 -KSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       157 -~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                       ....++..|+|||++.+..++.++
T Consensus       273 ~~~~~~~~~y~aPE~~~~~~~~~~s  297 (375)
T cd05104         273 KGNARLPVKWMAPESIFNCVYTFES  297 (375)
T ss_pred             cCCCCCCcceeChhHhcCCCCCCCC
Confidence             112345679999999988887654

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.5e-32  Score=201.95  Aligned_cols=171  Identities=30%  Similarity=0.485  Sum_probs=144.0

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      +++|++.+.||+|+||.||++.+..+++.+|+|.+.....  ....+.+|+.+++.++|+|++++++++..++..+++||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            5789999999999999999999998999999998875432  23467789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCC
Q 030211           79 YAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRP  156 (181)
Q Consensus        79 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~  156 (181)
                      |+++ +|.+.+... ..++...+..++.|++.||.+||++|++|+||+|+||++++++  .++|+|||++...... ...
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG--ELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECccccceecCCCcccc
Confidence            9975 777776544 3588999999999999999999999999999999999997555  4999999998653322 222


Q ss_pred             CcccCCCCccCcccccCC
Q 030211          157 KSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~  174 (181)
                      ....+++.|+|||.+.+.
T Consensus       162 ~~~~~~~~y~aPE~~~~~  179 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGS  179 (309)
T ss_pred             ccccccccccCCHHHhCC
Confidence            334678999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.8e-33  Score=209.04  Aligned_cols=177  Identities=24%  Similarity=0.332  Sum_probs=144.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc-----CCcEEEEEEccccccc--cHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRKI--DENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~   73 (181)
                      ++|++.+.||+|+||.||++.+..     ++..||+|.+......  .+.+.+|+.+++.+ +|+|++++++.+...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            479999999999999999998643     3357999998754322  35678899999998 899999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhc-------------------------------------------------------------
Q 030211           74 AIVMEYAAGGELFDRICNA-------------------------------------------------------------   92 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~-------------------------------------------------------------   92 (181)
                      +++|||+++++|.+++...                                                             
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            9999999999998877432                                                             


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC---Cccc
Q 030211           93 ---------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTV  160 (181)
Q Consensus        93 ---------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~---~~~~  160 (181)
                               .++++..++.++.|++.||.|||++|++|+||+|+||+++++.  .++|+|||++.........   ....
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~--~~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR--VAKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC--eEEEeeceeeeeccCCcceeeccCCC
Confidence                     2467888999999999999999999999999999999997555  4999999998654332211   1123


Q ss_pred             CCCCccCcccccCCccCCCC
Q 030211          161 GTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       161 ~~~~~~aPE~~~~~~~~~~~  180 (181)
                      +++.|+|||++.+..+++++
T Consensus       276 ~~~~y~aPE~~~~~~~~~~~  295 (374)
T cd05106         276 LPVKWMAPESIFDCVYTVQS  295 (374)
T ss_pred             CccceeCHHHhcCCCCCccc
Confidence            45679999999988887764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-32  Score=213.39  Aligned_cols=176  Identities=29%  Similarity=0.439  Sum_probs=147.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC-------
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPT-------   71 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-------   71 (181)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.....   ....+.+|+..+..++|+++++++..+...+       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            689999999999999999999999999999999865432   2345778899999999999999988775432       


Q ss_pred             -eEEEEEeecCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCC
Q 030211           72 -HLAIVMEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (181)
Q Consensus        72 -~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~  146 (181)
                       .++++|||+.+++|.+.+..    ...+++..+..++.|++.+|.|||++|++|+||||+||++++++.  ++|+|||+
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DFGl  189 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFGF  189 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEeccc
Confidence             36899999999999988754    346899999999999999999999999999999999999976554  99999999


Q ss_pred             cccccCC---CCCCcccCCCCccCcccccCCccCCC
Q 030211          147 SKSSVLH---SRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       147 a~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.....   .......|++.|+|||++.+..++.+
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k  225 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK  225 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCCCCcH
Confidence            8754322   22334578999999999998888764

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.6e-32  Score=200.70  Aligned_cols=175  Identities=31%  Similarity=0.476  Sum_probs=151.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|++|.||++.+..++..+++|.+.....  ....+.+|+.++..++|||++++++.+.+++..++++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            579999999999999999999998899999998765322  235678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      +++++|.+++.+...+++..+..++.|++.+|.|||+ .+++|+||+|+||++++++.  ++|+|||.+..... .....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~~~~  157 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  157 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCcccccc-ccccc
Confidence            9999999999888889999999999999999999997 59999999999999976554  99999998864322 22344


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..+++.|+|||.+.+..++.+
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~  178 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQ  178 (308)
T ss_pred             CCCCcCccChhHhcCCCCCcc
Confidence            578899999999987776654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.5e-32  Score=196.83  Aligned_cols=169  Identities=34%  Similarity=0.491  Sum_probs=147.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|++|.||++.+..+++.+++|++..... ....+.+|+.+++.++|||++++++.+...+..++++||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            579999999999999999999998899999999875432 2356778999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~~~  159 (181)
                      ++++|.+.+.....+++..+..++.|++.++.+||+.|++|+|++|+||++++++.  ++|+|||++....... .....
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06646          89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRKSF  166 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccCcc
Confidence            99999998877778999999999999999999999999999999999999975554  9999999987553322 23345


Q ss_pred             cCCCCccCccccc
Q 030211          160 VGTPAYIAPEVLS  172 (181)
Q Consensus       160 ~~~~~~~aPE~~~  172 (181)
                      .+++.|+|||.+.
T Consensus       167 ~~~~~y~~PE~~~  179 (267)
T cd06646         167 IGTPYWMAPEVAA  179 (267)
T ss_pred             ccCccccCHhHcc
Confidence            6888999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-32  Score=198.37  Aligned_cols=176  Identities=21%  Similarity=0.297  Sum_probs=145.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEc---cCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|++.+.||+|+||.||+++++   ..+..+++|.+.....  ....+.+|+..+..++|||++++++++..++..+++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            47999999999999999999875   3456899998876432  235678899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      |||+++++|.+++... ..+++..++.++.|++.||++||++|++|+||+|+||+++++.  .+++.|||.+........
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~--~~~l~dfg~~~~~~~~~~  162 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL--VCKISGFRRLQEDKSEAI  162 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC--cEEECCCcccccccccch
Confidence            9999999999888664 4789999999999999999999999999999999999997555  499999997654322211


Q ss_pred             CC--cccCCCCccCcccccCCccCCC
Q 030211          156 PK--STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~--~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..  ...++..|+|||.+.+..++.+
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~  188 (266)
T cd05064         163 YTTMSGKSPVLWAAPEAIQYHHFSSA  188 (266)
T ss_pred             hcccCCCCceeecCHHHHhhCCccch
Confidence            11  1234578999999988887764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-35  Score=212.28  Aligned_cols=176  Identities=32%  Similarity=0.498  Sum_probs=157.4

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      .|+..+.||+|.||.||+|.+..+++.||+|++.....  ..+.+.+|+.++.+++++|+...++.+..+..+|++|||+
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            57888999999999999999999999999999876543  3467888999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-CCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~~~~  159 (181)
                      .+|++.+.+.....+.+..+.-++++++.|+.|||..+.+|+||++.||++..+  +.++|.|||.+........ ...+
T Consensus        94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~--g~vkl~DfgVa~ql~~~~~rr~tf  171 (467)
T KOG0201|consen   94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES--GDVKLADFGVAGQLTNTVKRRKTF  171 (467)
T ss_pred             cCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc--CcEEEEecceeeeeechhhccccc
Confidence            999999999877777999999999999999999999999999999999999765  4599999999876544333 3678


Q ss_pred             cCCCCccCcccccCCccCCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      .|||.|||||++....|+.|.
T Consensus       172 vGTPfwMAPEVI~~~~Y~~KA  192 (467)
T KOG0201|consen  172 VGTPFWMAPEVIKQSGYDTKA  192 (467)
T ss_pred             cccccccchhhhccccccchh
Confidence            999999999999988998774

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.1e-32  Score=197.68  Aligned_cols=171  Identities=30%  Similarity=0.423  Sum_probs=146.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+.....  ..+.+.+|+.+++.++|||++++++.+...+..++++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            478999999999999999999998999999998865422  235688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~  159 (181)
                      +++++|..+    ..+++..+..++.|++.|+.+||+.|++|+||+|+||++++++.  ++|+|||++..... ......
T Consensus        81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~-~~~~~~  153 (279)
T cd06619          81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVN-SIAKTY  153 (279)
T ss_pred             CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceeccc-ccccCC
Confidence            999888643    24788999999999999999999999999999999999976554  99999999864432 233445


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .++..|+|||++.+..++.+
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~  173 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIH  173 (279)
T ss_pred             CCChhhcCceeecCCCCCCc
Confidence            78999999999988877654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9.6e-33  Score=206.53  Aligned_cols=166  Identities=30%  Similarity=0.469  Sum_probs=140.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|+..+.||+|+||.||++.+..+++.|++|++.....  ....+.+|+.+++.++|+|++++++++.+.+.++++|||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            568889999999999999999998999999999865432  235688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCCc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~~  158 (181)
                      +.+++|...    ...++..+..++.|++.||.|||++|++|+||+|+||+++++..  ++|+|||++....... ....
T Consensus       154 ~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~  227 (353)
T PLN00034        154 MDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCNS  227 (353)
T ss_pred             CCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceecccccccccc
Confidence            999888643    23567788899999999999999999999999999999976554  9999999987543322 2334


Q ss_pred             ccCCCCccCcccccC
Q 030211          159 TVGTPAYIAPEVLSR  173 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~  173 (181)
                      ..|+..|+|||++..
T Consensus       228 ~~gt~~y~aPE~~~~  242 (353)
T PLN00034        228 SVGTIAYMSPERINT  242 (353)
T ss_pred             cccCccccCcccccc
Confidence            578999999999854

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.7e-32  Score=197.06  Aligned_cols=175  Identities=32%  Similarity=0.500  Sum_probs=148.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++.+.||+|++|.||++.++.+++.+++|.+.....   ..+.+.+|+.+++.++|+|++++++++..++..+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            589999999999999999999998899999998865432   23567789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCC
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~  157 (181)
                      |++++++.........+++..+..++.|++.+|.+||+.|++|+||+|+||++++++  .++|+|||++....... ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG--QIKLCDFGFARILTGPGDDYT  158 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC--cEEECccccceecCCCccccc
Confidence            999888877766666799999999999999999999999999999999999997555  49999999987654433 223


Q ss_pred             cccCCCCccCcccccC-CccCC
Q 030211          158 STVGTPAYIAPEVLSR-REYDG  178 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~-~~~~~  178 (181)
                      ...++..|+|||.+.+ ..++.
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~  180 (286)
T cd07847         159 DYVATRWYRAPELLVGDTQYGP  180 (286)
T ss_pred             CcccccccCCHHHHhCCCCcCc
Confidence            3457889999999875 33443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-32  Score=197.78  Aligned_cols=169  Identities=34%  Similarity=0.517  Sum_probs=146.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+...... ...+.+|+.+++.++|||++++++.+...+..++++||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            5789999999999999999999989999999998754322 345678899999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCCCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~~~~  159 (181)
                      ++++|.+++.....+++..+..++.|++.++.+||+.|++|+||+|+||+++.+.  .++|+|||.+...... ......
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06645          89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG--HVKLADFGVSAQITATIAKRKSF  166 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECcceeeeEccCcccccccc
Confidence            9999999988778899999999999999999999999999999999999996554  4999999998654322 223345


Q ss_pred             cCCCCccCccccc
Q 030211          160 VGTPAYIAPEVLS  172 (181)
Q Consensus       160 ~~~~~~~aPE~~~  172 (181)
                      .+++.|+|||++.
T Consensus       167 ~~~~~y~aPE~~~  179 (267)
T cd06645         167 IGTPYWMAPEVAA  179 (267)
T ss_pred             cCcccccChhhhc
Confidence            6889999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.1e-32  Score=200.84  Aligned_cols=177  Identities=25%  Similarity=0.330  Sum_probs=143.4

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcE--EEEEEccccc--cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKEL--VAVKYIERGR--KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~--v~~K~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +++|++.+.||+|+||.||+|.+..++..  +++|.+....  .....+.+|+.++..+ +|+|++++++++.+.+.+++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            47899999999999999999998776654  5777665422  2235677899999988 89999999999999999999


Q ss_pred             EEeecCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcE
Q 030211           76 VMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL  139 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v  139 (181)
                      ++||+++++|.+++...                ..+++.+++.++.|++.|+++||++|++|+||+|+||+++++..  +
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~--~  163 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--A  163 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--E
Confidence            99999999999888643                25788999999999999999999999999999999999975554  9


Q ss_pred             EEeecCCcccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          140 KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       140 ~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +|+|||++..............+..|+|||.+.+..++++
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  203 (303)
T cd05088         164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN  203 (303)
T ss_pred             EeCccccCcccchhhhcccCCCcccccCHHHHhccCCccc
Confidence            9999998863222112222234567999999988777654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=9.3e-33  Score=198.14  Aligned_cols=175  Identities=30%  Similarity=0.542  Sum_probs=153.9

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      +|++.+.||.|++|.||++.+..++..+++|.+....    ...+.+.+|+..+++++|||++++++.+.+++..++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5899999999999999999999889999999987543    223678889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      |+.+++|...+....++++..+..++.|++.+|.+||++|++|+||+|+||+++++..  ++|+|||.+...........
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence            9999999998877778999999999999999999999999999999999999976554  99999999876555544455


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..++..|+|||.+.+..++.+
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~  179 (258)
T cd05578         159 TSGTPGYMAPEVLCRQGYSVA  179 (258)
T ss_pred             cCCChhhcCHHHHcccCCCCc
Confidence            668889999999987766554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.9e-32  Score=193.31  Aligned_cols=175  Identities=33%  Similarity=0.550  Sum_probs=149.3

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      +|++.+.||+|++|.||.+.+..+++.+++|.+....  ...+.+.+|+.+++.++|+|++++.+.+.+.+.+++++||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5899999999999999999999999999999886432  22356778899999999999999999999999999999999


Q ss_pred             CCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCC
Q 030211           81 AGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPK  157 (181)
Q Consensus        81 ~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~  157 (181)
                      ++++|.+.+..  ...+++..+..++.|++.||.+||++|++|+||+|+||++++++.  ++|+|||.+....... ...
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccc
Confidence            99999887754  335889999999999999999999999999999999999976554  9999999986543322 233


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...+++.|+|||++.+..++++
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~  180 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNK  180 (255)
T ss_pred             cccCCccccCHHHHccCCcCch
Confidence            4568889999999988776654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=215.76  Aligned_cols=176  Identities=33%  Similarity=0.456  Sum_probs=152.6

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC------eEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPT------HLA   74 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~------~~~   74 (181)
                      -|...+.+|+|+||.||++.++.+|+.||+|.+..-.  ...+..-+|+.+++++.|+|||+++++-++..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3566788999999999999999999999999987632  23456778999999999999999999866543      478


Q ss_pred             EEEeecCCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEec--cCCCCcEEEeecCCccc
Q 030211           75 IVMEYAAGGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD--GSAAPRLKICDFGYSKS  149 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~--~~~~~~v~l~dfg~a~~  149 (181)
                      ++||||.+|+|...+.+..   -+++...+.++.++..||.+||++||+||||||.||++-  .++...-||+|||.|+.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            9999999999999886533   599999999999999999999999999999999999983  34555789999999998


Q ss_pred             ccCCCCCCcccCCCCccCcccccC-CccCC
Q 030211          150 SVLHSRPKSTVGTPAYIAPEVLSR-REYDG  178 (181)
Q Consensus       150 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~  178 (181)
                      ....+...+..||+.|.+||++.+ +.|+.
T Consensus       174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~  203 (732)
T KOG4250|consen  174 LDDNSLFTSLVGTEEYLHPELYERQKKYTA  203 (732)
T ss_pred             CCCCCeeeeecCchhhcChHHHhhccCcCc
Confidence            888888888999999999999997 66554

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.4e-32  Score=194.51  Aligned_cols=175  Identities=26%  Similarity=0.431  Sum_probs=147.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      +.|++.+.||+|+||.||++.+++ +..+++|.+.........+.+|+.+++.++|||++++++++.+.+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            579999999999999999998865 5579999887665556778899999999999999999999999999999999999


Q ss_pred             CCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC--Cc
Q 030211           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--KS  158 (181)
Q Consensus        82 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~--~~  158 (181)
                      +++|.+.+... ..+++..+..++.|++.||++||++|++|+||+|+||+++++.  .++|+|||.+.........  ..
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG--VVKVSDFGMTRYVLDDEYTSSSG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC--eEEECCCCCccccCCCceeccCC
Confidence            99999888653 4689999999999999999999999999999999999997555  4999999988754322221  12


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..++..|+|||++....++.+
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~  181 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYSSK  181 (256)
T ss_pred             CCCchhhCChhhcccCccchh
Confidence            234568999999987776654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.7e-32  Score=193.65  Aligned_cols=175  Identities=34%  Similarity=0.511  Sum_probs=151.0

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc---ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +|++.+.||+|++|.+|++.++.+++.+++|.+...   ......+.+|+.+++.++|||++++++.+.+.+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            488999999999999999999999999999988643   22346788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-C
Q 030211           80 AAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-P  156 (181)
Q Consensus        80 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~  156 (181)
                      +++++|.+++...  ..+++..++.++.|++.||.+||++|++|+||+|+||+++++..  ++|+|||.+........ .
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~  158 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFA  158 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchh
Confidence            9999999988664  47899999999999999999999999999999999999976554  99999999875543332 2


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+++.|+|||+..+..++++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~  181 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKPYNEK  181 (256)
T ss_pred             hccccCccccCHHHhcCCCCCCc
Confidence            23467889999999998877665

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.6e-32  Score=220.59  Aligned_cols=179  Identities=36%  Similarity=0.605  Sum_probs=148.9

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEc--CCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLT--PTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~   75 (181)
                      +++|++++.||+|+||+||+|.+..++..+++|.+....   .....+..|+.++..++||||++++++|.+  .+.+|+
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            478999999999999999999999999999999887532   223568889999999999999999998865  456999


Q ss_pred             EEeecCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhc-------CeeeeCCCCCCEEeccC----------
Q 030211           76 VMEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSM-------QICHRDLKLENTLLDGS----------  134 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~-------gi~h~dl~p~ni~i~~~----------  134 (181)
                      +|||+++++|.+++..    ...+++..++.++.||+.||.|||+.       +|+|+||+|+|||++.+          
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            9999999999988754    24799999999999999999999985       49999999999999642          


Q ss_pred             -----CCCcEEEeecCCcccccCCCCCCcccCCCCccCcccccC--CccCCC
Q 030211          135 -----AAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR--REYDGK  179 (181)
Q Consensus       135 -----~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~  179 (181)
                           ....++|+|||++.............+++.|+|||++..  ..++++
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~K  223 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK  223 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCch
Confidence                 234589999999976554444455678999999999854  335543

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.6e-32  Score=195.96  Aligned_cols=177  Identities=27%  Similarity=0.432  Sum_probs=148.8

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|++|.||++.+..+++.+++|.+.....    ....+.+|+.+++.++|||++++++++.+.+..+++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            5789999999999999999999998999999998754221    124578899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           77 MEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      +||+++++|.+++..    ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++.  ++|.|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~  158 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSS  158 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccc
Confidence            999999999877642    345889999999999999999999999999999999999976554  99999998865433


Q ss_pred             CCC-CCcccCCCCccCcccccCCccCCC
Q 030211          153 HSR-PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ... .....+++.|+|||.+.+..++.+
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~  186 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHENGYNFK  186 (267)
T ss_pred             hhHHHhcCCCCccccChhhhccCCCCch
Confidence            222 223467889999999987766554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-32  Score=193.16  Aligned_cols=171  Identities=36%  Similarity=0.517  Sum_probs=149.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.+|.|++|.+|++.+..+++.+++|.+..... ..+.+.+|+.+++.++|||++++++.+.+.+.++++||++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            689999999999999999999998899999999876533 3467888999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCCc
Q 030211           81 AGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKS  158 (181)
Q Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~~  158 (181)
                      ++++|.+++... ..+++..+..++.|++.++.+||++|++|+||+|+||++++++.  ++|+|||.+....... ....
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhcccc
Confidence            999999988766 68999999999999999999999999999999999999976554  9999999987544332 2333


Q ss_pred             ccCCCCccCcccccCC
Q 030211          159 TVGTPAYIAPEVLSRR  174 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~  174 (181)
                      ..++..|+|||.+...
T Consensus       161 ~~~~~~y~~Pe~~~~~  176 (262)
T cd06613         161 FIGTPYWMAPEVAAVE  176 (262)
T ss_pred             ccCCccccCchhhccc
Confidence            4678899999999766

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.8e-32  Score=206.43  Aligned_cols=173  Identities=28%  Similarity=0.431  Sum_probs=145.0

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC-----eEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPT-----HLA   74 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-----~~~   74 (181)
                      +|++.+.||+|+||.||++.+..+++.||+|.+.....   ..+.+.+|+.+++.++|+|++++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            47899999999999999999998999999998865321   2356788999999999999999999998876     789


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +++||+. ++|...+.....+++..+..++.|++.||.|||++|++|+||+|+||+++++.  .++|+|||++.......
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC--VLKICDFGLARVEEPDE  157 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC--CEEeccccceeecccCc
Confidence            9999996 57888787777899999999999999999999999999999999999997655  49999999987543222


Q ss_pred             C--CCcccCCCCccCcccccCCc-cCC
Q 030211          155 R--PKSTVGTPAYIAPEVLSRRE-YDG  178 (181)
Q Consensus       155 ~--~~~~~~~~~~~aPE~~~~~~-~~~  178 (181)
                      .  .....+++.|+|||.+.+.. ++.
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~  184 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTS  184 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCc
Confidence            1  22345788999999987643 443

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=212.07  Aligned_cols=170  Identities=27%  Similarity=0.433  Sum_probs=144.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      +...+++.||+|.||+||++.+..   .||||.++....   ..+.|++|+..+++-+|.||+-+++++..++. .+|+.
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq  467 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ  467 (678)
T ss_pred             HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence            356788999999999999999973   399999876433   34789999999999999999999999998877 99999


Q ss_pred             ecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc---cCCC
Q 030211           79 YAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS---VLHS  154 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~---~~~~  154 (181)
                      ||+|.+|...++-.. .|...+.+.|++|+++++.|||.++|+|+|||..|||+.++  .+|+|+|||++..-   .-..
T Consensus       468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~--~kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED--LKVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC--CcEEEecccceeeeeeecccc
Confidence            999999998887544 79999999999999999999999999999999999999765  45999999998532   2223


Q ss_pred             CCCcccCCCCccCcccccCCccC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYD  177 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~  177 (181)
                      ......+..-|||||+++.+.-+
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~n  568 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDN  568 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccC
Confidence            33445688999999999865433

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.6e-32  Score=210.10  Aligned_cols=175  Identities=27%  Similarity=0.393  Sum_probs=142.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC------CCCeeEEEEeEEcC-CeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR------HPNIIRFKEVVLTP-THLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~------~~~i~~~~~~~~~~-~~~~   74 (181)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++............|+.++..++      +.+++.+++++... +.++
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            5799999999999999999999988999999998754433444555666665554      45688899988765 5688


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCC--------------CcE
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAA--------------PRL  139 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~--------------~~v  139 (181)
                      ++|+++ +++|.+++.+...+++..+..++.|++.||.|||+ .||+|+||||+||+++.++.              ..+
T Consensus       209 iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~v  287 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV  287 (467)
T ss_pred             EEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceE
Confidence            999988 66888888887889999999999999999999998 59999999999999965432              259


Q ss_pred             EEeecCCcccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          140 KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       140 ~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +|+|||.+...  ........|++.|+|||++.+..++.+
T Consensus       288 kl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~~~  325 (467)
T PTZ00284        288 RICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWMYS  325 (467)
T ss_pred             EECCCCccccC--ccccccccCCccccCcHHhhcCCCCcH
Confidence            99999987532  223345678999999999998888764

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.1e-32  Score=194.11  Aligned_cols=175  Identities=36%  Similarity=0.531  Sum_probs=149.2

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----------cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCe
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----------DENVAREIINHRSLRHPNIIRFKEVVLTPTH   72 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----------~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~   72 (181)
                      +|.+...||+|++|.||+|.+..+++.+++|.+......          .+.+.+|+.+++.++||+++++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            688999999999999999999888999999988653221          1457788999999999999999999999999


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      .++++||+++++|.+++.....+++..+..++.|++.+|.+||++|++|+||+|+||+++++..  ++|+|||.+.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~  158 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEA  158 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccc
Confidence            9999999999999999988788999999999999999999999999999999999999975554  99999999875432


Q ss_pred             CC-------CCCcccCCCCccCcccccCCccCCC
Q 030211          153 HS-------RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~-------~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..       ......++..|+|||.+.+..++++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~  192 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK  192 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCCCCch
Confidence            11       1122357889999999988776654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.2e-32  Score=207.72  Aligned_cols=169  Identities=24%  Similarity=0.289  Sum_probs=144.2

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      .|.+.+.||+|+||.||++.+..+++.|++|...     ...+.+|+.+++.++|+||+++++++...+..+++|+++. 
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-  243 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-  243 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence            6999999999999999999999999999999532     2345789999999999999999999999999999999995 


Q ss_pred             CChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC---CCc
Q 030211           83 GELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKS  158 (181)
Q Consensus        83 ~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~---~~~  158 (181)
                      ++|..++... ..+++..++.++.|++.+|.|||++||+|+||||+||+++.+.  .++|+|||+++.......   ...
T Consensus       244 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~--~vkL~DFGla~~~~~~~~~~~~~~  321 (461)
T PHA03211        244 SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE--DICLGDFGAACFARGSWSTPFHYG  321 (461)
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC--CEEEcccCCceecccccccccccc
Confidence            5787777553 4699999999999999999999999999999999999997555  499999999865432211   223


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..|++.|+|||++.+..++.+
T Consensus       322 ~~GT~~Y~APE~~~~~~~~~~  342 (461)
T PHA03211        322 IAGTVDTNAPEVLAGDPYTPS  342 (461)
T ss_pred             cCCCcCCcCHHHHcCCCCCch
Confidence            468999999999998887765

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4e-32  Score=197.29  Aligned_cols=177  Identities=21%  Similarity=0.360  Sum_probs=147.4

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCC-----cEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETK-----ELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~-----~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~   73 (181)
                      +++|++.+.||+|++|.||++.+...+     ..+++|.+.....  ....+.+|+..+..++||+++++++++...+..
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            367999999999999999999976544     6799998865432  235678899999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCC
Q 030211           74 AIVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP  137 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~  137 (181)
                      ++++||+++++|.+++...                ..+++..+..++.|++.||.+||++|++|+||+|+||+++++.. 
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~-  162 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT-  162 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc-
Confidence            9999999999999888654                34778899999999999999999999999999999999976554 


Q ss_pred             cEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          138 RLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       138 ~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                       ++|+|||++........   .....+++.|+|||.+.+..++++
T Consensus       163 -~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (283)
T cd05048         163 -VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE  206 (283)
T ss_pred             -EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh
Confidence             99999999875432221   223356788999999988887765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-33  Score=213.19  Aligned_cols=172  Identities=28%  Similarity=0.413  Sum_probs=146.9

Q ss_pred             eeeeeeCCccceeEEEEEEccCCcEEEEEEc-----cccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCe--EEEEE
Q 030211            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTH--LAIVM   77 (181)
Q Consensus         5 ~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~-----~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~--~~~v~   77 (181)
                      +..+.||+|+|.+||+|.|..+|..||=-.+     .+.+...+.++.|+.+|+.++|+||+++++.|.+...  +.+++
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4567899999999999999999988763322     2233445789999999999999999999999998765  89999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc--CeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM--QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      |.+..|+|..+..+....+...+..|++||+++|.|||++  -|+|||||-+||||+ ...+.|||+|+|+|..... ..
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin-G~~G~VKIGDLGLAtl~r~-s~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN-GNLGEVKIGDLGLATLLRK-SH  200 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc-CCcCceeecchhHHHHhhc-cc
Confidence            9999999999999999999999999999999999999988  599999999999997 4567899999999974433 33


Q ss_pred             CCcccCCCCccCcccccCCccCCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..+..|||+|||||++. ..|+..
T Consensus       201 aksvIGTPEFMAPEmYE-E~YnE~  223 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE-ENYNEL  223 (632)
T ss_pred             cceeccCccccChHHHh-hhcchh
Confidence            44478999999999998 556543

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.6e-32  Score=192.86  Aligned_cols=175  Identities=26%  Similarity=0.407  Sum_probs=147.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|++|.||.+.+.. +..+++|.+.......+.+.+|+.++..++|||++++++++.+.+..+++|||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            579999999999999999998764 4569999887655555778999999999999999999999999999999999999


Q ss_pred             CCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC--Cc
Q 030211           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--KS  158 (181)
Q Consensus        82 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~--~~  158 (181)
                      +++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++++.  .++|+|||.+.........  ..
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG--CVKVSDFGLSRYVLDDEYTSSVG  160 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--CEEECCCccceecCCCceeecCC
Confidence            99999988664 3689999999999999999999999999999999999997554  5999999998654332211  12


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..++..|+|||.+....++.+
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~  181 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFSSK  181 (256)
T ss_pred             CccChhhCCHHHHhcCcccch
Confidence            234567999999987776654

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.7e-32  Score=197.54  Aligned_cols=171  Identities=29%  Similarity=0.496  Sum_probs=144.6

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      +++|++.+.||+|++|.||++.+..+++.|++|.+.....  ....+.+|+..++.++|+|++++++++..++..++++|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            5789999999999999999999998899999998864332  23467789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CC
Q 030211           79 YAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RP  156 (181)
Q Consensus        79 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~  156 (181)
                      |++ ++|.+.+... ..+++..+..++.|++.||++||++|++|+||+|+||++++++.  ++|+|||++....... ..
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCcc
Confidence            996 4888777553 46899999999999999999999999999999999999976554  9999999986433222 22


Q ss_pred             CcccCCCCccCcccccCC
Q 030211          157 KSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~  174 (181)
                      ....+++.|+|||.+.+.
T Consensus       162 ~~~~~~~~y~~PE~~~~~  179 (301)
T cd07873         162 SNEVVTLWYRPPDILLGS  179 (301)
T ss_pred             cccceeecccCcHHHhCC
Confidence            334578899999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.3e-32  Score=203.98  Aligned_cols=176  Identities=25%  Similarity=0.318  Sum_probs=143.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC-----CcEEEEEEccccccc--cHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET-----KELVAVKYIERGRKI--DENVAREIINHRSLR-HPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~-----~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~   73 (181)
                      ++|++++.||+|+||.||++.+...     ...||+|.+......  .+.+.+|+.++..+. |||++++++++.+.+..
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            4688999999999999999987432     346999998654322  356888999999995 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhc-------------------------------------------------------------
Q 030211           74 AIVMEYAAGGELFDRICNA-------------------------------------------------------------   92 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~-------------------------------------------------------------   92 (181)
                      +++|||+++++|.+++..+                                                             
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            9999999999998876532                                                             


Q ss_pred             -----------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCC
Q 030211           93 -----------------------------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP  137 (181)
Q Consensus        93 -----------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~  137 (181)
                                                         ..+++..+..++.|++.||.|||++|++|+||+|+||+++++.  
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~--  274 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK--  274 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC--
Confidence                                               1367788899999999999999999999999999999997554  


Q ss_pred             cEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          138 RLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       138 ~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .++|+|||++........   .....+++.|+|||.+.+..++++
T Consensus       275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  319 (400)
T cd05105         275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL  319 (400)
T ss_pred             EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCch
Confidence            499999999875433222   222346678999999988877765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.8e-31  Score=191.23  Aligned_cols=175  Identities=35%  Similarity=0.548  Sum_probs=150.7

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc---ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +|++.+.||.|++|.+|.+.+..++..+++|.+...   ......+.+|+.+++.++|+|++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            699999999999999999999999999999987643   22345688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CC
Q 030211           80 AAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RP  156 (181)
Q Consensus        80 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~  156 (181)
                      +++++|.+.+...  ..+++..+..++.|++.++.+||+.|++|+||+|+||+++++..  ++|+|||.+....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~  158 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMA  158 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccc
Confidence            9999999988664  46899999999999999999999999999999999999976554  9999999987543333 23


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+++.|+|||++.+..++.+
T Consensus       159 ~~~~~~~~y~ape~~~~~~~~~~  181 (256)
T cd08221         159 ETVVGTPYYMSPELCQGVKYNFK  181 (256)
T ss_pred             cccCCCccccCHhhcCCCCCCCc
Confidence            34568899999999987766543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.5e-31  Score=192.64  Aligned_cols=176  Identities=34%  Similarity=0.486  Sum_probs=147.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcC--CeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK------IDENVAREIINHRSLRHPNIIRFKEVVLTP--THL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~   73 (181)
                      .+|++.+.||+|++|.||.+.+.++++.|++|.+.....      ..+.+.+|+.++..+.|+|++++++++.++  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            589999999999999999999999999999998753221      124677799999999999999999998774  468


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      ++++|++++++|.+++.+...+++.....++.|++.+|++||++|++|+||+|+||+++++..  ++|+|||.+......
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~  159 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCccccccccc
Confidence            899999999999998877778899999999999999999999999999999999999976554  999999988643221


Q ss_pred             ----CCCCcccCCCCccCcccccCCccCCC
Q 030211          154 ----SRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ----~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                          .......++..|+|||.+.+..++.+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  189 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRK  189 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCcc
Confidence                12223457889999999987776554

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-31  Score=192.49  Aligned_cols=175  Identities=24%  Similarity=0.300  Sum_probs=147.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|++|.||++.+.. ++.+++|.+.......+.+.+|+..++.++|+|++++++++...+..+++||+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            579999999999999999999764 5679999987655555778899999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC--
Q 030211           82 GGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK--  157 (181)
Q Consensus        82 ~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~--  157 (181)
                      +++|.+++....  .+++..+..++.|++.|+.+||++|++|+||+|+||++++++.  ++|+|||++..........  
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEARE  162 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCcccccC
Confidence            999999886544  6899999999999999999999999999999999999976554  9999999987554222111  


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+..|+|||++.+..++.+
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~  184 (261)
T cd05068         163 GAKFPIKWTAPEAALYNRFSIK  184 (261)
T ss_pred             CCcCceeccCccccccCCCCch
Confidence            1122457999999988777654

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1e-31  Score=195.45  Aligned_cols=176  Identities=35%  Similarity=0.544  Sum_probs=149.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++.+.||+|++|.||++.+.++++.|++|.+....   ...+.+.+|+.+++.++|+|++++++++..++..++++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            58999999999999999999999889999999886532   224678899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC--CC
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RP  156 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~--~~  156 (181)
                      |++++.+.....+...+++..+..++.|++.++.+||++|++|+||+|+||+++++.  .++|+|||.+.......  ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~--~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG--VLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEEeeecccccCCCccccc
Confidence            998866665555556799999999999999999999999999999999999997655  49999999987654433  33


Q ss_pred             CcccCCCCccCcccccCC-ccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRR-EYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~-~~~~~  179 (181)
                      ....++..|+|||++.+. .++.+
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~  182 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKP  182 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCch
Confidence            345678899999999877 55443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.6e-31  Score=195.53  Aligned_cols=175  Identities=30%  Similarity=0.494  Sum_probs=150.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      .+|++.+.||+|++|.||++.+..+++.+++|.+...... .+.+.+|+.+++.+.|+|++++++.+..+...+++|||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            5899999999999999999999888999999988754332 356788999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-CCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~~~~  159 (181)
                      ++++|.+++.. ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++  .++|+|||.+........ ....
T Consensus       100 ~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~  176 (296)
T cd06654         100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTM  176 (296)
T ss_pred             CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC--CEEECccccchhccccccccCcc
Confidence            99999988754 4688999999999999999999999999999999999997555  499999998875433322 2234


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+++.|+|||.+.+..++++
T Consensus       177 ~~~~~y~aPE~~~~~~~~~~  196 (296)
T cd06654         177 VGTPYWMAPEVVTRKAYGPK  196 (296)
T ss_pred             cCCccccCHHHHcCCCCCcc
Confidence            68889999999988776654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-34  Score=200.99  Aligned_cols=177  Identities=40%  Similarity=0.612  Sum_probs=158.4

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccccc----HHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      |++|..++++|+|.||.|.+++.+.+++.+|+|++++.-...    ..-+.|-+.+...+||.+..+-..|+..+.+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            578999999999999999999999999999999998754322    3456678889999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc-cCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-VLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~-~~~~~  155 (181)
                      |||..|+.|..-+.....|++...+.+-..|+.||.|||+++|+.+|+|.+|.+++.|++  ||+.|||+|+.. ..+..
T Consensus       247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhcccccce
Confidence            999999999877777778999999999999999999999999999999999999987777  999999999754 45556


Q ss_pred             CCcccCCCCccCcccccCCccCCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+.++|||+|+|||++....|+..
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgra  348 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRA  348 (516)
T ss_pred             eccccCChhhcCchhhccccccce
Confidence            777899999999999999888764

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.4e-32  Score=192.89  Aligned_cols=171  Identities=30%  Similarity=0.475  Sum_probs=149.7

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +|+..+.||+|++|.||+|.+..++..+++|.+.....      ..+.+.+|+.+++.++|++++++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            68899999999999999999988899999998865431      235688899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      +||+++++|.+++.+...+++..++.++.|++.++.+||+.|++|+||+|+||+++++..  ++|+|||.+.........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~  158 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFA  158 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccc
Confidence            999999999999887778999999999999999999999999999999999999976554  999999998765444444


Q ss_pred             CcccCCCCccCcccccCCc
Q 030211          157 KSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~  175 (181)
                      ....++..|+|||.+....
T Consensus       159 ~~~~~~~~y~~pe~~~~~~  177 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQG  177 (258)
T ss_pred             cccCCCcceeCHHHhcCCC
Confidence            4566889999999987655

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.2e-31  Score=196.23  Aligned_cols=175  Identities=30%  Similarity=0.497  Sum_probs=150.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|++|.||++.+..+++.|++|.+..... ..+.+.+|+.+++.++|+|++++++.+..++..+++|||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            589999999999999999999988899999998875432 2356778999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC-Ccc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~-~~~  159 (181)
                      ++++|.+++.+ ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++  .++|+|||.+......... ...
T Consensus        99 ~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~--~~~l~Dfg~~~~~~~~~~~~~~~  175 (297)
T cd06656          99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTM  175 (297)
T ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEECcCccceEccCCccCcCcc
Confidence            99999988754 4688999999999999999999999999999999999997555  4999999998754433322 234


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+++.|+|||.+.+..++++
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~  195 (297)
T cd06656         176 VGTPYWMAPEVVTRKAYGPK  195 (297)
T ss_pred             cCCccccCHHHHcCCCCCcH
Confidence            67889999999988777654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1e-31  Score=196.25  Aligned_cols=176  Identities=27%  Similarity=0.379  Sum_probs=147.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCC----------------cEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETK----------------ELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRF   63 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~----------------~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~   63 (181)
                      ++|++++.||+|+||.||+|.+...+                ..+++|.+.....  ..+.+.+|+.++..++|+|++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            68999999999999999999876533                4589998875432  23577889999999999999999


Q ss_pred             EEeEEcCCeEEEEEeecCCCChHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEec
Q 030211           64 KEVVLTPTHLAIVMEYAAGGELFDRICNAG-----------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD  132 (181)
Q Consensus        64 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~  132 (181)
                      ++++...+..++++|++.+++|.+++....           .+++..++.++.|++.||.+||++|++|+||+|+||+++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~  164 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec
Confidence            999999999999999999999999887654           689999999999999999999999999999999999997


Q ss_pred             cCCCCcEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          133 GSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       133 ~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.  .++|+|||.+........   .....+++.|+|||++.++.++++
T Consensus       165 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  212 (296)
T cd05051         165 KNY--TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK  212 (296)
T ss_pred             CCC--ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc
Confidence            654  599999999865432221   222345678999999988777655

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2e-31  Score=195.76  Aligned_cols=176  Identities=34%  Similarity=0.524  Sum_probs=149.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|++|.||++.+..+++.|++|.+.....    ..+.+.+|+.+++.++|||++++++.+..++..+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            479999999999999999999999999999998875432    2346778899999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC---
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~---  154 (181)
                      |++++++|.+++.....+++..+..++.|++.++.+||++|++|+||+|+||++++++  .++|+|||+++......   
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~--~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC--CEEEeeCCCccccCcCcccc
Confidence            9999999999998778899999999999999999999999999999999999997554  49999999875311100   


Q ss_pred             -------------CCCcccCCCCccCcccccCCccCCC
Q 030211          155 -------------RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 -------------~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                                   ......++..|+|||.+.+..++++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  196 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP  196 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCch
Confidence                         1112346788999999988777765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-31  Score=192.54  Aligned_cols=175  Identities=26%  Similarity=0.414  Sum_probs=146.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      .+|++.+.||+|++|.||++.++. +..+++|.+.........+.+|+.+++.++|+|++++++++.+.+..+++||+++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            468999999999999999998864 6679999987655555678889999999999999999999999999999999999


Q ss_pred             CCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC--Cc
Q 030211           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--KS  158 (181)
Q Consensus        82 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~--~~  158 (181)
                      +++|.+++..+ ..+++..+..++.|++.++.+||++|++|+||+|+||++++++.  ++|+|||.+.........  ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~~~  160 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSSQG  160 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceecccccccccCC
Confidence            99999988654 46899999999999999999999999999999999999976554  999999988654322211  11


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..++..|+|||.+.+..++.+
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~  181 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFSSK  181 (256)
T ss_pred             CCCCccccCHHHhccCCCCch
Confidence            223457999999988877654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-31  Score=192.67  Aligned_cols=175  Identities=28%  Similarity=0.366  Sum_probs=147.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|++|.||++... ++..+++|.+.......+.+.+|+.+++.++|+|++++++.+...+..++++|+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            68999999999999999999875 45679999887655445788899999999999999999999999999999999999


Q ss_pred             CCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--CC
Q 030211           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PK  157 (181)
Q Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--~~  157 (181)
                      +++|.+++...  ..++...+..++.|++.+|++||++|++|+||+|+||+++++.  .++|.|||.+........  ..
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL--MCKIADFGLARVIEDNEYTARE  162 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC--cEEECCCccceecCCCceeccC
Confidence            99999988653  4688899999999999999999999999999999999997655  499999999875432221  12


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...++..|+|||++..+.++++
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~  184 (261)
T cd05072         163 GAKFPIKWTAPEAINFGSFTIK  184 (261)
T ss_pred             CCccceecCCHHHhccCCCChh
Confidence            2345678999999988777654

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.3e-31  Score=192.87  Aligned_cols=176  Identities=23%  Similarity=0.319  Sum_probs=149.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ..|++.+.||+|++|.||++.+...++.+++|.+.........+.+|+..++.++|++++++++++...+.++++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            35889999999999999999999889999999987655445678899999999999999999999999999999999999


Q ss_pred             CCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC--
Q 030211           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK--  157 (181)
Q Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~--  157 (181)
                      +++|.+++...  ..+++..+..++.|++.+|++||++|++|+||+|+||+++++..  ++|+|||.+..........  
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~~~~  163 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHA  163 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceeeccC
Confidence            99999888653  35889999999999999999999999999999999999975554  9999999986543322211  


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+..|+|||.+....++++
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~  185 (263)
T cd05052         164 GAKFPIKWTAPESLAYNKFSIK  185 (263)
T ss_pred             CCCCccccCCHHHhccCCCCch
Confidence            1233567999999988777654

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.2e-32  Score=197.39  Aligned_cols=177  Identities=26%  Similarity=0.323  Sum_probs=143.7

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCc--EEEEEEccccc--cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKE--LVAVKYIERGR--KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~--~v~~K~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +++|++.+.||+|+||.||++.+..++.  .+++|.++...  ...+.+.+|+..+.++ +|||++++++++.+.+..++
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            5789999999999999999999876654  46888776422  2235678899999888 79999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcE
Q 030211           76 VMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL  139 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v  139 (181)
                      ++||+++++|.+++.++.                .+++..++.++.|++.|+++||++|++|+||+|+||+++++.  .+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~  158 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL--AS  158 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC--eE
Confidence            999999999998886532                478889999999999999999999999999999999997554  49


Q ss_pred             EEeecCCcccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          140 KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       140 ~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +|+|||++..............+..|+|||++.+..++.+
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  198 (297)
T cd05089         159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK  198 (297)
T ss_pred             EECCcCCCccccceeccCCCCcCccccCchhhccCCCCch
Confidence            9999998853222111222233557999999988877765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2e-31  Score=190.78  Aligned_cols=176  Identities=39%  Similarity=0.560  Sum_probs=151.7

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +|++.+.||+|++|.+|++.+..+++.+++|.+....   ...+.+.+|+.+++.++|++++++++.+...+..++++|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            6999999999999999999999899999999986542   2235788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           80 AAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        80 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      +++++|.+++...  ..+++..+..++.+++.++++||++|++|+||+|+||+++++. ..++|.|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK-MVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEccCCCceecCCCcccc
Confidence            9999999988653  3589999999999999999999999999999999999996433 358999999987665544444


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...++..|+|||.+.+..++.+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~  181 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQK  181 (256)
T ss_pred             ccccCCcccCchhccCCCCCcc
Confidence            5568899999999988776654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.8e-32  Score=203.85  Aligned_cols=171  Identities=25%  Similarity=0.345  Sum_probs=144.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEc--cCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK--ETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~--~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      .+|++.+.||+|++|.||++...  ..++.|++|.+...    ....+|+.+++.++|+|++++++.+...+..+++||+
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~  167 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK  167 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence            36999999999999999999764  34678999987653    3456799999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC---C
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---P  156 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~---~  156 (181)
                      +. ++|.+++.....+++..+..++.|++.||.|||++||+|+||||+||+++.++  .++|+|||++........   .
T Consensus       168 ~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~--~~~l~DfG~a~~~~~~~~~~~~  244 (392)
T PHA03207        168 YK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE--NAVLGDFGAACKLDAHPDTPQC  244 (392)
T ss_pred             cC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEccCccccccCcccccccc
Confidence            85 57888886677899999999999999999999999999999999999997555  499999999865433222   2


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....|++.|+|||++....++.+
T Consensus       245 ~~~~gt~~y~aPE~~~~~~~~~~  267 (392)
T PHA03207        245 YGWSGTLETNSPELLALDPYCAK  267 (392)
T ss_pred             cccccccCccCHhHhcCCCCCch
Confidence            23568999999999998887765

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.4e-32  Score=195.47  Aligned_cols=177  Identities=27%  Similarity=0.405  Sum_probs=149.8

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|++|.||++.+..+++.+++|.+.....    ....+.+|+.+++.++|+|++++++.+.+++..+++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            5789999999999999999999988899999998765322    235678899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           77 MEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ||++++++|.+++..    ...+++..++.++.|++.++.+||++|++|+||+|+||+++.++.  ++|+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~  158 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSS  158 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhcccc
Confidence            999999999887753    346899999999999999999999999999999999999975554  99999998865433


Q ss_pred             CCC-CCcccCCCCccCcccccCCccCCC
Q 030211          153 HSR-PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ... .....++..|+|||.+.+..++.+
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~  186 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFK  186 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccch
Confidence            222 223467889999999987776654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-31  Score=194.15  Aligned_cols=175  Identities=31%  Similarity=0.518  Sum_probs=152.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||.|++|.||++.+..++..+++|.+....  .....+.+|+.+++.++|+|++++++.+.++...++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            58999999999999999999999899999999886543  2235677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCCCc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~~~  158 (181)
                      +++++|.+.+..+ .+++..++.++.|++.++.+||+++++|+||+|+||++++++.  ++|+|||.+...... .....
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence            9999999888654 7899999999999999999999999999999999999976554  999999998765544 23334


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..+++.|+|||.+.+..++++
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~  178 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEK  178 (274)
T ss_pred             ccCCccccChhhhccCCCCch
Confidence            567889999999998877655

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3e-31  Score=194.09  Aligned_cols=175  Identities=31%  Similarity=0.514  Sum_probs=150.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      .+|++.+.||.|++|.||++.+..+++.+++|.+..... ..+.+.+|+..++.++|+|++++++.+...+.+++++||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            579999999999999999999998999999998865432 2456788999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC-Ccc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~-~~~  159 (181)
                      .+++|...+.. ..+++..+..++.|++.++++||+.|++|+||+|+||++++++.  ++|+|||++......... ...
T Consensus        99 ~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~  175 (296)
T cd06655          99 AGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKRSTM  175 (296)
T ss_pred             CCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccCCCc
Confidence            99999887754 46899999999999999999999999999999999999976554  999999998754443322 234


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+++.|+|||.+.+..++.+
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~  195 (296)
T cd06655         176 VGTPYWMAPEVVTRKAYGPK  195 (296)
T ss_pred             CCCccccCcchhcCCCCCch
Confidence            67889999999988777654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.4e-31  Score=191.55  Aligned_cols=175  Identities=30%  Similarity=0.496  Sum_probs=152.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|++|.+|++.+..+++.+++|.+..... .+.+.+|+.+++.++|+|++++++.+.+....++++|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            689999999999999999999998889999999875433 5788899999999999999999999999999999999999


Q ss_pred             CCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCCcc
Q 030211           82 GGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKST  159 (181)
Q Consensus        82 ~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~~~  159 (181)
                      +++|.+.+.. ...+++..+..++.|++.++.+||+.|++|+||+|+||++++++.  ++|+|||.+....... .....
T Consensus        82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~~  159 (256)
T cd06612          82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNTV  159 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCccccccc
Confidence            9999998865 447899999999999999999999999999999999999976554  9999999987654433 22334


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .++..|+|||++.+..++.+
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~  179 (256)
T cd06612         160 IGTPFWMAPEVIQEIGYNNK  179 (256)
T ss_pred             cCCccccCHHHHhcCCCCch
Confidence            57889999999988777654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-31  Score=196.01  Aligned_cols=176  Identities=34%  Similarity=0.496  Sum_probs=148.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+......    .+.+.+|+..+..+.|++++++++.+.+.+..+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            5799999999999999999999988999999998764322    245778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           78 EYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      |++.+++|.+++...  ..+++..+..++.|++.+|.+||+.|++|+||+|+||++++++  .++|.|||++........
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG--HIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC--CEEEeecchhhccccccc
Confidence            999999999988654  4689999999999999999999999999999999999997655  499999998764322111


Q ss_pred             ------------------------------CCcccCCCCccCcccccCCccCCC
Q 030211          156 ------------------------------PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ------------------------------~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                                                    .....|+..|+|||++.+..++.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~  212 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA  212 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCch
Confidence                                          112357888999999988776553

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.5e-31  Score=194.01  Aligned_cols=170  Identities=33%  Similarity=0.489  Sum_probs=145.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++++.||+|++|.||++.+..+++.+++|.+..... ..+.+.+|+.+++.++|+|++++++.+...+..+++|||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            569999999999999999999999999999999875432 2456778999999999999999999999999999999999


Q ss_pred             CCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCCCc
Q 030211           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKS  158 (181)
Q Consensus        81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~~~  158 (181)
                      ++++|...+.+ ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.++  .++|+|||++...... .....
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~  169 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG--DIKLADFGVSAKNVKTLQRRDS  169 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC--CEEEccCccceeccccccccce
Confidence            99999877654 34689999999999999999999999999999999999996554  4999999988653222 22234


Q ss_pred             ccCCCCccCcccccC
Q 030211          159 TVGTPAYIAPEVLSR  173 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~  173 (181)
                      ..+++.|+|||++..
T Consensus       170 ~~~~~~y~aPE~~~~  184 (292)
T cd06644         170 FIGTPYWMAPEVVMC  184 (292)
T ss_pred             ecCCccccCceeecc
Confidence            567889999999853

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.8e-31  Score=192.01  Aligned_cols=174  Identities=26%  Similarity=0.333  Sum_probs=144.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|++|.||+|.+..+ ..+++|.+.......+.+.+|+.++..++|+|++++++.+. .+..+++||+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            6899999999999999999998765 45999998765444567888999999999999999998875 456899999999


Q ss_pred             CCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--CC
Q 030211           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PK  157 (181)
Q Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--~~  157 (181)
                      +++|.+++.+.  ..+++..+..++.|++.||++||++|++|+||+|+||+++++..  ++|+|||.+........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~~~  161 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQ  161 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeecccccccccc
Confidence            99999988653  35789999999999999999999999999999999999976554  99999999865432222  12


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...++..|+|||++.++.++.+
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~  183 (262)
T cd05071         162 GAKFPIKWTAPEAALYGRFTIK  183 (262)
T ss_pred             CCcccceecCHhHhccCCCCch
Confidence            2345678999999987776654

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.4e-31  Score=197.45  Aligned_cols=175  Identities=23%  Similarity=0.329  Sum_probs=144.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCc----EEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKE----LVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~----~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      .+|++.+.||+|+||.||+|.+..++.    .|++|.+....  ...+.+.+|+.+++.+.|+|++++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            579999999999999999999865554    38999886432  2246788899999999999999999988764 5678


Q ss_pred             EEeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           76 VMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +++++.+++|.+++..+. .++...+..++.|++.||+|||++|++|+||+|+||+++++..  ++|+|||++.......
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~  163 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGADE  163 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccCCC
Confidence            999999999999887643 6889999999999999999999999999999999999976554  9999999997654333


Q ss_pred             CCC---cccCCCCccCcccccCCccCCC
Q 030211          155 RPK---STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~---~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...   ....+..|+|||++.+..++.+
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~  191 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHRIYTHQ  191 (316)
T ss_pred             cceeccCCccceeecChHHhccCCCCch
Confidence            222   1234568999999988877754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.2e-31  Score=188.87  Aligned_cols=175  Identities=27%  Similarity=0.505  Sum_probs=147.0

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEc-CCeEEEEEe
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLT-PTHLAIVME   78 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e   78 (181)
                      .|++.+.||+|++|.||.+.++.+++.+++|.+.....   ..+.+.+|+..++.++|++++++.+.+.. .+.+++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            58999999999999999999998899999999865322   23567888999999999999999998865 446899999


Q ss_pred             ecCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-
Q 030211           79 YAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        79 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-  155 (181)
                      ++++++|.+.+..  ...+++.++..++.|++.++++||++|++|+||+|+||+++++.  .++|+|||.+........ 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~--~~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN--IIKVGDLGIARVLENQCDM  158 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC--cEEEecccceEEecccCCc
Confidence            9999999888865  34689999999999999999999999999999999999997555  499999999875433222 


Q ss_pred             CCcccCCCCccCcccccCCccCCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .....+++.|+|||++.+..++.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~  182 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKPYNYK  182 (257)
T ss_pred             cccccCCcCccChhHhcCCCCCch
Confidence            233467899999999998877764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-31  Score=190.63  Aligned_cols=172  Identities=28%  Similarity=0.413  Sum_probs=147.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|++|.||++...  ++.+++|.+.......+.+.+|+.+++.++|+|++++++++.+.+..+++||+++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            57999999999999999999875  7889999987654445678889999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcc
Q 030211           82 GGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (181)
Q Consensus        82 ~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~  159 (181)
                      +++|.+++....  .+++..+..++.|++.++.+||++|++|+||+|+||++++++  .++|+|||.+........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~--~~~l~d~g~~~~~~~~~~--~~  159 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL--VAKVSDFGLAKEASQGQD--SG  159 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC--CEEEcccccccccccccc--cC
Confidence            999999887655  689999999999999999999999999999999999997555  499999999875532222  23


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..+..|+|||.+..+.++.+
T Consensus       160 ~~~~~~~ape~~~~~~~~~~  179 (256)
T cd05039         160 KLPVKWTAPEALREKKFSTK  179 (256)
T ss_pred             CCcccccCchhhcCCcCCcH
Confidence            34567999999987776653

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.8e-31  Score=189.95  Aligned_cols=177  Identities=28%  Similarity=0.433  Sum_probs=149.7

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|++|.||+|.+..+++.+++|.++...    ...+.+.+|+.+++.++|++++++++.+...+..+++
T Consensus         1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            478999999999999999999999889999999876422    1245788899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           77 MEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      |||+++++|..++..    ...+++..+..++.+++.++.+||+.|++|+||+|+||++++++.  ++|.|||.+.....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~  158 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccC
Confidence            999999999887753    235899999999999999999999999999999999999975554  99999998864433


Q ss_pred             CC-CCCcccCCCCccCcccccCCccCCC
Q 030211          153 HS-RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .. ......+++.|+|||.+.+..++.+
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~  186 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHENGYNFK  186 (267)
T ss_pred             CCcccceecCCccccCHHHhccCCCCch
Confidence            22 2223467889999999987776644

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.9e-32  Score=201.17  Aligned_cols=171  Identities=26%  Similarity=0.455  Sum_probs=142.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcC------Ce
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTP------TH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~------~~   72 (181)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.....   ....+.+|+.+++.++|+|++++++++...      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            689999999999999999999998999999999875422   234577899999999999999999887643      34


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      .+++++++ +++|.+.+ ....+++..+..++.|++.||.|||++|++|+||+|+||++++++.  ++|+|||++.....
T Consensus        95 ~~~~~~~~-~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~  170 (343)
T cd07878          95 VYLVTNLM-GADLNNIV-KCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQADD  170 (343)
T ss_pred             EEEEeecC-CCCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecCC
Confidence            78999987 66887665 3457999999999999999999999999999999999999976554  99999999875432


Q ss_pred             CCCCCcccCCCCccCcccccC-CccCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSR-REYDG  178 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-~~~~~  178 (181)
                        ......+++.|+|||++.+ ..++.
T Consensus       171 --~~~~~~~t~~y~aPE~~~~~~~~~~  195 (343)
T cd07878         171 --EMTGYVATRWYRAPEIMLNWMHYNQ  195 (343)
T ss_pred             --CcCCccccccccCchHhcCCccCCc
Confidence              2334578999999999876 34444

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.5e-31  Score=193.78  Aligned_cols=176  Identities=27%  Similarity=0.399  Sum_probs=146.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|.+.+.||+|+||.||++.+.     .++..+++|.+..... ..+.+.+|+..++.++|++++++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            47899999999999999999853     3456689998875432 24568889999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEe
Q 030211           76 VMEYAAGGELFDRICNAG-------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKIC  142 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~  142 (181)
                      ++||+++++|.+++....             .+++..+..++.|++.||++||++|++|+||+|+||+++++..  ++|+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~kl~  162 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIG  162 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EEec
Confidence            999999999998886443             4899999999999999999999999999999999999976554  9999


Q ss_pred             ecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          143 DFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       143 dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      |||++........   .....+++.|+|||.+.+..++++
T Consensus       163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  202 (288)
T cd05093         163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE  202 (288)
T ss_pred             cCCccccccCCceeecCCCCCccccccCHHHhccCCCCch
Confidence            9999875432221   222345678999999988777664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-31  Score=194.59  Aligned_cols=176  Identities=27%  Similarity=0.364  Sum_probs=147.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc-----CCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|.+.+.||+|++|.||++.+.+     .++.+++|.+......  .+.+.+|+.+++.++|+|++++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            578999999999999999998753     3578999998765433  367888999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEE
Q 030211           75 IVMEYAAGGELFDRICNA--------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLK  140 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~  140 (181)
                      ++|||+++++|.+++...              ..+++..+..++.|++.++.+||++|++|+||+|+||+++.+.  .++
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~k  162 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL--VVK  162 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC--eEE
Confidence            999999999999988654              2478889999999999999999999999999999999997654  599


Q ss_pred             EeecCCcccccCCC---CCCcccCCCCccCcccccCCccCCC
Q 030211          141 ICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       141 l~dfg~a~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      |+|||.+.......   ......+++.|+|||++.+..++++
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  204 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE  204 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhccCCcchh
Confidence            99999986432221   1223345688999999998888765

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-31  Score=190.80  Aligned_cols=175  Identities=26%  Similarity=0.331  Sum_probs=148.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|++|.||++.+.+ ++.+++|.+.......+.+.+|+..++.++|++++++++++......+++||+++
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS   84 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence            689999999999999999999764 5779999988665556788999999999999999999999999899999999999


Q ss_pred             CCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--CC
Q 030211           82 GGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PK  157 (181)
Q Consensus        82 ~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--~~  157 (181)
                      +++|.+++....  .++...+..++.|++.|+.+||++|++|+||+|+||+++++.  .++|+|||.+........  ..
T Consensus        85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~  162 (261)
T cd05034          85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL--VCKIADFGLARLIEDDEYTARE  162 (261)
T ss_pred             CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC--CEEECccccceeccchhhhhhh
Confidence            999999886543  689999999999999999999999999999999999997665  499999999865432211  11


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+..|+|||.+.+..++++
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~  184 (261)
T cd05034         163 GAKFPIKWTAPEAANYGRFTIK  184 (261)
T ss_pred             ccCCCccccCHHHhccCCcCch
Confidence            2234568999999988777654

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.9e-31  Score=192.86  Aligned_cols=177  Identities=20%  Similarity=0.305  Sum_probs=145.0

Q ss_pred             CccceeeeeeCCccceeEEEEEEc----cCCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~----~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++.|++.+.||+|+||.||+|.+.    ..+..+++|.+......  ...+.+|+.+++.++|||++++++++...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            467999999999999999999853    45678999988743221  246778999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCC
Q 030211           75 IVMEYAAGGELFDRICNA-----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP  137 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~  137 (181)
                      ++|||+++++|.+++...                 ..+++.....++.|++.||.|||++|++|+||+|+||+++++.. 
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~-  162 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc-
Confidence            999999999999887432                 24778889999999999999999999999999999999976554 


Q ss_pred             cEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          138 RLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       138 ~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                       ++|+|||++........   .....++..|+|||++.+..++++
T Consensus       163 -~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (283)
T cd05090         163 -VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD  206 (283)
T ss_pred             -EEeccccccccccCCcceecccCCCccceecChHHhccCCCCch
Confidence             99999999875433221   222345677999999987777654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.8e-31  Score=190.07  Aligned_cols=176  Identities=32%  Similarity=0.498  Sum_probs=154.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|++|.+|+|.+..+++.+++|.+.....  ....+.+|+..+..++|++++++++++..++..++++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            479999999999999999999999999999998876542  346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC-
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK-  157 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~-  157 (181)
                      +++++|.+++.....+++...+.++.|++.++.+||+ .|++|+||+|+||++++++  .++|+|||.+.......... 
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~--~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG--EVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC--CEEEccCccceecccCCCccc
Confidence            9999999999877889999999999999999999999 9999999999999997655  49999999987554433332 


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...++..|+|||.+.+..++.+
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~  180 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYA  180 (264)
T ss_pred             ceeecccccCHhhhCCCCCCch
Confidence            4467889999999988766654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=202.21  Aligned_cols=173  Identities=27%  Similarity=0.473  Sum_probs=152.2

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCC
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (181)
                      |.+++++|+|.+|.||+|.++++|..+|+|.+.... ..+++..|+.++.++..+++|++++.|.-...+|+|||||..+
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence            678899999999999999999999999999887643 4578889999999999999999999999999999999999999


Q ss_pred             ChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCCcccC
Q 030211           84 ELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTVG  161 (181)
Q Consensus        84 ~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~~~~~  161 (181)
                      +..+.+.. +.++++.++..+++..+++|+|||...-+|+|||..||+++  ..+..+|.|||.|......- ...+..|
T Consensus       114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN--T~G~AKLADFGVAGQLTDTMAKRNTVIG  191 (502)
T KOG0574|consen  114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN--TDGIAKLADFGVAGQLTDTMAKRNTVIG  191 (502)
T ss_pred             cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc--ccchhhhhhccccchhhhhHHhhCcccc
Confidence            99998854 45899999999999999999999999999999999999995  44559999999986433222 2344579


Q ss_pred             CCCccCcccccCCccCCC
Q 030211          162 TPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~  179 (181)
                      ||.|||||++..-.|+.+
T Consensus       192 TPFWMAPEVI~EIGY~~~  209 (502)
T KOG0574|consen  192 TPFWMAPEVIEEIGYDTK  209 (502)
T ss_pred             CcccccHHHHHHhccchh
Confidence            999999999999888765

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-31  Score=194.72  Aligned_cols=175  Identities=29%  Similarity=0.467  Sum_probs=151.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|++|+||++.+..+++.+++|++....  ...+.+.+|+.+++.++|||++++++.+...+.+++++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            57999999999999999999999889999999876542  2346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      +++++|..++.+...+++..+..++.+++.++.+||+ .|++|+||+|+||+++++.  .++|+|||++..... .....
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~d~gl~~~~~~-~~~~~  161 (284)
T cd06620          85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG--QIKLCDFGVSGELIN-SIADT  161 (284)
T ss_pred             CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC--cEEEccCCcccchhh-hccCc
Confidence            9999999888777789999999999999999999997 5999999999999997555  499999998764322 22334


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..++..|+|||++.+..++.+
T Consensus       162 ~~~~~~~~aPE~~~~~~~~~~  182 (284)
T cd06620         162 FVGTSTYMSPERIQGGKYTVK  182 (284)
T ss_pred             cccCcccCCHHHHccCCCCcc
Confidence            578999999999987766654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4e-31  Score=192.06  Aligned_cols=168  Identities=33%  Similarity=0.484  Sum_probs=143.7

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      .|++.+.||+|++|.||++.+..++..+++|.+..... ..+.+.+|+.+++.++|+|++++++.+...+..++++||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            47889999999999999999998899999998865432 24567889999999999999999999999999999999999


Q ss_pred             CCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCCCcc
Q 030211           82 GGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKST  159 (181)
Q Consensus        82 ~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~~~~  159 (181)
                      +++|...+.+ ..++++..+..++.|++.+|.+||+.|++|+||+|+||++++++  .++|+|||++...... ......
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC--CEEEccccccccccccccccccc
Confidence            9999887754 45789999999999999999999999999999999999997555  4999999998654322 223345


Q ss_pred             cCCCCccCccccc
Q 030211          160 VGTPAYIAPEVLS  172 (181)
Q Consensus       160 ~~~~~~~aPE~~~  172 (181)
                      .+++.|+|||++.
T Consensus       164 ~~~~~y~aPE~~~  176 (282)
T cd06643         164 IGTPYWMAPEVVM  176 (282)
T ss_pred             cccccccCHhhcc
Confidence            6889999999984

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.98  E-value=4.1e-31  Score=192.24  Aligned_cols=170  Identities=29%  Similarity=0.499  Sum_probs=142.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEeEE-----cCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVL-----TPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~-----~~~~~~~   75 (181)
                      ++|++.+.||+|++|.||++.+..+++.+++|++.........+.+|+.++..+ +|+|++++++++.     .++.+++
T Consensus        18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   97 (286)
T cd06638          18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL   97 (286)
T ss_pred             cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence            689999999999999999999998999999998765444456778889888888 6999999999874     3457899


Q ss_pred             EEeecCCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           76 VMEYAAGGELFDRIC----NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        76 v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      +|||+++++|.+++.    ....+++..++.++.|++.++.+||+.+++|+||+|+||++++++.  ++|.|||++....
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~  175 (286)
T cd06638          98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLT  175 (286)
T ss_pred             EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceeecc
Confidence            999999999988764    2346889999999999999999999999999999999999976554  9999999987543


Q ss_pred             CCC-CCCcccCCCCccCcccccC
Q 030211          152 LHS-RPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       152 ~~~-~~~~~~~~~~~~aPE~~~~  173 (181)
                      ... ......+++.|+|||++..
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~  198 (286)
T cd06638         176 STRLRRNTSVGTPFWMAPEVIAC  198 (286)
T ss_pred             cCCCccccccCCCcccChhhhch
Confidence            322 2233468899999999853

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.98  E-value=2.1e-31  Score=191.95  Aligned_cols=176  Identities=32%  Similarity=0.503  Sum_probs=149.7

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +|+..+.||+|++|.||++.+..++..+++|.+.....       ..+.+..|+..++.++|+|++++++.+.+++..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            58899999999999999999988999999998864321       23567889999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      ++||+.+++|.+.+....++++..+..++.|++.||.+||++|++|+||+|+||+++.++ ..++|+|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~-~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG-QRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEcccccccccccccc
Confidence            999999999999988777899999999999999999999999999999999999996432 2599999999865543321


Q ss_pred             -----CCcccCCCCccCcccccCCccCCC
Q 030211          156 -----PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 -----~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                           .....++..|+|||.+.+..++.+
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~  188 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRS  188 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcc
Confidence                 122357889999999987766543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.98  E-value=3.1e-31  Score=192.16  Aligned_cols=176  Identities=20%  Similarity=0.282  Sum_probs=143.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|++|.||++.+.     .++..+++|.+.....  ....+.+|+.+++.++|+|++++++++.+....+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            57999999999999999999864     2356799998864332  2345788999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeec
Q 030211           75 IVMEYAAGGELFDRICNA----------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~df  144 (181)
                      ++|||+++++|.+++.+.          ..++...+..++.|++.+|.+||+.|++|+||+|+||+++++.  .++|+||
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~--~~~l~df  163 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDF  163 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC--CEEECCC
Confidence            999999999999887642          1356778899999999999999999999999999999997555  4999999


Q ss_pred             CCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          145 GYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       145 g~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      |++........   .....+++.|+|||.+.++.++.+
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  201 (277)
T cd05062         164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY  201 (277)
T ss_pred             CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCch
Confidence            99864432221   111234678999999988777654

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.98  E-value=4.6e-31  Score=189.74  Aligned_cols=171  Identities=32%  Similarity=0.504  Sum_probs=149.4

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +|.+.+.||+|++|.+|++.+..+++.+++|.+.....   ..+.+..|+.+++.++|++++++++.+...+..++++||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            69999999999999999999988899999999876543   346788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC--
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK--  157 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~--  157 (181)
                      +++++|.+.+.....+++..+..++.+++.++.+||+.|++|+||+|+||++++++  .++|+|||.+..........  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~--~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG--VIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEcccccccccCCCCCcccc
Confidence            99999999988777789999999999999999999999999999999999997654  49999999987544332221  


Q ss_pred             ---cccCCCCccCcccccCCc
Q 030211          158 ---STVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       158 ---~~~~~~~~~aPE~~~~~~  175 (181)
                         ...+++.|+|||++....
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~  179 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGK  179 (264)
T ss_pred             cccCCcCCcCccChhhccCCC
Confidence               245788999999988765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.98  E-value=2.2e-31  Score=190.45  Aligned_cols=170  Identities=28%  Similarity=0.379  Sum_probs=140.5

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCCh
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   85 (181)
                      +.||+|++|.||++.+..+++.+++|.+....  .....+.+|+.+++.++|+|++++++++...+..+++|||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999999889999999876432  2235688899999999999999999999999999999999999999


Q ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC---CcccC
Q 030211           86 FDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVG  161 (181)
Q Consensus        86 ~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~---~~~~~  161 (181)
                      .+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++++.  .++|+|||.+.........   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN--VLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC--cEEECccccCcccccccccccCCCCCC
Confidence            99886543 689999999999999999999999999999999999997555  4999999998643221111   11122


Q ss_pred             CCCccCcccccCCccCCC
Q 030211          162 TPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~  179 (181)
                      +..|+|||.+.++.++.+
T Consensus       159 ~~~y~aPE~~~~~~~~~~  176 (252)
T cd05084         159 PVKWTAPEALNYGRYSSE  176 (252)
T ss_pred             ceeecCchhhcCCCCChH
Confidence            456999999988776654

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=4e-31  Score=211.31  Aligned_cols=169  Identities=27%  Similarity=0.431  Sum_probs=147.0

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|+||.||++.+..+++.||+|++......    ...+..|+.++..++|++++++++.+...+.++++
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            57899999999999999999999999999999998754322    25677888999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-C
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-R  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~  155 (181)
                      |||+.+++|..++.....+++..++.++.|++.||.|||.+||+|+||+|+||+++.++  .++|+|||+++...... .
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g--~vkL~DFGls~~~~~~~~~  160 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG--HIKLTDFGLSKVTLNRELN  160 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC--CEEEEeCCCCccccCCccc
Confidence            99999999999988777899999999999999999999999999999999999997555  59999999997543322 3


Q ss_pred             CCcccCCCCccCcccc
Q 030211          156 PKSTVGTPAYIAPEVL  171 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~  171 (181)
                      .....+++.|++||..
T Consensus       161 ~~~~~~t~~~~~pe~~  176 (669)
T cd05610         161 MMDILTTPSMAKPKND  176 (669)
T ss_pred             ccccccCccccCcccc
Confidence            3445788889999853

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.98  E-value=2.3e-31  Score=194.67  Aligned_cols=168  Identities=33%  Similarity=0.464  Sum_probs=144.6

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc------cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI------DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~------~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +|++.+.||+|++|.||++.+..+++.|++|.+......      ...+..|+..++.++|+|++++++++.+.+..+++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            689999999999999999999988999999998754322      34567789999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-
Q 030211           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-  154 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-  154 (181)
                      |||+ +++|.+++.... .+++..+..++.|++.||.+||++|++|+||+|+||++++++  .++|+|||++....... 
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~--~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG--VLKLADFGLARSFGSPNR  157 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC--CEEEccceeeeeccCCCc
Confidence            9999 889999887765 799999999999999999999999999999999999997655  49999999987654332 


Q ss_pred             CCCcccCCCCccCcccccC
Q 030211          155 RPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~  173 (181)
                      ......+++.|+|||.+.+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~  176 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFG  176 (298)
T ss_pred             cccccccceeeeCHHHHhC
Confidence            2233356788999998854

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.98  E-value=5.6e-31  Score=192.02  Aligned_cols=175  Identities=32%  Similarity=0.516  Sum_probs=145.0

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      +++|++.+.||+|++|.||++.++.+++.|++|.+.....  ....+.+|+.+++.++|+|++++++++.+.+..+++||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            5789999999999999999999998899999999865322  23456789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-C
Q 030211           79 YAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-P  156 (181)
Q Consensus        79 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~  156 (181)
                      |+.+ +|.+++... ..+++..+..++.|++.||.+||++|++|+||+|+||++++++.  ++|+|||++........ .
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCccc
Confidence            9975 888877654 36899999999999999999999999999999999999976554  99999999864322211 2


Q ss_pred             CcccCCCCccCcccccC-CccCC
Q 030211          157 KSTVGTPAYIAPEVLSR-REYDG  178 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~-~~~~~  178 (181)
                      ....++..|+|||++.+ ..++.
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~  183 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYST  183 (291)
T ss_pred             cccccccccCCcHHhhcCcccCc
Confidence            22346788999998865 33443

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.98  E-value=5.4e-31  Score=189.83  Aligned_cols=176  Identities=26%  Similarity=0.353  Sum_probs=146.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC---CcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|++.+.||+|+||.||+|.+..+   ...+++|.+......  ...+.+|+..++.++|+|++++++.+...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            5799999999999999999998643   457999988654322  35678899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-CC
Q 030211           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HS  154 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~~  154 (181)
                      ||++++++|.+++..+. .+++..+..++.|++.++.+||++|++|+||+|+||+++++..  ++|+|||.+..... ..
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhccccccc
Confidence            99999999999886643 6899999999999999999999999999999999999976554  99999999876531 11


Q ss_pred             CCC--cccCCCCccCcccccCCccCCC
Q 030211          155 RPK--STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~--~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...  ...+++.|+|||.+.+..++++
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~  188 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRKFTSA  188 (266)
T ss_pred             ceeccCCCCCccccChhhhccCCCccc
Confidence            111  1234578999999988777654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.98  E-value=3.4e-31  Score=191.17  Aligned_cols=176  Identities=25%  Similarity=0.371  Sum_probs=145.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCc---EEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKE---LVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~---~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +.|++.+.||+|++|.||+|.+..+++   .+++|.+....  .....+..|+..++.+.|||++++.+++.+++..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            579999999999999999999876654   59999987532  2235788899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      |||+++++|.+++... ..++...++.++.|++.|+.+||++|++|+||+|+||+++++.  .++|.|||.+........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC--cEEECCCccccccccCcc
Confidence            9999999999888653 4689999999999999999999999999999999999996544  599999998864432222


Q ss_pred             CCcc---c---CCCCccCcccccCCccCCC
Q 030211          156 PKST---V---GTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~~---~---~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....   .   .+..|+|||.+.+..++.+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~  191 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSA  191 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccch
Confidence            1111   1   1357999999988777654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.98  E-value=5.6e-31  Score=189.81  Aligned_cols=176  Identities=31%  Similarity=0.460  Sum_probs=147.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcC--CeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK------IDENVAREIINHRSLRHPNIIRFKEVVLTP--THL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~   73 (181)
                      .+|++.+.||+|++|.||++.+..+++.+++|.+.....      ....+.+|+.+++.++|+|++++++.+.+.  +.+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            369999999999999999999998999999998764321      124577799999999999999999988763  578


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      ++++|++++++|.+.+.+...+++...+.++.|++.+|++||+++++|+||+|+||+++++..  ++|+|||++......
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~  159 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccc
Confidence            899999999999999887778999999999999999999999999999999999999975554  999999998654321


Q ss_pred             ----CCCCcccCCCCccCcccccCCccCCC
Q 030211          154 ----SRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ----~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                          .......++..|+|||.+.+..++.+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  189 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRK  189 (266)
T ss_pred             cccCCccccCCccccccCHHHhCCCCCCch
Confidence                11223457889999999988776654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.98  E-value=4e-31  Score=190.66  Aligned_cols=176  Identities=27%  Similarity=0.350  Sum_probs=145.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCC---cEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETK---ELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~---~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|++.+.||+|+||.||++.+..++   ..+++|.+.....  ..+.+.+|+..++.++|||++++++++..++..+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            58999999999999999999886433   3689998865432  235778899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      ||++++++|.+++... ..++...+..++.|++.++.+||+.|++|+||+|+||+++++.  .++|+|||.+........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC--eEEeCCCCcccccccccc
Confidence            9999999999988664 4689999999999999999999999999999999999996554  599999999875443322


Q ss_pred             CCc----ccCCCCccCcccccCCccCCC
Q 030211          156 PKS----TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~----~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...    ...+..|+|||.+.+..++++
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~  189 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRKFTSA  189 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCccCch
Confidence            111    122467999999988777654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.98  E-value=3.5e-31  Score=198.09  Aligned_cols=173  Identities=28%  Similarity=0.394  Sum_probs=146.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcC------Ce
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP------TH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~------~~   72 (181)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+....   .....+.+|+.+++.++|+|++++++++...      ..
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            68999999999999999999999999999999986432   2234677899999999999999999988654      35


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      .+++||++.+ +|.+.+...  +++..+..++.|++.||++||++|++|+||+|+||++++++.  ++|+|||++.....
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~  170 (353)
T cd07850          96 VYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT  170 (353)
T ss_pred             EEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeCCC
Confidence            7999999965 777776544  899999999999999999999999999999999999976554  99999999976554


Q ss_pred             CCCCCcccCCCCccCcccccCCccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ........+++.|+|||.+.+..++++
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~  197 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYKEN  197 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCCCc
Confidence            444445567899999999998887765

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.98  E-value=1.4e-31  Score=194.57  Aligned_cols=170  Identities=31%  Similarity=0.525  Sum_probs=143.4

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +|++.+.||+|++|.||+|.+..+|..+++|.+.....   ....+.+|+..++.++|+|++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            69999999999999999999999999999999865322   235677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCC
Q 030211           80 AAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPK  157 (181)
Q Consensus        80 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~  157 (181)
                      +++ +|.+.+.+ ...+++..++.++.|++.||.+||++|++|+||+|+||++++++.  ++|+|||++....... ...
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~  157 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYS  157 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcC
Confidence            965 77776654 457899999999999999999999999999999999999976554  9999999987543222 223


Q ss_pred             cccCCCCccCcccccCCc
Q 030211          158 STVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~  175 (181)
                      ...+++.|+|||++.+..
T Consensus       158 ~~~~~~~y~aPE~~~~~~  175 (284)
T cd07839         158 AEVVTLWYRPPDVLFGAK  175 (284)
T ss_pred             CCccccCCcChHHHhCCc
Confidence            345788999999987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.98  E-value=7e-31  Score=191.57  Aligned_cols=170  Identities=29%  Similarity=0.421  Sum_probs=141.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+......  ...+.+|+.+++.++|+|++++++++.+.+..++++|+
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            5799999999999999999999988999999998654322  34677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCC
Q 030211           80 AAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPK  157 (181)
Q Consensus        80 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~  157 (181)
                      +. +++.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++  .++|+|||++....... ...
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~  161 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG--ELKLADFGLARAKSIPSQTYS  161 (291)
T ss_pred             cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC--cEEEeccccccccCCCCCCCC
Confidence            95 567666544 34678888999999999999999999999999999999997555  49999999886432222 223


Q ss_pred             cccCCCCccCcccccCC
Q 030211          158 STVGTPAYIAPEVLSRR  174 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~  174 (181)
                      ...+++.|+|||.+.+.
T Consensus       162 ~~~~~~~y~aPE~~~~~  178 (291)
T cd07870         162 SEVVTLWYRPPDVLLGA  178 (291)
T ss_pred             CccccccccCCceeecC
Confidence            34568899999998653

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.98  E-value=2e-31  Score=194.81  Aligned_cols=176  Identities=27%  Similarity=0.395  Sum_probs=143.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC--------------CcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET--------------KELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKE   65 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~--------------~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~   65 (181)
                      ++|++.+.||+|+||.||++.+...              ...|++|.+.....  ....+.+|+..++.++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            4899999999999999999987542              23589998875322  2356888999999999999999999


Q ss_pred             eEEcCCeEEEEEeecCCCChHHHHhhcC------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc
Q 030211           66 VVLTPTHLAIVMEYAAGGELFDRICNAG------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG  133 (181)
Q Consensus        66 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~  133 (181)
                      ++...+..+++|||+++++|.+++....            .+++..+..++.|++.||.+||++|++|+||+|+||++++
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~  164 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN  164 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence            9999999999999999999998875431            3678899999999999999999999999999999999975


Q ss_pred             CCCCcEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          134 SAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       134 ~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +..  ++|+|||++........   .....++..|+|||.+.++.++.+
T Consensus       165 ~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  211 (295)
T cd05097         165 HYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA  211 (295)
T ss_pred             CCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCch
Confidence            554  99999999865432221   112234678999999988877664

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-31  Score=201.99  Aligned_cols=176  Identities=30%  Similarity=0.388  Sum_probs=149.1

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCc---E-EEEEEcccc----ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKE---L-VAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~---~-v~~K~~~~~----~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      +..+.++||+|+||.||++..+..+.   . ||+|.....    .....++.+|.+++++++|||+++++++......++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            44567899999999999999764322   3 899987742    233578999999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           75 IVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      ++||+|.+|+|.+++.+++ .++..+...++.+.+.+|+|||+++++||||-..|++++.+..  +|++|||+++.....
T Consensus       238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~~~  315 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGSQY  315 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCcce
Confidence            9999999999999999887 5999999999999999999999999999999999999975554  899999998755422


Q ss_pred             CCCC-cccCCCCccCcccccCCccCCCC
Q 030211          154 SRPK-STVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       154 ~~~~-~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      .... ...-..+|+|||.+..+-|+++.
T Consensus       316 ~~~~~~~klPirWLAPEtl~~~~~s~kT  343 (474)
T KOG0194|consen  316 VMKKFLKKLPIRWLAPETLNTGIFSFKT  343 (474)
T ss_pred             eeccccccCcceecChhhhccCcccccc
Confidence            2222 22356899999999999998764

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.98  E-value=1.3e-31  Score=192.41  Aligned_cols=175  Identities=22%  Similarity=0.298  Sum_probs=149.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|++|.||+|.+.. ++.+++|.+..... ....+.+|+.+++.++|+|++++++++.+.+..+++|||+
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            468999999999999999999987 88899999876544 3467888999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-CC
Q 030211           81 AGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PK  157 (181)
Q Consensus        81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~~  157 (181)
                      ++++|.+++.+.  ..+++..+..++.|++.|+.+||++|++|+||+|+||+++++..  ++|+|||.+........ ..
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~~  162 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSS  162 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCcccccc
Confidence            999999988653  36899999999999999999999999999999999999976554  99999999865433222 22


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...++..|+|||.+.++.++.+
T Consensus       163 ~~~~~~~~~~PE~~~~~~~~~~  184 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTFSTK  184 (261)
T ss_pred             CCCCceEecCHHHHccCCCCch
Confidence            2345678999999988777654

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.98  E-value=4.5e-31  Score=189.82  Aligned_cols=168  Identities=30%  Similarity=0.527  Sum_probs=146.5

Q ss_pred             eCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCCh
Q 030211           10 LGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (181)
Q Consensus        10 i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   85 (181)
                      ||.|++|.||++.+..+++.+++|.+.....    ..+.+.+|+.+++.++|+|++++++.+.+++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999999998899999999875432    235688899999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccCCCCc
Q 030211           86 FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAY  165 (181)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~  165 (181)
                      .+++.+...+++..+..++.|++.+|++||++|++|+||+|+||++++++.  ++|+|||.+.............+++.|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~  158 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEY  158 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCc
Confidence            999988778999999999999999999999999999999999999976554  999999998765444334445688999


Q ss_pred             cCcccccCCccCCC
Q 030211          166 IAPEVLSRREYDGK  179 (181)
Q Consensus       166 ~aPE~~~~~~~~~~  179 (181)
                      +|||.+.+..++.+
T Consensus       159 ~~PE~~~~~~~~~~  172 (262)
T cd05572         159 VAPEIILNKGYDFS  172 (262)
T ss_pred             cChhHhcCCCCCCh
Confidence            99999987776654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.98  E-value=5.2e-31  Score=191.55  Aligned_cols=176  Identities=30%  Similarity=0.423  Sum_probs=143.3

Q ss_pred             ccc-eeeeeeCCccceeEEEEE----EccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcC--Ce
Q 030211            2 EKY-ELVKDLGAGNFGVARLLR----HKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTP--TH   72 (181)
Q Consensus         2 ~~y-~~~~~i~~g~~~~v~~~~----~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~   72 (181)
                      +|| ++.+.||+|+||+||.+.    ...++..+++|.+.....  ....+.+|+..++.++|||++++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            566 999999999999998765    345677899999875432  345678899999999999999999987653  46


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      .+++||++.+++|.+++.. ..+++..++.++.|++.|+.+||++|++|+||+|+||+++++.  .++|+|||++.....
T Consensus        83 ~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~  159 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPE  159 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC--cEEEeecccccccCC
Confidence            8999999999999988865 3699999999999999999999999999999999999997655  499999999875433


Q ss_pred             CCC----CCcccCCCCccCcccccCCccCCCC
Q 030211          153 HSR----PKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       153 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ...    .....++..|+|||.+.+..++.++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~  191 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYAS  191 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCccc
Confidence            222    1122355679999999887777653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.98  E-value=3.4e-32  Score=204.70  Aligned_cols=175  Identities=33%  Similarity=0.478  Sum_probs=151.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---------cHHHHHHHHHHhhCC---CCCeeEEEEeEEc
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---------DENVAREIINHRSLR---HPNIIRFKEVVLT   69 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---------~~~~~~e~~~~~~~~---~~~i~~~~~~~~~   69 (181)
                      ..|..++.+|+|+||.|+.|.+++....|++|.+.+....         .-.+-.|+.++..+.   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            5699999999999999999999998999999988765321         123455777777775   9999999999999


Q ss_pred             CCeEEEEEeecCCC-ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211           70 PTHLAIVMEYAAGG-ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus        70 ~~~~~~v~e~~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      ++++|++||....+ +|.+++.-.+++++.++..|++|++.++++||+.||+|||||.+|++++.++.  ++|+|||.|.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgsaa  718 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGSAA  718 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccchh
Confidence            99999999988665 78899988899999999999999999999999999999999999999965554  9999999885


Q ss_pred             cccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          149 SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                       ....+..-.+.||..|.|||++.+.+|-.|
T Consensus       719 -~~ksgpfd~f~gtv~~aapevl~g~~y~gk  748 (772)
T KOG1152|consen  719 -YTKSGPFDVFVGTVDYAAPEVLGGEKYLGK  748 (772)
T ss_pred             -hhcCCCcceeeeeccccchhhhCCCccCCC
Confidence             444555566889999999999999988655

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2.4e-31  Score=192.94  Aligned_cols=170  Identities=32%  Similarity=0.496  Sum_probs=145.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||.|++|.||++.+..++..+++|.+..... ..+.+..|+.+++.++|+|++++++.+.+++..+++|||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            579999999999999999999988899999999865432 2356788999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCCc
Q 030211           81 AGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKS  158 (181)
Q Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~~  158 (181)
                      ++++|..++.+. ..+++..++.++.|++.++.+||++|++|+||+|+||+++.+.  .++|+|||.+....... ....
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~  162 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG--DVKLADFGVSAKNKSTLQKRDT  162 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC--CEEEccCccchhhcccccccce
Confidence            999999887654 4699999999999999999999999999999999999997554  49999999876543222 2233


Q ss_pred             ccCCCCccCcccccC
Q 030211          159 TVGTPAYIAPEVLSR  173 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~  173 (181)
                      ..+++.|+|||.+..
T Consensus       163 ~~~~~~y~~PE~~~~  177 (280)
T cd06611         163 FIGTPYWMAPEVVAC  177 (280)
T ss_pred             eecchhhcCHHHHhh
Confidence            468889999999853

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=7.3e-31  Score=189.02  Aligned_cols=176  Identities=35%  Similarity=0.513  Sum_probs=147.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc------cccHHHHHHHHHHhhCCCCCeeEEEEeEEcC--CeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR------KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~   73 (181)
                      .+|++.+.||+|++|.||++.+..+++.+++|.+....      .....+.+|+.+++.++|++++++++.+.+.  +.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47999999999999999999999899999999875321      1224677899999999999999999998764  468


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      ++++|++++++|.+.+.+...+++..+..++.|++.++.+||++|++|+||+|+||+++++.  .++|.|||.+......
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~  159 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEECccccccccccc
Confidence            89999999999999887777789999999999999999999999999999999999997555  4999999998754221


Q ss_pred             ----CCCCcccCCCCccCcccccCCccCCC
Q 030211          154 ----SRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ----~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                          .......++..|+|||++.+..++.+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  189 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRK  189 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCcc
Confidence                11223457889999999987766544

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.98  E-value=5.4e-31  Score=189.24  Aligned_cols=174  Identities=26%  Similarity=0.352  Sum_probs=144.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|++|.||++.+.. +..+++|.+.......+.+.+|+.+++.++|++++++++++. .+..+++||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            689999999999999999998764 566999998765555567889999999999999999999875 456889999999


Q ss_pred             CCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC--C
Q 030211           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--K  157 (181)
Q Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~--~  157 (181)
                      +++|.+++.+.  ..+++..+..++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||.+.........  .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL--VCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc--eEEeCCceeeeeccCccccccc
Confidence            99999988653  3589999999999999999999999999999999999997554  5999999998654332221  1


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...++..|+|||.+.+..++.+
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~  183 (260)
T cd05070         162 GAKFPIKWTAPEAALYGRFTIK  183 (260)
T ss_pred             CCCCCccccChHHHhcCCCcch
Confidence            2234567999999987776654

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.98  E-value=5.3e-31  Score=191.00  Aligned_cols=168  Identities=32%  Similarity=0.446  Sum_probs=143.8

Q ss_pred             eCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCCh
Q 030211           10 LGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (181)
Q Consensus        10 i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   85 (181)
                      ||+|+||+||+|.+..+++.+++|.+.....    ....+.+|+.+++.++||+++++.+.+...+..+++|||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            6899999999999998999999998865321    234567899999999999999999999999999999999999999


Q ss_pred             HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccCCC
Q 030211           86 FDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP  163 (181)
Q Consensus        86 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~  163 (181)
                      .+.+.+..  .+++..+..++.|++.++.+||++|++|+||+|+||++++++.  ++|+|||.+.............++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCC
Confidence            98887655  7999999999999999999999999999999999999976554  9999999887554444444456788


Q ss_pred             CccCcccccCCccCCC
Q 030211          164 AYIAPEVLSRREYDGK  179 (181)
Q Consensus       164 ~~~aPE~~~~~~~~~~  179 (181)
                      .|+|||++.+..++.+
T Consensus       159 ~y~~PE~~~~~~~~~~  174 (277)
T cd05577         159 GYMAPEVLQGEVYDFS  174 (277)
T ss_pred             CcCCHHHhcCCCCCch
Confidence            9999999987776544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.98  E-value=1.1e-30  Score=187.93  Aligned_cols=175  Identities=31%  Similarity=0.496  Sum_probs=149.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||.|++|+||++.+..++..+++|++....  ...+.+.+|+..++.++|++++++++.+...+..++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            57999999999999999999998889999999986543  2346788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           80 AAGGELFDRICNA---GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        80 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      +++++|.+.+...   ..+++..++.++.|++.|+++||+.|++|+||+|+||+++++.  .++|+|||.+.........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~--~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG--SVKIADFGVSASLADGGDR  158 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEcccchHHHhccCccc
Confidence            9999999988654   3589999999999999999999999999999999999997655  4999999998654433322


Q ss_pred             -----CcccCCCCccCcccccCC-ccCC
Q 030211          157 -----KSTVGTPAYIAPEVLSRR-EYDG  178 (181)
Q Consensus       157 -----~~~~~~~~~~aPE~~~~~-~~~~  178 (181)
                           ....++..|+|||++.+. .++.
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~  186 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDF  186 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCc
Confidence                 234578899999998876 4443

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.98  E-value=4.7e-31  Score=190.61  Aligned_cols=169  Identities=30%  Similarity=0.498  Sum_probs=143.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcC------CeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTP------THLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~------~~~~   74 (181)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+.........+..|+.++..+ +|+|++++.+.+...      ..++
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            468999999999999999999999999999999876655556788888888888 699999999998753      4689


Q ss_pred             EEEeecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           75 IVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ++|||+++++|.+++...  ..+++..+..++.|++.++.|||+++++|+||+|+||+++++..  ++|+|||++.....
T Consensus        86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~~  163 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDR  163 (272)
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceeccc
Confidence            999999999999888653  36899999999999999999999999999999999999976554  99999999875432


Q ss_pred             C-CCCCcccCCCCccCccccc
Q 030211          153 H-SRPKSTVGTPAYIAPEVLS  172 (181)
Q Consensus       153 ~-~~~~~~~~~~~~~aPE~~~  172 (181)
                      . .......+++.|+|||++.
T Consensus       164 ~~~~~~~~~g~~~y~aPE~~~  184 (272)
T cd06637         164 TVGRRNTFIGTPYWMAPEVIA  184 (272)
T ss_pred             ccccCCcccccccccCHhHhc
Confidence            2 2233456889999999986

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.98  E-value=6.1e-31  Score=190.67  Aligned_cols=178  Identities=22%  Similarity=0.306  Sum_probs=146.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc-----CCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|.+.+.||+|++|.||+|.+..     .+..+++|.+......  ...+..|+..++.++|+|++++++++.+.+..+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            578999999999999999999976     6778999987643322  346888999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-CCcEEEeecCC
Q 030211           75 IVMEYAAGGELFDRICNAG-------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGY  146 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-~~~v~l~dfg~  146 (181)
                      ++||++.+++|.+++....       .+++..+..++.|++.++++||+++++|+||+|+||++++++ ...++|+|||+
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence            9999999999999886542       488999999999999999999999999999999999997544 23589999999


Q ss_pred             cccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          147 SKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       147 a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +........   ......+..|+|||++.+..++.+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  201 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK  201 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcCCcCch
Confidence            875422211   112233568999999988877765

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.98  E-value=8e-31  Score=188.79  Aligned_cols=174  Identities=29%  Similarity=0.455  Sum_probs=146.9

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +|++.+.||+|+||.||++.+. +++.+++|.+.....       ....+.+|+..++.++|+|++++.+++.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            5889999999999999999875 578899998764321       12457789999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC---
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL---  152 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~---  152 (181)
                      ++||+++++|.+++.+..++++..+..++.|++.++++||+.|++|+||+|+||++++++.  ++|+|||.+.....   
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccc
Confidence            9999999999999987778999999999999999999999999999999999999975554  99999998864321   


Q ss_pred             ----CCCCCcccCCCCccCcccccCCccCCC
Q 030211          153 ----HSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ----~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                          ........++..|+|||++.+..++++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~  188 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRK  188 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcch
Confidence                111223457889999999988777654

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.98  E-value=9e-31  Score=190.42  Aligned_cols=175  Identities=27%  Similarity=0.412  Sum_probs=144.6

Q ss_pred             cceeeeeeCCccceeEEEEEE----ccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcC--CeEE
Q 030211            3 KYELVKDLGAGNFGVARLLRH----KETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THLA   74 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~----~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~   74 (181)
                      .|++++.||+|+||.||.+..    ..++..+++|.+....  .....+.+|+.+++.++|+|++++.+++.+.  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            468999999999999999974    4567889999986432  2235688899999999999999999998875  5689


Q ss_pred             EEEeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           75 IVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      ++|||+++++|.+++.+.. .+++..+..++.|++.+|.+||++|++|+||+|+||++++++  .++|.|||.+......
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~--~~~l~dfg~~~~~~~~  162 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETD  162 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC--CEEECCCccccccccC
Confidence            9999999999999886543 689999999999999999999999999999999999997655  4999999998754332


Q ss_pred             CC----CCcccCCCCccCcccccCCccCCC
Q 030211          154 SR----PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ~~----~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..    .....++..|+|||++.+..++++
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~  192 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIA  192 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhccCCCCcc
Confidence            22    123446678999999988777654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.98  E-value=8.6e-31  Score=190.92  Aligned_cols=176  Identities=22%  Similarity=0.315  Sum_probs=142.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc-----CCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|++|.||++.+++     .+..|++|.+......  ...+.+|+..++.++|++++++++.+.+++..+
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            589999999999999999997652     3557999987644322  235678899999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeec
Q 030211           75 IVMEYAAGGELFDRICNA----------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~df  144 (181)
                      ++|||+++++|.+++...          ...+...+..++.|++.||.+||++|++|+||+|+||+++++.  .++|+||
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~--~~~L~Df  163 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF--TVKIGDF  163 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC--cEEECcC
Confidence            999999999999988642          2346678899999999999999999999999999999997554  5999999


Q ss_pred             CCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          145 GYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       145 g~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      |++........   .....++..|+|||.+.++.++.+
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~  201 (288)
T cd05061         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS  201 (288)
T ss_pred             CccccccccccccccCCCcccccccCHHHhccCCCChH
Confidence            99865432221   112234678999999988877664

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.98  E-value=6.8e-31  Score=190.96  Aligned_cols=176  Identities=31%  Similarity=0.467  Sum_probs=142.9

Q ss_pred             ccceeeeeeCCccceeEEEEEE----ccCCcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEEEEeEEcC--CeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRH----KETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTP--THLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~----~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~   74 (181)
                      ++|++.+.||+|+||.||++..    ..++..+++|.+...... .+.+.+|+..+..++|||++++.+++...  ..++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4789999999999999999973    456888999998754332 35778899999999999999999987543  4689


Q ss_pred             EEEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           75 IVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      +++||+++++|.+++.+. ..+++..+..++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||++......
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~--~~~l~dfg~~~~~~~~  161 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN--RVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC--eEEECCCcccccccCC
Confidence            999999999999988654 4689999999999999999999999999999999999997555  4999999998755332


Q ss_pred             CCC----CcccCCCCccCcccccCCccCCC
Q 030211          154 SRP----KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ~~~----~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...    ....++..|+|||++.+..++.+
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  191 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVA  191 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChH
Confidence            221    11123445999999987776653

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.98  E-value=1.2e-30  Score=189.67  Aligned_cols=169  Identities=30%  Similarity=0.518  Sum_probs=141.8

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +|++.+.||+|++|.||++.+..++..|++|.+.....   ....+.+|+.++..++|||++++++++.+++..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            58999999999999999999998899999998865322   235678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-
Q 030211           80 AAGGELFDRICN---AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        80 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-  155 (181)
                      ++ ++|.+++..   +..+++..++.++.|++.||.+||++|++|+||+|+||++++++.  ++|+|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV  157 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence            97 577776643   246899999999999999999999999999999999999976555  99999999864432222 


Q ss_pred             CCcccCCCCccCcccccCC
Q 030211          156 PKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~  174 (181)
                      .....+++.|+|||.+.+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~  176 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGS  176 (285)
T ss_pred             ccCCcccccccChHHhcCC
Confidence            2233568899999988654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.98  E-value=7e-31  Score=188.25  Aligned_cols=170  Identities=29%  Similarity=0.421  Sum_probs=146.1

Q ss_pred             eeeCCccceeEEEEEEccC---CcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKET---KELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|++|.||++.+...   +..+++|.+......  .+.+.+|+..+..++|++++++++++.+....+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4789999999999999866   889999998765433  46788899999999999999999999999999999999999


Q ss_pred             CChHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           83 GELFDRICNA---------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        83 ~~l~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      ++|.+++...         ..+++..++.++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||.+......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~--~~~l~dfg~~~~~~~~  158 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL--VVKISDFGLSRDVYDD  158 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC--cEEEcccccccccccc
Confidence            9999998775         6899999999999999999999999999999999999997654  4999999998765443


Q ss_pred             C---CCCcccCCCCccCcccccCCccCCC
Q 030211          154 S---RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ~---~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .   ......+++.|+|||.+....++.+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  187 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSK  187 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchh
Confidence            2   2333457889999999987766543

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.98  E-value=8.6e-31  Score=190.42  Aligned_cols=170  Identities=29%  Similarity=0.473  Sum_probs=146.1

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +|++.+.||+|++|.||+|.+..+++.+++|.+.....   ....+.+|+.+++.++|+|++++++++...+..++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            69999999999999999999998899999999875432   235788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--C
Q 030211           80 AAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--P  156 (181)
Q Consensus        80 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--~  156 (181)
                      + +++|.+.+.. ...+++..++.++.|++.+|++||+.|++|+||+|+||++++++  .++|+|||.+........  .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~--~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG--VLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC--cEEEeeeeecccccCCCCCcc
Confidence            9 8899988754 35789999999999999999999999999999999999997654  499999999875543332  3


Q ss_pred             CcccCCCCccCcccccCCc
Q 030211          157 KSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~  175 (181)
                      ....++..|+|||.+.+..
T Consensus       158 ~~~~~~~~y~aPE~~~~~~  176 (286)
T cd07832         158 SHQVATRWYRAPELLYGAR  176 (286)
T ss_pred             ccccCcccccCceeeeccc
Confidence            3456888999999986543

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.98  E-value=2e-30  Score=189.22  Aligned_cols=171  Identities=29%  Similarity=0.498  Sum_probs=144.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcC-----CeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTP-----THLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~-----~~~~~   75 (181)
                      ++|++.+.||+|++|.||++.+..+++.+++|++.........+.+|+.++..+ +|||++++++++...     +..++
T Consensus        22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l  101 (291)
T cd06639          22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL  101 (291)
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence            579999999999999999999999999999999876554456777888888888 799999999998754     35899


Q ss_pred             EEeecCCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           76 VMEYAAGGELFDRIC----NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        76 v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      ++||+++++|.+.+.    ....+++..++.++.|++.+|++||+.|++|+||+|+||+++++..  ++|+|||.+....
T Consensus       102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~~  179 (291)
T cd06639         102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLT  179 (291)
T ss_pred             EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchhcc
Confidence            999999999988764    2357899999999999999999999999999999999999976554  9999999987543


Q ss_pred             CCCC-CCcccCCCCccCcccccCC
Q 030211          152 LHSR-PKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       152 ~~~~-~~~~~~~~~~~aPE~~~~~  174 (181)
                      .... .....++..|+|||.+...
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~  203 (291)
T cd06639         180 STRLRRNTSVGTPFWMAPEVIACE  203 (291)
T ss_pred             cccccccCccCCccccChhhhcCC
Confidence            3322 2334678899999998654

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.98  E-value=1.1e-31  Score=193.07  Aligned_cols=175  Identities=32%  Similarity=0.509  Sum_probs=151.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|++|.||++.++.+++.+++|.+.....  ..+.+.+|+.+++.+.|||++++++.+...+..++++|+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            478999999999999999999998899999998876532  235678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           80 AAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        80 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      +++.+|.+++... ..+++..+..++.|++.++++||+ .|++|+||+|+||++++++  .++|+|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~--~~~l~d~g~~~~~~~~~~~-  157 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLVNSLAK-  157 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC--CEEEeecccchhhHHHHhh-
Confidence            9989999988766 689999999999999999999999 9999999999999997654  4999999988644322222 


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...++..|+|||.+.+..++.+
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~  179 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDYSVK  179 (265)
T ss_pred             cccCChhccCHHHHcCCCCCch
Confidence            2678889999999988766654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.98  E-value=5.1e-31  Score=193.72  Aligned_cols=176  Identities=26%  Similarity=0.323  Sum_probs=143.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc-------CCcEEEEEEccccc--cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE-------TKELVAVKYIERGR--KIDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~-------~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~   71 (181)
                      ++|.+.+.||+|+||.||.+.+..       ....+++|.+....  .....+.+|+.++..+ +|++++++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            579999999999999999998643       23469999987542  2235677899999988 7999999999999999


Q ss_pred             eEEEEEeecCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC
Q 030211           72 HLAIVMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~  135 (181)
                      ..+++|||+++++|.+++....                .++..+++.++.|++.||++||++|++|+||+|+||++++++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  177 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  177 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence            9999999999999999886532                478889999999999999999999999999999999997655


Q ss_pred             CCcEEEeecCCcccccCCCCC---CcccCCCCccCcccccCCccCCC
Q 030211          136 APRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       136 ~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                        .++|+|||.+.........   ....+++.|+|||.+.+..++.+
T Consensus       178 --~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  222 (307)
T cd05098         178 --VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ  222 (307)
T ss_pred             --cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH
Confidence              4999999998654322211   11223468999999988776654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=2.3e-32  Score=193.38  Aligned_cols=166  Identities=29%  Similarity=0.445  Sum_probs=143.7

Q ss_pred             eeeeCCccceeEEEEEEccCCcEEEEEEccccccc-cHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEeecCCCC
Q 030211            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGE   84 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   84 (181)
                      .+.+|+|+++.|-.++...++..+|+|++.+.+.. ...+.+|+.++.+. .|+||++++++|++...+|+|||-+.|++
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            35689999999999999999999999999887544 47788999999887 59999999999999999999999999999


Q ss_pred             hHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEec-cCCCCcEEEeecCCcccccCC--------CC
Q 030211           85 LFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD-GSAAPRLKICDFGYSKSSVLH--------SR  155 (181)
Q Consensus        85 l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~-~~~~~~v~l~dfg~a~~~~~~--------~~  155 (181)
                      |++.+.++..|++.++.++..+|+.||.+||.+||+|+||||+||+.. ++.-..|||+||.+.......        ..
T Consensus       163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~  242 (463)
T KOG0607|consen  163 LLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPE  242 (463)
T ss_pred             HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCcc
Confidence            999999989999999999999999999999999999999999999994 444467999999886432211        11


Q ss_pred             CCcccCCCCccCccccc
Q 030211          156 PKSTVGTPAYIAPEVLS  172 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~  172 (181)
                      -.+.+|+-+|||||+..
T Consensus       243 L~tPvGSAEfMAPEVVd  259 (463)
T KOG0607|consen  243 LLTPVGSAEFMAPEVVD  259 (463)
T ss_pred             ccCcccchhhcchhHHh
Confidence            22346899999999874

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.6e-30  Score=185.74  Aligned_cols=174  Identities=32%  Similarity=0.480  Sum_probs=151.6

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +|++.+.||+|++|.+|++.+..+++.+++|.+.....   ..+.+.+|+.++..++|++++++++++.+.+..++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            68999999999999999999998899999999876543   346788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-CCc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~~~  158 (181)
                      +++++|.+.+.....+++..++.++.|++.++.+||++|++|+||+|+||++++++  .++|.|||.+........ ...
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC--CEEEeccccceecCCCcccccc
Confidence            99999999988778899999999999999999999999999999999999997654  599999999876544333 233


Q ss_pred             ccCCCCccCcccccCCccCC
Q 030211          159 TVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ..++..|+|||...+...+.
T Consensus       159 ~~~~~~y~~pe~~~~~~~~~  178 (254)
T cd06627         159 VVGTPYWMAPEVIEMSGAST  178 (254)
T ss_pred             cccchhhcCHhhhcCCCCCc
Confidence            46788999999987766443

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-32  Score=199.10  Aligned_cols=176  Identities=29%  Similarity=0.433  Sum_probs=157.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +.|+.-.+||+|+||.||-+....+|+.+|+|.+.+..    ....-.++|-.++..+..+.||.+-..|+..+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45777889999999999999999999999999886532    22345778899999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           78 EYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      ..|.||+|.--+.+.  +-|++..++.++.+|+.+|++||+.+|+.||+||+||++|+.++  +.|+|+|+|..+.....
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGKP  342 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCCCc
Confidence            999999997555443  47999999999999999999999999999999999999976666  99999999999888888


Q ss_pred             CCcccCCCCccCcccccCCccCCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...+.||.+|||||++.++.|+-+
T Consensus       343 ~~~rvGT~GYMAPEvl~ne~Y~~s  366 (591)
T KOG0986|consen  343 IRGRVGTVGYMAPEVLQNEVYDFS  366 (591)
T ss_pred             cccccCcccccCHHHHcCCcccCC
Confidence            888899999999999999998754

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=1.2e-30  Score=188.58  Aligned_cols=171  Identities=34%  Similarity=0.482  Sum_probs=145.4

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-----------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-----------IDENVAREIINHRSLRHPNIIRFKEVVLTPT   71 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-----------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~   71 (181)
                      +|.+.+.||+|++|.||++.+..+++.+++|.+.....           ..+.+..|+..++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            68999999999999999999988899999998753211           1135677889999999999999999999999


Q ss_pred             eEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      ..++++||+.+++|.+.+.+...+++..+..++.|++.+|.+||++|++|+||+|+||+++++.  .++|.|||++....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~--~~~l~d~~~~~~~~  159 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG--ICKISDFGISKKSD  159 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC--eEEEeecccccccc
Confidence            9999999999999999988878899999999999999999999999999999999999997555  49999999986533


Q ss_pred             CCC---CCCcccCCCCccCcccccCCc
Q 030211          152 LHS---RPKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       152 ~~~---~~~~~~~~~~~~aPE~~~~~~  175 (181)
                      ...   ......++..|+|||.+....
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~  186 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYS  186 (272)
T ss_pred             ccccccccccccCCccccCHHHhcccc
Confidence            221   122345788999999987655

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.2e-30  Score=188.91  Aligned_cols=176  Identities=23%  Similarity=0.326  Sum_probs=145.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC-----CcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET-----KELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~-----~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|++|.||++.+...     +..+++|.+......  ...+.+|+.+++.++|+|++++++++...+..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            6899999999999999999988643     478999998654322  346778999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeec
Q 030211           75 IVMEYAAGGELFDRICNA----------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~df  144 (181)
                      ++|||+++++|.+++...          ..+++..+..++.|++.||.+||++|++|+||+|+||++++++.  ++|+||
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl~df  163 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDF  163 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEECCc
Confidence            999999999999887542          23677889999999999999999999999999999999976554  999999


Q ss_pred             CCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          145 GYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       145 g~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      |++........   .....++..|+|||.+.++.++++
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  201 (277)
T cd05032         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK  201 (277)
T ss_pred             ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcc
Confidence            99865433221   122345778999999988777664

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=2.6e-30  Score=184.22  Aligned_cols=175  Identities=35%  Similarity=0.578  Sum_probs=153.3

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      .|++.+.||+|++|.+|++.+..++..+++|.+..... ..+.+.+|+..+..++|++++++.+.+...+..++++|+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            48899999999999999999998899999999876543 34678899999999999999999999999999999999999


Q ss_pred             CCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCccc
Q 030211           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV  160 (181)
Q Consensus        82 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~  160 (181)
                      +++|.+++... ..+++..+..++.|++.++.+||++|++|+||+|+||+++++.  .++|+|||.+.............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG--EVKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC--eEEEeecccccccccccccccee
Confidence            99999988765 5799999999999999999999999999999999999997654  49999999987655544344567


Q ss_pred             CCCCccCcccccCCccCCC
Q 030211          161 GTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       161 ~~~~~~aPE~~~~~~~~~~  179 (181)
                      ++..|+|||.+.....+.+
T Consensus       159 ~~~~~~~PE~~~~~~~~~~  177 (253)
T cd05122         159 GTPYWMAPEVINGKPYDYK  177 (253)
T ss_pred             cCCcccCHHHHcCCCCCcc
Confidence            8899999999987765543

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=1.5e-30  Score=191.77  Aligned_cols=176  Identities=26%  Similarity=0.327  Sum_probs=142.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-------cCCcEEEEEEcccccc--ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-------ETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-------~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~   71 (181)
                      ++|.+.+.||+|++|.||++.+.       .....+++|.+.....  ....+..|+.+++.+ +|||++++++++.+.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            57999999999999999999863       2345689998775332  234677899999888 6999999999999999


Q ss_pred             eEEEEEeecCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC
Q 030211           72 HLAIVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~  135 (181)
                      ..++++||+++++|.+++...                ..+++..+..++.|++.||.+||++|++|+||+|+||++++++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence            999999999999999888653                2478889999999999999999999999999999999997555


Q ss_pred             CCcEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          136 APRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       136 ~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                        .++|+|||.++.......   .....++..|+|||.+.++.++.+
T Consensus       172 --~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  216 (314)
T cd05099         172 --VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ  216 (314)
T ss_pred             --cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc
Confidence              499999999875432221   111223467999999988877665

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=1.3e-30  Score=187.23  Aligned_cols=174  Identities=26%  Similarity=0.368  Sum_probs=145.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      +.|++.+.||+|++|.||+|...+ ++.+++|.+.........+.+|+.+++.++|+|++++++++. .+..+++||++.
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            579999999999999999998764 678999998876655678889999999999999999998874 457899999999


Q ss_pred             CCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--CC
Q 030211           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PK  157 (181)
Q Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--~~  157 (181)
                      +++|.+.+...  ..++...+..++.|++.+|++||+.|++|+||+|+||+++++..  ++|+|||.+........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05067          84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTARE  161 (260)
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCccccc
Confidence            99999887543  36889999999999999999999999999999999999976555  99999999865432221  12


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...++..|+|||++....++.+
T Consensus       162 ~~~~~~~y~~pe~~~~~~~~~~  183 (260)
T cd05067         162 GAKFPIKWTAPEAINYGTFTIK  183 (260)
T ss_pred             CCcccccccCHHHhccCCcCcc
Confidence            2345678999999987776654

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=3.9e-31  Score=196.71  Aligned_cols=177  Identities=23%  Similarity=0.356  Sum_probs=142.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEccccccc--cHHHHHHHHHHhhC-CCCCeeEEEEeEEcC-Ce
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRKI--DENVAREIINHRSL-RHPNIIRFKEVVLTP-TH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~-~~   72 (181)
                      ++|++.+.||+|+||.||+|.+.     .+++.|++|.+......  .+.+..|+.++..+ +|+|++++++++... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            58999999999999999999753     34578999988753322  24567789999888 799999999988654 56


Q ss_pred             EEEEEeecCCCChHHHHhhc------------------------------------------------------------
Q 030211           73 LAIVMEYAAGGELFDRICNA------------------------------------------------------------   92 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~------------------------------------------------------------   92 (181)
                      +++++||+++++|.+++...                                                            
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            88999999999998877432                                                            


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC---CCcccCCCCccCc
Q 030211           93 -GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAP  168 (181)
Q Consensus        93 -~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aP  168 (181)
                       ..+++..+..++.|++.||+|||++|++|+||+|+||+++++.  .++|+|||++........   .....++..|+||
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~--~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC--cEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence             2578899999999999999999999999999999999997554  499999999875433221   1223456789999


Q ss_pred             ccccCCccCCCC
Q 030211          169 EVLSRREYDGKQ  180 (181)
Q Consensus       169 E~~~~~~~~~~~  180 (181)
                      |++.+..+++++
T Consensus       245 E~~~~~~~~~~~  256 (337)
T cd05054         245 ESIFDKVYTTQS  256 (337)
T ss_pred             HHhcCCCCCccc
Confidence            999988887763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=6.2e-31  Score=188.57  Aligned_cols=163  Identities=19%  Similarity=0.197  Sum_probs=137.8

Q ss_pred             eeeCCccceeEEEEEEccCC----------cEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            8 KDLGAGNFGVARLLRHKETK----------ELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~----------~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +.||+|+||.||++.+..++          ..+++|.+.........+.+|+.+++.++|+|++++++++.. +..++++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46899999999999998766          357888776554435778899999999999999999999988 7789999


Q ss_pred             eecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCC-----CcEEEeecCCccccc
Q 030211           78 EYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA-----PRLKICDFGYSKSSV  151 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~-----~~v~l~dfg~a~~~~  151 (181)
                      ||+++++|.+++.... .++...+..++.|++.||.+||++|++|+||+|+||+++.+..     ..++|+|||++....
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~  159 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL  159 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence            9999999999887665 7899999999999999999999999999999999999975552     159999999987543


Q ss_pred             CCCCCCcccCCCCccCcccccCC
Q 030211          152 LHSRPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~  174 (181)
                      .   .....++..|+|||++...
T Consensus       160 ~---~~~~~~~~~y~aPE~~~~~  179 (259)
T cd05037         160 S---REERVERIPWIAPECIRNG  179 (259)
T ss_pred             c---ccccccCCCccChhhhcCC
Confidence            3   2334567789999998876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-31  Score=207.54  Aligned_cols=176  Identities=29%  Similarity=0.445  Sum_probs=145.6

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc-cccHHHHHHHHHHhhCC-CCCeeEEEEeEE-c---C---CeE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLR-HPNIIRFKEVVL-T---P---THL   73 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~-~---~---~~~   73 (181)
                      +++|.+.|.+|||+.||.|.+...+..+|+|++.... ...+.+.+|+.+++++. |+|||.+++... .   .   -++
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            5788999999999999999999887999999886553 34578999999999996 999999999422 1   1   257


Q ss_pred             EEEEeecCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           74 AIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~g--i~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      +++||||+++.|.++|..  +..|++.+++.|+++++.|+.+||..+  |||||||-+|||+..++.  .||+|||.|..
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSatt  195 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSATT  195 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCccccccc
Confidence            899999999999999973  346999999999999999999999998  999999999999976665  99999999875


Q ss_pred             ccCCC-CCC---------cccCCCCccCccccc---CCccCCCC
Q 030211          150 SVLHS-RPK---------STVGTPAYIAPEVLS---RREYDGKQ  180 (181)
Q Consensus       150 ~~~~~-~~~---------~~~~~~~~~aPE~~~---~~~~~~~~  180 (181)
                      ..... ...         ....|+.|.|||++-   +.++++|+
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKs  239 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKS  239 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchh
Confidence            43333 211         124799999999974   67777664

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=1.4e-30  Score=186.55  Aligned_cols=175  Identities=33%  Similarity=0.582  Sum_probs=148.8

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +|++.+.||+|++|.+|.+.+..+++.+++|.+....   ...+.+.+|+..++.++|+|++++.+.+.+.+..++++|+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            6999999999999999999999899999999886432   2235788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-C
Q 030211           80 AAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-P  156 (181)
Q Consensus        80 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~  156 (181)
                      +.+++|.+.+....  .+++..+..++.|++.++.+||++|++|+||+|+||+++++..  ++|+|||.+........ .
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~  158 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA  158 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence            99999998886543  5789999999999999999999999999999999999976554  99999998865433222 2


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+++.|+|||+..++.++.+
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~  181 (256)
T cd08218         159 RTCIGTPYYLSPEICENRPYNNK  181 (256)
T ss_pred             hhccCCccccCHHHhCCCCCCCc
Confidence            23457889999999988776654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=8.4e-31  Score=191.32  Aligned_cols=172  Identities=35%  Similarity=0.475  Sum_probs=144.3

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcC--CeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTP--THLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~   75 (181)
                      +++|++.+.||+|++|.||+|.+..+++.+++|.++.....   ...+.+|+.++..++|||++++.+++...  +..++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            46899999999999999999999988999999998754322   23567899999999999999999998877  88999


Q ss_pred             EEeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-
Q 030211           76 VMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-  153 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-  153 (181)
                      ++||+.+ +|.+.+.... .+++..+..++.|++.||++||++|++|+||+|+||++++++  .++|+|||.+...... 
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG--ILKICDFGLAREYGSPL  160 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC--cEEEeecCceeeccCCc
Confidence            9999975 8888776544 589999999999999999999999999999999999997655  4999999998755433 


Q ss_pred             CCCCcccCCCCccCcccccCCc
Q 030211          154 SRPKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~  175 (181)
                      .......+++.|+|||.+.+..
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~  182 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAK  182 (293)
T ss_pred             cccccccccccccCchhhcCCc
Confidence            2233345788999999986543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=1.2e-30  Score=186.92  Aligned_cols=174  Identities=32%  Similarity=0.402  Sum_probs=147.0

Q ss_pred             ceeeeeeCCccceeEEEEEEccCC----cEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            4 YELVKDLGAGNFGVARLLRHKETK----ELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~----~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +++.+.||+|++|.||++.+...+    ..+++|.+.....  ..+.+..|+..+..+.|++++++++.+.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            467899999999999999998766    8899999876543  3467888999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           78 EYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      |++++++|.+.+.....  +++..+..++.|++.++.+||+.|++|+||+|+||+++++.  .++|+|||++........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC--eEEEcccCCceecccccc
Confidence            99999999998876554  89999999999999999999999999999999999997655  499999999875543322


Q ss_pred             CC--cccCCCCccCcccccCCccCCC
Q 030211          156 PK--STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~--~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..  ...+++.|+|||.+.+..++.+
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~  184 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSK  184 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcc
Confidence            22  1236688999999977666554

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.97  E-value=1.2e-30  Score=190.49  Aligned_cols=176  Identities=27%  Similarity=0.366  Sum_probs=146.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      .+|.+.+.||+|++|.||++.+.     .++..+++|.+...... .+.+.+|+..++.++|+|++++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            57899999999999999999864     24556888887654332 3568889999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcE
Q 030211           76 VMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL  139 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v  139 (181)
                      +|||+++++|.+++..+.                .+++..++.++.|++.|+++||++|++|+||+|+||+++++.  .+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~--~~  162 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL--LV  162 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--cE
Confidence            999999999999886542                378899999999999999999999999999999999997655  49


Q ss_pred             EEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          140 KICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       140 ~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +|+|||.+........   .....++..|+|||.+....++++
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  205 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE  205 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch
Confidence            9999999875433221   223446788999999988777664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-32  Score=205.38  Aligned_cols=167  Identities=34%  Similarity=0.454  Sum_probs=152.0

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCC
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (181)
                      ..-++=+|+|+.|-||+++.+  +..||||.++.      ....+++-|++++|+||+.+.+++.....++++||||..+
T Consensus       126 IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhhhhccCcccceeeeecc--CceehhHHHhh------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            344567899999999999987  67899997654      3346788899999999999999999999999999999999


Q ss_pred             ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccCCC
Q 030211           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP  163 (181)
Q Consensus        84 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~  163 (181)
                      .|...+....+++......+..+|+.++.|||.+.|||+|||.-||+|..+..  |||.|||.++.......+.++.||.
T Consensus       198 qL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGTV  275 (904)
T KOG4721|consen  198 QLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGTV  275 (904)
T ss_pred             cHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhhH
Confidence            99999999999999999999999999999999999999999999999964444  9999999999888889999999999


Q ss_pred             CccCcccccCCccCCCC
Q 030211          164 AYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       164 ~~~aPE~~~~~~~~~~~  180 (181)
                      .|||||+|++.+.+.|+
T Consensus       276 aWMAPEvIrnePcsEKV  292 (904)
T KOG4721|consen  276 AWMAPEVIRNEPCSEKV  292 (904)
T ss_pred             hhhCHHHhhcCCccccc
Confidence            99999999999999886

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=4.1e-31  Score=192.18  Aligned_cols=171  Identities=33%  Similarity=0.527  Sum_probs=145.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+.....   ..+.+.+|+.++..++|||++++++++...+..++++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            579999999999999999999998899999998865432   23567789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-CC
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~~  157 (181)
                      |++++++.........+++..+..++.|++.++.+||+.|++|+|++|+||+++++..  ++|+|||++........ ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYT  158 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccC
Confidence            9998888776655557899999999999999999999999999999999999976554  99999999875433322 22


Q ss_pred             cccCCCCccCcccccCC
Q 030211          158 STVGTPAYIAPEVLSRR  174 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~  174 (181)
                      ...++..|+|||++.+.
T Consensus       159 ~~~~~~~y~aPE~~~~~  175 (286)
T cd07846         159 DYVATRWYRAPELLVGD  175 (286)
T ss_pred             cccceeeccCcHHhccc
Confidence            34578899999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=1.5e-30  Score=188.78  Aligned_cols=175  Identities=22%  Similarity=0.343  Sum_probs=142.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCc----EEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKE----LVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~----~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|++.+.||+|++|+||+|.+..++.    .||+|.+.....  ....+.+|...+..+.|+|++++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            578999999999999999999876665    479998864322  235677888899999999999999988754 5778


Q ss_pred             EEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +++++++++|.+.+..+ ..+++..+..++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||++.......
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~--~~kL~dfG~~~~~~~~~  163 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN--HVKITDFGLARLLDIDE  163 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC--cEEECCCCceeeccccc
Confidence            99999999999988664 4689999999999999999999999999999999999996555  49999999987554322


Q ss_pred             CC---CcccCCCCccCcccccCCccCCC
Q 030211          155 RP---KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~---~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..   ....+++.|+|||.+.+..++.+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~  191 (279)
T cd05109         164 TEYHADGGKVPIKWMALESILHRRFTHQ  191 (279)
T ss_pred             ceeecCCCccchhhCCHHHhccCCCCch
Confidence            21   12234678999999988777654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.2e-34  Score=210.62  Aligned_cols=176  Identities=29%  Similarity=0.468  Sum_probs=158.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++.+.+..+|-|+||.|=++..++....+|+|++++..    +..+.+..|-.++...+.|.||+++..|.++.++|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45667788999999999999887666568999987643    33456788889999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      |.|-||.++..+.+.+.|++.+++.++.+++.|++|||++||+.+||||+|.+++.++.  +||+|||+|+.........
T Consensus       500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KTw  577 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKTW  577 (732)
T ss_pred             HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCcee
Confidence            99999999999999999999999999999999999999999999999999999975555  9999999999999999999


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +++|||+|.|||++.+...+..
T Consensus       578 TFcGTpEYVAPEIILnKGHD~a  599 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHDRA  599 (732)
T ss_pred             eecCCcccccchhhhccCcchh
Confidence            9999999999999998876543

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=1.9e-30  Score=186.52  Aligned_cols=173  Identities=25%  Similarity=0.324  Sum_probs=143.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|++|.||++.+..+ ..+++|.+.......+.+.+|+.+++.++|++++++++++. .+..+++||++.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            6799999999999999999988754 45899988765555567889999999999999999998875 456889999999


Q ss_pred             CCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--CC
Q 030211           82 GGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PK  157 (181)
Q Consensus        82 ~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--~~  157 (181)
                      +++|.+++....  .+++..+..++.|++.||.+||+.|++|+||+|+||+++++..  ++|+|||.+........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCcccccC
Confidence            999998886533  4789999999999999999999999999999999999976554  99999999865432221  12


Q ss_pred             cccCCCCccCcccccCCccCC
Q 030211          158 STVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ...++..|+|||.+.+..++.
T Consensus       162 ~~~~~~~y~~Pe~~~~~~~~~  182 (260)
T cd05069         162 GAKFPIKWTAPEAALYGRFTI  182 (260)
T ss_pred             CCccchhhCCHHHhccCCcCh
Confidence            234567899999988776654

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=2.4e-30  Score=187.92  Aligned_cols=169  Identities=26%  Similarity=0.394  Sum_probs=138.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc--cHHHHHHHHH-HhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIIN-HRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~-~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+......  ...+..|+.. ++...|||++++++.+..++..++++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            5799999999999999999999999999999998764322  2344445554 566789999999999999999999999


Q ss_pred             ecCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           79 YAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        79 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~-gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      |++ ++|.+++..    ...+++..++.++.|++.++.+||++ +++|+||+|+||+++++..  ++|+|||.+......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence            996 567665533    34689999999999999999999997 9999999999999976554  999999998754333


Q ss_pred             CCCCcccCCCCccCcccccC
Q 030211          154 SRPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~  173 (181)
                      .......++..|+|||.+.+
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~  177 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINP  177 (283)
T ss_pred             cccccccCCccccChhhcCC
Confidence            33333567889999998864

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=5.9e-31  Score=191.47  Aligned_cols=171  Identities=27%  Similarity=0.432  Sum_probs=145.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++++.||+|++|.||++.+..+++.+++|.+.....  ....+.+|+.+++.++|+|++++++.+..++..++++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            579999999999999999999998899999998865322  235678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           80 AAGGELFDRICNA---GRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        80 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      +++++|.+++...   ..+++..+..++.|++.++.+||+ .|++|+||+|+||++++++  .++|+|||.+..... ..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~-~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVSGNLVA-SL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC--CEEEeecCCcccccC-Cc
Confidence            9999998887653   378999999999999999999997 5999999999999997644  599999998864322 22


Q ss_pred             CCcccCCCCccCcccccCCc
Q 030211          156 PKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~  175 (181)
                      .....+++.|+|||.+.+..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~  177 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGG  177 (286)
T ss_pred             cccCCCccCccCcchhcCCC
Confidence            33345788999999986544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.1e-30  Score=188.00  Aligned_cols=175  Identities=23%  Similarity=0.355  Sum_probs=144.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCc----EEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKE----LVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~----~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|++.+.||+|+||.||++.++.++.    .+++|.+.....  ....+.+|+..++.++|+|++++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            579999999999999999999876554    588998765432  23567889999999999999999999887 78899


Q ss_pred             EEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      ++||+++++|.+.+..+ ..+++..+..++.|++.|+++||++|++|+||+|+||+++++.  .++|+|||.+.......
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLDVDE  163 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC--eEEECCCcccccccCcc
Confidence            99999999999988764 4689999999999999999999999999999999999997555  49999999987554332


Q ss_pred             CCCc---ccCCCCccCcccccCCccCCC
Q 030211          155 RPKS---TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~---~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....   ..++..|+|||.+....++.+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~  191 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYTHK  191 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcCch
Confidence            2211   123567999999987766543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-30  Score=188.36  Aligned_cols=171  Identities=33%  Similarity=0.534  Sum_probs=145.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCC------eEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPT------HLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~------~~~   74 (181)
                      ++|++.+.||+|++|.+|+|.+..+++.+++|++.......+.+.+|+.+++.+ .|+|++++++++.+..      .++
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW   85 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence            689999999999999999999988899999999887655557788999999988 6999999999997644      489


Q ss_pred             EEEeecCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc
Q 030211           75 IVMEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS  150 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~  150 (181)
                      ++|||+++++|.+.+..    +..+++..+..++.|++.||.+||++|++|+||+|+||++++++  .++|+|||.+...
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~--~~~l~d~~~~~~~  163 (275)
T cd06608          86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA--EVKLVDFGVSAQL  163 (275)
T ss_pred             EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC--eEEECCCccceec
Confidence            99999999999887754    35789999999999999999999999999999999999997554  4999999988654


Q ss_pred             cCC-CCCCcccCCCCccCcccccCC
Q 030211          151 VLH-SRPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       151 ~~~-~~~~~~~~~~~~~aPE~~~~~  174 (181)
                      ... .......++..|+|||++...
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~  188 (275)
T cd06608         164 DSTLGRRNTFIGTPYWMAPEVIACD  188 (275)
T ss_pred             ccchhhhcCccccccccCHhHhccc
Confidence            322 223345688899999998643

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=1.9e-30  Score=189.34  Aligned_cols=176  Identities=27%  Similarity=0.354  Sum_probs=143.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC-----CcEEEEEEcccccc--ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET-----KELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~-----~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~   73 (181)
                      ++|++.+.||+|++|.||++.+...     ...+++|.+.....  ....+.+|+.++..+ +|+|++++++++...+.+
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            5799999999999999999997643     36789998875322  224577899999888 799999999999999999


Q ss_pred             EEEEeecCCCChHHHHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCC
Q 030211           74 AIVMEYAAGGELFDRICN----------------AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP  137 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~----------------~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~  137 (181)
                      +++|||+++++|.+++..                ...+++..+..++.|++.|+.|||++|++|+||+|+||+++++.  
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~--  169 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH--  169 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC--
Confidence            999999999999988853                23588899999999999999999999999999999999997554  


Q ss_pred             cEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          138 RLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       138 ~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .++|+|||.+........   .....++..|+|||.+.+..++.+
T Consensus       170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  214 (293)
T cd05053         170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ  214 (293)
T ss_pred             eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc
Confidence            599999999875433221   111234567999999887776654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=1.5e-30  Score=190.10  Aligned_cols=175  Identities=31%  Similarity=0.500  Sum_probs=149.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc-cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+.... ...+.+.+|+.+++.++|||++++++.+..++..++++||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            68999999999999999999998889999999986432 22456788999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-CCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~~~~  159 (181)
                      ++++|.+++.+ ..+++..+..++.|++.++.+||++|++|+||+|+||+++.++  .++|+|||.+....+... ....
T Consensus        99 ~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~--~~kL~dfg~~~~~~~~~~~~~~~  175 (293)
T cd06647          99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTM  175 (293)
T ss_pred             CCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC--CEEEccCcceecccccccccccc
Confidence            99999988754 3578999999999999999999999999999999999997655  499999998765443332 2234


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+++.|+|||.+.+..++++
T Consensus       176 ~~~~~y~~PE~~~~~~~~~~  195 (293)
T cd06647         176 VGTPYWMAPEVVTRKAYGPK  195 (293)
T ss_pred             cCChhhcCchhhccCCCCch
Confidence            57889999999988776654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.97  E-value=1.6e-30  Score=190.80  Aligned_cols=176  Identities=24%  Similarity=0.329  Sum_probs=144.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEcccccc--ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~   73 (181)
                      ++|.+.+.||+|+||.||++.+.     .++..+++|.+.....  ..+.+.+|+.+++.+ +|+|++++++.+...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            57899999999999999999852     3455799998875432  235688899999999 799999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           74 AIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      +++|||+++++|.+++....  .+++.++..++.|++.+|.+||++|++|+||+|+||+++++.  .++|+|||.+....
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~dfg~~~~~~  192 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK--IVKICDFGLARDIM  192 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC--eEEECCCccccccc
Confidence            99999999999999886543  389999999999999999999999999999999999996544  59999999987543


Q ss_pred             CCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          152 LHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       152 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....   .....++..|+|||.+..+.++++
T Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  223 (302)
T cd05055         193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFE  223 (302)
T ss_pred             CCCceeecCCCCcccccCCHhhhccCCCCcH
Confidence            3221   112345678999999988777654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=5.3e-31  Score=191.46  Aligned_cols=176  Identities=19%  Similarity=0.308  Sum_probs=144.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc-----CCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      .+|++.+.||+|+||.||++.+..     .++.+++|.+......  .+.+.+|..++..++|||++++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            578999999999999999998753     3578999998754322  356788999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCc
Q 030211           75 IVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPR  138 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~  138 (181)
                      +++||+.+++|.+++...                ..++...+..++.|++.||.+||++|++|+||||+||+++++..  
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN--  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc--
Confidence            999999999998887431                24788889999999999999999999999999999999975554  


Q ss_pred             EEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          139 LKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       139 v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ++|+|||++........   .....+++.|+|||.+.++.++++
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID  206 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc
Confidence            99999999865432221   122345678999999988777664

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=2.6e-30  Score=185.22  Aligned_cols=174  Identities=27%  Similarity=0.425  Sum_probs=146.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|++|.||++.+.. ++.+++|.+.........+.+|+.+++.++||+++++++++......++++||+.
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            578999999999999999998864 6679999887655555678999999999999999999999999999999999999


Q ss_pred             CCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--CCc
Q 030211           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PKS  158 (181)
Q Consensus        82 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--~~~  158 (181)
                      +++|.+++... ..++++.++.++.|++.++++||+.|++|+||+|+||+++++.  .++|+|||.+........  ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDFGMTRFVLDDQYTSSTG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC--eEEECCCcceeecccCcccccCC
Confidence            99999888654 4689999999999999999999999999999999999997554  499999998864432211  112


Q ss_pred             ccCCCCccCcccccCCccCC
Q 030211          159 TVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ...+..|+|||.+.++.++.
T Consensus       161 ~~~~~~~~aPe~~~~~~~~~  180 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYSS  180 (256)
T ss_pred             CccchhhcCHhHhccCCcCh
Confidence            33457899999998776654

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=1.6e-30  Score=190.16  Aligned_cols=176  Identities=26%  Similarity=0.400  Sum_probs=143.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc----------------CCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE----------------TKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRF   63 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~----------------~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~   63 (181)
                      ++|++.+.||+|+||.||++.+..                ++..+++|.+.....  ....+.+|+..++.++|+|++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            579999999999999999986542                244689998875432  23568889999999999999999


Q ss_pred             EEeEEcCCeEEEEEeecCCCChHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEec
Q 030211           64 KEVVLTPTHLAIVMEYAAGGELFDRICNAG-----------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD  132 (181)
Q Consensus        64 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~  132 (181)
                      ++++...+..+++|||+++++|.+++....           .+++.++..++.|++.|+++||++|++|+||+|+||+++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~  164 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence            999999999999999999999998886542           366778999999999999999999999999999999997


Q ss_pred             cCCCCcEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          133 GSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       133 ~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.  .++|+|||++........   .....+++.|+|||+...+.++.+
T Consensus       165 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~  212 (296)
T cd05095         165 KNY--TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA  212 (296)
T ss_pred             CCC--CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccch
Confidence            554  499999999875433221   112234678999999888877764

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=4.2e-30  Score=187.72  Aligned_cols=172  Identities=31%  Similarity=0.505  Sum_probs=142.4

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +++|++.+.||+|++|.||++.+..+++.+++|.+.....   ..+.+.+|+.+++.++|+|++++++++.+++..+++|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            5899999999999999999999998899999998865422   2356778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-
Q 030211           78 EYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-  154 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-  154 (181)
                      ||+++ ++.+.+....  .+++..++.++.|++.||++||++|++|+||+|+||+++++. ..++|+|||++....... 
T Consensus        81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~-~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT-NALKLADFGLARAFGIPVR  158 (294)
T ss_pred             ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC-CEEEEcccccccccCCCcc
Confidence            99964 7776665443  357888999999999999999999999999999999997432 358999999986543222 


Q ss_pred             CCCcccCCCCccCcccccCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~  174 (181)
                      ......+++.|+|||++.+.
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~  178 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGS  178 (294)
T ss_pred             ccccCceeecccCHHHHhCC
Confidence            22234568899999998653

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=1.4e-30  Score=191.16  Aligned_cols=176  Identities=26%  Similarity=0.334  Sum_probs=143.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-------cCCcEEEEEEccccc--cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-------ETKELVAVKYIERGR--KIDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-------~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~   71 (181)
                      ++|++.+.||+|+||.||.+.+.       ..+..+++|.+....  ...+.+.+|+.+++.+ +|||++++++.+...+
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            57899999999999999999752       234578999886532  2235688899999998 8999999999999999


Q ss_pred             eEEEEEeecCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC
Q 030211           72 HLAIVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~  135 (181)
                      ..+++|||+.+++|.+++.+.                ..++...+..++.|++.||.|||++|++|+||+|+||++++++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~  174 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN  174 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence            999999999999999988653                2467788999999999999999999999999999999997554


Q ss_pred             CCcEEEeecCCcccccCCCCC---CcccCCCCccCcccccCCccCCC
Q 030211          136 APRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       136 ~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                        .++|+|||.+.........   ....+++.|+|||++.+..++.+
T Consensus       175 --~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  219 (304)
T cd05101         175 --VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ  219 (304)
T ss_pred             --cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch
Confidence              5999999998765433222   12234578999999988777654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=3.2e-30  Score=184.39  Aligned_cols=175  Identities=36%  Similarity=0.519  Sum_probs=153.0

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcC--CeEEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THLAIVM   77 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~   77 (181)
                      +|+..+.||+|++|.+|++.+..+++.+++|++....   ...+.+.+|+..++.+.|++++++++.+.+.  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            5889999999999999999999889999999987654   2356788899999999999999999999988  8899999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--  155 (181)
                      |++.+++|.+++.+...+++..+..++.|++.++.+||+.|++|+||+|+||++++++  .++|+|||.+........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEcccccEEecccccccc
Confidence            9999999999988777899999999999999999999999999999999999997644  599999999876554443  


Q ss_pred             -CCcccCCCCccCcccccCCccCCC
Q 030211          156 -PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 -~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                       .....++..|+|||.+.....+.+
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~  183 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRA  183 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCch
Confidence             444578899999999887765443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=1.8e-30  Score=188.27  Aligned_cols=175  Identities=30%  Similarity=0.497  Sum_probs=148.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +.|+..+.||.|++|.||.+.+..++..+++|.+....  .....+.+|+.+++.+.|++++++++.+.+++..+++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            36888999999999999999999889999999887543  2235678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-CCc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~~~  158 (181)
                      +++++|.+.+.. .++++..+..++.|++.++++||+++++|+||+|+||+++++..  ++|+|||.+........ ...
T Consensus        84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCcccccc
Confidence            999999988754 57899999999999999999999999999999999999976554  99999999865433322 223


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..++..|+|||++.+..++.+
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~  181 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSK  181 (277)
T ss_pred             ccCcccccCHhHhccCCCccH
Confidence            457888999999987776654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=2.4e-30  Score=187.79  Aligned_cols=175  Identities=21%  Similarity=0.303  Sum_probs=141.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCc----EEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKE----LVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~----~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|++.+.||+|+||.||++.+..++.    .+++|.+.....  ....+..++..+..+.|||++++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            578999999999999999999876665    477777653321  2245666777888999999999999875 445778


Q ss_pred             EEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      ++|++++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++++.  .++|+|||.+.......
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~--~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS--IVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEEcCCccceeccCCC
Confidence            99999999999998654 4789999999999999999999999999999999999997554  59999999987544332


Q ss_pred             CC---CcccCCCCccCcccccCCccCCC
Q 030211          155 RP---KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~---~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..   ....++..|+|||.+.++.++.+
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~  191 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYTHQ  191 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcCch
Confidence            21   22345678999999988877754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=2.3e-30  Score=185.54  Aligned_cols=172  Identities=27%  Similarity=0.406  Sum_probs=142.4

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEE-cCCeEEEEEee
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVL-TPTHLAIVMEY   79 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-~~~~~~~v~e~   79 (181)
                      +++|++.+.||+|++|.||++...  +..+++|.+.... ..+.+.+|+.+++.++|++++++++++. ..+..++++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            367999999999999999999765  7779999876432 3457889999999999999999999764 45678999999


Q ss_pred             cCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           80 AAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        80 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      +++++|.+++.+..  .+++.....++.|++.+|.+||++|++|+||+|+||++++++  .++|+|||++.......  .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~~--~  157 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASSTQ--D  157 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC--cEEecCCccceeccccC--C
Confidence            99999999886543  488999999999999999999999999999999999997555  49999999986433222  2


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+..|+|||++.+..++.+
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~  179 (256)
T cd05082         158 TGKLPVKWTAPEALREKKFSTK  179 (256)
T ss_pred             CCccceeecCHHHHccCCCCch
Confidence            2344568999999988777654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=3e-30  Score=185.41  Aligned_cols=174  Identities=26%  Similarity=0.354  Sum_probs=144.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|++|.||++.+.. +..+++|.+.......+.+.+|+.+++.++|++++++.+.+.+ ...+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            689999999999999999998664 5569999887655445678889999999999999999999887 77899999999


Q ss_pred             CCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--CC
Q 030211           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PK  157 (181)
Q Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--~~  157 (181)
                      +++|.+++.+.  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++++.  .++|+|||.+........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~  161 (260)
T cd05073          84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTARE  161 (260)
T ss_pred             CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCCcceeeccCCCccccc
Confidence            99999988653  3578889999999999999999999999999999999997555  499999998864432221  12


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...++..|+|||++..+.++.+
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~  183 (260)
T cd05073         162 GAKFPIKWTAPEAINFGSFTIK  183 (260)
T ss_pred             CCcccccccCHhHhccCCcCcc
Confidence            2334577999999988776654

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=3e-30  Score=184.59  Aligned_cols=175  Identities=37%  Similarity=0.591  Sum_probs=150.8

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +|++.+.||+|++|.+|++.+..++..+++|.+.....   ....+.+|+..++.++|+|++++.+.+...+..++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            68999999999999999999998899999999876432   345688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-
Q 030211           80 AAGGELFDRICNA----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-  154 (181)
Q Consensus        80 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-  154 (181)
                      +++++|.+.+...    ..++...+..++.+++.++.+||++|++|+||+|+||+++++..  ++|+|||.+....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVD  158 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcc
Confidence            9999999888653    67999999999999999999999999999999999999976554  9999999986543333 


Q ss_pred             CCCcccCCCCccCcccccCCccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ......+++.|+|||...+..++.+
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~  183 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYK  183 (258)
T ss_pred             eecceeeeecccChhHhccCCCCcc
Confidence            2333567889999999887776554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=2.5e-30  Score=188.22  Aligned_cols=176  Identities=32%  Similarity=0.563  Sum_probs=152.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      +.|++.+.+++|++|.+|++.+..++..+++|.+.......+.+.+|+..++.++|+|++++++.+...+..++++||++
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   98 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD   98 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence            46888999999999999999999889999999987654445678889999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-CCcc
Q 030211           82 GGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKST  159 (181)
Q Consensus        82 ~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~~~~  159 (181)
                      +++|.+++.... .++...+..++.|++.+|.+||+.|++|+||+|+||++++++.  ++|+|||.+........ ....
T Consensus        99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~  176 (286)
T cd06614          99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKRNSV  176 (286)
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhhhccc
Confidence            999999998776 8999999999999999999999999999999999999975554  99999998764432221 2233


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+++.|+|||.+.+..++.+
T Consensus       177 ~~~~~y~~PE~~~~~~~~~~  196 (286)
T cd06614         177 VGTPYWMAPEVIKRKDYGPK  196 (286)
T ss_pred             cCCcccCCHhHhcCCCCCCc
Confidence            57789999999988877665

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-32  Score=190.36  Aligned_cols=172  Identities=40%  Similarity=0.565  Sum_probs=146.8

Q ss_pred             ccceee-eeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHh-hCCCCCeeEEEEeEEcC----CeEEE
Q 030211            2 EKYELV-KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR-SLRHPNIIRFKEVVLTP----THLAI   75 (181)
Q Consensus         2 ~~y~~~-~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~-~~~~~~i~~~~~~~~~~----~~~~~   75 (181)
                      ++|++. ++||-|-.|.|-.+.++.+|..+|+|++..+++.    .+|++++- ...|+|||.++++|++.    ..+.+
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KA----RrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi  136 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKA----RREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI  136 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHH----HhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence            345543 5679999999999999999999999999876543    46666654 34899999999999864    46889


Q ss_pred             EEeecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEec-cCCCCcEEEeecCCcccccC
Q 030211           76 VMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD-GSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~-~~~~~~v~l~dfg~a~~~~~  152 (181)
                      |||.++||.|.+.+..++  .|++..+..|+.||..|+.|||+.+|+||||||+|+++. ...+..+||+|||+|+....
T Consensus       137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            999999999999997766  599999999999999999999999999999999999994 33345799999999998777


Q ss_pred             CCCCCcccCCCCccCcccccCCccC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYD  177 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~  177 (181)
                      .....+.+-||.|.|||++....|+
T Consensus       217 ~~~L~TPc~TPyYvaPevlg~eKyd  241 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAPEVLGPEKYD  241 (400)
T ss_pred             CccccCCcccccccCHHHhCchhcC
Confidence            7777778889999999999988765

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=1.6e-30  Score=188.82  Aligned_cols=176  Identities=28%  Similarity=0.387  Sum_probs=144.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      .+|++.++||+|+||.||++...     .++..+++|.+..... ....+.+|+..++.++|+|++++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            57899999999999999999743     3466788998765432 23578889999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEE
Q 030211           76 VMEYAAGGELFDRICNAG---------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLK  140 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~  140 (181)
                      ++||+++++|.+++....               .+++..+..++.|++.|+.+||++|++|+||+|+||+++++..  ++
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~--~k  162 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV--VK  162 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC--EE
Confidence            999999999998886542               4788999999999999999999999999999999999976554  99


Q ss_pred             EeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          141 ICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       141 l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      |+|||++........   .....+++.|+|||.+.+..++.+
T Consensus       163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  204 (280)
T cd05092         163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE  204 (280)
T ss_pred             ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch
Confidence            999999864432221   122334678999999988877665

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=2.4e-30  Score=186.61  Aligned_cols=176  Identities=26%  Similarity=0.339  Sum_probs=145.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCc---EEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKE---LVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~---~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|+..+.||+|++|.||+|.+..++.   .+++|.+....  ...+.+..|+.++..++|+|++++.+++...+..+++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            578999999999999999999875554   68999886542  2235688899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      ||++++++|.+++... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++++.  .++|+|||++........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL--ECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC--cEEECCCccceecccccc
Confidence            9999999999888654 4789999999999999999999999999999999999997555  499999999865433222


Q ss_pred             CCc----ccCCCCccCcccccCCccCCC
Q 030211          156 PKS----TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~----~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...    ...++.|+|||++.+..++.+
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~  190 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKFTSA  190 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCcChH
Confidence            111    123457999999987776654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=1.4e-30  Score=197.36  Aligned_cols=176  Identities=26%  Similarity=0.345  Sum_probs=143.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEccccccc--cHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRKI--DENVAREIINHRSLR-HPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~   73 (181)
                      ++|.+.+.||+|+||.||+|.+.     ..++.||+|++......  .+.+..|+.++..+. |||++++++++...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            46888999999999999999964     24567999999754322  246788999999997 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhcC------------------------------------------------------------
Q 030211           74 AIVMEYAAGGELFDRICNAG------------------------------------------------------------   93 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~------------------------------------------------------------   93 (181)
                      ++++||+++++|.+++..+.                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999988875421                                                            


Q ss_pred             --------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC
Q 030211           94 --------------------------------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (181)
Q Consensus        94 --------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~  135 (181)
                                                            .++...++.++.|++.||+|||++|++|+||+|+||+++++.
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~  276 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK  276 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence                                                  256667888999999999999999999999999999997544


Q ss_pred             CCcEEEeecCCcccccCCC---CCCcccCCCCccCcccccCCccCCC
Q 030211          136 APRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       136 ~~~v~l~dfg~a~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                        .++|+|||++.......   ......+++.|+|||.+.+..++++
T Consensus       277 --~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  321 (401)
T cd05107         277 --LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL  321 (401)
T ss_pred             --EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH
Confidence              59999999987543221   1223356788999999988877664

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=4.1e-31  Score=191.55  Aligned_cols=175  Identities=32%  Similarity=0.488  Sum_probs=148.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +.|+..+.||+|++|.||++.+..++..+++|.+....  ...+.+.+|+.+++.++|+|++++++.+..++..++++||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            35788899999999999999999889999999887433  2235688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-CCc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~~~  158 (181)
                      +++++|.+.+.. ..+++..+..++.|++.++.+||++|++|+||+|+||++++++.  ++|.|||++........ ...
T Consensus        84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhc
Confidence            999999887754 57899999999999999999999999999999999999976554  99999999865433222 222


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..++..|+|||.+.+..++.+
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~  181 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYDFK  181 (277)
T ss_pred             ccCcccccCHHHhCcCCCchh
Confidence            457889999999988776654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PHA02988 hypothetical protein; Provisional

Probab=99.97  E-value=2e-30  Score=188.62  Aligned_cols=166  Identities=17%  Similarity=0.165  Sum_probs=140.3

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEcccccccc----HHHHHHHHHHhhCCCCCeeEEEEeEEc----CCeEEEEEee
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKEVVLT----PTHLAIVMEY   79 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~~~~~~~~~i~~~~~~~~~----~~~~~~v~e~   79 (181)
                      ..|++|+++.||++..  +++.||+|.+.......    +.+.+|+.++.+++|||++++++++.+    ...++++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5689999999999988  48899999987654333    556799999999999999999999877    4578999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      +.+++|.+++.++..+++.....++.+++.++.+||+. +++|+||+|+||++++++  .++|+|||++......  ...
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~--~~kl~dfg~~~~~~~~--~~~  179 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY--KLKIICHGLEKILSSP--PFK  179 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC--cEEEcccchHhhhccc--ccc
Confidence            99999999998888899999999999999999999985 999999999999997655  4999999998654322  223


Q ss_pred             ccCCCCccCcccccC--CccCCC
Q 030211          159 TVGTPAYIAPEVLSR--REYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~--~~~~~~  179 (181)
                      ..+++.|+|||++.+  ..++.+
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k  202 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIK  202 (283)
T ss_pred             ccCcccccCHHHhhhccccccch
Confidence            467899999999976  556554

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-31  Score=198.48  Aligned_cols=176  Identities=36%  Similarity=0.620  Sum_probs=160.2

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      -|.+-+.||+|.|..|-+|++.=+|..||+|++.+-+..   ...+..|++.++.++|||||+++++.-..-.+|+++|+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            478889999999999999999989999999999875433   25688899999999999999999999989999999999


Q ss_pred             cCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           80 AAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      =.+++|.+++.++. -++++.+..++.||+.|+.|+|...++|+||||+|+++- ...+.|||.|||++-.+.++..-..
T Consensus        99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF-EKlGlVKLTDFGFSNkf~PG~kL~T  177 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF-EKLGLVKLTDFGFSNKFQPGKKLTT  177 (864)
T ss_pred             cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe-eecCceEeeeccccccCCCcchhhc
Confidence            88899999998876 699999999999999999999999999999999999875 2445699999999988999999999


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+|++.|-|||++.++.|+..
T Consensus       178 sCGSLAYSAPEILLGDsYDAP  198 (864)
T KOG4717|consen  178 SCGSLAYSAPEILLGDSYDAP  198 (864)
T ss_pred             ccchhhccCchhhhcCccCCc
Confidence            999999999999999999864

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.3e-31  Score=206.00  Aligned_cols=175  Identities=25%  Similarity=0.402  Sum_probs=134.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCc-EEEE------------------EEccccccccHHHHHHHHHHhhCCCCCeeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKE-LVAV------------------KYIERGRKIDENVAREIINHRSLRHPNIIR   62 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~-~v~~------------------K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~   62 (181)
                      ++|++.+.||+|+||.||++..+.... ..+.                  |.+.........+.+|+.++..++|+|+++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            589999999999999999987643221 1111                  212222222345778999999999999999


Q ss_pred             EEEeEEcCCeEEEEEeecCCCChHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCC
Q 030211           63 FKEVVLTPTHLAIVMEYAAGGELFDRICNA-----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP  137 (181)
Q Consensus        63 ~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~  137 (181)
                      +++++.+.+..+++++++.+ ++..++...     .......++.++.|++.||.|||++||+|+||||+||+++.++  
T Consensus       228 l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~--  304 (501)
T PHA03210        228 IEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG--  304 (501)
T ss_pred             EeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--
Confidence            99999999999999999854 666655432     1234567888999999999999999999999999999997555  


Q ss_pred             cEEEeecCCcccccCCCC--CCcccCCCCccCcccccCCccCCC
Q 030211          138 RLKICDFGYSKSSVLHSR--PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       138 ~v~l~dfg~a~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .++|+|||++........  .....|++.|+|||++.+..++.+
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  348 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI  348 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH
Confidence            499999999975533222  223578999999999998887654

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=1.7e-30  Score=192.56  Aligned_cols=173  Identities=27%  Similarity=0.446  Sum_probs=140.6

Q ss_pred             eeeeeeCCc--cceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            5 ELVKDLGAG--NFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         5 ~~~~~i~~g--~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++.++||+|  ++++||++.++.+++.||+|.+.....   ..+.+.+|+.+++.++|||++++++++..++..+++|||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            357889999  788999999999999999999875432   234677799999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--
Q 030211           80 AAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (181)
Q Consensus        80 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--  155 (181)
                      +++++|.+++..+  ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+.  .+++.||+.+......+.  
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~--~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC--cEEEcccchhhccccccccc
Confidence            9999999988653  3589999999999999999999999999999999999997555  499999976533221111  


Q ss_pred             ------CCcccCCCCccCcccccCC--ccCCC
Q 030211          156 ------PKSTVGTPAYIAPEVLSRR--EYDGK  179 (181)
Q Consensus       156 ------~~~~~~~~~~~aPE~~~~~--~~~~~  179 (181)
                            .....++..|+|||++.+.  .++++
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  190 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK  190 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCch
Confidence                  1122456789999999763  45544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=4e-30  Score=184.46  Aligned_cols=169  Identities=28%  Similarity=0.324  Sum_probs=140.2

Q ss_pred             eeeCCccceeEEEEEEccCC---cEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKETK---ELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~---~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|++|.||+|.....+   ..+++|.+.....  ..+.+.+|+.+++.+.|+|++++++++. .+..+++||++.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999876544   7899999876544  3457888999999999999999999875 5568999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc----
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS----  158 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~----  158 (181)
                      ++|.+++.++..+++..+..++.|++.++.+||+.|++|+||+|+||+++++..  ++|+|||.+...........    
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccC
Confidence            999999988778999999999999999999999999999999999999976554  99999999875533322111    


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..++..|+|||.+....++.+
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~  178 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSK  178 (257)
T ss_pred             ccccccccCHHHhcCCCCCcc
Confidence            123467999999988777654

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=3.9e-30  Score=185.67  Aligned_cols=170  Identities=34%  Similarity=0.532  Sum_probs=140.6

Q ss_pred             ccceeeeee--CCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHh-hCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDL--GAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR-SLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i--~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~-~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++.+.+  |+|+||.||++.++.++..+++|.+........    |..... ..+|+|++++++.+...+..+++||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            467777777  999999999999999999999999865422111    121222 2279999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      |+++++|.+++..+..++++.++.++.|++.++.+||+.|++|+||+|+||+++++. ..++|+|||.+....   ....
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~~l~dfg~~~~~~---~~~~  165 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK-DRIYLCDYGLCKIIG---TPSC  165 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC-CeEEEecCccceecC---CCcc
Confidence            999999999998777899999999999999999999999999999999999997554 259999999886432   2233


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..++..|+|||++.+..++++
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~  186 (267)
T PHA03390        166 YDGTLDYFSPEKIKGHNYDVS  186 (267)
T ss_pred             CCCCCcccChhhhcCCCCCch
Confidence            467899999999998887765

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=2.1e-30  Score=187.52  Aligned_cols=176  Identities=22%  Similarity=0.354  Sum_probs=145.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc-----CCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||.||++.++.     ..+.+++|.+......  .+.+.+|+.++..++|+|++++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            579999999999999999999753     3567899987654332  367889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecC
Q 030211           75 IVMEYAAGGELFDRICNAG---------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG  145 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg  145 (181)
                      ++|||+++++|.+++....         .+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.  ++++|||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~~  162 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLLS  162 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEcccc
Confidence            9999999999999887655         6899999999999999999999999999999999999976554  9999999


Q ss_pred             CcccccCCC--CCCcccCCCCccCcccccCCccCCC
Q 030211          146 YSKSSVLHS--RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       146 ~a~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+.......  ......++..|+|||.+.+..++++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~  198 (275)
T cd05046         163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTK  198 (275)
T ss_pred             cccccCcccccccCCceeEEeecChhhhccCCCCch
Confidence            876432211  1222345677999999887766543

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.97  E-value=1.1e-30  Score=194.68  Aligned_cols=176  Identities=24%  Similarity=0.353  Sum_probs=140.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEcccccc--ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcC-Ce
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTP-TH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~-~~   72 (181)
                      ++|++.+.||+|+||.||+|.+.     .+++.||+|.+.....  ....+.+|+.++..+ +|+|++++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            58999999999999999999853     4577899999875432  234677899999998 679999999987654 56


Q ss_pred             EEEEEeecCCCChHHHHhhc------------------------------------------------------------
Q 030211           73 LAIVMEYAAGGELFDRICNA------------------------------------------------------------   92 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~------------------------------------------------------------   92 (181)
                      .+++|||+++++|.+++...                                                            
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            88999999999998887532                                                            


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC---CCcccCC
Q 030211           93 -------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGT  162 (181)
Q Consensus        93 -------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~  162 (181)
                             ..++...+..++.|++.||+|||++|++|+||+|+||+++.+.  .++|+|||++........   .....++
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC--cEEEEecccccccccCcchhhcCCCCCC
Confidence                   1357778889999999999999999999999999999997555  499999999865422211   1122345


Q ss_pred             CCccCcccccCCccCCC
Q 030211          163 PAYIAPEVLSRREYDGK  179 (181)
Q Consensus       163 ~~~~aPE~~~~~~~~~~  179 (181)
                      +.|+|||.+.+..++.+
T Consensus       245 ~~y~aPE~~~~~~~~~~  261 (343)
T cd05103         245 LKWMAPETIFDRVYTIQ  261 (343)
T ss_pred             cceECcHHhcCCCCCch
Confidence            67999999988777654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=2.8e-30  Score=187.60  Aligned_cols=170  Identities=30%  Similarity=0.486  Sum_probs=142.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEeEEc------CCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLT------PTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~------~~~~~   74 (181)
                      ++|++.+.+|+|+||.||++.+..+++.+++|++.........+..|+.+++.+ +|+|++++++++..      .+..+
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            578999999999999999999998999999999876554456777888888887 69999999999853      45789


Q ss_pred             EEEeecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           75 IVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ++|||+++++|.+++...  ..+++..+..++.|++.|+.|||+.|++|+|++|+||++++++.  ++|+|||.+.....
T Consensus        96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~  173 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDR  173 (282)
T ss_pred             EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhc
Confidence            999999999998887543  35888889999999999999999999999999999999975554  99999999865432


Q ss_pred             -CCCCCcccCCCCccCcccccC
Q 030211          153 -HSRPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       153 -~~~~~~~~~~~~~~aPE~~~~  173 (181)
                       ........+++.|+|||.+..
T Consensus       174 ~~~~~~~~~~~~~y~aPE~l~~  195 (282)
T cd06636         174 TVGRRNTFIGTPYWMAPEVIAC  195 (282)
T ss_pred             cccCCCcccccccccCHhhcCc
Confidence             223344568899999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=6.1e-30  Score=186.36  Aligned_cols=175  Identities=31%  Similarity=0.476  Sum_probs=146.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcC--CeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTP--THLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~   77 (181)
                      ++|+..+.||.|++|.||++.+..+++.+++|.+.....  ....+.+|+.+++.++|||++++++++.+.  +.++++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            579999999999999999999998899999998875433  245688899999999999999999988654  4689999


Q ss_pred             eecCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           78 EYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        78 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      ||+++++|.+++..    ...++...+..++.|++.+|.|||+.|++|+||+|+||+++++..  ++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~  158 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS  158 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence            99999999876542    346889999999999999999999999999999999999975554  999999998643322


Q ss_pred             CCCCcccCCCCccCcccccCCccCCC
Q 030211          154 SRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      . .....++..|+|||.+.+..++.+
T Consensus       159 ~-~~~~~~~~~y~~pE~~~~~~~~~~  183 (287)
T cd06621         159 L-AGTFTGTSFYMAPERIQGKPYSIT  183 (287)
T ss_pred             c-cccccCCccccCHHHhcCCCCCch
Confidence            2 223457889999999988877654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=2.6e-30  Score=190.68  Aligned_cols=170  Identities=29%  Similarity=0.421  Sum_probs=135.2

Q ss_pred             eeeeCCccceeEEEEEEc--cCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEc--CCeEEEEEeecCC
Q 030211            7 VKDLGAGNFGVARLLRHK--ETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT--PTHLAIVMEYAAG   82 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~--~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~~~~   82 (181)
                      .++||+|+||.||+|.++  .+++.+++|.+.... ......+|+.+++.++|||++++++.+..  ....++++|++.+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence            468999999999999975  357889999886542 34567789999999999999999999865  4568999999854


Q ss_pred             CChHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc--CCCCcEEEeecCCccccc
Q 030211           83 GELFDRICNA---------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG--SAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        83 ~~l~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~--~~~~~v~l~dfg~a~~~~  151 (181)
                       +|.+++...         ..+++..++.++.|++.||.|||++|++|+||+|+||++..  +..+.++|+|||++....
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07868          85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence             776665321         25889999999999999999999999999999999999942  234569999999997543


Q ss_pred             CCC----CCCcccCCCCccCcccccCCc-cCC
Q 030211          152 LHS----RPKSTVGTPAYIAPEVLSRRE-YDG  178 (181)
Q Consensus       152 ~~~----~~~~~~~~~~~~aPE~~~~~~-~~~  178 (181)
                      ...    ......+++.|+|||++.+.. ++.
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  195 (317)
T cd07868         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTK  195 (317)
T ss_pred             CCCccccccCCccccccccCCHHHcCCCCcCc
Confidence            322    223456799999999997643 544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=7.3e-31  Score=190.12  Aligned_cols=175  Identities=33%  Similarity=0.491  Sum_probs=150.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|.+.+.||+|++|.||++.+..+++.+++|++.....    ..+.+.+|..++..++ |+|++++++++.+.+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            579999999999999999999998999999999875322    2356778889999998 99999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-  155 (181)
                      ||++.+++|.+.+.+...+++..++.++.|++.+|.+||++|++|+||+|+||++++++.  ++|+|||.+........ 
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCcccc
Confidence            999999999999988888999999999999999999999999999999999999976554  99999999865432221 


Q ss_pred             --------------------CCcccCCCCccCcccccCCccCC
Q 030211          156 --------------------PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       156 --------------------~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                                          .....++..|+|||...+...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~  201 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK  201 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCCh
Confidence                                12235678999999988766554

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=1.6e-30  Score=186.04  Aligned_cols=174  Identities=37%  Similarity=0.549  Sum_probs=149.7

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +|++.+.||+|++|.+|++.+..++..+++|.+....   .....+.+|+..++.++|+|++++.+.+.+.+..++++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5899999999999999999999889999999987532   2235677889999999999999999999999999999999


Q ss_pred             cCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           80 AAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        80 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      +++++|.+++..    ...+++..+..++.|++.||++||+.|++|+||+|+||+++++.  .++|+|||.+...... .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~--~~kl~d~g~~~~~~~~-~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND--LVKIGDLGISKVLKKN-M  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC--cEEEeeccchhhhccC-C
Confidence            999999888755    35689999999999999999999999999999999999997654  4999999998755444 3


Q ss_pred             CCcccCCCCccCcccccCCccCCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .....+++.|+|||.+.+..++++
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~  181 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPYSYK  181 (256)
T ss_pred             cccccCCccccCHHHHCCCCCCch
Confidence            333567889999999988877654

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=3.8e-30  Score=184.62  Aligned_cols=168  Identities=27%  Similarity=0.379  Sum_probs=137.6

Q ss_pred             eeCCccceeEEEEEE--ccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCC
Q 030211            9 DLGAGNFGVARLLRH--KETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (181)
Q Consensus         9 ~i~~g~~~~v~~~~~--~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (181)
                      .||+|+||.||++.+  ..++..+++|++.....   ..+.+.+|+.+++.++|+|++++++++. .+..+++||+++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999975  35678899998865432   2356788999999999999999999875 45678999999999


Q ss_pred             ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC----CCcc
Q 030211           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR----PKST  159 (181)
Q Consensus        84 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~----~~~~  159 (181)
                      +|.+++.....+++..+..++.|++.|+++||++|++|+||+|+||+++++.  .++|+|||.+........    ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH--YAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC--eEEECCCccccccCCCCCeeeecCCC
Confidence            9999988777899999999999999999999999999999999999997654  499999999865433222    1122


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+++.|+|||.+....++.+
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~  178 (257)
T cd05116         159 KWPVKWYAPECMNYYKFSSK  178 (257)
T ss_pred             CCCccccCHhHhccCCcCch
Confidence            33578999999987766653

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=3.3e-30  Score=186.23  Aligned_cols=170  Identities=26%  Similarity=0.330  Sum_probs=136.9

Q ss_pred             eeeCCccceeEEEEEEccCCc--EEEEEEccccc--cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKETKE--LVAVKYIERGR--KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~--~v~~K~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|++|.||++.+++++.  .+++|.+....  ...+.+..|+..+..+ +|||++++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999987765  46888776432  2235677899999888 799999999999999999999999999


Q ss_pred             CChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCC
Q 030211           83 GELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (181)
Q Consensus        83 ~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~  146 (181)
                      ++|.+++....                .+++..+..++.|++.|+++||++|++|+||+|+||+++++.  .++|+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~--~~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC--eEEECCCCC
Confidence            99998886532                478899999999999999999999999999999999997555  499999998


Q ss_pred             cccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          147 SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       147 a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +..............+..|+|||++....++.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~  191 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN  191 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCCCch
Confidence            853222211222233567999999988777654

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=5.1e-30  Score=184.13  Aligned_cols=175  Identities=35%  Similarity=0.579  Sum_probs=147.4

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEc--CCeEEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLT--PTHLAIVM   77 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~   77 (181)
                      +|++.+.+|.|++|.||++.+..++..+++|.+.....   ..+.+..|+..++.++|+|++++++.+..  ....++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            58999999999999999999998999999998865322   23567789999999999999999998764  45689999


Q ss_pred             eecCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH-----hcCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211           78 EYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCH-----SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus        78 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh-----~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      ||+++++|.+++..    ...+++..++.++.|++.+|.+||     +.+++|+||+|+||+++++.  .++|+|||++.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~--~~kl~d~g~~~  158 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN--NVKLGDFGLAK  158 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC--CEEEecccccc
Confidence            99999999888754    357899999999999999999999     99999999999999997655  49999999987


Q ss_pred             cccCCCC-CCcccCCCCccCcccccCCccCCC
Q 030211          149 SSVLHSR-PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       149 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....... .....+++.|+|||.+.+..++.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~  190 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK  190 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCch
Confidence            6544333 334568899999999988776644

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=3.9e-30  Score=191.15  Aligned_cols=176  Identities=24%  Similarity=0.320  Sum_probs=142.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC-------CcEEEEEEcccccc--ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET-------KELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~-------~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~   71 (181)
                      .+|++.+.||+|+||.||.|.+...       +..+++|.+.....  ..+.+.+|+.++..+ +|+|++++++.+...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            3799999999999999999986432       23689998775322  235788899999998 7999999999999999


Q ss_pred             eEEEEEeecCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC
Q 030211           72 HLAIVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~  135 (181)
                      ..++++||+++++|.+++...                ..++...+..++.|++.||.+||++|++|+||+|+||+++++.
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~  171 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN  171 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence            999999999999999888643                2477788899999999999999999999999999999997555


Q ss_pred             CCcEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          136 APRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       136 ~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                        .++|+|||.+........   .....++..|+|||++.+..++.+
T Consensus       172 --~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  216 (334)
T cd05100         172 --VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ  216 (334)
T ss_pred             --cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch
Confidence              499999999865433221   112233467999999988777654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=5.6e-30  Score=185.64  Aligned_cols=174  Identities=29%  Similarity=0.489  Sum_probs=146.8

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      -|++.+.||+|+||.||++.+..++..+++|.+.....  ..+.+.+|+..+..++|+|++++++.+..++..++++||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            47889999999999999999988899999998764332  2356778999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-CCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~~~~  159 (181)
                      ++++|.+++.+ ..+++..+..++.|++.++.+||++|++|+||+|+||++++++.  ++|+|||++........ ....
T Consensus        85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhccc
Confidence            99999887753 46899999999999999999999999999999999999976554  99999998865433221 2234


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .++..|+|||.+.+..++.+
T Consensus       162 ~~~~~y~~PE~~~~~~~~~~  181 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYDSK  181 (277)
T ss_pred             cCCccccChhhhccCCCCch
Confidence            57888999999987766554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.97  E-value=3.4e-31  Score=190.38  Aligned_cols=172  Identities=34%  Similarity=0.506  Sum_probs=140.0

Q ss_pred             eeeeeeCCccceeEEEEEEc----cCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            5 ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         5 ~~~~~i~~g~~~~v~~~~~~----~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      .+.+.||.|.||.||+|...    ..+..|++|.+.....  ..+.+.+|+..+.+++|||++++++++...+..++++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            57889999999999999987    4466799999965322  24788999999999999999999999998888999999


Q ss_pred             ecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-
Q 030211           79 YAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        79 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-  155 (181)
                      |+++++|.+++...  ..++......++.|++.||.|||+++++|++|+|+||+++++.  .+||+|||.+........ 
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~--~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG--QVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT--EEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccc
Confidence            99999999999876  6899999999999999999999999999999999999997555  599999999875522211 


Q ss_pred             --CCcccCCCCccCcccccCCccCC
Q 030211          156 --PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                        .........|+|||.+....++.
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~  184 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTK  184 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESH
T ss_pred             ccccccccccccccccccccccccc
Confidence              22234677899999998776553

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.9e-30  Score=184.23  Aligned_cols=167  Identities=31%  Similarity=0.471  Sum_probs=138.4

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEcccccccc----HHHHHHHH-HHhhCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREII-NHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~-~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|++|.||+|.+..+++.+++|.+.+.....    ..+..|.. +.....|+|++++++.+...+..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57899999999999999889999999987543211    22233333 34456899999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccCC
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT  162 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~  162 (181)
                      ++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++++.  .++|+|||.+.....   .....++
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~---~~~~~~~  156 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG--HLKLTDFGLSRNGLE---NKKFVGT  156 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--cEEEeecccceeccc---cccCCCC
Confidence            99999988777899999999999999999999999999999999999997654  499999998864322   3344678


Q ss_pred             CCccCcccccCCccCCC
Q 030211          163 PAYIAPEVLSRREYDGK  179 (181)
Q Consensus       163 ~~~~aPE~~~~~~~~~~  179 (181)
                      +.|+|||.+.+..++.+
T Consensus       157 ~~y~~pe~~~~~~~~~~  173 (260)
T cd05611         157 PDYLAPETILGVGDDKM  173 (260)
T ss_pred             cCccChhhhcCCCCcch
Confidence            89999999988776554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=6.1e-30  Score=186.54  Aligned_cols=170  Identities=31%  Similarity=0.529  Sum_probs=144.4

Q ss_pred             cceeeeeeCCccceeEEEEEEc---cCCcEEEEEEccccc-----cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeE
Q 030211            3 KYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR-----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~-----~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~   73 (181)
                      +|++.+.||+|++|.||.|.+.   .+|..+++|++....     ...+.+.+|+.++..+ +|++++.+++.+..++.+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            5899999999999999999874   468899999987532     1235677889999988 589999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      ++++|++++++|.+++.....+++..+..++.|++.+|.+||+.|++|+||+|+||++++++  .++|+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~  158 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC--CEEEeeCccceecccc
Confidence            99999999999999988777899999999999999999999999999999999999997654  5999999998754332


Q ss_pred             C--CCCcccCCCCccCcccccCC
Q 030211          154 S--RPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       154 ~--~~~~~~~~~~~~aPE~~~~~  174 (181)
                      .  ......++..|+|||.+.+.
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~  181 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGG  181 (290)
T ss_pred             cccccccccCCcccCChhhccCC
Confidence            2  22235688999999998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=9.8e-30  Score=182.59  Aligned_cols=168  Identities=27%  Similarity=0.395  Sum_probs=135.5

Q ss_pred             eeCCccceeEEEEEEc--cCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCC
Q 030211            9 DLGAGNFGVARLLRHK--ETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGE   84 (181)
Q Consensus         9 ~i~~g~~~~v~~~~~~--~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   84 (181)
                      .||+|+||.||++.+.  +.+..|++|++.....  ..+.+.+|+.+++.++|+|++++++++. .+..+++|||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999875  4455799998875432  2356888999999999999999999875 457899999999999


Q ss_pred             hHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC----Ccc
Q 030211           85 LFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP----KST  159 (181)
Q Consensus        85 l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~----~~~  159 (181)
                      |.+++.. ...+++..++.++.|++.++.+||++|++|+||+|+||+++++.  .++|+|||++.........    ...
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH--YAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC--cEEeccCCccccccCCccceeccCCC
Confidence            9988864 44789999999999999999999999999999999999997555  4999999998644322211    111


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+++.|+|||.+....++.+
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~  178 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSR  178 (257)
T ss_pred             CCCcccCCHHHHccCCCCch
Confidence            23568999999987776654

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=6.8e-30  Score=185.50  Aligned_cols=168  Identities=30%  Similarity=0.503  Sum_probs=135.8

Q ss_pred             eeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHH---hhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            9 DLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINH---RSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         9 ~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~---~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      .||+|+||.||++.+..+++.+++|.+......    .....++..++   ....|++++.+.+.+...+..+++|||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999988999999988654221    12233444333   33478999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccC
Q 030211           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG  161 (181)
Q Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~  161 (181)
                      +++|.+++..+..+++..+..++.|++.||++||++|++|+||+|+||++++++  .++|+|||++...... ......+
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~--~~~l~dfg~~~~~~~~-~~~~~~~  157 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKK-KPHASVG  157 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC--CEEEccCCcceecccc-CccCcCC
Confidence            999999888878899999999999999999999999999999999999997555  4999999998643322 2233468


Q ss_pred             CCCccCcccccC-CccCCC
Q 030211          162 TPAYIAPEVLSR-REYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~-~~~~~~  179 (181)
                      ++.|+|||.+.+ ..++.+
T Consensus       158 ~~~y~aPE~~~~~~~~~~~  176 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSS  176 (279)
T ss_pred             CcCccCHHHhcCCCCCCch
Confidence            999999999864 344443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=5.2e-30  Score=188.80  Aligned_cols=171  Identities=29%  Similarity=0.404  Sum_probs=140.7

Q ss_pred             cceeeeeeCCccceeEEEEEEcc--CCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcC--CeEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKE--TKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THLA   74 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~--~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~   74 (181)
                      +|++.+.||+|++|.||+|.+..  +++.+|+|.+....    ...+...+|+.++..++|||++++++++.+.  +.++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  78999999987632    2245678899999999999999999999988  8899


Q ss_pred             EEEeecCCCChHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccC--CCCcEEEeecCCc
Q 030211           75 IVMEYAAGGELFDRICN-----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS--AAPRLKICDFGYS  147 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~--~~~~v~l~dfg~a  147 (181)
                      ++||++++ ++.+.+..     ...+++..++.++.|++.+|.+||++|++|+||+|+||+++.+  ..+.++|+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999965 66655532     1268899999999999999999999999999999999999651  1456999999998


Q ss_pred             ccccCCCC----CCcccCCCCccCcccccCC
Q 030211          148 KSSVLHSR----PKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       148 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~  174 (181)
                      ........    .....+++.|+|||++.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  190 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGA  190 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCC
Confidence            75432222    2234578889999988654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=8.7e-31  Score=191.32  Aligned_cols=174  Identities=29%  Similarity=0.494  Sum_probs=146.5

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      .|.....||+|++|.||++.+..++..+++|.+..... ..+.+.+|+..+..++|+|++++++.+..++..+++||+++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            45667889999999999999988899999998865332 23567889999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCCccc
Q 030211           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTV  160 (181)
Q Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~~~~  160 (181)
                      +++|.+++. ...+++..+..++.|++.++++||++|++|+||+|+||+++++.  .++|+|||++....... ......
T Consensus       103 ~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~--~~kL~dfg~~~~~~~~~~~~~~~~  179 (292)
T cd06658         103 GGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG--RIKLSDFGFCAQVSKEVPKRKSLV  179 (292)
T ss_pred             CCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--CEEEccCcchhhcccccccCceee
Confidence            999988764 45689999999999999999999999999999999999997655  49999999886443222 223356


Q ss_pred             CCCCccCcccccCCccCCC
Q 030211          161 GTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       161 ~~~~~~aPE~~~~~~~~~~  179 (181)
                      +++.|+|||.+.+..++.+
T Consensus       180 ~~~~y~aPE~~~~~~~~~~  198 (292)
T cd06658         180 GTPYWMAPEVISRLPYGTE  198 (292)
T ss_pred             cCccccCHHHHccCCCCch
Confidence            8899999999988776654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-31  Score=175.18  Aligned_cols=173  Identities=31%  Similarity=0.541  Sum_probs=148.4

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      |++|.-.++||+|.+|+||++++.++...||+|.++....   .....++|+.+++.+.|.|+|+++++....+.+-+|+
T Consensus         1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            5788999999999999999999999999999999875433   3478999999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CC
Q 030211           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SR  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~  155 (181)
                      |+| ..+|..+..+ ++.++.+.++.++.|+++++.++|+..+.|+|+||.|.+|+.++  .++|.|||+++...-. ..
T Consensus        81 e~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng--elkladfglarafgipvrc  157 (292)
T KOG0662|consen   81 EFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG--ELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             HHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC--cEEecccchhhhcCCceEe
Confidence            999 4577777654 55799999999999999999999999999999999999996544  5999999999764332 23


Q ss_pred             CCcccCCCCccCcccccCCcc
Q 030211          156 PKSTVGTPAYIAPEVLSRREY  176 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~  176 (181)
                      .+...-|+.|.+|+++-+...
T Consensus       158 ysaevvtlwyrppdvlfgakl  178 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKL  178 (292)
T ss_pred             eeceeeeeeccCcceeeeeeh
Confidence            344456899999999876553

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=8.8e-30  Score=185.99  Aligned_cols=170  Identities=31%  Similarity=0.413  Sum_probs=139.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCe-----
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLR-HPNIIRFKEVVLTPTH-----   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~-----   72 (181)
                      ++|++.+.||+|++|.||++.+..+++.|++|.+.....   ....+.+|+.+++.+. |+|++++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            589999999999999999999998999999998765432   2356788999999985 5999999999887665     


Q ss_pred             EEEEEeecCCCChHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCc
Q 030211           73 LAIVMEYAAGGELFDRICNA-----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a  147 (181)
                      .+++|||+++ +|.+++...     ..+++..++.++.|++.||.+||++|++|+||+|+||++++ ..+.++|+|||.+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~-~~~~~kl~dfg~~  158 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK-QKGLLKIADLGLG  158 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec-CCCeEEEeecccc
Confidence            8999999976 787776542     35799999999999999999999999999999999999975 1345999999998


Q ss_pred             ccccCC-CCCCcccCCCCccCcccccC
Q 030211          148 KSSVLH-SRPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       148 ~~~~~~-~~~~~~~~~~~~~aPE~~~~  173 (181)
                      ...... .......+++.|+|||.+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~  185 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLG  185 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhC
Confidence            754322 22223356888999998865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.6e-30  Score=185.48  Aligned_cols=170  Identities=29%  Similarity=0.496  Sum_probs=144.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCC---CCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR---HPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~---~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +.|++.+.||+|++|.+|++.+..+++.+++|.+....  ...+.+.+|+.+++.++   ||+++++++.+...+..+++
T Consensus         1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            35889999999999999999998889999999886532  22356778888888886   99999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-  155 (181)
                      |||+++++|.+++.. ..+++..++.++.|++.++.+||+.|++|+||+|+||++++++  .++|+|||.+........ 
T Consensus        81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG--NVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC--CEEEccCCceeecCCCccc
Confidence            999999999988755 4789999999999999999999999999999999999997654  599999999876543332 


Q ss_pred             CCcccCCCCccCcccccCC
Q 030211          156 PKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~  174 (181)
                      .....++..|+|||.+.++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~  176 (277)
T cd06917         158 RSTFVGTPYWMAPEVITEG  176 (277)
T ss_pred             cccccCCcceeCHHHhccC
Confidence            2334688899999998754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=7.8e-30  Score=184.19  Aligned_cols=174  Identities=23%  Similarity=0.323  Sum_probs=140.6

Q ss_pred             ceeeeeeCCccceeEEEEEEccC---CcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCe-----
Q 030211            4 YELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTH-----   72 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~-----   72 (181)
                      |.+++.||+|+||.||+|....+   +..+|+|.+......   ...+.+|+..++.++|+|++++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            67899999999999999997643   477999998754322   2467889999999999999999998866544     


Q ss_pred             -EEEEEeecCCCChHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecC
Q 030211           73 -LAIVMEYAAGGELFDRICNA------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG  145 (181)
Q Consensus        73 -~~~v~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg  145 (181)
                       .++++||+++++|...+...      ..+++..+..++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM--TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC--eEEECCcc
Confidence             79999999999998877432      3689999999999999999999999999999999999997554  49999999


Q ss_pred             CcccccCCCCC---CcccCCCCccCcccccCCccCCC
Q 030211          146 YSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       146 ~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.........   .....+..|+|||.+.+..++.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~  195 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK  195 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcc
Confidence            98754333221   11234578999999988777665

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=6.1e-30  Score=187.90  Aligned_cols=171  Identities=30%  Similarity=0.474  Sum_probs=139.7

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC------
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPT------   71 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~------   71 (181)
                      +++|++.+.||+|++|.||+|.+..+++.+++|.+.....   ......+|+.+++.++||+++++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            4789999999999999999999999999999998864322   1235567999999999999999999887643      


Q ss_pred             --eEEEEEeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211           72 --HLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus        72 --~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                        ..++++||+++ ++.+.+.... .+++..++.++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||++.
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~  167 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG--ILKLADFGLAR  167 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC--cEEECcCCCcc
Confidence              45999999965 7777665443 789999999999999999999999999999999999997555  49999999986


Q ss_pred             cccCCCC-----CCcccCCCCccCcccccCC
Q 030211          149 SSVLHSR-----PKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       149 ~~~~~~~-----~~~~~~~~~~~aPE~~~~~  174 (181)
                      .......     .....++..|+|||.+.+.
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  198 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGE  198 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCC
Confidence            5432222     1234567889999988654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=3.7e-30  Score=187.49  Aligned_cols=176  Identities=26%  Similarity=0.397  Sum_probs=144.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||.||+|.+.     .++..+++|.+.....  ....+.+|+..++.+.||+++++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            57999999999999999999874     3577899998875432  2356788999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhc----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEec
Q 030211           75 IVMEYAAGGELFDRICNA----------------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD  132 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~----------------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~  132 (181)
                      +++|++++++|.+++...                      ..+++..+..++.|++.||.+||++|++|+||+|+||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~  164 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG  164 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence            999999999999888642                      1367888899999999999999999999999999999997


Q ss_pred             cCCCCcEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          133 GSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       133 ~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.  .++|+|||.+........   ......++.|+|||.+.+..++.+
T Consensus       165 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  212 (288)
T cd05050         165 ENM--VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE  212 (288)
T ss_pred             CCC--ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch
Confidence            555  499999998864432221   122234667999999988877664

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=5.8e-30  Score=186.69  Aligned_cols=175  Identities=24%  Similarity=0.321  Sum_probs=141.6

Q ss_pred             cceeeeeeCCccceeEEEEEEcc-----CCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +|++.+.||+|+||.||++.+..     ....+++|.+......  ...+.+|+..++.+.|||++++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            58899999999999999998753     2356888887654322  2467789999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEe
Q 030211           76 VMEYAAGGELFDRICNA------------------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLL  131 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~------------------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i  131 (181)
                      ++||+.+++|.+++...                        ..+++..++.++.|++.+|.+||++|++|+||+|+||++
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill  160 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV  160 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence            99999999998877532                        247788999999999999999999999999999999999


Q ss_pred             ccCCCCcEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          132 DGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       132 ~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +++.  .++|+|||++........   .....++..|+|||.+.+..++.+
T Consensus       161 ~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~  209 (290)
T cd05045         161 AEGR--KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ  209 (290)
T ss_pred             cCCC--cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH
Confidence            7555  599999999865432221   122234678999999887766654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=1.3e-29  Score=183.95  Aligned_cols=168  Identities=30%  Similarity=0.499  Sum_probs=136.6

Q ss_pred             eeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHH---HHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            9 DLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREII---NHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         9 ~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~---~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      .||+|++|.||++.+..+++.||+|.+......    ......+..   .+....|++++.+.+.+.+.+..+++|||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            479999999999999988999999988754221    112333333   3344578999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccC
Q 030211           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG  161 (181)
Q Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~  161 (181)
                      +++|...+.....+++..+..++.|++.++++||+.+++|+||+|+||+++.++  .++|+|||.+...... ......+
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~--~~kl~dfg~~~~~~~~-~~~~~~~  157 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKK-KPHASVG  157 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC--CEEEccCcCccccCcc-CCcCcCC
Confidence            999998887777899999999999999999999999999999999999997555  4999999998644322 2234568


Q ss_pred             CCCccCcccccCC-ccCCC
Q 030211          162 TPAYIAPEVLSRR-EYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~~-~~~~~  179 (181)
                      +..|+|||.+.++ .++.+
T Consensus       158 ~~~y~aPE~~~~~~~~~~~  176 (278)
T cd05606         158 THGYMAPEVLQKGVAYDSS  176 (278)
T ss_pred             CcCCcCcHHhcCCCCCCcc
Confidence            9999999999754 45543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=4.3e-30  Score=191.14  Aligned_cols=174  Identities=36%  Similarity=0.540  Sum_probs=145.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcC-----CeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP-----THL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~   73 (181)
                      ++|.+.+.||+|++|+||++.+..+++.|++|.+....   .....+.+|+.+++.++|+|++++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            58999999999999999999999999999999886532   2234567899999999999999999988654     348


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      ++++||+. ++|.+.+.....+++..+..++.|++.||.+||++|++|+||+|+||+++.++.  ++|+|||++......
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~  161 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSEK  161 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCCC
Confidence            99999995 588888877778999999999999999999999999999999999999976554  999999998755433


Q ss_pred             -CCCCcccCCCCccCcccccCC-ccCC
Q 030211          154 -SRPKSTVGTPAYIAPEVLSRR-EYDG  178 (181)
Q Consensus       154 -~~~~~~~~~~~~~aPE~~~~~-~~~~  178 (181)
                       .......++..|+|||.+.+. .++.
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~  188 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTT  188 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCC
Confidence             223344678899999988753 3443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=1.1e-29  Score=184.41  Aligned_cols=169  Identities=30%  Similarity=0.498  Sum_probs=142.5

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      +|++.+.||.|++|.||++.+..++..+++|.+.....  ....+.+|+.+++.++|+|++++++.+.+.+..+++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            58999999999999999999998999999998875432  2356778999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-C
Q 030211           81 AGGELFDRICNA---GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-P  156 (181)
Q Consensus        81 ~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~  156 (181)
                      ++ +|.+++...   ..+++..+..++.|++.+|.+||+.|++|+||+|+||++++++.  ++|+|||.+........ .
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCcccc
Confidence            75 777776543   35899999999999999999999999999999999999976554  99999999864433222 2


Q ss_pred             CcccCCCCccCcccccCC
Q 030211          157 KSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~  174 (181)
                      ....+++.|+|||++.+.
T Consensus       158 ~~~~~~~~y~~PE~~~~~  175 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGS  175 (284)
T ss_pred             ccccccccccChHHhcCC
Confidence            233567889999988654

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=2.4e-30  Score=189.46  Aligned_cols=173  Identities=29%  Similarity=0.491  Sum_probs=145.9

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      |+....||+|+||.||++.+..+++.+++|.+..... ..+.+.+|+..+..++|||++++++.+..++..++++||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            4556679999999999999988899999999865432 235677899999999999999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-CCcccC
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~~~~~~  161 (181)
                      ++|...+. ...+++..++.++.|++.+|.+||++|++|+||+|+||++++++.  ++|+|||++........ .....+
T Consensus       103 ~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~  179 (297)
T cd06659         103 GALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLVG  179 (297)
T ss_pred             CCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccceec
Confidence            99987653 457899999999999999999999999999999999999976554  99999998864433322 233568


Q ss_pred             CCCccCcccccCCccCCC
Q 030211          162 TPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~  179 (181)
                      +..|+|||++.+..++.+
T Consensus       180 ~~~y~aPE~~~~~~~~~~  197 (297)
T cd06659         180 TPYWMAPEVISRTPYGTE  197 (297)
T ss_pred             CccccCHHHHccCCCCch
Confidence            899999999988777654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=1.1e-29  Score=184.30  Aligned_cols=166  Identities=30%  Similarity=0.451  Sum_probs=138.9

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc--cHHHHHHHHHHhhCC-CCCeeEEEEeEEcC--CeEEEEEe
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIINHRSLR-HPNIIRFKEVVLTP--THLAIVME   78 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~--~~~~~v~e   78 (181)
                      |++.+.||+|++|.||++.+..+++.+++|.+......  ......|+..+..+. |+|++++++++.++  +..++++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            78899999999999999999988999999988754222  233456777777774 99999999999987  88999999


Q ss_pred             ecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           79 YAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      |+++ ++.+.+.. ...+++..++.++.|++.||++||++|++|+||+|+||++++   +.++|+|||.+..........
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~---~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD---DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC---CCeEEEecccccccccCCCcC
Confidence            9965 77777755 347899999999999999999999999999999999999976   569999999987655444444


Q ss_pred             cccCCCCccCcccccC
Q 030211          158 STVGTPAYIAPEVLSR  173 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~  173 (181)
                      ...+++.|+|||.+..
T Consensus       157 ~~~~~~~y~aPE~~~~  172 (282)
T cd07831         157 EYISTRWYRAPECLLT  172 (282)
T ss_pred             CCCCCcccCChhHhhc
Confidence            5567899999997654

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=9.1e-31  Score=199.32  Aligned_cols=173  Identities=31%  Similarity=0.524  Sum_probs=148.2

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      |..++.||-|+||.|.++...++...+|+|.+.+..-.    ...++.|-++|..-..+=+|+++..|.+.+.+|+||+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            67788999999999999999999889999988764321    23466778888888899999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-----
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-----  154 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-----  154 (181)
                      ++||++..++.+-+-|.++.++.++..+..|+++.|+.|+||+||||+||+||.+++  |||.|||+|......-     
T Consensus       711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceeccccccc
Confidence            999999999988899999999999999999999999999999999999999987766  9999999986432000     


Q ss_pred             --------------------------------------CCCcccCCCCccCcccccCCccCC
Q 030211          155 --------------------------------------RPKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       155 --------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                                                            ......||+.|+|||++.+..|+.
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q  850 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ  850 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence                                                  001235899999999999988764

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=9.1e-30  Score=187.23  Aligned_cols=171  Identities=35%  Similarity=0.511  Sum_probs=141.3

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcC--CeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTP--THLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~   75 (181)
                      +++|++.+.||+|++|.||++.+..++..|++|.+......   .....+|+.+++.++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            47899999999999999999999999999999998644322   23456799999999999999999998765  56899


Q ss_pred             EEeecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           76 VMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +||++.+ +|.+++.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||++++++  .++|+|||.+.......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG--CLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECccceeeecCCcc
Confidence            9999965 77777654 35789999999999999999999999999999999999997555  49999999987554332


Q ss_pred             -CCCcccCCCCccCcccccCC
Q 030211          155 -RPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       155 -~~~~~~~~~~~~aPE~~~~~  174 (181)
                       ......+++.|+|||.+.+.
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~  183 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGC  183 (309)
T ss_pred             CCCCcccccccccChhhhcCC
Confidence             22223457889999998653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=202.98  Aligned_cols=171  Identities=33%  Similarity=0.514  Sum_probs=143.5

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccccc----HHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      |.=+..||.|.||-||-|.+..+...||||.+.-+-+..    +.++.|++++.+++|||.+.+-++|.-....|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            445677999999999999999999999999987543322    4688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           80 AAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      |-| +-.+.+.-+ .++.+-.+..|..+.+.+|+|||+.+.||+|||..||++.+.+  .|||.|||.|..   .....+
T Consensus       108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g--~VKLaDFGSAsi---~~PAns  181 (948)
T KOG0577|consen  108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG--LVKLADFGSASI---MAPANS  181 (948)
T ss_pred             Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC--eeeeccccchhh---cCchhc
Confidence            966 444444322 3688999999999999999999999999999999999996555  499999998764   344567


Q ss_pred             ccCCCCccCccccc---CCccCCCC
Q 030211          159 TVGTPAYIAPEVLS---RREYDGKQ  180 (181)
Q Consensus       159 ~~~~~~~~aPE~~~---~~~~~~~~  180 (181)
                      +.|||.|||||+|.   .+.|+.|+
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkv  206 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKV  206 (948)
T ss_pred             ccCCccccchhHheeccccccCCcc
Confidence            89999999999997   56666554

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=1.4e-29  Score=183.83  Aligned_cols=176  Identities=30%  Similarity=0.439  Sum_probs=145.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEc----cCCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEc--CCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLT--PTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~----~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~   73 (181)
                      +.|++.+.||+|+||.||++...    .++..+++|.+......  .+.+.+|+..++.+.|+|++++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46888999999999999999864    34788999998865543  5678899999999999999999999887  5579


Q ss_pred             EEEEeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           74 AIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      +++|||+++++|.+++.... .+++..+..++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||.+.....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~  161 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED--LVKISDFGLAKVLPE  161 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEccccccccccc
Confidence            99999999999999887654 689999999999999999999999999999999999997654  599999999875542


Q ss_pred             CCCC----CcccCCCCccCcccccCCccCCC
Q 030211          153 HSRP----KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....    ....++..|+|||.+....++.+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~  192 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSA  192 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcc
Confidence            2221    11234567999999987766543

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.5e-30  Score=191.74  Aligned_cols=174  Identities=34%  Similarity=0.510  Sum_probs=148.3

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC-----eEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPT-----HLA   74 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-----~~~   74 (181)
                      ||++.+.||+|++|.||++.+..++..+++|.+....   ...+.+.+|+..++.++|+|++++.+++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            6999999999999999999999889999999887543   22467888999999999999999999998875     789


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      ++|++++ ++|.+.+.....+++..++.++.|++.+|++||++|++|+||+|+||+++++  +.++|+|||.+.......
T Consensus        81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~--~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN--CDLKICDFGLARGVDPDE  157 (330)
T ss_pred             EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--CCEEEcccCceEeecccc
Confidence            9999997 4788888777789999999999999999999999999999999999999765  459999999987654443


Q ss_pred             ----CCCcccCCCCccCcccccCC-ccCCC
Q 030211          155 ----RPKSTVGTPAYIAPEVLSRR-EYDGK  179 (181)
Q Consensus       155 ----~~~~~~~~~~~~aPE~~~~~-~~~~~  179 (181)
                          ......+++.|+|||.+.+. .++.+
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  187 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKA  187 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcc
Confidence                23344678899999999877 45443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=1.3e-29  Score=186.28  Aligned_cols=165  Identities=32%  Similarity=0.475  Sum_probs=139.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|++|.||++.+..+++.|++|.+......    .+.+.+|+.+++.++|||++++.+++.+.+..++++
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4789999999999999999999888999999988643221    246778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      ||+.+ ++.+.+.. ...+++..+..++.|++.+|.+||+.|++|+||+|+||++++++.  ++|+|||++....+.   
T Consensus        95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~~---  168 (307)
T cd06607          95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSPA---  168 (307)
T ss_pred             HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCCC---
Confidence            99964 66665543 457899999999999999999999999999999999999976554  999999988643322   


Q ss_pred             CcccCCCCccCccccc
Q 030211          157 KSTVGTPAYIAPEVLS  172 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~  172 (181)
                      ....+++.|+|||++.
T Consensus       169 ~~~~~~~~y~aPE~~~  184 (307)
T cd06607         169 NSFVGTPYWMAPEVIL  184 (307)
T ss_pred             CCccCCccccCceeee
Confidence            2346788999999884

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=9.1e-30  Score=183.82  Aligned_cols=175  Identities=26%  Similarity=0.309  Sum_probs=142.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC---CcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|.+.+.||+|++|.||+|.+.+.   ...+++|.......  ..+.+.+|+.+++.++|+|++++++++.+ +..+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4689999999999999999987643   44689998765432  23578889999999999999999998875 457899


Q ss_pred             EeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      ||++++++|.+++.+.. .+++..++.++.|++.+|++||+.|++|+||+|+||+++.+.  .++|+|||++........
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD--CVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC--CeEEccCceeeecccccc
Confidence            99999999999987644 689999999999999999999999999999999999997555  499999999865433322


Q ss_pred             CC--cccCCCCccCcccccCCccCCC
Q 030211          156 PK--STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~--~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..  ...++..|+|||.+....++.+
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~  188 (270)
T cd05056         163 YKASKGKLPIKWMAPESINFRRFTSA  188 (270)
T ss_pred             eecCCCCccccccChhhhccCCCCch
Confidence            21  2233467999999887776554

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=7.8e-30  Score=184.24  Aligned_cols=174  Identities=25%  Similarity=0.354  Sum_probs=138.5

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCc--EEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcC------Ce
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKE--LVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP------TH   72 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~--~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~------~~   72 (181)
                      +.+.+.||+|++|.||++.+...+.  .+++|.++...   ...+.+.+|+..++.++|+|++++++.+...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4578999999999999999876664  58999876542   2235677899999999999999999976432      24


Q ss_pred             EEEEEeecCCCChHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCC
Q 030211           73 LAIVMEYAAGGELFDRICN------AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~  146 (181)
                      .++++||+++++|.+++..      ...+++..+..++.|++.||.|||++|++|+||+|+||+++++..  ++|+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence            7899999999999877632      234789999999999999999999999999999999999975554  99999999


Q ss_pred             cccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          147 SKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       147 a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +........   .....+++.|+|||.+.+..++++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~  194 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK  194 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChH
Confidence            875433221   122245678999999988877664

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=1.7e-29  Score=183.86  Aligned_cols=174  Identities=30%  Similarity=0.512  Sum_probs=146.9

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      +|...+.||+|++|.+|++.+..+++.+++|.+...... .+.+.+|+.++..+.|++++++++++..++..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            456677999999999999999888999999987644322 3557889999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCCccc
Q 030211           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTV  160 (181)
Q Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~~~~  160 (181)
                      +++|.+.+.. .+++...+..++.|++.++++||++|++|+||+|+||+++.++  .++|+|||.+....... ......
T Consensus       100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~d~g~~~~~~~~~~~~~~~~  176 (285)
T cd06648         100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG--RVKLSDFGFCAQVSKEVPRRKSLV  176 (285)
T ss_pred             CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC--cEEEcccccchhhccCCccccccc
Confidence            9999988866 6789999999999999999999999999999999999997555  49999999876443222 222345


Q ss_pred             CCCCccCcccccCCccCCC
Q 030211          161 GTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       161 ~~~~~~aPE~~~~~~~~~~  179 (181)
                      +++.|+|||.+.+..++.+
T Consensus       177 ~~~~y~aPE~~~~~~~~~~  195 (285)
T cd06648         177 GTPYWMAPEVISRLPYGTE  195 (285)
T ss_pred             CCccccCHHHhcCCCCCCc
Confidence            8889999999988777654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=1.3e-29  Score=183.93  Aligned_cols=176  Identities=20%  Similarity=0.222  Sum_probs=144.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc----CCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEc-CCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE----TKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLT-PTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~----~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~   74 (181)
                      ++|++.+.||+|+||.||++.+.+    .+..|++|.+.....  ..+.+.+|+..++.+.|+|++++++++.. +...+
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            589999999999999999999875    357799998765422  23567889999999999999999998766 56789


Q ss_pred             EEEeecCCCChHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCC
Q 030211           75 IVMEYAAGGELFDRICNA--------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~  146 (181)
                      ++++++++++|..++...        ..+++..+..++.|++.||+|||+++++|+||+|+||+++++.  .++|+|||+
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kl~d~g~  163 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL--QVKITDNAL  163 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC--cEEECCCCC
Confidence            999999999999887543        4588999999999999999999999999999999999997554  499999999


Q ss_pred             cccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          147 SKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       147 a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ++...+...   .....++..|+|||++.+..++.+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~  199 (280)
T cd05043         164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA  199 (280)
T ss_pred             cccccCCceEEeCCCCCcchhccCHHHHhcCCCCch
Confidence            875433322   122345678999999988776654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=8.7e-30  Score=182.40  Aligned_cols=171  Identities=27%  Similarity=0.387  Sum_probs=141.4

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      +++|++.+.||+|++|.||++..  .++.+++|.+... ...+.+.+|+.+++.++|+|++++++++... ..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            36899999999999999999864  4778999988653 2346788899999999999999999998764 578999999


Q ss_pred             CCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           81 AGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      ++++|.+++....  .+++..+..++.|++.|+.+||++|++|+||+|+||+++.++  .++|+|||++......  ...
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~--~~kl~Dfg~~~~~~~~--~~~  156 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG--VAKVSDFGLARVGSMG--VDN  156 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--cEEECCCccceecccc--CCC
Confidence            9999999886543  578999999999999999999999999999999999997555  4999999998643221  122


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...+..|+|||.+.++.++.+
T Consensus       157 ~~~~~~y~~pe~~~~~~~~~~  177 (254)
T cd05083         157 SKLPVKWTAPEALKHKKFSSK  177 (254)
T ss_pred             CCCCceecCHHHhccCCcCch
Confidence            334567999999988777654

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=8.3e-30  Score=182.55  Aligned_cols=176  Identities=35%  Similarity=0.560  Sum_probs=148.6

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +|++.+.||+|++|.||++.+..++..+++|.+....   ...+.+.+|+.+++.++|+|++++++.+.+.+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            6899999999999999999999999999999886532   2335677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC-
Q 030211           80 AAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-  156 (181)
Q Consensus        80 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~-  156 (181)
                      +++++|.+++....  .+++..+..++.|++.++.+||+++++|+||+|+||+++++. ..++|+|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNG-MVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCC-CeEEecccccchhccCCcccc
Confidence            99999998886543  578999999999999999999999999999999999997543 24799999988654333222 


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+++.|+|||+..+..++.+
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~  182 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNK  182 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCch
Confidence            22357889999999987766654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=1.8e-29  Score=180.22  Aligned_cols=169  Identities=27%  Similarity=0.327  Sum_probs=138.4

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCCh
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   85 (181)
                      +.||+|++|.||++... +++.+++|.+......  ...+.+|+.+++.++|||++++++++...+..+++|||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            47899999999999865 5778999988654322  34677899999999999999999999999999999999999999


Q ss_pred             HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC--cccCC
Q 030211           86 FDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK--STVGT  162 (181)
Q Consensus        86 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~--~~~~~  162 (181)
                      .+++... ..+++..+..++.|++.+|.+||++|++|+||+|+||+++++.  .++|+|||++..........  ...++
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN--VLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC--eEEECCCccceeccccccccCCCCCCc
Confidence            9887653 4688999999999999999999999999999999999997555  49999999886432222111  12345


Q ss_pred             CCccCcccccCCccCCC
Q 030211          163 PAYIAPEVLSRREYDGK  179 (181)
Q Consensus       163 ~~~~aPE~~~~~~~~~~  179 (181)
                      ..|+|||++.++.++.+
T Consensus       158 ~~y~aPE~~~~~~~~~~  174 (250)
T cd05085         158 IKWTAPEALNYGRYSSE  174 (250)
T ss_pred             ccccCHHHhccCCCCch
Confidence            67999999987776654

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=2.5e-29  Score=181.38  Aligned_cols=172  Identities=29%  Similarity=0.425  Sum_probs=142.3

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      +......||+|+||.||++.+..++..+++|.+..... ..+.+.+|+.+++.++|+|++++++++..++..++++|+++
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   88 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP   88 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence            34455689999999999999998899999998765432 24578889999999999999999999999999999999999


Q ss_pred             CCChHHHHhhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCC
Q 030211           82 GGELFDRICNA-GRF--SEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPK  157 (181)
Q Consensus        82 ~~~l~~~~~~~-~~~--~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~  157 (181)
                      +++|.+.+... ..+  ++..+..++.|++.|+++||++|++|+||+|+||+++.+ ...++|+|||.+....... ...
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~-~~~~~l~dfg~~~~~~~~~~~~~  167 (268)
T cd06624          89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTY-SGVVKISDFGTSKRLAGINPCTE  167 (268)
T ss_pred             CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCeEEEecchhheecccCCCccc
Confidence            99999988654 345  788899999999999999999999999999999999642 2359999999886543222 223


Q ss_pred             cccCCCCccCcccccCCc
Q 030211          158 STVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~  175 (181)
                      ...+++.|+|||++.+..
T Consensus       168 ~~~~~~~~~aPE~~~~~~  185 (268)
T cd06624         168 TFTGTLQYMAPEVIDKGP  185 (268)
T ss_pred             cCCCCccccChhhhcccc
Confidence            345789999999987654

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=6.1e-30  Score=183.76  Aligned_cols=168  Identities=32%  Similarity=0.522  Sum_probs=143.4

Q ss_pred             eCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCCh
Q 030211           10 LGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (181)
Q Consensus        10 i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   85 (181)
                      ||.|++|.||++.+..+++.+++|.+.....    ..+.+.+|+..++.++|+|++++++.+...+..++++|++++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            5899999999999998899999999875432    235678889999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC---------CC
Q 030211           86 FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---------RP  156 (181)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~---------~~  156 (181)
                      .+++.+...+++..+..++.|++.+|.+||+.|++|+||+|+||++++++.  ++|+|||++.......         ..
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence            999887778999999999999999999999999999999999999976655  9999999886543322         12


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....++..|+|||...+...+.+
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~  181 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQGHSKT  181 (265)
T ss_pred             cCcccCccccCHHHhcCCCCCcc
Confidence            23457889999999887765543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=5.1e-30  Score=190.50  Aligned_cols=169  Identities=29%  Similarity=0.490  Sum_probs=142.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEc----CCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLT----PTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~----~~~~~   74 (181)
                      ++|++.+.||+|++|.||++.+..++..|++|.+....   .....+.+|+.+++.++|+|++++.+++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            57999999999999999999999999999999987542   223567789999999999999999988763    35689


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +++||+. ++|.+.+.....+++..++.++.|++.||.+||++|++|+||+|+||++++++.  ++|+|||++.......
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~  161 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSP  161 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccC
Confidence            9999995 588888877778999999999999999999999999999999999999976554  9999999986543222


Q ss_pred             C-----CCcccCCCCccCcccccC
Q 030211          155 R-----PKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       155 ~-----~~~~~~~~~~~aPE~~~~  173 (181)
                      .     .....++..|+|||.+.+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~  185 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLS  185 (334)
T ss_pred             cCCCcccccccccccccChHHhcC
Confidence            1     123467889999999865

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=200.76  Aligned_cols=167  Identities=31%  Similarity=0.471  Sum_probs=145.7

Q ss_pred             eeCCccceeEEEEEEccCCcEEEEEEcccc-ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCChHH
Q 030211            9 DLGAGNFGVARLLRHKETKELVAVKYIERG-RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD   87 (181)
Q Consensus         9 ~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~   87 (181)
                      ++|.|.+|+||-+.+.+++..+|+|-+... ....+-+.+|+.+++.++|.|||++++.+.+++++-+.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            589999999999999999999999987643 3334668899999999999999999999999999999999999999999


Q ss_pred             HHhhcC-CC--CHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCCCcccCCC
Q 030211           88 RICNAG-RF--SEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTP  163 (181)
Q Consensus        88 ~~~~~~-~~--~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~~~  163 (181)
                      .+.... ++  ++.++..+..||+.+|.|||++.|+|+|||-+|++|+ ...+.+||.|||.+++...- ....++.||+
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN-TySGvlKISDFGTsKRLAginP~TETFTGTL  740 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN-TYSGVLKISDFGTSKRLAGINPCTETFTGTL  740 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe-eccceEEecccccchhhccCCccccccccch
Confidence            886543 55  8899999999999999999999999999999999996 45667999999999876433 4455678999


Q ss_pred             CccCcccccCCcc
Q 030211          164 AYIAPEVLSRREY  176 (181)
Q Consensus       164 ~~~aPE~~~~~~~  176 (181)
                      .|||||+|-.++-
T Consensus       741 QYMAPEvIDqG~R  753 (1226)
T KOG4279|consen  741 QYMAPEVIDQGPR  753 (1226)
T ss_pred             hhhChHhhccCCc
Confidence            9999999987753

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=1.1e-29  Score=186.37  Aligned_cols=175  Identities=23%  Similarity=0.345  Sum_probs=141.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCc----EEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKE----LVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~----~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|+..+.||+|++|.||++.+..++.    .+++|.+......  ...+.+|+.+++.+.|||++++++++..+ ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            468899999999999999999876665    4688877653221  23677889999999999999999988754 4678


Q ss_pred             EEeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           76 VMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +++++++++|.+++..+. .+++..+..++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||++.......
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~--~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN--HVKITDFGLARLLEGDE  163 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC--ceEEccccccccccCcc
Confidence            999999999998886644 689999999999999999999999999999999999996555  49999999987543322


Q ss_pred             CC---CcccCCCCccCcccccCCccCCC
Q 030211          155 RP---KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~---~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..   ....++..|+|||++.+..++.+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~  191 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHYRKFTHQ  191 (303)
T ss_pred             cccccCCCccccccCCHHHhccCCCChH
Confidence            21   12334678999999988777654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=1.2e-29  Score=182.99  Aligned_cols=175  Identities=33%  Similarity=0.543  Sum_probs=144.2

Q ss_pred             cceeeeeeCCccceeEEEEEEcc-CCcEEEEEEccccc-----------cccHHHHHHHHHHh-hCCCCCeeEEEEeEEc
Q 030211            3 KYELVKDLGAGNFGVARLLRHKE-TKELVAVKYIERGR-----------KIDENVAREIINHR-SLRHPNIIRFKEVVLT   69 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~-~~~~v~~K~~~~~~-----------~~~~~~~~e~~~~~-~~~~~~i~~~~~~~~~   69 (181)
                      .|++.+.||+|++|.||++.+.. +++.+++|.+....           .....+..|+.++. .++|+|++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 67889999875321           11134566777665 4799999999999999


Q ss_pred             CCeEEEEEeecCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCCCcEEEeec
Q 030211           70 PTHLAIVMEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDF  144 (181)
Q Consensus        70 ~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~~~v~l~df  144 (181)
                      .+..+++|||+++++|.+.+..    ...+++..++.++.|++.++.+||+ .|++|+||+|+||+++++..  ++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecc
Confidence            9999999999999999877632    3468999999999999999999996 78999999999999976554  999999


Q ss_pred             CCcccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          145 GYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       145 g~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      |.+.............++..|+|||.+.++.++++
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~  193 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEK  193 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCchH
Confidence            99876554444445678899999999998776654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=186.00  Aligned_cols=178  Identities=28%  Similarity=0.499  Sum_probs=156.0

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc----ccccHHHHHHHHHHhh-CCCCCeeEEEEeEEcCCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRS-LRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~~~~-~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++.|+++.+||+|.+..|-.+..+++.+.+|+|++++.    .+...++..|.....+ ..+|.+|-++.+|+..+.+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            47899999999999999999999999999999998763    2334566666655543 478999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc-cCCC
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-VLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~-~~~~  154 (181)
                      |.||+.+++|.--+..+..++++.++.+...|..||.|||++||+.+|||.+|++++..+.  +||.|+|+++.. .++.
T Consensus       329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccchhhcCCCCCc
Confidence            9999999999877777889999999999999999999999999999999999999975555  999999999765 5566


Q ss_pred             CCCcccCCCCccCcccccCCccCCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ..++++|||.|.|||.+++..|+-++
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsv  432 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSV  432 (593)
T ss_pred             ccccccCCCcccchhhhcccccCcee
Confidence            67778999999999999999998654

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=8.2e-30  Score=189.55  Aligned_cols=173  Identities=32%  Similarity=0.522  Sum_probs=140.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcC-----CeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTP-----THLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~   74 (181)
                      ++|++.+.||+|++|.||++.+..+++.|++|.+....  .....+.+|+.+++.++|+|++++++++...     ...+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            68999999999999999999999999999999886422  2235677899999999999999999887654     3589


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +++|++++ ++...+ ....+++..+..++.|++.||.+||++|++|+||+|+||++++++.  ++|+|||++.......
T Consensus        85 lv~e~~~~-~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~  160 (336)
T cd07849          85 IVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEH  160 (336)
T ss_pred             EEehhccc-CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeeccccc
Confidence            99999965 777665 3457999999999999999999999999999999999999976554  9999999986543222


Q ss_pred             C----CCcccCCCCccCcccccC-CccCC
Q 030211          155 R----PKSTVGTPAYIAPEVLSR-REYDG  178 (181)
Q Consensus       155 ~----~~~~~~~~~~~aPE~~~~-~~~~~  178 (181)
                      .    .....+++.|+|||.+.+ ..++.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  189 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTK  189 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCc
Confidence            2    223467889999998754 34443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=1.6e-29  Score=183.70  Aligned_cols=170  Identities=31%  Similarity=0.482  Sum_probs=142.5

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +|++.+.||.|++|.||+|.+..+++.+++|.+.....   ....+.+|+..++.++|||++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            58999999999999999999998899999998864322   235688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CC
Q 030211           80 AAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RP  156 (181)
Q Consensus        80 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~  156 (181)
                      +. ++|..++..  ...+++..+..++.|++.|++|||+.|++|+||+|+||+++++..  ++|+|||.+....... ..
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~  157 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY  157 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence            95 578777754  346899999999999999999999999999999999999976654  9999999886443222 12


Q ss_pred             CcccCCCCccCcccccCCc
Q 030211          157 KSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~  175 (181)
                      ....+++.|+|||.+.+..
T Consensus       158 ~~~~~~~~y~aPE~~~~~~  176 (284)
T cd07860         158 THEVVTLWYRAPEILLGCK  176 (284)
T ss_pred             ccccccccccCCeEEecCC
Confidence            2234678899999886543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=2e-29  Score=183.23  Aligned_cols=167  Identities=34%  Similarity=0.532  Sum_probs=142.0

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcC--CeEEEEEe
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THLAIVME   78 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e   78 (181)
                      |++.+.||+|++|.||++.+..+++.+++|.+....   .....+.+|+.+++.+.|+|++++++++.+.  +..++++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            789999999999999999999889999999998653   2235678899999999999999999999988  88999999


Q ss_pred             ecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--
Q 030211           79 YAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (181)
Q Consensus        79 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--  155 (181)
                      |+++ +|.+.+... ..+++..++.++.|++.|+++||+.|++|+||+|+||++++++.  ++|+|||.+........  
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence            9975 788777654 47999999999999999999999999999999999999976554  99999999875544331  


Q ss_pred             CCcccCCCCccCcccccC
Q 030211          156 PKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~  173 (181)
                      .....++..|+|||.+.+
T Consensus       158 ~~~~~~~~~y~~PE~~~~  175 (287)
T cd07840         158 YTNRVITLWYRPPELLLG  175 (287)
T ss_pred             ccccccccccCCceeeEc
Confidence            223356788999997764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=1.6e-29  Score=181.18  Aligned_cols=169  Identities=33%  Similarity=0.438  Sum_probs=140.5

Q ss_pred             eeeCCccceeEEEEEEcc-CCc--EEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKE-TKE--LVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~-~~~--~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|++|.||++.+.. .++  .+++|.+.....  ..+.+..|+..++.++|+|++++++.+.. +..++++|++++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999865 333  689999876544  24678889999999999999999999988 889999999999


Q ss_pred             CChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC----C
Q 030211           83 GELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR----P  156 (181)
Q Consensus        83 ~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~----~  156 (181)
                      ++|.+.+....  .+++..++.++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||++........    .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD--KVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC--EEEeccccccccccccccceecc
Confidence            99999887654  689999999999999999999999999999999999997664  599999999875433221    1


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....++..|+|||++....++.+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~  180 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHA  180 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCch
Confidence            12346678999999987776654

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=3e-29  Score=179.18  Aligned_cols=169  Identities=27%  Similarity=0.337  Sum_probs=140.3

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCCh
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   85 (181)
                      +.||+|++|.||++.+.. ++.|++|.+.....  ....+.+|+.+++.+.|++++++++++.+....++++|++.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            468999999999999987 89999998875433  235788899999999999999999999999999999999999999


Q ss_pred             HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC---CcccC
Q 030211           86 FDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVG  161 (181)
Q Consensus        86 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~---~~~~~  161 (181)
                      .+++.+ ...++...+..++.+++.++.+||+++++|+||+|+||++++++  .++|+|||.+.........   .....
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN--VLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC--cEEEeeccccccccCCcceeccccCcc
Confidence            988855 34688999999999999999999999999999999999997555  4999999998643321111   11223


Q ss_pred             CCCccCcccccCCccCCC
Q 030211          162 TPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~  179 (181)
                      +..|+|||.+.++.++.+
T Consensus       158 ~~~y~~PE~~~~~~~~~~  175 (251)
T cd05041         158 PIKWTAPEALNYGRYTSE  175 (251)
T ss_pred             eeccCChHhhccCCCCcc
Confidence            567999999988777654

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=1.7e-29  Score=187.69  Aligned_cols=171  Identities=26%  Similarity=0.371  Sum_probs=141.7

Q ss_pred             cccee-eeeeCCccceeEEEEEEccCCcEEEEEEcccccccc---------------HHHHHHHHHHhhCCCCCeeEEEE
Q 030211            2 EKYEL-VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---------------ENVAREIINHRSLRHPNIIRFKE   65 (181)
Q Consensus         2 ~~y~~-~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~---------------~~~~~e~~~~~~~~~~~i~~~~~   65 (181)
                      +||.. .+.||+|++|.||++.+..+++.|++|.+.......               ..+.+|+..+..++|+|++++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            57765 577999999999999999889999999886532211               24678999999999999999999


Q ss_pred             eEEcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecC
Q 030211           66 VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG  145 (181)
Q Consensus        66 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg  145 (181)
                      ++...+..+++||++. ++|.+.+.....+++.....++.|++.||.+||++|++|+||+|+||++++++.  ++|+|||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~dfg  164 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFG  164 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECCcc
Confidence            9999999999999996 588888877778999999999999999999999999999999999999976554  9999999


Q ss_pred             CcccccC---------------CCCCCcccCCCCccCcccccCCc
Q 030211          146 YSKSSVL---------------HSRPKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       146 ~a~~~~~---------------~~~~~~~~~~~~~~aPE~~~~~~  175 (181)
                      .+.....               ........+++.|+|||.+.+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  209 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE  209 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccCC
Confidence            8864331               11111224578899999987543

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.7e-30  Score=193.61  Aligned_cols=170  Identities=26%  Similarity=0.334  Sum_probs=141.8

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEe
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      .|++.++||+||.+.||++...+. +.+|+|.+.....   ...-+..|+..|.++ +|.+|++++++-...+++|+|||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            589999999999999999998754 4567776544322   346789999999988 57999999999999999999999


Q ss_pred             ecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           79 YAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      + +..+|.+++.+.. ..+...+..++.|++.|+.++|..||||.||||.|+++.   .+.+||+|||+|..+.+.....
T Consensus       441 ~-Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV---kG~LKLIDFGIA~aI~~DTTsI  516 (677)
T KOG0596|consen  441 C-GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV---KGRLKLIDFGIANAIQPDTTSI  516 (677)
T ss_pred             c-ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE---eeeEEeeeechhcccCccccce
Confidence            5 5779999887655 344458899999999999999999999999999999994   4459999999998877776643


Q ss_pred             ---cccCCCCccCcccccCCccC
Q 030211          158 ---STVGTPAYIAPEVLSRREYD  177 (181)
Q Consensus       158 ---~~~~~~~~~aPE~~~~~~~~  177 (181)
                         +-+||+.|||||.+....++
T Consensus       517 ~kdsQvGT~NYMsPEAl~~~~s~  539 (677)
T KOG0596|consen  517 VKDSQVGTVNYMSPEALTDMSSS  539 (677)
T ss_pred             eeccccCcccccCHHHHhhcccc
Confidence               34799999999999877665

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=2.9e-29  Score=180.66  Aligned_cols=168  Identities=18%  Similarity=0.200  Sum_probs=134.3

Q ss_pred             eeeCCccceeEEEEEEccC------------CcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            8 KDLGAGNFGVARLLRHKET------------KELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~------------~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      +.||+|++|.||+++....            ...+++|.+..... ....+.+++.++..++|||++++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            4689999999999985422            23588888765432 2356778889999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCC-----CcEEEeecCCcc
Q 030211           75 IVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA-----PRLKICDFGYSK  148 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~-----~~v~l~dfg~a~  148 (181)
                      ++|||+++++|..++.. ...+++..+..++.|++.|++|||++|++|+||+|+||+++.++.     ..+++.|||.+.
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~  160 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI  160 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence            99999999998887764 346899999999999999999999999999999999999964432     238999999875


Q ss_pred             cccCCCCCCcccCCCCccCcccccC-CccCC
Q 030211          149 SSVLHSRPKSTVGTPAYIAPEVLSR-REYDG  178 (181)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~  178 (181)
                      ...   ......++..|+|||.+.+ ..++.
T Consensus       161 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~  188 (262)
T cd05077         161 TVL---SRQECVERIPWIAPECVEDSKNLSI  188 (262)
T ss_pred             ccc---CcccccccccccChhhhcCCCCCCc
Confidence            432   2223457788999999874 44443

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=3.2e-29  Score=184.77  Aligned_cols=170  Identities=29%  Similarity=0.437  Sum_probs=133.9

Q ss_pred             eeeeCCccceeEEEEEEcc--CCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEc--CCeEEEEEeecCC
Q 030211            7 VKDLGAGNFGVARLLRHKE--TKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT--PTHLAIVMEYAAG   82 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~--~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~~~~   82 (181)
                      ..+||+|+||.||+|.+.+  ++..+++|.+.... ....+.+|+.+++.++|||++++++++..  ....++++||+++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            4679999999999999754  56789999886543 34567789999999999999999998854  5678999999865


Q ss_pred             CChHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc--CCCCcEEEeecCCccccc
Q 030211           83 GELFDRICN---------AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG--SAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        83 ~~l~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~--~~~~~v~l~dfg~a~~~~  151 (181)
                       +|.+.+..         ...+++..++.++.|++.||.+||+.|++|+||+|+||++..  +..+.++|+|||++....
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence             67666532         124888999999999999999999999999999999999942  234469999999997543


Q ss_pred             CCCC----CCcccCCCCccCcccccCCc-cCC
Q 030211          152 LHSR----PKSTVGTPAYIAPEVLSRRE-YDG  178 (181)
Q Consensus       152 ~~~~----~~~~~~~~~~~aPE~~~~~~-~~~  178 (181)
                      ....    .....+++.|+|||++.+.. ++.
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  195 (317)
T cd07867         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTK  195 (317)
T ss_pred             CCcccccccCcceecccccCcHHhcCCCccCc
Confidence            3221    22346789999999987643 443

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=4.2e-30  Score=184.51  Aligned_cols=164  Identities=17%  Similarity=0.191  Sum_probs=135.4

Q ss_pred             eeeCCccceeEEEEEEccCCc-------EEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            8 KDLGAGNFGVARLLRHKETKE-------LVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~-------~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +.||+|+||.||++.+...+.       .+++|.+..... ..+.+.+|..+++.+.|||++++++++..++..+++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            478999999999998865433       378887754332 235678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCC------cEEEeecCCcccccC
Q 030211           80 AAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP------RLKICDFGYSKSSVL  152 (181)
Q Consensus        80 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~------~v~l~dfg~a~~~~~  152 (181)
                      +.+++|..++..+. .+++.....++.|++.||++||++|++|+||+|+||+++++...      .+++.|||.+.....
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~  160 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP  160 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence            99999999886644 58999999999999999999999999999999999999755432      479999998764332


Q ss_pred             CCCCCcccCCCCccCcccccCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~  174 (181)
                         .....+++.|+|||++.+.
T Consensus       161 ---~~~~~~~~~y~aPE~~~~~  179 (258)
T cd05078         161 ---KEILLERIPWVPPECIENP  179 (258)
T ss_pred             ---chhccccCCccCchhccCC
Confidence               2234678899999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-29  Score=184.00  Aligned_cols=168  Identities=38%  Similarity=0.547  Sum_probs=143.1

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCeEEEEEeec
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      |++.+.||+|++|.||+|....+++.+++|.+.....  ......+|+..+..++ |++++++++++.+++..+++||++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            7889999999999999999998899999998865432  1234456888888888 999999999999999999999999


Q ss_pred             CCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           81 AGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                       +++|.+.+....  .+++..+..++.|++.+|.+||++|++|+||+|+||+++++.  .++|+|||.+...........
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE--VVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC--CEEEeecccceeccCCCCcCC
Confidence             778888876654  789999999999999999999999999999999999997655  499999999876555444455


Q ss_pred             ccCCCCccCcccccCC
Q 030211          159 TVGTPAYIAPEVLSRR  174 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~  174 (181)
                      ..++..|+|||++.+.
T Consensus       158 ~~~~~~~~aPE~~~~~  173 (283)
T cd07830         158 YVSTRWYRAPEILLRS  173 (283)
T ss_pred             CCCcccccCceeeecC
Confidence            6688899999988543

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=1.4e-29  Score=183.33  Aligned_cols=167  Identities=20%  Similarity=0.198  Sum_probs=133.7

Q ss_pred             eeCCccceeEEEEEEcc------------------------CCcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEE
Q 030211            9 DLGAGNFGVARLLRHKE------------------------TKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRF   63 (181)
Q Consensus         9 ~i~~g~~~~v~~~~~~~------------------------~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~   63 (181)
                      .||+|+||.||++....                        ....|++|.+...... ...+.+++.+++.++|||++++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997532                        1235888887654322 3567788889999999999999


Q ss_pred             EEeEEcCCeEEEEEeecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-----CC
Q 030211           64 KEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-----AP  137 (181)
Q Consensus        64 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-----~~  137 (181)
                      ++++.+.+..++||||+++++|..++.. .+.+++..+..++.|++.||+|||++|++|+||+|+||++++.+     ..
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~  161 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP  161 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence            9999999999999999999999888765 45789999999999999999999999999999999999996432     23


Q ss_pred             cEEEeecCCcccccCCCCCCcccCCCCccCcccccCC-ccCC
Q 030211          138 RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR-EYDG  178 (181)
Q Consensus       138 ~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~  178 (181)
                      .+++.|||.+.....   .....++..|+|||.+.+. .+++
T Consensus       162 ~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~  200 (274)
T cd05076         162 FIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLST  200 (274)
T ss_pred             eeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCc
Confidence            489999998753322   1224567889999988763 3443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=5.4e-29  Score=181.00  Aligned_cols=173  Identities=31%  Similarity=0.473  Sum_probs=142.1

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhC---CCCCeeEEEEeEEcCCe-----
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSL---RHPNIIRFKEVVLTPTH-----   72 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~---~~~~i~~~~~~~~~~~~-----   72 (181)
                      |++.+.||+|++|.||++.++.+++.+++|.+......   ...+.+|+.++..+   .|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            78999999999999999999988999999998743222   23455666666554   69999999999998776     


Q ss_pred             EEEEEeecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc
Q 030211           73 LAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS  150 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~  150 (181)
                      .+++||++.+ +|.+++....  .+++..++.++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||.+...
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~--~~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG--QVKIADFGLARIY  157 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC--CEEEeccCcceec
Confidence            9999999965 7877776533  589999999999999999999999999999999999997664  5999999998765


Q ss_pred             cCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          151 VLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       151 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..........++..|+|||++.+..++.+
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~  186 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQSSYATP  186 (287)
T ss_pred             cCCcccccccccccccChHHhccCCCCCc
Confidence            44444444557889999999988776654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=2.8e-29  Score=181.18  Aligned_cols=164  Identities=22%  Similarity=0.320  Sum_probs=131.1

Q ss_pred             eeeCCccceeEEEEEEcc--CCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCC
Q 030211            8 KDLGAGNFGVARLLRHKE--TKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~--~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (181)
                      +.||+|+||.||++....  ....+++|.+.....  ....+.+|+..++.++|+|++++++.+...+..+++|||++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999997543  345688887754322  2346778999999999999999999999999999999999999


Q ss_pred             ChHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC---
Q 030211           84 ELFDRICNAG-----RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---  155 (181)
Q Consensus        84 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~---  155 (181)
                      +|.+++....     ..++.....++.|++.|++|||++|++|+||+|+||+++++..  ++|+|||++........   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheec
Confidence            9999886543     2467788999999999999999999999999999999976554  99999999864332211   


Q ss_pred             CCcccCCCCccCcccccC
Q 030211          156 PKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~  173 (181)
                      .....+++.|+|||++..
T Consensus       159 ~~~~~~~~~y~aPE~~~~  176 (269)
T cd05042         159 KDCHAVPLRWLAPELVEI  176 (269)
T ss_pred             cCCCCCcccccCHHHHhh
Confidence            222345678999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.5e-29  Score=187.49  Aligned_cols=166  Identities=28%  Similarity=0.444  Sum_probs=139.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC------e
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPT------H   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~------~   72 (181)
                      ++|++.+.||+|++|.||++.+..++..||+|.+.....   ....+.+|+.+++.++|+|++++++++....      .
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            589999999999999999999998999999998864321   2346778999999999999999999987653      4


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ++++++++ +++|...+. ...+++..++.++.|++.||.+||+.|++|+||+|+||++++++  .++|+|||++.....
T Consensus        95 ~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~--~~kl~dfg~~~~~~~  170 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQTDS  170 (343)
T ss_pred             EEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeccccccccc
Confidence            68999998 668877664 45799999999999999999999999999999999999997555  499999999865422


Q ss_pred             CCCCCcccCCCCccCcccccC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~  173 (181)
                        ......+++.|+|||.+.+
T Consensus       171 --~~~~~~~~~~y~aPE~~~~  189 (343)
T cd07880         171 --EMTGYVVTRWYRAPEVILN  189 (343)
T ss_pred             --CccccccCCcccCHHHHhC
Confidence              2233467889999999875

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=2.6e-29  Score=184.10  Aligned_cols=171  Identities=33%  Similarity=0.539  Sum_probs=140.4

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC------
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPT------   71 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~------   71 (181)
                      +++|++.+.||+|++|.||++.++.+++.|++|.+....   .....+.+|+.+++.++|||++++++++.+..      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            368999999999999999999999889999999986542   22346678999999999999999999887655      


Q ss_pred             ----eEEEEEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCC
Q 030211           72 ----HLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (181)
Q Consensus        72 ----~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~  146 (181)
                          .+++++||+++ ++...+... ..+++..++.++.|++.||.+||++|++|+||+|+||+++++..  ++|+|||.
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~  162 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGL  162 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccc
Confidence                78999999976 666666543 46899999999999999999999999999999999999976554  99999999


Q ss_pred             cccccCCCC--CCcccCCCCccCcccccCC
Q 030211          147 SKSSVLHSR--PKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       147 a~~~~~~~~--~~~~~~~~~~~aPE~~~~~  174 (181)
                      +........  .....++..|+|||.+.+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  192 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGE  192 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCC
Confidence            875433322  1223457789999988643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=3.4e-29  Score=181.92  Aligned_cols=168  Identities=33%  Similarity=0.512  Sum_probs=142.2

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      |++.+.||.|++|.||++.+..++..+++|.+.....   ....+.+|+..++.++|++++++++++.+++..++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            7889999999999999999998999999998875432   2356788999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCC
Q 030211           81 AGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPK  157 (181)
Q Consensus        81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~  157 (181)
                      + ++|.+++....  .+++..+..++.|++.+|.+||+++++|+||+|+||++++++  .++|+|||.+....... ...
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--cEEEeecccccccCCCccccC
Confidence            5 58888887655  689999999999999999999999999999999999997655  49999999986543222 222


Q ss_pred             cccCCCCccCcccccCC
Q 030211          158 STVGTPAYIAPEVLSRR  174 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~  174 (181)
                      ...+++.|+|||++.+.
T Consensus       158 ~~~~~~~~~aPE~~~~~  174 (283)
T cd07835         158 HEVVTLWYRAPEILLGS  174 (283)
T ss_pred             ccccccCCCCCceeecC
Confidence            33567889999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=2.2e-29  Score=183.91  Aligned_cols=172  Identities=28%  Similarity=0.476  Sum_probs=144.9

Q ss_pred             eeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCC
Q 030211            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (181)
Q Consensus         5 ~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (181)
                      +....||+|++|.||++....++..+++|.+..... ....+.+|+.+++.++|+|++++++.+..++..+++|||++++
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            334679999999999999998899999998764332 2456788999999999999999999999999999999999999


Q ss_pred             ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCCcccCC
Q 030211           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTVGT  162 (181)
Q Consensus        84 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~~~~~~  162 (181)
                      +|.+.+. ...+++..++.++.|++.++++||++|++|+||+|+||++++++.  ++|+|||.+....... ......++
T Consensus       103 ~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~  179 (292)
T cd06657         103 ALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLVGT  179 (292)
T ss_pred             cHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceecccccccccccccC
Confidence            9988663 456899999999999999999999999999999999999976554  9999999876543332 22335678


Q ss_pred             CCccCcccccCCccCCC
Q 030211          163 PAYIAPEVLSRREYDGK  179 (181)
Q Consensus       163 ~~~~aPE~~~~~~~~~~  179 (181)
                      +.|+|||.+.+..++++
T Consensus       180 ~~y~~pE~~~~~~~~~~  196 (292)
T cd06657         180 PYWMAPELISRLPYGPE  196 (292)
T ss_pred             ccccCHHHhcCCCCCch
Confidence            89999999988777654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=2.7e-29  Score=182.90  Aligned_cols=170  Identities=25%  Similarity=0.333  Sum_probs=140.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|+..+.||+|++|.||++.+..+++.+++|.+.....  ....+.+|+..+..+. |+|++++++++..++..+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            467888999999999999999999999999998875432  2356778888888885 9999999999999999999999


Q ss_pred             ecCCCChHHHH---h--hcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           79 YAAGGELFDRI---C--NAGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        79 ~~~~~~l~~~~---~--~~~~~~~~~~~~~~~~i~~~l~~lh~~-gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ++.. ++.+..   .  ....+++..+..++.|++.||++||+. +++|+||+|+||++++++.  ++|+|||++.....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhcc
Confidence            9854 544322   1  235799999999999999999999975 9999999999999976554  99999999875544


Q ss_pred             CCCCCcccCCCCccCcccccCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~  174 (181)
                      ........+++.|+|||.+.+.
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~  182 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPS  182 (288)
T ss_pred             CCccccccCccCccCHHHhccc
Confidence            4444445688999999999876

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=2.3e-29  Score=184.91  Aligned_cols=171  Identities=30%  Similarity=0.468  Sum_probs=138.1

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcC-------
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTP-------   70 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-------   70 (181)
                      +++|++.+.||+|++|.||+|.+..+++.+++|.+.....   ......+|+.+++.++|+|++++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4799999999999999999999998999999998864322   124567899999999999999999887543       


Q ss_pred             -CeEEEEEeecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211           71 -THLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus        71 -~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                       ..++++++|+.. ++...+.. ...+++..+..++.|++.||.+||++|++|+||+|+||++++++.  ++|+|||++.
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~  163 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR  163 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccch
Confidence             347999999865 66665544 347999999999999999999999999999999999999976554  9999999986


Q ss_pred             cccCCCCC------------CcccCCCCccCcccccCC
Q 030211          149 SSVLHSRP------------KSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       149 ~~~~~~~~------------~~~~~~~~~~aPE~~~~~  174 (181)
                      ........            ....+++.|+|||.+.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  201 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE  201 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCC
Confidence            43322211            112457889999987653

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=5.8e-29  Score=179.59  Aligned_cols=164  Identities=25%  Similarity=0.316  Sum_probs=132.5

Q ss_pred             eeeCCccceeEEEEEEcc--CCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCC
Q 030211            8 KDLGAGNFGVARLLRHKE--TKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~--~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (181)
                      +.||+|+||.||++....  ++..+++|.+......  ...+.+|+.+++.++|||++++++.+.+....+++|||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653  4567899987654322  246788999999999999999999999999999999999999


Q ss_pred             ChHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC---
Q 030211           84 ELFDRICNAG-----RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---  155 (181)
Q Consensus        84 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~---  155 (181)
                      +|.+++....     ..++..+..++.|++.|+++||++|++|+||+|+||+++.+.  .++|+|||.+........   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~--~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL--TVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEECCccccccccCcceeec
Confidence            9998886422     356678889999999999999999999999999999997654  499999999864322221   


Q ss_pred             CCcccCCCCccCcccccC
Q 030211          156 PKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~  173 (181)
                      .....+++.|+|||++.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~  176 (269)
T cd05087         159 PDQLWVPLRWIAPELVDE  176 (269)
T ss_pred             CCCcCCcccccCHhHhcc
Confidence            122346788999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=2.4e-29  Score=182.44  Aligned_cols=172  Identities=35%  Similarity=0.542  Sum_probs=145.5

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      |++.+.||+|++|.+|++++..+++.+++|.+....   ...+.+..|+..++.+.|++++++.+++.+.+..++++|++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            678899999999999999999889999999987642   23456778999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCCc
Q 030211           81 AGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKS  158 (181)
Q Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~~  158 (181)
                      + ++|.+++... ..+++..+..++.|++.+|.+||++|++|+||+|+||+++++.  .++|+|||.+....... ....
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~--~~~l~d~g~~~~~~~~~~~~~~  157 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG--VLKLADFGLARAFGIPLRTYTH  157 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC--CEEEecCCcccccCCCccccCc
Confidence            7 4898888765 5799999999999999999999999999999999999997654  49999999987543332 2223


Q ss_pred             ccCCCCccCcccccCC-ccCC
Q 030211          159 TVGTPAYIAPEVLSRR-EYDG  178 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~-~~~~  178 (181)
                      ...+..|+|||.+.+. .+++
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~  178 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYST  178 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCc
Confidence            3457789999998766 4444

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=4.3e-29  Score=182.64  Aligned_cols=172  Identities=26%  Similarity=0.389  Sum_probs=139.8

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +++|++.+.||+|++|.||++.+..+++.+++|.+.....  ....+..++..+... .|+|++++++++.+....+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            4689999999999999999999998899999999875432  234455666655555 5999999999999999999999


Q ss_pred             eecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      |++++ .+...... ...+++..+..++.|++.++.|||+ .|++|+||+|+||+++++.  .++|+|||.+........
T Consensus        94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~--~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG--NVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC--CEEECccccchhccCCCc
Confidence            99854 66655543 3478999999999999999999997 5999999999999997555  499999999875544444


Q ss_pred             CCcccCCCCccCcccccCCc
Q 030211          156 PKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~  175 (181)
                      .....+++.|+|||.+.+..
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~  190 (296)
T cd06618         171 KTRSAGCAAYMAPERIDPPD  190 (296)
T ss_pred             ccCCCCCccccCHhhcCCCC
Confidence            44456788999999997654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=6.3e-29  Score=181.70  Aligned_cols=175  Identities=17%  Similarity=0.217  Sum_probs=131.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC---CcEEEEEEcccccccc--H----------HHHHHHHHHhhCCCCCeeEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGRKID--E----------NVAREIINHRSLRHPNIIRFKEV   66 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~~~--~----------~~~~e~~~~~~~~~~~i~~~~~~   66 (181)
                      ++|++.+.||+|+||.||+|.+.++   +..+++|.........  +          ....++..+..+.|++++++++.
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            4799999999999999999998876   6667777643222111  0          11223344556789999999987


Q ss_pred             EEcCC----eEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEe
Q 030211           67 VLTPT----HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKIC  142 (181)
Q Consensus        67 ~~~~~----~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~  142 (181)
                      +....    ..+++++++.. ++.+.+......++..+..++.|++.||.+||+++++||||||+||+++++.  .++|+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~--~~~l~  168 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN--RGYII  168 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--cEEEE
Confidence            66543    35677887643 6666665555578889999999999999999999999999999999997554  49999


Q ss_pred             ecCCcccccCCC--------CCCcccCCCCccCcccccCCccCCC
Q 030211          143 DFGYSKSSVLHS--------RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       143 dfg~a~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      |||+|.......        ......||+.|+|||+..+..++.+
T Consensus       169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~  213 (294)
T PHA02882        169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR  213 (294)
T ss_pred             EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH
Confidence            999987543221        1223468999999999998888765

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=2.5e-29  Score=187.01  Aligned_cols=168  Identities=33%  Similarity=0.505  Sum_probs=139.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc---ccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcC--CeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSL-RHPNIIRFKEVVLTP--THLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~--~~~~~   75 (181)
                      ++|++.+.||+|++|.||++.+..++..+++|.+...   ......+.+|+.++.++ +|+|++++++++...  ...++
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            6899999999999999999999988999999987542   12234567799999999 999999999988654  36899


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-  154 (181)
                      +||++. ++|...+..+ .+++.....++.|++.+|.+||++|++|+||+|+||++++++.  ++|+|||.+....... 
T Consensus        87 v~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          87 VFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELEE  162 (337)
T ss_pred             Eecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhccccccc
Confidence            999996 4888777654 7889999999999999999999999999999999999976655  9999999987543322 


Q ss_pred             -----CCCcccCCCCccCcccccC
Q 030211          155 -----RPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       155 -----~~~~~~~~~~~~aPE~~~~  173 (181)
                           ......++..|+|||.+.+
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~  186 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLG  186 (337)
T ss_pred             cccCcchhcccccccccCceeeec
Confidence                 1223457889999998765

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=4e-29  Score=178.36  Aligned_cols=167  Identities=38%  Similarity=0.648  Sum_probs=144.2

Q ss_pred             eCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCCh
Q 030211           10 LGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (181)
Q Consensus        10 i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   85 (181)
                      ||+|++|.+|++.+..+++.+++|.+.....    ....+..|+.+++.++|++++++++.+..++..+++||++++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999999988899999999876533    234678889999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCCCcccCCCC
Q 030211           86 FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPA  164 (181)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~~~~  164 (181)
                      .+++.....+++..+..++.|++.++.+||+.+++|+||+|+||++++++  .++|+|||.+...... .......++..
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG--HIKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC--cEEEeecCcceecccCCCcccCCcCCcc
Confidence            99998777899999999999999999999999999999999999997655  4999999998754433 23344567889


Q ss_pred             ccCcccccCCccCC
Q 030211          165 YIAPEVLSRREYDG  178 (181)
Q Consensus       165 ~~aPE~~~~~~~~~  178 (181)
                      |+|||.+.+...+.
T Consensus       159 ~~~Pe~~~~~~~~~  172 (250)
T cd05123         159 YLAPEVLLGKGYGK  172 (250)
T ss_pred             ccChHHhCCCCCCc
Confidence            99999988766544

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=191.36  Aligned_cols=165  Identities=28%  Similarity=0.365  Sum_probs=137.5

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHH--hhCCCCCeeEEEEeEEcCC----eEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH--RSLRHPNIIRFKEVVLTPT----HLAIV   76 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~--~~~~~~~i~~~~~~~~~~~----~~~~v   76 (181)
                      ..++.++||+|.||.||+|+-.  ++.||||++....+  +.+.+|-.+.  ..++|+||++++..-.-..    .+++|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~k--qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEK--QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc--CceeEEEecCHHHH--HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            4567889999999999999876  58899999986544  4555555554  4678999999998876554    79999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---------cCeeeeCCCCCCEEeccCCCCcEEEeecCCc
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS---------MQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---------~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a  147 (181)
                      ++|.+.++|.+++.. ..+++....+++..++++|+|||+         ..|+|||||..||++.+|.+  ..|.|||+|
T Consensus       287 t~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGLA  363 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFGLA  363 (534)
T ss_pred             eeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeecccee
Confidence            999999999999854 589999999999999999999997         35999999999999987776  999999999


Q ss_pred             ccccCCCCCCc---ccCCCCccCcccccCC
Q 030211          148 KSSVLHSRPKS---TVGTPAYIAPEVLSRR  174 (181)
Q Consensus       148 ~~~~~~~~~~~---~~~~~~~~aPE~~~~~  174 (181)
                      ....+......   -.||.+|||||++++.
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEga  393 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGA  393 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhh
Confidence            77665444333   3689999999999864

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=203.67  Aligned_cols=171  Identities=31%  Similarity=0.456  Sum_probs=147.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc-cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      +.|+++..+|-|+||.||+|.+++++...|.|++.... ...+.++-|+.++..+.||+++.+++.|+..+.+|++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            35788999999999999999999988888889886543 34578889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCCCc
Q 030211           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKS  158 (181)
Q Consensus        81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~~~  158 (181)
                      +||-+...+.. ...+++..+.-+.+|++.||.|||++.|+|+||+..||+++-++.  |+|.|||.+...... ..--+
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRDs  189 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRDS  189 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhcc
Confidence            99988776654 447999999999999999999999999999999999999976665  999999987543322 33445


Q ss_pred             ccCCCCccCcccccCC
Q 030211          159 TVGTPAYIAPEVLSRR  174 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~  174 (181)
                      +.|||.|||||++...
T Consensus       190 FIGTPYWMAPEVvmCE  205 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCE  205 (1187)
T ss_pred             ccCCcccccchheeec
Confidence            7899999999998643

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=1.6e-28  Score=181.28  Aligned_cols=164  Identities=30%  Similarity=0.481  Sum_probs=138.3

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      .|+..+.||+|+||.+|++.+..++..+++|.+......    ...+..|+..++.++|+|++++++++.+.+..+++||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            477888999999999999999988999999988654222    2467789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           79 YAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      |+.+ ++.+.+.. ..++++..+..++.|++.++.+||++|++|+||+|+||++++++  .++|+|||.+.....   ..
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~--~~kl~dfg~~~~~~~---~~  179 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASIASP---AN  179 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC--CEEEecCCCccccCC---cc
Confidence            9975 66666543 45789999999999999999999999999999999999997555  499999998764322   23


Q ss_pred             cccCCCCccCccccc
Q 030211          158 STVGTPAYIAPEVLS  172 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~  172 (181)
                      ...+++.|+|||.+.
T Consensus       180 ~~~~~~~y~aPE~~~  194 (317)
T cd06635         180 SFVGTPYWMAPEVIL  194 (317)
T ss_pred             cccCCccccChhhhh
Confidence            346788999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=5.5e-29  Score=184.86  Aligned_cols=168  Identities=31%  Similarity=0.480  Sum_probs=138.1

Q ss_pred             cceeeeeeCCccceeEEEEEEccC--CcEEEEEEccccc---cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcC----Ce
Q 030211            3 KYELVKDLGAGNFGVARLLRHKET--KELVAVKYIERGR---KIDENVAREIINHRSL-RHPNIIRFKEVVLTP----TH   72 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~--~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~----~~   72 (181)
                      +|++.+.||+|+||.||++.+..+  +..+|+|.+....   ...+.+.+|+.++..+ .|+|++++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            589999999999999999999877  8899999886432   1235677889989888 599999999875432    45


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      .++++++++ .+|.+.+.....+++..++.++.|++.||++||++|++|+||+|+||++++++.  ++|+|||.+.....
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~  157 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE  157 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence            788999885 588888877778999999999999999999999999999999999999976554  99999999875432


Q ss_pred             CCC-----CCcccCCCCccCcccccC
Q 030211          153 HSR-----PKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       153 ~~~-----~~~~~~~~~~~aPE~~~~  173 (181)
                      ...     .....+++.|+|||.+.+
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~  183 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLS  183 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhC
Confidence            221     223468899999998765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=3.4e-30  Score=200.95  Aligned_cols=176  Identities=26%  Similarity=0.378  Sum_probs=151.7

Q ss_pred             cceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +.++++.||+|+||.||+|...     .....||||.++.....  ..+|.+|+.++..++|||||++++++.+++.+++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            4577889999999999999864     23457999999876543  5789999999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhc----------CC----CCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEE
Q 030211           76 VMEYAAGGELFDRICNA----------GR----FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKI  141 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~----------~~----~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l  141 (181)
                      |+|||..|+|.+++..+          .+    ++..+.+.++.||+.+++||-++.++|+||-..|.+|.+.-  .|||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l--~VKI  644 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL--VVKI  644 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce--EEEe
Confidence            99999999999998642          22    78889999999999999999999999999999999996444  5999


Q ss_pred             eecCCcccccCCCCCCcc---cCCCCccCcccccCCccCCCC
Q 030211          142 CDFGYSKSSVLHSRPKST---VGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       142 ~dfg~a~~~~~~~~~~~~---~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      .|||+++......-....   .-..+|||||.|..+.|+++|
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteS  686 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTES  686 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchh
Confidence            999999876655554433   346899999999999999876

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=9.6e-29  Score=183.28  Aligned_cols=171  Identities=30%  Similarity=0.508  Sum_probs=140.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEc-CCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLT-PTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~   77 (181)
                      ++|++.+.||.|++|.||++.+..+++.+++|.+....   ...+.+.+|+.++..++|||++++.+++.. ....++++
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            58999999999999999999999999999999875422   223567789999999999999999999876 45789999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      |++ +++|...+. ..+++...+..++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||.+.....  ...
T Consensus        90 e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~--~~~l~dfg~~~~~~~--~~~  163 (328)
T cd07856          90 ELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC--DLKICDFGLARIQDP--QMT  163 (328)
T ss_pred             ehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC--CEEeCccccccccCC--CcC
Confidence            998 457877664 45688899999999999999999999999999999999997554  499999998864322  223


Q ss_pred             cccCCCCccCcccccC-CccCC
Q 030211          158 STVGTPAYIAPEVLSR-REYDG  178 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~-~~~~~  178 (181)
                      ...+++.|+|||.+.. ..++.
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~  185 (328)
T cd07856         164 GYVSTRYYRAPEIMLTWQKYDV  185 (328)
T ss_pred             CCcccccccCceeeeccCCcCc
Confidence            3456889999998765 33443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=3.6e-29  Score=180.50  Aligned_cols=171  Identities=25%  Similarity=0.347  Sum_probs=139.4

Q ss_pred             eeCCccceeEEEEEEccCC------cEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            9 DLGAGNFGVARLLRHKETK------ELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         9 ~i~~g~~~~v~~~~~~~~~------~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      .||+|++|.||++++.+..      ..+++|.+....  .....+.+|+..++.++|||++++++++...+..+++||++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            6899999999999986433      678999876543  23457888999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC---CCcEEEeecCCcccc
Q 030211           81 AGGELFDRICNA-------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA---APRLKICDFGYSKSS  150 (181)
Q Consensus        81 ~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~---~~~v~l~dfg~a~~~  150 (181)
                      ++++|.+++...       ..+++..+..++.|++.++.+||+++++|+||+|+||+++++.   ...++|+|||++...
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~  161 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI  161 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence            999999888542       2478899999999999999999999999999999999997554   225999999998654


Q ss_pred             cCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          151 VLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       151 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .....   .....++..|+|||.+.++.++.+
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  193 (269)
T cd05044         162 YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQ  193 (269)
T ss_pred             ccccccccCcccCCCccccCHHHHccCCcccc
Confidence            32211   112345678999999988877664

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=2.9e-29  Score=182.08  Aligned_cols=168  Identities=34%  Similarity=0.489  Sum_probs=143.3

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      |++.+.||+|++|.+|++.+..+++.+++|.+......   ...+.+|+.+++.++|++++++++++.+++..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            67889999999999999999988999999988654322   356778999999999999999999999999999999999


Q ss_pred             CCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCCc
Q 030211           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKS  158 (181)
Q Consensus        81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~~  158 (181)
                      ++ ++.+.+.. +..+++..+..++.|++.+|.+||+.|++|+||+|+||+++++.  .++|+|||.+....... ....
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~df~~~~~~~~~~~~~~~  157 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG--VLKLADFGLARSFGSPVRPYTH  157 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC--cEEEeeeeeeEecCCCcccccC
Confidence            75 77777755 35789999999999999999999999999999999999997555  49999999986554433 2333


Q ss_pred             ccCCCCccCcccccCC
Q 030211          159 TVGTPAYIAPEVLSRR  174 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~  174 (181)
                      ..++..|+|||.+.+.
T Consensus       158 ~~~~~~~~~PE~~~~~  173 (283)
T cd05118         158 YVVTRWYRAPELLLGD  173 (283)
T ss_pred             ccCcccccCcHHHhcC
Confidence            4578889999998766

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=6.3e-29  Score=181.04  Aligned_cols=171  Identities=31%  Similarity=0.544  Sum_probs=143.6

Q ss_pred             cceeeeeeCCccceeEEEEEEc---cCCcEEEEEEccccc-----cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeE
Q 030211            3 KYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR-----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~-----~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~   73 (181)
                      +|++.+.||+|++|.||++.+.   .++..+++|.+....     ...+.+.+|+.++..+ .|++++.+.+.+...+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5899999999999999999864   457889999886432     1234577899999999 589999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      +++|||+.+++|...+..+..+++..+..++.|++.+|.+||+.|++|+||+|+||+++++.  .++|+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~  158 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG--HVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEEECccccccccc
Confidence            99999999999999888777899999999999999999999999999999999999997655  4999999998654333


Q ss_pred             CC--CCcccCCCCccCcccccCCc
Q 030211          154 SR--PKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       154 ~~--~~~~~~~~~~~aPE~~~~~~  175 (181)
                      ..  .....++..|+|||.+.+..
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~  182 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGS  182 (288)
T ss_pred             cccccccccCCccccCHHHhcCCC
Confidence            22  22345788999999987654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=9.3e-29  Score=184.53  Aligned_cols=172  Identities=27%  Similarity=0.448  Sum_probs=140.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcC------Ce
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTP------TH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~------~~   72 (181)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+.....   ..+.+.+|+.++..++|+|++++++++...      +.
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            689999999999999999999988899999999875322   235677899999999999999999988643      34


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      .+++++++ +++|.+.+. ...+++..++.++.|++.|+.+||++|++|+||+|+||++++++.  ++|+|||++.... 
T Consensus        97 ~~lv~~~~-~~~L~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~~-  171 (345)
T cd07877          97 VYLVTHLM-GADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD-  171 (345)
T ss_pred             EEEEehhc-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEeccccccccc-
Confidence            77888877 668877664 346899999999999999999999999999999999999976554  9999999986432 


Q ss_pred             CCCCCcccCCCCccCcccccC-CccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSR-REYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~  179 (181)
                       .......++..|+|||.+.+ ..++++
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~  198 (345)
T cd07877         172 -DEMTGYVATRWYRAPEIMLNWMHYNQT  198 (345)
T ss_pred             -ccccccccCCCccCHHHHhCccCCCch
Confidence             22334567889999999865 344443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2.8e-29  Score=186.09  Aligned_cols=161  Identities=17%  Similarity=0.161  Sum_probs=124.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc-CCcEEEEEEcccc------ccccHHHHHHHHHHhhCCCCCeeE-EEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE-TKELVAVKYIERG------RKIDENVAREIINHRSLRHPNIIR-FKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~-~~~~v~~K~~~~~------~~~~~~~~~e~~~~~~~~~~~i~~-~~~~~~~~~~~   73 (181)
                      ++|++.+.||+|+||+||+|.+.. +++.+|+|.....      ....+.+.+|+.+++.++|++++. +++    .+..
T Consensus        18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~   93 (365)
T PRK09188         18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKD   93 (365)
T ss_pred             CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCc
Confidence            679999999999999999999875 6777899986532      112356889999999999999885 443    2467


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCC-CCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL-KLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl-~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      +++|||+++++|.. ...   ..   ...++.|++.+|.+||++||+|||| ||+||+++.++  .++|+|||+|+....
T Consensus        94 ~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~--~ikLiDFGlA~~~~~  164 (365)
T PRK09188         94 GLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG--EAAVIDFQLASVFRR  164 (365)
T ss_pred             EEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC--CEEEEECccceeccc
Confidence            99999999988863 211   11   2467899999999999999999999 99999996544  599999999986544


Q ss_pred             CCCC---------CcccCCCCccCcccccCCc
Q 030211          153 HSRP---------KSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       153 ~~~~---------~~~~~~~~~~aPE~~~~~~  175 (181)
                      .+..         ....+++.|+|||++.-..
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~  196 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPRE  196 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence            3322         2234678899999987543

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.96  E-value=3e-28  Score=179.60  Aligned_cols=164  Identities=32%  Similarity=0.483  Sum_probs=137.6

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      .|...+.||+|++|.||++.+..++..+++|.+......    ...+.+|+..++.++|+|++++++++.+.+..+++||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            466678899999999999999988999999988653221    2457789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           79 YAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      |+.+ ++.+.+.. ..++++..+..++.|++.++.+||++|++|+||+|+||++++++  .++|+|||.+....   ...
T Consensus       102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~--~~kL~dfg~~~~~~---~~~  175 (313)
T cd06633         102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASKSS---PAN  175 (313)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC--CEEEeecCCCcccC---CCC
Confidence            9965 66666644 44789999999999999999999999999999999999997555  49999999875322   223


Q ss_pred             cccCCCCccCccccc
Q 030211          158 STVGTPAYIAPEVLS  172 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~  172 (181)
                      ...++..|+|||++.
T Consensus       176 ~~~~~~~y~aPE~~~  190 (313)
T cd06633         176 SFVGTPYWMAPEVIL  190 (313)
T ss_pred             CccccccccChhhcc
Confidence            456788999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-28  Score=191.63  Aligned_cols=172  Identities=30%  Similarity=0.527  Sum_probs=150.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEeEEc-----CCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLT-----PTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~-----~~~~~~   75 (181)
                      +.|++.+.||.|.+|.||++++...++..|+|+.......++++..|..+++.. .|||++.++++|.-     ++.+|+
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL   98 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL   98 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence            468999999999999999999999999999999988877788999999999877 58999999999864     467999


Q ss_pred             EEeecCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-C
Q 030211           76 VMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-L  152 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~  152 (181)
                      |||||.+|+..++..+  ...+.++.+..|.+.++.++.+||.+.++|+|++-.||+++.++  .|||+|||.+.... -
T Consensus        99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~--~VKLvDFGvSaQldsT  176 (953)
T KOG0587|consen   99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDST  176 (953)
T ss_pred             EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC--cEEEeeeeeeeeeecc
Confidence            9999999999887753  45799999999999999999999999999999999999996554  59999999976543 3


Q ss_pred             CCCCCcccCCCCccCcccccCCc
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~  175 (181)
                      -+......|||.|||||++...+
T Consensus       177 ~grRnT~iGtP~WMAPEViac~e  199 (953)
T KOG0587|consen  177 VGRRNTFIGTPYWMAPEVIACDE  199 (953)
T ss_pred             cccccCcCCCcccccceeeeccc
Confidence            34455568999999999998654

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.96  E-value=1.6e-28  Score=176.54  Aligned_cols=170  Identities=25%  Similarity=0.332  Sum_probs=134.3

Q ss_pred             eeeCCccceeEEEEEEcc---CCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEE-cCCeEEEEEeecC
Q 030211            8 KDLGAGNFGVARLLRHKE---TKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVL-TPTHLAIVMEYAA   81 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~---~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~-~~~~~~~v~e~~~   81 (181)
                      +.||+|+||.||+|.+.+   ....+++|.+.....  ..+.+.+|..+++.++|||++++++++. .++..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998653   345799998754322  2356778889999999999999999765 4556889999999


Q ss_pred             CCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-----C
Q 030211           82 GGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-----R  155 (181)
Q Consensus        82 ~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-----~  155 (181)
                      +++|.+++.+.. ..+......++.|++.||.+||+.+++|+||+|+||+++++..  ++|+|||++.......     .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecc
Confidence            999999886543 4677788899999999999999999999999999999976554  9999999986543221     1


Q ss_pred             CCcccCCCCccCcccccCCccCCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .....++..|+|||.+.+..++.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~  182 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTK  182 (262)
T ss_pred             cccCcCCccccChhHhccCccchH
Confidence            112235678999999987777654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.96  E-value=4e-29  Score=179.46  Aligned_cols=174  Identities=32%  Similarity=0.512  Sum_probs=142.2

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc------cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR------KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ||.+.+.||+|++|.||++.+...+..+++|+.+...      .....+..|..+++.++|||++++++.+.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            6999999999999999999998766666666654321      1123456788899999999999999999999999999


Q ss_pred             EeecCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           77 MEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      +||+++++|.+.+..    ...+++..+..++.|++.|+.+||++|++|+||+|+||++++   +.++|+|||.+.....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~---~~~~l~d~g~~~~~~~  157 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN---NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec---CCEeecccCceeecCC
Confidence            999999999877643    357899999999999999999999999999999999999964   2499999998865433


Q ss_pred             CCC-CCcccCCCCccCcccccCCccCCC
Q 030211          153 HSR-PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ... .....+++.|+|||.+.+..++.+
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~  185 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQGYDSK  185 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCCCCch
Confidence            222 333467889999999887766544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.96  E-value=5.7e-30  Score=205.59  Aligned_cols=177  Identities=33%  Similarity=0.476  Sum_probs=141.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEc----------
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLT----------   69 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~----------   69 (181)
                      ..|+..+.+|+||||.||+|+++-+|+.+|+|.+....  .....+.+|+..+.++.|||+|+++..|.+          
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            46888999999999999999999999999999998763  334678899999999999999998544300          


Q ss_pred             --------------------------------------------------------------------C-----------
Q 030211           70 --------------------------------------------------------------------P-----------   70 (181)
Q Consensus        70 --------------------------------------------------------------------~-----------   70 (181)
                                                                                          +           
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                0           


Q ss_pred             ------------------------------CeEEEEEeecCCCChHHHHhhcCCC-CHHHHHHHHHHHHHHHHHHHhcCe
Q 030211           71 ------------------------------THLAIVMEYAAGGELFDRICNAGRF-SEDEGRYFFQQLISGVNYCHSMQI  119 (181)
Q Consensus        71 ------------------------------~~~~~v~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~i~~~l~~lh~~gi  119 (181)
                                                    ..+|+-||||+..++.+++..+-.. .....|+++++|+.||.|+|++|+
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi  718 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI  718 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence                                          1257888898777777766554333 477899999999999999999999


Q ss_pred             eeeCCCCCCEEeccCCCCcEEEeecCCccccc-------------------CCCCCCcccCCCCccCcccccCCc---cC
Q 030211          120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-------------------LHSRPKSTVGTPAYIAPEVLSRRE---YD  177 (181)
Q Consensus       120 ~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~~~---~~  177 (181)
                      +||||||.|||++++..  |||+|||+|+...                   ..+...+..||--|+|||++.+..   |+
T Consensus       719 IHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             eeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999986666  9999999997511                   111233457899999999999776   77


Q ss_pred             CCC
Q 030211          178 GKQ  180 (181)
Q Consensus       178 ~~~  180 (181)
                      .|.
T Consensus       797 ~Ki  799 (1351)
T KOG1035|consen  797 SKI  799 (1351)
T ss_pred             chh
Confidence            663

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=1.4e-28  Score=174.70  Aligned_cols=159  Identities=19%  Similarity=0.266  Sum_probs=133.0

Q ss_pred             ccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCChHHHHhhc
Q 030211           13 GNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNA   92 (181)
Q Consensus        13 g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~   92 (181)
                      |.++.||+|.+..+++.+++|.+.....    ...+...+....|||++++++++.+.+..+++|||+++++|.+.+.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            8899999999999999999999876432    223444445567999999999999999999999999999999998877


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccCCCCccCccccc
Q 030211           93 GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS  172 (181)
Q Consensus        93 ~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~  172 (181)
                      ..+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.  ++|+|||.+......  .....++..|+|||.+.
T Consensus        80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG  155 (237)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhccccc--cccCCcCccccCCcccC
Confidence            78999999999999999999999999999999999999975554  999999987543322  22344567899999998


Q ss_pred             CCccCCC
Q 030211          173 RREYDGK  179 (181)
Q Consensus       173 ~~~~~~~  179 (181)
                      +.+++++
T Consensus       156 ~~~~~~~  162 (237)
T cd05576         156 ISEETEA  162 (237)
T ss_pred             CCCCCch
Confidence            7777654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.96  E-value=1.6e-28  Score=177.46  Aligned_cols=174  Identities=25%  Similarity=0.336  Sum_probs=138.0

Q ss_pred             ceeeeeeCCccceeEEEEEEcc---CCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC------
Q 030211            4 YELVKDLGAGNFGVARLLRHKE---TKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPT------   71 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~---~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~------   71 (181)
                      |++.+.||+|++|.||+|.+..   +++.+++|++.....   ..+.+.+|+..++.++||+++++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            6788999999999999998653   467899998865322   2346778999999999999999999887543      


Q ss_pred             eEEEEEeecCCCChHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecC
Q 030211           72 HLAIVMEYAAGGELFDRICNA------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG  145 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg  145 (181)
                      ..+++++|+.+++|..++...      ..++......++.|++.++++||++|++|+||+|+||+++++..  ++|+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECccc
Confidence            246888999999988766421      24788899999999999999999999999999999999975554  9999999


Q ss_pred             CcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          146 YSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       146 ~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ++........   .....+++.|++||.+....++.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~  195 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH  195 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchh
Confidence            9875433221   122335678999999987776654

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-29  Score=180.73  Aligned_cols=175  Identities=31%  Similarity=0.423  Sum_probs=149.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCC--C----CeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH--P----NIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~--~----~i~~~~~~~~~~~~~~~   75 (181)
                      +||.+++.+|+|.||.|-++.+.+++..||+|+++.-.+..+...-|+..+.++.+  |    -++.+.++|...+..++
T Consensus        89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCi  168 (415)
T KOG0671|consen   89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICI  168 (415)
T ss_pred             cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEE
Confidence            58999999999999999999999999999999999877777778888888888832  3    36778888999999999


Q ss_pred             EEeecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC------------------
Q 030211           76 VMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA------------------  135 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~------------------  135 (181)
                      |+|.+ |.++.+++.++.  +++...++.+++|++.++++||+++++|.||||+||++.+..                  
T Consensus       169 vfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~k  247 (415)
T KOG0671|consen  169 VFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLK  247 (415)
T ss_pred             EEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCC
Confidence            99988 668999997765  799999999999999999999999999999999999984222                  


Q ss_pred             CCcEEEeecCCcccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          136 APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       136 ~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +..|+++|||.|....  ........|..|.|||++.+-.++..
T Consensus       248 s~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~p  289 (415)
T KOG0671|consen  248 STAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQP  289 (415)
T ss_pred             CcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCCc
Confidence            2358999999987533  23355688999999999999888764

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.9e-30  Score=187.29  Aligned_cols=177  Identities=32%  Similarity=0.519  Sum_probs=151.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccccc----HHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ..|.++.+||.|+||.|.++..+.+...+|+|++++.-..+    +--..|-+.|... +-|.+++++.+|+.-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46889999999999999999999999999999998753222    2233455666555 457899999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc-cCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-VLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~-~~~~~  155 (181)
                      |||+.|++|...+..-+.|.+..+..++..|+.+|-+||++||+.+|||.+||+++.+++  |+|.|||+++.. .....
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~~~~T  506 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIFDGVT  506 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeecccccccccCCcc
Confidence            999999999888877788999999999999999999999999999999999999976665  999999999754 44455


Q ss_pred             CCcccCCCCccCcccccCCccCCCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ..+++|||.|+|||++..++|+-++
T Consensus       507 TkTFCGTPdYiAPEIi~YqPYgksv  531 (683)
T KOG0696|consen  507 TKTFCGTPDYIAPEIIAYQPYGKSV  531 (683)
T ss_pred             eeeecCCCcccccceEEecccccch
Confidence            6678999999999999999998653

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.96  E-value=4.3e-28  Score=175.03  Aligned_cols=164  Identities=22%  Similarity=0.296  Sum_probs=130.5

Q ss_pred             eeeCCccceeEEEEEEccC--CcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCC
Q 030211            8 KDLGAGNFGVARLLRHKET--KELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~--~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (181)
                      +.||+|+||.||++.....  ...+++|.+....  ...+.+.+|+..+..++|||++++++.+.+....+++|||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3689999999999975432  3346677665432  22457888889999999999999999999999999999999999


Q ss_pred             ChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC---CCC
Q 030211           84 ELFDRICNA----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH---SRP  156 (181)
Q Consensus        84 ~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~---~~~  156 (181)
                      +|.+++...    ...+...+..++.|++.||.|||+++++|+||+|+||+++++..  ++|+|||++......   ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcc
Confidence            999888653    24566778899999999999999999999999999999975554  999999987532211   122


Q ss_pred             CcccCCCCccCcccccC
Q 030211          157 KSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~  173 (181)
                      ....++..|+|||++..
T Consensus       159 ~~~~~~~~y~aPE~~~~  175 (268)
T cd05086         159 DDKCVPLRWLAPELVGE  175 (268)
T ss_pred             cCCcCcccccCchhccc
Confidence            33457889999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.3e-29  Score=199.77  Aligned_cols=176  Identities=27%  Similarity=0.385  Sum_probs=149.0

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCc-----EEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKE-----LVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~-----~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +.++...||+|.||.||.+.-.+...     .|++|.+.+...  ...+|++|..+++...|||||++++++.++...++
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            45678899999999999998764322     489998887643  34689999999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211           76 VMEYAAGGELFDRICNA-------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      ++|||++|+|+.++.+.       ..++....+.++.+|++++.||++++++|+||...|.|++..  ..+|++|||+|+
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~--r~VKIaDFGlAr  850 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER--RVVKIADFGLAR  850 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc--CcEEEcccchhH
Confidence            99999999999999875       368999999999999999999999999999999999999644  669999999998


Q ss_pred             cccCCCC---CCcccCCCCccCcccccCCccCCCC
Q 030211          149 SSVLHSR---PKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       149 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      .+....-   .....-...|||||.+..+.++.|+
T Consensus       851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskS  885 (1025)
T KOG1095|consen  851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKS  885 (1025)
T ss_pred             hhhhchheeccCccccceecCCHHHHhhccccccc
Confidence            5432222   1112335789999999999999875

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=2.3e-28  Score=182.25  Aligned_cols=165  Identities=32%  Similarity=0.473  Sum_probs=136.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcC------Ce
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP------TH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~------~~   72 (181)
                      ++|.+.+.||+|++|.||+|.+..+++.+|+|.+....   .....+.+|+.+++.++|+|++++++++...      ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            68999999999999999999999889999999886532   2234577899999999999999999998754      34


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ++++++++.. ++....  ...++++.+..++.|++.||++||+.|++|+||+|+||++++++  .++|+|||++.....
T Consensus        95 ~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~--~~kL~dfg~~~~~~~  169 (342)
T cd07879          95 FYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC--ELKILDFGLARHADA  169 (342)
T ss_pred             EEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCCCCcCCCC
Confidence            6999999854 666554  34689999999999999999999999999999999999997655  499999999864322


Q ss_pred             CCCCCcccCCCCccCcccccC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~  173 (181)
                        ......+++.|+|||.+.+
T Consensus       170 --~~~~~~~~~~y~aPE~~~~  188 (342)
T cd07879         170 --EMTGYVVTRWYRAPEVILN  188 (342)
T ss_pred             --CCCCceeeecccChhhhcC
Confidence              2233467888999999876

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=172.16  Aligned_cols=172  Identities=27%  Similarity=0.405  Sum_probs=143.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc-cccHHHHHHHHHHhhCCCCCeeEEEEeEEcC-----CeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTP-----THLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~   75 (181)
                      +||++.+.+|+|||+-||.++.-++++.+|+|.+.... +..+...+|++..++.+|||++++++....+     ...|+
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            58999999999999999999999999999999887655 4567899999999999999999998875432     45999


Q ss_pred             EEeecCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           76 VMEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~g--i~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      +++|+..++|.+.+..    +..+++..++.++.++++||++||+..  ++|+||||.||++.++.  .++|.|||.+..
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~--~~vl~D~GS~~~  178 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG--LPVLMDLGSATQ  178 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC--ceEEEeccCccc
Confidence            9999999999887743    447999999999999999999999998  99999999999997544  499999999864


Q ss_pred             ccCCCCCC----------cccCCCCccCcccccCCc
Q 030211          150 SVLHSRPK----------STVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       150 ~~~~~~~~----------~~~~~~~~~aPE~~~~~~  175 (181)
                      ....-...          .-..|..|.|||.+.-..
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~  214 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKS  214 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheeccc
Confidence            33221111          113689999999986443

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4.6e-30  Score=207.21  Aligned_cols=172  Identities=33%  Similarity=0.465  Sum_probs=149.1

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc---ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ||.-.-.||.|.||.||.+.+.++|...|+|-+.-.   .+..+...+|+.++..+.|||+|+++++-.+.+..++.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            566778899999999999999999999999976543   23346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-----
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-----  154 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-----  154 (181)
                      |++|+|.+.+.-....++....-+..|++.+++|||+.||+|+|+||.||+++.++  .+|++|||.|......-     
T Consensus      1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g--~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG--LIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC--cEEeecccceeEecCchhcCCH
Confidence            99999999887766777888888999999999999999999999999999997555  59999999998764442     


Q ss_pred             CCCcccCCCCccCcccccCCcc
Q 030211          155 RPKSTVGTPAYIAPEVLSRREY  176 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~  176 (181)
                      .-....||+.|||||++++...
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~ 1415 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKG 1415 (1509)
T ss_pred             HHHhhcCCchhcCchhhccccc
Confidence            2234679999999999997654

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=4.8e-30  Score=174.32  Aligned_cols=168  Identities=26%  Similarity=0.481  Sum_probs=148.9

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC-CCCeeEEEEeEEcCC--eEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLTPT--HLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~--~~~~v~   77 (181)
                      .++|++..++|+|.++.||.+.+..+...+++|+++.-++  +.+.+|+.++.-++ +|||+.++++..++.  ...+++
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk--kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK--KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH--HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            3689999999999999999999988889999999886543  67889999999886 999999999998864  477999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      |++.+.+.....   ++++...++.++.++++||.|+|++||.|+|+||+|++|+. ...+++|+|||+|....+.....
T Consensus       115 E~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh-~~rkLrlIDWGLAEFYHp~~eYn  190 (338)
T KOG0668|consen  115 EYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGKEYN  190 (338)
T ss_pred             hhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech-hhceeeeeecchHhhcCCCceee
Confidence            999887776654   45889999999999999999999999999999999999973 45689999999999999999999


Q ss_pred             cccCCCCccCcccccCC
Q 030211          158 STVGTPAYIAPEVLSRR  174 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~  174 (181)
                      .+..+..|--||.+..-
T Consensus       191 VRVASRyfKGPELLVdy  207 (338)
T KOG0668|consen  191 VRVASRYFKGPELLVDY  207 (338)
T ss_pred             eeeehhhcCCchheeec
Confidence            99999999999998753

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.96  E-value=2.7e-28  Score=181.86  Aligned_cols=169  Identities=31%  Similarity=0.426  Sum_probs=138.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEEEEeEEcC----------
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTP----------   70 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~~~~~~~~----------   70 (181)
                      ++|++.+.||+|++|.||++.+..+++.|++|.+...... .+.+.+|+.+++.++|||++++++.+...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            5899999999999999999999999999999988654332 35688899999999999999998776654          


Q ss_pred             ----CeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCC
Q 030211           71 ----THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (181)
Q Consensus        71 ----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~  146 (181)
                          ...++++||++ ++|.+.+. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ ...++|+|||.
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~-~~~~kl~dfg~  161 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTE-DLVLKIGDFGL  161 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC-CceEEECCccc
Confidence                35789999996 47877664 3468999999999999999999999999999999999999632 23589999999


Q ss_pred             cccccCCCCC----CcccCCCCccCcccccC
Q 030211          147 SKSSVLHSRP----KSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       147 a~~~~~~~~~----~~~~~~~~~~aPE~~~~  173 (181)
                      +.........    ....++..|+|||.+.+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  192 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS  192 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhC
Confidence            8654332221    22356888999998754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.96  E-value=4e-28  Score=179.93  Aligned_cols=166  Identities=23%  Similarity=0.331  Sum_probs=134.1

Q ss_pred             eeeeCCc--cceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            7 VKDLGAG--NFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         7 ~~~i~~g--~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      .+.||+|  ++++||.+.+..+++.||+|++......   .+.+.+|+.+++.++|||++++++++..++..++++|++.
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            3567766  8899999999999999999998754322   2567788888889999999999999999999999999999


Q ss_pred             CCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC----
Q 030211           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR----  155 (181)
Q Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~----  155 (181)
                      ++++.+++...  ..+++..+..++.|++.||+|||++|++|+||||+||++++++.  +++.||+.+........    
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccCccccc
Confidence            99999887653  35889999999999999999999999999999999999976554  99999975432211111    


Q ss_pred             ----CCcccCCCCccCcccccCC
Q 030211          156 ----PKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       156 ----~~~~~~~~~~~aPE~~~~~  174 (181)
                          .....++..|+|||++.++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~  183 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQD  183 (328)
T ss_pred             cccccccccCccCccChhhhcCC
Confidence                1112345679999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=1.1e-29  Score=179.24  Aligned_cols=177  Identities=29%  Similarity=0.404  Sum_probs=143.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC----CcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEc-CCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET----KELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLT-PTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~----~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~   73 (181)
                      ..|++.+.||+|.+|.||+|..+++    .+.+|+|.++..+..   ..+.-+|+.+++.++|+|++.+..+|.. ...+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            5699999999999999999976543    236899988765432   4678899999999999999999999988 7789


Q ss_pred             EEEEeecCCCChHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccC--CCCcEEEeecCC
Q 030211           74 AIVMEYAAGGELFDRICNA-----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS--AAPRLKICDFGY  146 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~--~~~~v~l~dfg~  146 (181)
                      ++++||.+. +|.+.+.-+     ..++...+..+++||+.++.|||++=++||||||.||++..+  ..++|||.|+|+
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999999865 888877422     358889999999999999999999999999999999999433  347899999999


Q ss_pred             cccccCCCCCC----cccCCCCccCcccccCCccCCC
Q 030211          147 SKSSVLHSRPK----STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       147 a~~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.....-..-    ...-|..|.|||.+.+...-++
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~  219 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTK  219 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccc
Confidence            98654433322    2345889999999987765443

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.96  E-value=4.1e-28  Score=178.45  Aligned_cols=164  Identities=30%  Similarity=0.464  Sum_probs=137.8

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      .|...+.||+|++|.||++.+..++..+++|.+.....    ....+.+|+.+++.++|++++++.+++...+..++++|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            57788899999999999999998899999998864321    12457789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           79 YAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      |+.+ ++.+.+.. ...+++..+..++.|++.++.+||++|++|+||+|+||++++++  .++|+|||.+....+   ..
T Consensus        96 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~---~~  169 (308)
T cd06634          96 YCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP---AN  169 (308)
T ss_pred             ccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC--cEEECCcccceeecC---cc
Confidence            9964 67665543 44689999999999999999999999999999999999997554  599999998865432   23


Q ss_pred             cccCCCCccCccccc
Q 030211          158 STVGTPAYIAPEVLS  172 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~  172 (181)
                      ...+++.|+|||.+.
T Consensus       170 ~~~~~~~y~aPE~~~  184 (308)
T cd06634         170 XFVGTPYWMAPEVIL  184 (308)
T ss_pred             cccCCccccCHHHHh
Confidence            346788999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.7e-28  Score=182.95  Aligned_cols=166  Identities=27%  Similarity=0.420  Sum_probs=139.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCe------
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTH------   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~------   72 (181)
                      ++|++.+.||+|++|.||++.+..++..+++|.+....   ...+.+.+|+.+++.++|+|++++.+++...+.      
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            57999999999999999999999899999999886532   223556789999999999999999988876554      


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      .++++|++ +++|.+.+.. ..+++..++.++.|++.++.+||+.|++|+||+|+||++++++  .++|+|||++.....
T Consensus        95 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~--~~kL~dfg~~~~~~~  170 (343)
T cd07851          95 VYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC--ELKILDFGLARHTDD  170 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEccccccccccc
Confidence            89999998 5588877754 5799999999999999999999999999999999999997655  499999999875432


Q ss_pred             CCCCCcccCCCCccCcccccC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~  173 (181)
                      .  .....++..|+|||.+.+
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~  189 (343)
T cd07851         171 E--MTGYVATRWYRAPEIMLN  189 (343)
T ss_pred             c--ccCCcccccccCHHHHhC
Confidence            2  334567889999999865

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2e-28  Score=179.43  Aligned_cols=165  Identities=30%  Similarity=0.384  Sum_probs=135.3

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHH--hhCCCCCeeEEEEeEEcCC----eEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH--RSLRHPNIIRFKEVVLTPT----HLAIV   76 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~--~~~~~~~i~~~~~~~~~~~----~~~~v   76 (181)
                      ...+.+.||+|.||.||++.++  |..||+|+|..-++  +...+|.++.  ..++|+||+.++..=..+.    .+|+|
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv  287 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV  287 (513)
T ss_pred             eeEEEEEecCccccceeecccc--CCceEEEEecccch--hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence            4578999999999999999998  78899999986432  3334444444  3559999999988654332    48999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM--------QICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      ++|.+.|+|.+++.. .+++.+....++..++.+|++||-.        .|+|||||.+||++.+++.  ..|+|+|+|.
T Consensus       288 TdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGLAv  364 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAV  364 (513)
T ss_pred             eecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EEEeeceeeE
Confidence            999999999999976 6899999999999999999999962        4999999999999976665  9999999997


Q ss_pred             cccCCC-----CCCcccCCCCccCcccccCC
Q 030211          149 SSVLHS-----RPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       149 ~~~~~~-----~~~~~~~~~~~~aPE~~~~~  174 (181)
                      ......     ......||.+|||||++-+.
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdet  395 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDET  395 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhh
Confidence            665442     24556899999999998754

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.9e-29  Score=182.25  Aligned_cols=178  Identities=29%  Similarity=0.409  Sum_probs=151.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccH--------HHHHHHHHHhhCCCCCeeEEEEeEE-cCCe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE--------NVAREIINHRSLRHPNIIRFKEVVL-TPTH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~--------~~~~e~~~~~~~~~~~i~~~~~~~~-~~~~   72 (181)
                      +||.++..+|+|||+.||+|.+...++.||+|+-..++.+.+        ..-+|.++++.+.||.||+++++|. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            578899999999999999999998899999998776655543        3556889999999999999999986 4678


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc--CeeeeCCCCCCEEec-cCCCCcEEEeecCCccc
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM--QICHRDLKLENTLLD-GSAAPRLKICDFGYSKS  149 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--gi~h~dl~p~ni~i~-~~~~~~v~l~dfg~a~~  149 (181)
                      ++-|+|||+|.+|.-++..+..+++.+++.|+-||+.||.||.+.  .|+|-||||.||++. ....+.|+|.|||+++.
T Consensus       543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            999999999999998888888999999999999999999999976  699999999999984 34456899999999986


Q ss_pred             ccCCCC--------CCcccCCCCccCcccccCCccCCC
Q 030211          150 SVLHSR--------PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       150 ~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +...+.        .+...||..|++||++.=+.-.||
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPK  660 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPK  660 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCc
Confidence            544333        234568999999999987655554

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-28  Score=186.03  Aligned_cols=175  Identities=26%  Similarity=0.384  Sum_probs=150.7

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      +-.++++||+|.||.|.++.-.. +..||+|.++.....  ..+|..|++++.+++||||+.+++++...+.+++++||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             heehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            45789999999999999998764 688999999875433  478999999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC--
Q 030211           81 AGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--  156 (181)
Q Consensus        81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~--  156 (181)
                      +.|+|.+++..+  +.+..+...+++.||+.+++||.+..++|||+.+.|++++.+.  .+|++|||+++....+...  
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~--~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF--TIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc--cEEecCcccccccccCCceee
Confidence            999999999887  4556677788999999999999999999999999999996555  4999999999754443332  


Q ss_pred             -CcccCCCCccCcccccCCccCCCC
Q 030211          157 -KSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       157 -~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                       ....-..+|||||.+.-+.++.++
T Consensus       696 qgr~vlpiRwmawEsillgkFttaS  720 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTAS  720 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccchh
Confidence             234567899999999999998875

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.96  E-value=1.7e-27  Score=175.51  Aligned_cols=159  Identities=29%  Similarity=0.474  Sum_probs=130.3

Q ss_pred             cceeEEEEEEccCCcEEEEEEcccc---ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCChHHHHh
Q 030211           14 NFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC   90 (181)
Q Consensus        14 ~~~~v~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~   90 (181)
                      +.+.+|.+.+..+++.+|+|.+...   ....+.+..|+..++.++|+|++++++++.+.+..+++|||+++++|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            4456677777778999999998754   2223578889999999999999999999999999999999999999998886


Q ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--------CCccc
Q 030211           91 NA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--------PKSTV  160 (181)
Q Consensus        91 ~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--------~~~~~  160 (181)
                      ..  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++  .++|.||+.+........        .....
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~--~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~  169 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG--KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV  169 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC--ceEEecCccceeecccccccccccccccccc
Confidence            53  3688999999999999999999999999999999999997555  499999998764432211        22234


Q ss_pred             CCCCccCcccccCC
Q 030211          161 GTPAYIAPEVLSRR  174 (181)
Q Consensus       161 ~~~~~~aPE~~~~~  174 (181)
                      ++..|+|||++...
T Consensus       170 ~~~~y~aPE~~~~~  183 (314)
T cd08216         170 KNLPWLSPEVLQQN  183 (314)
T ss_pred             ccccccCHHHhcCC
Confidence            67789999998763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=8.6e-27  Score=163.53  Aligned_cols=173  Identities=43%  Similarity=0.691  Sum_probs=148.8

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      |.+.+.|++|+++.+|++....+++.+++|.+.....  ..+.+.+|+..+..++|++++++++.+...+..++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            6788999999999999999998889999999886543  35678889999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC--CCCc
Q 030211           82 GGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPKS  158 (181)
Q Consensus        82 ~~~l~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~--~~~~  158 (181)
                      +++|.+.+..... +++.....++.+++.++.+||+.|++|+|++|+||+++++  ..++|+|||.+.......  ....
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~--~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD--GLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--CCEEEeeCceeeEecCcccccccc
Confidence            9899998877666 8999999999999999999999999999999999999765  459999999987654443  3344


Q ss_pred             ccCCCCccCcccc-cCCccCC
Q 030211          159 TVGTPAYIAPEVL-SRREYDG  178 (181)
Q Consensus       159 ~~~~~~~~aPE~~-~~~~~~~  178 (181)
                      ..++..|++||.. ...+++.
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~  179 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGE  179 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCc
Confidence            5678899999998 4444443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.1e-26  Score=179.05  Aligned_cols=172  Identities=22%  Similarity=0.287  Sum_probs=125.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEc----------------cCCcEEEEEEccccccc-c--------------HHHHHHHH
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK----------------ETKELVAVKYIERGRKI-D--------------ENVAREII   50 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~----------------~~~~~v~~K~~~~~~~~-~--------------~~~~~e~~   50 (181)
                      ++|++.++||+|+||.||++...                ..++.||+|.+...... .              +....|+.
T Consensus       145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~  224 (507)
T PLN03224        145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY  224 (507)
T ss_pred             cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence            68999999999999999999642                23567999987643211 1              12233555


Q ss_pred             HHhhCCCCC-----eeEEEEeEEc--------CCeEEEEEeecCCCChHHHHhhc------------------------C
Q 030211           51 NHRSLRHPN-----IIRFKEVVLT--------PTHLAIVMEYAAGGELFDRICNA------------------------G   93 (181)
Q Consensus        51 ~~~~~~~~~-----i~~~~~~~~~--------~~~~~~v~e~~~~~~l~~~~~~~------------------------~   93 (181)
                      ++..++|.+     ++.+++++..        .+..++|+||+++++|.+.+...                        .
T Consensus       225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~  304 (507)
T PLN03224        225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD  304 (507)
T ss_pred             HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence            556665544     3556666543        35689999999999998877531                        1


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcc--cCCCCccCcccc
Q 030211           94 RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL  171 (181)
Q Consensus        94 ~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~--~~~~~~~aPE~~  171 (181)
                      .+++..++.++.|++.+|.+||+.+++|+||||+||+++.+.  .++|+|||++............  ..++.|+|||.+
T Consensus       305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG--QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC--cEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence            235667888999999999999999999999999999997655  4999999998654333222222  347899999998


Q ss_pred             cCCc
Q 030211          172 SRRE  175 (181)
Q Consensus       172 ~~~~  175 (181)
                      ....
T Consensus       383 ~~~~  386 (507)
T PLN03224        383 VMPQ  386 (507)
T ss_pred             cCCC
Confidence            7544

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.95  E-value=5.6e-27  Score=194.91  Aligned_cols=166  Identities=20%  Similarity=0.301  Sum_probs=135.5

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      .+.....||+|+||.||+|.+..++..||+|.+......   ...|+..++.++|||++++++++.+.+..++||||+++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~  767 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG  767 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence            355667899999999999999888999999988654322   23457888999999999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcc
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCH---SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~  159 (181)
                      ++|.+++..   +++..+..++.|++.|++|||   +.+++|+|++|+||+++.+...++.   ++.+....   .....
T Consensus       768 g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~---~~~~~~~~---~~~~~  838 (968)
T PLN00113        768 KNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLC---TDTKC  838 (968)
T ss_pred             CcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE---eccccccc---cCCCc
Confidence            999998853   789999999999999999999   6799999999999999766653443   43332111   12223


Q ss_pred             cCCCCccCcccccCCccCCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      .+++.|+|||++.+..++.++
T Consensus       839 ~~t~~y~aPE~~~~~~~~~~s  859 (968)
T PLN00113        839 FISSAYVAPETRETKDITEKS  859 (968)
T ss_pred             cccccccCcccccCCCCCccc
Confidence            678999999999998888764

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=7.4e-27  Score=183.27  Aligned_cols=171  Identities=22%  Similarity=0.221  Sum_probs=120.2

Q ss_pred             CccceeeeeeCCccceeEEEEEEccC----CcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEe------EEcC
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKET----KELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEV------VLTP   70 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~----~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~------~~~~   70 (181)
                      .++|++.+.||+|+||.||+|.+..+    +..||+|.+...... +....+ .+ ....+.++..+...      ....
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e-~l-~~~~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE-RV-RRACPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH-HH-HhhchhhHHHHHHhhhcccccccC
Confidence            36899999999999999999999988    889999987643221 111111 11 11111122111111      2345


Q ss_pred             CeEEEEEeecCCCChHHHHhhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEE
Q 030211           71 THLAIVMEYAAGGELFDRICNAGR--------------------FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTL  130 (181)
Q Consensus        71 ~~~~~v~e~~~~~~l~~~~~~~~~--------------------~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~  130 (181)
                      ...++++||+++++|.+++.....                    .....+..++.|++.+|.|||++||+|+||||+||+
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL  287 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII  287 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence            679999999999999888754321                    123346679999999999999999999999999999


Q ss_pred             eccCCCCcEEEeecCCcccccCC--CCCCcccCCCCccCcccccCCc
Q 030211          131 LDGSAAPRLKICDFGYSKSSVLH--SRPKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       131 i~~~~~~~v~l~dfg~a~~~~~~--~~~~~~~~~~~~~aPE~~~~~~  175 (181)
                      ++++ .+.++|+|||+|......  .......+++.|+|||.+....
T Consensus       288 l~~~-~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~  333 (566)
T PLN03225        288 FSEG-SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST  333 (566)
T ss_pred             EeCC-CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccC
Confidence            9742 235999999999754322  2234567899999999765433

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.95  E-value=7.6e-28  Score=167.38  Aligned_cols=168  Identities=26%  Similarity=0.359  Sum_probs=138.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      +..+.++.+|+|..|+|+++..+++|..+|+|.+.+..  ...+.++..+++.... .+|.||+.+++|..+..+++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            34566778999999999999999999999999998753  3346677777766544 58999999999999999999999


Q ss_pred             ecCCCChHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           79 YAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        79 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~-gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      .|.. -...++. -..++++.-+=.+...+.+||.||-++ ||+|+|+||+||++|..++  |||+|||++.+.......
T Consensus       172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeeccccc
Confidence            8843 3333222 234688888888999999999999965 9999999999999976666  999999999877777777


Q ss_pred             CcccCCCCccCccccc
Q 030211          157 KSTVGTPAYIAPEVLS  172 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~  172 (181)
                      ....|.+.|||||-+.
T Consensus       249 trsAGC~~YMaPERid  264 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERID  264 (391)
T ss_pred             ccccCCccccCccccC
Confidence            7778999999999875

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.95  E-value=7.7e-27  Score=160.07  Aligned_cols=137  Identities=20%  Similarity=0.195  Sum_probs=107.6

Q ss_pred             eeeeCCccceeEEEEEEccCCcEEEEEEccccccc--c-------------------------HHHHHHHHHHhhCCCCC
Q 030211            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--D-------------------------ENVAREIINHRSLRHPN   59 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~-------------------------~~~~~e~~~~~~~~~~~   59 (181)
                      .+.||+|++|.||+|.+. +|+.||+|+++.....  .                         .....|...+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999997 7999999998754211  0                         12234888888887777


Q ss_pred             eeEEEEeEEcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-HhcCeeeeCCCCCCEEeccCCCCc
Q 030211           60 IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQICHRDLKLENTLLDGSAAPR  138 (181)
Q Consensus        60 i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~gi~h~dl~p~ni~i~~~~~~~  138 (181)
                      +..+.......  .+++|||++++++.........++.+.+..++.|++.+|.++ |+.|++|+||||+||++++   +.
T Consensus        81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~---~~  155 (190)
T cd05147          81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD---GK  155 (190)
T ss_pred             CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC---Cc
Confidence            64443333222  389999998877655544456789999999999999999999 7999999999999999973   35


Q ss_pred             EEEeecCCccc
Q 030211          139 LKICDFGYSKS  149 (181)
Q Consensus       139 v~l~dfg~a~~  149 (181)
                      ++|+|||+|..
T Consensus       156 v~LiDFG~a~~  166 (190)
T cd05147         156 LYIIDVSQSVE  166 (190)
T ss_pred             EEEEEcccccc
Confidence            99999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=1.5e-27  Score=178.15  Aligned_cols=174  Identities=23%  Similarity=0.315  Sum_probs=151.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC------CCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR------HPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~------~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|.+....|+|-|++|..|.+...+..||||++..++...+.=+.|+.+|+++.      -.++++++..|...+++|+
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl  511 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL  511 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence            5899999999999999999999988999999999998877788889999999884      2478999999999999999


Q ss_pred             EEeecCCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           76 VMEYAAGGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      |+|.+ ...|.+.+.+-+   -+....++.++.|++.||..|-.+|++|+||||+||+++. ....++|+|||.|... .
T Consensus       512 VFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE-~k~iLKLCDfGSA~~~-~  588 (752)
T KOG0670|consen  512 VFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE-SKNILKLCDFGSASFA-S  588 (752)
T ss_pred             Eehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc-CcceeeeccCcccccc-c
Confidence            99988 568998887643   4778899999999999999999999999999999999974 4457999999998643 3


Q ss_pred             CCCCCcccCCCCccCcccccCCccCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ......+.-+..|.|||+|.+-+|+-
T Consensus       589 eneitPYLVSRFYRaPEIiLG~~yd~  614 (752)
T KOG0670|consen  589 ENEITPYLVSRFYRAPEIILGLPYDY  614 (752)
T ss_pred             cccccHHHHHHhccCcceeecCcccC
Confidence            44445567788999999999998863

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.94  E-value=3e-26  Score=162.25  Aligned_cols=164  Identities=43%  Similarity=0.687  Sum_probs=143.2

Q ss_pred             cceeEEEEEEccCCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCChHHHHhh
Q 030211           14 NFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN   91 (181)
Q Consensus        14 ~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~   91 (181)
                      ++|.+|++.+..++..+++|++......  .+.+.+|+..++.++|++++++++.+......++++|++++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            5899999999988999999998765433  47888999999999999999999999999999999999999999998877


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccCCCCccCcccc
Q 030211           92 AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL  171 (181)
Q Consensus        92 ~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~  171 (181)
                      ...++...++.++.+++.++.+||+.|++|+||+|+||+++++.  .++|+|||.+.............++..|+|||..
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG--HVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC--cEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            66689999999999999999999999999999999999997654  5999999998766555455556788899999999


Q ss_pred             cCCccCCC
Q 030211          172 SRREYDGK  179 (181)
Q Consensus       172 ~~~~~~~~  179 (181)
                      .+..++++
T Consensus       159 ~~~~~~~~  166 (244)
T smart00220      159 LGKGYGKA  166 (244)
T ss_pred             ccCCCCch
Confidence            87776654

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=3e-25  Score=153.71  Aligned_cols=164  Identities=44%  Similarity=0.645  Sum_probs=141.1

Q ss_pred             eCCccceeEEEEEEccCCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCChHH
Q 030211           10 LGAGNFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD   87 (181)
Q Consensus        10 i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~   87 (181)
                      ||+|.+|.+|++....+++.+++|.+......  .+.+.+|+..++.++|++++++++++......++++|++++.+|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999888999999998876542  4678899999999999999999999999999999999999899999


Q ss_pred             HHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCCcccCCCCc
Q 030211           88 RICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTVGTPAY  165 (181)
Q Consensus        88 ~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~~~~~~~~~  165 (181)
                      ++... ..++....+.++.+++.++.+||+.|++|+||+|.||++++. ...++|+||+.+....... ......+...|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD-NGKVKLADFGLSKLLTSDKSLLKTIVGTPAY  159 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC-CCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence            88765 478999999999999999999999999999999999999751 3359999999986543332 23335678899


Q ss_pred             cCcccccCC
Q 030211          166 IAPEVLSRR  174 (181)
Q Consensus       166 ~aPE~~~~~  174 (181)
                      ++||.....
T Consensus       160 ~~pe~~~~~  168 (215)
T cd00180         160 MAPEVLLGK  168 (215)
T ss_pred             cChhHhccc
Confidence            999998775

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.94  E-value=7.2e-26  Score=155.63  Aligned_cols=140  Identities=16%  Similarity=0.130  Sum_probs=109.8

Q ss_pred             eeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---------------------------cHHHHHHHHHHhhCCCC
Q 030211            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---------------------------DENVAREIINHRSLRHP   58 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---------------------------~~~~~~e~~~~~~~~~~   58 (181)
                      +.+.||+|++|.||+|.+. +|+.||+|++......                           ......|...+..+.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 7999999998764211                           11235678888888888


Q ss_pred             CeeEEEEeEEcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCCC
Q 030211           59 NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAP  137 (181)
Q Consensus        59 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~~  137 (181)
                      ++.....+....  .+++|||++++++.........++......++.|++.++.++|. +|++|+||+|+||+++ +  +
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~--~  154 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D--G  154 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C--C
Confidence            875554444333  47999999887554433344567888999999999999999999 9999999999999996 3  4


Q ss_pred             cEEEeecCCccccc
Q 030211          138 RLKICDFGYSKSSV  151 (181)
Q Consensus       138 ~v~l~dfg~a~~~~  151 (181)
                      .++|+|||+|....
T Consensus       155 ~~~liDFG~a~~~~  168 (190)
T cd05145         155 KPYIIDVSQAVELD  168 (190)
T ss_pred             CEEEEEcccceecC
Confidence            59999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1e-26  Score=176.85  Aligned_cols=170  Identities=34%  Similarity=0.507  Sum_probs=143.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHH-HHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~-~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      +.|++...+|.|+|+.+-.+.+..+++..++|++.+....   ..+|. ..+..-.|+|++++.+.+.++.+.|+|||.+
T Consensus       322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~---~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l  398 (612)
T KOG0603|consen  322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD---NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL  398 (612)
T ss_pred             hhhccccccCCCCccceeeeeccccccchhheeccccccc---cccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence            5789999999999999999999999999999999876322   22344 3344557999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEec-cCCCCcEEEeecCCcccccCCCCCCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD-GSAAPRLKICDFGYSKSSVLHSRPKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~-~~~~~~v~l~dfg~a~~~~~~~~~~~~  159 (181)
                      .++-+...+.+...+. ..+..|+++|+.|+.+||++|++||||+|+||+++ +.+  .++|+|||.++.....  ....
T Consensus       399 ~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g--~lrltyFG~a~~~~~~--~~tp  473 (612)
T KOG0603|consen  399 DGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG--HLRLTYFGFWSELERS--CDTP  473 (612)
T ss_pred             cccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC--cEEEEEechhhhCchh--hccc
Confidence            9998888777666555 78888999999999999999999999999999994 444  4999999999765554  3344


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +-|..|.|||++...+|++.
T Consensus       474 ~~t~~y~APEvl~~~~yt~a  493 (612)
T KOG0603|consen  474 ALTLQYVAPEVLAIQEYTEA  493 (612)
T ss_pred             chhhcccChhhhccCCCCcc
Confidence            56889999999999888874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=3.5e-28  Score=185.67  Aligned_cols=169  Identities=36%  Similarity=0.525  Sum_probs=150.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++...+|+|.+|.||+++++.++...|+|+++-.+.. .+.+..|+.+++..+||||+.+++-+...+..|+.||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            5799999999999999999999999999999999875544 356677888899999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc-cCCCCCCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-VLHSRPKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~-~~~~~~~~~  159 (181)
                      .+++|.+..+--.++++..+....+..+++++|||+.|-+|||||-.||++++.+.  ++|.|||.+-.+ ..-...+++
T Consensus        95 gggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~Krksf  172 (829)
T KOG0576|consen   95 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKRKSF  172 (829)
T ss_pred             CCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhhhcc
Confidence            99999998888889999999999999999999999999999999999999975555  999999987543 223345668


Q ss_pred             cCCCCccCccccc
Q 030211          160 VGTPAYIAPEVLS  172 (181)
Q Consensus       160 ~~~~~~~aPE~~~  172 (181)
                      .||+.|||||+..
T Consensus       173 iGtpywmapEvaa  185 (829)
T KOG0576|consen  173 IGTPYWMAPEVAA  185 (829)
T ss_pred             cCCccccchhHHH
Confidence            8999999999865

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.94  E-value=9.3e-27  Score=180.61  Aligned_cols=175  Identities=27%  Similarity=0.382  Sum_probs=149.4

Q ss_pred             cceeeeeeCCccceeEEEEEEccCC---cEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETK---ELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~---~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ...+-++||.|.||.||++.-+..+   ..||||-++.+.  +...+|+.|..++-+..||||+++.++......+.+++
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            3567889999999999999987555   469999998764  44578999999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           78 EYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |||++++|..++..++ .|+..+...+++.|+.++.||-+++++||||...||++++  +-..|+.|||+++...... .
T Consensus       710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNs--nLvCKVsDFGLSRvledd~-~  786 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNS--NLVCKVSDFGLSRVLEDDP-E  786 (996)
T ss_pred             hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeecc--ceEEEeccccceeecccCC-C
Confidence            9999999999998765 7999999999999999999999999999999999999964  4459999999998543333 2


Q ss_pred             Cccc---C--CCCccCcccccCCccCCCC
Q 030211          157 KSTV---G--TPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       157 ~~~~---~--~~~~~aPE~~~~~~~~~~~  180 (181)
                      ..+.   |  ..+|.|||.|....++..+
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsAS  815 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKFTSAS  815 (996)
T ss_pred             ccccccCCccceeecChhHhhhcccCchh
Confidence            2222   2  4789999999988887653

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-25  Score=165.37  Aligned_cols=177  Identities=27%  Similarity=0.273  Sum_probs=141.8

Q ss_pred             cceeeeeeCCccceeEEEEEEccCC-cEEEEEEcccccccc-HHHHHHHHHHhhCC----CCCeeEEEEeE-EcCCeEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETK-ELVAVKYIERGRKID-ENVAREIINHRSLR----HPNIIRFKEVV-LTPTHLAI   75 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~-~~v~~K~~~~~~~~~-~~~~~e~~~~~~~~----~~~i~~~~~~~-~~~~~~~~   75 (181)
                      +|++.+.||+|+||.||.+.+.+.+ ..+|+|......... ..+..|...+..+.    .++++.+++.+ ...++.|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7999999999999999999998764 578888876643322 25667777777775    36999999999 58889999


Q ss_pred             EEeecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC---CCcEEEeecCCcc--
Q 030211           76 VMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA---APRLKICDFGYSK--  148 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~---~~~v~l~dfg~a~--  148 (181)
                      ||+.+ |.+|.++....  ..++..++..++.|++.+|++||+.|++||||||+|+.+....   ...+.|+|||+|+  
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            99988 77998877443  4799999999999999999999999999999999999996432   2579999999998  


Q ss_pred             cccCCC--------C-CCcccCCCCccCcccccCCccCCCC
Q 030211          149 SSVLHS--------R-PKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       149 ~~~~~~--------~-~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ......        . ...+.||.+|+|+.+..+.+.++++
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~D  218 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRD  218 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCch
Confidence            321111        1 2334599999999999888877653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=8.4e-26  Score=154.73  Aligned_cols=169  Identities=25%  Similarity=0.304  Sum_probs=137.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCC-CCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH-PNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~-~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++++.||+|+||.+|.+....+|..||+|+-..... ...+.-|.++...+++ .+++.+..++.+..+-.+||+..
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL   93 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL   93 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence            689999999999999999999999999999998665433 3455667777777765 89999999999999999999998


Q ss_pred             CCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccC-CCCcEEEeecCCcccccC------
Q 030211           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-AAPRLKICDFGYSKSSVL------  152 (181)
Q Consensus        81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~-~~~~v~l~dfg~a~~~~~------  152 (181)
                       |.+|.+...- +..|+..+++.++-|++.-++|+|.++++|+||||+|+++.-+ ...++.|+|||+|+....      
T Consensus        94 -GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~H  172 (341)
T KOG1163|consen   94 -GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQH  172 (341)
T ss_pred             -CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccccc
Confidence             6588776632 3479999999999999999999999999999999999999432 334799999999986432      


Q ss_pred             --CCCCCcccCCCCccCccccc
Q 030211          153 --HSRPKSTVGTPAYIAPEVLS  172 (181)
Q Consensus       153 --~~~~~~~~~~~~~~aPE~~~  172 (181)
                        ........||-+|.|--...
T Consensus       173 Ipyre~r~ltGTaRYASinAh~  194 (341)
T KOG1163|consen  173 IPYREDRNLTGTARYASINAHL  194 (341)
T ss_pred             CccccCCccceeeeehhhhhhh
Confidence              23334456888887765443

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.94  E-value=3.5e-26  Score=174.18  Aligned_cols=173  Identities=25%  Similarity=0.351  Sum_probs=144.4

Q ss_pred             ceeeeeeCCccceeEEEEEEccC----CcEEEEEEcccc--ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            4 YELVKDLGAGNFGVARLLRHKET----KELVAVKYIERG--RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~----~~~v~~K~~~~~--~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      .++.++||.|-||.||++.-.+.    .-.||+|..+..  ....+.|+.|..+++..+||||+++++++.+. ..|+||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence            45667899999999999986433    335889988763  23357899999999999999999999999754 689999


Q ss_pred             eecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           78 EYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |.++-|.|.+++..+. .++..+...+..||+.||.|||+..++||||-..||++.+...  |||+|||+++......-.
T Consensus       470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccccchh
Confidence            9999999999997654 7999999999999999999999999999999999999987776  999999999876555554


Q ss_pred             CcccC--CCCccCcccccCCccCCC
Q 030211          157 KSTVG--TPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~--~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+  ..-|||||.+.-..++..
T Consensus       548 kaS~~kLPIKWmaPESINfRrFTtA  572 (974)
T KOG4257|consen  548 KASRGKLPIKWMAPESINFRRFTTA  572 (974)
T ss_pred             hccccccceeecCccccchhcccch
Confidence            44444  456999999987776653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-25  Score=159.95  Aligned_cols=173  Identities=26%  Similarity=0.310  Sum_probs=143.4

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      +|+++++||+|.||.++.+++--.+.+||||.-.... ...++..|.+..+.+ ..++|+.++.+..++.+-.+|+|++ 
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC-CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence            6999999999999999999998889999999765433 345667788888777 4699999999999999999999998 


Q ss_pred             CCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC---CCcEEEeecCCccccc------
Q 030211           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA---APRLKICDFGYSKSSV------  151 (181)
Q Consensus        82 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~---~~~v~l~dfg~a~~~~------  151 (181)
                      |.+|.++.... ..|+-+++..++.|++.-++++|++.+|.+||||+|++|...+   ...|.++|||+|+...      
T Consensus       107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tkq  186 (449)
T KOG1165|consen  107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQ  186 (449)
T ss_pred             CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccc
Confidence            66888776543 4799999999999999999999999999999999999994322   3469999999997543      


Q ss_pred             --CCCCCCcccCCCCccCcccccCCccC
Q 030211          152 --LHSRPKSTVGTPAYIAPEVLSRREYD  177 (181)
Q Consensus       152 --~~~~~~~~~~~~~~~aPE~~~~~~~~  177 (181)
                        +....++..||-+|||--...+.+-+
T Consensus       187 HIPYrE~KSLsGTARYMSINTHlGrEQS  214 (449)
T KOG1165|consen  187 HIPYREHKSLSGTARYMSINTHLGREQS  214 (449)
T ss_pred             cCccccccccccceeeeEeeccccchhh
Confidence              44445667899999998766655443

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.93  E-value=3e-26  Score=153.57  Aligned_cols=165  Identities=25%  Similarity=0.391  Sum_probs=134.0

Q ss_pred             eeeeeCCccceeEEEEEEccCCcEEEEEEcccc--ccccHHHHHHHHHHh-hCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDENVAREIINHR-SLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~e~~~~~-~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      ..+.||+|++|.+=+..+..+|...|+|.+...  ....+..+.|+.+.. ...+|..|.+++.+.....+|+.||.+ .
T Consensus        50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~  128 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-D  128 (282)
T ss_pred             hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-h
Confidence            456799999999999999999999999998653  233456677776654 447899999999999999999999998 4


Q ss_pred             CChHH----HHhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           83 GELFD----RICNAGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        83 ~~l~~----~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      .+|..    .+..+..+++..+=.++..+..||.+||++ .++|||+||+||+|+.++  ++|++|||++......-...
T Consensus       129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G--qVKiCDFGIsG~L~dSiAkt  206 (282)
T KOG0984|consen  129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG--QVKICDFGISGYLVDSIAKT  206 (282)
T ss_pred             hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC--cEEEcccccceeehhhhHHH
Confidence            46643    345567899999999999999999999986 999999999999996554  59999999986443333333


Q ss_pred             cccCCCCccCcccccC
Q 030211          158 STVGTPAYIAPEVLSR  173 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~  173 (181)
                      --.|...|||||-+..
T Consensus       207 ~daGCkpYmaPEri~~  222 (282)
T KOG0984|consen  207 MDAGCKPYMAPERINP  222 (282)
T ss_pred             HhcCCCccCChhhcCc
Confidence            3578899999998864

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=2.3e-28  Score=168.29  Aligned_cols=171  Identities=30%  Similarity=0.438  Sum_probs=137.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcc-ccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEc--------C
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGR--KIDENVAREIINHRSLRHPNIIRFKEVVLT--------P   70 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~-~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--------~   70 (181)
                      +.|+-+.+||+|.||.||+|..+.+++.|++|..- .++  -.....++|++++..+.|+|++.+++.+..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45777889999999999999999999999988643 222  224678899999999999999998776643        1


Q ss_pred             CeEEEEEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           71 THLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        71 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      ..+|+|+++|+. +|...+.+. -.++..++..++.+++.+|.|+|++.|+|||+||.|++|+.++.  ++|.|||.++.
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--lklADFGlar~  173 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--LKLADFGLARA  173 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--EEeeccccccc
Confidence            348999999965 787777554 47999999999999999999999999999999999999975554  99999999964


Q ss_pred             ccCCC-----CCCcccCCCCccCcccccCCc
Q 030211          150 SVLHS-----RPKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       150 ~~~~~-----~~~~~~~~~~~~aPE~~~~~~  175 (181)
                      .+...     ....+.-|+.|.+||.+.+..
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r  204 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDR  204 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhccc
Confidence            33221     122334589999999998654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=3.8e-26  Score=161.49  Aligned_cols=173  Identities=27%  Similarity=0.362  Sum_probs=147.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcC------Ce
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP------TH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~------~~   72 (181)
                      .||.-+..++.|.. .|..|.+.-.+++|++|......   ...+..++|+..+..+.|+|+++++.+|...      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            36778888998888 88888898889999999876542   2236788999999999999999999999754      35


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      +|+|||++ ..+|.+.+..  .++.++++.++.|++.|+.+||+.||+||||||+||++..+..  +|+.|||+|.....
T Consensus        96 ~y~v~e~m-~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLARTEDT  170 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhhcccCc
Confidence            89999999 4477776653  4889999999999999999999999999999999999976665  99999999987766


Q ss_pred             CCCCCcccCCCCccCcccccCCccCCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ......+..+..|.|||++.+..|.+.+
T Consensus       171 ~~~mtpyVvtRyyrapevil~~~~ke~v  198 (369)
T KOG0665|consen  171 DFMMTPYVVTRYYRAPEVILGMGYKENV  198 (369)
T ss_pred             ccccCchhheeeccCchheeccCCcccc
Confidence            6677788999999999999998877653

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-27  Score=164.16  Aligned_cols=165  Identities=27%  Similarity=0.375  Sum_probs=135.1

Q ss_pred             eeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHh-hCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHR-SLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~-~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      -++.||.|.||+|++..++.+|+.+|+|+++...  +..++++.|+.... +-..|+||++++.....+.-|+.||.| .
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d  146 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-D  146 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-h
Confidence            3567999999999999999999999999998653  33466777776654 447899999999999999999999998 4


Q ss_pred             CChHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           83 GELFDRI-----CNAGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        83 ~~l~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~lh~~-gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      .++..+.     .....+++.-.-.+....+.||.||-+. .|+|||+||+||+++..  +.|||+|||++......-..
T Consensus       147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~--G~vKLCDFGIcGqLv~SiAk  224 (361)
T KOG1006|consen  147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH--GDVKLCDFGICGQLVDSIAK  224 (361)
T ss_pred             hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC--CCEeeecccchHhHHHHHHh
Confidence            4553322     2345788988888999999999999965 89999999999999644  45999999999766555556


Q ss_pred             CcccCCCCccCcccccC
Q 030211          157 KSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~  173 (181)
                      ..-.|...|||||-+..
T Consensus       225 T~daGCrpYmAPERi~p  241 (361)
T KOG1006|consen  225 TVDAGCRPYMAPERIDP  241 (361)
T ss_pred             hhccCCccccChhccCC
Confidence            66789999999998874

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.92  E-value=2.6e-25  Score=173.45  Aligned_cols=167  Identities=32%  Similarity=0.320  Sum_probs=134.0

Q ss_pred             eeeeeCCccce-eEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEeecCCC
Q 030211            6 LVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (181)
Q Consensus         6 ~~~~i~~g~~~-~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (181)
                      -.+++|.|..| .||++.-.  ++.||+|++-...  ..-..+|+..+... +|||+++++..-.+.+..|+..|.|.. 
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-  587 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-  587 (903)
T ss_pred             cHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence            34667888888 58999876  7899999876532  34567889888766 799999999999999999999999954 


Q ss_pred             ChHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc---CCCCcEEEeecCCcccccCCCC-
Q 030211           84 ELFDRICNAG----RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG---SAAPRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        84 ~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~---~~~~~v~l~dfg~a~~~~~~~~-  155 (181)
                      +|.+++....    .......+..+.|++.||++||+.+|+||||||.||+|+.   ++...++|.|||++++...+.. 
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS  667 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS  667 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence            8998886631    1222456888999999999999999999999999999964   4556899999999987654443 


Q ss_pred             ---CCcccCCCCccCcccccCCccC
Q 030211          156 ---PKSTVGTPAYIAPEVLSRREYD  177 (181)
Q Consensus       156 ---~~~~~~~~~~~aPE~~~~~~~~  177 (181)
                         .....||.+|+|||++.+..-+
T Consensus       668 ~~r~s~~sGt~GW~APE~L~~~~~~  692 (903)
T KOG1027|consen  668 FSRLSGGSGTSGWQAPEQLREDRKT  692 (903)
T ss_pred             hhcccCCCCcccccCHHHHhccccC
Confidence               3344799999999999876543

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=2e-25  Score=171.90  Aligned_cols=175  Identities=29%  Similarity=0.401  Sum_probs=145.3

Q ss_pred             cceeeeeeCCccceeEEEEEEccC-C--cEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKET-K--ELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~-~--~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ...+.|.||+|.||.|+++.|... |  ..||+|++.....  ....|++|+..+.+++|+++++++++..+ .-+-+|+
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            456788999999999999998643 2  3589999987643  34789999999999999999999999988 6788999


Q ss_pred             eecCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           78 EYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      |+++.|+|.+.+.+  ...|--.....++.||+.|+.||..+++||+||-..|+++-...  .|||+|||+.+.......
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr--tVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR--TVKICDFGLMRALGENED  267 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc--eeeeecccceeccCCCCc
Confidence            99999999999987  33677888999999999999999999999999999999995433  499999999875443333


Q ss_pred             CCc----ccCCCCccCcccccCCccCCCC
Q 030211          156 PKS----TVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       156 ~~~----~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      .-.    ..-...|+|||.+....++-++
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaS  296 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHAS  296 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccc
Confidence            222    2235679999999998887654

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.9e-25  Score=169.58  Aligned_cols=175  Identities=23%  Similarity=0.315  Sum_probs=150.6

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCC
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (181)
                      .....++|-|-+|.||.+.|+...-.||+|.++......++|+.|..+++.+.|||+|+++++|.....+|+++|||..+
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG  348 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG  348 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence            34567899999999999999988888999999887777799999999999999999999999999999999999999999


Q ss_pred             ChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcc--
Q 030211           84 ELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--  159 (181)
Q Consensus        84 ~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~--  159 (181)
                      .|++++...  ..++.-..+.++.||..|++||..+.+||+||-..|.++.  .+..||+.|||+++.+.........  
T Consensus       349 NLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg--EnhiVKvADFGLsRlMtgDTYTAHAGA  426 (1157)
T KOG4278|consen  349 NLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHIVKVADFGLSRLMTGDTYTAHAGA  426 (1157)
T ss_pred             cHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc--ccceEEeeccchhhhhcCCceecccCc
Confidence            999999653  3577778888999999999999999999999999999995  5556999999999865544433222  


Q ss_pred             cCCCCccCcccccCCccCCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      .-..-|.|||.+.-..++-|+
T Consensus       427 KFPIKWTAPEsLAyNtFSiKS  447 (1157)
T KOG4278|consen  427 KFPIKWTAPESLAYNTFSIKS  447 (1157)
T ss_pred             cCcccccCcccccccccccch
Confidence            235679999999888877664

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.1e-25  Score=155.12  Aligned_cols=170  Identities=30%  Similarity=0.464  Sum_probs=139.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEE-eEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKE-VVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~-~~~~~~~~~~v~e~   79 (181)
                      +.|.+.+++|+|-||.+-++.++.++..+++|.+++......+|.+|..---.+ .|.||+.-++ .|+..+.+++++|+
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            568899999999999999999999999999999999888888999988665444 5788888665 47778899999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~  159 (181)
                      ++-++|.+.... .-+.+.....++.|++.|+++||+++++|||||.+||+|-....-+|||+|||.....  +..-...
T Consensus       104 aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~--g~tV~~~  180 (378)
T KOG1345|consen  104 APRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV--GTTVKYL  180 (378)
T ss_pred             CccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc--Cceehhh
Confidence            999999987744 4578889999999999999999999999999999999994334448999999987531  1122223


Q ss_pred             cCCCCccCcccccCC
Q 030211          160 VGTPAYIAPEVLSRR  174 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~  174 (181)
                      .....|.+||.....
T Consensus       181 ~~~~~y~~pe~~~~~  195 (378)
T KOG1345|consen  181 EYVNNYHAPELCDTV  195 (378)
T ss_pred             hhhcccCCcHHHhhc
Confidence            356778899876543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.2e-27  Score=164.61  Aligned_cols=168  Identities=29%  Similarity=0.432  Sum_probs=136.5

Q ss_pred             eeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC-----eEEEE
Q 030211            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPT-----HLAIV   76 (181)
Q Consensus         5 ~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-----~~~~v   76 (181)
                      +.-+-||.|+||.||.+++..+|+.|++|.+..-..   ..+.+.+|+.++...+|.|++..+++...++     ++|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            445679999999999999999999999998764322   2367889999999999999999999887653     46788


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      +|.+ ..+|...+-+...++.+.+.-+++||+++|.|||+.+|.|+||||.|.+++  .++.+||+|||+|+.-......
T Consensus       136 TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN--SNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  136 TELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN--SNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec--cCceEEecccccccccchhhhh
Confidence            8887 447777776777899999999999999999999999999999999999996  4556999999999743332221


Q ss_pred             --CcccCCCCccCcccccCCc
Q 030211          157 --KSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       157 --~~~~~~~~~~aPE~~~~~~  175 (181)
                        ..-.-|-.|.|||.+.+..
T Consensus       213 hMTqEVVTQYYRAPEiLMGaR  233 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGAR  233 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcch
Confidence              1223477899999998754

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=4.9e-25  Score=172.12  Aligned_cols=173  Identities=27%  Similarity=0.362  Sum_probs=147.8

Q ss_pred             eeeeeeCCccceeEEEEEEccC----CcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            5 ELVKDLGAGNFGVARLLRHKET----KELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         5 ~~~~~i~~g~~~~v~~~~~~~~----~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      +-.++||+|+||+||++.+--.    .-+|++|++....  +...++++|+-.+.+++|||++++++++..+. +-+|++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3457899999999999998422    3368999887543  34678999999999999999999999998776 788999


Q ss_pred             ecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           79 YAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      |++.|.|+++...+. ++.....+.|..||++++.|||+++++||||-..|+++.....  +++.|||+++...++...-
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCcccccc
Confidence            999999999987654 8999999999999999999999999999999999999975555  9999999998877776655


Q ss_pred             cccC---CCCccCcccccCCccCCCC
Q 030211          158 STVG---TPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       158 ~~~~---~~~~~aPE~~~~~~~~~~~  180 (181)
                      ...+   .+-|||-|.+....|+.++
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thqS  881 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQS  881 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCchh
Confidence            5433   5779999999999998765

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=1.9e-24  Score=157.49  Aligned_cols=142  Identities=26%  Similarity=0.387  Sum_probs=125.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc---CCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE---TKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +.|.++++||+|.|++||++.+..   .++.||+|.+..-. ....+..|+.++..+ .+.|++.+.+++..++...+|+
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl  114 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL  114 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence            468899999999999999999877   78889999887532 246788999999888 5789999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      ||+++....++...   ++...++.+++.++.||.++|.+||+|+|+||.|++++.. ..+-.|+|||+|.
T Consensus       115 p~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~-t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  115 PYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRR-TQRGVLVDFGLAQ  181 (418)
T ss_pred             cccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccc-cCCceEEechhHH
Confidence            99999988887754   6789999999999999999999999999999999999743 4467899999986

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-23  Score=165.98  Aligned_cols=175  Identities=26%  Similarity=0.389  Sum_probs=144.4

Q ss_pred             ceeeeeeCCccceeEEEEEEc----c---CCcEEEEEEccccccc--cHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeE
Q 030211            4 YELVKDLGAGNFGVARLLRHK----E---TKELVAVKYIERGRKI--DENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~----~---~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~   73 (181)
                      ..+.+.+|+|.||.|+++.-.    .   ....||+|..+.....  .+.+..|+.+++.+ .|+|++.+++++...+..
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~  377 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL  377 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence            356679999999999999743    1   1456899988755433  46788999999888 599999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCC
Q 030211           74 AIVMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP  137 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~  137 (181)
                      ++++||+..++|..++..+.                .++......++.||+.+++||++..++||||-..||++..+.  
T Consensus       378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~--  455 (609)
T KOG0200|consen  378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK--  455 (609)
T ss_pred             EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC--
Confidence            99999999999999987654                488899999999999999999999999999999999997554  


Q ss_pred             cEEEeecCCcccccCCCCCCc--cc--CCCCccCcccccCCccCCCC
Q 030211          138 RLKICDFGYSKSSVLHSRPKS--TV--GTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       138 ~v~l~dfg~a~~~~~~~~~~~--~~--~~~~~~aPE~~~~~~~~~~~  180 (181)
                      .++++|||+|+..........  ..  -...|||||.+....|+.|+
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kS  502 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKS  502 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccc
Confidence            599999999986544433321  12  23459999999999998875

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=4.5e-23  Score=143.63  Aligned_cols=136  Identities=16%  Similarity=0.184  Sum_probs=109.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHH----------HHHHHHHHhhCCCCCeeEEEEeEEcC-
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----------VAREIINHRSLRHPNIIRFKEVVLTP-   70 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~----------~~~e~~~~~~~~~~~i~~~~~~~~~~-   70 (181)
                      ++|++.++++.|+||.||.+..  +++.+++|++.......+.          +.+|+..+.++.|++++.+.+++... 
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            5899999999999999999766  3667999998754332222          57888889999999999999887643 


Q ss_pred             -------CeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEee
Q 030211           71 -------THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICD  143 (181)
Q Consensus        71 -------~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~d  143 (181)
                             +..+++|||++|.+|.+..    .+++    ....+++.++..+|+.|++|||++|.||++++++   ++|+|
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~liD  177 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRIID  177 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEEE
Confidence                   3578999999999997763    2333    2466999999999999999999999999997544   99999


Q ss_pred             cCCcccc
Q 030211          144 FGYSKSS  150 (181)
Q Consensus       144 fg~a~~~  150 (181)
                      ||.....
T Consensus       178 fg~~~~~  184 (232)
T PRK10359        178 LSGKRCT  184 (232)
T ss_pred             CCCcccc
Confidence            9987543

>smart00090 RIO RIO-like kinase

Probab=99.90  E-value=4e-23  Score=146.13  Aligned_cols=140  Identities=16%  Similarity=0.102  Sum_probs=109.4

Q ss_pred             ceeeeeeCCccceeEEEEE-EccCCcEEEEEEccccccc-------------------------cHHHHHHHHHHhhCCC
Q 030211            4 YELVKDLGAGNFGVARLLR-HKETKELVAVKYIERGRKI-------------------------DENVAREIINHRSLRH   57 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~-~~~~~~~v~~K~~~~~~~~-------------------------~~~~~~e~~~~~~~~~   57 (181)
                      |++.+.||+|++|.||+|. +..+|+.||+|++......                         ...+..|...+..+.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            7788999999999999998 6667999999998754210                         0124578888888865


Q ss_pred             --CCeeEEEEeEEcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-eeeeCCCCCCEEeccC
Q 030211           58 --PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ-ICHRDLKLENTLLDGS  134 (181)
Q Consensus        58 --~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~g-i~h~dl~p~ni~i~~~  134 (181)
                        ..++.++..    +..+++||++++.++.................++.|++.++.+||+.| ++|+|++|+||+++  
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~--  183 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH--  183 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE--
Confidence              334455542    235899999999877665544455667778899999999999999999 99999999999997  


Q ss_pred             CCCcEEEeecCCcccc
Q 030211          135 AAPRLKICDFGYSKSS  150 (181)
Q Consensus       135 ~~~~v~l~dfg~a~~~  150 (181)
                       ...++|+|||.+...
T Consensus       184 -~~~i~LiDFg~a~~~  198 (237)
T smart00090      184 -DGKVVIIDVSQSVEL  198 (237)
T ss_pred             -CCCEEEEEChhhhcc
Confidence             345999999998743

>PRK10345 hypothetical protein; Provisional

Probab=99.90  E-value=2e-22  Score=139.62  Aligned_cols=137  Identities=22%  Similarity=0.270  Sum_probs=106.6

Q ss_pred             eeeeeCCccceeEEEEEEccCCcEEEEEEccccc-cccHHHHHHHHHHhhC-----CCCCeeEEEEeEEcCC---eEE-E
Q 030211            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSL-----RHPNIIRFKEVVLTPT---HLA-I   75 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~~~~~-----~~~~i~~~~~~~~~~~---~~~-~   75 (181)
                      -.+.||+|+++.||.  +..+... ++|++.... ...+.+.+|+..++.+     .||||++++++++++.   .++ +
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            457899999999995  6666555 689876542 2346789999999988     5799999999999874   434 7


Q ss_pred             EEee--cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHH-HHHHhcCeeeeCCCCCCEEeccC--CCCcEEEee-cCCcc
Q 030211           76 VMEY--AAGGELFDRICNAGRFSEDEGRYFFQQLISGV-NYCHSMQICHRDLKLENTLLDGS--AAPRLKICD-FGYSK  148 (181)
Q Consensus        76 v~e~--~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l-~~lh~~gi~h~dl~p~ni~i~~~--~~~~v~l~d-fg~a~  148 (181)
                      ++||  +.+++|.+++.. ..+++.  ..++.+++.++ +|||+++|+|+||||+||+++..  +...++|+| ||...
T Consensus        83 I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~  158 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGEST  158 (210)
T ss_pred             EecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence            8999  446899999855 346555  46678888877 89999999999999999999642  334799999 55443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=3.1e-23  Score=167.10  Aligned_cols=175  Identities=25%  Similarity=0.317  Sum_probs=139.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccH-HHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE-NVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~-~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      +.|.|.+.+|+|++|.||+|...+ |+.||+|+-+....+.- ....-...|+..--+.+..+..++...+.-+++++|.
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~  776 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYS  776 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecc
Confidence            468899999999999999999987 99999998776554431 1111112222112356777788888888889999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEec-----cCCCCcEEEeecCCcccccCCC-
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD-----GSAAPRLKICDFGYSKSSVLHS-  154 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~-----~~~~~~v~l~dfg~a~~~~~~~-  154 (181)
                      +.|+|++++..+..+++..+..+..|++..++.||..+||||||||+|+++.     +...--++|+|||.+.++.... 
T Consensus       777 ~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~  856 (974)
T KOG1166|consen  777 PYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPD  856 (974)
T ss_pred             ccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCC
Confidence            9999999998888899999999999999999999999999999999999992     2334459999999987653333 


Q ss_pred             --CCCcccCCCCccCcccccCCccC
Q 030211          155 --RPKSTVGTPAYIAPEVLSRREYD  177 (181)
Q Consensus       155 --~~~~~~~~~~~~aPE~~~~~~~~  177 (181)
                        ......++..|-.+|+..+.+|+
T Consensus       857 ~~~F~~~~~td~f~C~EM~~grpWt  881 (974)
T KOG1166|consen  857 GTKFKAVWHTDLFDCIEMREGRPWT  881 (974)
T ss_pred             CcEEeeeeccccchhHHHhcCCCCc
Confidence              34445688999999999999886

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=2.2e-22  Score=137.70  Aligned_cols=135  Identities=19%  Similarity=0.212  Sum_probs=106.5

Q ss_pred             eeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccH-----HHHHHHHHHhhCCC-CCeeEEEEeEEcCCeEEEEEe
Q 030211            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE-----NVAREIINHRSLRH-PNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         5 ~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~-----~~~~e~~~~~~~~~-~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      .+...+++|+||+||.+..  .+.+++.+.+...+.+..     .+.+|+.+++++.| +++++++++    +..+++|+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            4678899999999997766  577788787776655433     47889999999955 889999885    45799999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCC-CCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL-KLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl-~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      |+.|.+|.+....       ....++.|++.++.++|++|++|+|| +|+||++++++  .++|+|||+|....+..
T Consensus        79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g--~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG--SPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC--CEEEEECCCceecCCcc
Confidence            9998888653311       12357889999999999999999999 79999997554  49999999997544433

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=4.6e-22  Score=147.81  Aligned_cols=132  Identities=25%  Similarity=0.396  Sum_probs=115.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC--------CCCeeEEEEeEEc----
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR--------HPNIIRFKEVVLT----   69 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~--------~~~i~~~~~~~~~----   69 (181)
                      +||.+.++||=|.|++||++++....+.||+|+.+..+...+..+.|+.++++++        ..++|++++.|..    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            5899999999999999999999999999999999887767788899999999883        2469999999875    


Q ss_pred             CCeEEEEEeecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccC
Q 030211           70 PTHLAIVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGS  134 (181)
Q Consensus        70 ~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~  134 (181)
                      +.++++|+|++ |.+|+.++...  .-++...+..|++|+|.+|.|||+ .||+|.||||+||++..+
T Consensus       158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST  224 (590)
T ss_pred             CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence            45799999999 55777777554  368999999999999999999996 599999999999999644

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.7e-21  Score=136.07  Aligned_cols=134  Identities=25%  Similarity=0.237  Sum_probs=110.2

Q ss_pred             eeeeCCccceeEEEEEEccCCcEEEEEEccccccc---------cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---------DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---------~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++.||+|++|.||++.+  .+..+++|........         ...+.+|...+..+.+++++.+..++.+.+..+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36789999999999987  4677899976542211         134667888888899998888777777778889999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      ||+++.+|.+.+.....    ....++.+++.++.++|+.|++|+|++|.||+++   .+.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~---~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS---GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE---CCCEEEEECCcccC
Confidence            99999999988755322    7889999999999999999999999999999997   34599999998864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.87  E-value=5.8e-21  Score=132.20  Aligned_cols=130  Identities=22%  Similarity=0.196  Sum_probs=103.2

Q ss_pred             eeCCccceeEEEEEEccCCcEEEEEEcccccc-c--------cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            9 DLGAGNFGVARLLRHKETKELVAVKYIERGRK-I--------DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         9 ~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~--------~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      .||+|++|.||++..  .+..+++|....... .        ...+.+|+.++..++++++..+..++...+..+++||+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            479999999999985  467899998653221 1        14466788899888888766655556666777899999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS  150 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~  150 (181)
                      +++.+|.+.+.....       .++.+++.+|.+||+.|++|+|++|.||+++   .+.++++|||.+...
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~---~~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR---DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE---CCcEEEEECCCCcCC
Confidence            999999887644211       8899999999999999999999999999997   345999999998654

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.87  E-value=3.5e-20  Score=136.09  Aligned_cols=167  Identities=40%  Similarity=0.619  Sum_probs=141.4

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCC-CeeEEEEeEEcCCeEEEEEe
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHP-NIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~-~i~~~~~~~~~~~~~~~v~e   78 (181)
                      |.+.+.+|.|+|+.||.+.+.   ..+++|.+.....    ....+.+|...+..+.|+ +++++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999988   6789998876543    245788899999999988 79999999988888899999


Q ss_pred             ecCCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-
Q 030211           79 YAAGGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-  154 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-  154 (181)
                      ++.++++.+.+....   .++......++.|++.++.++|+.|++|+|++|+||+++.... .+++.|||.+....... 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence            999999997776554   7999999999999999999999999999999999999964431 59999999987443332 


Q ss_pred             ------CCCcccCCCCccCcccccCC
Q 030211          155 ------RPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       155 ------~~~~~~~~~~~~aPE~~~~~  174 (181)
                            ......++..|+|||.+...
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~  183 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGL  183 (384)
T ss_pred             cccccccccccccccccCCHHHhcCC
Confidence                  34566899999999999873

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.86  E-value=8.4e-21  Score=131.34  Aligned_cols=134  Identities=22%  Similarity=0.256  Sum_probs=102.8

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc-----------------------cHHHHHHHHHHhhCCCC--
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-----------------------DENVAREIINHRSLRHP--   58 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-----------------------~~~~~~e~~~~~~~~~~--   58 (181)
                      |.+.+.||+|++|.||++... +++.+++|++..+...                       ......|...+..+.++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            778899999999999999875 6899999986543210                       11245677777777666  


Q ss_pred             CeeEEEEeEEcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCc
Q 030211           59 NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPR  138 (181)
Q Consensus        59 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~  138 (181)
                      .++.+++    .+..+++|||+++.+|.....      ......++.+++.++.++|+.|++|+||+|+||+++.+.  .
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~--~  163 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE--K  163 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC--c
Confidence            3444443    245589999999988865432      135667889999999999999999999999999997544  5


Q ss_pred             EEEeecCCcccc
Q 030211          139 LKICDFGYSKSS  150 (181)
Q Consensus       139 v~l~dfg~a~~~  150 (181)
                      ++|+|||.+...
T Consensus       164 ~~liDfg~~~~~  175 (198)
T cd05144         164 IYIIDWPQMVST  175 (198)
T ss_pred             EEEEECCccccC
Confidence            999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.85  E-value=4.1e-20  Score=145.08  Aligned_cols=135  Identities=22%  Similarity=0.178  Sum_probs=107.7

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEcc-cccc--------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRK--------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~-~~~~--------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      |...+.||+|++|.||++.+...  .+++|... +...        ..+.+.+|+.++..++|++++.+..+.......+
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            45678999999999999987643  34444321 1111        1245778999999999999988887777777889


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      ++|||+++++|.+.+.        ....++.+++.++.+||+.|++|+|++|+||+++ +.  .++|+|||+++...
T Consensus       413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--~~~liDFGla~~~~  478 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKYSD  478 (535)
T ss_pred             EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--cEEEEeCcccccCC
Confidence            9999999999988764        4567899999999999999999999999999993 33  49999999997543

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.82  E-value=6.7e-20  Score=125.67  Aligned_cols=136  Identities=20%  Similarity=0.231  Sum_probs=94.4

Q ss_pred             eeeeeCCccceeEEEEEEccCCcEEEEEEccccccccH---H----------------------HHHHHHHHhhCCCCC-
Q 030211            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE---N----------------------VAREIINHRSLRHPN-   59 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~---~----------------------~~~e~~~~~~~~~~~-   59 (181)
                      +.+.||+|++|+||+|.+. +++.|++|++........   .                      ...|...+..+.+.+ 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999987 688999998875422111   1                      123444444443332 


Q ss_pred             -eeEEEEeEEcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCCC
Q 030211           60 -IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAP  137 (181)
Q Consensus        60 -i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~~  137 (181)
                       ++.++.+    ...+++|||++++.+.......... ......++.+++.++.++|. .|++|+|++|+||+++ +  +
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~--~  151 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D--G  151 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C--C
Confidence             4444443    2358999999885432111111111 16788999999999999999 9999999999999997 3  3


Q ss_pred             cEEEeecCCcccc
Q 030211          138 RLKICDFGYSKSS  150 (181)
Q Consensus       138 ~v~l~dfg~a~~~  150 (181)
                      .++|+|||.+...
T Consensus       152 ~~~liDfg~a~~~  164 (187)
T cd05119         152 KVYIIDVPQAVEI  164 (187)
T ss_pred             cEEEEECcccccc
Confidence            5999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.80  E-value=1.4e-18  Score=114.74  Aligned_cols=132  Identities=25%  Similarity=0.267  Sum_probs=109.7

Q ss_pred             eeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCC--CCeeEEEEeEEcCCeEEEEEeecCCC
Q 030211            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH--PNIIRFKEVVLTPTHLAIVMEYAAGG   83 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~--~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (181)
                      +++.+++|.++.+|++....  ..+++|....... ...+..|...+..+++  ..+++++.+....+..++++|++.+.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            56789999999999999864  6799998866443 4567888888888876  58899999888888899999999887


Q ss_pred             ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM---QICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        84 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      .+...       +......++.+++.+++.||..   +++|+|++|+||++++.  +.++++||+.+..
T Consensus        79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~--~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG--KILGIIDWEYAGY  138 (155)
T ss_pred             ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC--cEEEEEecccccC
Confidence            66543       5567778899999999999984   79999999999999753  4599999998763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.80  E-value=3.1e-20  Score=151.81  Aligned_cols=122  Identities=16%  Similarity=0.137  Sum_probs=89.2

Q ss_pred             CCeeEEEEeE-------EcCCeEEEEEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCE
Q 030211           58 PNIIRFKEVV-------LTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENT  129 (181)
Q Consensus        58 ~~i~~~~~~~-------~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni  129 (181)
                      .|+.++++.|       .....++.++|++ +.+|.+++... ..++...+..++.||+.||.|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            3566666665       2234577888877 55999988653 4699999999999999999999999999999999999


Q ss_pred             Eecc-----------------CCCCcEEEeecCCcccccCCC-----------------CCCcccCCCCccCcccccCCc
Q 030211          130 LLDG-----------------SAAPRLKICDFGYSKSSVLHS-----------------RPKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       130 ~i~~-----------------~~~~~v~l~dfg~a~~~~~~~-----------------~~~~~~~~~~~~aPE~~~~~~  175 (181)
                      +++.                 +....+++.|||+++......                 ......+|+.|||||++.+..
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            9953                 223356777777765321100                 001134788899999999988


Q ss_pred             cCCCC
Q 030211          176 YDGKQ  180 (181)
Q Consensus       176 ~~~~~  180 (181)
                      ++.++
T Consensus       192 ~~~~s  196 (793)
T PLN00181        192 SNCAS  196 (793)
T ss_pred             CCchh
Confidence            87653

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.80  E-value=3.2e-18  Score=121.40  Aligned_cols=135  Identities=19%  Similarity=0.209  Sum_probs=100.8

Q ss_pred             eeeC-CccceeEEEEEEccCCcEEEEEEccccc--------------cccHHHHHHHHHHhhCCCCCe--eEEEEeEEcC
Q 030211            8 KDLG-AGNFGVARLLRHKETKELVAVKYIERGR--------------KIDENVAREIINHRSLRHPNI--IRFKEVVLTP   70 (181)
Q Consensus         8 ~~i~-~g~~~~v~~~~~~~~~~~v~~K~~~~~~--------------~~~~~~~~e~~~~~~~~~~~i--~~~~~~~~~~   70 (181)
                      ..+| .|+.|++|.+...  +..+++|.+....              .....+.+|+.++..++++++  +.++++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            3566 8899999988775  6778999875421              112457789999999988775  6666654332


Q ss_pred             -Ce---EEEEEeecCC-CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecC
Q 030211           71 -TH---LAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG  145 (181)
Q Consensus        71 -~~---~~~v~e~~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg  145 (181)
                       ..   .++++|++++ .+|.+.+.. .+++..    .+.+++.++.+||++||+|+||+|.||++++++  .++|+|||
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~--~v~LIDfg  187 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG--KFWLIDFD  187 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC--CEEEEECC
Confidence             22   3599999987 578777644 345544    367899999999999999999999999997544  59999999


Q ss_pred             Cccccc
Q 030211          146 YSKSSV  151 (181)
Q Consensus       146 ~a~~~~  151 (181)
                      .+....
T Consensus       188 ~~~~~~  193 (239)
T PRK01723        188 RGELRT  193 (239)
T ss_pred             CcccCC
Confidence            887543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=6.5e-20  Score=144.38  Aligned_cols=172  Identities=34%  Similarity=0.545  Sum_probs=135.4

Q ss_pred             eeeeeeCCccceeEEEEEEccCCcEEEEEEcc----cccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIE----RGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         5 ~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~----~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      .....+|.|.+|.++.+...........|.+.    ....   ....+..|+.+-..+.|++++..+....+.......|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            35567899999988888876655555555433    1111   1122556677778889999988888877777766679


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--  155 (181)
                      ||++. +|...+.....++...+..++.|++.++.|||+.|+.|+|+||+|+++..++  .++++|||.+....-...  
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g--~lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG--ILKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC--ceEEeecCcceeeccCcchh
Confidence            99999 9999888777899999999999999999999999999999999999997555  599999999865433322  


Q ss_pred             ---CCcccCCCCccCcccccCCccCCC
Q 030211          156 ---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                         .....|+..|+|||++...+|.+.
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~~ydpr  504 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGKEYDPR  504 (601)
T ss_pred             hhhhcCcccCCcCcCcccccccccCcc
Confidence               344679999999999999999875

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.72  E-value=1.6e-16  Score=108.53  Aligned_cols=137  Identities=13%  Similarity=0.132  Sum_probs=99.6

Q ss_pred             eeeeCCccceeEEEEEEcc------CCcEEEEEEcccc-------------c----------ccc----HHHHHHHHHHh
Q 030211            7 VKDLGAGNFGVARLLRHKE------TKELVAVKYIERG-------------R----------KID----ENVAREIINHR   53 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~------~~~~v~~K~~~~~-------------~----------~~~----~~~~~e~~~~~   53 (181)
                      ...||.|.-+.||.|...+      .+..+|+|+.+.+             .          ...    .+..+|.+.+.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4689999999999998654      3578999987421             0          001    13447888888


Q ss_pred             hCCC--CCeeEEEEeEEcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-HhcCeeeeCCCCCCEE
Q 030211           54 SLRH--PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQICHRDLKLENTL  130 (181)
Q Consensus        54 ~~~~--~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~gi~h~dl~p~ni~  130 (181)
                      .+..  -.++.++++    ...+++||++++..+.....+...++.+....+..+++.++..| |+.|++||||+|.||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8754  456666654    45688999997653322222233455667778889999999988 8999999999999999


Q ss_pred             eccCCCCcEEEeecCCcccc
Q 030211          131 LDGSAAPRLKICDFGYSKSS  150 (181)
Q Consensus       131 i~~~~~~~v~l~dfg~a~~~  150 (181)
                      +.+   +++.|+|||.+...
T Consensus       158 ~~~---~~v~iIDF~qav~~  174 (197)
T cd05146         158 WHD---GKVWFIDVSQSVEP  174 (197)
T ss_pred             EEC---CcEEEEECCCceeC
Confidence            963   35999999988643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.70  E-value=6.3e-17  Score=118.28  Aligned_cols=176  Identities=17%  Similarity=0.171  Sum_probs=133.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCC-----cEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEc-CCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETK-----ELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLT-PTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~-----~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~   73 (181)
                      .|+++...+-+|.||.||.+.+.+.+     +.|.+|.++...  .....++.|--++--..|||+.++.++..+ ....
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P  363 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP  363 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence            36777788899999999999876433     235555554332  222456666666777789999999888765 4567


Q ss_pred             EEEEeecCCCChHHHHh-----h---cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecC
Q 030211           74 AIVMEYAAGGELFDRIC-----N---AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG  145 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~-----~---~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg  145 (181)
                      ++++++...+.|..++.     +   ...++......++.|++.|+++||+.|++|.||-..|.+|++.  -+++|.|-.
T Consensus       364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~--LqVkltDsa  441 (563)
T KOG1024|consen  364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ--LQVKLTDSA  441 (563)
T ss_pred             eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh--eeEEeccch
Confidence            88999998899999886     1   2357777888899999999999999999999999999999644  569999998


Q ss_pred             CcccccCCCCCC---cccCCCCccCcccccCCccCCC
Q 030211          146 YSKSSVLHSRPK---STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       146 ~a~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +++...+..-..   .--....|||||.+.+..|+..
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa  478 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA  478 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhhhhcch
Confidence            887655443321   1123567999999999998764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.67  E-value=1.2e-15  Score=102.87  Aligned_cols=129  Identities=19%  Similarity=0.222  Sum_probs=95.0

Q ss_pred             eeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCC-eeEEEEeEEcCCeEEEEEeecCCCCh
Q 030211            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN-IIRFKEVVLTPTHLAIVMEYAAGGEL   85 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~-i~~~~~~~~~~~~~~~v~e~~~~~~l   85 (181)
                      .+.++.|..+.+|++...  +..+++|..............|...+..+...+ +++++....  ...+++||++++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            467888999999999865  778999987655432344567888887775544 345555443  334789999999877


Q ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCe-----eeeCCCCCCEEeccCCCCcEEEeecCCcccc
Q 030211           86 FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI-----CHRDLKLENTLLDGSAAPRLKICDFGYSKSS  150 (181)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi-----~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~  150 (181)
                      ...        .......+.+++.+++.||..++     +|+|++|.||+++ +  +.++++||+.+...
T Consensus        79 ~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~--~~~~liDf~~a~~~  137 (170)
T cd05151          79 LTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D--GRLWLIDWEYAGMN  137 (170)
T ss_pred             ccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C--CeEEEEecccccCC
Confidence            542        11123457889999999999985     9999999999997 2  34999999988643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.67  E-value=3.7e-16  Score=114.70  Aligned_cols=119  Identities=29%  Similarity=0.440  Sum_probs=94.1

Q ss_pred             CCCCeeEEEEeEEcC---------------------------CeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHH
Q 030211           56 RHPNIIRFKEVVLTP---------------------------THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI  108 (181)
Q Consensus        56 ~~~~i~~~~~~~~~~---------------------------~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~  108 (181)
                      +||||+++..+|.++                           ..+|+||..+.. +|.+++..+ ..+..+.+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence            699999998887542                           247999998844 898888654 456678888999999


Q ss_pred             HHHHHHHhcCeeeeCCCCCCEEe--ccCCCCcEEEeecCCcccccC-------CCCCCcccCCCCccCcccccCCcc
Q 030211          109 SGVNYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVL-------HSRPKSTVGTPAYIAPEVLSRREY  176 (181)
Q Consensus       109 ~~l~~lh~~gi~h~dl~p~ni~i--~~~~~~~v~l~dfg~a~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~  176 (181)
                      .|+.+||.+|++|+|+|.+||++  ++|..+.+.+.|||+|-....       .+..-..-|+-..||||+....+-
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG  428 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG  428 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence            99999999999999999999999  677888999999999743222       122223447778999999886553

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.66  E-value=3.8e-15  Score=99.26  Aligned_cols=130  Identities=24%  Similarity=0.225  Sum_probs=102.4

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEE-ccccccc--------cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKY-IERGRKI--------DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~-~~~~~~~--------~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ..+.+|+-+.+|.+.+.  |.++++|. +++....        .....+|.+++..++.-+++.+.-+..+++...++||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            45789999999999775  55567773 3222111        1356778888988887788888888888888899999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      |++|..|.+.+...       ...++..+-..+.-||.+||+||||.++||++.++.   +.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCcccc
Confidence            99998888887654       256777888889999999999999999999996433   99999999864

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.66  E-value=2.1e-15  Score=115.51  Aligned_cols=138  Identities=20%  Similarity=0.210  Sum_probs=91.2

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEcccccccc-----------------------------------H------HHH
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-----------------------------------E------NVA   46 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~-----------------------------------~------~~~   46 (181)
                      +.|++|+.|+||+|+.+ +|+.||+|+.+.+-...                                   .      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            56999999999999986 58899999976431000                                   0      122


Q ss_pred             HHHHHHhhC----CC-CCeeEEEEeEEcCCeEEEEEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHH-HHHHHHhcCe
Q 030211           47 REIINHRSL----RH-PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLIS-GVNYCHSMQI  119 (181)
Q Consensus        47 ~e~~~~~~~----~~-~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~-~l~~lh~~gi  119 (181)
                      .|...+..+    ++ +++.-..-+.......+++|||++|.++.+..... ...   ....++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence            233333332    22 33322222223345578999999999887765322 122   23345555555 4678999999


Q ss_pred             eeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211          120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus       120 ~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      +|+|++|.||++++++  .++|+|||++....
T Consensus       279 ~H~D~hPgNilv~~~g--~i~liDfG~~~~l~  308 (437)
T TIGR01982       279 FHADLHPGNIFVLKDG--KIIALDFGIVGRLS  308 (437)
T ss_pred             eeCCCCcccEEECCCC--cEEEEeCCCeeECC
Confidence            9999999999996554  59999999987544

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.65  E-value=1.1e-15  Score=109.83  Aligned_cols=165  Identities=23%  Similarity=0.212  Sum_probs=99.2

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCC----------CCCeeEEEEeEEc
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLR----------HPNIIRFKEVVLT   69 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~----------~~~i~~~~~~~~~   69 (181)
                      ...++.||.|+++.||.+++.+++..+++|++......    -+.+.+|.-....+.          |-.++-.++...-
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            45678899999999999999999999999988654322    234444443333321          2233333333221


Q ss_pred             C------------C-----eEEEEEeecCCCChHHHH---hhcCCC----CHHHHHHHHHHHHHHHHHHHhcCeeeeCCC
Q 030211           70 P------------T-----HLAIVMEYAAGGELFDRI---CNAGRF----SEDEGRYFFQQLISGVNYCHSMQICHRDLK  125 (181)
Q Consensus        70 ~------------~-----~~~~v~e~~~~~~l~~~~---~~~~~~----~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~  125 (181)
                      .            .     +.+++|+.+ .++|...+   ......    .......+..|+.+.+++||+.|++|+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence            1            1     246778876 44666553   222222    222334456899999999999999999999


Q ss_pred             CCCEEeccCCCCcEEEeecCCcccccCCCCCCcccCCCCccCcccccC
Q 030211          126 LENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       126 p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~  173 (181)
                      |+|++++.++  .++|+||+...........  ...+..|.+||....
T Consensus       173 ~~nfll~~~G--~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~  216 (288)
T PF14531_consen  173 PENFLLDQDG--GVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESC  216 (288)
T ss_dssp             GGGEEE-TTS---EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHH
T ss_pred             eeeEEEcCCC--CEEEcChHHHeecCceeec--cCCCcccCChhhhhh
Confidence            9999997655  4999999876543322222  334477899987643

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.64  E-value=2.5e-17  Score=126.17  Aligned_cols=159  Identities=28%  Similarity=0.474  Sum_probs=131.3

Q ss_pred             eeCCccceeEEEEE---EccCCcEEEEEEccccccc---cHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            9 DLGAGNFGVARLLR---HKETKELVAVKYIERGRKI---DENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         9 ~i~~g~~~~v~~~~---~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      .+|+|.+|.++.+.   ..+.+..+++|+..+....   ......|..++..++ +|.++.+...++.+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            36889999888775   3456778899987653211   123444666666676 8999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccC
Q 030211           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG  161 (181)
Q Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~  161 (181)
                      ++.+...+.+...+++.....+...++.+++++|+.|++++|+|++||+++.++.  +++.|||.++........   +|
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~~---cg  155 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKIA---CG  155 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhhc---cc
Confidence            9999888888888999999999999999999999999999999999999975555  999999998755444444   89


Q ss_pred             CCCccCccccc
Q 030211          162 TPAYIAPEVLS  172 (181)
Q Consensus       162 ~~~~~aPE~~~  172 (181)
                      +..|||||++.
T Consensus       156 t~eymApEI~~  166 (612)
T KOG0603|consen  156 TYEYRAPEIIN  166 (612)
T ss_pred             chhhhhhHhhh
Confidence            99999999998

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.64  E-value=1.7e-16  Score=123.29  Aligned_cols=142  Identities=23%  Similarity=0.305  Sum_probs=91.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-----------------------------------ccHH--
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-----------------------------------IDEN--   44 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-----------------------------------~~~~--   44 (181)
                      +.|+. +.+++|+.|+||+|+.+++|+.||+|+.+++-.                                   ..+.  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35666 789999999999999998899999999875310                                   0011  


Q ss_pred             ----HHHHHHHHhhC----CCCCeeEEEEeE-EcCCeEEEEEeecCCCChHHHH--hhcC----CCCHHHHHHHHHHHHH
Q 030211           45 ----VAREIINHRSL----RHPNIIRFKEVV-LTPTHLAIVMEYAAGGELFDRI--CNAG----RFSEDEGRYFFQQLIS  109 (181)
Q Consensus        45 ----~~~e~~~~~~~----~~~~i~~~~~~~-~~~~~~~~v~e~~~~~~l~~~~--~~~~----~~~~~~~~~~~~~i~~  109 (181)
                          +..|...+.++    .+...+.+=.++ ......+++|||+.|.++.+..  ...+    .+.+..+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence                22233333333    233323322222 2245678999999999887642  2222    13333333344444  


Q ss_pred             HHHHHHhcCeeeeCCCCCCEEeccCC--CCcEEEeecCCccccc
Q 030211          110 GVNYCHSMQICHRDLKLENTLLDGSA--APRLKICDFGYSKSSV  151 (181)
Q Consensus       110 ~l~~lh~~gi~h~dl~p~ni~i~~~~--~~~v~l~dfg~a~~~~  151 (181)
                           ...|++|+|++|.||+++.++  .++++++|||++....
T Consensus       277 -----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 -----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                 469999999999999996544  2369999999986543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.62  E-value=1.2e-16  Score=112.02  Aligned_cols=166  Identities=21%  Similarity=0.368  Sum_probs=135.3

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ..+..+|.+...|..|+++++  |..++.|++...+   .....|.+|.-.++...|||++.+++.+..+.+..++..|+
T Consensus       192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            345667889999999999998  4557788876543   23467888888899999999999999999999999999999


Q ss_pred             CCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcC--eeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           81 AGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~g--i~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      +.++|...++...  -.+..++.+++.+++.+++|||+..  |.--.|+...++|+++-+.++...|.-++      ...
T Consensus       270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs------fqe  343 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS------FQE  343 (448)
T ss_pred             cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee------eec
Confidence            9999999998765  3677889999999999999999874  55667899999999888877777775433      233


Q ss_pred             CcccCCCCccCcccccCCccC
Q 030211          157 KSTVGTPAYIAPEVLSRREYD  177 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~  177 (181)
                      ....-+|.|||||.+.+.+-+
T Consensus       344 ~gr~y~pawmspealqrkped  364 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPED  364 (448)
T ss_pred             cccccCcccCCHHHHhcCchh
Confidence            445568899999999988754

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.57  E-value=9.6e-14  Score=92.49  Aligned_cols=143  Identities=17%  Similarity=0.143  Sum_probs=109.2

Q ss_pred             eeeeeCCccceeEEEEEEccCCcEEEEEE-cccc--------ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            6 LVKDLGAGNFGVARLLRHKETKELVAVKY-IERG--------RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~~~v~~K~-~~~~--------~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ..+.+.+|+-+.|+++.+.  |+..++|. +.+.        +-..+..++|.+.+.+++--+|.-+.-++.+...-.+.
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            4677889999999999876  67667773 3221        11235677888999888777888888888888888999


Q ss_pred             EeecCCC-ChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCC-cEEEeecCCcccc
Q 030211           77 MEYAAGG-ELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP-RLKICDFGYSKSS  150 (181)
Q Consensus        77 ~e~~~~~-~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~-~v~l~dfg~a~~~  150 (181)
                      |||+++. ++.+++.+.  .....+....++.++-..+..||.++++||||..+||++.++++. .+.|+|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9999773 666666543  233444448899999999999999999999999999999765553 3689999997543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.56  E-value=1.6e-14  Score=97.92  Aligned_cols=84  Identities=24%  Similarity=0.231  Sum_probs=68.5

Q ss_pred             CChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccC
Q 030211           83 GELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG  161 (181)
Q Consensus        83 ~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~  161 (181)
                      |+|.+++.. ...+++..++.++.|++.||.|||+.+      ||+||+++.+..  +++  ||.+......    ...+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~----~~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE----QSRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc----cCCC
Confidence            578888876 346999999999999999999999998      999999975554  777  9988654332    2267


Q ss_pred             CCCccCcccccCCccCCCC
Q 030211          162 TPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~~~  180 (181)
                      ++.|+|||++.+..+++++
T Consensus        67 ~~~y~aPE~~~~~~~~~~~   85 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEKA   85 (176)
T ss_pred             cccccChHHhcCCCCcchh
Confidence            8999999999999888763

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.56  E-value=6.4e-16  Score=125.05  Aligned_cols=166  Identities=25%  Similarity=0.401  Sum_probs=124.6

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc--cHHHH---HHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--DENVA---REIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~---~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +|...+.+|++.|=.+.++++.+ |. |++|++-+....  ...+.   ++.+ ...+++||++++..+-......|++-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            46778999999999999999875 43 899998765432  23333   3334 55679999999988877777788888


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccc-ccCCCCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~-~~~~~~~  156 (181)
                      +|..+ +|.+.+...+=+...+..-|+.|++.|+..+|+.||.|||||.+||+|++.+  .+.|.||..-+. ..++..+
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN--W~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN--WLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec--hhhhhcccccCCccCCCCCc
Confidence            88854 8888886666566777778899999999999999999999999999997544  589999975442 2333333


Q ss_pred             Ccc---c----CCCCccCcccccCC
Q 030211          157 KST---V----GTPAYIAPEVLSRR  174 (181)
Q Consensus       157 ~~~---~----~~~~~~aPE~~~~~  174 (181)
                      ..+   .    .-..|.|||-+...
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~  202 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSA  202 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhcc
Confidence            222   1    23569999987653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.53  E-value=7.7e-15  Score=118.43  Aligned_cols=139  Identities=35%  Similarity=0.570  Sum_probs=95.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      +.|..++.|+.|++|.||.+.++.+.+++|+| ++++.    .+.+.  ++.....|.+|                    
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~----lilRn--ilt~a~npfvv--------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN----LILRN--ILTFAGNPFVV--------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccc----hhhhc--cccccCCccee--------------------
Confidence            35888999999999999999999999999995 33322    12221  22222333333                    


Q ss_pred             CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc----------
Q 030211           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV----------  151 (181)
Q Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~----------  151 (181)
                       ++=...+..-++++...        +.+++|||+.||+|+|++|+|.+|..-+.  +||.|||+.+...          
T Consensus       136 -gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~atnl~eg  204 (1205)
T KOG0606|consen  136 -GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLATNLKEG  204 (1205)
T ss_pred             -chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccchhhhc
Confidence             12222232323333332        88999999999999999999999975554  9999999976422          


Q ss_pred             ------CCCCCCcccCCCCccCcccccCCccCC
Q 030211          152 ------LHSRPKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       152 ------~~~~~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                            .+...+..+||+.|.|||++-+..|+-
T Consensus       205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygk  237 (1205)
T KOG0606|consen  205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGK  237 (1205)
T ss_pred             chHHHHHHhhhccccCCccccChhhhhhhccCC
Confidence                  112233457999999999999987764

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.52  E-value=5.3e-13  Score=93.63  Aligned_cols=140  Identities=22%  Similarity=0.274  Sum_probs=99.8

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCC--CeeEEEEeEEcCC---eEEEEEeec
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHP--NIIRFKEVVLTPT---HLAIVMEYA   80 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~--~i~~~~~~~~~~~---~~~~v~e~~   80 (181)
                      +.++.|..+.+|++...+ |..+++|.......  ....+..|...+..+++.  .+++++.+.....   ..+++||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568899999999998754 57899998765443  345778899999888764  4566777766542   568999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS--------------------------------------------  116 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~--------------------------------------------  116 (181)
                      ++.++...+.. ..++.+....++.+++.++..||+                                            
T Consensus        83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            98877654421 234555555555555555555552                                            


Q ss_pred             ------------cCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211          117 ------------MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus       117 ------------~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                                  ..++|+|++|.||+++++..+.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        347899999999999763234588999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.50  E-value=1.6e-12  Score=93.53  Aligned_cols=131  Identities=15%  Similarity=0.054  Sum_probs=93.9

Q ss_pred             eeEEEEEEccCCcEEEEEEcccccc-----------c-cHHHHHHHHHHhhCCCCCeeE--EEEeEEc-----CCeEEEE
Q 030211           16 GVARLLRHKETKELVAVKYIERGRK-----------I-DENVAREIINHRSLRHPNIIR--FKEVVLT-----PTHLAIV   76 (181)
Q Consensus        16 ~~v~~~~~~~~~~~v~~K~~~~~~~-----------~-~~~~~~e~~~~~~~~~~~i~~--~~~~~~~-----~~~~~~v   76 (181)
                      ..|+++..  .|+.+.+|.......           . ...+.+|...+..+...++..  ++.+++.     ....+++
T Consensus        36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            34555544  367899997643210           0 113678888888775555444  4555543     2347899


Q ss_pred             EeecCCC-ChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc-----CCCCcEEEeecCCcc
Q 030211           77 MEYAAGG-ELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-----SAAPRLKICDFGYSK  148 (181)
Q Consensus        77 ~e~~~~~-~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~-----~~~~~v~l~dfg~a~  148 (181)
                      ||++++. +|.+++..  ..+.+......++.+++..+..||++|++|+|++|.||+++.     ++...+.|+||+.+.
T Consensus       114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9999886 78777643  335566778899999999999999999999999999999974     234579999999875

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.46  E-value=2.1e-12  Score=88.09  Aligned_cols=123  Identities=26%  Similarity=0.286  Sum_probs=80.1

Q ss_pred             EEEEEEccCCcEEEEEEcccc--------------cc---------c----cHHHHHHHHHHhhCCCC--CeeEEEEeEE
Q 030211           18 ARLLRHKETKELVAVKYIERG--------------RK---------I----DENVAREIINHRSLRHP--NIIRFKEVVL   68 (181)
Q Consensus        18 v~~~~~~~~~~~v~~K~~~~~--------------~~---------~----~~~~~~e~~~~~~~~~~--~i~~~~~~~~   68 (181)
                      ||.|...+ +..+|+|+.+.+              ..         .    ..+..+|.+.|..+..-  ++++++++. 
T Consensus         2 Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    2 VYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             EEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            78888764 668999986421              00         0    13677899999999766  466666542 


Q ss_pred             cCCeEEEEEeecC--CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH-HHhcCeeeeCCCCCCEEeccCCCCcEEEeecC
Q 030211           69 TPTHLAIVMEYAA--GGELFDRICNAGRFSEDEGRYFFQQLISGVNY-CHSMQICHRDLKLENTLLDGSAAPRLKICDFG  145 (181)
Q Consensus        69 ~~~~~~~v~e~~~--~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~-lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg  145 (181)
                         ...++|||++  +..+......  .++.+....++.+++..+.. +|+.|++||||++.||+++++   ++.++|||
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~---~~~iIDf~  151 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG---KVYIIDFG  151 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT---CEEE--GT
T ss_pred             ---CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc---eEEEEecC
Confidence               3368999998  5455433221  12245667788888885555 679999999999999999755   49999999


Q ss_pred             Ccccc
Q 030211          146 YSKSS  150 (181)
Q Consensus       146 ~a~~~  150 (181)
                      .+...
T Consensus       152 qav~~  156 (188)
T PF01163_consen  152 QAVDS  156 (188)
T ss_dssp             TEEET
T ss_pred             cceec
Confidence            88643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.41  E-value=3.7e-14  Score=112.18  Aligned_cols=173  Identities=31%  Similarity=0.504  Sum_probs=135.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-cCCcEEEEEEcccccc---ccHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-ETKELVAVKYIERGRK---IDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ..|.+.+.||+|.++.+-.+... +....++.|.+.....   .......|..+.+.+. |+|++.+++...++++.++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            35888899999999998888764 3344566666654432   2234445777777776 99999999999999999999


Q ss_pred             EeecCCCChHHHH-hhcC-CCCHHHHHHHHHHHHHHHHHHH-hcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-
Q 030211           77 MEYAAGGELFDRI-CNAG-RFSEDEGRYFFQQLISGVNYCH-SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-  152 (181)
Q Consensus        77 ~e~~~~~~l~~~~-~~~~-~~~~~~~~~~~~~i~~~l~~lh-~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-  152 (181)
                      +++..++++...+ .... ..+...+..++.|+..++.|+| ..++.|+|++|+|.+++.... .+++.|||+|..... 
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNK  178 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhcccccc
Confidence            9998888887777 4443 6778899999999999999999 999999999999999975552 599999999976544 


Q ss_pred             CCC---CCcccC-CCCccCcccccCCc
Q 030211          153 HSR---PKSTVG-TPAYIAPEVLSRRE  175 (181)
Q Consensus       153 ~~~---~~~~~~-~~~~~aPE~~~~~~  175 (181)
                      .+.   .....| ++.|+|||...+..
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~  205 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKA  205 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchh
Confidence            222   333568 99999999998843

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.37  E-value=6.2e-12  Score=97.91  Aligned_cols=123  Identities=17%  Similarity=0.245  Sum_probs=100.9

Q ss_pred             EEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCChHHHHhhcCCCCHH
Q 030211           20 LLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSED   98 (181)
Q Consensus        20 ~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~   98 (181)
                      .+..+.++.+|.+.....+.. ......+.+..++.++||||+++++.++..+..|+|+|.+  .+|..++..   ++..
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~---l~~~  104 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE---LGKE  104 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH---hHHH
Confidence            456667788888887766544 2355778889999999999999999999999999999987  355555544   3477


Q ss_pred             HHHHHHHHHHHHHHHHH-hcCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           99 EGRYFFQQLISGVNYCH-SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        99 ~~~~~~~~i~~~l~~lh-~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      ...--+.||+.||.+|| +++++|+||+.+.+|++..+.  .+|.+|..+..
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~  154 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSK  154 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEec
Confidence            88888999999999998 679999999999999976665  99999987753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.35  E-value=1.4e-11  Score=86.99  Aligned_cols=132  Identities=20%  Similarity=0.240  Sum_probs=98.9

Q ss_pred             eeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----------------c-------ccHHHHHHHHHHhhCCCC--C
Q 030211            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----------------K-------IDENVAREIINHRSLRHP--N   59 (181)
Q Consensus         5 ~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----------------~-------~~~~~~~e~~~~~~~~~~--~   59 (181)
                      .++..||-|.-+.||.+.+.+ |.++++|.-+.+.                .       ......+|...|..+...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            467889999999999999984 7889999643210                0       012466777888777544  5


Q ss_pred             eeEEEEeEEcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcE
Q 030211           60 IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL  139 (181)
Q Consensus        60 i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v  139 (181)
                      ++.+++    .+.-.++||++.+..|...-     ++.+....++..|+..+...-..|++|||+++-||++++++.  +
T Consensus       173 VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--~  241 (304)
T COG0478         173 VPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--I  241 (304)
T ss_pred             CCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--E
Confidence            666655    35678999999887665422     245666777788888888888999999999999999987655  9


Q ss_pred             EEeecCCcc
Q 030211          140 KICDFGYSK  148 (181)
Q Consensus       140 ~l~dfg~a~  148 (181)
                      .++||.-+.
T Consensus       242 ~vIDwPQ~v  250 (304)
T COG0478         242 VVIDWPQAV  250 (304)
T ss_pred             EEEeCcccc
Confidence            999997664

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.32  E-value=2e-13  Score=103.23  Aligned_cols=104  Identities=30%  Similarity=0.380  Sum_probs=86.8

Q ss_pred             eEEEEEeecCCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211           72 HLAIVMEYAAGGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      ++|+.|++|.-.+|.+++....   .-+......++.|+..+++|   +|.+|+|++|.||+...+.  .++|.|||+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~--q~kIgDFgl~t  404 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD--QLKIGDFGLVT  404 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch--hhhhhhhhhee
Confidence            5889999999999999886433   46677888899999999999   9999999999999996555  59999999987


Q ss_pred             cccCCC-------CCCcccCCCCccCcccccCCccCCCC
Q 030211          149 SSVLHS-------RPKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       149 ~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      .....+       ....-.||..||+||.+.+..|+.||
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kv  443 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKV  443 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhc
Confidence            665555       23334689999999999999999876

>PRK09902 hypothetical protein; Provisional

Probab=99.30  E-value=1.4e-10  Score=79.84  Aligned_cols=136  Identities=12%  Similarity=0.112  Sum_probs=98.9

Q ss_pred             CCccceeEEEEEEccCCcEEEEEEcc-c---c---ccccHHHHHHHHHHhhCCCCC--eeEEEEeEE---cC--CeEEEE
Q 030211           11 GAGNFGVARLLRHKETKELVAVKYIE-R---G---RKIDENVAREIINHRSLRHPN--IIRFKEVVL---TP--THLAIV   76 (181)
Q Consensus        11 ~~g~~~~v~~~~~~~~~~~v~~K~~~-~---~---~~~~~~~~~e~~~~~~~~~~~--i~~~~~~~~---~~--~~~~~v   76 (181)
                      ++||-+.|+.....  |..+-+|.-. +   +   +.....+.+|...+..+..-+  ++++. ++.   .+  -..++|
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            35888899988765  3368888754 1   1   234578999999998885433  44444 222   11  236899


Q ss_pred             EeecCCC-ChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           77 MEYAAGG-ELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        77 ~e~~~~~-~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      +|-+++. +|.+++.+.  ++.+......++.++..++..||+.|+.|+|+.+.||+++.++...+.|+||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9977654 777766442  245777788999999999999999999999999999999755544699999986653

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.28  E-value=1e-10  Score=89.16  Aligned_cols=137  Identities=19%  Similarity=0.234  Sum_probs=107.0

Q ss_pred             cceeEEEEEEccCCcEEEEEEcccccccc-HHHHHHHHHHhhCCCCCeeEEEEeEEc----CCeEEEEEeecCCC-ChHH
Q 030211           14 NFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNIIRFKEVVLT----PTHLAIVMEYAAGG-ELFD   87 (181)
Q Consensus        14 ~~~~v~~~~~~~~~~~v~~K~~~~~~~~~-~~~~~e~~~~~~~~~~~i~~~~~~~~~----~~~~~~v~e~~~~~-~l~~   87 (181)
                      -..+.|++...-+|..+++|+++-.+... ...-.-+.+.+++.|.|++++.++|..    ...+++|++|++.. +|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            34589999999999999999994322211 123345778899999999999998873    45789999999885 6666


Q ss_pred             HHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           88 RICNA---------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        88 ~~~~~---------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ....+               ...+++..|.++.|+..||.++|+.|++-.-|.|.+|+++  +..+|+|...|+.....+
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~--G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT--GKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee--CcceEEEecccceeeecC
Confidence            54322               2477899999999999999999999999999999999995  555688888777654433

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.28  E-value=3.5e-12  Score=97.84  Aligned_cols=170  Identities=21%  Similarity=0.201  Sum_probs=133.0

Q ss_pred             cceeeeeeCC--ccceeEEEEEE--ccCCcEEEEEEcccc---ccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEE
Q 030211            3 KYELVKDLGA--GNFGVARLLRH--KETKELVAVKYIERG---RKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         3 ~y~~~~~i~~--g~~~~v~~~~~--~~~~~~v~~K~~~~~---~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~   74 (181)
                      .+.+.+.+|.  |.+|.+|.+..  ..++..+++|.-+..   .......++++...+.+ .|++.++.+..++..+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3556677888  99999999998  788888999874332   23345566777777766 5899999999999999999


Q ss_pred             EEEeecCCCChHHHHhh-cCCCCHHHHHHHHHHHHH----HHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           75 IVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLIS----GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~----~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      +-+|.+. .++..+-.. ..-++....+..+.+...    |+.++|...++|-|++|+||+...+. ...++.|||....
T Consensus       195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df~~v~~  272 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW-TSCKLTDFGLVSK  272 (524)
T ss_pred             eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc-ceeecCCcceeEE
Confidence            9999985 466555433 334888999999999999    99999999999999999999997662 2388999999876


Q ss_pred             ccCCCCCCc------ccCCCCccCcccccCC
Q 030211          150 SVLHSRPKS------TVGTPAYIAPEVLSRR  174 (181)
Q Consensus       150 ~~~~~~~~~------~~~~~~~~aPE~~~~~  174 (181)
                      .........      ..+...|++||...+-
T Consensus       273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l  303 (524)
T KOG0601|consen  273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGL  303 (524)
T ss_pred             ccCCccccceeeeecCCCCceEeChhhhccc
Confidence            655554332      2577889999988753

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.27  E-value=3.8e-11  Score=83.56  Aligned_cols=108  Identities=19%  Similarity=0.186  Sum_probs=84.1

Q ss_pred             cHHHHHHHHHHhhCCCCC--eeEEEEeEEcC----CeEEEEEeecCCC-ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Q 030211           42 DENVAREIINHRSLRHPN--IIRFKEVVLTP----THLAIVMEYAAGG-ELFDRICNAGRFSEDEGRYFFQQLISGVNYC  114 (181)
Q Consensus        42 ~~~~~~e~~~~~~~~~~~--i~~~~~~~~~~----~~~~~v~e~~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l  114 (181)
                      .....+|...+..+...+  .+.++.+.+..    ...++++|.+++. +|.+++......+......++.++...+..|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            346778888877775444  44456665542    2358999999885 7888887644577778899999999999999


Q ss_pred             HhcCeeeeCCCCCCEEeccCC-CCcEEEeecCCccc
Q 030211          115 HSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKS  149 (181)
Q Consensus       115 h~~gi~h~dl~p~ni~i~~~~-~~~v~l~dfg~a~~  149 (181)
                      |++|++|+|++|.||+++.+. ...+.|+||+-+..
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999997554 44699999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.27  E-value=1.2e-11  Score=94.70  Aligned_cols=124  Identities=25%  Similarity=0.356  Sum_probs=100.1

Q ss_pred             HhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCe-eeeCCCCCCE
Q 030211           52 HRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQI-CHRDLKLENT  129 (181)
Q Consensus        52 ~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi-~h~dl~p~ni  129 (181)
                      ++.+.|.|+.++++.+.+++..+.+.++|+-++|.+.+.... .+++.....++++++.+++|||...| .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            356789999999999999999999999999999999987643 78888899999999999999998865 8999999999


Q ss_pred             EeccCCCCcEEEeecCCcccccCC---CCCCcccCCCCccCcccccCCccC
Q 030211          130 LLDGSAAPRLKICDFGYSKSSVLH---SRPKSTVGTPAYIAPEVLSRREYD  177 (181)
Q Consensus       130 ~i~~~~~~~v~l~dfg~a~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~  177 (181)
                      +++...  .+||.|||+.......   ..........-|.|||.++.....
T Consensus        81 lvd~~w--~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~  129 (484)
T KOG1023|consen   81 LVDSRW--VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQ  129 (484)
T ss_pred             eeeeeE--EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccc
Confidence            996554  4999999987543221   111112245669999999986443

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=99.15  E-value=1e-09  Score=76.92  Aligned_cols=136  Identities=17%  Similarity=0.153  Sum_probs=94.4

Q ss_pred             eeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-------------------------ccHHHHHHHHHHhhCC--CC
Q 030211            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------------------------IDENVAREIINHRSLR--HP   58 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------------------------~~~~~~~e~~~~~~~~--~~   58 (181)
                      +...|++|.-+.||.|... ++..+|+|++.....                         ...+...|+..|..+.  +-
T Consensus        52 ~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV  130 (268)
T COG1718          52 LVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV  130 (268)
T ss_pred             eEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence            3457889999999999874 477899998753210                         1135667777777764  34


Q ss_pred             CeeEEEEeEEcCCeEEEEEeecCCCChH-HHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCC
Q 030211           59 NIIRFKEVVLTPTHLAIVMEYAAGGELF-DRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAA  136 (181)
Q Consensus        59 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~  136 (181)
                      .++.++.+.    ...++|||++....- -.+ +.-++..+....+..+++..+.-|.. .|++|+||+.-||++. ++ 
T Consensus       131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~-  203 (268)
T COG1718         131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG-  203 (268)
T ss_pred             CCCCceeec----CCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC-
Confidence            455555544    347899999664111 111 11123334688888999999998887 8999999999999996 33 


Q ss_pred             CcEEEeecCCcccc
Q 030211          137 PRLKICDFGYSKSS  150 (181)
Q Consensus       137 ~~v~l~dfg~a~~~  150 (181)
                       .+.++||+-|...
T Consensus       204 -~p~iID~~QaV~~  216 (268)
T COG1718         204 -EPYIIDVSQAVTI  216 (268)
T ss_pred             -eEEEEECcccccc
Confidence             4999999988643

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=99.14  E-value=3.7e-09  Score=73.24  Aligned_cols=134  Identities=16%  Similarity=0.172  Sum_probs=81.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccH----------HHHHHHHHHhhC---CCCCeeEEEE---
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE----------NVAREIINHRSL---RHPNIIRFKE---   65 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~----------~~~~e~~~~~~~---~~~~i~~~~~---   65 (181)
                      ++|.+.+.+-.....-|-  .-.-.++.+++|.........+          ...+.+.....+   .......++-   
T Consensus        31 ~~~~~~kv~k~~~r~~Va--lIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVA--LIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             CCceEEEeecCCCccEEE--EEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            356677777655544444  3344477899997654221111          122222222222   2222222222   


Q ss_pred             --eEEcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEee
Q 030211           66 --VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICD  143 (181)
Q Consensus        66 --~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~d  143 (181)
                        .+......+++|||++|..|.+...    +++    .+...+..++..||+.|++|||.+|.|+++.++.   ++++|
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iID  177 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRIID  177 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEEE
Confidence              2223456789999999988765431    333    2445677889999999999999999999996443   99999


Q ss_pred             cCCcc
Q 030211          144 FGYSK  148 (181)
Q Consensus       144 fg~a~  148 (181)
                      |+..+
T Consensus       178 ~~~k~  182 (229)
T PF06176_consen  178 TQGKR  182 (229)
T ss_pred             Ccccc
Confidence            97654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.01  E-value=4.2e-10  Score=86.61  Aligned_cols=147  Identities=22%  Similarity=0.232  Sum_probs=111.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-cCCcEEEEEEcccccccc---HHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-ETKELVAVKYIERGRKID---ENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-~~~~~v~~K~~~~~~~~~---~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      .+|..+..|+.+.++.++.+... .++..+++|-...+....   .--..|+.+...+ .|.+.+.....|......++-
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            46788999999999999988755 567778888665443221   1122344444433 578888888888777777899


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      .||+.++++.....-...+++...+.+..|++.++.++|++.++|.|++|+||++.+++ .-.++.||++...
T Consensus       345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTR  416 (524)
T ss_pred             hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccc
Confidence            99998887765554444578889999999999999999999999999999999997543 3477889988754

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=99.00  E-value=6.4e-09  Score=81.02  Aligned_cols=138  Identities=20%  Similarity=0.164  Sum_probs=88.9

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEccccc----------------------cc-----c--------HH------HH
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGR----------------------KI-----D--------EN------VA   46 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----------------------~~-----~--------~~------~~   46 (181)
                      +-|+.++-|+||+|+-++ |+.||||+.+++-                      ..     .        +.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            456788999999999986 8999999875421                      00     0        11      22


Q ss_pred             HHHHHHhhC-----CCCCeeEEEEeEEcCCeEEEEEeecCCCChHHHHh-hcCCCCHHHHHHHHHHHHHH-HHHHHhcCe
Q 030211           47 REIINHRSL-----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISG-VNYCHSMQI  119 (181)
Q Consensus        47 ~e~~~~~~~-----~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~-l~~lh~~gi  119 (181)
                      .|...+...     ..+.+.-+.-+++..+...++|||+.|..+.+... +...++...+..   .++.+ +..+-..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~---~~~~~f~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAE---LLVRAFLRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHH---HHHHHHHHHHHhcCc
Confidence            222222222     23555444555556677899999999988776632 223444333333   23322 334456899


Q ss_pred             eeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211          120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus       120 ~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      +|+|.+|.||+++.+  +++.+.|||+.....
T Consensus       287 fHaDpHpGNi~v~~~--g~i~~lDfGi~g~l~  316 (517)
T COG0661         287 FHADPHPGNILVRSD--GRIVLLDFGIVGRLD  316 (517)
T ss_pred             cccCCCccceEEecC--CcEEEEcCcceecCC
Confidence            999999999999765  459999999986544

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.93  E-value=6.6e-08  Score=68.25  Aligned_cols=72  Identities=18%  Similarity=0.163  Sum_probs=54.4

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCC--eeEEEEeEEcCCeEEEEEeecCCCC
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN--IIRFKEVVLTPTHLAIVMEYAAGGE   84 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~--i~~~~~~~~~~~~~~~v~e~~~~~~   84 (181)
                      ..|++|..+.+|+.    .+..+++|...... ......+|.+.+..+..-+  +++++.+...++...++|++++|.+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            57899999999974    24457889876533 3456788998888876443  4778888888888899999998863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.91  E-value=1.5e-07  Score=64.83  Aligned_cols=134  Identities=24%  Similarity=0.260  Sum_probs=92.2

Q ss_pred             eeeeCCccceeEEEEEEccCCcEEEEEEccccc-----------------cccHHHHHHHHHHhhCC------CCCeeEE
Q 030211            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGR-----------------KIDENVAREIINHRSLR------HPNIIRF   63 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-----------------~~~~~~~~e~~~~~~~~------~~~i~~~   63 (181)
                      ...|++|+.-.||.  +.+ +...++|+.....                 ....+..+|+.....+.      +..++++
T Consensus         6 ~~~i~~G~~R~cy~--HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEE--CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            35688999999994  333 3346889887654                 12345566665554444      7899999


Q ss_pred             EEeEEcCCeEEEEEeecCC------CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCC-
Q 030211           64 KEVVLTPTHLAIVMEYAAG------GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA-  136 (181)
Q Consensus        64 ~~~~~~~~~~~~v~e~~~~------~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~-  136 (181)
                      +++.+.+....+|+|.+.+      .+|.+++ .++.++. .   +...+-.-..+|-+.+|+.+|++|+||++..... 
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-~~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYL-KEGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHH-HcCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999999999997754      2566666 3444555 3   3333445556778999999999999999953333 


Q ss_pred             -CcEEEee-cCCcc
Q 030211          137 -PRLKICD-FGYSK  148 (181)
Q Consensus       137 -~~v~l~d-fg~a~  148 (181)
                       ..+.|+| ||...
T Consensus       158 ~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  158 EFRLVLIDGLGEKE  171 (199)
T ss_pred             ceEEEEEeCCCCcc
Confidence             3588888 66543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.89  E-value=8e-08  Score=79.66  Aligned_cols=78  Identities=21%  Similarity=0.236  Sum_probs=56.2

Q ss_pred             eeeeCCccceeEEEEEEccCC--cEEEEEEcccccc--ccHHHHHHHHHHhhCC-CCCe--eEEEEeEEcC---CeEEEE
Q 030211            7 VKDLGAGNFGVARLLRHKETK--ELVAVKYIERGRK--IDENVAREIINHRSLR-HPNI--IRFKEVVLTP---THLAIV   76 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~--~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~-~~~i--~~~~~~~~~~---~~~~~v   76 (181)
                      ++.++.|.+..+|.+.....+  ..+++|+......  ....+.+|..+++.+. |.++  ++++.++.++   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            567888889999998765432  4678887655432  2356888999998885 5654  7777777664   457899


Q ss_pred             EeecCCCC
Q 030211           77 MEYAAGGE   84 (181)
Q Consensus        77 ~e~~~~~~   84 (181)
                      ||++++..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.79  E-value=2.9e-07  Score=65.75  Aligned_cols=76  Identities=13%  Similarity=0.038  Sum_probs=52.9

Q ss_pred             eeeCCccc-eeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCeEEEEEeecCCCCh
Q 030211            8 KDLGAGNF-GVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (181)
Q Consensus         8 ~~i~~g~~-~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   85 (181)
                      +.|..|.+ ..||++...  +..+++|+.....  ......|+..++.+. +--+++++.+...++..+++|++++|.++
T Consensus         4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            34555666 688988754  3578889876543  345667787777663 24466788887777778999999988776


Q ss_pred             HH
Q 030211           86 FD   87 (181)
Q Consensus        86 ~~   87 (181)
                      ..
T Consensus        80 ~~   81 (244)
T cd05150          80 AA   81 (244)
T ss_pred             hH
Confidence            53

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.74  E-value=2.2e-07  Score=72.53  Aligned_cols=137  Identities=20%  Similarity=0.218  Sum_probs=85.7

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEcccccc--------------------------------ccHH------HHHHH
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRK--------------------------------IDEN------VAREI   49 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--------------------------------~~~~------~~~e~   49 (181)
                      +.|+....++|++|+-++ |..||+|+-+.+-+                                ..+.      |..|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            457888999999999987 88999998653100                                0011      22222


Q ss_pred             HH----HhhCCCCC------eeEEEEeEEcCCeEEEEEeecCCCChHH--HHhhcCCCCHHHHHHHHHHHHHHHH-HHHh
Q 030211           50 IN----HRSLRHPN------IIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVN-YCHS  116 (181)
Q Consensus        50 ~~----~~~~~~~~------i~~~~~~~~~~~~~~~v~e~~~~~~l~~--~~~~~~~~~~~~~~~~~~~i~~~l~-~lh~  116 (181)
                      +.    ...+.|-+      +++++.-  ......++|||+.|..+.+  .+.++ .++..   .++..+..+.. .+-.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~---~i~~~l~~~~~~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKR-GISPH---DILNKLVEAYLEQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHc-CCCHH---HHHHHHHHHHHHHHHh
Confidence            22    22223333      3333332  2346789999999986654  34333 34444   34444444433 3457


Q ss_pred             cCeeeeCCCCCCEEeccC--CCCcEEEeecCCccccc
Q 030211          117 MQICHRDLKLENTLLDGS--AAPRLKICDFGYSKSSV  151 (181)
Q Consensus       117 ~gi~h~dl~p~ni~i~~~--~~~~v~l~dfg~a~~~~  151 (181)
                      .|++|+|-+|.||++.++  +...+.+.|||+.....
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            899999999999999743  45679999999976443

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.73  E-value=2.4e-07  Score=65.37  Aligned_cols=78  Identities=19%  Similarity=0.199  Sum_probs=53.5

Q ss_pred             eeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCC--CeeEEEEeEE---cCCeEEEEEeecC
Q 030211            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP--NIIRFKEVVL---TPTHLAIVMEYAA   81 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~--~i~~~~~~~~---~~~~~~~v~e~~~   81 (181)
                      ++.++.|..+.+|.+...+  ..+++|..... .....+..|...+..+...  .+++++....   .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4678889999999999875  47999987655 3345666777777666433  3556665432   2345799999999


Q ss_pred             CCChHH
Q 030211           82 GGELFD   87 (181)
Q Consensus        82 ~~~l~~   87 (181)
                      +.++..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            887665

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.69  E-value=1.6e-08  Score=73.50  Aligned_cols=123  Identities=19%  Similarity=0.314  Sum_probs=88.6

Q ss_pred             HHHhhCCCCCeeEEEEeEEcCC-----eEEEEEeecCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhc--C
Q 030211           50 INHRSLRHPNIIRFKEVVLTPT-----HLAIVMEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSM--Q  118 (181)
Q Consensus        50 ~~~~~~~~~~i~~~~~~~~~~~-----~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~--g  118 (181)
                      ..+.++-|.|+++++.++.+.+     ...+++||+..+++.+++.+    +..+......+|..||+.||.|||+.  -
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            4456677999999999987754     47899999999999988854    33678888899999999999999987  4


Q ss_pred             eeeeCCCCCCEEeccCCCCcEEEeecCCcccc-----cCCCCCCcccCCCCccCcccccCC
Q 030211          119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-----VLHSRPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       119 i~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~-----~~~~~~~~~~~~~~~~aPE~~~~~  174 (181)
                      ++|+++..+.|++..++-  |++.-.......     ..........+.+.|.|||.=...
T Consensus       199 iihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t  257 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT  257 (458)
T ss_pred             cccCCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc
Confidence            999999999999974443  554321110000     111122333567888999875543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.69  E-value=3.3e-07  Score=61.32  Aligned_cols=128  Identities=20%  Similarity=0.162  Sum_probs=88.8

Q ss_pred             eeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeE-EEEeEEcCCeEEEEEeecCCC
Q 030211            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR-FKEVVLTPTHLAIVMEYAAGG   83 (181)
Q Consensus         5 ~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~-~~~~~~~~~~~~~v~e~~~~~   83 (181)
                      ++.+.|+.|.+|.||++.+.  +..+++|+-... .....+..|.+++..++-.++.+ ++.+..+    ++.|||..|.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCC-cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence            45677899999999999987  668899975543 33577888999888887665544 5554432    3459999888


Q ss_pred             ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCC-CCCEEeccCCCCcEEEeecCCcc
Q 030211           84 ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK-LENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus        84 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~-p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      +|.......   +    +.-...++..-.-|...||-|+.++ |..+++.++.  ++.|+||..|+
T Consensus        98 ~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~--~~~iIDFd~At  154 (201)
T COG2112          98 PLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR--DVYIIDFDSAT  154 (201)
T ss_pred             chhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC--cEEEEEccchh
Confidence            887654321   2    2233344555555778899999997 4444443333  59999999886

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.66  E-value=3.4e-07  Score=68.06  Aligned_cols=138  Identities=18%  Similarity=0.196  Sum_probs=98.5

Q ss_pred             eeeeeeCCccceeEEEEEEccCCcEEEEEEcccc-------------------------c--cccHHHHHHHHHHhhCCC
Q 030211            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIERG-------------------------R--KIDENVAREIINHRSLRH   57 (181)
Q Consensus         5 ~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~-------------------------~--~~~~~~~~e~~~~~~~~~   57 (181)
                      .+..+|+.|.-+.||.|...+ |..+|||+++.+                         +  ...-+...|++.|+.+..
T Consensus       147 ~inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            356789999999999998764 777999987521                         0  011367788888988877


Q ss_pred             CCeeEEEEeEEcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-hcCeeeeCCCCCCEEeccCCC
Q 030211           58 PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH-SMQICHRDLKLENTLLDGSAA  136 (181)
Q Consensus        58 ~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~gi~h~dl~p~ni~i~~~~~  136 (181)
                      .+|+-+.-...  ....|||+|++...-..-..+..+++...+..+-.+++.-+.-|. .++++|+||+--|+++-   .
T Consensus       226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh---d  300 (520)
T KOG2270|consen  226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH---D  300 (520)
T ss_pred             cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE---C
Confidence            77665544443  234789999964322211223445777778888888888887765 67999999999999994   3


Q ss_pred             CcEEEeecCCcc
Q 030211          137 PRLKICDFGYSK  148 (181)
Q Consensus       137 ~~v~l~dfg~a~  148 (181)
                      ++++++|.+-+.
T Consensus       301 G~lyiIDVSQSV  312 (520)
T KOG2270|consen  301 GKLYIIDVSQSV  312 (520)
T ss_pred             CEEEEEEccccc
Confidence            459999998764

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.64  E-value=5.1e-07  Score=68.12  Aligned_cols=160  Identities=13%  Similarity=0.047  Sum_probs=106.6

Q ss_pred             eeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEe------EEcCC-eEEEEE
Q 030211            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEV------VLTPT-HLAIVM   77 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~------~~~~~-~~~~v~   77 (181)
                      ....+|+|+.+-+|..-.-.   ..+.|++.......+..  .+.++... .||-+..=+.+      .-+.+ .+.++|
T Consensus        15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~aq--k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQAQ--KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchhh---chhheeecCCCchHHHH--HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            34568999999999765432   23568887665433221  22223322 34432220111      11122 367888


Q ss_pred             eecCCCChHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc
Q 030211           78 EYAAGGELFDRICN-------AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS  150 (181)
Q Consensus        78 e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~  150 (181)
                      +.+++..-...+.+       -+.+.+....+.++.++.+.+.||+.|-+.||++++|+++.++..  |.|+|-+.-...
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~  167 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQIN  167 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeec
Confidence            88877633322221       235788999999999999999999999999999999999976655  999986554334


Q ss_pred             cCCCCCCcccCCCCccCccccc
Q 030211          151 VLHSRPKSTVGTPAYIAPEVLS  172 (181)
Q Consensus       151 ~~~~~~~~~~~~~~~~aPE~~~  172 (181)
                      ..+...-+..|..+|.+||...
T Consensus       168 ~ng~~~~cpVg~~eftPPElQ~  189 (637)
T COG4248         168 ANGTLHLCPVGVSEFTPPELQT  189 (637)
T ss_pred             cCCceEecccCccccCCHHHhc
Confidence            5555666778999999999876

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.54  E-value=1.7e-06  Score=61.50  Aligned_cols=73  Identities=11%  Similarity=-0.004  Sum_probs=45.6

Q ss_pred             eeeeCCccce-eEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCC---CeeEEEEeEEcC---CeEEEEEee
Q 030211            7 VKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP---NIIRFKEVVLTP---THLAIVMEY   79 (181)
Q Consensus         7 ~~~i~~g~~~-~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~---~i~~~~~~~~~~---~~~~~v~e~   79 (181)
                      ++.++.|+.. .||++.     ..+++|..... .....+..|...+..+...   -++.++......   ...+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~-~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAA-GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEcC-----CceEEEcCCcc-chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            3566766666 588762     24778875542 2345788888888776532   344455544332   245889999


Q ss_pred             cCCCCh
Q 030211           80 AAGGEL   85 (181)
Q Consensus        80 ~~~~~l   85 (181)
                      ++|.++
T Consensus        76 i~G~~l   81 (235)
T cd05155          76 LEGETA   81 (235)
T ss_pred             ecCCCC
Confidence            988665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.45  E-value=1e-05  Score=57.33  Aligned_cols=75  Identities=17%  Similarity=0.254  Sum_probs=47.6

Q ss_pred             eeeeCCccceeEEEEEEcc-CCcEEEEEEccccccccHHHHHHHHHHhhCCCCCe-eEEEEeEEcCCeEEEEEeecCCCC
Q 030211            7 VKDLGAGNFGVARLLRHKE-TKELVAVKYIERGRKIDENVAREIINHRSLRHPNI-IRFKEVVLTPTHLAIVMEYAAGGE   84 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~-~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i-~~~~~~~~~~~~~~~v~e~~~~~~   84 (181)
                      .+.+..|-...+|++...+ .++.+++|+........-....|+.++..+...++ ++++....  +  .+++||+++.+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~   78 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT   78 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence            4566677788999997653 35678999876543322334567777777744333 44544332  2  37999998866


Q ss_pred             h
Q 030211           85 L   85 (181)
Q Consensus        85 l   85 (181)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=98.45  E-value=1.5e-05  Score=58.70  Aligned_cols=77  Identities=9%  Similarity=-0.013  Sum_probs=55.0

Q ss_pred             eeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCC---CCeeEEEEeEEcC---CeEEEEEee
Q 030211            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH---PNIIRFKEVVLTP---THLAIVMEY   79 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~---~~i~~~~~~~~~~---~~~~~v~e~   79 (181)
                      -.+.|+.|..+.+|.....+ + .+++|..+. ......+..|...++.+..   -.++++++++..+   +..+++||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQ-G-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCC-C-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            35678999999999987543 3 467787433 2233578888988887753   3578888877543   668999999


Q ss_pred             cCCCCh
Q 030211           80 AAGGEL   85 (181)
Q Consensus        80 ~~~~~l   85 (181)
                      +++.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            988654

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.36  E-value=7.9e-06  Score=58.80  Aligned_cols=132  Identities=15%  Similarity=0.103  Sum_probs=74.9

Q ss_pred             eeCCccceeEEEEEEccCCcEEEEEEcccccccc-HHHHHHHHHHhhCCCCCe-eEEEEeEEcCCeEEEEEeecCCCChH
Q 030211            9 DLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI-IRFKEVVLTPTHLAIVMEYAAGGELF   86 (181)
Q Consensus         9 ~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~-~~~~~e~~~~~~~~~~~i-~~~~~~~~~~~~~~~v~e~~~~~~l~   86 (181)
                      .+..|-...+|++..  +++.+++|......... -...+|..+++.+...++ ++++...  .  -+++++|++|.++.
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence            455677778998873  46678899765433221 235678888877754433 3444433  2  26899999886542


Q ss_pred             HH-----------------HhhcC----CCCH-HHHHHHHHHH---------HHHHHHHHh--------cCeeeeCCCCC
Q 030211           87 DR-----------------ICNAG----RFSE-DEGRYFFQQL---------ISGVNYCHS--------MQICHRDLKLE  127 (181)
Q Consensus        87 ~~-----------------~~~~~----~~~~-~~~~~~~~~i---------~~~l~~lh~--------~gi~h~dl~p~  127 (181)
                      ..                 ++..+    +++. .....+..++         ...+..+..        ..++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            11                 11111    1111 1111221111         111222221        25899999999


Q ss_pred             CEEeccCCCCcEEEeecCCccc
Q 030211          128 NTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus       128 ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      ||++++++   +.|+||..|..
T Consensus       157 Nil~~~~~---~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG---LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC---CEEEeccccCc
Confidence            99997543   78999988754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.24  E-value=2.8e-05  Score=57.09  Aligned_cols=136  Identities=18%  Similarity=0.128  Sum_probs=76.8

Q ss_pred             eeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCC--eeEEEEe------EEcCCeEEEEEe
Q 030211            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN--IIRFKEV------VLTPTHLAIVME   78 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~--i~~~~~~------~~~~~~~~~v~e   78 (181)
                      .+.+..|....+|++...  +..+++|+...  ........|+.++..+...+  +++++..      ...++..+.+++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            445666777889988653  34689998764  22345566676666663322  4444332      233456789999


Q ss_pred             ecCCCChHH----H----------Hhhc-CCCC--------HHHHHH------------HHHHHHHHHHHHHh-------
Q 030211           79 YAAGGELFD----R----------ICNA-GRFS--------EDEGRY------------FFQQLISGVNYCHS-------  116 (181)
Q Consensus        79 ~~~~~~l~~----~----------~~~~-~~~~--------~~~~~~------------~~~~i~~~l~~lh~-------  116 (181)
                      +++|.++..    .          ++.. ..+.        ......            ....+..++..+.+       
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            998865421    0          0100 0000        000000            11112233334332       


Q ss_pred             cCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211          117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus       117 ~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      .+++|+|++|.|++++++.  .+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~--~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDE--LSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCc--eEEEeehhhhc
Confidence            4799999999999997543  36799998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.22  E-value=1.2e-05  Score=55.11  Aligned_cols=96  Identities=15%  Similarity=0.093  Sum_probs=73.6

Q ss_pred             HHHHHHhhCCC-CCeeEEEEeEEcCCeEEEEEeecCCCChHHH---HhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCe
Q 030211           47 REIINHRSLRH-PNIIRFKEVVLTPTHLAIVMEYAAGGELFDR---ICNAGRFSEDEGRYFFQQLISGVNYCHS---MQI  119 (181)
Q Consensus        47 ~e~~~~~~~~~-~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~gi  119 (181)
                      .|..++..+++ ++++++++.+    ..+++.|+.+.+++...   +..-...++..+..++.+++..+++++.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            46777777776 6899999987    33668899876655321   1111246899999999999999999998   458


Q ss_pred             eeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211          120 CHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus       120 ~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      .-+|++|+|+.+++++.  ++++|...+.
T Consensus        84 ~lcDv~~~nfgv~~~~~--lk~iDld~v~  110 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGR--LKLIDLDDVF  110 (188)
T ss_pred             EEeecchHHeEEeCCCc--EEEEechhcc
Confidence            89999999999975544  9999987653

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.20  E-value=1.4e-06  Score=63.92  Aligned_cols=132  Identities=14%  Similarity=0.156  Sum_probs=90.4

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-------------------cc----HHHHHHHHHHhhCCC--C
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------------------ID----ENVAREIINHRSLRH--P   58 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------------------~~----~~~~~e~~~~~~~~~--~   58 (181)
                      +.++.+||-|.-+-||.+-+.+ |++.++|+-..+..                   |.    =...+|...++.+..  -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            4578899999999999998875 77889996432111                   10    123445666665543  2


Q ss_pred             CeeEEEEeEEcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCc
Q 030211           59 NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPR  138 (181)
Q Consensus        59 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~  138 (181)
                      -++..++    -+..++||+++.+-+|.+.-.-      .....+...+..-+--|.++|++|||.+--||++.++..  
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~--  240 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK--  240 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC--
Confidence            3444444    3567899999988777654321      233445556667777889999999999999999975554  


Q ss_pred             EEEeecCCcc
Q 030211          139 LKICDFGYSK  148 (181)
Q Consensus       139 v~l~dfg~a~  148 (181)
                      ++++||.-+.
T Consensus       241 i~vIDFPQmv  250 (465)
T KOG2268|consen  241 IVVIDFPQMV  250 (465)
T ss_pred             EEEeechHhh
Confidence            9999997653

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.18  E-value=0.00012  Score=50.52  Aligned_cols=124  Identities=19%  Similarity=0.223  Sum_probs=84.0

Q ss_pred             ccceeeeeeCCccc-eeEEEEEEccCCcEEEEEEccc----cc------------------cccHHHHHHHHHHhhC---
Q 030211            2 EKYELVKDLGAGNF-GVARLLRHKETKELVAVKYIER----GR------------------KIDENVAREIINHRSL---   55 (181)
Q Consensus         2 ~~y~~~~~i~~g~~-~~v~~~~~~~~~~~v~~K~~~~----~~------------------~~~~~~~~e~~~~~~~---   55 (181)
                      ++++.++.+|.|.. |.||++...  |+.+|+|++..    ..                  ....-|..|-+....+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            46889999999999 999999876  77999999421    00                  0012355565554444   


Q ss_pred             CCCCe--eEEEEeEEcCC------------------eEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 030211           56 RHPNI--IRFKEVVLTPT------------------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH  115 (181)
Q Consensus        56 ~~~~i--~~~~~~~~~~~------------------~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh  115 (181)
                      .+.++  ++.+++..-..                  ...+|-||.+...             .....-+.+|+.-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhHHHHHHHHHHHHH
Confidence            44555  88888774331                  1345666554432             123334567788888999


Q ss_pred             hcCeeeeCCCCCCEEeccCCCCcEEEeecCCc
Q 030211          116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (181)
Q Consensus       116 ~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a  147 (181)
                      ..||+-+|+++.|..=       -+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~~-------G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYRG-------GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCccccccC-------CEEEecccC
Confidence            9999999999999852       578999864

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.16  E-value=0.00026  Score=54.10  Aligned_cols=76  Identities=16%  Similarity=0.118  Sum_probs=50.2

Q ss_pred             eeeeCCccceeEEEEEEccCCcEEEEEEccc-----cc---cccHHHHHHHHHHhhCC---CCCeeEEEEeEEcCCeEEE
Q 030211            7 VKDLGAGNFGVARLLRHKETKELVAVKYIER-----GR---KIDENVAREIINHRSLR---HPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~-----~~---~~~~~~~~e~~~~~~~~---~~~i~~~~~~~~~~~~~~~   75 (181)
                      .+.+|-|....||++...+.++.+++|.-..     ++   ...+....|...+..+.   -..+++++.+  ++...++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            3568889999999999875445799997431     11   12244555666666542   2356667766  4455789


Q ss_pred             EEeecCCCC
Q 030211           76 VMEYAAGGE   84 (181)
Q Consensus        76 v~e~~~~~~   84 (181)
                      +||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999997643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=98.10  E-value=9.5e-05  Score=54.51  Aligned_cols=74  Identities=11%  Similarity=0.130  Sum_probs=47.1

Q ss_pred             eeeCCccceeEEEEEEcc------CCcEEEEEEccccccccHHHHHHHHHHhhCCCCC-eeEEEEeEEcCCeEEEEEeec
Q 030211            8 KDLGAGNFGVARLLRHKE------TKELVAVKYIERGRKIDENVAREIINHRSLRHPN-IIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~------~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~-i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      +.+..|-...+|++....      .++.+++|+.............|..++..+...+ .++++..+..    ..+++|+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            455556667899987643      2578999997765443345667777777665433 3445555432    3478888


Q ss_pred             CCCCh
Q 030211           81 AGGEL   85 (181)
Q Consensus        81 ~~~~l   85 (181)
                      +|.++
T Consensus        80 ~G~~l   84 (302)
T cd05156          80 PSRTL   84 (302)
T ss_pred             CCCcC
Confidence            77655

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=98.10  E-value=0.00012  Score=54.33  Aligned_cols=30  Identities=27%  Similarity=0.392  Sum_probs=24.5

Q ss_pred             cCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211          117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus       117 ~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      .|++|+|++|+||+++++.  ...++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~--~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDR--LSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCc--eEEEEeccccc
Confidence            4899999999999996432  35799999875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.08  E-value=9e-07  Score=73.02  Aligned_cols=143  Identities=22%  Similarity=0.256  Sum_probs=101.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccccc----HHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +.+.+.+-+.++.++.++.+.-..++.....++........    +....+-.++...++|-++.....+......++++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            34556667778888888877766555444444433322211    12222222222334566666555555566789999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~  146 (181)
                      ++..+++|...+++.++.+.+-.+.....+..+.++||..-+.|+|++|+|.++..++.  ..+.||+.
T Consensus       884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t  950 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGT  950 (1205)
T ss_pred             HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCcccc
Confidence            99999999999988888888899999999999999999999999999999999965554  77888863

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.06  E-value=2e-06  Score=67.97  Aligned_cols=158  Identities=21%  Similarity=0.242  Sum_probs=103.3

Q ss_pred             eCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCC-eeEEEEeEEcCCeEEEEEeecCCC-ChHH
Q 030211           10 LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN-IIRFKEVVLTPTHLAIVMEYAAGG-ELFD   87 (181)
Q Consensus        10 i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~-i~~~~~~~~~~~~~~~v~e~~~~~-~l~~   87 (181)
                      +++++.+..++.....+.. ...+++...    .+..-++++|.+++||| .+..++-+..+++.++.++++.++ +...
T Consensus       250 fvK~altknpKkRptaekl-L~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~  324 (829)
T KOG0576|consen  250 FVKGALTKNPKKRPTAEKL-LQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL  324 (829)
T ss_pred             HHHHHhcCCCccCCChhhh-eeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence            3455566666555433222 223333221    34455788899999999 555555555667889999999776 2222


Q ss_pred             HHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccCCCCcc
Q 030211           88 RICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI  166 (181)
Q Consensus        88 ~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~  166 (181)
                      .+.. .-.+.........+.-.++++++|+.--+|+|    ||+-.+   ...++.||+.+.............+++.|+
T Consensus       325 ~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~---~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~  397 (829)
T KOG0576|consen  325 EMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE---EEVKLLDFAVPPQLTRTMKPRTAIGTPEPL  397 (829)
T ss_pred             cCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc---cccccccccCCcccCcccccccCCCCCCCC
Confidence            2211 11344445555666677788999988767777    777643   348899999887666665666778999999


Q ss_pred             CcccccCCccCCC
Q 030211          167 APEVLSRREYDGK  179 (181)
Q Consensus       167 aPE~~~~~~~~~~  179 (181)
                      |||++.++.+..+
T Consensus       398 ~pev~~~~~~~~~  410 (829)
T KOG0576|consen  398 APEVIQENTIDGC  410 (829)
T ss_pred             CchhhcccccccC
Confidence            9999988877654

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=98.01  E-value=0.00018  Score=53.30  Aligned_cols=137  Identities=18%  Similarity=0.174  Sum_probs=74.5

Q ss_pred             eeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCC--eeEEEEeE------EcCCeEEEEEe
Q 030211            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN--IIRFKEVV------LTPTHLAIVME   78 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~--i~~~~~~~------~~~~~~~~v~e   78 (181)
                      .+.++.|....+|++...  +..+++|+..... ....+..+..++..+...+  +++++...      ...+..+++++
T Consensus        27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeC--CCcEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            345566666789988643  3357889875422 1234445555555553222  34444321      22456789999


Q ss_pred             ecCCCChH-----------HH---Hhhc-CCCCH-------HHHH----------------HHHHHHHHHHHHHH-----
Q 030211           79 YAAGGELF-----------DR---ICNA-GRFSE-------DEGR----------------YFFQQLISGVNYCH-----  115 (181)
Q Consensus        79 ~~~~~~l~-----------~~---~~~~-~~~~~-------~~~~----------------~~~~~i~~~l~~lh-----  115 (181)
                      |++|.++.           ..   ++.. ..++.       ...+                .....+...++++.     
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            99885431           00   1110 01100       0000                00111223344443     


Q ss_pred             --hcCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211          116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus       116 --~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                        ..+++|+|+++.|++++++.  .+.++||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~--~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDS--VKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCc--eEEEeeccccc
Confidence              26899999999999997554  36899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.95  E-value=0.00025  Score=52.45  Aligned_cols=76  Identities=14%  Similarity=0.070  Sum_probs=44.8

Q ss_pred             eeeeeeCCccceeEEEEEEccCCcEEEEEEccc-c--ccccHHHHHHHHHHhhCCCCCeeE--EEEeEEcCC--eEEEEE
Q 030211            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIER-G--RKIDENVAREIINHRSLRHPNIIR--FKEVVLTPT--HLAIVM   77 (181)
Q Consensus         5 ~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~-~--~~~~~~~~~e~~~~~~~~~~~i~~--~~~~~~~~~--~~~~v~   77 (181)
                      .+++.+..|-...+|.....  ++.++++ .+. .  ........+|+..+..+..-.++.  .+..+.+..  ..|.+|
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            34555655555667766655  7778888 332 1  122345666777777665433333  344444433  569999


Q ss_pred             eecCCC
Q 030211           78 EYAAGG   83 (181)
Q Consensus        78 e~~~~~   83 (181)
                      +++++.
T Consensus       105 ~~veGe  110 (321)
T COG3173         105 EWVEGE  110 (321)
T ss_pred             EEecce
Confidence            999883

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.89  E-value=0.00012  Score=53.32  Aligned_cols=32  Identities=25%  Similarity=0.328  Sum_probs=24.8

Q ss_pred             CeeeeCCCCCCEEeccCCCCcEEEeecCCcccc
Q 030211          118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSS  150 (181)
Q Consensus       118 gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~  150 (181)
                      .++|+|++|.||+++++ ....-++||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~-~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDED-ARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCC-CCEEEEECcHhcccC
Confidence            48999999999999753 223569999987643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=97.79  E-value=2.5e-05  Score=62.13  Aligned_cols=74  Identities=15%  Similarity=0.316  Sum_probs=52.5

Q ss_pred             HHHHHHHHHHHHhc-CeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC----------CCcccCCCCccCccccc
Q 030211          104 FQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR----------PKSTVGTPAYIAPEVLS  172 (181)
Q Consensus       104 ~~~i~~~l~~lh~~-gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~----------~~~~~~~~~~~aPE~~~  172 (181)
                      +.+.+.|+.++|.. +++|+++.|++|+++..+  ..||.+|+++....+...          .....-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~--~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANG--DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheeeccCc--ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34455999999965 999999999999996444  499999998754433111          11113578999999998


Q ss_pred             CCccCCC
Q 030211          173 RREYDGK  179 (181)
Q Consensus       173 ~~~~~~~  179 (181)
                      ....++.
T Consensus       183 ~~~~~~~  189 (700)
T KOG2137|consen  183 GTTNTPA  189 (700)
T ss_pred             ccccccc
Confidence            7544443

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.79  E-value=0.0013  Score=48.73  Aligned_cols=30  Identities=20%  Similarity=0.241  Sum_probs=25.3

Q ss_pred             CeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211          118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus       118 gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      +++|+|+.++|+++++++.  +.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRG--GYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCC--EEEEEhhhccc
Confidence            7999999999999965544  89999988753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.70  E-value=0.0013  Score=49.24  Aligned_cols=74  Identities=14%  Similarity=0.150  Sum_probs=44.5

Q ss_pred             eeeCCccceeEEEEEEccC---CcEEEEEEccccccccHHHHHHHHHHhhCCCCCe-eEEEEeEEcCCeEEEEEeecCCC
Q 030211            8 KDLGAGNFGVARLLRHKET---KELVAVKYIERGRKIDENVAREIINHRSLRHPNI-IRFKEVVLTPTHLAIVMEYAAGG   83 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i-~~~~~~~~~~~~~~~v~e~~~~~   83 (181)
                      +.+..|-...+|++.....   +..+++|+........-...+|..+++.+...++ ++++.++. ++   ++.+|+.+.
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~   95 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR   95 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence            3444466668898875432   3478999877654333234567777777755444 45665553 22   478888765


Q ss_pred             Ch
Q 030211           84 EL   85 (181)
Q Consensus        84 ~l   85 (181)
                      ++
T Consensus        96 ~l   97 (330)
T PLN02421         96 TL   97 (330)
T ss_pred             CC
Confidence            54

>PLN02236 choline kinase

Probab=97.70  E-value=0.0015  Score=49.28  Aligned_cols=137  Identities=16%  Similarity=0.190  Sum_probs=77.3

Q ss_pred             eeeCCccceeEEEEEEcc----CCcEEEEEEccccccccHHHHHHHHHHhhCCCCCe-eEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHKE----TKELVAVKYIERGRKIDENVAREIINHRSLRHPNI-IRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~----~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i-~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      ..+..|-...+|++...+    .++.+++|+........-....|..+++.+...++ +++++.+..+    .+++|+++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            345457777899987532    24679999887654332233567777777754444 4456655332    47888877


Q ss_pred             CChHHH-----------------HhhcC------CCCHHHHHHHHHHH-----------------HHHHHHH--------
Q 030211           83 GELFDR-----------------ICNAG------RFSEDEGRYFFQQL-----------------ISGVNYC--------  114 (181)
Q Consensus        83 ~~l~~~-----------------~~~~~------~~~~~~~~~~~~~i-----------------~~~l~~l--------  114 (181)
                      .++...                 ++..+      ....+.+..+..++                 ...+..|        
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            655311                 01101      01122222222111                 1111111        


Q ss_pred             HhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211          115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus       115 h~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      +...+.|+|+++.||+++++ ...+.|+||..|..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~-~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEE-TRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCC-CCcEEEEeehhccc
Confidence            12358899999999999742 24599999988764

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.70  E-value=0.0047  Score=45.66  Aligned_cols=29  Identities=31%  Similarity=0.637  Sum_probs=24.3

Q ss_pred             cCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211          117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus       117 ~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      .+++|||+++.|+++++ +  .+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~--~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N--EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C--cEEEEECcccc
Confidence            57999999999999975 2  48999998664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=97.59  E-value=0.00069  Score=50.57  Aligned_cols=131  Identities=16%  Similarity=0.173  Sum_probs=73.5

Q ss_pred             cceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCC------eeEEEEe--EEcCC--eEEEEEeecCCC
Q 030211           14 NFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN------IIRFKEV--VLTPT--HLAIVMEYAAGG   83 (181)
Q Consensus        14 ~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~------i~~~~~~--~~~~~--~~~~v~e~~~~~   83 (181)
                      .-..+|++...+ |+ +++|+.... ....++..|+..+.-+...+      ++..-+-  ..-+.  +.+.+.+|++|.
T Consensus        37 ~eN~~f~~~~~~-g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTED-GR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecC-CC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            455788888764 33 499998877 55566677777766553221      1222111  11123  788999999887


Q ss_pred             ChHH-H--------------Hhh--------cC----CCCHH----HH---------HHHHHHHHHHHHHHH--------
Q 030211           84 ELFD-R--------------ICN--------AG----RFSED----EG---------RYFFQQLISGVNYCH--------  115 (181)
Q Consensus        84 ~l~~-~--------------~~~--------~~----~~~~~----~~---------~~~~~~i~~~l~~lh--------  115 (181)
                      .+.. .              ++.        ++    ...+.    ..         .....++...+..+.        
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            7652 0              000        01    01111    00         001222222222222        


Q ss_pred             hcC--eeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211          116 SMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus       116 ~~g--i~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      ..+  ++|+|+.|+||+++.+.. .+.++||+-|.
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~  227 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAG  227 (331)
T ss_pred             cccceeeecCCCccceeEcCCCC-eeeEEEccccc
Confidence            233  999999999999975543 47899999875

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.57  E-value=0.0036  Score=47.26  Aligned_cols=73  Identities=18%  Similarity=0.107  Sum_probs=43.8

Q ss_pred             eeCCccceeEEEEEEccCCcEEEEEEcc----c-c---ccccHHHHHHHHHHhhCC--CC-CeeEEEEeEEcCCeEEEEE
Q 030211            9 DLGAGNFGVARLLRHKETKELVAVKYIE----R-G---RKIDENVAREIINHRSLR--HP-NIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         9 ~i~~g~~~~v~~~~~~~~~~~v~~K~~~----~-~---~~~~~~~~~e~~~~~~~~--~~-~i~~~~~~~~~~~~~~~v~   77 (181)
                      .||-|-...||++.....++.++||.-.    . +   +...+...-|...++...  .| .+++++  +.++....++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence            4688888899999986544679999632    1 1   122234445555555442  24 344433  34555567899


Q ss_pred             eecCCC
Q 030211           78 EYAAGG   83 (181)
Q Consensus        78 e~~~~~   83 (181)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            988664

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.55  E-value=0.003  Score=46.31  Aligned_cols=75  Identities=12%  Similarity=0.061  Sum_probs=46.7

Q ss_pred             eeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC---CCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL---RHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         5 ~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~---~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      +-.+.++-|....+|++.  .+++.+.+|.-..  .....+..|..-|+.+   ..-.+++++.+....+.-++++||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~--~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE--SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG--GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecCh--hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            334567778888999887  5577899997663  2235667777777766   34568889999988877899999997


Q ss_pred             CC
Q 030211           82 GG   83 (181)
Q Consensus        82 ~~   83 (181)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            76

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.54  E-value=0.0022  Score=49.14  Aligned_cols=73  Identities=18%  Similarity=0.163  Sum_probs=46.6

Q ss_pred             eeeeeCCccceeEEEEEEccCCcEEEEEEcc-----cccc---ccHHHHHHHHHHhhCC---CCCeeEEEEeEEcCCeEE
Q 030211            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIE-----RGRK---IDENVAREIINHRSLR---HPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~-----~~~~---~~~~~~~e~~~~~~~~---~~~i~~~~~~~~~~~~~~   74 (181)
                      ..+.||-|-...||++.+.  ++.+++|.-.     .+..   .......|...|....   -..+++++.+..+  ..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence            3567788888899999874  4568999755     2221   2233333455555443   2467778877763  356


Q ss_pred             EEEeecCC
Q 030211           75 IVMEYAAG   82 (181)
Q Consensus        75 ~v~e~~~~   82 (181)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            78999976

>PRK11768 serine/threonine protein kinase; Provisional

Probab=97.52  E-value=0.0072  Score=45.21  Aligned_cols=71  Identities=10%  Similarity=0.025  Sum_probs=41.6

Q ss_pred             ccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCC--eeEEE---E--eEEcCCeEEEEEeecCCCC
Q 030211           13 GNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN--IIRFK---E--VVLTPTHLAIVMEYAAGGE   84 (181)
Q Consensus        13 g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~--i~~~~---~--~~~~~~~~~~v~e~~~~~~   84 (181)
                      +.-..||++...+ +..+++|+...+......+..|+..+..+....  ++...   +  ....++..+.++++.+|..
T Consensus        36 s~eN~vy~v~~~~-~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDED-GRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecCC-CCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            4455788887643 567899988654434556667776665443221  12211   1  1222456788999987754

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.36  E-value=0.0044  Score=47.39  Aligned_cols=75  Identities=16%  Similarity=0.110  Sum_probs=45.6

Q ss_pred             eeeeCCccceeEEEEEEccCCcEEEEEEc----ccccc---ccHHHHHHHHHHhhCC--CC-CeeEEEEeEEcCCeEEEE
Q 030211            7 VKDLGAGNFGVARLLRHKETKELVAVKYI----ERGRK---IDENVAREIINHRSLR--HP-NIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~~~v~~K~~----~~~~~---~~~~~~~e~~~~~~~~--~~-~i~~~~~~~~~~~~~~~v   76 (181)
                      .+.||-|--.-||++.+...++.|+||.-    +.++.   ..+...-|...++...  .| .+++++.  .++....++
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            56778888899999998544567999863    22222   2244555666665442  24 3444544  344555678


Q ss_pred             EeecCCC
Q 030211           77 MEYAAGG   83 (181)
Q Consensus        77 ~e~~~~~   83 (181)
                      ||+++..
T Consensus       112 MEdL~~~  118 (409)
T PRK12396        112 MEDLSDH  118 (409)
T ss_pred             HHhCccc
Confidence            8887553

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.30  E-value=0.0016  Score=49.02  Aligned_cols=72  Identities=24%  Similarity=0.282  Sum_probs=56.0

Q ss_pred             CCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211           70 PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus        70 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      .-+.|++|++. |+++.-.  +  ....+++..+++++...++-+..+ ..-|+|+..+||+|+ .++  |.|+||-+++
T Consensus       298 ~~y~yl~~kdh-gt~is~i--k--~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn--vtLIDfklsR  369 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII--K--ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGN--VTLIDFKLSR  369 (488)
T ss_pred             ceEEEEEEecC-Cceeeee--e--cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCc--eEEEEeeeee
Confidence            34678888876 5455422  1  246788999999999988888865 788999999999997 444  9999999987


Q ss_pred             c
Q 030211          149 S  149 (181)
Q Consensus       149 ~  149 (181)
                      .
T Consensus       370 l  370 (488)
T COG5072         370 L  370 (488)
T ss_pred             c
Confidence            4

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=97.29  E-value=0.0027  Score=44.72  Aligned_cols=113  Identities=17%  Similarity=0.097  Sum_probs=69.6

Q ss_pred             ccceeEEEEEEccCCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCChHHHHh
Q 030211           13 GNFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC   90 (181)
Q Consensus        13 g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~   90 (181)
                      ++.++.-.++.+-  .+.++|.+...+--  ..-+..+.+++..+.  +++++..=  ++-.+.++.|+|-....     
T Consensus        73 ~gNsTl~~~kt~i--G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI--GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----  141 (308)
T ss_pred             CCceEEEEecccc--chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----
Confidence            3444444333332  34567777665433  345677788877665  77777632  23346688888833111     


Q ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHh--cCeeeeCCCCCCEEeccCCCCcEEEeecCC
Q 030211           91 NAGRFSEDEGRYFFQQLISGVNYCHS--MQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (181)
Q Consensus        91 ~~~~~~~~~~~~~~~~i~~~l~~lh~--~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~  146 (181)
                              ....+...=+++|.-.|+  .+.+|||..|+||+.+..+.  +||+|-+.
T Consensus       142 --------~~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~--lKlVDP~~  189 (308)
T PF07387_consen  142 --------NFSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGY--LKLVDPVC  189 (308)
T ss_pred             --------chhHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCC--EEecChhh
Confidence                    111222223577888884  47999999999999976666  99999654

The function of this family is unknown.

>PTZ00384 choline kinase; Provisional

Probab=97.27  E-value=0.0087  Score=45.79  Aligned_cols=75  Identities=9%  Similarity=-0.001  Sum_probs=44.4

Q ss_pred             eeeeCCccceeEEEEEEccCC------cEEEEEEccccccccHHHHHHHHHHhhCCCC-CeeEEEEeEEcCCeEEEEEee
Q 030211            7 VKDLGAGNFGVARLLRHKETK------ELVAVKYIERGRKIDENVAREIINHRSLRHP-NIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~------~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~-~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      .+.+..|-...+|++...+..      +.|.++.........-.-..|..+++.+... .-+++++.+..    +++.||
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            345555778899999754321      1245554332222222335577788777554 45667776642    589999


Q ss_pred             cCCCCh
Q 030211           80 AAGGEL   85 (181)
Q Consensus        80 ~~~~~l   85 (181)
                      +++.++
T Consensus       131 IeGr~l  136 (383)
T PTZ00384        131 VEGNTM  136 (383)
T ss_pred             eccccC
Confidence            988765

>PRK06148 hypothetical protein; Provisional

Probab=97.17  E-value=0.015  Score=49.96  Aligned_cols=32  Identities=31%  Similarity=0.485  Sum_probs=25.5

Q ss_pred             cCeeeeCCCCCCEEeccCCCCcEE-EeecCCcc
Q 030211          117 MQICHRDLKLENTLLDGSAAPRLK-ICDFGYSK  148 (181)
Q Consensus       117 ~gi~h~dl~p~ni~i~~~~~~~v~-l~dfg~a~  148 (181)
                      .+++|+|++++||+++.+....+. |+|||-+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            579999999999999765432344 99999875

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.14  E-value=0.0016  Score=45.44  Aligned_cols=55  Identities=16%  Similarity=0.077  Sum_probs=31.0

Q ss_pred             CcEEEEEEccccccccHHHHHHHHHHhhCCCCCe-eEEEEeEEcCCeEEEEEeecCCCCh
Q 030211           27 KELVAVKYIERGRKIDENVAREIINHRSLRHPNI-IRFKEVVLTPTHLAIVMEYAAGGEL   85 (181)
Q Consensus        27 ~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i-~~~~~~~~~~~~~~~v~e~~~~~~l   85 (181)
                      ++.|++|+........-....|...++.+...++ +++++.+..+    .+.+|+.+.+|
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l   57 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTL   57 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE-
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEeccccc
Confidence            4568899887765444555667777776654443 5566655332    35688866543

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PTZ00296 choline kinase; Provisional

Probab=96.92  E-value=0.034  Score=43.43  Aligned_cols=75  Identities=15%  Similarity=0.078  Sum_probs=44.8

Q ss_pred             eeeeCCccceeEEEEEEccC--------CcEEEEEEccccccccHHHHHHHHHHhhCCCCCe-eEEEEeEEcCCeEEEEE
Q 030211            7 VKDLGAGNFGVARLLRHKET--------KELVAVKYIERGRKIDENVAREIINHRSLRHPNI-IRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~--------~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i-~~~~~~~~~~~~~~~v~   77 (181)
                      .+.+..|-.-.+|++.....        ++.|++|+...+....-....|...++.+...++ +++++.+.  +  +.+.
T Consensus       110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~--g--g~I~  185 (442)
T PTZ00296        110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS--G--GRIE  185 (442)
T ss_pred             EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC--C--CEEE
Confidence            44555566678888875421        4679999887654433234556666666644443 34555542  2  3478


Q ss_pred             eecCCCCh
Q 030211           78 EYAAGGEL   85 (181)
Q Consensus        78 e~~~~~~l   85 (181)
                      +|+++.++
T Consensus       186 efi~g~~l  193 (442)
T PTZ00296        186 EWLYGDPL  193 (442)
T ss_pred             EeeCCccC
Confidence            88887643

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.88  E-value=0.0082  Score=46.08  Aligned_cols=58  Identities=16%  Similarity=0.096  Sum_probs=40.9

Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-hcCeeeeCCCCCCEEec
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH-SMQICHRDLKLENTLLD  132 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~gi~h~dl~p~ni~i~  132 (181)
                      .++-+|..+-++..++. ....+++....++.-...|+-.|- -.+++|+|++|.||++.
T Consensus       321 vl~E~~~~Gl~v~~~v~-~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVK-WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             eeeeeccccccHHhhhh-cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            45556666667766653 334556677777777777776655 45899999999999993

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.64  E-value=0.0055  Score=52.34  Aligned_cols=135  Identities=20%  Similarity=0.219  Sum_probs=90.6

Q ss_pred             HHHHHHHHHhhCCCCCeeEEEEeEEcCCeE----EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCe
Q 030211           44 NVAREIINHRSLRHPNIIRFKEVVLTPTHL----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI  119 (181)
Q Consensus        44 ~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~----~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi  119 (181)
                      ...-|...+....|+|++.++.+.......    .+..+++..-++...+..-...+.++.+.+..+.+.++.++|+...
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l  307 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL  307 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence            344466777888999999999888765432    2445677777777777777789999999999999999999999966


Q ss_pred             eeeCCCCC---CEEeccCCCCcEEEeecCCcccccCCCCCCcccCCCCccCcccccCCccCC
Q 030211          120 CHRDLKLE---NTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       120 ~h~dl~p~---ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      .|.-+..+   +--++.++.-..-+.||+...................+.+||......+..
T Consensus       308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~  369 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKK  369 (1351)
T ss_pred             ceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchh
Confidence            66655555   222222233223334777766544444444445566677777776655443

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=96.56  E-value=0.0088  Score=41.34  Aligned_cols=36  Identities=19%  Similarity=0.199  Sum_probs=27.8

Q ss_pred             hcCeeeeCCCCCCEEeccCCCC---cEEEeecCCccccc
Q 030211          116 SMQICHRDLKLENTLLDGSAAP---RLKICDFGYSKSSV  151 (181)
Q Consensus       116 ~~gi~h~dl~p~ni~i~~~~~~---~v~l~dfg~a~~~~  151 (181)
                      ...+.|||+++.|+++..+..+   .+.|+||..+....
T Consensus       119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~g~  157 (196)
T smart00587      119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHYGS  157 (196)
T ss_pred             ceEEeeCCCCccceeeccCCCCCccceEEEecccCCcCC
Confidence            3568999999999999654432   58999999886433

subfamily of choline kinases

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.05  E-value=0.097  Score=37.28  Aligned_cols=73  Identities=22%  Similarity=0.222  Sum_probs=49.0

Q ss_pred             eeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC---CCCCeeEEEEeEEcCCeEEEEEeecCCCCh
Q 030211            9 DLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL---RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (181)
Q Consensus         9 ~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~---~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   85 (181)
                      .+.-|.--..|.+.+.  ..++.+|+-...  ...-+..|..-|..+   ....+++++....+.++.|+|++|++.+++
T Consensus        23 ~v~gG~inea~~v~dg--~~~~FvK~n~~~--~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          23 EVSGGDINEAWRLRDG--TDPFFVKCNQRE--QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             ccCCccccceeEeecC--CcceEEEecchh--hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            3444444455555443  456888864432  234566666666555   345688999999999999999999988655

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	181
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-92
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-91
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-91
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-91
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-91
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-89
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-35
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-35
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-35
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-35
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-35
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-35
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-34
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-34
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-34
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-34
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-34
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-34
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-34
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-33
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-32
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-32
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-32
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-32
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-28
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-28
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-28
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-28
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-28
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-28
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-28
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-28
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-28
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-28
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-28
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-28
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-28
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-28
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-28
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-27
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-27
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-27
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-27
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-27
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-27
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-27
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-27
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-27
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-27
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-27
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-27
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-27
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-27
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-27
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-27
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-27
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-27
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-27
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-27
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-27
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-27
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-27
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-26
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-26
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-26
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-26
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-26
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-25
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-25
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-25
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-25
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-25
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-25
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-25
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-25
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-25
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-25
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-25
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-25
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-25
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-25
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-25
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-25
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-25
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-25
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-25
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-25
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-25
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-25
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-25
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-25
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		9e-25
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		9e-25
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-25
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-24
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-24
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-24
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-24
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-24
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-24
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-24
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-24
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-24
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-24
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-24
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-24
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-24
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-24
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-24
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-24
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-24
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-24
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-24
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-24
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-24
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-24
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-24
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-24
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-24
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-24
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-24
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-24
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-24
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-24
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-24
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-24
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-24
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-24
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-24
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-24
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-24
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-24
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-24
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-24
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-24
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-24
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-24
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-24
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-24
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-24
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-24
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-24
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-24
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-24
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-24
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		9e-24
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-23
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-23
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-23
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-23
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-23
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-23
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-23
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-23
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-23
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-23
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-23
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-23
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-23
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-23
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-23
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-23
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-23
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-23
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-23
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-23
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-23
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-23
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-23
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-23
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-23
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-23
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-23
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-23
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-23
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-23
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-23
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-23
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-23
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-23
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-23
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-23
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-23
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-23
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-23
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-22
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-22
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-22
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-22
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-22
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-22
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-22
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-22
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-22
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-22
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-22
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-22
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-22
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-21
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-21
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-21
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-21
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-21
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-21
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-21
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-21
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-21
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-21
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-21
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-21
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-21
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-21
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		8e-21
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-21
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		9e-21
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		9e-21
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-21
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-20
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-20
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-20
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-20
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-20
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-20
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-19
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-19
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-19
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-19
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-19
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-19
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-19
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-19
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-19
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-19
3soa_A	444	Full-Length Human Camkii Length = 444		1e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-18
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-18
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-18
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-18
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-18
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-18
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-18
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-18
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-18
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-18
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-18
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		6e-18
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		6e-18
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-18
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-18
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		6e-18
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-18
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-18
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-18
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-18
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-18
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-18
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-17
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-17
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-17
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-17
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-17
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-17
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-17
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-17
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-17
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-17
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-17
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-17
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-17
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-17
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-17
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-17
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-17
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-17
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-17
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-17
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-17
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-17
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-17
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-17
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-17
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		6e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-17
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-17
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-17
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-17
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		9e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-16
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-16
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-16
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-16
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-16
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-16
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-16
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-16
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-15
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-15
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-15
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-15
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-15
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-14
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-14
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-14
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-14
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-14
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-14
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-14
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-14
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-14
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-14
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-14
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-14
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-14
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-13
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		9e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-13
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-12
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-12
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-12
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		9e-12
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-11
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-11
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-11
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-11
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-11
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-11
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-11
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-11
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-11
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-11
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-11
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-11
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-11
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-11
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-11
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-11
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-11
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-11
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-10
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-10
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-09
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-09
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		7e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-09
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		9e-09
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		9e-09
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-08
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-08
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-08
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-08
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-08
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		5e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-08
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-08
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		9e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-07
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-07
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-07
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-07
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-07
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-07
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-07
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		9e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-06
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-06
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-06
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-06
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-06
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-06
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-06
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-06
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-06
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-06
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-06
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-06
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-06
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-06
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-06
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-06
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-06
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-06
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-06
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-06
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-06
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-06
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-06
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-06
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-06
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-06
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-06
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-06
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-06
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-06
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-06
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-06
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-06
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-06
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-06
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-06
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-06
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-06
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-06
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-06
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-06
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-06
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-06
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-06
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-06
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-06
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-06
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-06
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-06
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-06
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-06
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-06
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		7e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-06
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		7e-06
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		8e-06
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		8e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		8e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		9e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-05
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-05
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-05
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-05
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-05
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-05
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-05
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-05
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-05
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-05
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-05
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-05
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-05
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-05
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-05
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-05
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-05
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-05
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-05
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		8e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-05
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-04
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-04
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-04
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-04
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-04
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-04
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-04
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-04
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-04
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-04
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-04
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-04
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-04
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-04
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-04
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-04
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-04
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-04
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-04
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-04
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-04
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-04
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		3e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-04
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-04
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-04
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-04
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-04
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-04
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-04
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-04
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-04
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-04
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-04
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-04
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-04
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		5e-04
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		6e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-04
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-04
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-04

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  334 bits (857), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 153/178 (85%), Positives = 171/178 (96%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++YELVKD+G+GNFGVARL+R K++ ELVAVKYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 77
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSEDE R+FFQQLISGV+YCH+MQ+CH
Sbjct: 78  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 137
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           RDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL ++EYDGK
Sbjct: 138 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 195

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  331 bits (849), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 152/178 (85%), Positives = 169/178 (94%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++Y+ VKD+G+GNFGVARL+R K TKELVAVKYIERG  IDENV REIINHRSLRHPNI+
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           RFKEV+LTPTHLAI+MEYA+GGEL++RICNAGRFSEDE R+FFQQL+SGV+YCHSMQICH
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           RDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL R+EYDGK
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK 197

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  331 bits (849), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 152/178 (85%), Positives = 170/178 (95%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++YELVKD+G+GNFGVARL+R K++ ELVAVKYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSEDE R+FFQQLISGV+YCH+MQ+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           RDLKLENTLLDGS APRLKIC FGYSKSSVLHS+PKSTVGTPAYIAPEVL ++EYDGK
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  329 bits (844), Expect = 5e-91,   Method: Compositional matrix adjust.
 Identities = 151/178 (84%), Positives = 169/178 (94%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++YELVKD+G+GNFGVARL+R K++ ELVAVKYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSEDE R+FFQQLISGV+YCH+MQ+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           RDLKLENTLLDGS APRLKIC FGYSKSSVLHS+PK TVGTPAYIAPEVL ++EYDGK
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGK 196

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  329 bits (843), Expect = 6e-91,   Method: Compositional matrix adjust.
 Identities = 151/178 (84%), Positives = 169/178 (94%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++YELVKD+G+GNFGVARL+R K++ ELVAVKYIERG KI  NV REIINHRSLRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIV 78
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSEDE R+FFQQLISGV+YCH+MQ+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           RDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL ++EYDGK
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  322 bits (826), Expect = 6e-89,   Method: Compositional matrix adjust.
 Identities = 149/178 (83%), Positives = 166/178 (93%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++YELVKD+GAGNFGVARL+R K+  ELVAVKYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELF+RICNAGRFSEDE R+FFQQLISGV+Y H+MQ+ H
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAH 138
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           RDLKLENTLLDGS APRLKI DFGYSK+SVLHS+PKS VGTPAYIAPEVL ++EYDGK
Sbjct: 139 RDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGK 196

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  145 bits (366), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/181 (45%), Positives = 107/181 (59%), Gaps = 6/181 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDE--NVAREIINHRSLRHPN 59
           Y L   LG G FG  ++ +H+ T   VAVK + R   R +D    + REI N +  RHP+
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           II+  +V+ TP+ + +VMEY +GGELFD IC  GR  E E R  FQQ++SGV+YCH   +
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMV 137
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD  A    KI DFG S         + + G+P Y APEV+S R Y G 
Sbjct: 138 VHRDLKPENVLLD--AHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGP 195
Query: 180 Q 180
           +
Sbjct: 196 E 196

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  145 bits (366), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/181 (45%), Positives = 115/181 (63%), Gaps = 7/181 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDEN--VAREIINHRSLRHPN 59
           Y + + LG G+FG  +L  H +T++ VA+K+I R   +K D +  V REI   + LRHP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           II+  +V+ TPT + +V+EYA GGELFD I    R +EDEGR FFQQ+I  + YCH  +I
Sbjct: 71  IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD +    +KI DFG S      +  K++ G+P Y APEV++ + Y G 
Sbjct: 130 VHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 180 Q 180
           +
Sbjct: 188 E 188

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  144 bits (364), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 82/181 (45%), Positives = 105/181 (58%), Gaps = 6/181 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKID--ENVAREIINHRSLRHPN 59
           Y L   LG G FG  ++  H+ T   VAVK + R   R +D    + REI N +  RHP+
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           II+  +V+ TPT   +VMEY +GGELFD IC  GR  E E R  FQQ++S V+YCH   +
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD  A    KI DFG S         +++ G+P Y APEV+S R Y G 
Sbjct: 133 VHRDLKPENVLLD--AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 180 Q 180
           +
Sbjct: 191 E 191

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  144 bits (362), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 82/181 (45%), Positives = 104/181 (57%), Gaps = 6/181 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKID--ENVAREIINHRSLRHPN 59
           Y L   LG G FG  ++  H+ T   VAVK + R   R +D    + REI N +  RHP+
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           II+  +V+ TPT   +VMEY +GGELFD IC  GR  E E R  FQQ++S V+YCH   +
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD  A    KI DFG S         + + G+P Y APEV+S R Y G 
Sbjct: 133 VHRDLKPENVLLD--AHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGP 190
Query: 180 Q 180
           +
Sbjct: 191 E 191

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  142 bits (359), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 76/180 (42%), Positives = 106/180 (58%), Gaps = 5/180 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNI 60
           Y L K +G GNF   +L RH  T   VAVK I++ +      + + RE+   + L HPNI
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+FD +   GR  E E R  F+Q++S V YCH   I 
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIV 136
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLK EN LLDG     +KI DFG+S    + ++  +  G+P Y APE+   ++YDG +
Sbjct: 137 HRDLKAENLLLDGDM--NIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPE 194

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  142 bits (358), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 76/180 (42%), Positives = 107/180 (59%), Gaps = 5/180 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T + VAVK I++ +    ++    RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+FD +   GR  E E R  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLK EN LLD  A   +KI DFG+S      ++  +  G+P Y APE+   ++YDG +
Sbjct: 136 HRDLKAENLLLD--ADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  142 bits (358), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 76/180 (42%), Positives = 107/180 (59%), Gaps = 5/180 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T + VAVK I++ +      + + RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+FD +   GR  E E R  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLK EN LLD  A   +KI DFG+S      ++  +  G+P Y APE+   ++YDG +
Sbjct: 136 HRDLKAENLLLD--ADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  141 bits (356), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 74/180 (41%), Positives = 107/180 (59%), Gaps = 5/180 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T   VA+K I++ +      + + RE+   + L HPNI
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L ++MEYA+GGE+FD +   GR  E E R  F+Q++S V YCH  +I 
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 133
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLK EN LLD  A   +KI DFG+S    +  +  +  G+P Y APE+   ++YDG +
Sbjct: 134 HRDLKAENLLLD--ADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE 191

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  141 bits (356), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 76/180 (42%), Positives = 106/180 (58%), Gaps = 5/180 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T + VAVK I++ +      + + RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+FD +   GR  E E R  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLK EN LLD  A   +KI DFG+S      ++  +  G P Y APE+   ++YDG +
Sbjct: 136 HRDLKAENLLLD--ADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  141 bits (355), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 75/180 (41%), Positives = 107/180 (59%), Gaps = 5/180 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T + VAV+ I++ +      + + RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+FD +   GR  E E R  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLK EN LLD  A   +KI DFG+S      ++  +  G+P Y APE+   ++YDG +
Sbjct: 136 HRDLKAENLLLD--ADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  140 bits (353), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 74/180 (41%), Positives = 106/180 (58%), Gaps = 5/180 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T   VA+K I++ +      + + RE+   + L HPNI
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L ++MEYA+GGE+FD +   GR  E E R  F+Q++S V YCH  +I 
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLK EN LLD  A   +KI DFG+S    +  +  +  G P Y APE+   ++YDG +
Sbjct: 137 HRDLKAENLLLD--ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  140 bits (353), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 75/180 (41%), Positives = 106/180 (58%), Gaps = 5/180 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T + VAV+ I++ +      + + RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+FD +   GR  E E R  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLK EN LLD  A   +KI DFG+S      ++     G+P Y APE+   ++YDG +
Sbjct: 136 HRDLKAENLLLD--ADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPE 193

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  140 bits (352), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 75/180 (41%), Positives = 106/180 (58%), Gaps = 5/180 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T + VAVK I++ +      + + RE+   + L HPNI
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+FD +   G   E E R  F+Q++S V YCH   I 
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLK EN LLD  A   +KI DFG+S      ++  +  G+P Y APE+   ++YDG +
Sbjct: 129 HRDLKAENLLLD--ADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  138 bits (348), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 75/180 (41%), Positives = 105/180 (58%), Gaps = 5/180 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNI 60
           Y L+K +G GNF   +L RH  T + VAVK I++ +      + + RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++  EV+ T   L +V EYA+GGE+FD +   GR  E E R  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLK EN LLD  A   +KI DFG+S      ++  +  G P Y APE+   ++YDG +
Sbjct: 136 HRDLKAENLLLD--ADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  134 bits (337), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 78/181 (43%), Positives = 106/181 (58%), Gaps = 7/181 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPN 59
           Y++VK LG G+FG  +L  H  T + VA+K I +       +   + REI   R LRHP+
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           II+  +V+ +   + +V+EYA G ELFD I    + SE E R FFQQ+IS V YCH  +I
Sbjct: 76  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 134
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+S + Y G 
Sbjct: 135 VHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 192
Query: 180 Q 180
           +
Sbjct: 193 E 193

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  134 bits (337), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 78/181 (43%), Positives = 106/181 (58%), Gaps = 7/181 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPN 59
           Y++VK LG G+FG  +L  H  T + VA+K I +       +   + REI   R LRHP+
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           II+  +V+ +   + +V+EYA G ELFD I    + SE E R FFQQ+IS V YCH  +I
Sbjct: 75  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 133
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+S + Y G 
Sbjct: 134 VHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 191
Query: 180 Q 180
           +
Sbjct: 192 E 192

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  134 bits (337), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 78/181 (43%), Positives = 106/181 (58%), Gaps = 7/181 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPN 59
           Y++VK LG G+FG  +L  H  T + VA+K I +       +   + REI   R LRHP+
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           II+  +V+ +   + +V+EYA G ELFD I    + SE E R FFQQ+IS V YCH  +I
Sbjct: 66  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 124
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+S + Y G 
Sbjct: 125 VHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 182
Query: 180 Q 180
           +
Sbjct: 183 E 183

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  134 bits (337), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 78/181 (43%), Positives = 106/181 (58%), Gaps = 7/181 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPN 59
           Y++VK LG G+FG  +L  H  T + VA+K I +       +   + REI   R LRHP+
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           II+  +V+ +   + +V+EYA G ELFD I    + SE E R FFQQ+IS V YCH  +I
Sbjct: 70  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 128
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+S + Y G 
Sbjct: 129 VHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 186
Query: 180 Q 180
           +
Sbjct: 187 E 187

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  121 bits (304), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 66/178 (37%), Positives = 103/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTPA++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVN 190

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  121 bits (303), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           YE+ ++LG+G F + R  R K T +  A K+I++ R          E + RE+   R +R
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNII   ++    T + +++E  +GGELFD +      +EDE   F +Q++ GV+Y HS
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN  LLD +   PR+K+ DFG +      +  K+  GTP ++APE+++
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 205

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  120 bits (302), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           YE+ ++LG+G F + R  R K T +  A K+I++ R          E + RE+   R +R
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNII   ++    T + +++E  +GGELFD +      +EDE   F +Q++ GV+Y HS
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN  LLD +   PR+K+ DFG +      +  K+  GTP ++APE+++
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 191

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  120 bits (302), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           YE+ ++LG+G F + R  R K T +  A K+I++ R          E + RE+   R +R
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNII   ++    T + +++E  +GGELFD +      +EDE   F +Q++ GV+Y HS
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN  LLD +   PR+K+ DFG +      +  K+  GTP ++APE+++
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 184

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  120 bits (300), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  120 bits (300), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  120 bits (300), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  119 bits (299), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  119 bits (299), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  119 bits (299), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  119 bits (299), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  119 bits (299), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  119 bits (299), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  119 bits (299), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  119 bits (299), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  118 bits (296), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  118 bits (295), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 176 Y 176
           +
Sbjct: 184 F 184

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  117 bits (294), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 Y 176
           +
Sbjct: 184 F 184

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 Y 176
           +
Sbjct: 184 F 184

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 124 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 176 Y 176
           +
Sbjct: 182 F 182

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 Y 176
           +
Sbjct: 184 F 184

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 Y 176
           +
Sbjct: 184 F 184

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 Y 176
           +
Sbjct: 184 F 184

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 Y 176
           +
Sbjct: 184 F 184

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 101/178 (56%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSLR 56
           Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPN+I   EV    T + ++ E  AGGELFD +      +E+E   F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +QI H DLK EN  LLD +   PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  117 bits (294), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  117 bits (293), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  116 bits (291), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 64/176 (36%), Positives = 95/176 (53%), Gaps = 3/176 (1%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDENVAREIINHRSLRHPNII 61
           +E  + LG G F    L   K T +L AVK I +   +  + ++  EI   R ++H NI+
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
             +++  +P HL +VM+  +GGELFDRI   G ++E +     +Q++  V Y H M I H
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVH 143
Query: 122 RDLKLENTL-LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           RDLK EN L        ++ I DFG SK         +  GTP Y+APEVL+++ Y
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPY 199

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  116 bits (290), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 104/181 (57%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  +  L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 Y 176
           +
Sbjct: 184 F 184

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  115 bits (289), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 70/181 (38%), Positives = 104/181 (57%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G  G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 Y 176
           +
Sbjct: 183 F 183

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 71/182 (39%), Positives = 97/182 (53%), Gaps = 5/182 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHP 58
           E+Y +V  LG G+FG     + + T++  AVK I +     K    + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI++  E++   +   IV E   GGELFD I    RFSE +     +Q+ SG+ Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 119 ICHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 178 GK 179
            K
Sbjct: 201 EK 202

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/171 (40%), Positives = 97/171 (56%), Gaps = 6/171 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR-EIINHRSLRHPNIIR 62
           +E+  +LG G   +    + K T++  A+K +++   +D+ + R EI     L HPNII+
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
            KE+  TPT +++V+E   GGELFDRI   G +SE +     +Q++  V Y H   I HR
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHR 172
Query: 123 DLKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           DLK EN LL  + AP   LKI DFG SK        K+  GTP Y APE+L
Sbjct: 173 DLKPEN-LLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  113 bits (283), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 71/182 (39%), Positives = 97/182 (53%), Gaps = 5/182 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHP 58
           E+Y +V  LG G+FG     + + T++  AVK I +     K    + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI++  E++   +   IV E   GGELFD I    RFSE +     +Q+ SG+ Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 119 ICHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 178 GK 179
            K
Sbjct: 201 EK 202

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  113 bits (283), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 71/182 (39%), Positives = 97/182 (53%), Gaps = 5/182 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHP 58
           E+Y +V  LG G+FG     + + T++  AVK I +     K    + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI++  E++   +   IV E   GGELFD I    RFSE +     +Q+ SG+ Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 119 ICHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 178 GK 179
            K
Sbjct: 201 EK 202

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLMIDQQG--YIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 D 177
           +
Sbjct: 217 N 217

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 62/169 (36%), Positives = 96/169 (56%), Gaps = 3/169 (1%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVL 68
           LG+G F    L++ + T +L A+K I++     D ++  EI   + ++H NI+  +++  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
           + TH  +VM+  +GGELFDRI   G ++E +     QQ++S V Y H   I HRDLK EN
Sbjct: 77  STTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPEN 136
Query: 129 TL-LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            L L      ++ I DFG SK    +    +  GTP Y+APEVL+++ Y
Sbjct: 137 LLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKPY 184

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  110 bits (276), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH--- 57
           ++++E ++ LG G+FG   L++HKET    A+K +++ + +        +N + ++    
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVN 100
Query: 58  -PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +V+EYA GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQG--YIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 D 177
           +
Sbjct: 217 N 217

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  110 bits (275), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 65/173 (37%), Positives = 98/173 (56%), Gaps = 5/173 (2%)
Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEV 66
           K LG G+F + R   HK++ +  AVK I   ++++ N  +EI   +    HPNI++  EV
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 67  VLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKL 126
                H  +VME   GGELF+RI     FSE E  Y  ++L+S V++ H + + HRDLK 
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 127 ENTLL-DGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVLSRREYD 177
           EN L  D +    +KI DFG+++     ++P K+   T  Y APE+L++  YD
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD 187

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  110 bits (275), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 96/178 (53%), Gaps = 7/178 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNII 61
           Y+    LG G F    L   K T++LVA+K I  E     + ++  EI     ++HPNI+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
              ++  +  HL ++M+  +GGELFDRI   G ++E +      Q++  V Y H + I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 122 RDLKLENTL---LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           RDLK EN L   LD  +  ++ I DFG SK     S   +  GTP Y+APEVL+++ Y
Sbjct: 140 RDLKPENLLYYSLDEDS--KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 195

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  110 bits (274), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 96/178 (53%), Gaps = 7/178 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNII 61
           Y+    LG G F    L   K T++LVA+K I  E     + ++  EI     ++HPNI+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
              ++  +  HL ++M+  +GGELFDRI   G ++E +      Q++  V Y H + I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 122 RDLKLENTL---LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           RDLK EN L   LD  +  ++ I DFG SK     S   +  GTP Y+APEVL+++ Y
Sbjct: 140 RDLKPENLLYYSLDEDS--KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 195

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  110 bits (274), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 96/178 (53%), Gaps = 7/178 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNII 61
           Y+    LG G F    L   K T++LVA+K I  E     + ++  EI     ++HPNI+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
              ++  +  HL ++M+  +GGELFDRI   G ++E +      Q++  V Y H + I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 122 RDLKLENTL---LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           RDLK EN L   LD  +  ++ I DFG SK     S   +  GTP Y+APEVL+++ Y
Sbjct: 140 RDLKPENLLYYSLDEDS--KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 195

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  110 bits (274), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 D 177
           +
Sbjct: 217 N 217

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  110 bits (274), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 64/178 (35%), Positives = 96/178 (53%), Gaps = 7/178 (3%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKIDENVAREIINHRSLRHPNII 61
           Y+    LG G F    L   K T++LVA+K I +      + ++  EI     ++HPNI+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
              ++  +  HL ++M+  +GGELFDRI   G ++E +      Q++  V Y H + I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 122 RDLKLENTL---LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           RDLK EN L   LD  +  ++ I DFG SK     S   +  GTP Y+APEVL+++ Y
Sbjct: 140 RDLKPENLLYYSLDEDS--KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 195

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  110 bits (274), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 D 177
           +
Sbjct: 217 N 217

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  110 bits (274), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 D 177
           +
Sbjct: 217 N 217

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  110 bits (274), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 153 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 177 D 177
           +
Sbjct: 209 N 209

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLAGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  110 bits (274), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 181 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 177 D 177
           +
Sbjct: 237 N 237

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMIDQQG--YIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLXGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  109 bits (272), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 D 177
           +
Sbjct: 217 N 217

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  109 bits (272), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 68/175 (38%), Positives = 97/175 (55%), Gaps = 5/175 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKID-ENVAREIINHRSLRH 57
           ++Y+  + LG G+FG   L + K T +  AVK I +    +K D E++ RE+   + L H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI++  E      +  +V E   GGELFD I +  RFSE +     +Q++SG+ Y H  
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 118 QICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 200

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 68/175 (38%), Positives = 97/175 (55%), Gaps = 5/175 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKID-ENVAREIINHRSLRH 57
           ++Y+  + LG G+FG   L + K T +  AVK I +    +K D E++ RE+   + L H
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 108
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI++  E      +  +V E   GGELFD I +  RFSE +     +Q++SG+ Y H  
Sbjct: 109 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 168
Query: 118 QICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 223

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 68/175 (38%), Positives = 97/175 (55%), Gaps = 5/175 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKID-ENVAREIINHRSLRH 57
           ++Y+  + LG G+FG   L + K T +  AVK I +    +K D E++ RE+   + L H
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 109
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI++  E      +  +V E   GGELFD I +  RFSE +     +Q++SG+ Y H  
Sbjct: 110 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 169
Query: 118 QICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL
Sbjct: 170 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 224

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 27  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 86
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 146
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 147 LDLIYRDLKPENLLIDEQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 202
Query: 177 D 177
           +
Sbjct: 203 N 203

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 68/175 (38%), Positives = 97/175 (55%), Gaps = 5/175 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKID-ENVAREIINHRSLRH 57
           ++Y+  + LG G+FG   L + K T +  AVK I +    +K D E++ RE+   + L H
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI++  E      +  +V E   GGELFD I +  RFSE +     +Q++SG+ Y H  
Sbjct: 92  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 151
Query: 118 QICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 206

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 98/178 (55%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLR 56
           Y++ ++LG+G F + +  R K T    A K+I++ +          E + RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNII   +V    T + +++E  +GGELFD +      SE+E   F +Q++ GVNY H+
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGS-AAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN  LLD +   P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  108 bits (270), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 101/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P + + +      ++L +VMEYA GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLMIDQQG--YIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 D 177
           +
Sbjct: 217 N 217

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  108 bits (270), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 85
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R  +  GTP Y+APE++  + Y
Sbjct: 146 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGY 201
Query: 177 D 177
           +
Sbjct: 202 N 202

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R  +  GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGY 216
Query: 177 D 177
           +
Sbjct: 217 N 217

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 101/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P + + +      ++L +VMEYA GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLMIDQQG--YIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 D 177
           +
Sbjct: 217 N 217

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/182 (37%), Positives = 100/182 (54%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M ++E +K LG G FG   L++ K T    A+K +++   +  + VA  +  +R L   R
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     FSED  R++  +++S ++Y HS
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266
Query: 117 MQ-ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRR 174
            + + +RDLKLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   
Sbjct: 267 EKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 175 EY 176
           +Y
Sbjct: 325 DY 326

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLIIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIIISKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/182 (37%), Positives = 100/182 (54%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M ++E +K LG G FG   L++ K T    A+K +++   +  + VA  +  +R L   R
Sbjct: 150 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 209
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     FSED  R++  +++S ++Y HS
Sbjct: 210 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 269
Query: 117 MQ-ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRR 174
            + + +RDLKLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   
Sbjct: 270 EKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 327
Query: 175 EY 176
           +Y
Sbjct: 328 DY 329

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 95/181 (52%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M  ++ +K LG G FG   L+R K T    A+K + +   I  + VA  +   R L   R
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 176 Y 176
           Y
Sbjct: 182 Y 182

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 95/181 (52%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M  ++ +K LG G FG   L+R K T    A+K + +   I  + VA  +   R L   R
Sbjct: 7   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS
Sbjct: 67  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +
Sbjct: 127 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 184
Query: 176 Y 176
           Y
Sbjct: 185 Y 185

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 63/183 (34%), Positives = 103/183 (56%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  GE++  +    +F E     +  +L + ++YCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 132 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 188
Query: 177 DGK 179
           D K
Sbjct: 189 DEK 191

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF+E   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 101/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMIDQQG--YIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 101/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K +G G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 95/181 (52%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M  ++ +K LG G FG   L+R K T    A+K + +   I  + VA  +   R L   R
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 176 Y 176
           Y
Sbjct: 182 Y 182

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/183 (37%), Positives = 99/183 (54%), Gaps = 6/183 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRH 57
           ++Y+ VK LG+G +G   L + K T    A+K I++      + +  +++     + L H
Sbjct: 4   DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI++  E      +  +VME   GGELFD I    +FSE +     +Q++SG  Y H  
Sbjct: 64  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 123
Query: 118 QICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            I HRDLK EN LL+  +   L KI DFG S    +  + K  +GT  YIAPEVL R++Y
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKY 182
Query: 177 DGK 179
           D K
Sbjct: 183 DEK 185

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 101/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++HKET    A+K +++ + +        +N +    ++ 
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 153 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 177 D 177
           +
Sbjct: 209 N 209

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 101/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 D 177
           +
Sbjct: 217 N 217

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 68/175 (38%), Positives = 96/175 (54%), Gaps = 5/175 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKID-ENVAREIINHRSLRH 57
           ++Y+  + LG G+FG   L + K T +  AVK I +    +K D E++ RE+   + L H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI +  E      +  +V E   GGELFD I +  RFSE +     +Q++SG+ Y H  
Sbjct: 86  PNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKN 145
Query: 118 QICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVL 200

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 101/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG +K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMIDQQG--YIKVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/182 (38%), Positives = 96/182 (52%), Gaps = 5/182 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRHP 58
           E Y+ VK LG+G +G   L R K T    A+K I +       +  +  E+   + L HP
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI++  +      +  +VME   GGELFD I +  +F+E +     +Q++SGV Y H   
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 119 ICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+      L KI DFG S       + K  +GT  YIAPEVL R++YD
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYD 215
Query: 178 GK 179
            K
Sbjct: 216 EK 217

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 101/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 101/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 101/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 180
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 181 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 177 D 177
           +
Sbjct: 237 N 237

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +     +  GTP Y+APE++  + Y
Sbjct: 181 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGATWTLCGTPEYLAPEIILSKGY 236
Query: 177 D 177
           +
Sbjct: 237 N 237

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  107 bits (267), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 68/182 (37%), Positives = 99/182 (54%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M ++E +K LG G FG   L++ K T    A+K +++   +  + VA  +  +R L   R
Sbjct: 7   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     FSED  R++  +++S ++Y HS
Sbjct: 67  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 126
Query: 117 MQ-ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRR 174
            + + +RDLKLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   
Sbjct: 127 EKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 184
Query: 175 EY 176
           +Y
Sbjct: 185 DY 186

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  107 bits (267), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 68/182 (37%), Positives = 99/182 (54%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M ++E +K LG G FG   L++ K T    A+K +++   +  + VA  +  +R L   R
Sbjct: 8   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     FSED  R++  +++S ++Y HS
Sbjct: 68  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 127
Query: 117 MQ-ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRR 174
            + + +RDLKLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   
Sbjct: 128 EKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 185
Query: 175 EY 176
           +Y
Sbjct: 186 DY 187

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  107 bits (267), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 68/182 (37%), Positives = 99/182 (54%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M ++E +K LG G FG   L++ K T    A+K +++   +  + VA  +  +R L   R
Sbjct: 9   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 68
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     FSED  R++  +++S ++Y HS
Sbjct: 69  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 128
Query: 117 MQ-ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRR 174
            + + +RDLKLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   
Sbjct: 129 EKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 186
Query: 175 EY 176
           +Y
Sbjct: 187 DY 188

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  107 bits (267), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 94/181 (51%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M  ++ +K LG G FG   L+R K T    A+K + +   I  + VA  +   R L   R
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 176 Y 176
           Y
Sbjct: 182 Y 182

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  107 bits (267), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 68/183 (37%), Positives = 99/183 (54%), Gaps = 6/183 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRH 57
           ++Y+ VK LG+G +G   L + K T    A+K I++      + +  +++     + L H
Sbjct: 21  DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 80
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI++  E      +  +VME   GGELFD I    +FSE +     +Q++SG  Y H  
Sbjct: 81  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 140
Query: 118 QICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            I HRDLK EN LL+  +   L KI DFG S    +  + K  +GT  YIAPEVL R++Y
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKY 199
Query: 177 DGK 179
           D K
Sbjct: 200 DEK 202

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  107 bits (267), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 35  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 94
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 154
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 155 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 210
Query: 177 D 177
           +
Sbjct: 211 N 211

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  107 bits (267), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 63/183 (34%), Positives = 102/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  GE++  +    +F E     +  +L + ++YCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 132 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRXXLXGTLDYLPPEMIEGRMH 188
Query: 177 DGK 179
           D K
Sbjct: 189 DEK 191

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  107 bits (267), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 94/181 (51%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M  ++ +K LG G FG   L+R K T    A+K + +   I  + VA  +   R L   R
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 176 Y 176
           Y
Sbjct: 182 Y 182

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  107 bits (267), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 94/181 (51%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M  ++ +K LG G FG   L+R K T    A+K + +   I  + VA  +   R L   R
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 176 Y 176
           Y
Sbjct: 182 Y 182

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  107 bits (267), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 94/181 (51%), Gaps = 7/181 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---R 56
           M  ++ +K LG G FG   L+R K T    A+K + +   I  + VA  +   R L   R
Sbjct: 9   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 68
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS
Sbjct: 69  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 128
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   +
Sbjct: 129 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 186
Query: 176 Y 176
           Y
Sbjct: 187 Y 187

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+AP ++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPAIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  107 bits (266), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 100/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P + + +      ++L +VMEYA GGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLMIDQQG--YIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 D 177
           +
Sbjct: 217 N 217

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  106 bits (265), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 101/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K +G G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GG++F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  106 bits (265), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 101/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K +G G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GG++F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  106 bits (265), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 101/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +++ DFG +K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMIDQQG--YIQVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  106 bits (264), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 66/188 (35%), Positives = 99/188 (52%), Gaps = 15/188 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDEN---------VAR 47
           E Y  V+ LG+G +G   L + K      A+K I     ++GR  D+N         +  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 48  EIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQL 107
           EI   +SL HPNII+  +V     +  +V E+  GGELF++I N  +F E +     +Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 108 ISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI 166
           +SG+ Y H   I HRD+K EN LL+  ++   +KI DFG S       + +  +GT  YI
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 167 APEVLSRR 174
           APEVL ++
Sbjct: 216 APEVLKKK 223

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 102/181 (56%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP  +APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEALAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 100/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 100/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 D 177
           +
Sbjct: 217 N 217

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 100/181 (55%), Gaps = 8/181 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           ++++E +K LG G+FG   L++H ET    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRF E   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 D 177
           +
Sbjct: 216 N 216

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 102/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 11  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 70
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 130
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 131 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 187
Query: 177 DGK 179
           D K
Sbjct: 188 DEK 190

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  105 bits (261), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 102/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 177 DGK 179
           D K
Sbjct: 187 DEK 189

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  105 bits (261), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 102/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 6   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 65
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 66  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 125
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 126 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 182
Query: 177 DGK 179
           D K
Sbjct: 183 DEK 185

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  105 bits (261), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 102/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 132 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 188
Query: 177 DGK 179
           D K
Sbjct: 189 DEK 191

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  105 bits (261), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 102/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 177 DGK 179
           D K
Sbjct: 187 DEK 189

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  105 bits (261), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 102/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRAALCGTLDYLPPEMIEGRMH 183
Query: 177 DGK 179
           D K
Sbjct: 184 DEK 186

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  105 bits (261), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 102/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 128 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRDTLCGTLDYLPPEMIEGRMH 184
Query: 177 DGK 179
           D K
Sbjct: 185 DEK 187

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  105 bits (261), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 102/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 183
Query: 177 DGK 179
           D K
Sbjct: 184 DEK 186

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  105 bits (261), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 102/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 33  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 92
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 152
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 153 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 209
Query: 177 DGK 179
           D K
Sbjct: 210 DEK 212

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  105 bits (261), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 102/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 24  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 83
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 84  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 143
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 144 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 200
Query: 177 DGK 179
           D K
Sbjct: 201 DEK 203

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  105 bits (261), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S      SR  +  GT  Y+ PE++  R +
Sbjct: 128 KRVIHRDIKPENLLL-GSAG-ELKIADFGWS-CHAPSSRRTTLSGTLDYLPPEMIEGRMH 184
Query: 177 DGK 179
           D K
Sbjct: 185 DEK 187

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  104 bits (260), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 102/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRAALCGTLDYLPPEMIEGRMH 186
Query: 177 DGK 179
           D K
Sbjct: 187 DEK 189

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  104 bits (260), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE +  R +
Sbjct: 132 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEXIEGRXH 188
Query: 177 DGK 179
           D K
Sbjct: 189 DEK 191

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  104 bits (260), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 132 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMH 188
Query: 177 DGK 179
           D K
Sbjct: 189 DEK 191

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRDDLCGTLDYLPPEMIEGRMH 186
Query: 177 DGK 179
           D K
Sbjct: 187 DEK 189

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTXLCGTLDYLPPEMIEGRMH 183
Query: 177 DGK 179
           D K
Sbjct: 184 DEK 186

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRXXLCGTLDYLPPEMIEGRMH 183
Query: 177 DGK 179
           D K
Sbjct: 184 DEK 186

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 177 DGK 179
           D K
Sbjct: 184 DEK 186

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 177 DGK 179
           D K
Sbjct: 184 DEK 186

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K +K ++A+K + + +     ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 67  HPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 127 KKVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRAALCGTLDYLPPEMIEGRMH 183
Query: 177 DGK 179
           D K
Sbjct: 184 DEK 186

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 128 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMH 184
Query: 177 DGK 179
           D K
Sbjct: 185 DEK 187

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRXXLCGTLDYLPPEMIEGRMH 186
Query: 177 DGK 179
           D K
Sbjct: 187 DEK 189

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTELCGTLDYLPPEMIEGRMH 183
Query: 177 DGK 179
           D K
Sbjct: 184 DEK 186

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 128
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 129 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRXXLCGTLDYLPPEMIEGRMH 185
Query: 177 DGK 179
           D K
Sbjct: 186 DEK 188

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 33  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 92
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 152
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 153 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRDDLCGTLDYLPPEMIEGRMH 209
Query: 177 DGK 179
           D K
Sbjct: 210 DEK 212

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K+ K ++A+K + + +     ++  + RE+     LR
Sbjct: 4   LEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 63
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 64  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 123
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 124 KRVIHRDIKPENLLL-GSAG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 180
Query: 177 DGK 179
           D K
Sbjct: 181 DEK 183

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 95/178 (53%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLR 56
           Y++ ++LG+G F + +  R K T    A K+I++ +          E + RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H N+I   +V    T + +++E  +GGELFD +      SE+E   F +Q++ GVNY H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN +L       P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLR 56
           Y++ ++LG+G F + +  R K T    A K+I++ +          E + RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H N+I   +V    T + +++E  +GGELFD +      SE+E   F +Q++ GVNY H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGS-AAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN  LLD +   P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 96/180 (53%), Gaps = 8/180 (4%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-----RHP 58
           +  +K +G G+FG   L RHK  +   AVK +++   + +   + I++ R++     +HP
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
            ++       T   L  V++Y  GGELF  +     F E   R++  ++ S + Y HS+ 
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 159
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLSRREYD 177
           I +RDLK EN LLD      + + DFG  K ++ H+   ST  GTP Y+APEVL ++ YD
Sbjct: 160 IVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 95/178 (53%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLR 56
           Y++ ++LG+G F + +  R K T    A K+I++ +          E + RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H N+I   +V    T + +++E  +GGELFD +      SE+E   F +Q++ GVNY H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN +L       P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 95/178 (53%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLR 56
           Y++ ++LG+G F + +  R K T    A K+I++ +          E + RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H N+I   +V    T + +++E  +GGELFD +      SE+E   F +Q++ GVNY H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN +L       P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 64/182 (35%), Positives = 96/182 (52%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---- 55
           ++ +E ++ LG G+FG   L R KET +L AVK +++   + D++V   +   R L    
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP + +      TP  L  VME+  GG+L   I  + RF E   R++  ++IS + + H
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLSRR 174
              I +RDLKL+N LLD       K+ DFG  K  + +    +T  GTP YIAPE+L   
Sbjct: 142 DKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 175 EY 176
            Y
Sbjct: 200 LY 201

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 95/178 (53%), Gaps = 9/178 (5%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLR 56
           Y++ ++LG+G F + +  R K T    A K+I++ +          E + RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H N+I   +V    T + +++E  +GGELFD +      SE+E   F +Q++ GVNY H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            +I H DLK EN +L       P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  103 bits (257), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 61/183 (33%), Positives = 102/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI +FG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GSAG-ELKIANFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 177 DGK 179
           D K
Sbjct: 187 DEK 189

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  103 bits (256), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 61/183 (33%), Positives = 102/183 (55%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 128
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GSA   LKI +FG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 129 KRVIHRDIKPENLLL-GSAG-ELKIANFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 185
Query: 177 DGK 179
           D K
Sbjct: 186 DEK 188

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 98/183 (53%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           ++ +++V+ LG G FG   L R K+ K ++A+K + + +     ++  + REI     LR
Sbjct: 13  IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R          + +++E+A  GEL+  +   GRF E     F ++L   ++YCH 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN L+       LKI DFG+S  +    R +   GT  Y+ PE++  + +
Sbjct: 133 RKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPSLRR-RXMCGTLDYLPPEMIEGKTH 189
Query: 177 DGK 179
           D K
Sbjct: 190 DEK 192

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/170 (36%), Positives = 90/170 (52%), Gaps = 2/170 (1%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNIIR 62
           Y L   +G G++G  ++   K T+   A K I +    D +   +EI   +SL HPNIIR
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
             E     T + +VME   GGELF+R+ +   F E +     + ++S V YCH + + HR
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 147
Query: 123 DLKLENTL-LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           DLK EN L L  S    LK+ DFG +         ++ VGTP Y++P+VL
Sbjct: 148 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 197

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  102 bits (253), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/170 (36%), Positives = 90/170 (52%), Gaps = 2/170 (1%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNIIR 62
           Y L   +G G++G  ++   K T+   A K I +    D +   +EI   +SL HPNIIR
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
             E     T + +VME   GGELF+R+ +   F E +     + ++S V YCH + + HR
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 130
Query: 123 DLKLENTL-LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           DLK EN L L  S    LK+ DFG +         ++ VGTP Y++P+VL
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 180

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 100/183 (54%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +++ + LG G FG   L R +++K ++A+K + + +     ++  + RE+     LR
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    RF E     +  +L + ++YCHS
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL  +    LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 131 KRVIHRDIKPENLLLGSNG--ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 187
Query: 177 DGK 179
           D K
Sbjct: 188 DEK 190

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 100/183 (54%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +++ + LG G FG   L R +++K ++A+K + + +     ++  + RE+     LR
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    RF E     +  +L + ++YCHS
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL  +    LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 131 KRVIHRDIKPENLLLGSNG--ELKIADFGWSVHAP-SSRRDTLCGTLDYLPPEMIEGRMH 187
Query: 177 DGK 179
           D K
Sbjct: 188 DEK 190

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  100 bits (248), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 68/180 (37%), Positives = 93/180 (51%), Gaps = 11/180 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-------GRKIDE--NVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA+K I +        R+ D   NV  EI   
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 69  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 128 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 187

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  100 bits (248), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 68/180 (37%), Positives = 93/180 (51%), Gaps = 11/180 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-------GRKIDE--NVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA+K I +        R+ D   NV  EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  100 bits (248), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 68/180 (37%), Positives = 93/180 (51%), Gaps = 11/180 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-------GRKIDE--NVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA+K I +        R+ D   NV  EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 99.8 bits (247), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 68/180 (37%), Positives = 93/180 (51%), Gaps = 11/180 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-------GRKIDE--NVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA+K I +        R+ D   NV  EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 99.8 bits (247), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 68/180 (37%), Positives = 93/180 (51%), Gaps = 11/180 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-------GRKIDE--NVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA+K I +        R+ D   NV  EI   
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 76  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 135 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 194

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 99.8 bits (247), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 67/183 (36%), Positives = 97/183 (53%), Gaps = 11/183 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           + YE+ +D+G G++ V +   HK T    AVK I++ ++ D     EI+  R  +HPNII
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKR-DPTEEIEIL-LRYGQHPNII 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
             K+V     ++ +V E   GGEL D+I     FSE E       +   V Y H+  + H
Sbjct: 80  TLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVH 139
Query: 122 RDLKLENTL-LDGSAAPR-LKICDFGYSKSSVLHSRPKSTVGTPAY----IAPEVLSRRE 175
           RDLK  N L +D S  P  ++ICDFG++K   L +     + TP Y    +APEVL R+ 
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAE-NGLLXTPCYTANFVAPEVLERQG 196
Query: 176 YDG 178
           YD 
Sbjct: 197 YDA 199

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 99.8 bits (247), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 97/183 (53%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           ++ +++ + LG G FG   L R K+ K ++A+K + + +     ++  + REI     LR
Sbjct: 14  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R          + +++E+A  GEL+  +   GRF E     F ++L   ++YCH 
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 133
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN L+       LKI DFG+S  +    R +   GT  Y+ PE++  + +
Sbjct: 134 RKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPSLRR-RXMCGTLDYLPPEMIEGKTH 190
Query: 177 DGK 179
           D K
Sbjct: 191 DEK 193

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 60/165 (36%), Positives = 84/165 (50%), Gaps = 2/165 (1%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           LG G FG         T   +A K I+ RG K  E V  EI     L H N+I+  +   
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 69  TPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
           +   + +VMEY  GGELFDRI +     +E +   F +Q+  G+ + H M I H DLK E
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPE 216
Query: 128 NTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           N L     A ++KI DFG ++      + K   GTP ++APEV++
Sbjct: 217 NILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN 261

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/183 (36%), Positives = 97/183 (53%), Gaps = 11/183 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           + YE+ +D+G G++ V +   HK T    AVK I++ ++ D     EI+  R  +HPNII
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-DPTEEIEIL-LRYGQHPNII 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
             K+V     ++ +V E   GGEL D+I     FSE E       +   V Y H+  + H
Sbjct: 80  TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVH 139
Query: 122 RDLKLENTL-LDGSAAPR-LKICDFGYSKSSVLHSRPKSTVGTPAY----IAPEVLSRRE 175
           RDLK  N L +D S  P  ++ICDFG++K   L +     + TP Y    +APEVL R+ 
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLERQG 196
Query: 176 YDG 178
           YD 
Sbjct: 197 YDA 199

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 98/183 (53%), Gaps = 8/183 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---- 55
           +E +EL K LG G+FG   L   K+T +  A+K +++   + D++V   ++  R L    
Sbjct: 17  IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP +        T  +L  VMEY  GG+L   I +  +F      ++  ++I G+ + H
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 136
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVGTPAYIAPEVLSRR 174
           S  I +RDLKL+N LLD      +KI DFG  K ++L  ++     GTP YIAPE+L  +
Sbjct: 137 SKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQ 194
Query: 175 EYD 177
           +Y+
Sbjct: 195 KYN 197

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/180 (37%), Positives = 93/180 (51%), Gaps = 11/180 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-------GRKIDE--NVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA++ I +        R+ D   NV  EI   
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 209 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 267
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 268 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 327

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/180 (37%), Positives = 93/180 (51%), Gaps = 11/180 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-------GRKIDE--NVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA++ I +        R+ D   NV  EI   
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 104/181 (57%), Gaps = 13/181 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRH---KETKELVAVKYIERGR-----KIDENVAREIINHRS 54
           ++EL+K LG G+FG   L++     + ++L A+K +++       ++   + R+I+    
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 83
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           + HP I++      T   L +++++  GG+LF R+     F+E++ +++  +L   +++ 
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 143
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSR 173
           HS+ I +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV++R
Sbjct: 144 HSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 201
Query: 174 R 174
           R
Sbjct: 202 R 202

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 106/190 (55%), Gaps = 18/190 (9%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRH 57
           MEKY  ++ +G G+FG A L++  E      +K I   R   K  E   RE+    +++H
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR---FSEDEGRYFFQQLISGVNYC 114
           PNI++++E       L IVM+Y  GG+LF RI NA +   F ED+   +F Q+   + + 
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 115 HSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPE 169
           H  +I HRD+K +N  L  DG+    +++ DFG ++  VL+S     ++ +GTP Y++PE
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGT----VQLGDFGIAR--VLNSTVELARACIGTPYYLSPE 195
Query: 170 VLSRREYDGK 179
           +   + Y+ K
Sbjct: 196 ICENKPYNNK 205

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 104/181 (57%), Gaps = 13/181 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRH---KETKELVAVKYIERGR-----KIDENVAREIINHRS 54
           ++EL+K LG G+FG   L++     + ++L A+K +++       ++   + R+I+    
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 82
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           + HP I++      T   L +++++  GG+LF R+     F+E++ +++  +L   +++ 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSR 173
           HS+ I +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV++R
Sbjct: 143 HSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 174 R 174
           R
Sbjct: 201 R 201

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 104/181 (57%), Gaps = 13/181 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRH---KETKELVAVKYIERGR-----KIDENVAREIINHRS 54
           ++EL+K LG G+FG   L++     + ++L A+K +++       ++   + R+I+    
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 82
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           + HP I++      T   L +++++  GG+LF R+     F+E++ +++  +L   +++ 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSR 173
           HS+ I +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV++R
Sbjct: 143 HSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 174 R 174
           R
Sbjct: 201 R 201

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 60/179 (33%), Positives = 90/179 (50%), Gaps = 4/179 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           + Y++ ++LG G F V R   HK T    A K I   +   +  + + RE    R L+HP
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +   +   +V +   GGELF+ I     +SE +  +  QQ++  + YCHS  
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 119 ICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HR+LK EN LL   A    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 60/179 (33%), Positives = 90/179 (50%), Gaps = 4/179 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           + Y++ ++LG G F V R   HK T    A K I   +   +  + + RE    R L+HP
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +   +   +V +   GGELF+ I     +SE +  +  QQ++  + YCHS  
Sbjct: 65  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 124
Query: 119 ICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HR+LK EN LL   A    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 183

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 60/179 (33%), Positives = 90/179 (50%), Gaps = 4/179 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           + Y++ ++LG G F V R   HK T    A K I   +   +  + + RE    R L+HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +   +   +V +   GGELF+ I     +SE +  +  QQ++  + YCHS  
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 119 ICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HR+LK EN LL   A    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 60/179 (33%), Positives = 90/179 (50%), Gaps = 4/179 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           + Y++ ++LG G F V R   HK T    A K I   +   +  + + RE    R L+HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +   +   +V +   GGELF+ I     +SE +  +  QQ++  + YCHS  
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 119 ICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HR+LK EN LL   A    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 103/180 (57%), Gaps = 13/180 (7%)
Query: 4   YELVKDLGAGNFGVARLLR---HKETKELVAVKYIERGR-----KIDENVAREIINHRSL 55
           +EL+K LG G+FG   L+R     ++  L A+K +++       ++   + R+I+    +
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILA--DV 87
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP +++      T   L +++++  GG+LF R+     F+E++ +++  +L  G+++ H
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLH 147
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSRR 174
           S+ I +RDLK EN LLD      +K+ DFG SK ++ H +   S  GT  Y+APEV++R+
Sbjct: 148 SLGIIYRDLKPENILLDEEG--HIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQ 205

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 96.3 bits (238), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 99/188 (52%), Gaps = 13/188 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RH 57
           E YE+VK +G G FG  +L+RHK T+++ A+K + +   I  + +      R +      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P +++         +L +VMEY  GG+L + + N     E   R++  +++  ++  HSM
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 192
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
              HRD+K +N LLD S    LK+ DFG     +K  ++  R  + VGTP YI+PEVL  
Sbjct: 193 GFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKS 248
Query: 174 REYDGKQG 181
           +  DG  G
Sbjct: 249 QGGDGYYG 256

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 96.3 bits (238), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/180 (37%), Positives = 95/180 (52%), Gaps = 11/180 (6%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y + + +G G++   +   HK T    AVK I++ ++ D +   EI+  R  +HPNII  
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKR-DPSEEIEIL-LRYGQHPNIITL 86
Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           K+V     H+ +V E   GGEL D+I     FSE E  +    +   V Y HS  + HRD
Sbjct: 87  KDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRD 146
Query: 124 LKLENTL-LDGSAAPR-LKICDFGYSKSSVLHSRPKSTVGTPAY----IAPEVLSRREYD 177
           LK  N L +D S  P  L+ICDFG++K   L +     + TP Y    +APEVL R+ YD
Sbjct: 147 LKPSNILYVDESGNPECLRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLKRQGYD 203

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 96.3 bits (238), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 99/188 (52%), Gaps = 13/188 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RH 57
           E YE+VK +G G FG  +L+RHK T+++ A+K + +   I  + +      R +      
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P +++         +L +VMEY  GG+L + + N     E   R++  +++  ++  HSM
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 187
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
              HRD+K +N LLD S    LK+ DFG     +K  ++  R  + VGTP YI+PEVL  
Sbjct: 188 GFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKS 243
Query: 174 REYDGKQG 181
           +  DG  G
Sbjct: 244 QGGDGYYG 251

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 96.3 bits (238), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/180 (37%), Positives = 95/180 (52%), Gaps = 11/180 (6%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y + + +G G++   +   HK T    AVK I++ ++ D +   EI+  R  +HPNII  
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKR-DPSEEIEIL-LRYGQHPNIITL 86
Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           K+V     H+ +V E   GGEL D+I     FSE E  +    +   V Y HS  + HRD
Sbjct: 87  KDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRD 146
Query: 124 LKLENTL-LDGSAAPR-LKICDFGYSKSSVLHSRPKSTVGTPAY----IAPEVLSRREYD 177
           LK  N L +D S  P  L+ICDFG++K   L +     + TP Y    +APEVL R+ YD
Sbjct: 147 LKPSNILYVDESGNPECLRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLKRQGYD 203

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 96.3 bits (238), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 99/188 (52%), Gaps = 13/188 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RH 57
           E YE+VK +G G FG  +L+RHK T+++ A+K + +   I  + +      R +      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P +++         +L +VMEY  GG+L + + N     E   R++  +++  ++  HSM
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 192
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
              HRD+K +N LLD S    LK+ DFG     +K  ++  R  + VGTP YI+PEVL  
Sbjct: 193 GFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKS 248
Query: 174 REYDGKQG 181
           +  DG  G
Sbjct: 249 QGGDGYYG 256

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 61/183 (33%), Positives = 97/183 (53%), Gaps = 8/183 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---- 55
           +E + L K LG G+FG   L   K+T +  A+K +++   + D++V   ++  R L    
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP +        T  +L  VMEY  GG+L   I +  +F      ++  ++I G+ + H
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSRPKSTVGTPAYIAPEVLSRR 174
           S  I +RDLKL+N LLD      +KI DFG  K ++L  ++     GTP YIAPE+L  +
Sbjct: 136 SKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQ 193
Query: 175 EYD 177
           +Y+
Sbjct: 194 KYN 196

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/182 (32%), Positives = 91/182 (50%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---- 55
           +  +  +  LG G+FG   L   K T EL AVK +++   I D++V   ++  R L    
Sbjct: 19  LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           + P + +      T   L  VMEY  GG+L   I   GRF E    ++  ++  G+ +  
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTVGTPAYIAPEVLSRR 174
           S  I +RDLKL+N +LD      +KI DFG  K ++      K   GTP YIAPE+++ +
Sbjct: 139 SKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQ 196
Query: 175 EY 176
            Y
Sbjct: 197 PY 198

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 105/216 (48%), Gaps = 45/216 (20%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID------------------ 42
           + +Y L  ++G G++GV +L  ++      A+K + + + I                   
Sbjct: 12  LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 43  ---------ENVAREIINHRSLRHPNIIRFKEVVLTPT--HLAIVMEYAAGGELFDRICN 91
                    E V +EI   + L HPN+++  EV+  P   HL +V E    G + + +  
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPT 130
Query: 92  AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSK- 148
               SED+ R++FQ LI G+ Y H  +I HRD+K  N L+  DG     +KI DFG S  
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG----HIKIADFGVSNE 186
Query: 149 ---SSVLHSRPKSTVGTPAYIAPEVLS--RREYDGK 179
              S  L S   +TVGTPA++APE LS  R+ + GK
Sbjct: 187 FKGSDALLS---NTVGTPAFMAPESLSETRKIFSGK 219

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 60/182 (32%), Positives = 91/182 (50%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---- 55
           +  +  +  LG G+FG   L   K T EL AVK +++   I D++V   ++  R L    
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           + P + +      T   L  VMEY  GG+L   I   GRF E    ++  ++  G+ +  
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTVGTPAYIAPEVLSRR 174
           S  I +RDLKL+N +LD      +KI DFG  K ++      K   GTP YIAPE+++ +
Sbjct: 460 SKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQ 517
Query: 175 EY 176
            Y
Sbjct: 518 PY 519

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 95/184 (51%), Gaps = 14/184 (7%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLR 56
           ++ +++++ LG G+FG   L+R +      A+K +++      K  E+   E +    + 
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP IIR          + ++M+Y  GGELF  +  + RF     +++  ++   + Y HS
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV---GTPAYIAPEVLSR 173
             I +RDLK EN LLD +    +KI DFG++K       P  T    GTP YIAPEV+S 
Sbjct: 125 KDIIYRDLKPENILLDKNG--HIKITDFGFAKYV-----PDVTYXLCGTPDYIAPEVVST 177
Query: 174 REYD 177
           + Y+
Sbjct: 178 KPYN 181

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 93.2 bits (230), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 93/182 (51%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL---- 55
           +  +  +  LG G+FG   L   K T+EL A+K +++   I D++V   ++  R L    
Sbjct: 18  LTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLD 77
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           + P + +      T   L  VMEY  GG+L   I   G+F E +  ++  ++  G+ + H
Sbjct: 78  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLH 137
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTVGTPAYIAPEVLSRR 174
              I +RDLKL+N +LD      +KI DFG  K  ++     +   GTP YIAPE+++ +
Sbjct: 138 KRGIIYRDLKLDNVMLDSEG--HIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQ 195
Query: 175 EY 176
            Y
Sbjct: 196 PY 197

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 90/180 (50%), Gaps = 5/180 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           ++Y+L ++LG G F V R      T +  A K I   +   +  + + RE    R L+HP
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +       +V +   GGELF+ I     +SE +  +  QQ++  VN+CH   
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 119 ICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSRREY 176
           I HRDLK EN LL   S    +K+ DFG +       +      GTP Y++PEVL +  Y
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 90/180 (50%), Gaps = 5/180 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           ++Y+L ++LG G F V R      T +  A K I   +   +  + + RE    R L+HP
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +       +V +   GGELF+ I     +SE +  +  QQ++  VN+CH   
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 119 ICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSRREY 176
           I HRDLK EN LL   S    +K+ DFG +       +      GTP Y++PEVL +  Y
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 2/172 (1%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           ++ Y++ ++LG G FGV   +  + T    A K++    + D E V +EI     LRHP 
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 109
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQ 118
           ++   +       + ++ E+ +GGELF+++ +   + SEDE   + +Q+  G+ + H   
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 169
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
             H DLK EN +     +  LK+ DFG +         K T GT  + APEV
Sbjct: 170 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 221

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/191 (34%), Positives = 91/191 (47%), Gaps = 13/191 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----------ERGRKIDENVAREIIN 51
           E YE  + LG G   V R   HK T +  AVK I          E  +++ E   +E+  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 52  HRSLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
            R +  HPNII+ K+   T T   +V +    GELFD +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +S  GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEI 194
Query: 171 LSRREYDGKQG 181
           +     D   G
Sbjct: 195 IECSMNDNHPG 205

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 2/172 (1%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           ++ Y++ ++LG G FGV   +  + T    A K++    + D E V +EI     LRHP 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQ 118
           ++   +       + ++ E+ +GGELF+++ +   + SEDE   + +Q+  G+ + H   
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
             H DLK EN +     +  LK+ DFG +         K T GT  + APEV
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 99/188 (52%), Gaps = 13/188 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RH 57
           E Y++VK +G G FG  +L+RHK ++++ A+K + +   I  + +      R +      
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P +++         +L +VMEY  GG+L + + N     E   +++  +++  ++  HSM
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSM 193
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            + HRD+K +N LLD      LK+ DFG      ++ ++H    + VGTP YI+PEVL  
Sbjct: 194 GLIHRDVKPDNMLLDKHG--HLKLADFGTCMKMDETGMVHC--DTAVGTPDYISPEVLKS 249
Query: 174 REYDGKQG 181
           +  DG  G
Sbjct: 250 QGGDGYYG 257

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 90/191 (47%), Gaps = 13/191 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----------ERGRKIDENVAREIIN 51
           E YE  + LG G   V R   HK T +  AVK I          E  +++ E   +E+  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 52  HRSLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
            R +  HPNII+ K+   T T   +V +    GELFD +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 171 LSRREYDGKQG 181
           +     D   G
Sbjct: 195 IECSMNDNHPG 205

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 90/191 (47%), Gaps = 13/191 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----------ERGRKIDENVAREIIN 51
           E YE  + LG G   V R   HK T +  AVK I          E  +++ E   +E+  
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 52  HRSLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
            R +  HPNII+ K+   T T   +V +    GELFD +      SE E R   + L+  
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 124 ICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 181
Query: 171 LSRREYDGKQG 181
           +     D   G
Sbjct: 182 IECSMNDNHPG 192

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 84/172 (48%), Gaps = 2/172 (1%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE-NVAREIINHRSLRHPNIIR 62
           Y+++++LG+G FGV      K T  +   K+I     +D+  V  EI     L HP +I 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICH 121
             +       + +++E+ +GGELFDRI     + SE E   + +Q   G+ + H   I H
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 172
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            D+K EN + +   A  +KI DFG +         K T  T  + APE++ R
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 224

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 87/178 (48%), Gaps = 5/178 (2%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNI 60
           Y+L ++LG G F V R        +  A K I   +   +  + + RE    R L+HPNI
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +R  + +    H  ++ +   GGELF+ I     +SE +  +  QQ++  V +CH M + 
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 143
Query: 121 HRDLKLENTLLDGS-AAPRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSRREY 176
           HRDLK EN LL        +K+ DFG +       +      GTP Y++PEVL +  Y
Sbjct: 144 HRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 201

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 92/181 (50%), Gaps = 7/181 (3%)
Query: 2   EKYELVKDLGAGNFGVAR----LLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH 57
           E+Y+L ++LG G F V R    +L  +E   ++ +   +   +  + + RE    R L+H
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMI-INTKKLSARDHQKLEREARICRLLKH 69
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI+R  + +    H  ++ +   GGELF+ I     +SE +  +  QQ++  V +CH M
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 118 QICHRDLKLENTLLDGS-AAPRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSRRE 175
            + HR+LK EN LL        +K+ DFG +       +      GTP Y++PEVL +  
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 176 Y 176
           Y
Sbjct: 190 Y 190

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/173 (35%), Positives = 89/173 (51%), Gaps = 7/173 (4%)
Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNIIRFKE 65
           + LG+G FG   L+  + +     +K I  +R +   E +  EI   +SL HPNII+  E
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNA---GR-FSEDEGRYFFQQLISGVNYCHSMQICH 121
           V     ++ IVME   GGEL +RI +A   G+  SE       +Q+++ + Y HS  + H
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 122 RDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
           +DLK EN L  D S    +KI DFG ++         +  GT  Y+APEV  R
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR 200

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 94/185 (50%), Gaps = 14/185 (7%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-----GRKIDENVAREIINHRSL 55
           ++ ++L++ +G G++    L+R K+T  + A+K +++        ID     + +  ++ 
Sbjct: 4   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP ++       T + L  V+EY  GG+L   +    +  E+  R++  ++   +NY H
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV----GTPAYIAPEVL 171
              I +RDLKL+N LLD      +K+ D+G  K  +   RP  T     GTP YIAPE+L
Sbjct: 124 ERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGL---RPGDTTSXFCGTPNYIAPEIL 178
Query: 172 SRREY 176
              +Y
Sbjct: 179 RGEDY 183

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 94/185 (50%), Gaps = 14/185 (7%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-----GRKIDENVAREIINHRSL 55
           ++ ++L++ +G G++    L+R K+T  + A+K +++        ID     + +  ++ 
Sbjct: 19  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 78
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP ++       T + L  V+EY  GG+L   +    +  E+  R++  ++   +NY H
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 138
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV----GTPAYIAPEVL 171
              I +RDLKL+N LLD      +K+ D+G  K  +   RP  T     GTP YIAPE+L
Sbjct: 139 ERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGL---RPGDTTSXFCGTPNYIAPEIL 193
Query: 172 SRREY 176
              +Y
Sbjct: 194 RGEDY 198

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 94/185 (50%), Gaps = 14/185 (7%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-----GRKIDENVAREIINHRSL 55
           ++ ++L++ +G G++    L+R K+T  + A+K +++        ID     + +  ++ 
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP ++       T + L  V+EY  GG+L   +    +  E+  R++  ++   +NY H
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV----GTPAYIAPEVL 171
              I +RDLKL+N LLD      +K+ D+G  K  +   RP  T     GTP YIAPE+L
Sbjct: 128 ERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGL---RPGDTTSXFCGTPNYIAPEIL 182
Query: 172 SRREY 176
              +Y
Sbjct: 183 RGEDY 187

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 95/184 (51%), Gaps = 13/184 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA++ +  + +   E +  EI+  R  ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ 118
           + + +  L    L +VMEY AGG L D +        DEG+     ++ +  + + HS Q
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRRE 175
           + HRD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV++R+ 
Sbjct: 137 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 176 YDGK 179
           Y  K
Sbjct: 193 YGPK 196

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/186 (33%), Positives = 97/186 (52%), Gaps = 14/186 (7%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNIIR 62
           +E++ +LG G FG     ++KET  L A K I+   + + E+   EI    S  HPNI++
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQICH 121
             +      +L I++E+ AGG +   +    R  +E + +   +Q +  +NY H  +I H
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 122 RDLKLENTL--LDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVL-----SR 173
           RDLK  N L  LDG     +K+ DFG S K++    R  S +GTP ++APEV+       
Sbjct: 159 RDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 174 REYDGK 179
           R YD K
Sbjct: 215 RPYDYK 220

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 93/182 (51%), Gaps = 8/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER-----GRKIDENVAREIINHRSL 55
           ++ ++L++ +G G++    L+R K+T  + A++ +++        ID     + +  ++ 
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP ++       T + L  V+EY  GG+L   +    +  E+  R++  ++   +NY H
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLSRR 174
              I +RDLKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L   
Sbjct: 171 ERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 175 EY 176
           +Y
Sbjct: 229 DY 230

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/186 (33%), Positives = 97/186 (52%), Gaps = 14/186 (7%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNIIR 62
           +E++ +LG G FG     ++KET  L A K I+   + + E+   EI    S  HPNI++
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQICH 121
             +      +L I++E+ AGG +   +    R  +E + +   +Q +  +NY H  +I H
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 122 RDLKLENTL--LDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVL-----SR 173
           RDLK  N L  LDG     +K+ DFG S K++    R  S +GTP ++APEV+       
Sbjct: 159 RDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 174 REYDGK 179
           R YD K
Sbjct: 215 RPYDYK 220

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 86/180 (47%), Gaps = 5/180 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           + Y+L ++LG G F V R    K   +  A K I   +   +  + + RE    R L+HP
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 90
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +       +V +   GGELF+ I     +SE +  +   Q++  VN+ H   
Sbjct: 91  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHD 150
Query: 119 ICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSRREY 176
           I HRDLK EN LL        +K+ DFG +       +      GTP Y++PEVL +  Y
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPY 210

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/176 (35%), Positives = 92/176 (52%), Gaps = 12/176 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 82
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 142
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD
Sbjct: 143 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 197

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/176 (35%), Positives = 92/176 (52%), Gaps = 12/176 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 76  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 132
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 133 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 192
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD
Sbjct: 193 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 247

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/176 (35%), Positives = 92/176 (52%), Gaps = 12/176 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 30  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 86
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 87  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 146
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD
Sbjct: 147 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 201

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/176 (35%), Positives = 92/176 (52%), Gaps = 12/176 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 31  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 87
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 88  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 147
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD
Sbjct: 148 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 202

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/176 (35%), Positives = 92/176 (52%), Gaps = 12/176 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 126
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 186
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD
Sbjct: 187 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 241

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/176 (35%), Positives = 92/176 (52%), Gaps = 12/176 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 82
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 142
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD
Sbjct: 143 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 197

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/176 (35%), Positives = 92/176 (52%), Gaps = 12/176 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 25  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 81
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 82  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 141
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD
Sbjct: 142 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 196

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/176 (35%), Positives = 92/176 (52%), Gaps = 12/176 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 32  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 88
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 89  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 148
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD
Sbjct: 149 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 203

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/176 (35%), Positives = 92/176 (52%), Gaps = 12/176 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 40  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 96
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 97  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 156
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD
Sbjct: 157 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 211

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/176 (35%), Positives = 92/176 (52%), Gaps = 12/176 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 80
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 81  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 140
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD
Sbjct: 141 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 195

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 5/180 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           ++Y+L +D+G G F V R      T    A K I   +   +  + + RE    R L+H 
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHS 63
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +       +V +   GGELF+ I     +SE +  +  QQ++  V +CH M 
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 123
Query: 119 ICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVLSRREY 176
           + HRDLK EN LL        +K+ DFG +       +      GTP Y++PEVL +  Y
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAY 183

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 97/184 (52%), Gaps = 13/184 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA++ +  + +   E +  EI+  R  ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ 118
           + + +  L    L +VMEY AGG L D +        DEG+     ++ +  + + HS Q
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           + HRD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV++R+ 
Sbjct: 137 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKA 192
Query: 176 YDGK 179
           Y  K
Sbjct: 193 YGPK 196

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R  S VGT  Y++PE+L+ +
Sbjct: 149 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 97/184 (52%), Gaps = 13/184 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA++ +  + +   E +  EI+  R  ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ 118
           + + +  L    L +VMEY AGG L D +        DEG+     ++ +  + + HS Q
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           + HRD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV++R+ 
Sbjct: 137 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA 192
Query: 176 YDGK 179
           Y  K
Sbjct: 193 YGPK 196

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 97/184 (52%), Gaps = 13/184 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA++ +  + +   E +  EI+  R  ++PNI
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ 118
           + + +  L    L +VMEY AGG L D +        DEG+     ++ +  + + HS Q
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           + HRD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV++R+ 
Sbjct: 138 VIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA 193
Query: 176 YDGK 179
           Y  K
Sbjct: 194 YGPK 197

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R  S VGT  Y++PE+L+ +
Sbjct: 153 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/179 (32%), Positives = 90/179 (50%), Gaps = 7/179 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR 56
           M++Y   + LG G F     +   +TKE+ A K + +   +     E ++ EI  H+SL 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           +P+++ F         + +V+E      L +        +E E RYF +Q I GV Y H+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
            ++ HRDLKL N  L+      +KI DFG  +K      R K+  GTP YIAPEVL ++
Sbjct: 161 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKK 217

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/176 (35%), Positives = 91/176 (51%), Gaps = 12/176 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 80
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 81  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 140
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +K EN LL  S  P   LK+ DFG++K +  H+       TP Y+APEVL   +YD
Sbjct: 141 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYD 195

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/179 (32%), Positives = 89/179 (49%), Gaps = 7/179 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR 56
           M++Y   + LG G F     +   +TKE+ A K + +   +     E ++ EI  H+SL 
Sbjct: 25  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 84
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           +P+++ F         + +V+E      L +        +E E RYF +Q I GV Y H+
Sbjct: 85  NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 144
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
            ++ HRDLKL N  L+      +KI DFG  +K      R K   GTP YIAPEVL ++
Sbjct: 145 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKK 201

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/179 (32%), Positives = 89/179 (49%), Gaps = 7/179 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR 56
           M++Y   + LG G F     +   +TKE+ A K + +   +     E ++ EI  H+SL 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           +P+++ F         + +V+E      L +        +E E RYF +Q I GV Y H+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
            ++ HRDLKL N  L+      +KI DFG  +K      R K   GTP YIAPEVL ++
Sbjct: 161 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKK 217

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 94/183 (51%), Gaps = 7/183 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           ++ +E+ + LG G FG   L R K++  +VA+K + + +     ++  + REI     L 
Sbjct: 22  IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R          + +++EYA  GEL+  +  +  F E       ++L   + YCH 
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL       LKI DFG+S  +    R K+  GT  Y+ PE++  R +
Sbjct: 142 KKVIHRDIKPENLLLGLKGE--LKIADFGWSVHAPSLRR-KTMCGTLDYLPPEMIEGRMH 198
Query: 177 DGK 179
           + K
Sbjct: 199 NEK 201

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/179 (32%), Positives = 89/179 (49%), Gaps = 7/179 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR 56
           M++Y   + LG G F     +   +TKE+ A K + +   +     E ++ EI  H+SL 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           +P+++ F         + +V+E      L +        +E E RYF +Q I GV Y H+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
            ++ HRDLKL N  L+      +KI DFG  +K      R K   GTP YIAPEVL ++
Sbjct: 161 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKK 217

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/186 (33%), Positives = 96/186 (51%), Gaps = 14/186 (7%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNIIR 62
           +E++ +LG G FG     ++KET  L A K I+   + + E+   EI    S  HPNI++
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQICH 121
             +      +L I++E+ AGG +   +    R  +E + +   +Q +  +NY H  +I H
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 122 RDLKLENTL--LDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVL-----SR 173
           RDLK  N L  LDG     +K+ DFG S K++    R    +GTP ++APEV+       
Sbjct: 159 RDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 174 REYDGK 179
           R YD K
Sbjct: 215 RPYDYK 220

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 21/195 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           E YE++  +G G++G  + +R K   +++  K ++ G   +   + +  E+   R L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 59  NIIRFKEVVL--TPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVN 112
           NI+R+ + ++  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 113 YCH-----SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH---SRPKSTVGTPA 164
            CH        + HRDLK  N  LDG     +K+ DFG ++  +L+   S  K+ VGTP 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLAR--ILNHDTSFAKTFVGTPY 181
Query: 165 YIAPEVLSRREYDGK 179
           Y++PE ++R  Y+ K
Sbjct: 182 YMSPEQMNRMSYNEK 196

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 95/184 (51%), Gaps = 13/184 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA++ +  + +   E +  EI+  R  ++PNI
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ 118
           + + +  L    L +VMEY AGG L D +        DEG+     ++ +  + + HS Q
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 119 ICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRRE 175
           + HR++K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV++R+ 
Sbjct: 138 VIHRNIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 193
Query: 176 YDGK 179
           Y  K
Sbjct: 194 YGPK 197

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 93/179 (51%), Gaps = 8/179 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLR 56
           +E +++   LG G+F          T   VA+K I++       + + V  E+  H  L+
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCH 115
           HP+I+          ++ +V+E    GE+   + N  + FSE+E R+F  Q+I+G+ Y H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSR 173
           S  I HRDL L N LL  +    +KI DFG  ++  + H +  +  GTP YI+PE+ +R
Sbjct: 130 SHGILHRDLTLSNLLLTRNM--NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 21/195 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           E YE++  +G G++G  + +R K   +++  K ++ G   +   + +  E+   R L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 59  NIIRFKEVVL--TPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVN 112
           NI+R+ + ++  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 113 YCH-----SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH---SRPKSTVGTPA 164
            CH        + HRDLK  N  LDG     +K+ DFG ++  +L+   S  K+ VGTP 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLAR--ILNHDTSFAKAFVGTPY 181
Query: 165 YIAPEVLSRREYDGK 179
           Y++PE ++R  Y+ K
Sbjct: 182 YMSPEQMNRMSYNEK 196

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 97/178 (54%), Gaps = 12/178 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLR 56
           M+KYE ++ +G G +G     +++ET E+VA+K + R    DE V     REI   + L+
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           H NI+R  +V+ +   L +V E+      + FD  CN G    +  + F  QL+ G+ +C
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CN-GDLDPEIVKSFLFQLLKGLGFC 117
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           HS  + HRDLK +N L++ +    LK+ DFG +++  +  R  S  V T  Y  P+VL
Sbjct: 118 HSRNVLHRDLKPQNLLINRNG--ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 84/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R  + VGT  Y++PE+L+ +
Sbjct: 150 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/175 (33%), Positives = 93/175 (53%), Gaps = 13/175 (7%)
Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH-----PNIIR 62
           K+LG G F V R    K T +  A K++++ R+  ++   EI++  ++       P +I 
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRIC---NAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
             EV    + + +++EYAAGGE+F  +C    A   SE++     +Q++ GV Y H   I
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFS-LCLPELAEMVSENDVIRLIKQILEGVYYLHQNNI 152
Query: 120 CHRDLKLENTLLDGSAAP--RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            H DLK +N LL  S  P   +KI DFG S+        +  +GTP Y+APE+L+
Sbjct: 153 VHLDLKPQNILL-SSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/174 (37%), Positives = 92/174 (52%), Gaps = 19/174 (10%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIER----GRKIDENVAREIINHRSLRHPNIIRFKE 65
           +GAG+FG     R +     VAVK +        +++E   RE+   + LRHPNI+ F  
Sbjct: 45  IGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNE-FLREVAIMKRLRHPNIVLFMG 101
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQ--QLISGVNYCHSMQ--IC 120
            V  P +L+IV EY + G L+  +  +G R   DE R       +  G+NY H+    I 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVL 171
           HR+LK  N L+D      +K+CDFG S+   S+ L S  KS  GTP ++APEVL
Sbjct: 162 HRNLKSPNLLVDKKYT--VKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVL 211

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 91/178 (51%), Gaps = 5/178 (2%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E +++++ LG G++G      HKET ++VA+K +     + E + +EI   +    P+++
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHVV 87
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++       T L IVMEY   G + D I       +EDE     Q  + G+ Y H M+  
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HRD+K  N LL+       K+ DFG + + +   ++    +GTP ++APEV+    Y+
Sbjct: 148 HRDIKAGNILLNTEG--HAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYN 203

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 150 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 150 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 89/186 (47%), Gaps = 14/186 (7%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNII 61
           +E+ + LG G FG      H++T E VA+K    E   K  E    EI   + L HPN++
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 62  RFKEVV-----LTPTHLAIV-MEYAAGGEL---FDRICNAGRFSEDEGRYFFQQLISGVN 112
             +EV      L P  L ++ MEY  GG+L    ++  N     E   R     + S + 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL--KICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           Y H  +I HRDLK EN +L      RL  KI D GY+K           VGT  Y+APE+
Sbjct: 137 YLHENRIIHRDLKPENIVLQ-PGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 195
Query: 171 LSRREY 176
           L +++Y
Sbjct: 196 LEQKKY 201

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 149 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 89/186 (47%), Gaps = 14/186 (7%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNII 61
           +E+ + LG G FG      H++T E VA+K    E   K  E    EI   + L HPN++
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 62  RFKEVV-----LTPTHLAIV-MEYAAGGEL---FDRICNAGRFSEDEGRYFFQQLISGVN 112
             +EV      L P  L ++ MEY  GG+L    ++  N     E   R     + S + 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRL--KICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           Y H  +I HRDLK EN +L      RL  KI D GY+K           VGT  Y+APE+
Sbjct: 136 YLHENRIIHRDLKPENIVLQ-PGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194
Query: 171 LSRREY 176
           L +++Y
Sbjct: 195 LEQKKY 200

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 150 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 153 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 155 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 127 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 134 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 128 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 130 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 129 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/174 (37%), Positives = 90/174 (51%), Gaps = 19/174 (10%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIER----GRKIDENVAREIINHRSLRHPNIIRFKE 65
           +GAG+FG     R +     VAVK +        +++E   RE+   + LRHPNI+ F  
Sbjct: 45  IGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNE-FLREVAIMKRLRHPNIVLFMG 101
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQ--QLISGVNYCHSMQ--IC 120
            V  P +L+IV EY + G L+  +  +G R   DE R       +  G+NY H+    I 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVL 171
           HRDLK  N L+D      +K+CDFG S+   S  L S  K   GTP ++APEVL
Sbjct: 162 HRDLKSPNLLVDKKYT--VKVCDFGLSRLKASXFLXS--KXAAGTPEWMAPEVL 211

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 157 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 95/171 (55%), Gaps = 9/171 (5%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  L R K +   VAVK ++ R ++  E +  E++  R  +H N++   +  L
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L ++ME+  GG L D I +  R +E++     + ++  + Y H+  + HRD+K ++
Sbjct: 113 VGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDS 171
Query: 129 TL--LDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            L  LDG    R+K+ DFG+ ++ S    + K  VGTP ++APEV+SR  Y
Sbjct: 172 ILLTLDG----RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLY 218

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/176 (34%), Positives = 91/176 (51%), Gaps = 12/176 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 126
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IV E   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 127 LYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRD 186
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +K EN LL  S  P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD
Sbjct: 187 VKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 241

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 92/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+ +    +  D     G        Y FQ L+ G+ +CH
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 121
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 122 SHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 98/189 (51%), Gaps = 20/189 (10%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID------ENVAREIINHRSLRH 57
           YEL + +G G F V R   ++ET +  AVK ++  +         E++ RE      L+H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI---CNAG-RFSEDEGRYFFQQLISGVNY 113
           P+I+   E   +   L +V E+  G +L   I    +AG  +SE    ++ +Q++  + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 114 CHSMQICHRDLKLENTLLDG--SAAPRLKICDFGYS----KSSVLHSRPKSTVGTPAYIA 167
           CH   I HRD+K EN LL    ++AP +K+ DFG +    +S ++       VGTP ++A
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAP-VKLGDFGVAIQLGESGLVAG---GRVGTPHFMA 201
Query: 168 PEVLSRREY 176
           PEV+ R  Y
Sbjct: 202 PEVVKREPY 210

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 92/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+ +    +  D     G        Y FQ L+ G+ +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 124 SHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/178 (33%), Positives = 97/178 (54%), Gaps = 12/178 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLR 56
           M+KYE ++ +G G +G     +++ET E+VA+K + R    DE V     REI   + L+
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           H NI+R  +V+ +   L +V E+      + FD  CN G    +  + F  QL+ G+ +C
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CN-GDLDPEIVKSFLFQLLKGLGFC 117
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           HS  + HRDLK +N L++ +    LK+ +FG +++  +  R  S  V T  Y  P+VL
Sbjct: 118 HSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 98/195 (50%), Gaps = 21/195 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           E YE++  +G G++G  + +R K   +++  K ++ G   +   + +  E+   R L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 59  NIIRFKEVVL--TPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVN 112
           NI+R+ + ++  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 113 YCH-----SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH---SRPKSTVGTPA 164
            CH        + HRDLK  N  LDG     +K+ DFG ++  +L+      K  VGTP 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLAR--ILNHDEDFAKEFVGTPY 181
Query: 165 YIAPEVLSRREYDGK 179
           Y++PE ++R  Y+ K
Sbjct: 182 YMSPEQMNRMSYNEK 196

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  G L   I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R  S VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 93/177 (52%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+++CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLSFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 95/183 (51%), Gaps = 15/183 (8%)
Query: 1   MEKYELVKDLGAGNFGVARLLRH---KETKELVAVKYIERGRKIDE-------NVAREII 50
           +E +EL+K LG G +G   L+R     +T +L A+K +++   + +          R+++
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 51  NHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
            H   + P ++       T T L ++++Y  GGELF  +    RF+E E + +  +++  
Sbjct: 113 EHIR-QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH--SRPKSTVGTPAYIAP 168
           + + H + I +RD+KLEN LLD +    + + DFG SK  V     R     GT  Y+AP
Sbjct: 172 LEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 169 EVL 171
           +++
Sbjct: 230 DIV 232

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 92/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+ +    +  D     G        Y FQ L+ G+ +CH
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 122
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 123 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVLSRR 174
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L   
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGX 178
Query: 175 EY 176
           +Y
Sbjct: 179 KY 180

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 127
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVLSRR 174
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L   
Sbjct: 128 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGX 185
Query: 175 EY 176
           +Y
Sbjct: 186 KY 187

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 92/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+ +    +  D     G        Y FQ L+ G+ +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 121
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 122 SHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 122
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 123 SHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 51/222 (22%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG--RKID----ENVAREIINHRSL 55
           +KY L   +G G++GV R+    +T+ + A+K + +   R+I+    E +  E+   + L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDR--------------------ICNAGRF 95
            HPNI R  EV     ++ +VME   GG L D+                    IC     
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 96  SED----------EGRYFFQ----------QLISGVNYCHSMQICHRDLKLENTLLDGSA 135
           +E+          E   F Q          Q+ S ++Y H+  ICHRD+K EN L   + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 136 APRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLS 172
           +  +K+ DFG SK     ++  +    +  GTP ++APEVL+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN 247

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 91/176 (51%), Gaps = 8/176 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           MEKYE +  +G G++G+    R+K+T  +VA+K     +  + + +   REI   + LRH
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N++   EV        +V E+     L D  +   G   +   +Y FQ +I+G+ +CHS
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ-IINGIGFCHS 142
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
             I HRD+K EN L+  S    +K+CDFG++++           V T  Y APE+L
Sbjct: 143 HNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL 196

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 92/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 121
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 122 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 176

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 92/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 92/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 92/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 92/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 127
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 128 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 182

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 92/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 124
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 125 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 179

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 90/169 (53%), Gaps = 5/169 (2%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   K T + VAVK ++ R ++  E +  E++  R   H N++      L
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++Y H+  + HRD+K ++
Sbjct: 113 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 171
Query: 129 TLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            LL      R+K+ DFG+ ++ S    + K  VGTP ++APEV+SR  Y
Sbjct: 172 ILLTSDG--RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPY 218

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 84/170 (49%), Gaps = 7/170 (4%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKE 65
           LG G F     +   +TKE+ A K + +   +     E ++ EI  HRSL H +++ F  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                  + +V+E      L +        +E E RY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 126 LENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           L N  L+      +KI DFG  +K      R K+  GTP YIAPEVLS++
Sbjct: 145 LGNLFLNEDL--EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKK 192

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 122
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 123 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 84/170 (49%), Gaps = 7/170 (4%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKE 65
           LG G F     +   +TKE+ A K + +   +     E ++ EI  HRSL H +++ F  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                  + +V+E      L +        +E E RY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 126 LENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           L N  L+      +KI DFG  +K      R K+  GTP YIAPEVLS++
Sbjct: 145 LGNLFLNEDL--EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKK 192

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 124
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 125 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 179

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 121
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 122 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 84/170 (49%), Gaps = 7/170 (4%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKE 65
           LG G F     +   +TKE+ A K + +   +     E ++ EI  HRSL H +++ F  
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                  + +V+E      L +        +E E RY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 126 LENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           L N  L+      +KI DFG  +K      R K+  GTP YIAPEVLS++
Sbjct: 149 LGNLFLNEDL--EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKK 196

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 88/180 (48%), Gaps = 12/180 (6%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE---------RGRKIDENVAREI-IN 51
           +KY+    +G G   V R   H+ T    AVK +E         +  ++ E   RE  I 
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 52  HRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
            +   HP+II   +   + + + +V +    GELFD +      SE E R   + L+  V
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           ++ H+  I HRDLK EN LLD +   ++++ DFG+S       + +   GTP Y+APE+L
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 122
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 123 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 174

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 121
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 122 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 174

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+         D     G        Y FQ L+ G+ +CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+         D     G        Y FQ L+ G+ +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 83/170 (48%), Gaps = 7/170 (4%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKE 65
           LG G F     +   +TKE+ A K + +   +     E ++ EI  HRSL H +++ F  
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                  + +V+E      L +        +E E RY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 126 LENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           L N  L+      +KI DFG  +K      R K   GTP YIAPEVLS++
Sbjct: 143 LGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 190

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 92/181 (50%), Gaps = 6/181 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRH 57
           + +E+++ +G G+FG   +++  +TK++ A+KY+ + + ++ N  R +       + L H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P ++           + +V++   GG+L   +     F E+  + F  +L+  ++Y  + 
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +I HRD+K +N LLD      + I DF  +      ++  +  GT  Y+APE+ S R+  
Sbjct: 135 RIIHRDMKPDNILLDEHG--HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGA 192
Query: 178 G 178
           G
Sbjct: 193 G 193

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 83/170 (48%), Gaps = 7/170 (4%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKE 65
           LG G F     +   +TKE+ A K + +   +     E ++ EI  HRSL H +++ F  
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                  + +V+E      L +        +E E RY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 126 LENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           L N  L+      +KI DFG  +K      R K   GTP YIAPEVLS++
Sbjct: 167 LGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 214

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 83/170 (48%), Gaps = 7/170 (4%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKE 65
           LG G F     +   +TKE+ A K + +   +     E ++ EI  HRSL H +++ F  
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLK 125
                  + +V+E      L +        +E E RY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 126 LENTLLDGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           L N  L+      +KI DFG  +K      R K   GTP YIAPEVLS++
Sbjct: 169 LGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 216

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+  I    +   +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+  I    +   +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 91/176 (51%), Gaps = 9/176 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHP 58
           E ++ V+ +G G +GV    R+K T E+VA+K I    +   +     REI   + L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NI++  +V+ T   L +V E+      +  D     G        Y FQ L+ G+ +CHS
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHS 120
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
            ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 121 HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 84/174 (48%), Gaps = 8/174 (4%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-ERGRKIDENVAR---EIINHRSLRH 57
           E+Y++V  LG G      L         VA+K I    R+ +E + R   E+ N   L H
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
            NI+   +V        +VMEY  G  L + I + G  S D    F  Q++ G+ + H M
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPE 169
           +I HRD+K +N L+D +    LKI DFG +K  S    ++    +GT  Y +PE
Sbjct: 131 RIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/190 (32%), Positives = 92/190 (48%), Gaps = 25/190 (13%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR----EIINHRSLRHPNIIRFKE 65
           LG G FG A  + H+ET E++ +K + R    DE   R    E+   R L HPN+++F  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V+     L  + EY  GG L   I +   ++   +   F + + SG+ Y HSM I HRDL
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSV--------LHSRPK-------STVGTPAYIAPE 169
              N L+  +    + + DFG ++  V        L S  K       + VG P ++APE
Sbjct: 135 NSHNCLVRENK--NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 170 VLSRREYDGK 179
           +++ R YD K
Sbjct: 193 MINGRSYDEK 202

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 87/191 (45%), Gaps = 24/191 (12%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKEL-VAVKYIERGRKIDENVAREIIN---------- 51
           +Y L   LG G FG      H+ T  L VA+K I R R +  +   + +           
Sbjct: 32  EYRLGPLLGKGGFGTV-FAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 52  -HRSLRHPNIIRFKEVVLTPTHLAIVMEYA-AGGELFDRICNAGRFSEDEGRYFFQQLIS 109
                 HP +IR  +   T     +V+E      +LFD I   G   E   R FF Q+++
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 110 GVNYCHSMQICHRDLKLENTLLD---GSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAY 165
            + +CHS  + HRD+K EN L+D   G A    K+ DFG    ++LH  P +   GT  Y
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCA----KLIDFG--SGALLHDEPYTDFDGTRVY 204
Query: 166 IAPEVLSRREY 176
             PE +SR +Y
Sbjct: 205 SPPEWISRHQY 215

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 93/171 (54%), Gaps = 9/171 (5%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      L
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++  H+  + HRD+K ++
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 146
Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 193

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 93/171 (54%), Gaps = 9/171 (5%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      L
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++  H+  + HRD+K ++
Sbjct: 92  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 150
Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y
Sbjct: 151 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 197

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 87/178 (48%), Gaps = 12/178 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           MEKYE +  +G G++GV    R+++T ++VA+K     E    I +   REI   + L+H
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PN++   EV      L +V EY     L +         E   +    Q +  VN+CH  
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK----STVGTPAYIAPEVL 171
              HRD+K EN L+   +   +K+CDFG+++   L + P       V T  Y +PE+L
Sbjct: 122 NCIHRDVKPENILITKHSV--IKLCDFGFAR---LLTGPSDYYDDEVATRWYRSPELL 174

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 93/171 (54%), Gaps = 9/171 (5%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      L
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++  H+  + HRD+K ++
Sbjct: 99  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 157
Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y
Sbjct: 158 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 204

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 93/171 (54%), Gaps = 9/171 (5%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      L
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++  H+  + HRD+K ++
Sbjct: 97  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 155
Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y
Sbjct: 156 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 202

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHK--ETKELVAVKYIERGRKIDENVAREIINHRSLRHP 58
           MEKY  ++ +G G +GV    ++   ET  L  ++  +    I     REI   + L+H 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NI++  +V+ T   L +V E+      +L D +C  G       + F  QL++G+ YCH 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGG-LESVTAKSFLLQLLNGIAYCHD 118
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
            ++ HRDLK +N L++      LKI DFG +++  +  R  +  V T  Y AP+VL
Sbjct: 119 RRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL 172

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHK--ETKELVAVKYIERGRKIDENVAREIINHRSLRHP 58
           MEKY  ++ +G G +GV    ++   ET  L  ++  +    I     REI   + L+H 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NI++  +V+ T   L +V E+      +L D +C  G       + F  QL++G+ YCH 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGG-LESVTAKSFLLQLLNGIAYCHD 118
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
            ++ HRDLK +N L++      LKI DFG +++  +  R  +  V T  Y AP+VL
Sbjct: 119 RRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL 172

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 93/171 (54%), Gaps = 9/171 (5%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      L
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++  H+  + HRD+K ++
Sbjct: 142 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 200
Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y
Sbjct: 201 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 247

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHK--ETKELVAVKYIERGRKIDENVAREIINHRSLRHP 58
           MEKY  ++ +G G +GV    ++   ET  L  ++  +    I     REI   + L+H 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NI++  +V+ T   L +V E+      +L D +C  G       + F  QL++G+ YCH 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGG-LESVTAKSFLLQLLNGIAYCHD 118
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
            ++ HRDLK +N L++      LKI DFG +++  +  R  +  + T  Y AP+VL
Sbjct: 119 RRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 93/171 (54%), Gaps = 9/171 (5%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           +G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      L
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
               L +VME+  GG L D I    R +E++       ++  ++  H+  + HRD+K ++
Sbjct: 219 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 277
Query: 129 TLL--DGSAAPRLKICDFGY-SKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y
Sbjct: 278 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 324

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 90/181 (49%), Gaps = 6/181 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPN 59
           E +  ++ +G G+FG         T+++VA+K I+        E++ +EI        P 
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + ++    L  T L I+MEY  GG   D +   G   E +     ++++ G++Y HS + 
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 145
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG +         ++T VGTP ++APEV+ +  YD 
Sbjct: 146 IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 203
Query: 179 K 179
           K
Sbjct: 204 K 204

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 89/192 (46%), Gaps = 18/192 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE---------NVAREIINH 52
           +KY  +  LG+G FG       KE  + V VK+I++ + +++          V  EI   
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVME-YAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
             + H NII+  ++        +VME + +G +LF  I    R  E    Y F+QL+S V
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK---STVGTPAYIAP 168
            Y     I HRD+K EN ++       +K+ DFG   S+    R K   +  GT  Y AP
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFG---SAAYLERGKLFYTFCGTIEYCAP 198
Query: 169 EVLSRREYDGKQ 180
           EVL    Y G +
Sbjct: 199 EVLMGNPYRGPE 210

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 85/173 (49%), Gaps = 6/173 (3%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNIIRFKEVV 67
           +G G+FG         TKE+VA+K I+        E++ +EI        P I R+    
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 68  LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
           L  T L I+MEY  GG   D +   G   E       ++++ G++Y HS +  HRD+K  
Sbjct: 87  LKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 145
Query: 128 NTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N LL  S    +K+ DFG + + +    +    VGTP ++APEV+ +  YD K
Sbjct: 146 NVLL--SEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFK 196

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 90/181 (49%), Gaps = 6/181 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPN 59
           E +  ++ +G G+FG         T+++VA+K I+        E++ +EI        P 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + ++    L  T L I+MEY  GG   D +   G   E +     ++++ G++Y HS + 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG +         ++T VGTP ++APEV+ +  YD 
Sbjct: 126 IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 183
Query: 179 K 179
           K
Sbjct: 184 K 184

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 89/169 (52%), Gaps = 6/169 (3%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           LG G +G+    R    +  +A+K I ER  +  + +  EI  H+ L+H NI+++     
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 69  TPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGR--YFFQQLISGVNYCHSMQICHRDLK 125
               + I ME   GG L   +    G   ++E    ++ +Q++ G+ Y H  QI HRD+K
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 126 LENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSR 173
            +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++ +
Sbjct: 136 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 183

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 89/169 (52%), Gaps = 6/169 (3%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           LG G +G+    R    +  +A+K I ER  +  + +  EI  H+ L+H NI+++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 69  TPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGR--YFFQQLISGVNYCHSMQICHRDLK 125
               + I ME   GG L   +    G   ++E    ++ +Q++ G+ Y H  QI HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 126 LENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSR 173
            +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++ +
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 89/174 (51%), Gaps = 7/174 (4%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           E +E+V +LG G FG     ++KET  L A K IE   + + E+   EI    +  HP I
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 70
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQI 119
           ++          L I++E+  GG +   +    R  +E + +   +Q++  +N+ HS +I
Sbjct: 71  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 130
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSV--LHSRPKSTVGTPAYIAPEVL 171
            HRDLK  N L+      RL   DFG S  ++  L  R  S +GTP ++APEV+
Sbjct: 131 IHRDLKAGNVLMTLEGDIRL--ADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVV 181

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 89/174 (51%), Gaps = 7/174 (4%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           E +E+V +LG G FG     ++KET  L A K IE   + + E+   EI    +  HP I
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 78
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQI 119
           ++          L I++E+  GG +   +    R  +E + +   +Q++  +N+ HS +I
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 138
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSV--LHSRPKSTVGTPAYIAPEVL 171
            HRDLK  N L+      RL   DFG S  ++  L  R  S +GTP ++APEV+
Sbjct: 139 IHRDLKAGNVLMTLEGDIRL--ADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVV 189

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 88/180 (48%), Gaps = 12/180 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSL 55
           +++Y  +  LG G +G         T E VA+K I     E G  +     RE+   + L
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG--VPGTAIREVSLLKEL 90
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           +H NII  K V+     L ++ EYA   +L   +      S    + F  QLI+GVN+CH
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 116 SMQICHRDLKLENTLL---DGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
           S +  HRDLK +N LL   D S  P LKI DFG +++  +  R  +  + T  Y  PE+L
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 90/181 (49%), Gaps = 6/181 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPN 59
           E +  ++ +G G+FG         T+++VA+K I+        E++ +EI        P 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + ++    L  T L I+MEY  GG   D +   G   E +     ++++ G++Y HS + 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG + + +    +    VGTP ++APEV+ +  YD 
Sbjct: 141 IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDS 198
Query: 179 K 179
           K
Sbjct: 199 K 199

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 23/187 (12%)
Query: 2   EKYELVKDLGAGNFG---VARLLRHKETKELVAVKYIERG-----------RKIDENVAR 47
           E +EL++ LG G +G     R +    T ++ A+K +++             K + N+  
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 48  EIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQL 107
           E+      +HP I+       T   L +++EY +GGELF ++   G F ED   ++  ++
Sbjct: 77  EV------KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYI 166
              + + H   I +RDLK EN +L+      +K+ DFG  K S+       T  GT  Y+
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLCKESIHDGTVTHTFCGTIEYM 188
Query: 167 APEVLSR 173
           APE+L R
Sbjct: 189 APEILMR 195

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 90/181 (49%), Gaps = 6/181 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPN 59
           E +  ++ +G G+FG         T+++VA+K I+        E++ +EI        P 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + ++    L  T L I+MEY  GG   D +   G   E +     ++++ G++Y HS + 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG + + +    +    VGTP ++APEV+ +  YD 
Sbjct: 126 IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDS 183
Query: 179 K 179
           K
Sbjct: 184 K 184

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 11/177 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE---RGRKIDENVAREIINHRSLRH 57
           MEKY+ ++ +G G +GV    +  + + +VA+K I        I     REI   + L H
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI+   +V+ +   L +V E+      ++ D   N     + + + +  QL+ GV +CH
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
             +I HRDLK +N L++   A  LK+ DFG +++  +  R  +  V T  Y AP+VL
Sbjct: 137 QHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL 191

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 91/181 (50%), Gaps = 6/181 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPN 59
           E +  ++ +G G+FG         T+++VA+K I+        E++ +EI          
Sbjct: 23  ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + ++    L  + L I+MEY  GG   D +  AG F E +     ++++ G++Y HS + 
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKK 141
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG +         ++T VGTP ++APEV+ +  YD 
Sbjct: 142 IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 199
Query: 179 K 179
           K
Sbjct: 200 K 200

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 11/177 (6%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE---RGRKIDENVAREIINHRSLRH 57
           MEKY+ ++ +G G +GV    +  + + +VA+K I        I     REI   + L H
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI+   +V+ +   L +V E+      ++ D   N     + + + +  QL+ GV +CH
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVL 171
             +I HRDLK +N L++   A  LK+ DFG +++  +  R  +  V T  Y AP+VL
Sbjct: 137 QHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL 191

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 95/189 (50%), Gaps = 20/189 (10%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID------ENVAREIINHRSLRH 57
           YEL + +G G F V R   ++ET +  AVK ++  +         E++ RE      L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI---CNAG-RFSEDEGRYFFQQLISGVNY 113
           P+I+   E   +   L +V E+  G +L   I    +AG  +SE    ++ +Q++  + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 114 CHSMQICHRDLKLENTLLDG--SAAPRLKICDFGYS----KSSVLHSRPKSTVGTPAYIA 167
           CH   I HRD+K    LL    ++AP +K+  FG +    +S ++       VGTP ++A
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAG---GRVGTPHFMA 201
Query: 168 PEVLSRREY 176
           PEV+ R  Y
Sbjct: 202 PEVVKREPY 210

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 92/186 (49%), Gaps = 16/186 (8%)
Query: 2   EKYELVKD-LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH--RSLRHP 58
           + Y+L K  LG G  G      H+ T +  A+K +      D   AR+ ++H  ++   P
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGP 82
Query: 59  NIIRFKEVVLTPTH----LAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVN 112
           +I+   +V     H    L I+ME   GGELF RI   G   F+E E     + + + + 
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPR-LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           + HS  I HRD+K EN L         LK+ DFG++K +  ++  ++   TP Y+APEVL
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAPEVL 201
Query: 172 SRREYD 177
              +YD
Sbjct: 202 GPEKYD 207

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 95/189 (50%), Gaps = 20/189 (10%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID------ENVAREIINHRSLRH 57
           YEL + +G G F V R   ++ET +  AVK ++  +         E++ RE      L+H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI---CNAG-RFSEDEGRYFFQQLISGVNY 113
           P+I+   E   +   L +V E+  G +L   I    +AG  +SE    ++ +Q++  + Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 114 CHSMQICHRDLKLENTLLDG--SAAPRLKICDFGYS----KSSVLHSRPKSTVGTPAYIA 167
           CH   I HRD+K    LL    ++AP +K+  FG +    +S ++       VGTP ++A
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAG---GRVGTPHFMA 203
Query: 168 PEVLSRREY 176
           PEV+ R  Y
Sbjct: 204 PEVVKREPY 212

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 90/188 (47%), Gaps = 23/188 (12%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA------REIINHRSL 55
           E +E++K +G G FG   +++ K T+ + A+K + +   +           R+++ +   
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYC 114
           +    + +        HL +VM+Y  GG+L   +     +  ED  R++  +++  ++  
Sbjct: 150 QWITALHY--AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 207
Query: 115 HSMQICHRDLKLENTLLDGSAAPR-------LKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           H +   HRD+K +N LLD +   R       LK+ D G  +SSV        VGTP YI+
Sbjct: 208 HQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-------AVGTPDYIS 260
Query: 168 PEVLSRRE 175
           PE+L   E
Sbjct: 261 PEILQAME 268

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 92/186 (49%), Gaps = 16/186 (8%)
Query: 2   EKYELVKD-LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH--RSLRHP 58
           + Y+L K  LG G  G      H+ T +  A+K +      D   AR+ ++H  ++   P
Sbjct: 9   DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGP 63
Query: 59  NIIRFKEVVLTPTH----LAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVN 112
           +I+   +V     H    L I+ME   GGELF RI   G   F+E E     + + + + 
Sbjct: 64  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 123
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPR-LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           + HS  I HRD+K EN L         LK+ DFG++K +  ++  ++   TP Y+APEVL
Sbjct: 124 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAPEVL 182
Query: 172 SRREYD 177
              +YD
Sbjct: 183 GPEKYD 188

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 90/188 (47%), Gaps = 23/188 (12%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA------REIINHRSL 55
           E +E++K +G G FG   +++ K T+ + A+K + +   +           R+++ +   
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYC 114
           +    + +        HL +VM+Y  GG+L   +     +  ED  R++  +++  ++  
Sbjct: 134 QWITALHY--AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 191
Query: 115 HSMQICHRDLKLENTLLDGSAAPR-------LKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           H +   HRD+K +N LLD +   R       LK+ D G  +SSV        VGTP YI+
Sbjct: 192 HQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-------AVGTPDYIS 244
Query: 168 PEVLSRRE 175
           PE+L   E
Sbjct: 245 PEILQAME 252

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 12/180 (6%)
Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDE---NVAREIINHRSLRHPNIIR 62
           ++++G G+FG     R     E+VA+K +   G++ +E   ++ +E+   + LRHPN I+
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
           ++   L      +VMEY  G        +     E E        + G+ Y HS  + HR
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV---LSRREYDGK 179
           D+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV   +   +YDGK
Sbjct: 179 DVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 233

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/179 (34%), Positives = 91/179 (50%), Gaps = 24/179 (13%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS-------LRHPNIIR 62
           +G G FG  ++ R     + VAVK        DE++++ I N R        L+HPNII 
Sbjct: 15  IGIGGFG--KVYRAFWIGDEVAVKAARHDP--DEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS---MQI 119
            + V L   +L +VME+A GG L +R+ +  R   D    +  Q+  G+NY H    + I
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 120 CHRDLKLENTLL-----DGSAAPR-LKICDFGYSKSSVLHSRPK-STVGTPAYIAPEVL 171
            HRDLK  N L+     +G  + + LKI DFG ++    H   K S  G  A++APEV+
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSAAGAYAWMAPEVI 186

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 87/181 (48%), Gaps = 14/181 (7%)
Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFK 64
           E+ + +G G FGV  + + K   + VA+K IE   +    +  E+     + HPNI++  
Sbjct: 12  EVEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIV-ELRQLSRVNHPNIVKLY 68
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNA---GRFSEDEGRYFFQQLISGVNYCHSMQ--- 118
              L P  + +VMEYA GG L++ +  A     ++      +  Q   GV Y HSMQ   
Sbjct: 69  GACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           + HRDLK  N LL       LKICDFG +     H    +  G+ A++APEV     Y  
Sbjct: 127 LIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQTHM--TNNKGSAAWMAPEVFEGSNYSE 183
Query: 179 K 179
           K
Sbjct: 184 K 184

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 87/181 (48%), Gaps = 14/181 (7%)
Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFK 64
           E+ + +G G FGV  + + K   + VA+K IE   +    +  E+     + HPNI++  
Sbjct: 11  EVEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIV-ELRQLSRVNHPNIVKLY 67
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRICNA---GRFSEDEGRYFFQQLISGVNYCHSMQ--- 118
              L P  + +VMEYA GG L++ +  A     ++      +  Q   GV Y HSMQ   
Sbjct: 68  GACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           + HRDLK  N LL       LKICDFG +     H    +  G+ A++APEV     Y  
Sbjct: 126 LIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQTHM--TNNKGSAAWMAPEVFEGSNYSE 182
Query: 179 K 179
           K
Sbjct: 183 K 183

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 12/180 (6%)
Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDE---NVAREIINHRSLRHPNIIR 62
           ++++G G+FG     R     E+VA+K +   G++ +E   ++ +E+   + LRHPN I+
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
           ++   L      +VMEY  G        +     E E        + G+ Y HS  + HR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV---LSRREYDGK 179
           D+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV   +   +YDGK
Sbjct: 140 DVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 194

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 82/178 (46%), Gaps = 15/178 (8%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G+FG    +  K+T    AVK +    +++   A E++    L  P I+     V  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPRIVPLYGAVRE 156
Query: 70  PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENT 129
              + I ME   GG L   +   G   ED   Y+  Q + G+ Y HS +I H D+K +N 
Sbjct: 157 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 216
Query: 130 LL--DGSAAPRLKICDFGYSKSSVLHSRPKSTV------GTPAYIAPEVLSRREYDGK 179
           LL  DGS A    +CDFG++         KS +      GT  ++APEV+  R  D K
Sbjct: 217 LLSSDGSHA---ALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAK 271

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 23/197 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + YEL + +G+G   V +       KE VA+K I  E+ +   + + +EI       HPN
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICN--------AGRFSEDEGRYFFQQLISGV 111
           I+ +    +    L +VM+  +GG + D I +        +G   E       ++++ G+
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 112 NYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSK-----SSVLHSRPKST-VGTP 163
            Y H     HRD+K  N LL  DGS    ++I DFG S        +  ++ + T VGTP
Sbjct: 130 EYLHKNGQIHRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 164 AYIAPEVLSR-REYDGK 179
            ++APEV+ + R YD K
Sbjct: 186 CWMAPEVMEQVRGYDFK 202

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 80/176 (45%), Gaps = 11/176 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G+FG    ++ K+T    AVK +    +++     E++    L  P I+     V  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 135
Query: 70  PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENT 129
              + I ME   GG L   I   G   ED   Y+  Q + G+ Y H+ +I H D+K +N 
Sbjct: 136 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 195
Query: 130 LLDGSAAPRLKICDFGYSKSSVLHSRPKSTV------GTPAYIAPEVLSRREYDGK 179
           LL  S   R  +CDFG++         KS +      GT  ++APEV+  +  D K
Sbjct: 196 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 250

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-Q 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 144
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 145 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 199

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 23/197 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + YEL + +G+G   V +       KE VA+K I  E+ +   + + +EI       HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICN--------AGRFSEDEGRYFFQQLISGV 111
           I+ +    +    L +VM+  +GG + D I +        +G   E       ++++ G+
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 112 NYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSK-----SSVLHSRPKST-VGTP 163
            Y H     HRD+K  N LL  DGS    ++I DFG S        +  ++ + T VGTP
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 164 AYIAPEVLSR-REYDGK 179
            ++APEV+ + R YD K
Sbjct: 191 CWMAPEVMEQVRGYDFK 207

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 126 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 90/187 (48%), Gaps = 23/187 (12%)
Query: 2   EKYELVKDLGAGNFG---VARLLRHKETKELVAVKYIERG-----------RKIDENVAR 47
           E +EL++ LG G +G     R +    T ++ A+K +++             K + N+  
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 48  EIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQL 107
           E+      +HP I+       T   L +++EY +GGELF ++   G F ED   ++  ++
Sbjct: 77  EV------KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYI 166
              + + H   I +RDLK EN +L+      +K+ DFG  K S+   +      GT  Y+
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLCKESIHDGTVTHXFCGTIEYM 188
Query: 167 APEVLSR 173
           APE+L R
Sbjct: 189 APEILMR 195

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 153 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 207

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 126 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 126 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 126 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 126 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-Q 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 187
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 188 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 242

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 97/195 (49%), Gaps = 28/195 (14%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR-----EIINHRSLR 56
           ++YE+++ +G G +GV    R + T + VA+K I     +  N  R     +I+ H   +
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKH--FK 111
Query: 57  HPNIIRFKEVVLTPT-------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLIS 109
           H NII  K++ L PT        + +V++     +L   I ++   + +  RYF  QL+ 
Sbjct: 112 HDNIIAIKDI-LRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLR 169
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-------KSTVGT 162
           G+ Y HS Q+ HRDLK  N L++ +    LKI DFG ++   L + P          V T
Sbjct: 170 GLKYMHSAQVIHRDLKPSNLLVNENC--ELKIGDFGMARG--LCTSPAEHQYFMTEYVAT 225
Query: 163 PAYIAPEV-LSRREY 176
             Y APE+ LS  EY
Sbjct: 226 RWYRAPELMLSLHEY 240

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 24/187 (12%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRH 57
           M  + + + +G G FG     R  +T ++ A+K +++ R   K  E +A   +N R +  
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNERIMLS 244
Query: 58  -------PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
                  P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLK----ICDFGYSKSSVLHSRPKSTVGTPAYI 166
           + + H+  + +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYM 357
Query: 167 APEVLSR 173
           APEVL +
Sbjct: 358 APEVLQK 364

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 24/187 (12%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRH 57
           M  + + + +G G FG     R  +T ++ A+K +++ R   K  E +A   +N R +  
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNERIMLS 244
Query: 58  -------PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
                  P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLK----ICDFGYSKSSVLHSRPKSTVGTPAYI 166
           + + H+  + +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYM 357
Query: 167 APEVLSR 173
           APEVL +
Sbjct: 358 APEVLQK 364

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 24/187 (12%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRH 57
           M  + + + +G G FG     R  +T ++ A+K +++ R   K  E +A   +N R +  
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNERIMLS 244
Query: 58  -------PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
                  P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLK----ICDFGYSKSSVLHSRPKSTVGTPAYI 166
           + + H+  + +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYM 357
Query: 167 APEVLSR 173
           APEVL +
Sbjct: 358 APEVLQK 364

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 24/187 (12%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRH 57
           M  + + + +G G FG     R  +T ++ A+K +++ R   K  E +A   +N R +  
Sbjct: 187 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNERIMLS 243
Query: 58  -------PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
                  P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 303
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLK----ICDFGYSKSSVLHSRPKSTVGTPAYI 166
           + + H+  + +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+
Sbjct: 304 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYM 356
Query: 167 APEVLSR 173
           APEVL +
Sbjct: 357 APEVLQK 363

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 97/195 (49%), Gaps = 28/195 (14%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR-----EIINHRSLR 56
           ++YE+++ +G G +GV    R + T + VA+K I     +  N  R     +I+ H   +
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKH--FK 112
Query: 57  HPNIIRFKEVVLTPT-------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLIS 109
           H NII  K++ L PT        + +V++     +L   I ++   + +  RYF  QL+ 
Sbjct: 113 HDNIIAIKDI-LRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLR 170
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-------KSTVGT 162
           G+ Y HS Q+ HRDLK  N L++ +    LKI DFG ++   L + P          V T
Sbjct: 171 GLKYMHSAQVIHRDLKPSNLLVNENC--ELKIGDFGMARG--LCTSPAEHQYFMTEYVAT 226
Query: 163 PAYIAPEV-LSRREY 176
             Y APE+ LS  EY
Sbjct: 227 RWYRAPELMLSLHEY 241

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 8/182 (4%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E+  L+K+LG+G FGV +L + K   + VAVK I+ G   ++   +E      L HP ++
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQIC 120
           +F  V      + IV EY + G L + + + G+     +       +  G+ +  S Q  
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYD 177
           HRDL   N L+D      +K+ DFG ++  VL  +  S+VGT     + APEV    +Y 
Sbjct: 127 HRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 178 GK 179
            K
Sbjct: 184 SK 185

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 15/178 (8%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           +G G+FG    ++ K+T    AVK +    +++     E++    L  P I+     V  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 70  PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENT 129
              + I ME   GG L   I   G   ED   Y+  Q + G+ Y H+ +I H D+K +N 
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181
Query: 130 LL--DGSAAPRLKICDFGYSKSSVLHSRPKSTV------GTPAYIAPEVLSRREYDGK 179
           LL  DGS   R  +CDFG++         KS +      GT  ++APEV+  +  D K
Sbjct: 182 LLSSDGS---RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 236

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 91/179 (50%), Gaps = 12/179 (6%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPNIIR 62
           +ELV+ +G G +G     RH +T +L A+K ++     +E + +EI +  +   H NI  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 63  FKEVVLTPT------HLAIVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYC 114
           +    +          L +VME+   G + D I N       E+   Y  ++++ G+++ 
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLS 172
           H  ++ HRD+K +N LL  +A   +K+ DFG S        R  + +GTP ++APEV++
Sbjct: 146 HQHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   ++H+ +  ++A K I  E    I   + RE+        P 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-Q 118
           I+ F     +   ++I ME+  GG L   +  A R  E+        ++ G+ Y     Q
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 135
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y+APE L    Y
Sbjct: 136 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMAPERLQGTHY 190

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 15/178 (8%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           +G G+FG    ++ K+T    AVK +    +++     E++    L  P I+     V  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 137
Query: 70  PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENT 129
              + I ME   GG L   I   G   ED   Y+  Q + G+ Y H+ +I H D+K +N 
Sbjct: 138 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 197
Query: 130 LL--DGSAAPRLKICDFGYSKSSVLHSRPKSTV------GTPAYIAPEVLSRREYDGK 179
           LL  DGS   R  +CDFG++         KS +      GT  ++APEV+  +  D K
Sbjct: 198 LLSSDGS---RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 252

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 81/178 (45%), Gaps = 15/178 (8%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G+FG    +  K+T    AVK +    +++   A E++    L  P I+     V  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPRIVPLYGAVRE 137
Query: 70  PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENT 129
              + I ME   GG L   +   G   ED   Y+  Q + G+ Y HS +I H D+K +N 
Sbjct: 138 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 197
Query: 130 LL--DGSAAPRLKICDFGYSKSSVLHSRPKSTV------GTPAYIAPEVLSRREYDGK 179
           LL  DGS A    +CDFG++         K  +      GT  ++APEV+  R  D K
Sbjct: 198 LLSSDGSHA---ALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAK 252

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + +G+       RE+   R L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 171 L 171
           +
Sbjct: 194 I 194

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + +G+       RE+   R L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 171 L 171
           +
Sbjct: 194 I 194

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 96/190 (50%), Gaps = 16/190 (8%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRH 57
            E+ E+ + +G G FG    + H      VA++ I+  R  ++ +    RE++ +R  RH
Sbjct: 32  FEQLEIGELIGKGRFGQ---VYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSE-DEGRYFFQQLISGVNYCHS 116
            N++ F    ++P HLAI+     G  L+  + +A    + ++ R   Q+++ G+ Y H+
Sbjct: 89  ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFG-YSKSSVLHS-----RPKSTVGTPAYIAPEV 170
             I H+DLK +N   D     ++ I DFG +S S VL +     + +   G   ++APE+
Sbjct: 149 KGILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 171 LSRREYDGKQ 180
           + +   D ++
Sbjct: 206 IRQLSPDTEE 215

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 1/170 (0%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           EKY + +DLG G FG+        +K+    K+++        V +EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
              E   +   L ++ E+ +G ++F+RI  +A   +E E   +  Q+   + + HS  I 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           H D++ EN +     +  +KI +FG ++        +     P Y APEV
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 83/178 (46%), Gaps = 6/178 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC-HSMQ 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y     +
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 128
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           I HRD+K  N L++      +K+CDFG S   ++       VGT +Y++PE L    Y
Sbjct: 129 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDEMANEFVGTRSYMSPERLQGTHY 183

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 87/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + +G+       RE+   R L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y        R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPATVY--RV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 171 L 171
           +
Sbjct: 194 I 194

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 83/177 (46%), Gaps = 9/177 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK------IDENVAREIINHRSL 55
           ++YE +  LG G F      R K T ++VA+K I+ G +      I+    REI   + L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HPNII   +     +++++V ++           N+   +    + +    + G+ Y H
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
              I HRDLK  N LLD +    LK+ DFG +KS    +R     V T  Y APE+L
Sbjct: 130 QHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELL 184

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 90
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 205
Query: 171 L 171
           +
Sbjct: 206 I 206

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 97
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 154 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 212
Query: 171 L 171
           +
Sbjct: 213 I 213

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 90/185 (48%), Gaps = 29/185 (15%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 64  ----------KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQ 106
                     K+VV    +L +V++Y    E   R+  A  +S  +        + +  Q
Sbjct: 79  RYFFYSSGEKKDVV----YLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQ 130
Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI 166
           L   + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 167 APEVL 171
           APE++
Sbjct: 190 APELI 194

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 90
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 205
Query: 171 L 171
           +
Sbjct: 206 I 206

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 86
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 143 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 201
Query: 171 L 171
           +
Sbjct: 202 I 202

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 82
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 138
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 139 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 197
Query: 171 L 171
           +
Sbjct: 198 I 198

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 171 L 171
           +
Sbjct: 194 I 194

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 171 L 171
           +
Sbjct: 194 I 194

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 79
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 135
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 136 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 194
Query: 171 L 171
           +
Sbjct: 195 I 195

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 112
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 227
Query: 171 L 171
           +
Sbjct: 228 I 228

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 91
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 147
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 148 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 206
Query: 171 L 171
           +
Sbjct: 207 I 207

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 171 L 171
           +
Sbjct: 194 I 194

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 85/175 (48%), Gaps = 7/175 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHP 58
           ME Y  +  LG G +      + K T  LVA+K I  E          RE+   + L+H 
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRF-SEDEGRYFFQQLISGVNYCHSM 117
           NI+   +++ T   L +V EY    +L   + + G   +    + F  QL+ G+ YCH  
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVL 171
           ++ HRDLK +N L++      LK+ DFG +++  + ++   + V T  Y  P++L
Sbjct: 120 KVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDIL 172

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 116
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 172
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 173 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 231
Query: 171 L 171
           +
Sbjct: 232 I 232

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 114
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 170
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 171 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 229
Query: 171 L 171
           +
Sbjct: 230 I 230

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 106
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 162
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 163 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 221
Query: 171 L 171
           +
Sbjct: 222 I 222

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 112
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 227
Query: 171 L 171
           +
Sbjct: 228 I 228

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 83
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 84  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 139
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 140 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 198
Query: 171 L 171
           +
Sbjct: 199 I 199

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 157
Query: 64  KEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEG-------RYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 213
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 214 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 272
Query: 171 L 171
           +
Sbjct: 273 I 273

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 90/184 (48%), Gaps = 15/184 (8%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVARE----IINHRS 54
           E +E++K +G G FG   +++ K   ++ A+K + +    ++ +    RE    ++N  S
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNY 113
                I           +L +VM+Y  GG+L   +     R  E+  R++  +++  ++ 
Sbjct: 134 KW---ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            H +   HRD+K +N L+D +    +++ DFG     +     +S+  VGTP YI+PE+L
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 172 SRRE 175
              E
Sbjct: 249 QAME 252

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 89/183 (48%), Gaps = 21/183 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVK------YIERGRKIDENVAREIINHRSL 55
           + +E++K +G G F    +++ K+T ++ A+K       ++RG        R+++ +   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYC 114
           R    + F        +L +VMEY  GG+L   +   G R   +  R++  +++  ++  
Sbjct: 121 RWITQLHF--AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST------VGTPAYIAP 168
           H +   HRD+K +N LLD      +++ DFG    S L  R   T      VGTP Y++P
Sbjct: 179 HRLGYVHRDIKPDNILLDRCG--HIRLADFG----SCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 169 EVL 171
           E+L
Sbjct: 233 EIL 235

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 81/185 (43%), Gaps = 20/185 (10%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNII 61
           ++L   LG G +GV     HK T E+VA+K IE   K        REI   +  +H NII
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
               +   P       E     EL      R+ +    S+D  +YF  Q +  V   H  
Sbjct: 73  TIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK----SSVLHSRP-------KSTVGTPAYI 166
            + HRDLK  N L++ +    LK+CDFG ++    S+  +S P          V T  Y 
Sbjct: 132 NVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYR 189
Query: 167 APEVL 171
           APEV+
Sbjct: 190 APEVM 194

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 91/191 (47%), Gaps = 21/191 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKE---LVAVKYI-----ERGRKIDENVAREIINH- 52
           ++YE V ++G G +G  ++ + ++ K     VA+K +     E G  +       ++ H 
Sbjct: 11  QQYECVAEIGEGAYG--KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 53  RSLRHPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQ 105
            +  HPN++R  +V         T L +V E+         D++   G  +E      FQ
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 106 QLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAY 165
            L+ G+++ HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y
Sbjct: 129 -LLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWY 185
Query: 166 IAPEVLSRREY 176
            APEVL +  Y
Sbjct: 186 RAPEVLLQSSY 196

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 81/185 (43%), Gaps = 20/185 (10%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNII 61
           ++L   LG G +GV     HK T E+VA+K IE   K        REI   +  +H NII
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
               +   P       E     EL      R+ +    S+D  +YF  Q +  V   H  
Sbjct: 73  TIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK----SSVLHSRPKST-------VGTPAYI 166
            + HRDLK  N L++ +    LK+CDFG ++    S+  +S P          V T  Y 
Sbjct: 132 NVIHRDLKPSNLLINSNC--DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYR 189
Query: 167 APEVL 171
           APEV+
Sbjct: 190 APEVM 194

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 81/185 (43%), Gaps = 20/185 (10%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNII 61
           ++L   LG G +GV     HK T E+VA+K IE   K        REI   +  +H NII
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
               +   P       E     EL      R+ +    S+D  +YF  Q +  V   H  
Sbjct: 73  TIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK----SSVLHSRPKST-------VGTPAYI 166
            + HRDLK  N L++ +    LK+CDFG ++    S+  +S P          V T  Y 
Sbjct: 132 NVIHRDLKPSNLLINSNC--DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 167 APEVL 171
           APEV+
Sbjct: 190 APEVM 194

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 91/191 (47%), Gaps = 21/191 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKE---LVAVKYI-----ERGRKIDENVAREIINH- 52
           ++YE V ++G G +G  ++ + ++ K     VA+K +     E G  +       ++ H 
Sbjct: 11  QQYECVAEIGEGAYG--KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 53  RSLRHPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQ 105
            +  HPN++R  +V         T L +V E+         D++   G  +E      FQ
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 106 QLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAY 165
            L+ G+++ HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y
Sbjct: 129 -LLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWY 185
Query: 166 IAPEVLSRREY 176
            APEVL +  Y
Sbjct: 186 RAPEVLLQSSY 196

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 91/191 (47%), Gaps = 21/191 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKE---LVAVKYI-----ERGRKIDENVAREIINH- 52
           ++YE V ++G G +G  ++ + ++ K     VA+K +     E G  +       ++ H 
Sbjct: 11  QQYECVAEIGEGAYG--KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 53  RSLRHPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQ 105
            +  HPN++R  +V         T L +V E+         D++   G  +E      FQ
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 106 QLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAY 165
            L+ G+++ HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y
Sbjct: 129 -LLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWY 185
Query: 166 IAPEVLSRREY 176
            APEVL +  Y
Sbjct: 186 RAPEVLLQSSY 196

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNI 60
           +++ ++ LG G +       +K T   VA+K ++   +        REI   + L+H NI
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65
Query: 61  IRFKEVVLTPTHLAIVMEYAAGG--ELFDR--ICNAGRFSE-DEGRYFFQQLISGVNYCH 115
           +R  +V+ T   L +V E+      +  D   + N  R  E +  +YF  QL+ G+ +CH
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVL 171
             +I HRDLK +N L++     +LK+ DFG +++  +  +   S V T  Y AP+VL
Sbjct: 126 ENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVL 180

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 125 HCHNXGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 183 YHRYHGRSA 191

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 84/169 (49%), Gaps = 16/169 (9%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR----FKE 65
           LG G  G    + +K T+E  A+K ++   K    V    ++ R+ + P+I+R    ++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 82
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRD 123
           +      L IVME   GGELF RI + G   F+E E     + +   + Y HS+ I HRD
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 142
Query: 124 LKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKS----TVGTPAYI 166
           +K EN LL  S  P   LK+ DFG++K +      KS    ++G   YI
Sbjct: 143 VKPEN-LLYTSKRPNAILKLTDFGFAKETTGEKYDKSCDMWSLGVIMYI 190

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 173 RREYDGK 179
              Y G+
Sbjct: 188 YHRYHGR 194

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 12/187 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 151
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 152 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 209
Query: 173 RREYDGK 179
              Y G+
Sbjct: 210 YHRYHGR 216

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 221
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 222 YHRYHGRSA 230

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 56  RH--PNIIRFKEVVLTPTHLAIVME-YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 186
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 187 YHRYHGRSA 195

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 183 YHRYHGRSA 191

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 229
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 230 YHRYHGRSA 238

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 183 YHRYHGRSA 191

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 203 YHRYHGRSA 211

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 186
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 187 YHRYHGRSA 195

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 127
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 128 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 185
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 186 YHRYHGRSA 194

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 188 YHRYHGRSA 196

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 215 YHRYHGRSA 223

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 201
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 202 YHRYHGRSA 210

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 201
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 202 YHRYHGRSA 210

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 216 YHRYHGRSA 224

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 215 YHRYHGRSA 223

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 216 YHRYHGRSA 224

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 215 YHRYHGRSA 223

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 87/194 (44%), Gaps = 22/194 (11%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-----GTPAYIA 167
           +CH+  + HRD+K EN L+D +    LK+ DFG    ++L    K TV     GT  Y  
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG--SGALL----KDTVYTDFDGTRVYSP 209
Query: 168 PEVLSRREYDGKQG 181
           PE +    Y G+  
Sbjct: 210 PEWIRYHRYHGRSA 223

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 203 YHRYHGRSA 211

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 203 YHRYHGRSA 211

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 87/194 (44%), Gaps = 22/194 (11%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-----GTPAYIA 167
           +CH+  + HRD+K EN L+D +    LK+ DFG    ++L    K TV     GT  Y  
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG--SGALL----KDTVYTDFDGTRVYSP 210
Query: 168 PEVLSRREYDGKQG 181
           PE +    Y G+  
Sbjct: 211 PEWIRYHRYHGRSA 224

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 188 YHRYHGRSA 196

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +A R    +   +  Q+  G+ Y  +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 136 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 172 SRREY 176
           +  ++
Sbjct: 193 TESKF 197

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 87/194 (44%), Gaps = 22/194 (11%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-----GTPAYIA 167
           +CH+  + HRD+K EN L+D +    LK+ DFG    ++L    K TV     GT  Y  
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG--SGALL----KDTVYTDFDGTRVYSP 210
Query: 168 PEVLSRREYDGKQG 181
           PE +    Y G+  
Sbjct: 211 PEWIRYHRYHGRSA 224

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE + 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 229
Query: 173 RREYDGKQG 181
              Y G+  
Sbjct: 230 YHRYHGRSA 238

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 87/194 (44%), Gaps = 22/194 (11%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 56  RH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 176
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-----GTPAYIA 167
           +CH+  + HRD+K EN L+D +    LK+ DFG    ++L    K TV     GT  Y  
Sbjct: 177 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG--SGALL----KDTVYTDFDGTRVYSP 229
Query: 168 PEVLSRREYDGKQG 181
           PE +    Y G+  
Sbjct: 230 PEWIRYHRYHGRSA 243

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 85/197 (43%), Gaps = 31/197 (15%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           +E +  LG G FG     R+       A+K I    +    +  E++   SL H  ++R+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 64  KEVVL-------------TPTHLAIVMEYAAGGELFDRICNAGRFSE-DEGRYFFQQLIS 109
               L               + L I MEY   G L+D I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-----SVL----HSRP---- 156
            ++Y HS  I HRDLK  N  +D S    +KI DFG +K+      +L     + P    
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 157 --KSTVGTPAYIAPEVL 171
              S +GT  Y+A EVL
Sbjct: 186 NLTSAIGTAMYVATEVL 202

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    ++ +  G +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 163 ANVLHRDLKPSNLLLNTTX--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 60/123 (48%), Gaps = 7/123 (5%)
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNYCH 115
           I+       T T L +VM    GG++   I N       F E    ++  Q++SG+ + H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRR 174
              I +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+L   
Sbjct: 307 QRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 175 EYD 177
           EYD
Sbjct: 365 EYD 367

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 60/123 (48%), Gaps = 7/123 (5%)
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNYCH 115
           I+       T T L +VM    GG++   I N       F E    ++  Q++SG+ + H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRR 174
              I +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+L   
Sbjct: 307 QRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 175 EYD 177
           EYD
Sbjct: 365 EYD 367

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 60/123 (48%), Gaps = 7/123 (5%)
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNYCH 115
           I+       T T L +VM    GG++   I N       F E    ++  Q++SG+ + H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRR 174
              I +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+L   
Sbjct: 307 QRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 175 EYD 177
           EYD
Sbjct: 365 EYD 367

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 8/178 (4%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            V+++G+G FG+  L  +   K+ VA+K I  G   +E+   E      L HP +++   
Sbjct: 11  FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V L    + +V E+   G L D +    G F+ +        +  G+ Y     + HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDL 129
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGK 179
              N L+  +    +K+ DFG ++  VL  +  S+ GT     + +PEV S   Y  K
Sbjct: 130 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 60/123 (48%), Gaps = 7/123 (5%)
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNYCH 115
           I+       T T L +VM    GG++   I N       F E    ++  Q++SG+ + H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRR 174
              I +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+L   
Sbjct: 307 QRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 175 EYD 177
           EYD
Sbjct: 365 EYD 367

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 91/182 (50%), Gaps = 19/182 (10%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-----DENVAREIINHRSLRH 57
           KY +   LG G++G  + +   ET    AVK +++ +       + NV +EI   R LRH
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 58  PNIIRFKEVVLT--PTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
            N+I+  +V+       + +VMEY   G  E+ D +    RF   +   +F QLI G+ Y
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGLEY 124
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP-----KSTVGTPAYIAP 168
            HS  I H+D+K  N LL  +    LKI   G +++  LH        +++ G+PA+  P
Sbjct: 125 LHSQGIVHKDIKPGNLLL--TTGGTLKISALGVAEA--LHPFAADDTCRTSQGSPAFQPP 180
Query: 169 EV 170
           E+
Sbjct: 181 EI 182

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 18  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 77
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 138 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 172 SRREY 176
           +  ++
Sbjct: 195 TESKF 199

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 151 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 172 SRREY 176
           +  ++
Sbjct: 208 TESKF 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 151 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 172 SRREY 176
           +  ++
Sbjct: 208 TESKF 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 20  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 79
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 140 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 172 SRREY 176
           +  ++
Sbjct: 197 TESKF 201

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 136 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 172 SRREY 176
           +  ++
Sbjct: 193 TESKF 197

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 11  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 70
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 131 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 172 SRREY 176
           +  ++
Sbjct: 188 TESKF 192

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 19  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 78
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 139 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 172 SRREY 176
           +  ++
Sbjct: 196 TESKF 200

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 164 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 172 SRREY 176
           +  ++
Sbjct: 221 TESKF 225

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 133 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 172 SRREY 176
           +  ++
Sbjct: 190 TESKF 194

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 17  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 76
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 137 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 172 SRREY 176
           +  ++
Sbjct: 194 TESKF 198

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 133 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 172 SRREY 176
           +  ++
Sbjct: 190 TESKF 194

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 12  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 71
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 132 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 172 SRREY 176
           +  ++
Sbjct: 189 TESKF 193

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 8/178 (4%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            V+++G+G FG+  L  +   K+ VA+K I  G   +E+   E      L HP +++   
Sbjct: 9   FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V L    + +V E+   G L D +    G F+ +        +  G+ Y     + HRDL
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGK 179
              N L+  +    +K+ DFG ++  VL  +  S+ GT     + +PEV S   Y  K
Sbjct: 128 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 8/178 (4%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            V+++G+G FG+  L  +   K+ VA+K I  G   +E+   E      L HP +++   
Sbjct: 14  FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V L    + +V E+   G L D +    G F+ +        +  G+ Y     + HRDL
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGK 179
              N L+  +    +K+ DFG ++  VL  +  S+ GT     + +PEV S   Y  K
Sbjct: 133 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 187

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 8/178 (4%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            V+++G+G FG+  L  +   K+ VA+K I  G   +E+   E      L HP +++   
Sbjct: 11  FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V L    + +V E+   G L D +    G F+ +        +  G+ Y     + HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 129
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGK 179
              N L+  +    +K+ DFG ++  VL  +  S+ GT     + +PEV S   Y  K
Sbjct: 130 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 89/191 (46%), Gaps = 27/191 (14%)
Query: 7   VKDLGAGNFGVARLLRH----KETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNI 60
           ++DLG G+FG   L R+      T E VAVK +  E G     ++ +EI   R+L H NI
Sbjct: 14  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 73
Query: 61  IRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSM 117
           +++K +        + ++ME+   G L + +  N  + +  +   +  Q+  G++Y  S 
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK----------------SSVLHSRPKSTVG 161
           Q  HRDL   N L++     ++KI DFG +K                S V    P+  + 
Sbjct: 134 QYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 162 TPAYIAPEVLS 172
           +  YIA +V S
Sbjct: 192 SKFYIASDVWS 202

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 89/191 (46%), Gaps = 27/191 (14%)
Query: 7   VKDLGAGNFGVARLLRH----KETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPNI 60
           ++DLG G+FG   L R+      T E VAVK +  E G     ++ +EI   R+L H NI
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 61  IRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSM 117
           +++K +        + ++ME+   G L + +  N  + +  +   +  Q+  G++Y  S 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK----------------SSVLHSRPKSTVG 161
           Q  HRDL   N L++     ++KI DFG +K                S V    P+  + 
Sbjct: 146 QYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 203
Query: 162 TPAYIAPEVLS 172
           +  YIA +V S
Sbjct: 204 SKFYIASDVWS 214

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 8/178 (4%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            V+++G+G FG+  L  +   K+ VA+K I  G   +E+   E      L HP +++   
Sbjct: 12  FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V L    + +V E+   G L D +    G F+ +        +  G+ Y     + HRDL
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGK 179
              N L+  +    +K+ DFG ++  VL  +  S+ GT     + +PEV S   Y  K
Sbjct: 131 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 82/178 (46%), Gaps = 8/178 (4%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            V+++G+G FG+  L  +   K+ VA+K I+ G   +++   E      L HP +++   
Sbjct: 31  FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V L    + +V E+   G L D +    G F+ +        +  G+ Y     + HRDL
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 149
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP---AYIAPEVLSRREYDGK 179
              N L+  +    +K+ DFG ++  VL  +  S+ GT     + +PEV S   Y  K
Sbjct: 150 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 204

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 12/162 (7%)
Query: 30  VAVKYIERGRKID-------ENVAREIINHRSLRH--PNIIRFKEVVLTPTHLAIVMEYA 80
           VA+K++E+ R  D         V  E++  + +      +IR  +    P    +++E  
Sbjct: 79  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 138
Query: 81  AG-GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL 139
               +LFD I   G   E+  R FF Q++  V +CH+  + HRD+K EN L+D +    L
Sbjct: 139 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-EL 197
Query: 140 KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQG 181
           K+ DFG S + +  +      GT  Y  PE +    Y G+  
Sbjct: 198 KLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA 238

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 84/192 (43%), Gaps = 17/192 (8%)
Query: 4   YELVKDLGAG--NFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHP 58
           YEL+  +G G  +     L R+K T E V V+ I      +E V     E+   +   HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHS 116
           NI+ ++   +    L +V  + A G   D IC       +E    Y  Q ++  ++Y H 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 117 MQICHRDLKLENTLL--DGSAA-----PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
           M   HR +K  + L+  DG          L +   G  +  V+H  PK +V    +++PE
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG-QRQRVVHDFPKYSVKVLPWLSPE 205
Query: 170 VLSR--REYDGK 179
           VL +  + YD K
Sbjct: 206 VLQQNLQGYDAK 217

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI    + RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ ++   LKICDFG ++ +   H         V T  Y APE++
Sbjct: 145 ANVLHRDLKPSNLLLNTTS--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 86/185 (46%), Gaps = 17/185 (9%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M+++++ +  G G FG  +L + K T   VA+K + +  +      + + +   L HPNI
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI 81
Query: 61  IRFKEVVLT-------PTHLAIVMEYAAGGELFDRIC-NAGRFSEDEG----RYFFQQLI 108
           ++ +    T         +L +VMEY    +   R C N  R          + F  QLI
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 109 SGVNYCH--SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI 166
             +   H  S+ +CHRD+K  N L++  A   LK+CDFG +K         + + +  Y 
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVN-EADGTLKLCDFGSAKKLSPSEPNVAYICSRYYR 198
Query: 167 APEVL 171
           APE++
Sbjct: 199 APELI 203

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 84/192 (43%), Gaps = 17/192 (8%)
Query: 4   YELVKDLGAG--NFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHP 58
           YEL+  +G G  +     L R+K T E V V+ I      +E V     E+   +   HP
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 70
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHS 116
           NI+ ++   +    L +V  + A G   D IC       +E    Y  Q ++  ++Y H 
Sbjct: 71  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 130
Query: 117 MQICHRDLKLENTLL--DGSAA-----PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
           M   HR +K  + L+  DG          L +   G  +  V+H  PK +V    +++PE
Sbjct: 131 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG-QRQRVVHDFPKYSVKVLPWLSPE 189
Query: 170 VLSR--REYDGK 179
           VL +  + YD K
Sbjct: 190 VLQQNLQGYDAK 201

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI    + RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 145 ANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 133 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 172 SRREY 176
           +  ++
Sbjct: 190 TESKF 194

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 7   VKDLGAGNFGVARLLRHKETK----ELVAVKYI--ERGRKIDENVAREIINHRSLRHPNI 60
           ++DLG G+FG   L  +  T     E+VAVK +  + G +      +EI   R+L H +I
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I++K          L +VMEY   G L D +         +   F QQ+  G+ Y H+  
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH 154
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
             HRDL   N LLD      +KI DFG +K+
Sbjct: 155 YIHRDLAARNVLLDNDRL--VKIGDFGLAKA 183

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 70/145 (48%), Gaps = 15/145 (10%)
Query: 44  NVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDE 99
           +  +EI   + L HPN+I++    +    L IV+E A  G+L   I +  +      E  
Sbjct: 78  DCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 137
Query: 100 GRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHS 154
              +F QL S + + HS ++ HRD+K  N  +  +    +K+ D G      SK++  H 
Sbjct: 138 VWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH- 194
Query: 155 RPKSTVGTPAYIAPEVLSRREYDGK 179
              S VGTP Y++PE +    Y+ K
Sbjct: 195 ---SLVGTPYYMSPERIHENGYNFK 216

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 147 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 31/197 (15%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           +E +  LG G FG     R+       A+K I    +    +  E++   SL H  ++R+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 64  KEVVL-------------TPTHLAIVMEYAAGGELFDRICNAGRFSE-DEGRYFFQQLIS 109
               L               + L I MEY     L+D I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-----SVL----HSRP---- 156
            ++Y HS  I HRDLK  N  +D S    +KI DFG +K+      +L     + P    
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 157 --KSTVGTPAYIAPEVL 171
              S +GT  Y+A EVL
Sbjct: 186 NLTSAIGTAMYVATEVL 202

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 85/182 (46%), Gaps = 24/182 (13%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  E+ E VA+K + + ++      RE+   R ++HPN++  
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN---RELQIMRIVKHPNVVDL 97
Query: 64  KEVVLT------PTHLAIVMEYAAGGELFDRICNAGRFSEDEG--------RYFFQQLIS 109
           K    +         L +V+EY       + +  A R              + +  QL+ 
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
            + Y HS+ ICHRD+K +N LLD  +   LK+ DFG +K  +      S + +  Y APE
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIAGEPNVSXICSRYYRAPE 211
Query: 170 VL 171
           ++
Sbjct: 212 LI 213

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 20/184 (10%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  +++   
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVNYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 87  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT--PA-YIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  VL     S+VG+  P  +  PEVL   +
Sbjct: 141 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYSK 197
Query: 176 YDGK 179
           +  K
Sbjct: 198 FSSK 201

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 203

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 85/179 (47%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  ++ +G G +G+         K  VA+K I     +   +   REI      RH N+
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENV 103
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I  ++++   T  A+    +++     +L+ ++  + + S D   YF  Q++ G+ Y HS
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLMETDLY-KLLKSQQLSNDHICYFLYQILRGLKYIHS 162
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N L++ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 163 ANVLHRDLKPSNLLINTTCD--LKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIM 219

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 148 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 204

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 82/185 (44%), Gaps = 18/185 (9%)
Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN--------VAREIINHRSLR 56
           E  K +G G FG+    R  + K +VA+K +  G    E           RE+    +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCH 115
           HPNI++   ++  P  +  VME+   G+L+ R+ + A              +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 116 SMQ--ICHRDLKLENTL---LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +    I HRDL+  N     LD +A    K+ DFG S+ SV HS     +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-HSV-SGLLGNFQWMAPET 197
Query: 171 LSRRE 175
           +   E
Sbjct: 198 IGAEE 202

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 104 IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 163 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 91
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 92  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 150
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 151 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 207

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 143 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 143 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 85
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 145 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 141 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 148 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 204

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 89
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 90  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 148
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 149 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 205

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 80
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 81  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 139
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 140 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 196

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 20/184 (10%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  +++   
Sbjct: 19  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 77
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVNYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 78  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 131
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT--PA-YIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  VL     S+VG+  P  +  PEVL   +
Sbjct: 132 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 188
Query: 176 YDGK 179
           +  K
Sbjct: 189 FSSK 192

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 20/184 (10%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  +++   
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVNYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 72  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT--PA-YIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  VL     S+VG+  P  +  PEVL   +
Sbjct: 126 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 182
Query: 176 YDGK 179
           +  K
Sbjct: 183 FSSK 186

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 141 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 83/189 (43%), Gaps = 20/189 (10%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSLR- 56
           +YE V ++G G +G     R   +   VA+K +     E G  I  +  RE+   R L  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRLEA 62
Query: 57  --HPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQL 107
             HPN++R  +V  T        + +V E+         D+    G  +E   +   +Q 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI-KDLMRQF 121
Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           + G+++ H+  I HRDLK EN L+       +K+ DFG ++           V T  Y A
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALAPVVVTLWYRA 179
Query: 168 PEVLSRREY 176
           PEVL +  Y
Sbjct: 180 PEVLLQSTY 188

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 83/189 (43%), Gaps = 20/189 (10%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSLR- 56
           +YE V ++G G +G     R   +   VA+K +     E G  I  +  RE+   R L  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRLEA 62
Query: 57  --HPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQL 107
             HPN++R  +V  T        + +V E+         D+    G  +E   +   +Q 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQF 121
Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           + G+++ H+  I HRDLK EN L+       +K+ DFG ++           V T  Y A
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALDPVVVTLWYRA 179
Query: 168 PEVLSRREY 176
           PEVL +  Y
Sbjct: 180 PEVLLQSTY 188

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 143 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 143 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 20/184 (10%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  +++   
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVNYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 87  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT--PA-YIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  VL     S+VG+  P  +  PEVL   +
Sbjct: 141 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 197
Query: 176 YDGK 179
           +  K
Sbjct: 198 FSSK 201

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 147 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 20/184 (10%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  +++   
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVNYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 67  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT--PA-YIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  VL     S+VG+  P  +  PEVL   +
Sbjct: 121 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 176 YDGK 179
           +  K
Sbjct: 178 FSSK 181

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 20/184 (10%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  +++   
Sbjct: 12  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVNYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 71  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT--PA-YIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  VL     S+VG+  P  +  PEVL   +
Sbjct: 125 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 181
Query: 176 YDGK 179
           +  K
Sbjct: 182 FSSK 185

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 82/185 (44%), Gaps = 18/185 (9%)
Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN--------VAREIINHRSLR 56
           E  K +G G FG+    R  + K +VA+K +  G    E           RE+    +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCH 115
           HPNI++   ++  P  +  VME+   G+L+ R+ + A              +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 116 SMQ--ICHRDLKLENTL---LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +    I HRDL+  N     LD +A    K+ DFG S+ SV HS     +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSV-HSV-SGLLGNFQWMAPET 197
Query: 171 LSRRE 175
           +   E
Sbjct: 198 IGAEE 202

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 14  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 73
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HR+L   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 134 KRYIHRNLATRNILVENEN--RVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESL 190
Query: 172 SRREY 176
           +  ++
Sbjct: 191 TESKF 195

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKCQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 5   ELVKDLGAGNFGVARLLRHK----ETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           + ++ LG GNFG   + R+      T E+VAVK ++   +    +  REI   +SL+H N
Sbjct: 16  KFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +    +L ++ME+   G L + +  +  R    +   +  Q+  G+ Y  +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L
Sbjct: 136 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 172 SRREY 176
           +  ++
Sbjct: 193 TESKF 197

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 80/179 (44%), Gaps = 16/179 (8%)
Query: 7   VKDLGAGNFGVARLLRH----KETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNII 61
           +  LG GNFG   L R+      T  LVAVK ++  G     +  REI   ++L    I+
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 71
Query: 62  RFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +++ V   P    L +VMEY   G L D +  +  R        +  Q+  G+ Y  S +
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 131
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA-----YIAPEVLS 172
             HRDL   N L++  A   +KI DFG +K   L  +    V  P      + APE LS
Sbjct: 132 CVHRDLAARNILVESEA--HVKIADFGLAKLLPL-DKDXXVVREPGQSPIFWYAPESLS 187

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 82/189 (43%), Gaps = 20/189 (10%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSLR- 56
           +YE V ++G G +G     R   +   VA+K +     E G  I  +  RE+   R L  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRLEA 62
Query: 57  --HPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQL 107
             HPN++R  +V  T        + +V E+         D+    G    +  +   +Q 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQF 121
Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIA 167
           + G+++ H+  I HRDLK EN L+       +K+ DFG ++           V T  Y A
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALFPVVVTLWYRA 179
Query: 168 PEVLSRREY 176
           PEVL +  Y
Sbjct: 180 PEVLLQSTY 188

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA++ I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 7   VKDLGAGNFGVARLLRH----KETKELVAVKYIER-GRKIDENVAREIINHRSLRHPNII 61
           +  LG GNFG   L R+      T  LVAVK ++  G     +  REI   ++L    I+
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 74
Query: 62  RFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +++ V   P    L +VMEY   G L D +  +  R        +  Q+  G+ Y  S +
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 134
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL   N L++  A   +KI DFG +K
Sbjct: 135 CVHRDLAARNILVESEA--HVKIADFGLAK 162

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 7   VKDLGAGNFGVARLLRH----KETKELVAVKYIER-GRKIDENVAREIINHRSLRHPNII 61
           +  LG GNFG   L R+      T  LVAVK ++  G     +  REI   ++L    I+
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 62  RFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +++ V   P    L +VMEY   G L D +  +  R        +  Q+  G+ Y  S +
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL   N L++  A   +KI DFG +K
Sbjct: 148 CVHRDLAARNILVESEA--HVKIADFGLAK 175

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 88/184 (47%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 168 FVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREY 176
            R++
Sbjct: 224 YRKF 227

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 7   VKDLGAGNFGVARLLRH----KETKELVAVKYIER-GRKIDENVAREIINHRSLRHPNII 61
           +  LG GNFG   L R+      T  LVAVK ++  G     +  REI   ++L    I+
Sbjct: 16  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 75
Query: 62  RFKEVVLTP--THLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +++ V   P    L +VMEY   G L D +  +  R        +  Q+  G+ Y  S +
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 135
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL   N L++  A   +KI DFG +K
Sbjct: 136 CVHRDLAARNILVESEA--HVKIADFGLAK 163

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 70/155 (45%), Gaps = 6/155 (3%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLR- 56
           + KYELVK LG G +G+      + T E+VAVK I    +   +     REI+    L  
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H NI+    V+       + + +         +  A        +Y   QLI  + Y HS
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV 151
             + HRD+K  N LL+  A   +K+ DFG S+S V
Sbjct: 128 GGLLHRDMKPSNILLN--AECHVKVADFGLSRSFV 160

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 7   VKDLGAGNFGVARLLRHKETK----ELVAVKYIER--GRKIDENVAREIINHRSLRHPNI 60
           ++DLG G+FG   L  +  T     E+VAVK ++   G +      +EI   R+L H +I
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I++K          L +VMEY   G L D +         +   F QQ+  G+ Y HS  
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHSQH 137
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
             HR+L   N LLD      +KI DFG +K+
Sbjct: 138 YIHRNLAARNVLLDNDRL--VKIGDFGLAKA 166

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCAKLTDDHVQFLIYQILRGLKY 136
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 76/182 (41%), Gaps = 18/182 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLRH 57
           ++YEL + LG G      L R       VAVK +      D +      RE  N  +L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           P I+   +     T       IVMEY  G  L D +   G  +              +N+
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIA 167
            H   I HRD+K  N L+  + A  +K+ DFG +++      SV  +   + +GT  Y++
Sbjct: 132 SHQNGIIHRDVKPANILISATNA--VKVVDFGIARAIADSGNSVXQT--AAVIGTAQYLS 187
Query: 168 PE 169
           PE
Sbjct: 188 PE 189

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 88/184 (47%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 96
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 97  IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 155
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 156 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 211
Query: 173 RREY 176
            R++
Sbjct: 212 YRKF 215

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 45/211 (21%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           +KY L K LG G+FG+   +   E+ +  A+K + +  +      RE+   + L H NII
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN---RELDIMKVLDHVNII 63
Query: 62  RF-----------------------------------KEVVLTPT---HLAIVMEYAAGG 83
           +                                    K V++ P+   +L ++MEY    
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 84  --ELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLK 140
             ++      +GR    +    +  QL   V + HS+ ICHRD+K +N L++ S    LK
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN-SKDNTLK 182
Query: 141 ICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           +CDFG +K  +      + + +  Y APE++
Sbjct: 183 LCDFGSAKKLIPSEPSVAXICSRFYRAPELM 213

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 88/184 (47%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 80  IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 139 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 173 RREY 176
            R++
Sbjct: 195 YRKF 198

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 18/179 (10%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
           HS  I HRDLK  N ++       LKI DFG ++          T GT   + PEV++R
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLAR----------TAGTSFMMTPEVVTR 189

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++      +  V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMEPEVVTRYYRAPEVI 197

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 25/196 (12%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSL 55
           + KYE +  +G G FG     RH++T + VA+K +     + G  I     REI   + L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI--TALREIKILQLL 74
Query: 56  RHPNIIRFKEVVLTPTH--------LAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQ 106
           +H N++   E+  T           + +V ++    +L   + N   +F+  E +   Q 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL--HSRPK---STVG 161
           L++G+ Y H  +I HRD+K  N L+       LK+ DFG +++  L  +S+P    + V 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 162 TPAYIAPE-VLSRREY 176
           T  Y  PE +L  R+Y
Sbjct: 192 TLWYRPPELLLGERDY 207

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 25/196 (12%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSL 55
           + KYE +  +G G FG     RH++T + VA+K +     + G  I     REI   + L
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI--TALREIKILQLL 73
Query: 56  RHPNIIRFKEVVLTPTH--------LAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQ 106
           +H N++   E+  T           + +V ++    +L   + N   +F+  E +   Q 
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL--HSRPK---STVG 161
           L++G+ Y H  +I HRD+K  N L+       LK+ DFG +++  L  +S+P    + V 
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 162 TPAYIAPE-VLSRREY 176
           T  Y  PE +L  R+Y
Sbjct: 191 TLWYRPPELLLGERDY 206

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 25/196 (12%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSL 55
           + KYE +  +G G FG     RH++T + VA+K +     + G  I     REI   + L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI--TALREIKILQLL 74
Query: 56  RHPNIIRFKEVVLTPTH--------LAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQ 106
           +H N++   E+  T           + +V ++    +L   + N   +F+  E +   Q 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL--HSRPK---STVG 161
           L++G+ Y H  +I HRD+K  N L+       LK+ DFG +++  L  +S+P    + V 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 162 TPAYIAPE-VLSRREY 176
           T  Y  PE +L  R+Y
Sbjct: 192 TLWYRPPELLLGERDY 207

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 88/184 (47%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREY 176
            R++
Sbjct: 224 YRKF 227

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 88/184 (47%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREY 176
            R++
Sbjct: 224 YRKF 227

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 88/184 (47%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREY 176
            R++
Sbjct: 224 YRKF 227

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 25/196 (12%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-----ERGRKIDENVAREIINHRSL 55
           + KYE +  +G G FG     RH++T + VA+K +     + G  I     REI   + L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI--TALREIKILQLL 74
Query: 56  RHPNIIRFKEVVLTPTH--------LAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQ 106
           +H N++   E+  T           + +V ++    +L   + N   +F+  E +   Q 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL--HSRPK---STVG 161
           L++G+ Y H  +I HRD+K  N L+       LK+ DFG +++  L  +S+P    + V 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 162 TPAYIAPE-VLSRREY 176
           T  Y  PE +L  R+Y
Sbjct: 192 TLWYRPPELLLGERDY 207

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 88/184 (47%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 106
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 107 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 165
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 166 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 221
Query: 173 RREY 176
            R++
Sbjct: 222 YRKF 225

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 88/184 (47%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREY 176
            R++
Sbjct: 224 YRKF 227

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++      +  V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMEPEVVTRYYRAPEVI 197

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 20/182 (10%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPNIIR 62
           +GAG FG     RL    + +  VA+K ++ G    E   RE ++  S+     HPNIIR
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYT--ERQRREFLSEASIMGQFEHPNIIR 81
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
            + VV     + I+ E+   G L  F R+ N G+F+  +     + + SG+ Y   M   
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYV 140
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+    +S   +   +        + APE ++ R
Sbjct: 141 HRDLAARNILVNSNLV--CKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 175 EY 176
           ++
Sbjct: 199 KF 200

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 22  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 81
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 82  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 141
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 142 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 196

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 85/173 (49%), Gaps = 9/173 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH-PNI 60
           + Y+LV+ LG G +       +    E V VK ++  +K    + REI    +LR  PNI
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--NKIKREIKILENLRGGPNI 94
Query: 61  IRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCHSM 
Sbjct: 95  ITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCHSMG 151
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L
Sbjct: 152 IMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 6   LVKDLGAGNFGVARL--LRHKETKEL-VAVK-----YIERGRKIDENVAREIINHRSLRH 57
           L++ LG G+FGV R         K + VAVK      + +   +D+ + RE+    SL H
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 80
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y  S
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-------SVLHSRPKSTVGTPAYIAPE 169
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 140 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF---AWCAPE 194
Query: 170 VLSRREY 176
            L  R +
Sbjct: 195 SLKTRTF 201

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 20/182 (10%)
Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL----RHPNIIR 62
           +GAG FG     RL    + +  VA+K ++ G    E   RE ++  S+     HPNIIR
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYT--ERQRREFLSEASIMGQFEHPNIIR 79
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
            + VV     + I+ E+   G L  F R+ N G+F+  +     + + SG+ Y   M   
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYV 138
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+    +S   +   +        + APE ++ R
Sbjct: 139 HRDLAARNILVNSNLV--CKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 175 EY 176
           ++
Sbjct: 197 KF 198

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 136
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 18/185 (9%)
Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN--------VAREIINHRSLR 56
           E  K +G G FG+    R  + K +VA+K +  G    E           RE+    +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCH 115
           HPNI++   ++  P  +  VME+   G+L+ R+ + A              +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 116 SMQ--ICHRDLKLENTL---LDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +    I HRDL+  N     LD +A    K+ DF  S+ SV HS     +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSV-HSV-SGLLGNFQWMAPET 197
Query: 171 LSRRE 175
           +   E
Sbjct: 198 IGAEE 202

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 136
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 180
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 213

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 214

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 180
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E  +LVK LGAG FG   +  +  + + VAVK ++ G    +    E    ++L+H  ++
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 71
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           R   VV     + I+ EY A G L D + +   G+    +   F  Q+  G+ Y      
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 131
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            HRDL+  N L+  S +   KI DFG ++
Sbjct: 132 IHRDLRAANVLV--SESLMCKIADFGLAR 158

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 6   LVKDLGAGNFGVARL--LRHKETKEL-VAVK-----YIERGRKIDENVAREIINHRSLRH 57
           L++ LG G+FGV R         K + VAVK      + +   +D+ + RE+    SL H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 70
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y  S
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-------SVLHSRPKSTVGTPAYIAPE 169
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF---AWCAPE 184
Query: 170 VLSRREY 176
            L  R +
Sbjct: 185 SLKTRTF 191

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 78/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VAVK + R    +   +   RE++  + + H
Sbjct: 23  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C       D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 197

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 28  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 88  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 147
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 148 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 202

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 76/182 (41%), Gaps = 18/182 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLRH 57
           ++YEL + LG G      L R       VAVK +      D +      RE  N  +L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           P I+   +     T       IVMEY  G  L D +   G  +              +N+
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIA 167
            H   I HRD+K  N ++  + A  +K+ DFG +++      SV  +   + +GT  Y++
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQT--AAVIGTAQYLS 187
Query: 168 PE 169
           PE
Sbjct: 188 PE 189

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 76/182 (41%), Gaps = 18/182 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLRH 57
           ++YEL + LG G      L R       VAVK +      D +      RE  N  +L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           P I+   +     T       IVMEY  G  L D +   G  +              +N+
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIA 167
            H   I HRD+K  N ++  + A  +K+ DFG +++      SV  +   + +GT  Y++
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQT--AAVIGTAQYLS 187
Query: 168 PE 169
           PE
Sbjct: 188 PE 189

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 7   VKDLGAGNFGVARLLRHKETK----ELVAVKYIERG--RKIDENVAREIINHRSLRHPNI 60
           ++DLG G+FG   L  +  T     E+VAVK ++ G   ++     REI   R+L H +I
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGELFD---RICNAGRFSEDEGRYFFQQLISGVNYCH 115
           +++K          + +VMEY   G L D   R C        +   F QQ+  G+ Y H
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLH 128
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
           +    HR L   N LLD      +KI DFG +K+
Sbjct: 129 AQHYIHRALAARNVLLDNDRL--VKIGDFGLAKA 160

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 84  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++  +   LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 142 YIHSADIIHRDLKPSNLAVNEDS--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 195
Query: 171 L 171
           +
Sbjct: 196 M 196

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 7   VKDLGAGNFGVARLLRHKETK----ELVAVKYIER--GRKIDENVAREIINHRSLRHPNI 60
           ++DLG G+FG   L  +  T     E+VAVK ++   G +      +EI   R+L H +I
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I++K          L +VMEY   G L D +         +   F QQ+  G+ Y H+  
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH 137
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
             HR+L   N LLD      +KI DFG +K+
Sbjct: 138 YIHRNLAARNVLLDNDRL--VKIGDFGLAKA 166

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E  +LVK LGAG FG   +  +  + + VAVK ++ G    +    E    ++L+H  ++
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 70
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           R   VV     + I+ E+ A G L D + +   G+    +   F  Q+  G+ Y      
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 130
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            HRDL+  N L+  S +   KI DFG ++
Sbjct: 131 IHRDLRAANVLV--SESLMCKIADFGLAR 157

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 91
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 92  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 149
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 150 YIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 203
Query: 171 L 171
           +
Sbjct: 204 M 204

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 76/182 (41%), Gaps = 18/182 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLRH 57
           ++YEL + LG G      L R       VAVK +      D +      RE  N  +L H
Sbjct: 29  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 88
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           P I+   +     T       IVMEY  G  L D +   G  +              +N+
Sbjct: 89  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 148
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIA 167
            H   I HRD+K  N ++  SA   +K+ DFG +++      SV  +   + +GT  Y++
Sbjct: 149 SHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQT--AAVIGTAQYLS 204
Query: 168 PE 169
           PE
Sbjct: 205 PE 206

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 7   VKDLGAGNFGVARLLRHKETK----ELVAVKYIERG--RKIDENVAREIINHRSLRHPNI 60
           ++DLG G+FG   L  +  T     E+VAVK ++ G   ++     REI   R+L H +I
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGELFD---RICNAGRFSEDEGRYFFQQLISGVNYCH 115
           +++K          + +VMEY   G L D   R C        +   F QQ+  G+ Y H
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLH 129
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
           +    HR L   N LLD      +KI DFG +K+
Sbjct: 130 AQHYIHRALAARNVLLDNDRL--VKIGDFGLAKA 161

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 86/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++  +   LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDS--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 77  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 136
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 76/182 (41%), Gaps = 18/182 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLRH 57
           ++YEL + LG G      L R       VAVK +      D +      RE  N  +L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           P I+   +     T       IVMEY  G  L D +   G  +              +N+
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYIA 167
            H   I HRD+K  N ++  + A  +K+ DFG +++      SV  +   + +GT  Y++
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQT--AAVIGTAQYLS 187
Query: 168 PE 169
           PE
Sbjct: 188 PE 189

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 83/181 (45%), Gaps = 14/181 (7%)
Query: 4   YELVKD-LGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREI-INHRSLRHPNI 60
           Y+L +D LG G     +   +  T +  AVK IE+    I   V RE+ + ++   H N+
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNV 73
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +   E         +V E   GG +   I     F+E E     Q + S +++ H+  I 
Sbjct: 74  LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 121 HRDLKLENTLLD--GSAAPRLKICDFGYSKSSVLH--SRPKST------VGTPAYIAPEV 170
           HRDLK EN L +     +P +KICDFG      L+    P ST       G+  Y+APEV
Sbjct: 134 HRDLKPENILCEHPNQVSP-VKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 171 L 171
           +
Sbjct: 193 V 193

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I  + + ++D  ++   Q++ G+ 
Sbjct: 82  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKSQKLTDDHVQFLIYQILRGLK 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++  +   LKI DFG  +    H+  + T  V T  Y APE+
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDS--ELKILDFGLCR----HTDDEMTGYVATRWYRAPEI 193
Query: 171 L 171
           +
Sbjct: 194 M 194

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 6   LVKDLGAGNFGVARL--LRHKETKEL-VAVK-----YIERGRKIDENVAREIINHRSLRH 57
           L++ LG G+FGV R         K + VAVK      + +   +D+ + RE+    SL H
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 80
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y  S
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-------SVLHSRPKSTVGTPAYIAPE 169
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 140 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCAPE 194
Query: 170 VLSRREY 176
            L  R +
Sbjct: 195 SLKTRTF 201

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 6   LVKDLGAGNFGVARL--LRHKETKEL-VAVK-----YIERGRKIDENVAREIINHRSLRH 57
           L++ LG G+FGV R         K + VAVK      + +   +D+ + RE+    SL H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 74
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y  S
Sbjct: 75  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-------SVLHSRPKSTVGTPAYIAPE 169
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 134 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCAPE 188
Query: 170 VLSRREY 176
            L  R +
Sbjct: 189 SLKTRTF 195

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 6   LVKDLGAGNFGVARL--LRHKETKEL-VAVK-----YIERGRKIDENVAREIINHRSLRH 57
           L++ LG G+FGV R         K + VAVK      + +   +D+ + RE+    SL H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 74
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y  S
Sbjct: 75  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-------SVLHSRPKSTVGTPAYIAPE 169
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 134 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCAPE 188
Query: 170 VLSRREY 176
            L  R +
Sbjct: 189 SLKTRTF 195

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMXGXVATRWYRAPEIM 214

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG---VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +G G FG     RL    + +  VA+K ++ G    +   R+ ++  S+     HPNI
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYT--DKQRRDFLSEASIMGQFDHPNI 92
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I  + VV     + I+ EY   G L  F R  N GRF+  +     + + SG+ Y   M 
Sbjct: 93  IHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLSDMS 151
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + APE ++
Sbjct: 152 AVHRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIA 207
Query: 173 RREY 176
            R++
Sbjct: 208 YRKF 211

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 86/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        ++   +AVK + R  +     +   RE+   + ++H 
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 110
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V    T L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 111 NVIGLLDVFTPATSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 169
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 170 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 223

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 6   LVKDLGAGNFGVARL--LRHKETKEL-VAVK-----YIERGRKIDENVAREIINHRSLRH 57
           L++ LG G+FGV R         K + VAVK      + +   +D+ + RE+    SL H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 70
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y  S
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-------SVLHSRPKSTVGTPAYIAPE 169
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCAPE 184
Query: 170 VLSRREY 176
            L  R +
Sbjct: 185 SLKTRTF 191

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 87  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 145 YIHSADIIHRDLKPSNLAVNEDX--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 198
Query: 171 L 171
           +
Sbjct: 199 M 199

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 6   LVKDLGAGNFGVARL--LRHKETKEL-VAVK-----YIERGRKIDENVAREIINHRSLRH 57
           L++ LG G+FGV R         K + VAVK      + +   +D+ + RE+    SL H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 70
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y  S
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-------SVLHSRPKSTVGTPAYIAPE 169
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCAPE 184
Query: 170 VLSRREY 176
            L  R +
Sbjct: 185 SLKTRTF 191

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG---VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +G G FG     RL    + +  VA+K ++ G    +   R+ ++  S+     HPNI
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYT--DKQRRDFLSEASIMGQFDHPNI 71
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I  + VV     + I+ EY   G L  F R  N GRF+  +     + + SG+ Y   M 
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLSDMS 130
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + APE ++
Sbjct: 131 YVHRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 173 RREY 176
            R++
Sbjct: 187 YRKF 190

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 78/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VAVK + R    +   +   RE++  + + H
Sbjct: 21  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 80
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C       D  R  Y   Q++ G+ + 
Sbjct: 81  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 140
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV+
Sbjct: 141 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTASTNFMMTPYVVTRYYRAPEVI 195

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG---VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +G G FG     RL    + +  VA+K ++ G    +   R+ ++  S+     HPNI
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYT--DKQRRDFLSEASIMGQFDHPNI 77
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I  + VV     + I+ EY   G L  F R  N GRF+  +     + + SG+ Y   M 
Sbjct: 78  IHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLSDMS 136
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + APE ++
Sbjct: 137 YVHRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 173 RREY 176
            R++
Sbjct: 193 YRKF 196

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 19/190 (10%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE------RGRKIDENVAREIINHRSLR 56
           +YE V ++G G +G     R   +   VA+K +        G  +  +  RE+   R L 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 57  ---HPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQ 106
              HPN++R  +V  T        + +V E+         D+    G  +E   +   +Q
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI-KDLMRQ 128
Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI 166
            + G+++ H+  I HRDLK EN L+       +K+ DFG ++           V T  Y 
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALTPVVVTLWYR 186
Query: 167 APEVLSRREY 176
           APEVL +  Y
Sbjct: 187 APEVLLQSTY 196

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 20/184 (10%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
            +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  +++   
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVNYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 72  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT--PA-YIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  VL     S+ G+  P  +  PEVL   +
Sbjct: 126 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYSK 182
Query: 176 YDGK 179
           +  K
Sbjct: 183 FSSK 186

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 217

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 82  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKXQKLTDDHVQFLIYQILRGLK 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDX--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 193
Query: 171 L 171
           +
Sbjct: 194 M 194

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 93  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 150
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 151 YIHSADIIHRDLKPSNLAVNEDX--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 204
Query: 171 L 171
           +
Sbjct: 205 M 205

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 87  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 145 YIHSADIIHRDLKPSNLAVNEDX--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 198
Query: 171 L 171
           +
Sbjct: 199 M 199

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG ++  VL   P++   T        + +PE ++
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLAR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREY 176
            R++
Sbjct: 224 YRKF 227

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 214

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKXQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 191

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 94  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 152 YIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 205
Query: 171 L 171
           +
Sbjct: 206 M 206

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 84  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 142 YIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 195
Query: 171 L 171
           +
Sbjct: 196 M 196

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 94  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 152 YIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 205
Query: 171 L 171
           +
Sbjct: 206 M 206

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 80
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 139
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 140 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 193

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTADEMTGYVATRWYRAPEIM 201

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 89  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTADEMTGYVATRWYRAPEI 200
Query: 171 L 171
           +
Sbjct: 201 M 201

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 82  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 193
Query: 171 L 171
           +
Sbjct: 194 M 194

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 205

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 213

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 78  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 189
Query: 171 L 171
           +
Sbjct: 190 M 190

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 191

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 82  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGXVATRWYRAPEI 193
Query: 171 L 171
           +
Sbjct: 194 M 194

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 79
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 138
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 139 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 192

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 201

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 25  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 84
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 85  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 144
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 145 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMVPFVVTRYYRAPEVI 199

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 82  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 193
Query: 171 L 171
           +
Sbjct: 194 M 194

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 89  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTADEMTGYVATRWYRAPEI 200
Query: 171 L 171
           +
Sbjct: 201 M 201

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMAGFVATRWYRAPEIM 190

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 76/183 (41%), Gaps = 20/183 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLRH 57
           ++YEL + LG G      L R       VAVK +      D +      RE  N  +L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRF-----KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           P I+        E    P    IVMEY  G  L D +   G  +              +N
Sbjct: 72  PAIVAVYATGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS------SVLHSRPKSTVGTPAYI 166
           + H   I HRD+K  N ++  + A  +K+ DFG +++      SV  +   + +GT  Y+
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQT--AAVIGTAQYL 186
Query: 167 APE 169
           +PE
Sbjct: 187 SPE 189

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 10  LGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNIIR 62
           +GAG FG   +  L+    +EL VA+K ++ G    E   R+ +   S+     HPNII 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNIIH 87
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
            + VV     + IV EY   G L   +  N G+F+  +     + + +G+ Y   M   H
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVH 147
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLSRRE 175
           RDL   N L++ +     K+ DFG S+  VL   P++   T        + APE ++ R+
Sbjct: 148 RDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 176 Y 176
           +
Sbjct: 204 F 204

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMAGFVATRWYRAPEIM 194

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 19/193 (9%)
Query: 1   MEKYELVKD-------LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR 53
           M+K+E+ +        LG G +G   +   K+    VAVK ++      E   +E    +
Sbjct: 24  MDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 83
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGV 111
            ++HPN+++   V        IV EY   G L D  R CN    +     Y   Q+ S +
Sbjct: 84  EIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAM 143
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYI 166
            Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  +    + 
Sbjct: 144 EYLEKKNFIHRDLAARNCLVGENHV--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWT 198
Query: 167 APEVLSRREYDGK 179
           APE L+   +  K
Sbjct: 199 APESLAYNTFSIK 211

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 82/195 (42%), Gaps = 29/195 (14%)
Query: 3   KYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREI--INHRSLRHPN 59
           +YE+V  LG G FG V   + HK     VAVK ++   +  E    EI  + H +   PN
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 60  ----IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNY 113
                ++  E      H+ IV E   G   +D I   G   F  D  R    Q+   VN+
Sbjct: 75  STFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 114 CHSMQICHRDLKLENTLL---DGSAA--------------PRLKICDFGYSKSSVLHSRP 156
            HS ++ H DLK EN L    D + A              P +K+ DFG +     H   
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-- 191
Query: 157 KSTVGTPAYIAPEVL 171
            + V T  Y APEV+
Sbjct: 192 STLVSTRHYRAPEVI 206

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMAGFVATRWYRAPEIM 194

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 87/184 (47%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG  +  VL   P++   T        + +PE ++
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREY 176
            R++
Sbjct: 224 YRKF 227

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 84/199 (42%), Gaps = 37/199 (18%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKY-IERGRK-----IDE-NVAREIINHRS 54
           E +EL K +G+G FG       K  K L    Y I+R +K     +DE N  RE+  H  
Sbjct: 10  EFHELEK-IGSGEFGSV----FKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 64
Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLIS 109
           L +H +++R+        H+ I  EY  GG L D I    R    F E E +    Q+  
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPR-----------------LKICDFGYSKSSVL 152
           G+ Y HSM + H D+K  N  +  ++ P                   KI D G+      
Sbjct: 125 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 182
Query: 153 HSRPKSTVGTPAYIAPEVL 171
            S P+   G   ++A EVL
Sbjct: 183 -SSPQVEEGDSRFLANEVL 200

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 84/199 (42%), Gaps = 37/199 (18%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKY-IERGRK-----IDE-NVAREIINHRS 54
           E +EL K +G+G FG       K  K L    Y I+R +K     +DE N  RE+  H  
Sbjct: 8   EFHELEK-IGSGEFGSV----FKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 62
Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLIS 109
           L +H +++R+        H+ I  EY  GG L D I    R    F E E +    Q+  
Sbjct: 63  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 122
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPR-----------------LKICDFGYSKSSVL 152
           G+ Y HSM + H D+K  N  +  ++ P                   KI D G+      
Sbjct: 123 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 180
Query: 153 HSRPKSTVGTPAYIAPEVL 171
            S P+   G   ++A EVL
Sbjct: 181 -SSPQVEEGDSRFLANEVL 198

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 84/199 (42%), Gaps = 37/199 (18%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKY-IERGRK-----IDE-NVAREIINHRS 54
           E +EL K +G+G FG       K  K L    Y I+R +K     +DE N  RE+  H  
Sbjct: 12  EFHELEK-IGSGEFGSV----FKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLIS 109
           L +H +++R+        H+ I  EY  GG L D I    R    F E E +    Q+  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPR-----------------LKICDFGYSKSSVL 152
           G+ Y HSM + H D+K  N  +  ++ P                   KI D G+      
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 153 HSRPKSTVGTPAYIAPEVL 171
            S P+   G   ++A EVL
Sbjct: 185 -SSPQVEEGDSRFLANEVL 202

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 84/199 (42%), Gaps = 37/199 (18%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKY-IERGRK-----IDE-NVAREIINHRS 54
           E +EL K +G+G FG       K  K L    Y I+R +K     +DE N  RE+  H  
Sbjct: 10  EFHELEK-IGSGEFGSV----FKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 64
Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLIS 109
           L +H +++R+        H+ I  EY  GG L D I    R    F E E +    Q+  
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPR-----------------LKICDFGYSKSSVL 152
           G+ Y HSM + H D+K  N  +  ++ P                   KI D G+      
Sbjct: 125 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 182
Query: 153 HSRPKSTVGTPAYIAPEVL 171
            S P+   G   ++A EVL
Sbjct: 183 -SSPQVEEGDSRFLANEVL 200

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMXGYVATRWYRAPEIM 217

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++   A   LKI DFG ++++         V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 13/179 (7%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGRKIDENVAREIINHRSLRHPNI 60
           +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAI----VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I   +++  PT   +    +++     +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-SSVLHSRP---KSTVGTPAYIAPEVL 171
             + HRDLK  N LL+ +    LKI DFG ++ +   H         V T  Y APE++
Sbjct: 143 ANVLHRDLKPSNLLLNTTXD--LKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + +  +     +   RE+   + ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 94  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 152 YIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 205
Query: 171 L 171
           +
Sbjct: 206 M 206

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 31  AVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTH--LAIVMEYAAGGEL--- 85
           A+K IE G  I  +  REI   R L+HPN+I  ++V L+     + ++ +YA        
Sbjct: 52  ALKQIE-GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHII 110
Query: 86  -FDRICNAGR----FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLL--DGSAAPR 138
            F R   A +          +    Q++ G++Y H+  + HRDLK  N L+  +G    R
Sbjct: 111 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170
Query: 139 LKICDFGYSKSSVLHSRP----KSTVGTPAYIAPEVL 171
           +KI D G+++      +P       V T  Y APE+L
Sbjct: 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 207

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI D+G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDYGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 87/184 (47%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV E    G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 168 AVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREY 176
            R++
Sbjct: 224 YRKF 227

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 87/184 (47%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV E    G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 80  IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 139 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 173 RREY 176
            R++
Sbjct: 195 YRKF 198

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G FG       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 139 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK 190

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 83/197 (42%), Gaps = 31/197 (15%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           +E +  LG G FG     R+       A+K I    +    +  E+    SL H  ++R+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRY 67
Query: 64  KEVVL-------------TPTHLAIVMEYAAGGELFDRICNAGRFSE-DEGRYFFQQLIS 109
               L               + L I  EY     L+D I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-----SVL----HSRPKST- 159
            ++Y HS  I HR+LK  N  +D S    +KI DFG +K+      +L     + P S+ 
Sbjct: 128 ALSYIHSQGIIHRNLKPXNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 160 -----VGTPAYIAPEVL 171
                +GT  Y+A EVL
Sbjct: 186 NLTSAIGTAXYVATEVL 202

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 87/184 (47%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +GAG FG   +  L+    KE+ VA+K ++ G    E   R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV     + IV E    G L  F R  +A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE ++
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 173 RREY 176
            R++
Sbjct: 224 YRKF 227

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 20/156 (12%)
Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +L K LGAG FG V     +K TK  VAVK ++ G    E    E    ++L+H  +
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKL 239
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--------FFQQLISGVN 112
           ++   VV T   + I+ E+ A G L D +        DEG          F  Q+  G+ 
Sbjct: 240 VKLHAVV-TKEPIYIITEFMAKGSLLDFL------KSDEGSKQPLPKLIDFSAQIAEGMA 292
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           +       HRDL+  N L+  SA+   KI DFG ++
Sbjct: 293 FIEQRNYIHRDLRAANILV--SASLVCKIADFGLAR 326

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 70/156 (44%), Gaps = 20/156 (12%)
Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +L K LGAG FG V     +K TK  VAVK ++ G    E    E    ++L+H  +
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKL 72
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--------FFQQLISGVN 112
           ++   VV T   + I+ E+ A G L D +        DEG          F  Q+  G+ 
Sbjct: 73  VKLHAVV-TKEPIYIITEFMAKGSLLDFL------KSDEGSKQPLPKLIDFSAQIAEGMA 125
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           +       HRDL+  N L+  S     KI DFG ++
Sbjct: 126 FIEQRNYIHRDLRAANILVSASLV--CKIADFGLAR 159

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 20/156 (12%)
Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +L K LGAG FG V     +K TK  VAVK ++ G    E    E    ++L+H  +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKL 245
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY--------FFQQLISGVN 112
           ++   VV T   + I+ E+ A G L D +        DEG          F  Q+  G+ 
Sbjct: 246 VKLHAVV-TKEPIYIITEFMAKGSLLDFL------KSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           +       HRDL+  N L+  SA+   KI DFG ++
Sbjct: 299 FIEQRNYIHRDLRAANILV--SASLVCKIADFGLAR 332

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++   A   LKI DFG ++++         V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 76/176 (43%), Gaps = 21/176 (11%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-----RGRKIDENVAREIINHRSLRHPNIIRFK 64
           +G G FGV  + +       VAVK +         ++ +   +EI      +H N++   
Sbjct: 39  MGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRI-CNAGR--FSEDEGRYFFQQLISGVNYCHSMQICH 121
                   L +V  Y   G L DR+ C  G    S        Q   +G+N+ H     H
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 156
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSS------VLHSRPKSTVGTPAYIAPEVL 171
           RD+K  N LLD   A   KI DFG +++S      V+ SR    VGT AY+APE L
Sbjct: 157 RDIKSANILLD--EAFTAKISDFGLARASEKFAQTVMXSR---IVGTTAYMAPEAL 207

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++   A   LKI DFG ++++         V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++   A   LKI DFG ++++         V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 4   YELVKD-LGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREI-INHRSLRHPNI 60
           Y+L +D LG G     +   +  T +  AVK IE+    I   V RE+ + ++   H N+
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNV 73
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +   E         +V E   GG +   I     F+E E     Q + S +++ H+  I 
Sbjct: 74  LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 121 HRDLKLENTLLD--GSAAPRLKICDFGYSKSSVLH--SRPKST------VGTPAYIAPEV 170
           HRDLK EN L +     +P +KICDF       L+    P ST       G+  Y+APEV
Sbjct: 134 HRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 171 L 171
           +
Sbjct: 193 V 193

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 20/173 (11%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNIIRFKEV 66
           +G+G +G       K + E VA+K + R  + +   +   RE++  + ++H N+I   +V
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 67  VLTPTHL------AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
               + L       +VM +        +I    +FSE++ +Y   Q++ G+ Y HS  + 
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTD--LQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
           HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APEV+
Sbjct: 149 HRDLKPGNLAVNEDC--ELKILDFGLAR----HADAEMTGYVVTRWYRAPEVI 195

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++   A   LKI DFG ++++         V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 33/190 (17%)
Query: 8   KDLGAGNFG---VARLLRHKETKEL-VAVKYIERG----RKIDENVAREIINHRSLRHPN 59
           K +GAG FG      L      KE+ VA+K ++ G    +++D      I+   S  H N
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHN 107
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI-------SGVN 112
           IIR + V+     + I+ EY   G L D+        E +G +   QL+       +G+ 
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGAL-DKF-----LREKDGEFSVLQLVGMLRGIAAGMK 161
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YI 166
           Y  +M   HRDL   N L++ +     K+ DFG S+  VL   P++T  T        + 
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEATYTTSGGKIPIRWT 217
Query: 167 APEVLSRREY 176
           APE +S R++
Sbjct: 218 APEAISYRKF 227

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I++E+   G L D  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 139 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK 190

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 21/180 (11%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNIIRFKEV 66
           +G+G +G       K + E VA+K + R  + +   +   RE++  + ++H N+I   +V
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 67  VLTPTHL------AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
               + L       +VM +        +I     FSE++ +Y   Q++ G+ Y HS  + 
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTD--LQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVV 166
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV-LSRREYD 177
           HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APEV LS   Y+
Sbjct: 167 HRDLKPGNLAVNEDC--ELKILDFGLAR----HADAEMTGYVVTRWYRAPEVILSWMHYN 220

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 87/188 (46%), Gaps = 15/188 (7%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR------EIIN-HR 53
           M++YE+   +G G+FG       +  +E VA+K I + +K   N A+      E++N H 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHD 111
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGV 111
           +     I+  K   +   HL +V E  +   L+D  R  N    S +  R F QQ+ + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 112 NYCHS--MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
            +  +  + I H DLK EN LL       +KI DFG   S  L  R    + +  Y +PE
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPE 228
Query: 170 VLSRREYD 177
           VL    YD
Sbjct: 229 VLLGMPYD 236

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 82  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DF  ++    H+  + T  V T  Y APE+
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDC--ELKILDFYLAR----HTDDEMTGYVATRWYRAPEI 193
Query: 171 L 171
           +
Sbjct: 194 M 194

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 87/188 (46%), Gaps = 15/188 (7%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR------EIIN-HR 53
           M++YE+   +G G+FG       +  +E VA+K I + +K   N A+      E++N H 
Sbjct: 34  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHD 92
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGV 111
           +     I+  K   +   HL +V E  +   L+D  R  N    S +  R F QQ+ + +
Sbjct: 93  TEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMCTAL 151
Query: 112 NYCHS--MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
            +  +  + I H DLK EN LL       +KI DFG   S  L  R    + +  Y +PE
Sbjct: 152 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPE 209
Query: 170 VLSRREYD 177
           VL    YD
Sbjct: 210 VLLGMPYD 217

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I++E+   G L D  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK 192

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 17/178 (9%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNI 60
           Y  ++ +G+G +G         T   VA+K + R  + +   +   RE+   + +RH N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 61  IRFKEVVLTP-------THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           I   +V  TP       T   +VM +   G    ++    +  ED  ++   Q++ G+ Y
Sbjct: 87  IGLLDV-FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            H+  I HRDLK  N  ++      LKI DFG ++ +   S     V T  Y APEV+
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQA--DSEMXGXVVTRWYRAPEVI 197

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 87/188 (46%), Gaps = 15/188 (7%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR------EIIN-HR 53
           M++YE+   +G G+FG       +  +E VA+K I + +K   N A+      E++N H 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHD 111
Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGV 111
           +     I+  K   +   HL +V E  +   L+D  R  N    S +  R F QQ+ + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 112 NYCHS--MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
            +  +  + I H DLK EN LL       +KI DFG   S  L  R    + +  Y +PE
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPE 228
Query: 170 VLSRREYD 177
           VL    YD
Sbjct: 229 VLLGMPYD 236

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 72/174 (41%), Gaps = 6/174 (3%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 128 NTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+  +   ++ P        + APE L+  ++  K
Sbjct: 143 NCLVGENHL--VKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK 194

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 72/174 (41%), Gaps = 6/174 (3%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 82  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 141
Query: 128 NTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+  +   ++ P        + APE L+  ++  K
Sbjct: 142 NCLVGENHL--VKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK 193

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I++E+   G L D  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK 192

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 81/195 (41%), Gaps = 29/195 (14%)
Query: 3   KYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREI--INHRSLRHPN 59
           +YE+V  LG G FG V   + HK     VAVK ++   +  E    EI  + H +   PN
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 60  ----IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNY 113
                ++  E      H+ IV E   G   +D I   G   F  D  R    Q+   VN+
Sbjct: 75  STFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 114 CHSMQICHRDLKLENTLL---DGSAA--------------PRLKICDFGYSKSSVLHSRP 156
            HS ++ H DLK EN L    D + A              P +K+ DFG +     H   
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-- 191
Query: 157 KSTVGTPAYIAPEVL 171
            + V    Y APEV+
Sbjct: 192 STLVXXRHYRAPEVI 206

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 11/148 (7%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRK--ID-ENVAREIINHRSLRHPNIIRFKEV 66
           +G G++G   L   K T++ VA+K + R  +  ID + + REI     L+   IIR  ++
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 67  V-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           +     L    L IV+E  A  +L          +E+  +     L+ G N+ H   I H
Sbjct: 94  IIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIH 152
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKS 149
           RDLK  N LL+   +  +K+CDFG +++
Sbjct: 153 RDLKPANCLLNQDCS--VKVCDFGLART 178

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 84/180 (46%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI  FG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILGFGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 77/177 (43%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 77/177 (43%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 77/177 (43%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHL 135
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 13/157 (8%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--ID-ENVAREIINHRSLRHP 58
           ++YE+   +G G++G       K  K +VA+K I R  +  ID + + REI     L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 59  NIIRFKEVVLTPT-----HLAIVMEYAAGGELFDRICNAGRF-SEDEGRYFFQQLISGVN 112
           ++++  ++V+         L +V+E A     F ++     + +E   +     L+ GV 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
           Y HS  I HRDLK  N L++   +  +K+CDFG +++
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLART 205

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 78/177 (44%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 77/177 (43%), Gaps = 8/177 (4%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGR--YFFQQLISGVNYC 114
            NII    V      L    +     EL D  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK 197

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 82  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI D G ++    H+  + T  V T  Y APE+
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDC--ELKILDAGLAR----HTDDEMTGYVATRWYRAPEI 193
Query: 171 L 171
           +
Sbjct: 194 M 194

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK 192

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I++E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 82  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 141
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 142 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK 193

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK 192

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 75/176 (42%), Gaps = 21/176 (11%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-----RGRKIDENVAREIINHRSLRHPNIIRFK 64
           +G G FGV  + +       VAVK +         ++ +   +EI      +H N++   
Sbjct: 33  MGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 90
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRI-CNAGR--FSEDEGRYFFQQLISGVNYCHSMQICH 121
                   L +V  Y   G L DR+ C  G    S        Q   +G+N+ H     H
Sbjct: 91  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 150
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSS------VLHSRPKSTVGTPAYIAPEVL 171
           RD+K  N LLD   A   KI DFG +++S      V+  R    VGT AY+APE L
Sbjct: 151 RDIKSANILLD--EAFTAKISDFGLARASEKFAQXVMXXR---IVGTTAYMAPEAL 201

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 81/192 (42%), Gaps = 21/192 (10%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNIIR 62
           Y  ++ LG G F    L+         A+K I    + D E   RE   HR   HPNI+R
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 63  FKEVVL---TPTHLA-IVMEYAAGGELFD---RICNAGRF-SEDEGRYFFQQLISGVNYC 114
                L      H A +++ +   G L++   R+ + G F +ED+  +    +  G+   
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH---SRPKSTVG-------TPA 164
           H+    HRDLK  N LL     P L   D G    + +H   SR   T+        T +
Sbjct: 151 HAKGYAHRDLKPTNILLGDEGQPVLM--DLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 165 YIAPEVLSRREY 176
           Y APE+ S + +
Sbjct: 209 YRAPELFSVQSH 220

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 139 NCLVGENHL--VKVADFGLSRLMTGDTFTAHAGAKFPI---KWTAPESLAYNKFSIK 190

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 75/176 (42%), Gaps = 21/176 (11%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-----RGRKIDENVAREIINHRSLRHPNIIRFK 64
           +G G FGV  + +       VAVK +         ++ +   +EI      +H N++   
Sbjct: 39  MGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 65  EVVLTPTHLAIVMEYAAGGELFDRI-CNAGR--FSEDEGRYFFQQLISGVNYCHSMQICH 121
                   L +V  Y   G L DR+ C  G    S        Q   +G+N+ H     H
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 156
Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSS------VLHSRPKSTVGTPAYIAPEVL 171
           RD+K  N LLD   A   KI DFG +++S      V+  R    VGT AY+APE L
Sbjct: 157 RDIKSANILLD--EAFTAKISDFGLARASEKFAQTVMXXR---IVGTTAYMAPEAL 207

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPT------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V  TP       +   ++ +  G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 82  NVIGLLDV-FTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI D G ++    H+  + T  V T  Y APE+
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDC--ELKILDGGLAR----HTDDEMTGYVATRWYRAPEI 193
Query: 171 L 171
           +
Sbjct: 194 M 194

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 84/180 (46%), Gaps = 17/180 (9%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G +L + I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDRGLAR----HTDDEMTGYVATRWYRAPEIM 194

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 13/178 (7%)
Query: 3   KYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP--- 58
           +YE++K +G G+FG V +   HK   + VA+K +   ++     A EI     LR     
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHK-VHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 59  ---NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
              N+I   E      H+ +  E  +    EL  +    G FS    R F   ++  ++ 
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDA 215
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            H  +I H DLK EN LL       +K+ DFG   S   H R  + + +  Y APEV+
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVI 271

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 77/172 (44%), Gaps = 11/172 (6%)
Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRF 63
           ++ +G+G +G          ++ VAVK + R  +         RE+   + L+H N+I  
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 64  KEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
            +V    T +     + +     G   + I  +   S++  ++   QL+ G+ Y HS  I
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGI 152
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            HRDLK  N  ++  +   L+I DFG ++ +         V T  Y APE++
Sbjct: 153 IHRDLKPSNVAVNEDS--ELRILDFGLARQA--DEEMTGYVATRWYRAPEIM 200

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I++E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK 197

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 13/178 (7%)
Query: 3   KYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP--- 58
           +YE++K +G G+FG V +   HK   + VA+K +   ++     A EI     LR     
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHK-VHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 59  ---NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
              N+I   E      H+ +  E  +    EL  +    G FS    R F   ++  ++ 
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDA 215
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            H  +I H DLK EN LL       +K+ DFG   S   H R  + + +  Y APEV+
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVI 271

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 12/180 (6%)
Query: 4   YELVKDL-GAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-VAREIIN-HRSLRHPNI 60
           Y+L  +L G G +   +     +  +  AVK IE+      + V RE+   ++   + NI
Sbjct: 14  YKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNI 73
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +   E     T   +V E   GG +   I     F+E E     + + + +++ H+  I 
Sbjct: 74  LELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIA 133
Query: 121 HRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLH------SRPKSTV--GTPAYIAPEVL 171
           HRDLK EN L +       +KICDF       L+      + P+ T   G+  Y+APEV+
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK 197

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 84/184 (45%), Gaps = 24/184 (13%)
Query: 10  LGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNIIR 62
           +GAG FG   +  L+    +E+ VA+K ++ G    E   R+ ++  S+     HPN+I 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIH 98
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
            + VV   T + I+ E+   G L  F R  N G+F+  +     + + +G+ Y   M   
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 157
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA--------YIAPEVLS 172
           HRDL   N L++ +     K+ DFG S+   L         T A        + APE + 
Sbjct: 158 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 213
Query: 173 RREY 176
            R++
Sbjct: 214 YRKF 217

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 79/185 (42%), Gaps = 23/185 (12%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF------ 63
           +G+G FG     +H+   +   +K ++     +E   RE+     L H NI+ +      
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKAEREVKALAKLDHVNIVHYNGCWDG 75
Query: 64  ---------KEVVLTPTH-LAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGV 111
                    K    + T  L I ME+   G L   I      +  +      F+Q+  GV
Sbjct: 76  FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGV 135
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           +Y HS ++ +RDLK  N  L      ++KI DFG   S     +   + GT  Y++PE +
Sbjct: 136 DYIHSKKLINRDLKPSNIFL--VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQI 193
Query: 172 SRREY 176
           S ++Y
Sbjct: 194 SSQDY 198

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 73/175 (41%), Gaps = 21/175 (12%)
Query: 11  GAGNFGVARLLRHKETKELVAVKYIE-----RGRKIDENVAREIINHRSLRHPNIIRFKE 65
           G G FGV  + +       VAVK +         ++ +   +EI      +H N++    
Sbjct: 31  GEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHR 122
                  L +V  Y   G L DR+ C  G    S        Q   +G+N+ H     HR
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHR 148
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKSS------VLHSRPKSTVGTPAYIAPEVL 171
           D+K  N LLD   A   KI DFG +++S      V  SR    VGT AY APE L
Sbjct: 149 DIKSANILLD--EAFTAKISDFGLARASEKFAQXVXXSR---IVGTTAYXAPEAL 198

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 9/175 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN---VAREIINHRSLRHP 58
           +  E + +LG G +GV   +RH  + +++AVK I       E    +    I+ R++  P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 59  NIIRFKEVVLTPTHLAIVMEY--AAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCH 115
             + F   +     + I ME    +  + + ++ + G+   ED        ++  + + H
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 116 S-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
           S + + HRD+K  N L++  A  ++K+CDFG S   V         G   Y+APE
Sbjct: 127 SKLSVIHRDVKPSNVLIN--ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE 179

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK 197

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK 197

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 143 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK 194

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 11/172 (6%)
Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRF 63
           ++ +G+G +G          ++ VAVK + R  +         RE+   + L+H N+I  
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 64  KEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
            +V    T +     + +     G   + I      S++  ++   QL+ G+ Y HS  I
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGI 152
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            HRDLK  N  ++  +   L+I DFG ++ +         V T  Y APE++
Sbjct: 153 IHRDLKPSNVAVNEDS--ELRILDFGLARQA--DEEMTGYVATRWYRAPEIM 200

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 85  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 144
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 145 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK 196

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 143 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK 194

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK 192

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 75/166 (45%), Gaps = 7/166 (4%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           +G+G+FG     +      +  +K ++   +  +    E+   R  RH NI+ F    +T
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY-MT 102
Query: 70  PTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLEN 128
             +LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRD+K  N
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNN 162
Query: 129 TLLDGSAAPRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVL 171
             L       +KI DFG +      S   + +   G+  ++APEV+
Sbjct: 163 IFLHEGLT--VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVI 206

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 9/175 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN---VAREIINHRSLRHP 58
           +  E + +LG G +GV   +RH  + +++AVK I       E    +    I+ R++  P
Sbjct: 51  DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 110
Query: 59  NIIRFKEVVLTPTHLAIVMEY--AAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCH 115
             + F   +     + I ME    +  + + ++ + G+   ED        ++  + + H
Sbjct: 111 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 170
Query: 116 S-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
           S + + HRD+K  N L++  A  ++K+CDFG S   V         G   Y+APE
Sbjct: 171 SKLSVIHRDVKPSNVLIN--ALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPE 223

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 94  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 153
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 154 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK 205

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK 192

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--ID-ENVAREIINHRSLRHP 58
           + YE+   +G G++G   L   K   + VA+K + R  +  ID + + REI     L+  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 59  NIIRFKEVV-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
            IIR  +++     L    L IV+E  A  +L          +E   +     L+ G  +
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
            H   I HRDLK  N LL+   +  +KICDFG +++
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCS--VKICDFGLART 180

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG---VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +G+G+ G     RL    +    VA+K ++ G    E   R+ ++  S+     HPNI
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNI 112
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV       IV EY   G L  F R  + G+F+  +     + + +G+ Y   + 
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L+D +     K+ DFG S+  VL   P +   T        + APE ++
Sbjct: 172 YVHRDLAARNVLVDSNLV--CKVSDFGLSR--VLEDDPDAAXTTTGGKIPIRWTAPEAIA 227
Query: 173 RREY 176
            R +
Sbjct: 228 FRTF 231

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 44/78 (56%), Gaps = 3/78 (3%)
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT 162
            F+Q+  GV+Y HS ++ HRDLK  N  L      ++KI DFG   S     +   + GT
Sbjct: 141 LFEQITKGVDYIHSKKLIHRDLKPSNIFL--VDTKQVKIGDFGLVTSLKNDGKRTRSKGT 198
Query: 163 PAYIAPEVLSRREYDGKQ 180
             Y++PE +S ++Y GK+
Sbjct: 199 LRYMSPEQISSQDY-GKE 215

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 22/184 (11%)
Query: 8   KDLGAGNFG---VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR----HPNI 60
           K +G+G+ G     RL    +    VA+K ++ G    E   R+ ++  S+     HPNI
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNI 112
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           IR + VV       IV EY   G L  F R  + G+F+  +     + + +G+ Y   + 
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLS 172
             HRDL   N L+D +     K+ DFG S+  VL   P +   T        + APE ++
Sbjct: 172 YVHRDLAARNVLVDSNLV--CKVSDFGLSR--VLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 173 RREY 176
            R +
Sbjct: 228 FRTF 231

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 11/172 (6%)
Query: 7   VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRF 63
           ++ +G+G +G          ++ VAVK + R  +         RE+   + L+H N+I  
Sbjct: 25  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 64  KEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
            +V    T +     + +     G   + I      S++  ++   QL+ G+ Y HS  I
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGI 144
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            HRDLK  N  ++      L+I DFG ++ +         V T  Y APE++
Sbjct: 145 IHRDLKPSNVAVNEDC--ELRILDFGLARQA--DEEMTGYVATRWYRAPEIM 192

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 68/147 (46%), Gaps = 9/147 (6%)
Query: 10  LGAGNFGVA---RLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHPNIIRFK 64
           +G G+FGV      +   + +   A+K + R  ++   E   RE +  R L HPN++   
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 65  EVVLTPTHLA-IVMEYAAGGELFDRICNAGRFSEDEGRYFF-QQLISGVNYCHSMQICHR 122
            ++L P  L  +++ Y   G+L   I +  R    +    F  Q+  G+ Y    +  HR
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHR 148
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKS 149
           DL   N +LD S    +K+ DFG ++ 
Sbjct: 149 DLAARNCMLDESFT--VKVADFGLARD 173

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 3   KYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP--- 58
           +YE++K +G G FG V +   HK   + VA+K +   ++     A EI     LR     
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHK-VHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 59  ---NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
              N+I   E      H+ +  E  +    EL  +    G FS    R F   ++  ++ 
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDA 215
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            H  +I H DLK EN LL       +K+ DFG   S   H R    + +  Y APEV+
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYXXIQSRFYRAPEVI 271

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    S     Y   Q+ S + Y       HR+L   
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 347
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 348 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK 399

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 20/162 (12%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNII 61
           +Y  +K LG G  G+       +  + VA+K I     +  ++  REI   R L H NI+
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 62  RFKEVVLTPT---------------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQ 106
           +  E+ L P+                + IV EY         +   G   E+  R F  Q
Sbjct: 72  KVFEI-LGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPLLEEHARLFMYQ 128
Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           L+ G+ Y HS  + HRDLK  N  ++      LKI DFG ++
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDL-VLKIGDFGLAR 169

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 22  RHKETKELVAVKY---IERGRKIDENVAREIINHRSLRHPNIIRF--KEVVLTPTHLAIV 76
           RHK+T +L A+K    I   R +D  + RE    + L H NI++    E   T  H  ++
Sbjct: 29  RHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87
Query: 77  MEYAAGGELFDRI---CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLL-- 131
           ME+   G L+  +    NA    E E     + ++ G+N+     I HR++K  N +   
Sbjct: 88  MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147
Query: 132 --DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
             DG +    K+ DFG ++      +  S  GT  Y+ P++  R
Sbjct: 148 GEDGQSV--YKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 83/180 (46%), Gaps = 16/180 (8%)
Query: 9   DLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDEN----VAREIINHRSLRHPNIIRF 63
           ++G G+F    + +  +T+  V V + E + RK+ ++       E    + L+HPNI+RF
Sbjct: 33  EIGRGSFKT--VYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 64  ----KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ- 118
               +  V     + +V E    G L   +           R + +Q++ G+ + H+   
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 119 -ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            I HRDLK +N  + G     +KI D G + +    S  K+ +GTP + APE    + YD
Sbjct: 151 PIIHRDLKCDNIFITGPTGS-VKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXYEEK-YD 207

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 84/192 (43%), Gaps = 25/192 (13%)
Query: 5   ELVKDLGA---GNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-----RSLR 56
           E +KDLG    G +G    + HK + +++AVK I     +DE   ++++       RS  
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS--TVDEKEQKQLLMDLDVVMRSSD 79
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE-------GRYFFQQLIS 109
            P I++F   +       I ME  +    FD+         D+       G+     + +
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
             +   +++I HRD+K  N LLD S    +K+CDFG S   V         G   Y+APE
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 195
Query: 170 VL----SRREYD 177
            +    SR+ YD
Sbjct: 196 RIDPSASRQGYD 207

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 22/182 (12%)
Query: 10  LGAGNFG---VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR----HPNIIR 62
           +GAG FG     RL    +    VA+K ++ G    E   R+ +   S+     HPN++ 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT--EKQRRDFLCEASIMGQFDHPNVVH 108
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
            + VV     + IV+E+   G L  F R  + G+F+  +     + + +G+ Y   M   
Sbjct: 109 LEGVVTRGKPVMIVIEFMENGALDAFLR-KHDGQFTVIQLVGMLRGIAAGMRYLADMGYV 167
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  V+   P++   T        + APE +  R
Sbjct: 168 HRDLAARNILVNSNLV--CKVSDFGLSR--VIEDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 175 EY 176
           ++
Sbjct: 224 KF 225

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 69/156 (44%), Gaps = 20/156 (12%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +L+K LG G FG   +   +  TK  VA+K ++ G    E+   E    + L+H  +
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTK--VAIKTLKPGTMSPESFLEEAQIMKKLKHDKL 66
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVN 112
           ++   VV +   + IV EY   G L D +       + EGR            Q+ +G+ 
Sbjct: 67  VQLYAVV-SEEPIYIVTEYMNKGSLLDFL------KDGEGRALKLPNLVDMAAQVAAGMA 119
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           Y   M   HRDL+  N L+        KI DFG ++
Sbjct: 120 YIERMNYIHRDLRSANILVGNGLI--CKIADFGLAR 153

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 15/170 (8%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 32  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +  +  +F   +     +Q   G++Y H+  I HRDL
Sbjct: 88  YSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVL 171
           K  N  L       +KI DFG +      S   + +   G+  ++APEV+
Sbjct: 147 KSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           SM I HRD+K  N L+D     +L++ D+G ++           V +  +  PE+L
Sbjct: 149 SMGIMHRDVKPHNVLIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT 69
           LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V   
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 326
Query: 70  PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLE 127
                I+ E+   G L D  R CN    +     Y   Q+ S + Y       HR+L   
Sbjct: 327 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 386
Query: 128 NTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K
Sbjct: 387 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK 438

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 15/170 (8%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 32  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +  +  +F   +     +Q   G++Y H+  I HRDL
Sbjct: 88  YSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVL 171
           K  N  L       +KI DFG +      S   + +   G+  ++APEV+
Sbjct: 147 KSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 37/206 (17%)
Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI------ERGRKIDENVAREIINHRSLRH 57
           + +++ +G G FG   L +H + K+  AVK +       R  KI+ ++ ++I  +  + +
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKI-QNDDINN 95
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC--NAGRFSEDEGRYFFQQLISGVNYCH 115
            NI+++    +   H+ ++ E   G  L++ I   N   F  ++ + +  +++  +NY  
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 116 SMQICHRDLKLENTLLDG-----------------------SAAPRLKICDFGYSK-SSV 151
            M + H DLK EN LLD                        + +  +K+ DFG +   S 
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214
Query: 152 LHSRPKSTVGTPAYIAPEVLSRREYD 177
            H    S + T  Y APEV+    +D
Sbjct: 215 YHG---SIINTRQYRAPEVILNLGWD 237

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 24/184 (13%)
Query: 10  LGAGNFG--VARLLRHKETKEL-VAVKYIERGRKIDENVAREIINHRSLR----HPNIIR 62
           +GAG FG   +  L+    +E+ VA+K ++ G    E   R+ ++  S+     HPN+I 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIH 72
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
            + VV   T + I+ E+   G L  F R  N G+F+  +     + + +G+ Y   M   
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 131
Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA--------YIAPEVLS 172
           HR L   N L++ +     K+ DFG S+   L         T A        + APE + 
Sbjct: 132 HRALAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 173 RREY 176
            R++
Sbjct: 188 YRKF 191

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 52/110 (47%), Gaps = 4/110 (3%)
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRDLKL 126
           T   L +V+    GG+L   I + G+  F E    ++  ++  G+   H  +I +RDLK 
Sbjct: 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314
Query: 127 ENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           EN LLD      ++I D G +         K  VGT  Y+APEV+    Y
Sbjct: 315 ENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 362

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 15/164 (9%)
Query: 22  RHKETKELVAVKY---IERGRKIDENVAREIINHRSLRHPNIIRF--KEVVLTPTHLAIV 76
           RHK+T +L A+K    I   R +D  + RE    + L H NI++    E   T  H  ++
Sbjct: 29  RHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87
Query: 77  MEYAAGGELFDRI---CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLL-- 131
           ME+   G L+  +    NA    E E     + ++ G+N+     I HR++K  N +   
Sbjct: 88  MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147
Query: 132 --DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
             DG +    K+ DFG ++      +     GT  Y+ P++  R
Sbjct: 148 GEDGQSV--YKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYER 189

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 82/196 (41%), Gaps = 29/196 (14%)
Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREI-----INHRSL 55
           E+YE+V  LG G FG V + + H+     VA+K I+   K  E    EI     IN +  
Sbjct: 33  ERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDP 92
Query: 56  RHPNI-IRFKEVVLTPTHLAIVMEYAAGGELFDRI--CNAGRFSEDEGRYFFQQLISGVN 112
            + N+ ++  +      H+ I  E   G   FD +   N   +   + R+   QL   V 
Sbjct: 93  DNKNLCVQMFDWFDYHGHMCISFE-LLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVK 151
Query: 113 YCHSMQICHRDLKLENTLLDGS-----------------AAPRLKICDFGYSKSSVLHSR 155
           + H  ++ H DLK EN L   S                  +  +++ DFG   ++  H  
Sbjct: 152 FLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFG--SATFDHEH 209
Query: 156 PKSTVGTPAYIAPEVL 171
             + V T  Y APEV+
Sbjct: 210 HSTIVSTRHYRAPEVI 225

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 79/171 (46%), Gaps = 17/171 (9%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 20  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +  +  +F   +     +Q   G++Y H+  I HRDL
Sbjct: 76  YSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 134
Query: 125 KLENTLLDGSAAPRLKICDFGY----SKSSVLHSRPKSTVGTPAYIAPEVL 171
           K  N  L       +KI DFG     S+ S  H   + + G+  ++APEV+
Sbjct: 135 KSNNIFLHEDNT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMAPEVI 182

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 73/185 (39%), Gaps = 10/185 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR---HP 58
           E   L + +G GNFG     R +    LVAVK        D   A+ +   R L+   HP
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK-AKFLQEARILKQYSHP 172
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSM 117
           NI+R   V      + IVME   GG+    +   G R              +G+ Y  S 
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV--LHSRPKSTVGTPA-YIAPEVLSRR 174
              HRDL   N L+       LKI DFG S+     +++        P  + APE L+  
Sbjct: 233 CCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 175 EYDGK 179
            Y  +
Sbjct: 291 RYSSE 295

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 79/179 (44%), Gaps = 26/179 (14%)
Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRHPNI 60
           E + ++G+G  G    +R ++T  ++AVK + R    +EN  R +++     +S   P I
Sbjct: 28  ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN-KRILMDLDVVLKSHDCPYI 86
Query: 61  IRFKEVVLTPTHLAIVMEYAAG----------GELFDRICNAGRFSEDEGRYFFQQLISG 110
           ++     +T T + I ME              G + +RI      +  +  Y+ ++    
Sbjct: 87  VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---- 142
Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
                   + HRD+K  N LLD     ++K+CDFG S   V       + G  AY+APE
Sbjct: 143 -----KHGVIHRDVKPSNILLDERG--QIKLCDFGISGRLVDDKAKDRSAGCAAYMAPE 194

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 52/110 (47%), Gaps = 4/110 (3%)
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRDLKL 126
           T   L +V+    GG+L   I + G+  F E    ++  ++  G+   H  +I +RDLK 
Sbjct: 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314
Query: 127 ENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           EN LLD      ++I D G +         K  VGT  Y+APEV+    Y
Sbjct: 315 ENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 362

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 76
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 77  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 136 YIHRDLRAANILVSDTLS--CKIADFGLAR 163

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 23  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 80
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 81  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 139
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 140 YIHRDLRAANILVSDTLS--CKIADFGLAR 167

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 21  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 78
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 79  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 137
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 138 YIHRDLRAANILVSDTLS--CKIADFGLAR 165

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 22  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 80  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 138
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 139 YIHRDLRAANILVSDTLS--CKIADFGLAR 166

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 76
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 77  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 136 YIHRDLRAANILVSDTLS--CKIADFGLAR 163

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 67/155 (43%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IVMEY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 77  QLYAVV-SEEPIYIVMEYMSKGCLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 162

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 202

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 130 YIHRDLRAANILVSDTLS--CKIADFGLAR 157

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 146
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 130 YIHRDLRAANILVSDTLS--CKIADFGLAR 157

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 15  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 72
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 73  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 131
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 132 YIHRDLRAANILVSDTLS--CKIADFGLAR 159

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 18  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 76  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 134
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 135 YIHRDLRAANILVSDTLS--CKIADFGLAR 162

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 130 YIHRDLRAANILVSDTLS--CKIADFGLAR 157

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 202

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 14  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 71
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 72  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 130
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 131 YIHRDLRAANILVSDTLS--CKIADFGLAR 158

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 58  PNIIRFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 153
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L
Sbjct: 154 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 208

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 83/209 (39%), Gaps = 32/209 (15%)
Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHP 58
           +  +E ++ LG G FGV    ++K      A+K I    +    E V RE+     L HP
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63
Query: 59  NIIRFKEVVL-----------TP-THLAIVMEYAAGGELFDRICNAGRFSEDEGR---YF 103
            I+R+    L           +P  +L I M+      L D +       E E     + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 104 FQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY--------SKSSVL--- 152
           F Q+   V + HS  + HRDLK  N          +K+ DFG          + +VL   
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 153 --HSRPKSTVGTPAYIAPEVLSRREYDGK 179
             ++R    VGT  Y++PE +    Y  K
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHK 210

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 66
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 67  QLYAVV-SEEPIXIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAY 119
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 120 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 152

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 65
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 66  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 124
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 125 YIHRDLRAANILVSDTLS--CKIADFGLAR 152

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 61/151 (40%), Gaps = 7/151 (4%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR---HP 58
           E   L + +G GNFG     R +    LVAVK        D   A+ +   R L+   HP
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK-AKFLQEARILKQYSHP 172
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSM 117
           NI+R   V      + IVME   GG+    +   G R              +G+ Y  S 
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              HRDL   N L+       LKI DFG S+
Sbjct: 233 CCIHRDLAARNCLVTEKNV--LKISDFGMSR 261

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 4   YELVKDLGAGNFGVARLLR-HKETKELVAVKYI---ERGRKIDENVAREI--INHRSLRH 57
           Y ++K +G+G  G +++ +   E K++ A+KY+   E   +  ++   EI  +N      
Sbjct: 58  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAPEV 170
            I H DLK  N L+ DG     LK+ DFG +       +SV+     S VGT  Y+ PE 
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKD---SQVGTVNYMPPEA 227
Query: 171 L 171
           +
Sbjct: 228 I 228

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 58  PNIIRFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNII   ++V  P     A+V E+    + F ++      ++ + R++  +++  ++YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLRQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV+EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 77  QLYAVV-SEEPIYIVIEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 162

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 4   YELVKDLGAGNFGVARLLR-HKETKELVAVKYI---ERGRKIDENVAREI--INHRSLRH 57
           Y ++K +G+G  G +++ +   E K++ A+KY+   E   +  ++   EI  +N      
Sbjct: 11  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H  
Sbjct: 69  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAPEV 170
            I H DLK  N L+ DG     LK+ DFG +       +SV+     S VGT  Y+ PE 
Sbjct: 128 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKD---SQVGTVNYMPPEA 180
Query: 171 L 171
           +
Sbjct: 181 I 181

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 4   YELVKDLGAGNFGVARLLR-HKETKELVAVKYI---ERGRKIDENVAREI--INHRSLRH 57
           Y ++K +G+G  G +++ +   E K++ A+KY+   E   +  ++   EI  +N      
Sbjct: 30  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAPEV 170
            I H DLK  N L+ DG     LK+ DFG +       +SV+     S VGT  Y+ PE 
Sbjct: 147 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKD---SQVGTVNYMPPEA 199
Query: 171 L 171
           +
Sbjct: 200 I 200

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV+EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 77  QLYAVV-SEEPIYIVIEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 162

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 4   YELVKDLGAGNFGVARLLR-HKETKELVAVKYI---ERGRKIDENVAREI--INHRSLRH 57
           Y ++K +G+G  G +++ +   E K++ A+KY+   E   +  ++   EI  +N      
Sbjct: 58  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAPEV 170
            I H DLK  N L+ DG     LK+ DFG +       +SV+     S VGT  Y+ PE 
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKD---SQVGTVNYMPPEA 227
Query: 171 L 171
           +
Sbjct: 228 I 228

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 326 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKG------ETGKYLRLPQLVDMAAQIASGMAY 378
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 379 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 411

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 4   YELVKDLGAGNFGVARLLR-HKETKELVAVKYI---ERGRKIDENVAREI--INHRSLRH 57
           Y ++K +G+G  G +++ +   E K++ A+KY+   E   +  ++   EI  +N      
Sbjct: 14  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 71
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H  
Sbjct: 72  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 130
Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAPEV 170
            I H DLK  N L+ DG     LK+ DFG +       +SV+     S VGT  Y+ PE 
Sbjct: 131 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKD---SQVGTVNYMPPEA 183
Query: 171 L 171
           +
Sbjct: 184 I 184

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 69
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 70  QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAY 122
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 123 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 155

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 4   YELVKDLGAGNFGVARLLR-HKETKELVAVKYI---ERGRKIDENVAREI--INHRSLRH 57
           Y ++K +G+G  G +++ +   E K++ A+KY+   E   +  ++   EI  +N      
Sbjct: 10  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 67
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H  
Sbjct: 68  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 126
Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAPEV 170
            I H DLK  N L+ DG     LK+ DFG +       +SV+     S VGT  Y+ PE 
Sbjct: 127 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKD---SQVGTVNYMPPEA 179
Query: 171 L 171
           +
Sbjct: 180 I 180

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 296 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 328

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 296 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 328

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 77  QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 162

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 17/175 (9%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 16  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 72  YSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 125 KLENTLLDGSAAPRLKICDFGY----SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           K  N  L       +KI DFG     S+ S  H   + + G+  ++APEV+  ++
Sbjct: 131 KSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMAPEVIRMQD 182

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 65
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 66  QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 118
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 119 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 151

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 17/178 (9%)
Query: 4   YELVKDLGAGNFGVARLLR-HKETKELVAVKYI---ERGRKIDENVAREI--INHRSLRH 57
           Y ++K +G+G  G +++ +   E K++ A+KY+   E   +  ++   EI  +N      
Sbjct: 30  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTPAYIAPEVL 171
            I H DLK  N L+ DG     LK+ DFG +   +         S VGT  Y+ PE +
Sbjct: 147 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAI 200

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 67
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 68  QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 120
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 121 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 153

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 77  QLYAVV-SEEPIYIVCEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 162

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 15/174 (8%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 16  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 72  YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVLSRRE 175
           K  N  L       +KI DFG +      S   + +   G+  ++APEV+  ++
Sbjct: 131 KSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 22/187 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++ ++VK +G G +G   +   K   E VAVK      +       EI     +RH NI+
Sbjct: 37  KQIQMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENIL 94
Query: 62  RFKEVVL----TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS- 116
            F    +    + T L ++ +Y   G L+D + +    ++   +  +   +SG+ + H+ 
Sbjct: 95  GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS-VSGLCHLHTE 153
Query: 117 -------MQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPA 164
                    I HRDLK +N L+  +      I D G      S ++ +   P + VGT  
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 165 YIAPEVL 171
           Y+ PEVL
Sbjct: 212 YMPPEVL 218

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 17/175 (9%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 16  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 72  YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 125 KLENTLLDGSAAPRLKICDFGY----SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           K  N  L       +KI DFG     S+ S  H   + + G+  ++APEV+  ++
Sbjct: 131 KSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMAPEVIRMQD 182

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 74/183 (40%), Gaps = 22/183 (12%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF-- 63
           L + +G G FG   + R K   E VAVK      +       EI     LRH NI+ F  
Sbjct: 10  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 67
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
              +   T T L +V +Y   G LFD + N    + +          SG+ + H      
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 126
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 184
Query: 169 EVL 171
           EVL
Sbjct: 185 EVL 187

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 17/175 (9%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 21  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 77  YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 135
Query: 125 KLENTLLDGSAAPRLKICDFGY----SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           K  N  L       +KI DFG     S+ S  H   + + G+  ++APEV+  ++
Sbjct: 136 KSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMAPEVIRMQD 187

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 74/183 (40%), Gaps = 22/183 (12%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF-- 63
           L + +G G FG   + R K   E VAVK      +       EI     LRH NI+ F  
Sbjct: 8   LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 65
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
              +   T T L +V +Y   G LFD + N    + +          SG+ + H      
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 124
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 182
Query: 169 EVL 171
           EVL
Sbjct: 183 EVL 185

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 76/170 (44%), Gaps = 15/170 (8%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 44  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 100 YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 158
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVL 171
           K  N  L       +KI DFG +      S   + +   G+  ++APEV+
Sbjct: 159 KSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 206

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 64/152 (42%), Gaps = 18/152 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLV 243
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 244 QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 296
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
              M   HRDL+  N L+  +     K+ DFG
Sbjct: 297 VERMNYVHRDLRAANILVGENLV--CKVADFG 326

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 17/175 (9%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 18  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 74  YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 132
Query: 125 KLENTLLDGSAAPRLKICDFGY----SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           K  N  L       +KI DFG     S+ S  H   + + G+  ++APEV+  ++
Sbjct: 133 KSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMAPEVIRMQD 184

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 17/175 (9%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 21  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 77  YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 135
Query: 125 KLENTLLDGSAAPRLKICDFGY----SKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           K  N  L       +KI DFG     S+ S  H   + + G+  ++APEV+  ++
Sbjct: 136 KSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMAPEVIRMQD 187

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 74/183 (40%), Gaps = 22/183 (12%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF-- 63
           L + +G G FG   + R K   E VAVK      +       EI     LRH NI+ F  
Sbjct: 13  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 70
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
              +   T T L +V +Y   G LFD + N    + +          SG+ + H      
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 129
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 187
Query: 169 EVL 171
           EVL
Sbjct: 188 EVL 190

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 76/170 (44%), Gaps = 15/170 (8%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 36  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 92  YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 150
Query: 125 KLENTLLDGSAAPRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVL 171
           K  N  L       +KI DFG +      S   + +   G+  ++APEV+
Sbjct: 151 KSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 198

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 74/183 (40%), Gaps = 22/183 (12%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF-- 63
           L + +G G FG   + R K   E VAVK      +       EI     LRH NI+ F  
Sbjct: 7   LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 64
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
              +   T T L +V +Y   G LFD + N    + +          SG+ + H      
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 169 EVL 171
           EVL
Sbjct: 182 EVL 184

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 74/183 (40%), Gaps = 22/183 (12%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF-- 63
           L + +G G FG   + R K   E VAVK      +       EI     LRH NI+ F  
Sbjct: 33  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 90
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
              +   T T L +V +Y   G LFD + N    + +          SG+ + H      
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 149
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 150 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 207
Query: 169 EVL 171
           EVL
Sbjct: 208 EVL 210

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 38/77 (49%), Gaps = 7/77 (9%)
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP---RLKICDFGYSKSSVL----HSR 155
             QQ  SG+ + HS+ I HRDLK  N L+    A    +  I DFG  K   +     SR
Sbjct: 123 LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 156 PKSTVGTPAYIAPEVLS 172
                GT  +IAPE+LS
Sbjct: 183 RSGVPGTEGWIAPEMLS 199

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 243 QLYAVV-SEEPIYIVGEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 296 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 328

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 17/171 (9%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 43  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 99  YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 157
Query: 125 KLENTLLDGSAAPRLKICDFGY----SKSSVLHSRPKSTVGTPAYIAPEVL 171
           K  N  L       +KI DFG     S+ S  H   + + G+  ++APEV+
Sbjct: 158 KSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMAPEVI 205

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 17/171 (9%)
Query: 10  LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNIIRFKE 65
           +G+G+FG V +   H +    VAVK +       + +     E+   R  RH NI+ F  
Sbjct: 44  IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
               P  LAIV ++  G  L+  +     +F   +     +Q   G++Y H+  I HRDL
Sbjct: 100 YSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 158
Query: 125 KLENTLLDGSAAPRLKICDFGY----SKSSVLHSRPKSTVGTPAYIAPEVL 171
           K  N  L       +KI DFG     S+ S  H   + + G+  ++APEV+
Sbjct: 159 KSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMAPEVI 206

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 74/183 (40%), Gaps = 22/183 (12%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF-- 63
           L + +G G FG   + R K   E VAVK      +       EI     LRH NI+ F  
Sbjct: 46  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
              +   T T L +V +Y   G LFD + N    + +          SG+ + H      
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGY-----SKSSVLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 169 EVL 171
           EVL
Sbjct: 221 EVL 223

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 9   ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 66
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 67  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 125
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HR+L+  N L+  + +   KI DFG ++
Sbjct: 126 YIHRNLRAANILVSDTLS--CKIADFGLAR 153

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 65/155 (41%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY   G L D +        + G+Y           Q+ SG+ Y
Sbjct: 74  QLYAVV-SEEPIYIVTEYMNKGSLLDFL------KGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 127 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 159

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 65/155 (41%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 77  QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL   N L+  +     K+ DFG ++
Sbjct: 130 VERMNYVHRDLAAANILVGENLV--CKVADFGLAR 162

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 77/195 (39%), Gaps = 27/195 (13%)
Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E+YE+V +LG G FG V   L H   K  VA+K I    K  E    EI   + ++  + 
Sbjct: 51  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 110
Query: 61  -IRFKEVVLTPT-----HLAIVMEYAAGGEL-FDRICNAGRFSEDEGRYFFQQLISGVNY 113
             +F  V+++       H+ I  E        F +  N   +     R+   QL   + +
Sbjct: 111 ENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 170
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRL-----------------KICDFGYSKSSVLHSRP 156
            H  Q+ H DLK EN L   S    L                 ++ DFG   ++  H   
Sbjct: 171 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEHH 228
Query: 157 KSTVGTPAYIAPEVL 171
            + V T  Y  PEV+
Sbjct: 229 TTIVATRHYRPPEVI 243

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 65/155 (41%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY   G L D +        + G+Y           Q+ SG+ Y
Sbjct: 74  QLYAVV-SEEPIYIVTEYMNKGSLLDFL------KGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 127 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 159

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + +RH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 77  QLYAVV-SEEPIYIVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 162

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 77/195 (39%), Gaps = 27/195 (13%)
Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E+YE+V +LG G FG V   L H   K  VA+K I    K  E    EI   + ++  + 
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 61  -IRFKEVVLTPT-----HLAIVMEYAAGGEL-FDRICNAGRFSEDEGRYFFQQLISGVNY 113
             +F  V+++       H+ I  E        F +  N   +     R+   QL   + +
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRL-----------------KICDFGYSKSSVLHSRP 156
            H  Q+ H DLK EN L   S    L                 ++ DFG   ++  H   
Sbjct: 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEHH 196
Query: 157 KSTVGTPAYIAPEVL 171
            + V T  Y  PEV+
Sbjct: 197 TTIVATRHYRPPEVI 211

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 77/195 (39%), Gaps = 27/195 (13%)
Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E+YE+V +LG G FG V   L H   K  VA+K I    K  E    EI   + ++  + 
Sbjct: 28  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 87
Query: 61  -IRFKEVVLTPT-----HLAIVMEYAAGGEL-FDRICNAGRFSEDEGRYFFQQLISGVNY 113
             +F  V+++       H+ I  E        F +  N   +     R+   QL   + +
Sbjct: 88  ENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 147
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRL-----------------KICDFGYSKSSVLHSRP 156
            H  Q+ H DLK EN L   S    L                 ++ DFG   ++  H   
Sbjct: 148 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEHH 205
Query: 157 KSTVGTPAYIAPEVL 171
            + V T  Y  PEV+
Sbjct: 206 TTIVATRHYRPPEVI 220

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 23/181 (12%)
Query: 4   YELVKDLGAGNFGVARLLR-HKETKELVAVKYI---ERGRKIDENVAREI--INHRSLRH 57
           Y ++K +G+G  G +++ +   E K++ A+KY+   E   +  ++   EI  +N      
Sbjct: 58  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAPEV 170
            I H DLK  N L+ DG     LK+ DFG +       +SV+     S VG   Y+ PE 
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKD---SQVGAVNYMPPEA 227
Query: 171 L 171
           +
Sbjct: 228 I 228

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYF--------FQQLISGVNY 113
           +   VV +   + IV EY + G L D +        + G+Y           Q+ SG+ Y
Sbjct: 77  QLYAVV-SEEPIYIVTEYMSKGCLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              M   HRDL+  N L+  +     K+ DFG ++
Sbjct: 130 VERMNYVHRDLRAANILVGENLV--CKVADFGLAR 162

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 78/192 (40%), Gaps = 43/192 (22%)
Query: 7   VKDLGAG-NFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF-- 63
            +D+G+G  + + RLL ++E K    ++ +   +K+               HPNI++F  
Sbjct: 47  AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS-------------GHPNIVQFCS 93
Query: 64  ------KEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
                 +E         ++ E   G   E   ++ + G  S D     F Q    V + H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 116 SMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG------------ 161
             +  I HRDLK+EN LL       +K+CDFG S +++ H    S               
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGT--IKLCDFG-SATTISHYPDYSWSAQRRALVEEEITR 210
Query: 162 --TPAYIAPEVL 171
             TP Y  PE++
Sbjct: 211 NTTPMYRTPEII 222

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 77  NPHVCRLLGICLTST-VQLIMQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAKGM 131
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 132 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 166

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 8/150 (5%)
Query: 2   EKYELVKDLGAGNFGVARL-LRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG  G   +   +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 13  ETLKLVERLGAGQAGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 130 YIHRDLRAANILVSDTLS--CKIADFGLAR 157

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 61/138 (44%), Gaps = 24/138 (17%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSED---EGRY----FFQQLIS 109
           HPN+IR+     T   L I +E      L D + +     E+   +  Y      +Q+ S
Sbjct: 68  HPNVIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 110 GVNYCHSMQICHRDLKLENTLLD-----------GSAAPRLKICDFGYSK-----SSVLH 153
           GV + HS++I HRDLK +N L+            G+   R+ I DFG  K      S   
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 154 SRPKSTVGTPAYIAPEVL 171
           +   +  GT  + APE+L
Sbjct: 187 TNLNNPSGTSGWRAPELL 204

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 75/175 (42%), Gaps = 9/175 (5%)
Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN---VAREIINHRSLRHP 58
           +  E + +LG G +GV    RH  + ++ AVK I       E    +    I+ R++  P
Sbjct: 34  DDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCP 93
Query: 59  NIIRFKEVVLTPTHLAIVMEY--AAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCH 115
             + F   +     + I  E    +  + + ++ + G+   ED        ++  + + H
Sbjct: 94  FTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 153
Query: 116 S-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPE 169
           S + + HRD+K  N L++  A  ++K CDFG S   V         G   Y APE
Sbjct: 154 SKLSVIHRDVKPSNVLIN--ALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPE 206

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 24/193 (12%)
Query: 6   LVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPN 59
           L ++LG G FG   L     L  ++ K LVAVK ++       ++  RE     +L+H +
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELF--------DRICNA-----GRFSEDEGRYFFQQ 106
           I++F  V +    L +V EY   G+L         D +  A        ++ +  +  QQ
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 107 LISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--SVLHSRPKSTVGTPA 164
           + +G+ Y  S    HRDL   N L+  +    +KI DFG S+   S  + R       P 
Sbjct: 137 IAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 165 -YIAPEVLSRREY 176
            ++ PE +  R++
Sbjct: 195 RWMPPESIMYRKF 207

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 57/115 (49%), Gaps = 6/115 (5%)
Query: 59  NIIRFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NII+  + V  P     A+V EY    + F ++      ++ + R++  +L+  ++YCHS
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCHS 155
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
             I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L
Sbjct: 156 KGIMHRDVKPHNVMIDHQQK-KLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELL 209

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 57/115 (49%), Gaps = 6/115 (5%)
Query: 59  NIIRFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NII+  + V  P     A+V EY    + F ++      ++ + R++  +L+  ++YCHS
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCHS 150
Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
             I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L
Sbjct: 151 KGIMHRDVKPHNVMIDHQQK-KLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELL 204

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 13/126 (10%)
Query: 58  PNIIRFKEVV-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYD 177
             ++YD
Sbjct: 199 DLQDYD 204

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 13/126 (10%)
Query: 58  PNIIRFKEVVL-----TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 87  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 140
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 141 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 172 SRREYD 177
             ++YD
Sbjct: 200 DLQDYD 205

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 13/126 (10%)
Query: 58  PNIIRFKEVV-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYD 177
             ++YD
Sbjct: 199 DLQDYD 204

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 13/126 (10%)
Query: 58  PNIIRFKEVV-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYD 177
             ++YD
Sbjct: 199 DLQDYD 204

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 13/126 (10%)
Query: 58  PNIIRFKEVVL-----TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYD 177
             ++YD
Sbjct: 199 DLQDYD 204

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 13/126 (10%)
Query: 58  PNIIRFKEVV-----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYD 177
             ++YD
Sbjct: 199 DLQDYD 204

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 13/126 (10%)
Query: 58  PNIIRFKEVVL-----TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 87  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 140
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 141 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 172 SRREYD 177
             ++YD
Sbjct: 200 DLQDYD 205

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 13/126 (10%)
Query: 58  PNIIRFKEVVL-----TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 107 PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 160
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 161 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 219
Query: 172 SRREYD 177
             ++YD
Sbjct: 220 DLQDYD 225

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 13/126 (10%)
Query: 58  PNIIRFKEVVL-----TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYD 177
             ++YD
Sbjct: 199 DLQDYD 204

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 80  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 134
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 135 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 169

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 13/126 (10%)
Query: 58  PNIIRFKEVVL-----TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           PNI++  ++V      TP+   ++ EY       D        ++ + RY+  +L+  ++
Sbjct: 88  PNIVKLLDIVRDQHSKTPS---LIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALD 141
Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 142 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 200
Query: 172 SRREYD 177
             ++YD
Sbjct: 201 DLQDYD 206

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 78  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 132
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 133 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 167

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 76  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 130
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 131 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 165

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 77  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 131
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 132 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 166

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 79  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 133
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 134 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 168

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 10/149 (6%)
Query: 7   VKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNI 60
           VK LG+G FG       +   +  K  VA+K +      K ++ +  E      +  P +
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
            R   + LT T + +V +    G L D +  N GR    +   +  Q+  G++Y   +++
Sbjct: 82  SRLLGICLTST-VQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRL 140
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            HRDL   N L+   +   +KI DFG ++
Sbjct: 141 VHRDLAARNVLV--KSPNHVKITDFGLAR 167

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 78  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 132
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 133 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAK 167

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 78  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 132
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 133 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAK 167

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 80  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 134
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 135 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAK 169

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 31/204 (15%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDX 212
Query: 155 RPKSTVG-TPA-YIAPEVLSRREY 176
             K+T G  P  ++APE L  R Y
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVY 236

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 59/138 (42%), Gaps = 24/138 (17%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSED---EGRY----FFQQLIS 109
           HPN+IR+     T   L I +E      L D + +     E+   +  Y      +Q+ S
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 110 GVNYCHSMQICHRDLKLENTLLD-----------GSAAPRLKICDFGYSK-----SSVLH 153
           GV + HS++I HRDLK +N L+            G+   R+ I DFG  K          
Sbjct: 145 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 204
Query: 154 SRPKSTVGTPAYIAPEVL 171
               +  GT  + APE+L
Sbjct: 205 XNLNNPSGTSGWRAPELL 222

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 7   VKDLGAGNFGVAR---LLRHKETKEL-VAVKYIER--GRKIDENVAREIINHRSLRHPNI 60
           VK LG+G FG       +   ET ++ VA+K +    G K +     E +   S+ HP++
Sbjct: 43  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +R   V L+PT + +V +    G L + +  +           +  Q+  G+ Y    ++
Sbjct: 103 VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 161
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            HRDL   N L+   +   +KI DFG ++
Sbjct: 162 VHRDLAARNVLV--KSPNHVKITDFGLAR 188

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 59/138 (42%), Gaps = 24/138 (17%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSED---EGRY----FFQQLIS 109
           HPN+IR+     T   L I +E      L D + +     E+   +  Y      +Q+ S
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 110 GVNYCHSMQICHRDLKLENTLLD-----------GSAAPRLKICDFGYSK-----SSVLH 153
           GV + HS++I HRDLK +N L+            G+   R+ I DFG  K          
Sbjct: 145 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 204
Query: 154 SRPKSTVGTPAYIAPEVL 171
               +  GT  + APE+L
Sbjct: 205 XNLNNPSGTSGWRAPELL 222

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 59/138 (42%), Gaps = 24/138 (17%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSED---EGRY----FFQQLIS 109
           HPN+IR+     T   L I +E      L D + +     E+   +  Y      +Q+ S
Sbjct: 68  HPNVIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 110 GVNYCHSMQICHRDLKLENTLLD-----------GSAAPRLKICDFGYSK-----SSVLH 153
           GV + HS++I HRDLK +N L+            G+   R+ I DFG  K          
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 186
Query: 154 SRPKSTVGTPAYIAPEVL 171
               +  GT  + APE+L
Sbjct: 187 XNLNNPSGTSGWRAPELL 204

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 7   VKDLGAGNFGVAR---LLRHKETKEL-VAVKYIER--GRKIDENVAREIINHRSLRHPNI 60
           VK LG+G FG       +   ET ++ VA+K +    G K +     E +   S+ HP++
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +R   V L+PT + +V +    G L + +  +           +  Q+  G+ Y    ++
Sbjct: 80  VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 138
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            HRDL   N L+   +   +KI DFG ++
Sbjct: 139 VHRDLAARNVLV--KSPNHVKITDFGLAR 165

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAKGM 130
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 131 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 165

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 86/199 (43%), Gaps = 33/199 (16%)
Query: 6   LVKDLGAGNFGVARL-----LRHKETKELVAVKYIE----RGRKIDENVAREIINHRSLR 56
           L ++LG G FG   L     L   + K LVAVK ++      RK  +  A  + N   L+
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN---LQ 75
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FDR-------ICNAGRFSEDEGRYFFQQL 107
           H +I++F  V      L +V EY   G+L  F R       I   G+  + +G     Q+
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 108 I-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--SVLHSRPKS 158
           +       SG+ Y  S    HRDL   N L+   A   +KI DFG S+   S  + R   
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSRDVYSTDYYRVGG 193
Query: 159 TVGTPA-YIAPEVLSRREY 176
               P  ++ PE +  R++
Sbjct: 194 HTMLPIRWMPPESIMYRKF 212

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 76/186 (40%), Gaps = 28/186 (15%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
           L++ +G G +G   + R     E VAVK      +       E+ N   LRH NI+ F  
Sbjct: 41  LLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 98
Query: 66  VVLTPTH----LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
             +T  H    L ++  Y   G L+D +                 + SG+ + H      
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--------VGTPAY 165
                I HRDLK +N L+  +   +  I D G +   V+HS+  +         VGT  Y
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNG--QCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRY 212
Query: 166 IAPEVL 171
           +APEVL
Sbjct: 213 MAPEVL 218

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 76/186 (40%), Gaps = 28/186 (15%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
           L++ +G G +G   + R     E VAVK      +       E+ N   LRH NI+ F  
Sbjct: 12  LLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 66  VVLTPTH----LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
             +T  H    L ++  Y   G L+D +                 + SG+ + H      
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--------VGTPAY 165
                I HRDLK +N L+  +   +  I D G +   V+HS+  +         VGT  Y
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNG--QCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRY 183
Query: 166 IAPEVL 171
           +APEVL
Sbjct: 184 MAPEVL 189

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 71/176 (40%), Gaps = 33/176 (18%)
Query: 5   ELVKDLGAGNFGV-----ARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRH 57
           E V+D+G G FG      A  L   E   +VAVK +  E    +  +  RE        +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFD----------------------RICNAG-- 93
           PNI++   V      + ++ EY A G+L +                      R+ + G  
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 94  RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
             S  E     +Q+ +G+ Y    +  HRDL   N L+  +    +KI DFG S++
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRN 223

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 76/186 (40%), Gaps = 28/186 (15%)
Query: 6   LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKE 65
           L++ +G G +G   + R     E VAVK      +       E+ N   LRH NI+ F  
Sbjct: 12  LLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 66  VVLTPTH----LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH------ 115
             +T  H    L ++  Y   G L+D +                 + SG+ + H      
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--------VGTPAY 165
                I HRDLK +N L+  +   +  I D G +   V+HS+  +         VGT  Y
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNG--QCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRY 183
Query: 166 IAPEVL 171
           +APEVL
Sbjct: 184 MAPEVL 189

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 31/204 (15%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 155 RPKSTVG-TPA-YIAPEVLSRREY 176
             K+T G  P  ++APE L  R Y
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVY 236

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 31/204 (15%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 155 RPKSTVG-TPA-YIAPEVLSRREY 176
             K+T G  P  ++APE L  R Y
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVY 236

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 31/204 (15%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 155 RPKSTVG-TPA-YIAPEVLSRREY 176
             K+T G  P  ++APE L  R Y
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVY 236

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 84/206 (40%), Gaps = 35/206 (16%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------FDRICNAGRFSEDEG 100
               +H NII           L +++EYA+ G L            +   +  R  E++ 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQ- 153
Query: 101 RYFFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVL 152
              F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +
Sbjct: 154 -MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNI 210
Query: 153 HSRPKSTVG-TPA-YIAPEVLSRREY 176
               K+T G  P  ++APE L  R Y
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVY 236

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 78  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 132
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 133 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 167

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K L +G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++M+    G L D +    R  +D    +Y      Q+  G+
Sbjct: 83  NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 137
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 138 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 172

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 79  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 133
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 134 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 168

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 83  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 137
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 138 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 172

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 79  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 133
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 134 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 168

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 44/76 (57%), Gaps = 5/76 (6%)
Query: 105 QQLISGVNYCHSMQ-ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP 163
           + +++  +Y H+ + ICHRD+K  N L+D +   R+K+ DFG S+  V   + K + GT 
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNG--RVKLSDFGESEYMV-DKKIKGSRGTY 214
Query: 164 AYIAPEVLSRR-EYDG 178
            ++ PE  S    Y+G
Sbjct: 215 EFMPPEFFSNESSYNG 230

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 82  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 136
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 137 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 171

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 31/204 (15%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLH 153
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  +++ +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 154 SRPKSTVGTPA-YIAPEVLSRREY 176
            +  +    P  ++APE L  R Y
Sbjct: 213 YKNTTNGRLPVKWMAPEALFDRVY 236

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 31/204 (15%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 204
Query: 155 RPKSTVG-TPA-YIAPEVLSRREY 176
             K+T G  P  ++APE L  R Y
Sbjct: 205 YKKTTNGRLPVKWMAPEALFDRVY 228

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 31/204 (15%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNV--MKIADFGLARDINNIDY 199
Query: 155 RPKSTVG-TPA-YIAPEVLSRREY 176
             K+T G  P  ++APE L  R Y
Sbjct: 200 YKKTTNGRLPVKWMAPEALFDRVY 223

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 73  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAEGM 127
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 128 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 162

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 130
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 131 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 165

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 79  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 133
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 134 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 168

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 101 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 155
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 156 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 190

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 19/123 (15%)
Query: 57  HPNIIR-FKEVVLTPTHLA----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
           HP+I++ F  V  T  H      IVMEY  G  L  +     +    E   +  +++  +
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL--KRSKGQKLPVAEAIAYLLEILPAL 195
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS---TVGTPAYIAP 168
           +Y HS+ + + DLK EN +L      +LK+ D G        SR  S     GTP + AP
Sbjct: 196 SYLHSIGLVYNDLKPENIML---TEEQLKLIDLGAV------SRINSFGYLYGTPGFQAP 246
Query: 169 EVL 171
           E++
Sbjct: 247 EIV 249

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 31/204 (15%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 201
Query: 155 RPKSTVG-TPA-YIAPEVLSRREY 176
             K+T G  P  ++APE L  R Y
Sbjct: 202 YKKTTNGRLPVKWMAPEALFDRVY 225

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 130
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 131 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 165

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 70  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 124
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 125 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 159

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 86  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 140
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 141 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 175

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 31/204 (15%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 258
Query: 155 RPKSTVG-TPA-YIAPEVLSRREY 176
             K+T G  P  ++APE L  R Y
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVY 282

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 70/177 (39%), Gaps = 23/177 (12%)
Query: 13  GNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF----KEVVL 68
           G FG   + + +   + VAVK      K      REI +   ++H N+++F    K    
Sbjct: 26  GRFGC--VWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 69  TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-----------M 117
               L ++  +   G L D +      + +E  +  + +  G++Y H             
Sbjct: 84  LEVELWLITAFHDKGSLTDYL-KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKP 142
Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST---VGTPAYIAPEVL 171
            I HRD K +N LL       L   DFG +        P  T   VGT  Y+APEVL
Sbjct: 143 SIAHRDFKSKNVLLKSDLTAVL--ADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVL 197

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 23/166 (13%)
Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+FG+     AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 16  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 73
Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--------CNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L   +         N GR      E   
Sbjct: 74  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 133
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++
Sbjct: 134 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTR 177

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 71/175 (40%), Gaps = 20/175 (11%)
Query: 13  GNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF----KEVVL 68
           G FG   + + +   E VAVK      K       E+ +   ++H NI++F    K    
Sbjct: 35  GRFGC--VWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 69  TPTHLAIVMEYAAGGELFDRI-CNAGRFSE--------DEGRYFFQQLISGVNYCHSMQI 119
               L ++  +   G L D +  N   ++E          G  +  + I G+   H   I
Sbjct: 93  VDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI 152
Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTPAYIAPEVL 171
            HRD+K +N LL  +      I DFG +   ++          VGT  Y+APEVL
Sbjct: 153 SHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 83  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 137
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 138 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAK 172

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 23/166 (13%)
Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+FG+     AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 74
Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--------CNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L   +         N GR      E   
Sbjct: 75  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTR 178

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 23/166 (13%)
Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+FG+     AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 74
Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--------CNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L   +         N GR      E   
Sbjct: 75  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTR 178

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 23/166 (13%)
Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+FG+     AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 14  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 71
Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--------CNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L   +         N GR      E   
Sbjct: 72  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 131
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++
Sbjct: 132 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTR 175

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 23/166 (13%)
Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+FG+     AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 74
Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--------CNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L   +         N GR      E   
Sbjct: 75  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTR 178

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 130
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 131 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAK 165

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 31/204 (15%)
Query: 2   EKYELVKDLGAGNFGVARL-----LRHKETKELVAVKYIERGRKIDENVAREIINHRSL- 55
           +K  L K LG G FG   +     +   + KE V V          E    ++++   + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  ----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD----RICNAGRFSED-----EGRY 102
               +H NII           L +++EYA+ G L +    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    ++I DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MRIADFGLARDINNIDY 212
Query: 155 RPKSTVG-TPA-YIAPEVLSRREY 176
             K+T G  P  ++APE L  R Y
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVY 236

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 23/166 (13%)
Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+FG+     AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 74
Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--------CNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L   +         N GR      E   
Sbjct: 75  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTR 178

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K LG+G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 78  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 132
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 133 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAK 167

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 23/177 (12%)
Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH----PNIIRF 63
           K +G GNFG  RL ++  T E VA+K +E  +     +  E   ++ L      P +  F
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 64  KEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
                   + A+V+E       +LFD +C+   FS         QLIS + Y HS  + +
Sbjct: 74  GPC---GKYNAMVLELLGPSLEDLFD-LCDR-TFSLKTVLMIAIQLISRMEYVHSKNLIY 128
Query: 122 RDLKLENTLL--DGSAAPR-LKICDFGY--------SKSSVLHSRPKSTVGTPAYIA 167
           RD+K EN L+   G+   + + I DFG         +K  + +   KS  GT  Y++
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMS 185

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 67/164 (40%), Gaps = 23/164 (14%)
Query: 6   LVKDLGAGNFGVARL-----LRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPN 59
           L  +LG G FG   L     L  ++ K LVAVK + E      ++  RE      L+H +
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELF--------DRICNAGRFSEDEGRYFFQQLI--- 108
           I+RF  V      L +V EY   G+L         D    AG      G     QL+   
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 109 ----SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
               +G+ Y   +   HRDL   N L+       +KI DFG S+
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSR 206

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/179 (20%), Positives = 72/179 (40%), Gaps = 23/179 (12%)
Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFK 64
           EL K    GN  V ++L+ ++           + R  +E   R     R   HPN++   
Sbjct: 25  ELWKGRWQGNDIVVKVLKVRDWS-------TRKSRDFNEECPR----LRIFSHPNVLPVL 73
Query: 65  EVVLTPT--HLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSMQ-- 118
               +P   H  ++  +   G L++ +     F  D+ +   F   +  G+ + H+++  
Sbjct: 74  GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I    L   + ++D     R+ + D  +S  S         +  PA++APE L ++  D
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKPED 186

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVAR--LLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++ +K LG+G FG     L   +  K  + V  +E          +EI++      S+ 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 110 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 164
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 165 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 199

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/63 (42%), Positives = 35/63 (55%), Gaps = 5/63 (7%)
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTV-GTPAYI 166
           G++Y H+  I HRD+K  N LLD +  P  KI DFG SK  + +  +     V GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 167 APE 169
            PE
Sbjct: 209 DPE 211

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/63 (42%), Positives = 35/63 (55%), Gaps = 5/63 (7%)
Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTV-GTPAYI 166
           G++Y H+  I HRD+K  N LLD +  P  KI DFG SK  + +  +     V GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 167 APE 169
            PE
Sbjct: 209 DPE 211

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 9/146 (6%)
Query: 10  LGAGNFGVA---RLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF-QQLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 175
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK 148
           DL   N +LD      +K+ DFG ++
Sbjct: 176 DLAARNCMLDEKFT--VKVADFGLAR 199

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 9/146 (6%)
Query: 10  LGAGNFGVA---RLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF-QQLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 176
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK 148
           DL   N +LD      +K+ DFG ++
Sbjct: 177 DLAARNCMLDEKFT--VKVADFGLAR 200

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 67/164 (40%), Gaps = 23/164 (14%)
Query: 6   LVKDLGAGNFGVARL-----LRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPN 59
           L  +LG G FG   L     L  ++ K LVAVK + E      ++  RE      L+H +
Sbjct: 22  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELF--------DRICNAGRFSEDEGRYFFQQLI--- 108
           I+RF  V      L +V EY   G+L         D    AG      G     QL+   
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 109 ----SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
               +G+ Y   +   HRDL   N L+       +KI DFG S+
Sbjct: 142 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSR 183

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 9/146 (6%)
Query: 10  LGAGNFGVA---RLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF-QQLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 156
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK 148
           DL   N +LD      +K+ DFG ++
Sbjct: 157 DLAARNCMLDEKFT--VKVADFGLAR 180

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 79/195 (40%), Gaps = 26/195 (13%)
Query: 6   LVKDLGAGNFGVARL-----LRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPN 59
           L  +LG G FG   L     L  ++ K LVAVK + E      ++  RE      L+H +
Sbjct: 16  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELF--------DRICNAGRFSEDEGRYFFQQLI--- 108
           I+RF  V      L +V EY   G+L         D    AG      G     QL+   
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 109 ----SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--SVLHSRPKSTVGT 162
               +G+ Y   +   HRDL   N L+       +KI DFG S+   S  + R       
Sbjct: 136 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 163 PA-YIAPEVLSRREY 176
           P  ++ PE +  R++
Sbjct: 194 PIRWMPPESILYRKF 208

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 9/146 (6%)
Query: 10  LGAGNFGVA---RLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF-QQLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 149
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK 148
           DL   N +LD      +K+ DFG ++
Sbjct: 150 DLAARNCMLDEKFT--VKVADFGLAR 173

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 9/146 (6%)
Query: 10  LGAGNFGVA---RLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF-QQLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 157
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK 148
           DL   N +LD      +K+ DFG ++
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLAR 181

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 9/146 (6%)
Query: 10  LGAGNFGVA---RLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF-QQLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 152
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK 148
           DL   N +LD      +K+ DFG ++
Sbjct: 153 DLAARNCMLDEKFT--VKVADFGLAR 176

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 9/146 (6%)
Query: 10  LGAGNFGVA---RLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF-QQLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 154
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK 148
           DL   N +LD      +K+ DFG ++
Sbjct: 155 DLAARNCMLDEKFT--VKVADFGLAR 178

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 9/146 (6%)
Query: 10  LGAGNFGVA---RLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF-QQLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 155
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK 148
           DL   N +LD      +K+ DFG ++
Sbjct: 156 DLAARNCMLDEKFT--VKVADFGLAR 179

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 9/146 (6%)
Query: 10  LGAGNFGVA---RLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF-QQLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 157
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK 148
           DL   N +LD      +K+ DFG ++
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLAR 181

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 80/193 (41%), Gaps = 36/193 (18%)
Query: 6   LVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFK 64
           LV+ +G G +G V R L H E+   VAVK      +       EI N   LRH NI+ F 
Sbjct: 12  LVECVGKGRYGEVWRGLWHGES---VAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFI 68
Query: 65  EVVLTP----THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLIS---GVNYCH-- 115
              +T     T L ++  Y   G L+D +    +    E     +  +S   G+ + H  
Sbjct: 69  ASDMTSRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLAHLHVE 124
Query: 116 ------SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--------PKSTVG 161
                    I HRD K  N L+  +   +  I D G +   V+HS+            VG
Sbjct: 125 IFGTQGKPAIAHRDFKSRNVLVKSNL--QCCIADLGLA---VMHSQGSDYLDIGNNPRVG 179
Query: 162 TPAYIAPEVLSRR 174
           T  Y+APEVL  +
Sbjct: 180 TKRYMAPEVLDEQ 192

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 9/146 (6%)
Query: 10  LGAGNFGVA---RLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 65  EVVL-TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF-QQLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L + I N       +    F  Q+  G+ Y  S +  HR
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 156
Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK 148
           DL   N +LD      +K+ DFG ++
Sbjct: 157 DLAARNCMLDEKFT--VKVADFGLAR 180

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 23/177 (12%)
Query: 8   KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH----PNIIRF 63
           K +G GNFG  RL ++  T E VA+K +E  +     +  E   ++ L      P +  F
Sbjct: 10  KKIGCGNFGELRLGKNLYTNEYVAIK-LEPIKSRAPQLHLEYRFYKQLSATEGVPQVYYF 68
Query: 64  KEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
                   + A+V+E       +LFD +C+   F+         QLI+ + Y H+  + +
Sbjct: 69  GPXG---KYNAMVLELLGPSLEDLFD-LCDR-TFTLKTVLMIAIQLITRMEYVHTKSLIY 123
Query: 122 RDLKLENTLLDGSAAPR---LKICDFGY--------SKSSVLHSRPKSTVGTPAYIA 167
           RD+K EN L+      R   + I DFG         +K  + +   KS  GT  Y++
Sbjct: 124 RDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMS 180

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 13/153 (8%)
Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH----P 58
           K+ L + +G+G+FG   L  + +T E VA+K +E  +     +  E   +R L+     P
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           N+  F    +   +  +VM+       +LF+  C+  + S         Q+I+ V + HS
Sbjct: 67  NVRWFG---VEGDYNVLVMDLLGPSLEDLFN-FCSR-KLSLKTVLMLADQMINRVEFVHS 121
Query: 117 MQICHRDLKLENTLLD-GSAAPRLKICDFGYSK 148
               HRD+K +N L+  G  A ++ I DFG +K
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 48/121 (39%), Gaps = 20/121 (16%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI----------------CNAGRFSEDEG 100
           HPNII          +L + +EYA  G L D +                  A   S  + 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 101 RYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV 160
            +F   +  G++Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTM 200
Query: 161 G 161
           G
Sbjct: 201 G 201

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 48/121 (39%), Gaps = 20/121 (16%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI----------------CNAGRFSEDEG 100
           HPNII          +L + +EYA  G L D +                  A   S  + 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 101 RYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV 160
            +F   +  G++Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+
Sbjct: 135 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTM 190
Query: 161 G 161
           G
Sbjct: 191 G 191

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 39.7 bits (91), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K L +G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 83  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 137
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 138 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 172

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 39.7 bits (91), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 3   KYELVKDLGAGNFGVA----RLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           +++ +K L +G FG       +   ++ K  VA+K +      K ++ +  E     S+ 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDE--GRYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L D +    R  +D    +Y      Q+  G+
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 130
Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           NY    ++ HRDL   N L+       +KI DFG +K
Sbjct: 131 NYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAK 165

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 39.7 bits (91), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 73/166 (43%), Gaps = 23/166 (13%)
Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR 56
           EK  L+++LG G+FG+     AR +   E +  VAVK +     + E +  E +N  S+ 
Sbjct: 18  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 75
Query: 57  HP----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--------CNAGRFSE--DEGRY 102
                 +++R   VV       +VME  A G+L   +         N GR      E   
Sbjct: 76  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 135
Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              ++  G+ Y ++ +  HR+L   N ++       +KI DFG ++
Sbjct: 136 MAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFT--VKIGDFGMTR 179

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	181
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-119
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-100
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-99
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-76
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-75
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-74
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-74
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-74
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-73
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-73
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-70
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-70
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-70
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-69
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-69
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-69
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-68
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-67
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-67
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-67
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-67
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-67
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-66
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-66
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-66
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-66
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-66
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-66
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-65
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-65
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-64
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-64
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-64
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-64
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-63
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-63
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-63
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-62
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-62
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-62
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-62
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-62
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-62
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-62
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-62
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-61
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-61
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-60
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-60
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-60
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-60
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-59
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-59
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-59
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-59
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-59
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-59
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-58
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-58
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-58
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-57
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-56
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-53
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-53
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-51
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-50
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-49
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-48
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-47
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-47
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-46
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-44
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-44
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-41
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-41
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-41
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-41
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-41
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-41
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-41
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-41
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-41
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-41
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-40
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-40
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-40
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-40
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-40
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-39
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-39
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-39
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-39
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-38
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-38
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-38
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-38
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-38
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-37
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-37
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-37
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-37
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-37
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-36
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-36
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-36
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-36
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-36
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-36
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-36
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-36
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-36
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-36
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-36
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-35
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-35
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-35
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-35
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-35
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-34
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-34
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-34
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-34
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-33
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-33
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-33
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-32
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-32
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-32
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-32
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-32
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-31
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-31
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-31
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-11
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-31
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-30
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-30
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-29
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-29
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-28
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-28
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-28
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-27
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-27
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-27
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-27
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-27
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-26
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-26
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-26
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-26
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-25
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-25
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-25
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-25
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-24
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-24
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-24
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-23
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-23
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-21
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-21
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-20
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-19
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-19
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-19
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-19
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-18
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-18
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-18
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-17
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-17
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-17
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-17
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-17
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-17
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-16
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-16
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-16
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-16
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-16
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-16
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-16
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-15
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-15
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-15
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-15
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-15
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-15
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-15
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-14
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-14
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-14
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-14
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-14
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-13
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-13
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-12
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-12
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-12
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-12
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-12
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-07
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-07
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-06
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-06
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-05

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  340 bits (874), Expect = e-119
 Identities = 152/180 (84%), Positives = 169/180 (93%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
            ++Y+ VKD+G+GNFGVARL+R K TKELVAVKYIERG  IDENV REIINHRSLRHPNI
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +RFKEV+LTPTHLAI+MEYA+GGEL++RICNAGRFSEDE R+FFQQL+SGV+YCHSMQIC
Sbjct: 79  VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC 138

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
           HRDLKLENTLLDGS APRLKICDFGYSKSSVLHS+PKSTVGTPAYIAPEVL R+EYDGK 
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKI 198

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  290 bits (744), Expect = e-100
 Identities = 70/185 (37%), Positives = 105/185 (56%), Gaps = 7/185 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R        GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 176 YDGKQ 180
           +  + 
Sbjct: 184 FHAEP 188

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  286 bits (733), Expect = 6e-99
 Identities = 70/185 (37%), Positives = 105/185 (56%), Gaps = 7/185 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
           +E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N+++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R        GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 176 YDGKQ 180
           +  + 
Sbjct: 184 FHAEP 188

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  227 bits (581), Expect = 8e-76
 Identities = 79/182 (43%), Positives = 103/182 (56%), Gaps = 6/182 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +  Y L   LG G FG  ++  H+ T   VAVK + R +     +   + REI N +  R
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP+II+  +V+ TPT   +VMEY +GGELFD IC  GR  E E R  FQQ++S V+YCH 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
             + HRDLK EN LLD       KI DFG S         +++ G+P Y APEV+S R Y
Sbjct: 130 HMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187

Query: 177 DG 178
            G
Sbjct: 188 AG 189

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  226 bits (579), Expect = 5e-75
 Identities = 73/182 (40%), Positives = 107/182 (58%), Gaps = 7/182 (3%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHP 58
            Y L+K +G GNF   +L RH  T   VA+K I++  +++    + + RE+   + L HP
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHP 74

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI++  EV+ T   L ++MEYA+GGE+FD +   GR  E E R  F+Q++S V YCH  +
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           I HRDLK EN LLD      +KI DFG+S    +  +  +  G P Y APE+   ++YDG
Sbjct: 135 IVHRDLKAENLLLDADM--NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192

Query: 179 KQ 180
            +
Sbjct: 193 PE 194

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  224 bits (573), Expect = 2e-74
 Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 7/184 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
             +Y   + LG G F     +   +TKE+ A K + +         E ++ EI  HRSL 
Sbjct: 14  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H +++ F         + +V+E      L +        +E E RY+ +Q++ G  Y H 
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLSRRE 175
            ++ HRDLKL N  L+      +KI DFG +         K  + GTP YIAPEVLS++ 
Sbjct: 134 NRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191

Query: 176 YDGK 179
           +  +
Sbjct: 192 HSFE 195

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  228 bits (583), Expect = 8e-74
 Identities = 81/183 (44%), Positives = 107/183 (58%), Gaps = 8/183 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-----ENVAREIINHRSL 55
           +  Y L   LG G FG  ++ +H+ T   VAVK + R +KI        + REI N +  
Sbjct: 15  IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLF 73

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           RHP+II+  +V+ TP+ + +VMEY +GGELFD IC  GR  E E R  FQQ++SGV+YCH
Sbjct: 74  RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH 133

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
              + HRDLK EN LLD       KI DFG S         +++ G+P Y APEV+S R 
Sbjct: 134 RHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRL 191

Query: 176 YDG 178
           Y G
Sbjct: 192 YAG 194

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  222 bits (569), Expect = 2e-73
 Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 7/184 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
             +Y   + LG G F     +   +TKE+ A K + +         E ++ EI  HRSL 
Sbjct: 40  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H +++ F         + +V+E      L +        +E E RY+ +Q++ G  Y H 
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLSRRE 175
            ++ HRDLKL N  L+      +KI DFG +         K  + GTP YIAPEVLS++ 
Sbjct: 160 NRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 217

Query: 176 YDGK 179
           +  +
Sbjct: 218 HSFE 221

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  221 bits (566), Expect = 7e-73
 Identities = 80/180 (44%), Positives = 111/180 (61%), Gaps = 7/180 (3%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHP 58
            Y + + LG G+FG  +L  H +T++ VA+K+I R       +   V REI   + LRHP
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +II+  +V+ TPT + +V+EYA GGELFD I    R +EDEGR FFQQ+I  + YCH  +
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           I HRDLK EN LLD +    +KI DFG S      +  K++ G+P Y APEV++ + Y G
Sbjct: 129 IVHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAG 186

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  215 bits (549), Expect = 2e-70
 Identities = 57/190 (30%), Positives = 81/190 (42%), Gaps = 12/190 (6%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---------KIDENVAREIIN 51
            +KY  +  LG+G FG       KE  + V VK+I++ +              V  EI  
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82

Query: 52  HRSLRHPNIIRFKEVVLTPTHLAIVMEYAA-GGELFDRICNAGRFSEDEGRYFFQQLISG 110
              + H NII+  ++        +VME    G +LF  I    R  E    Y F+QL+S 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           V Y     I HRD+K EN ++       +K+ DFG +          +  GT  Y APEV
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200

Query: 171 LSRREYDGKQ 180
           L    Y G +
Sbjct: 201 LMGNPYRGPE 210

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  212 bits (543), Expect = 4e-70
 Identities = 57/185 (30%), Positives = 92/185 (49%), Gaps = 8/185 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +++   LG G+F          T   VA+K I++       + + V  E+  H  L+
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCH 115
           HP+I+          ++ +V+E    GE+   + N    FSE+E R+F  Q+I+G+ Y H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLSRR 174
           S  I HRDL L N LL  +    +KI DFG +    +      T+ GTP YI+PE+ +R 
Sbjct: 130 SHGILHRDLTLSNLLLTRNM--NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187

Query: 175 EYDGK 179
            +  +
Sbjct: 188 AHGLE 192

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  212 bits (542), Expect = 7e-70
 Identities = 57/183 (31%), Positives = 98/183 (53%), Gaps = 7/183 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           ++ +++ + LG G FG   L R K+ K ++A+K + + +     ++  + REI     LR
Sbjct: 13  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R          + +++E+A  GEL+  +   GRF E     F ++L   ++YCH 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN L+       LKI DFG+S  +    R ++  GT  Y+ PE++  + +
Sbjct: 133 RKVIHRDIKPENLLMGYKG--ELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTH 189

Query: 177 DGK 179
           D K
Sbjct: 190 DEK 192

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  210 bits (537), Expect = 3e-69
 Identities = 59/183 (32%), Positives = 98/183 (53%), Gaps = 7/183 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     ++  + RE+     LR
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL  +    LKI DFG+S      SR     GT  Y+ PE++  R +
Sbjct: 128 KRVIHRDIKPENLLLGSAG--ELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMH 184

Query: 177 DGK 179
           D K
Sbjct: 185 DEK 187

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  211 bits (540), Expect = 4e-69
 Identities = 52/192 (27%), Positives = 85/192 (44%), Gaps = 20/192 (10%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN--------VAREIINHRS 54
           +Y++   LG+G FG             VA+K++E+  +I +         V  E++  + 
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKK 102

Query: 55  LRH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGV 111
           +      +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 162

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTPAYIAP 168
            +CH+  + HRD+K EN L+D +    LK+ DFG     K +V         GT  Y  P
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSPP 217

Query: 169 EVLSRREYDGKQ 180
           E +    Y G+ 
Sbjct: 218 EWIRYHRYHGRS 229

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  211 bits (538), Expect = 6e-69
 Identities = 54/193 (27%), Positives = 76/193 (39%), Gaps = 20/193 (10%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRSL 55
           +Y L   LG G FG          +  VA+K I R R +             E+     +
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 56  R----HPNIIRFKEVVLTPTHLAIVMEYAA-GGELFDRICNAGRFSEDEGRYFFQQLISG 110
                HP +IR  +   T     +V+E      +LFD I   G   E   R FF Q+++ 
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS---KSSVLHSRPKSTVGTPAYIA 167
           + +CHS  + HRD+K EN L+D       K+ DFG                  GT  Y  
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVYSP 206

Query: 168 PEVLSRREYDGKQ 180
           PE +SR +Y    
Sbjct: 207 PEWISRHQYHALP 219

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  209 bits (535), Expect = 2e-68
 Identities = 56/189 (29%), Positives = 92/189 (48%), Gaps = 16/189 (8%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-----KIDENVAREIINHRSLRH 57
           KY +   LG G++G  + +   ET    AVK +++ +       + NV +EI   R LRH
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 58  PNIIRFKEVVL--TPTHLAIVMEYAAGG--ELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
            N+I+  +V+       + +VMEY   G  E+ D +    RF   +   +F QLI G+ Y
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEY 124

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEV 170
            HS  I H+D+K  N LL       LKI   G +++    +     +++ G+PA+  PE+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGG--TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182

Query: 171 LS-RREYDG 178
            +    + G
Sbjct: 183 ANGLDTFSG 191

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  206 bits (526), Expect = 5e-67
 Identities = 66/187 (35%), Positives = 91/187 (48%), Gaps = 11/187 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---------GRKIDENVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA+K I +               NV  EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128

Query: 113 YCHSMQICHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

Query: 172 SRREYDG 178
                 G
Sbjct: 189 VSVGTAG 195

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  205 bits (524), Expect = 7e-67
 Identities = 60/181 (33%), Positives = 101/181 (55%), Gaps = 9/181 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE-NVAREIINHRSLRHPNI 60
           + +  ++ LG+G F    L++ + T +L A+K I++     + ++  EI   + ++H NI
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +  +++  + TH  +VM+  +GGELFDRI   G ++E +     QQ++S V Y H   I 
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128

Query: 121 HRDLKLENTLLDGSAA-PRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           HRDLK EN L        ++ I DFG SK   + ++     +  GTP Y+APEVL+++ Y
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTPGYVAPEVLAQKPY 184

Query: 177 D 177
            
Sbjct: 185 S 185

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  204 bits (522), Expect = 7e-67
 Identities = 60/181 (33%), Positives = 91/181 (50%), Gaps = 6/181 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRH 57
           + Y++ ++LG G F V R   HK T    A K I   +K+     + + RE    R L+H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 64

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI+R  + +   +   +V +   GGELF+ I     +SE +  +  QQ++  + YCHS 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124

Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            I HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184

Query: 177 D 177
            
Sbjct: 185 S 185

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  204 bits (521), Expect = 8e-67
 Identities = 60/179 (33%), Positives = 92/179 (51%), Gaps = 5/179 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHPN 59
           + Y L   +G G++G  ++   K T+   A K I +   ++  +   +EI   +SL HPN
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHPN 67

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           IIR  E     T + +VME   GGELF+R+ +   F E +     + ++S V YCH + +
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127

Query: 120 CHRDLKLENTLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDLK EN L    +    LK+ DFG +         ++ VGTP Y++P+VL    Y 
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLYG 185

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  205 bits (523), Expect = 9e-67
 Identities = 64/191 (33%), Positives = 90/191 (47%), Gaps = 13/191 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----------ERGRKIDENVAREI-I 50
           E YE  + LG G   V R   HK T +  AVK I          E  +++ E   +E+ I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76

Query: 51  NHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
             +   HPNII+ K+   T T   +V +    GELFD +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194

Query: 171 LSRREYDGKQG 181
           +     D   G
Sbjct: 195 IECSMNDNHPG 205

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  204 bits (522), Expect = 1e-66
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 41/212 (19%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------------------- 42
           +Y L  ++G G++GV +L  ++      A+K + + + I                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 43  -------ENVAREIINHRSLRHPNIIRFKEVVLTPT--HLAIVMEYAAGGELFDRICNAG 93
                  E V +EI   + L HPN+++  EV+  P   HL +V E    G + + +    
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132

Query: 94  RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH 153
             SED+ R++FQ LI G+ Y H  +I HRD+K  N L+       +KI DFG S      
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG--HIKIADFGVSN---EF 187

Query: 154 SRP----KSTVGTPAYIAPEVLS--RREYDGK 179
                   +TVGTPA++APE LS  R+ + GK
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGK 219

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  206 bits (526), Expect = 1e-66
 Identities = 57/190 (30%), Positives = 88/190 (46%), Gaps = 12/190 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---------KIDENVAREI-IN 51
           +KY+    +G G   V R   H+ T    AVK +E            ++ E   RE  I 
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 52  HRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
            +   HP+II   +   + + + +V +    GELFD +      SE E R   + L+  V
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           ++ H+  I HRDLK EN LLD +    +++ DFG+S       + +   GTP Y+APE+L
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271

Query: 172 SRREYDGKQG 181
                +   G
Sbjct: 272 KCSMDETHPG 281

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  204 bits (521), Expect = 2e-66
 Identities = 44/189 (23%), Positives = 75/189 (39%), Gaps = 9/189 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPN 59
             + L   LG G        RHK+T +L A+K        +  +   RE    + L H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 60  IIRFKEVV--LTPTHLAIVMEYAAGGELFDRIC---NAGRFSEDEGRYFFQQLISGVNYC 114
           I++   +    T  H  ++ME+   G L+  +    NA    E E     + ++ G+N+ 
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 115 HSMQICHRDLKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
               I HR++K  N +       +   K+ DFG ++      +  S  GT  Y+ P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188

Query: 173 RREYDGKQG 181
           R        
Sbjct: 189 RAVLRKDHQ 197

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  204 bits (521), Expect = 5e-66
 Identities = 62/180 (34%), Positives = 91/180 (50%), Gaps = 7/180 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPNI 60
           + YE+ +D+G G++ V +   HK T    AVK I++ +    +   EI I  R  +HPNI
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---RDPTEEIEILLRYGQHPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           I  K+V     ++ +V E   GGEL D+I     FSE E       +   V Y H+  + 
Sbjct: 79  ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138

Query: 121 HRDLKLENTLLDGSA--APRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYD 177
           HRDLK  N L    +     ++ICDFG++K     +    T   T  ++APEVL R+ YD
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYD 198

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  205 bits (524), Expect = 6e-66
 Identities = 44/189 (23%), Positives = 75/189 (39%), Gaps = 9/189 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPN 59
             + L   LG G        RHK+T +L A+K        +  +   RE    + L H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 60  IIRFKEVV--LTPTHLAIVMEYAAGGELFDRIC---NAGRFSEDEGRYFFQQLISGVNYC 114
           I++   +    T  H  ++ME+   G L+  +    NA    E E     + ++ G+N+ 
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 115 HSMQICHRDLKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
               I HR++K  N +       +   K+ DFG ++      +  S  GT  Y+ P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188

Query: 173 RREYDGKQG 181
           R        
Sbjct: 189 RAVLRKDHQ 197

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  206 bits (526), Expect = 7e-66
 Identities = 65/187 (34%), Positives = 91/187 (48%), Gaps = 11/187 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---------GRKIDENVAREIINH 52
           ++Y + K LG+G  G  +L   ++T + VA++ I +               NV  EI   
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           + L HP II+ K       +  IV+E   GGELFD++    R  E   + +F Q++  V 
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253

Query: 113 YCHSMQICHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313

Query: 172 SRREYDG 178
                 G
Sbjct: 314 VSVGTAG 320

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  211 bits (539), Expect = 1e-65
 Identities = 60/189 (31%), Positives = 84/189 (44%), Gaps = 12/189 (6%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNI 60
            +E+ + LG G FG      H++T E VA+K   +    K  E    EI   + L HPN+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 61  IRFKEVVLTPTHLA------IVMEYAAGGELFDRIC---NAGRFSEDEGRYFFQQLISGV 111
           +  +EV      LA      + MEY  GG+L   +    N     E   R     + S +
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 112 NYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
            Y H  +I HRDLK EN +L         KI D GY+K           VGT  Y+APE+
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194

Query: 171 LSRREYDGK 179
           L +++Y   
Sbjct: 195 LEQKKYTVT 203

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  200 bits (512), Expect = 2e-65
 Identities = 63/185 (34%), Positives = 101/185 (54%), Gaps = 9/185 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRS 54
           + YE+ ++LG+G F + R  R K T +  A K+I++ R          E + RE+   R 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           +RHPNII   ++    T + +++E  +GGELFD +      +EDE   F +Q++ GV+Y 
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124

Query: 115 HSMQICHRDLKLENTLLDGSAAP--RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           HS +I H DLK EN +L     P  R+K+ DFG +      +  K+  GTP ++APE+++
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 184

Query: 173 RREYD 177
                
Sbjct: 185 YEPLG 189

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  198 bits (507), Expect = 1e-64
 Identities = 71/182 (39%), Positives = 97/182 (53%), Gaps = 5/182 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHP 58
           E+Y +V  LG G+FG     + + T++  AVK I +     K    + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI++  E++   +   IV E   GGELFD I    RFSE +     +Q+ SG+ Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 119 ICHRDLKLENTLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200

Query: 178 GK 179
            K
Sbjct: 201 EK 202

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  200 bits (511), Expect = 2e-64
 Identities = 66/177 (37%), Positives = 93/177 (52%), Gaps = 2/177 (1%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           + +E+  +LG G   +    + K T++  A+K +++     + V  EI     L HPNII
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-TVDKKIVRTEIGVLLRLSHPNII 111

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
           + KE+  TPT +++V+E   GGELFDRI   G +SE +     +Q++  V Y H   I H
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVH 171

Query: 122 RDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           RDLK EN L    +    LKI DFG SK        K+  GTP Y APE+L    Y 
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYG 228

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  200 bits (511), Expect = 3e-64
 Identities = 61/181 (33%), Positives = 91/181 (50%), Gaps = 6/181 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRH 57
           + Y++ ++LG G F V R   HK T    A K I   +K+     + + RE    R L+H
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 87

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI+R  + +   +   +V +   GGELF+ I     +SE +  +  QQ++  + YCHS 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147

Query: 118 QICHRDLKLENTLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            I HR+LK EN LL   A    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207

Query: 177 D 177
            
Sbjct: 208 S 208

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  197 bits (504), Expect = 4e-64
 Identities = 58/183 (31%), Positives = 89/183 (48%), Gaps = 8/183 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KID-ENVAREIINHRSLRHPN 59
           + +   + LG+G FG   L+  + +     +K I + R ++  E +  EI   +SL HPN
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRIC----NAGRFSEDEGRYFFQQLISGVNYCH 115
           II+  EV     ++ IVME   GGEL +RI          SE       +Q+++ + Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141

Query: 116 SMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           S  + H+DLK EN L    S    +KI DFG ++         +  GT  Y+APEV  +R
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-KR 200

Query: 175 EYD 177
           +  
Sbjct: 201 DVT 203

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  197 bits (503), Expect = 2e-63
 Identities = 63/185 (34%), Positives = 101/185 (54%), Gaps = 9/185 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRS 54
           + Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           ++HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130

Query: 115 HSMQICHRDLKLENTLLDGSAA--PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           HS+QI H DLK EN +L       PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

Query: 173 RREYD 177
                
Sbjct: 191 YEPLG 195

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  196 bits (500), Expect = 4e-63
 Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 1/177 (0%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           EKY + +DLG G FG+        +K+    K+++        V +EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQIC 120
              E   +   L ++ E+ +G ++F+RI  +    +E E   +  Q+   + + HS  I 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           H D++ EN +     +  +KI +FG ++        +     P Y APEV       
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  196 bits (500), Expect = 5e-63
 Identities = 57/185 (30%), Positives = 96/185 (51%), Gaps = 9/185 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRS 54
           + Y++ ++LG+G F + +  R K T    A K+I++ +          E + RE+   R 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           + H N+I   +V    T + +++E  +GGELFD +      SE+E   F +Q++ GVNY 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 115 HSMQICHRDLKLENTLLDGSA--APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           H+ +I H DLK EN +L       P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 173 RREYD 177
                
Sbjct: 192 YEPLG 196

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  196 bits (500), Expect = 1e-62
 Identities = 60/185 (32%), Positives = 95/185 (51%), Gaps = 9/185 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI-------ERGRKIDENVAREIINHRS 54
           + Y++ ++LG+G F + +  R K T    A K+I        R     E + RE+   R 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           + HPNII   +V    T + +++E  +GGELFD +      SE+E   F +Q++ GVNY 
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 115 HSMQICHRDLKLENTLLD--GSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           H+ +I H DLK EN +L       P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 173 RREYD 177
                
Sbjct: 192 YEPLG 196

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  194 bits (496), Expect = 2e-62
 Identities = 67/182 (36%), Positives = 100/182 (54%), Gaps = 8/182 (4%)

Query: 2   EKYEL---VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRH 57
           + Y+L    K LG G+F + R   HK++ +  AVK I +  +++ N  +EI        H
Sbjct: 8   QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGH 65

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI++  EV     H  +VME   GGELF+RI     FSE E  Y  ++L+S V++ H +
Sbjct: 66  PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125

Query: 118 QICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRRE 175
            + HRDLK EN L  D +    +KI DFG+++     ++P  T   T  Y APE+L++  
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG 185

Query: 176 YD 177
           YD
Sbjct: 186 YD 187

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  196 bits (499), Expect = 3e-62
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 2/178 (1%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           + Y+++++LG+G FGV      K T  +   K+I     +D   V  EI     L HP +
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQI 119
           I   +       + +++E+ +GGELFDRI     + SE E   + +Q   G+ + H   I
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            H D+K EN + +   A  +KI DFG +         K T  T  + APE++ R    
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 228

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  198 bits (505), Expect = 4e-62
 Identities = 70/182 (38%), Positives = 97/182 (53%), Gaps = 5/182 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           E+Y +V  LG G+FG     + + T++  AVK I +    +     + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI++  E++   +   IV E   GGELFD I    RFSE +     +Q+ SG+ Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 119 ICHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200

Query: 178 GK 179
            K
Sbjct: 201 EK 202

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  197 bits (502), Expect = 5e-62
 Identities = 57/182 (31%), Positives = 88/182 (48%), Gaps = 7/182 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           E+Y+L ++LG G F V R        +  A   I   +      + + RE    R L+HP
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI+R  + +    H  ++ +   GGELF+ I     +SE +  +  QQ++  V +CH M 
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130

Query: 119 ICHRDLKLENTLLDGSA--APRLKICDFGYSKSSVLHSRP-KSTVGTPAYIAPEVLSRRE 175
           + HR+LK EN LL      A  +K+ DFG +       +      GTP Y++PEVL +  
Sbjct: 131 VVHRNLKPENLLLASKLKGAA-VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189

Query: 176 YD 177
           Y 
Sbjct: 190 YG 191

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  198 bits (504), Expect = 8e-62
 Identities = 69/182 (37%), Positives = 96/182 (52%), Gaps = 5/182 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRHP 58
           E Y+ VK LG+G +G   L R K T    A+K I +       +  +  E+   + L HP
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NI++  +      +  +VME   GGELFD I +  +F+E +     +Q++SGV Y H   
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156

Query: 119 ICHRDLKLENTLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S       + K  +GT  YIAPEVL R++YD
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYD 215

Query: 178 GK 179
            K
Sbjct: 216 EK 217

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  199 bits (508), Expect = 9e-62
 Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 2/178 (1%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           + Y++ ++LG G FGV   +  + T    A K++    + D E V +EI     LRHP +
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +   +       + ++ E+ +GGELF+++ +   + SEDE   + +Q+  G+ + H    
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            H DLK EN +     +  LK+ DFG +         K T GT  + APEV   +   
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  197 bits (503), Expect = 9e-62
 Identities = 68/183 (37%), Positives = 98/183 (53%), Gaps = 6/183 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRH 57
           ++Y+  + LG G+FG   L + K T +  AVK I + +       E++ RE+   + L H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PNI++  E      +  +V E   GGELFD I +  RFSE +     +Q++SG+ Y H  
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 118 QICHRDLKLENTLLDGSAA-PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           +I HRDLK EN LL+  +    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 204

Query: 177 DGK 179
           D K
Sbjct: 205 DEK 207

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  191 bits (487), Expect = 2e-61
 Identities = 55/207 (26%), Positives = 82/207 (39%), Gaps = 31/207 (14%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
             +E +  LG G FG     R+       A+K I    +    +  E++   SL H  ++
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVV 65

Query: 62  RFKEV-------------VLTPTHLAIVMEYAAGGELFDRICNAGRF-SEDEGRYFFQQL 107
           R+                V   + L I MEY   G L+D I +       DE    F+Q+
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS---------------SVL 152
           +  ++Y HS  I HRDLK  N  +D S    +KI DFG +K+                  
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 153 HSRPKSTVGTPAYIAPEVLSRREYDGK 179
                S +GT  Y+A EVL    +  +
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNE 210

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  196 bits (499), Expect = 5e-61
 Identities = 66/193 (34%), Positives = 99/193 (51%), Gaps = 16/193 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--------------GRKIDENVAR 47
           E Y  V+ LG+G +G   L + K      A+K I++                K  E +  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 48  EIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQL 107
           EI   +SL HPNII+  +V     +  +V E+  GGELF++I N  +F E +     +Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155

Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYI 166
           +SG+ Y H   I HRD+K EN LL+   +   +KI DFG S       + +  +GT  YI
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215

Query: 167 APEVLSRREYDGK 179
           APEVL +++Y+ K
Sbjct: 216 APEVL-KKKYNEK 227

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  189 bits (483), Expect = 2e-60
 Identities = 59/184 (32%), Positives = 88/184 (47%), Gaps = 8/184 (4%)

Query: 2   EKYELV-KDLGAGNFGVARLLRHKETKELVAVKYIE---RGRKIDENVAREI-INHRSLR 56
             Y L  K+LG G F V R    K T +  A K+++   RG+     +  EI +   +  
Sbjct: 28  NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC--NAGRFSEDEGRYFFQQLISGVNYC 114
            P +I   EV    + + +++EYAAGGE+F       A   SE++     +Q++ GV Y 
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 115 HSMQICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
           H   I H DLK +N LL        +KI DFG S+        +  +GTP Y+APE+L+ 
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY 207

Query: 174 REYD 177
               
Sbjct: 208 DPIT 211

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  188 bits (480), Expect = 4e-60
 Identities = 51/191 (26%), Positives = 81/191 (42%), Gaps = 14/191 (7%)

Query: 2   EKYELVKD-LGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREI-INHRSLRHP 58
           + Y+L +D LG G     +   +  T +  AVK IE+        V RE+ + ++   H 
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           N++   E         +V E   GG +   I     F+E E     Q + S +++ H+  
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131

Query: 119 ICHRDLKLENTLLD--GSAAPRLKICDFGYSK--------SSVLHSRPKSTVGTPAYIAP 168
           I HRDLK EN L +     +P +KICDF            S +      +  G+  Y+AP
Sbjct: 132 IAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 169 EVLSRREYDGK 179
           EV+     +  
Sbjct: 191 EVVEAFSEEAS 201

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  189 bits (482), Expect = 8e-60
 Identities = 62/180 (34%), Positives = 87/180 (48%), Gaps = 4/180 (2%)

Query: 2   EKYELVK--DLGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHP 58
             Y + K   LG G FG         T   +A K I+ RG K  E V  EI     L H 
Sbjct: 87  SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA 146

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSM 117
           N+I+  +   +   + +VMEY  GGELFDRI +     +E +   F +Q+  G+ + H M
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            I H DLK EN L     A ++KI DFG ++      + K   GTP ++APEV++     
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS 266

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  187 bits (478), Expect = 8e-60
 Identities = 42/189 (22%), Positives = 78/189 (41%), Gaps = 13/189 (6%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRH 57
              Y ++K +G+G       + ++  K++ A+KY+      +   ++   EI     L+ 
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85

Query: 58  PN--IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            +  IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H
Sbjct: 86  HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLS 172
              I H DLK  N L+       LK+ DFG +             S VGT  Y+ PE + 
Sbjct: 145 QHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 173 RREYDGKQG 181
                 + G
Sbjct: 202 DMSSSRENG 210

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  189 bits (483), Expect = 1e-59
 Identities = 61/185 (32%), Positives = 94/185 (50%), Gaps = 13/185 (7%)

Query: 2   EKYELV-KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPN 59
           + Y++  + LG G  G    + +K T+E  A+K ++          RE+ ++ R+ + P+
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPH 116

Query: 60  IIRFKEV----VLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNY 113
           I+R  +V          L IVME   GGELF RI + G   F+E E     + +   + Y
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 114 CHSMQICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            HS+ I HRD+K EN L         LK+ DFG++K +  H+   +   TP Y+APEVL 
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 236

Query: 173 RREYD 177
             +YD
Sbjct: 237 PEKYD 241

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  187 bits (478), Expect = 2e-59
 Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 14/189 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID------ENVAREIINHRSL 55
           + YEL + +G G F V R   ++ET +  AVK ++  +         E++ RE      L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGV 111
           +HP+I+   E   +   L +V E+  G +L   I         +SE    ++ +Q++  +
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143

Query: 112 NYCHSMQICHRDLKLENTLLDGSA--APRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAP 168
            YCH   I HRD+K    LL      AP +K+  FG +             VGTP ++AP
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202

Query: 169 EVLSRREYD 177
           EV+ R  Y 
Sbjct: 203 EVVKREPYG 211

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  187 bits (477), Expect = 2e-59
 Identities = 57/185 (30%), Positives = 96/185 (51%), Gaps = 8/185 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRH 57
           MEKY  ++ +G G+FG A L++  E      +K I   R      E   RE+    +++H
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI--CNAGRFSEDEGRYFFQQLISGVNYCH 115
           PNI++++E       L IVM+Y  GG+LF RI       F ED+   +F Q+   + + H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSRR 174
             +I HRD+K +N  L       +++ DFG ++  +      ++ +GTP Y++PE+   +
Sbjct: 143 DRKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200

Query: 175 EYDGK 179
            Y+ K
Sbjct: 201 PYNNK 205

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  187 bits (476), Expect = 3e-59
 Identities = 38/207 (18%), Positives = 77/207 (37%), Gaps = 33/207 (15%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER------------------GRKID 42
           +  Y +++ L  G F    L       +  A+K  E+                   +   
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 43  ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG--------R 94
           ++   E+     +++   +  + ++     + I+ EY     +                 
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 95  FSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH 153
                 +   + +++  +Y H+   ICHRD+K  N L+D +   R+K+ DFG S+  V  
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG--RVKLSDFGESEYMV-D 204

Query: 154 SRPKSTVGTPAYIAPEVLSRRE-YDGK 179
            + K + GT  ++ PE  S    Y+G 
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGA 231

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  184 bits (470), Expect = 4e-59
 Identities = 46/197 (23%), Positives = 81/197 (41%), Gaps = 23/197 (11%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
              ++ ++ +G+G FG     +H+   +   +K ++      E   RE+     L H NI
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNI 66

Query: 61  IRFKE----------------VVLTPTHLAIVMEYAAGGELFDRI--CNAGRFSEDEGRY 102
           + +                         L I ME+   G L   I      +  +     
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 103 FFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT 162
            F+Q+  GV+Y HS ++ +RDLK  N  L  +   ++KI DFG   S     +   + GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGDFGLVTSLKNDGKRTRSKGT 184

Query: 163 PAYIAPEVLSRREYDGK 179
             Y++PE +S ++Y  +
Sbjct: 185 LRYMSPEQISSQDYGKE 201

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  186 bits (473), Expect = 8e-59
 Identities = 42/188 (22%), Positives = 79/188 (42%), Gaps = 13/188 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
             Y ++K +G+G       + ++  K++ A+KY+      +   ++   EI     L+  
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 59  N--IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           +  IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSR 173
             I H DLK  N L+       LK+ DFG +      +      S VGT  Y+ PE +  
Sbjct: 127 HGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 174 REYDGKQG 181
                + G
Sbjct: 184 MSSSRENG 191

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  184 bits (468), Expect = 5e-58
 Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 53/231 (22%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID------ENVAREIINHRSL 55
           +KY L   +G G++GV R+    +T+ + A+K + + +         E +  E+   + L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--------------------- 94
            HPNI R  EV     ++ +VME   GG L D++                          
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 95  -------------------FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA 135
                                E       +Q+ S ++Y H+  ICHRD+K EN L   + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205

Query: 136 APRLKICDFGYSKSSVLHSRP-----KSTVGTPAYIAPEVLS--RREYDGK 179
           +  +K+ DFG SK     +        +  GTP ++APEVL+     Y  K
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  185 bits (470), Expect = 7e-58
 Identities = 41/189 (21%), Positives = 78/189 (41%), Gaps = 13/189 (6%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRH 57
              Y ++K +G+G       + ++  K++ A+KY+      +   ++   EI     L+ 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113

Query: 58  PN--IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            +  IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V+  H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLS 172
              I H DLK  N L+       LK+ DFG +      +      S VG   Y+ PE + 
Sbjct: 173 QHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 173 RREYDGKQG 181
                 + G
Sbjct: 230 DMSSSRENG 238

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  181 bits (462), Expect = 7e-58
 Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 17/194 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRH 57
            E YE++  +G G++G  + +R K   +++  K ++ G   +   + +  E+   R L+H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64

Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGV 111
           PNI+R+ + ++  T   L IVMEY  GG+L   I    +      E+       QL   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 112 NYCHSM-----QICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAY 165
             CH        + HRDLK  N  LDG     +K+ DFG ++  +   S  K+ VGTP Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 166 IAPEVLSRREYDGK 179
           ++PE ++R  Y+ K
Sbjct: 183 MSPEQMNRMSYNEK 196

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  182 bits (464), Expect = 2e-57
 Identities = 56/185 (30%), Positives = 86/185 (46%), Gaps = 14/185 (7%)

Query: 2   EKYELVKD-LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPN 59
           + Y+L K  LG G  G      H+ T +  A+K +           +E+  + ++   P+
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGPH 83

Query: 60  IIRFKEVVLTPTHLA----IVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNY 113
           I+   +V     H      I+ME   GGELF RI   G   F+E E     + + + + +
Sbjct: 84  IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143

Query: 114 CHSMQICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            HS  I HRD+K EN L         LK+ DFG++K     +  ++   TP Y+APEVL 
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPEVLG 202

Query: 173 RREYD 177
             +YD
Sbjct: 203 PEKYD 207

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  179 bits (456), Expect = 1e-56
 Identities = 49/188 (26%), Positives = 84/188 (44%), Gaps = 11/188 (5%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR 56
           +  + + K +G G F              VA+K ++    +D     +  +EI   + L 
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVN 112
           HPN+I++    +    L IV+E A  G+L   I +  +      E     +F QL S + 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVL 171
           + HS ++ HRD+K  N  +  +    +K+ D G  +  S   +   S VGTP Y++PE +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208

Query: 172 SRREYDGK 179
               Y+ K
Sbjct: 209 HENGYNFK 216

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  172 bits (437), Expect = 1e-53
 Identities = 45/184 (24%), Positives = 73/184 (39%), Gaps = 9/184 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSL-R 56
            + ++ +  LG G++G    +R KE   L AVK      RG K       E+ +H  + +
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCH 115
           HP  +R ++       L +  E   G  L       G    E +   + +  +  + + H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           S  + H D+K  N  L      R K+ DFG           +   G P Y+APE+L +  
Sbjct: 175 SQGLVHLDVKPANIFLGPRG--RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL-QGS 231

Query: 176 YDGK 179
           Y   
Sbjct: 232 YGTA 235

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  170 bits (432), Expect = 4e-53
 Identities = 50/209 (23%), Positives = 75/209 (35%), Gaps = 32/209 (15%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHP 58
           +  +E ++ LG G FGV    ++K      A+K I    +      V RE+     L HP
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63

Query: 59  NIIRFKEVVLT------------PTHLAIVMEYAAGGELFDRI---CNAGRFSEDEGRYF 103
            I+R+    L               +L I M+      L D +   C           + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 104 FQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK-------------SS 150
           F Q+   V + HS  + HRDLK  N          +K+ DFG                  
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 151 VLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
             ++R    VGT  Y++PE +    Y  K
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHK 210

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  167 bits (424), Expect = 1e-51
 Identities = 45/195 (23%), Positives = 72/195 (36%), Gaps = 21/195 (10%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA-REIINHRSLRHPNI 60
           + Y  ++ LG G F    L+         A+K I    + D   A RE   HR   HPNI
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 61  IRFKEVVLTPT----HLAIVMEYAAGGELFDRI----CNAGRFSEDEGRYFFQQLISGVN 112
           +R     L          +++ +   G L++ I          +ED+  +    +  G+ 
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST----------VGT 162
             H+    HRDLK  N LL      +  + D G    + +H                  T
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDE--GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 163 PAYIAPEVLSRREYD 177
            +Y APE+ S + + 
Sbjct: 207 ISYRAPELFSVQSHC 221

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  162 bits (413), Expect = 3e-50
 Identities = 53/185 (28%), Positives = 80/185 (43%), Gaps = 34/185 (18%)

Query: 2   EKYELV-KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPN 59
           + Y++  + LG G  G    + +K T+E  A+K ++          RE+ ++ R+ + P+
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPH 72

Query: 60  IIRFKEV----VLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNY 113
           I+R  +V          L IVME   GGELF RI + G   F+E E     + +   + Y
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 114 CHSMQICHRDLKLENTLL-DGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
            HS+ I HRD+K EN L         LK+ DFG                     A E   
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETT- 171

Query: 173 RREYD 177
             +YD
Sbjct: 172 GEKYD 176

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  163 bits (413), Expect = 5e-49
 Identities = 52/195 (26%), Positives = 76/195 (38%), Gaps = 28/195 (14%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPNI 60
                 K LG G+ G     +       VAVK +       +    EI +   S  HPN+
Sbjct: 15  NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV 71

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRY-------FFQQLISGVNY 113
           IR+     T   L I +E      L D + +     E+             +Q+ SGV +
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 114 CHSMQICHRDLKLENTLLDGSAAP-----------RLKICDFGYSK-----SSVLHSRPK 157
            HS++I HRDLK +N L+  S+             R+ I DFG  K      S   +   
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190

Query: 158 STVGTPAYIAPEVLS 172
           +  GT  + APE+L 
Sbjct: 191 NPSGTSGWRAPELLE 205

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  159 bits (404), Expect = 2e-48
 Identities = 30/201 (14%), Positives = 67/201 (33%), Gaps = 23/201 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRKIDENVAREIIN-HRSL 55
           +   +   LG G F              + K+   +K  +     +  +  +++   +  
Sbjct: 65  KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS 124

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC-----NAGRFSEDEGRYFFQQLISG 110
                ++F    L      +V E  + G L + I            +     F  +++  
Sbjct: 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184

Query: 111 VNYCHSMQICHRDLKLENTLL---------DGSAAPRLKICDFGYSKSSVLHSRP---KS 158
           +   H  +I H D+K +N +L         +   +  L + D G S    L  +     +
Sbjct: 185 IEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244

Query: 159 TVGTPAYIAPEVLSRREYDGK 179
              T  +   E+LS + ++ +
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQ 265

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  158 bits (401), Expect = 3e-47
 Identities = 51/185 (27%), Positives = 70/185 (37%), Gaps = 13/185 (7%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHPNII 61
            +     LG G  G   + R       VAVK I    +      RE+ +   S  HPN+I
Sbjct: 25  SFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVI 81

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQIC 120
           R+           I +E      L + +          E     QQ  SG+ + HS+ I 
Sbjct: 82  RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140

Query: 121 HRDLKLENTLL---DGSAAPRLKICDFGYSK----SSVLHSRPKSTVGTPAYIAPEVLSR 173
           HRDLK  N L+   +     +  I DFG  K         SR     GT  +IAPE+LS 
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 174 REYDG 178
              + 
Sbjct: 201 DCKEN 205

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  154 bits (390), Expect = 6e-47
 Identities = 50/204 (24%), Positives = 80/204 (39%), Gaps = 29/204 (14%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIE---RGRKIDENVAREIINHRSL-RH 57
            ++  ++ +G+G FG       +    + A+K  +    G   ++N  RE+  H  L +H
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVNY 113
            +++R+        H+ I  EY  GG L D I    R    F E E +    Q+  G+ Y
Sbjct: 71  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 114 CHSMQICHRDLKLENTLLD-----------------GSAAPRLKICDFGYSKSSVLHSRP 156
            HSM + H D+K  N  +                   S     KI D G+       S P
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISSP 187

Query: 157 KSTVGTPAYIAPEVLS-RREYDGK 179
           +   G   ++A EVL     +  K
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPK 211

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  154 bits (392), Expect = 1e-46
 Identities = 47/208 (22%), Positives = 78/208 (37%), Gaps = 32/208 (15%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-VAREIINHRSLR-HPNI 60
           +  + + L  G F      +   +    A+K +    +     + +E+   + L  HPNI
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 61  IRF-------KEVVLTPTHLAIVMEYAAGGELFDRICNA---GRFSEDEGRYFFQQLISG 110
           ++F       KE   T     +++     G+L + +      G  S D     F Q    
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 111 VNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--------- 159
           V + H  +  I HRDLK+EN LL       +K+CDFG + +   +     +         
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 160 ----VGTPAYIAPEVL---SRREYDGKQ 180
                 TP Y  PE++   S      KQ
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQ 234

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  148 bits (375), Expect = 3e-44
 Identities = 49/185 (26%), Positives = 77/185 (41%), Gaps = 11/185 (5%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           +        +G G+FG    ++ K+T    AVK +     ++     E++    L  P I
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPRI 112

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +     V     + I ME   GG L   I   G   ED   Y+  Q + G+ Y H+ +I 
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAPEVLSRR 174
           H D+K +N LL    + R  +CDFG++                   GT  ++APEV+  +
Sbjct: 173 HGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231

Query: 175 EYDGK 179
             D K
Sbjct: 232 PCDAK 236

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  146 bits (372), Expect = 6e-44
 Identities = 56/184 (30%), Positives = 82/184 (44%), Gaps = 9/184 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
            E ++  K LG G+F    L R   T    A+K +E+   I EN    +   R     L 
Sbjct: 29  PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST---VGTPAYIAPEVLSR 173
             I HRDLK EN LL+      ++I DFG +K     S+       VGT  Y++PE+L+ 
Sbjct: 149 KGIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206

Query: 174 REYD 177
           +   
Sbjct: 207 KSAC 210

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  141 bits (358), Expect = 1e-41
 Identities = 65/186 (34%), Positives = 96/186 (51%), Gaps = 15/186 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           M  ++ +K LG G FG   L+R K T    A+K +   RK +  +A++ + H        
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL---RK-EVIIAKDEVAHTVTESRVL 59

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           ++ RHP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + 
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVL 171
           Y HS  + +RD+KLEN +LD      +KI DFG  K  +       T  GTP Y+APEVL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177

Query: 172 SRREYD 177
              +Y 
Sbjct: 178 EDNDYG 183

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  142 bits (360), Expect = 1e-41
 Identities = 45/182 (24%), Positives = 91/182 (50%), Gaps = 6/182 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
            + +E+++ +G G+FG   +++  +TK++ A+KY+ + + ++ N  R +         L 
Sbjct: 14  FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP ++           + +V++   GG+L   +     F E+  + F  +L+  ++Y  +
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K +N LLD      + I DF  +      ++  +  GT  Y+APE+ S R+ 
Sbjct: 134 QRIIHRDMKPDNILLD--EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191

Query: 177 DG 178
            G
Sbjct: 192 AG 193

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  140 bits (356), Expect = 2e-41
 Identities = 56/185 (30%), Positives = 93/185 (50%), Gaps = 16/185 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           ++ +++++ LG G+FG   L+R +      A+K +    K +  V  + + H        
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLML 60

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
             + HP IIR          + ++M+Y  GGELF  +  + RF     +++  ++   + 
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           Y HS  I +RDLK EN LLD      +KI DFG++K   +     +  GTP YIAPEV+S
Sbjct: 121 YLHSKDIIYRDLKPENILLD--KNGHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVS 176

Query: 173 RREYD 177
            + Y+
Sbjct: 177 TKPYN 181

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  140 bits (356), Expect = 3e-41
 Identities = 54/181 (29%), Positives = 103/181 (56%), Gaps = 8/181 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +        +N +    ++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R  +  GTP  +APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGY 215

Query: 177 D 177
           +
Sbjct: 216 N 216

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  140 bits (355), Expect = 4e-41
 Identities = 60/187 (32%), Positives = 93/187 (49%), Gaps = 16/187 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           +E + L K LG G+FG   L   K+T +  A+K +   +K D  +  + +          
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL---KK-DVVLMDDDVECTMVEKRVL 71

Query: 53  -RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
             +  HP +        T  +L  VMEY  GG+L   I +  +F      ++  ++I G+
Sbjct: 72  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEV 170
            + HS  I +RDLKL+N LLD      +KI DFG  K ++L     +T  GTP YIAPE+
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189

Query: 171 LSRREYD 177
           L  ++Y+
Sbjct: 190 LLGQKYN 196

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  139 bits (352), Expect = 4e-41
 Identities = 53/180 (29%), Positives = 92/180 (51%), Gaps = 5/180 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA++ +   ++   E +  EI+  R  ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           + + +  L    L +VMEY AGG L D +       E +     ++ +  + + HS Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRD+K +N LL       +K+ DFG+  + +   S+  + VGTP ++APEV++R+ Y  K
Sbjct: 139 HRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  140 bits (355), Expect = 4e-41
 Identities = 62/187 (33%), Positives = 93/187 (49%), Gaps = 16/187 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           ++ +E ++ LG G+FG   L R KET +L AVK +   +K D  +  + +          
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL---KK-DVILQDDDVECTMTEKRIL 77

Query: 53  -RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
             +  HP + +      TP  L  VME+  GG+L   I  + RF E   R++  ++IS +
Sbjct: 78  SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISAL 137

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEV 170
            + H   I +RDLKL+N LLD       K+ DFG  K  + +    +T  GTP YIAPE+
Sbjct: 138 MFLHDKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI 195

Query: 171 LSRREYD 177
           L    Y 
Sbjct: 196 LQEMLYG 202

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  140 bits (355), Expect = 4e-41
 Identities = 53/187 (28%), Positives = 93/187 (49%), Gaps = 16/187 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           ++ ++L++ +G G++    L+R K+T  + A+K +   +K +     E I+         
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV---KK-ELVNDDEDIDWVQTEKHVF 63

Query: 53  -RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
            ++  HP ++       T + L  V+EY  GG+L   +    +  E+  R++  ++   +
Sbjct: 64  EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 123

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEV 170
           NY H   I +RDLKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 181

Query: 171 LSRREYD 177
           L   +Y 
Sbjct: 182 LRGEDYG 188

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  140 bits (356), Expect = 5e-41
 Identities = 60/187 (32%), Positives = 94/187 (50%), Gaps = 16/187 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
              +  +K +G G+FG   L RHK  +   AVK +   +K    + ++   H        
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL---QK-KAILKKKEEKHIMSERNVL 92

Query: 53  -RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
            ++++HP ++       T   L  V++Y  GGELF  +     F E   R++  ++ S +
Sbjct: 93  LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL 152

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEV 170
            Y HS+ I +RDLK EN LLD      + + DFG  K ++ H+   ST  GTP Y+APEV
Sbjct: 153 GYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210

Query: 171 LSRREYD 177
           L ++ YD
Sbjct: 211 LHKQPYD 217

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  139 bits (351), Expect = 9e-41
 Identities = 53/180 (29%), Positives = 94/180 (52%), Gaps = 5/180 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
              +    +G G+ G+  L R K +   VAVK ++  ++   E +  E++  R  +H N+
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +   +  L    L ++ME+  GG L D I +  R +E++     + ++  + Y H+  + 
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVI 163

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRD+K ++ LL      R+K+ DFG+  + S    + KS VGTP ++APEV+SR  Y  +
Sbjct: 164 HRDIKSDSILLTLDG--RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATE 221

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  139 bits (353), Expect = 2e-40
 Identities = 52/187 (27%), Positives = 93/187 (49%), Gaps = 16/187 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           ++ ++L++ +G G++    L+R K+T  + A++ +   +K +     E I+         
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV---KK-ELVNDDEDIDWVQTEKHVF 106

Query: 53  -RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
            ++  HP ++       T + L  V+EY  GG+L   +    +  E+  R++  ++   +
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 166

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEV 170
           NY H   I +RDLKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+
Sbjct: 167 NYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 224

Query: 171 LSRREYD 177
           L   +Y 
Sbjct: 225 LRGEDYG 231

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  137 bits (347), Expect = 3e-40
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 6/181 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           E +  ++ +G G+FG         T+++VA+K I  E      E++ +EI        P 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + ++    L  T L I+MEY  GG   D +   G   E +     ++++ G++Y HS + 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL       +K+ DFG +   +    +  + VGTP ++APEV+ +  YD 
Sbjct: 141 IHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198

Query: 179 K 179
           K
Sbjct: 199 K 199

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  138 bits (350), Expect = 3e-40
 Identities = 57/187 (30%), Positives = 86/187 (45%), Gaps = 16/187 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           +  +  +  LG G+FG   L   K T EL AVK +   +K D  +  + +          
Sbjct: 19  LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL---KK-DVVIQDDDVECTMVEKRVL 74

Query: 53  -RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
               + P + +      T   L  VMEY  GG+L   I   GRF E    ++  ++  G+
Sbjct: 75  ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 134

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEV 170
            +  S  I +RDLKL+N +LD      +KI DFG  K ++       T  GTP YIAPE+
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI 192

Query: 171 LSRREYD 177
           ++ + Y 
Sbjct: 193 IAYQPYG 199

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  137 bits (346), Expect = 4e-40
 Identities = 53/180 (29%), Positives = 92/180 (51%), Gaps = 5/180 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E +++++ LG G++G      HKET ++VA+K +     + E + +EI   +    P+++
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHVV 87

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           ++       T L IVMEY   G + D I       +EDE     Q  + G+ Y H M+  
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRD+K  N LL+       K+ DFG + + +   ++  + +GTP ++APEV+    Y+  
Sbjct: 148 HRDIKAGNILLNTEG--HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCV 205

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  136 bits (345), Expect = 9e-40
 Identities = 54/185 (29%), Positives = 99/185 (53%), Gaps = 11/185 (5%)

Query: 1   MEKYELVKDLGAGNFG---VARLLRHKETKELVAVKYIERGRKIDENVAREIINHR---- 53
             ++EL+K LG G+FG   + + +   + ++L A+K + +   +           R    
Sbjct: 23  PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILV 81

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
            + HP I++      T   L +++++  GG+LF R+     F+E++ +++  +L   +++
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEVLS 172
            HS+ I +RDLK EN LLD      +K+ DFG SK S+ H +   +  GT  Y+APEV++
Sbjct: 142 LHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199

Query: 173 RREYD 177
           RR + 
Sbjct: 200 RRGHT 204

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  137 bits (348), Expect = 2e-39
 Identities = 68/187 (36%), Positives = 99/187 (52%), Gaps = 16/187 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           M ++E +K LG G FG   L++ K T    A+K +   +K +  VA++ + H        
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL---KK-EVIVAKDEVAHTLTENRVL 202

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           ++ RHP +   K    T   L  VMEYA GGELF  +     FSED  R++  +++S ++
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 262

Query: 113 YCHSMQ-ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEV 170
           Y HS + + +RDLKLEN +LD      +KI DFG  K  +       T  GTP Y+APEV
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 320

Query: 171 LSRREYD 177
           L   +Y 
Sbjct: 321 LEDNDYG 327

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  134 bits (339), Expect = 7e-39
 Identities = 55/189 (29%), Positives = 93/189 (49%), Gaps = 17/189 (8%)

Query: 1   MEKYELVKDLGAGNFG---VARLLRHKETKELVAVKYIERG---RKIDENVA-----REI 49
            E +EL++ LG G +G     R +    T ++ A+K +++    R   +  A     R I
Sbjct: 16  PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD-TAHTKAERNI 74

Query: 50  INHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLIS 109
           +    ++HP I+       T   L +++EY +GGELF ++   G F ED   ++  ++  
Sbjct: 75  LE--EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM 132

Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAP 168
            + + H   I +RDLK EN +L+      +K+ DFG  K S+       T  GT  Y+AP
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190

Query: 169 EVLSRREYD 177
           E+L R  ++
Sbjct: 191 EILMRSGHN 199

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  134 bits (340), Expect = 7e-39
 Identities = 56/183 (30%), Positives = 86/183 (46%), Gaps = 8/183 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN--VAREI-INHRSLRH 57
            + +E + +LGAGN GV   + HK +  ++A K I    K      + RE+ + H     
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NS 90

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS- 116
           P I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y    
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K  N L++      +K+CDFG S   +  S   S VGT +Y++PE L    Y
Sbjct: 151 HKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHY 207

Query: 177 DGK 179
             +
Sbjct: 208 SVQ 210

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  133 bits (336), Expect = 9e-39
 Identities = 56/185 (30%), Positives = 85/185 (45%), Gaps = 14/185 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
            ++ E+ + +G G FGV    + +     VA+K I       +    E+     + HPNI
Sbjct: 7   YKEIEVEEVVGRGAFGVVCKAKWRAKD--VAIKQI-ESESERKAFIVELRQLSRVNHPNI 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI---SGVNYCHSM 117
           ++     L P  + +VMEYA GG L++ +  A         +     +    GV Y HSM
Sbjct: 64  VKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 118 Q---ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           Q   + HRDLK  N LL  +    LKICDFG +    + +   +  G+ A++APEV    
Sbjct: 122 QPKALIHRDLKPPNLLLV-AGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEGS 178

Query: 175 EYDGK 179
            Y  K
Sbjct: 179 NYSEK 183

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  139 bits (350), Expect = 1e-38
 Identities = 57/187 (30%), Positives = 86/187 (45%), Gaps = 16/187 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
           +  +  +  LG G+FG   L   K T EL AVK +   +K D  +  + +          
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL---KK-DVVIQDDDVECTMVEKRVL 395

Query: 53  -RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
               + P + +      T   L  VMEY  GG+L   I   GRF E    ++  ++  G+
Sbjct: 396 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 455

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYIAPEV 170
            +  S  I +RDLKL+N +LD      +KI DFG  K ++       T  GTP YIAPE+
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI 513

Query: 171 LSRREYD 177
           ++ + Y 
Sbjct: 514 IAYQPYG 520

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  135 bits (341), Expect = 2e-38
 Identities = 60/191 (31%), Positives = 92/191 (48%), Gaps = 17/191 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
            E YE+VK +G G FG  +L+RHK T+++ A+K +       E + R             
Sbjct: 68  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIM 123

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                P +++         +L +VMEY  GG+L   + +     E   R++  +++  ++
Sbjct: 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALD 182

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEV 170
             HSM   HRD+K +N LLD S    LK+ DFG     +     R  + VGTP YI+PEV
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240

Query: 171 LSRREYDGKQG 181
           L  +  DG  G
Sbjct: 241 LKSQGGDGYYG 251

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  132 bits (333), Expect = 2e-38
 Identities = 52/177 (29%), Positives = 90/177 (50%), Gaps = 8/177 (4%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIE-RGRKIDENVAREIINHRSLRHPNIIRFKEVVL 68
           LG G +G+    R    +  +A+K I  R  +  + +  EI  H+ L+H NI+++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 69  TPTHLAIVMEYAAGGELFDRICNA-GRFSEDEG--RYFFQQLISGVNYCHSMQICHRDLK 125
               + I ME   GG L   + +  G   ++E    ++ +Q++ G+ Y H  QI HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149

Query: 126 LENTLLDGSAAPRLKICDFGYSK-SSVLHSRPKSTVGTPAYIAPEVL--SRREYDGK 179
            +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++    R Y   
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 205

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  133 bits (337), Expect = 3e-38
 Identities = 29/216 (13%), Positives = 52/216 (24%), Gaps = 42/216 (19%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR-- 56
                  LG  +         +ET E   V       +      + +  E++  R LR  
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 57  -----------------------HPNIIRFKEVVLTPTHLAIVMEYAA--------GGEL 85
                                     +IR +        L+    Y          G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 86  FDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
                               Q+I  +   H   + H  L+  + +LD      + +  F 
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG--GVFLTGFE 251

Query: 146 YSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGKQG 181
                V       +  +  +  PE+ +RR       
Sbjct: 252 ---HLVRDGARVVSSVSRGFEPPELEARRATISYHR 284

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  134 bits (338), Expect = 4e-38
 Identities = 45/192 (23%), Positives = 85/192 (44%), Gaps = 17/192 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
            + +E++K +G G F    +++ K+T ++ A+K +    K  + + R  ++         
Sbjct: 60  RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM---NK-WDMLKRGEVSCFREERDVL 115

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGV 111
            +     I +         +L +VMEY  GG+L   +   G R   +  R++  +++  +
Sbjct: 116 VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAI 175

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL--HSRPKSTVGTPAYIAPE 169
           +  H +   HRD+K +N LLD      +++ DFG           R    VGTP Y++PE
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCG--HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233

Query: 170 VLSRREYDGKQG 181
           +L         G
Sbjct: 234 ILQAVGGGPGTG 245

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  135 bits (342), Expect = 1e-37
 Identities = 49/182 (26%), Positives = 88/182 (48%), Gaps = 10/182 (5%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR------- 53
           M  + + + +G G FG     R  +T ++ A+K +++ R   +      +N R       
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           +   P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G+ +
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            H+  + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL +
Sbjct: 308 MHNRFVVYRDLKPANILLDEHG--HVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQK 364

Query: 174 RE 175
             
Sbjct: 365 GV 366

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  129 bits (326), Expect = 4e-37
 Identities = 42/184 (22%), Positives = 79/184 (42%), Gaps = 8/184 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREI-INHRSLRH 57
           +   E + ++G+G  G    +R ++T  ++AVK +     ++ ++ +  ++ +  +S   
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC 83

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS- 116
           P I++     +T T + I ME         +    G   E         ++  + Y    
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRRE 175
             + HRD+K  N LLD     ++K+CDFG S   V   + K    G  AY+APE +   +
Sbjct: 144 HGVIHRDVKPSNILLDERG--QIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPERIDPPD 200

Query: 176 YDGK 179
               
Sbjct: 201 PTKP 204

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  128 bits (324), Expect = 6e-37
 Identities = 56/186 (30%), Positives = 91/186 (48%), Gaps = 10/186 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           E +E+V +LG G FG     ++KET  L A K IE   + + E+   EI    +  HP I
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQI 119
           ++          L I++E+  GG +   +       +E + +   +Q++  +N+ HS +I
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 138

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVLSRRE--- 175
            HRDLK  N L+       +++ DFG S K+     +  S +GTP ++APEV+       
Sbjct: 139 IHRDLKAGNVLMTLEG--DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196

Query: 176 --YDGK 179
             YD K
Sbjct: 197 TPYDYK 202

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  132 bits (335), Expect = 8e-37
 Identities = 46/183 (25%), Positives = 76/183 (41%), Gaps = 8/183 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS----LR 56
              +   + LG G FG     + + T ++ A K +E+ R          +N +     + 
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYC 114
              ++       T   L +V+    GG+L   I + G+  F E    ++  ++  G+   
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           H  +I +RDLK EN LLD      ++I D G +         K  VGT  Y+APEV+   
Sbjct: 303 HRERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360

Query: 175 EYD 177
            Y 
Sbjct: 361 RYT 363

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  131 bits (330), Expect = 8e-37
 Identities = 48/192 (25%), Positives = 87/192 (45%), Gaps = 18/192 (9%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-------- 52
            E +E++K +G G FG   +++ K   ++ A+K +    K  E + R             
Sbjct: 73  REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKIL---NK-WEMLKRAETACFREERDVL 128

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGV 111
            +     I           +L +VM+Y  GG+L   +     R  E+  R++  +++  +
Sbjct: 129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAI 188

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPE 169
           +  H +   HRD+K +N L+D +    +++ DFG     +     +S+  VGTP YI+PE
Sbjct: 189 DSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246

Query: 170 VLSRREYDGKQG 181
           +L   E  GK  
Sbjct: 247 ILQAME-GGKGR 257

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  129 bits (324), Expect = 2e-36
 Identities = 31/211 (14%), Positives = 54/211 (25%), Gaps = 40/211 (18%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRHP 58
           K +LV+ L  G+  V  L+R  E  E  A+K    G +   +              L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 59  NIIRFKEV--------------------------VLTPTHLAIVMEYAAG------GELF 86
           +    ++                                +  ++M  A+         L 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 87  DRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY 146
                 G            QLI       S  + H     +N  +      RL + D   
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG--RLMLGDVSA 240

Query: 147 SKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
                + +R  ++     Y   E L+     
Sbjct: 241 LWK--VGTRGPASSVPVTYAPREFLNASTAT 269

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  131 bits (331), Expect = 2e-36
 Identities = 51/186 (27%), Positives = 81/186 (43%), Gaps = 11/186 (5%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR----SLR 56
            + +   + LG G FG     + K T +L A K + + R       +  +  +     + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVN 112
              I+       T T L +VM    GG++   I N       F E    ++  Q++SG+ 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVL 171
           + H   I +RDLK EN LLD      ++I D G +       ++ K   GTP ++APE+L
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 172 SRREYD 177
              EYD
Sbjct: 362 LGEEYD 367

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  126 bits (319), Expect = 2e-36
 Identities = 59/189 (31%), Positives = 82/189 (43%), Gaps = 18/189 (9%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-----ENVAREIINHRSLRHPN 59
            L + +G G FG  ++ R     + VAVK        D     ENV +E      L+HPN
Sbjct: 10  TLEEIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-- 117
           II  + V L   +L +VME+A GG L   +    R   D    +  Q+  G+NY H    
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 118 -QICHRDLKLENTLLDGSAAPR------LKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
             I HRDLK  N L+             LKI DFG ++     +   S  G  A++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEV 185

Query: 171 LSRREYDGK 179
           +    +   
Sbjct: 186 IRASMFSKG 194

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  126 bits (320), Expect = 2e-36
 Identities = 46/191 (24%), Positives = 85/191 (44%), Gaps = 15/191 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN--VAREI-INHRSLRH 57
            +  E + +LG G +GV   +RH  + +++AVK I       E   +  ++ I+ R++  
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICN-AGRFSEDEGRYFFQQLISGVNYC 114
           P  + F   +     + I ME       + + ++ +      ED        ++  + + 
Sbjct: 66  PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 115 HS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEV-- 170
           HS + + HRD+K  N L++     ++K+CDFG S   V     K    G   Y+APE   
Sbjct: 126 HSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERIN 182

Query: 171 --LSRREYDGK 179
             L+++ Y  K
Sbjct: 183 PELNQKGYSVK 193

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  127 bits (320), Expect = 3e-36
 Identities = 55/195 (28%), Positives = 89/195 (45%), Gaps = 19/195 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + YEL + +G+G   V +       KE VA+K I  E+ +   + + +EI       HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFD--------RICNAGRFSEDEGRYFFQQLISGV 111
           I+ +    +    L +VM+  +GG + D            +G   E       ++++ G+
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS------KSSVLHSRPKSTVGTPAY 165
            Y H     HRD+K  N LL    +  ++I DFG S           +   K+ VGTP +
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 166 IAPEVLSR-REYDGK 179
           +APEV+ + R YD K
Sbjct: 193 MAPEVMEQVRGYDFK 207

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  126 bits (318), Expect = 4e-36
 Identities = 51/191 (26%), Positives = 80/191 (41%), Gaps = 20/191 (10%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA--------REIINHRSLR 56
           E  K +G G FG+    R  + K +VA+K +  G    E           RE+    +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCH 115
           HPNI++   ++  P    +VME+   G+L+ R+ +                +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 116 SM--QICHRDLKLENTLLDG---SAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +    I HRDL+  N  L     +A    K+ DFG S+ SV        +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV--SGLLGNFQWMAPET 197

Query: 171 LSRRE--YDGK 179
           +   E  Y  K
Sbjct: 198 IGAEEESYTEK 208

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  128 bits (322), Expect = 4e-36
 Identities = 47/195 (24%), Positives = 82/195 (42%), Gaps = 19/195 (9%)

Query: 2   EKYELVKDLGAG--NFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLR 56
             YEL+  +G G  +     L R+K T E V V+ I       ++   +  E+   +   
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYC 114
           HPNI+ ++   +    L +V  + A G   D IC       +E    Y  Q ++  ++Y 
Sbjct: 85  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYS--------KSSVLHSRPKSTVGTPAYI 166
           H M   HR +K  + L+       + +     +        +  V+H  PK +V    ++
Sbjct: 145 HHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202

Query: 167 APEVLSR--REYDGK 179
           +PEVL +  + YD K
Sbjct: 203 SPEVLQQNLQGYDAK 217

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  126 bits (318), Expect = 5e-36
 Identities = 55/178 (30%), Positives = 85/178 (47%), Gaps = 12/178 (6%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLR 56
           MEKYE +  +G G++GV    R+++T ++VA+K      + D  +     REI   + L+
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLK 60

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           HPN++   EV      L +V EY         DR        E   +    Q +  VN+C
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFC 118

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           H     HRD+K EN L+   +   +K+CDFG+++     S      V T  Y +PE+L
Sbjct: 119 HKHNCIHRDVKPENILITKHS--VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELL 174

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  126 bits (318), Expect = 7e-36
 Identities = 54/193 (27%), Positives = 94/193 (48%), Gaps = 17/193 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNI 60
             +ELV+ +G G +G     RH +T +L A+K ++     +E + +EI   +    H NI
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI 83

Query: 61  IRF------KEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVN 112
             +      K        L +VME+   G + D  +        E+   Y  ++++ G++
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS-KSSVLHSRPKSTVGTPAYIAPEVL 171
           + H  ++ HRD+K +N LL  +A   +K+ DFG S +      R  + +GTP ++APEV+
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 172 SRRE-----YDGK 179
           +  E     YD K
Sbjct: 202 ACDENPDATYDFK 214

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  125 bits (317), Expect = 8e-36
 Identities = 62/190 (32%), Positives = 92/190 (48%), Gaps = 25/190 (13%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNII 61
            + + +GAG+FG   + R +     VAVK +       E V    RE+   + LRHPNI+
Sbjct: 40  NIKEKIGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLIS-------GVNYC 114
            F   V  P +L+IV EY + G L+  +      S    +   ++ +S       G+NY 
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLL----HKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 115 HSM--QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPE 169
           H+    I HR+LK  N L+D      +K+CDFG S+  +  S     KS  GTP ++APE
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPE 209

Query: 170 VLSRREYDGK 179
           VL     + K
Sbjct: 210 VLRDEPSNEK 219

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  126 bits (319), Expect = 8e-36
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 12/185 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----ERGRKIDENVAREIINHRSLRH 57
           + +  ++++G G+FG     R     E+VA+K +    ++  +  +++ +E+   + LRH
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PN I+++   L      +VMEY  G        +     E E        + G+ Y HS 
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS---RR 174
            + HRD+K  N LL       +K+ DFG   +S++     S VGTP ++APEV+      
Sbjct: 174 NMIHRDVKAGNILLSEPG--LVKLGDFGS--ASIMAPA-NSFVGTPYWMAPEVILAMDEG 228

Query: 175 EYDGK 179
           +YDGK
Sbjct: 229 QYDGK 233

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  126 bits (319), Expect = 1e-35
 Identities = 52/191 (27%), Positives = 92/191 (48%), Gaps = 21/191 (10%)

Query: 1   MEKYELVKDLGAGNFG---VARLLRHKETKELVAVKYIERGRKI--DENVAR-------- 47
           +E +EL+K LG G +G   + R +   +T +L A+K +++   +   +            
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112

Query: 48  EIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQL 107
           E I       P ++       T T L ++++Y  GGELF  +    RF+E E + +  ++
Sbjct: 113 EHIRQ----SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 168

Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH--SRPKSTVGTPAY 165
           +  + + H + I +RD+KLEN LLD +    + + DFG SK  V     R     GT  Y
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFVADETERAYDFCGTIEY 226

Query: 166 IAPEVLSRREY 176
           +AP+++   + 
Sbjct: 227 MAPDIVRGGDS 237

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  125 bits (317), Expect = 1e-35
 Identities = 55/178 (30%), Positives = 87/178 (48%), Gaps = 12/178 (6%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLR 56
           MEKYE +  +G G++G+    R+K+T  +VA+K        D+ V     REI   + LR
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLR 82

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           H N++   EV        +V E+      +  +   N         + +  Q+I+G+ +C
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFC 140

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           HS  I HRD+K EN L+  S    +K+CDFG++++           V T  Y APE+L
Sbjct: 141 HSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL 196

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  124 bits (314), Expect = 3e-35
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)

Query: 5   ELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHPNI 60
           E+ + +G G FG V     H E    VA++ I+  R  ++ +    RE++ +R  RH N+
Sbjct: 36  EIGELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQI 119
           + F    ++P HLAI+     G  L+  + +A      ++ R   Q+++ G+ Y H+  I
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAPEVLSR 173
            H+DLK +N   D     ++ I DFG         +     + +   G   ++APE++ +
Sbjct: 152 LHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208

Query: 174 REYDGKQ 180
              D ++
Sbjct: 209 LSPDTEE 215

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  123 bits (311), Expect = 5e-35
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 11/178 (6%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLR 56
           ME ++ V+ +G G +GV    R+K T E+VA+K I R     E V     REI   + L 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           HPNI++  +V+ T   L +V E+      +  D             + +  QL+ G+ +C
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFC 119

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           HS ++ HRDLK +N L++      +K+ DFG +++  +  R  +  V T  Y APE+L
Sbjct: 120 HSHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  123 bits (311), Expect = 7e-35
 Identities = 47/191 (24%), Positives = 82/191 (42%), Gaps = 14/191 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN--VAREI-INHRSLRH 57
            E  + + ++G G +G    + HK + +++AVK I       E   +  ++ +  RS   
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFDRICNA--GRFSEDEGRYFFQQLISGVNY 113
           P I++F   +       I ME  +    + +  + +       E+         +  +N+
Sbjct: 81  PYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 114 CHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL- 171
               ++I HRD+K  N LLD S    +K+CDFG S   V         G   Y+APE + 
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 198

Query: 172 ---SRREYDGK 179
              SR+ YD +
Sbjct: 199 PSASRQGYDVR 209

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  123 bits (310), Expect = 1e-34
 Identities = 61/179 (34%), Positives = 88/179 (49%), Gaps = 10/179 (5%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLR 56
           +++Y  +  LG G +G         T E VA+K I R    +E V     RE+   + L+
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQ 91

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           H NII  K V+     L ++ EYA   +L   +      S    + F  QLI+GVN+CHS
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS 150

Query: 117 MQICHRDLKLENTLLDGSAAPR---LKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
            +  HRDLK +N LL  S A     LKI DFG +++  +  R  +  + T  Y  PE+L
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  121 bits (305), Expect = 5e-34
 Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 19/192 (9%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIER-GRKIDENVAREIINHRSLRHPNIIRF 63
              + LG G FG A  + H+ET E++ +K + R   +      +E+   R L HPN+++F
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72

Query: 64  KEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQICHR 122
             V+     L  + EY  GG L   I +    +   +   F + + SG+ Y HSM I HR
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR 132

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK---------------SSVLHSRPKSTVGTPAYIA 167
           DL   N L+  +    + + DFG ++                     +  + VG P ++A
Sbjct: 133 DLNSHNCLVRENK--NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 168 PEVLSRREYDGK 179
           PE+++ R YD K
Sbjct: 191 PEMINGRSYDEK 202

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  119 bits (301), Expect = 9e-34
 Identities = 31/182 (17%), Positives = 66/182 (36%), Gaps = 17/182 (9%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNII 61
             +  L   + G   L + +     + VK ++      +   +   E    R   HPN++
Sbjct: 13  NFLTKLNENHSG--ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 62  RFKEVVLTP--THLAIVMEYAAGGELFDRICNAGRFSEDEGRY--FFQQLISGVNYCHSM 117
                  +P   H  ++  +   G L++ +     F  D+ +   F   +  G+ + H++
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130

Query: 118 Q--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRRE 175
           +  I    L   + ++D       +I       S          +  PA++APE L ++ 
Sbjct: 131 EPLIPRHALNSRSVMIDEDM--TARISMADVKFSFQS----PGRMYAPAWVAPEALQKKP 184

Query: 176 YD 177
            D
Sbjct: 185 ED 186

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  119 bits (302), Expect = 1e-33
 Identities = 58/178 (32%), Positives = 95/178 (53%), Gaps = 12/178 (6%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLR 56
           M+KYE ++ +G G +G     +++ET E+VA+K + R    DE V     REI   + L+
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           H NI+R  +V+ +   L +V E+      + FD     G    +  + F  QL+ G+ +C
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           HS  + HRDLK +N L++ +    LK+ +FG +++  +  R  S  V T  Y  P+VL
Sbjct: 118 HSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  118 bits (299), Expect = 2e-33
 Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 15/184 (8%)

Query: 1   MEKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLR 56
             +  + + +G+G+FG V +   H +    VAVK +       + +     E+   R  R
Sbjct: 23  DGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCH 115
           H NI+ F     T   LAIV ++  G  L+  +  +  +F   +     +Q   G++Y H
Sbjct: 79  HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLS 172
           +  I HRDLK  N  L       +KI DFG +          + +   G+  ++APEV+ 
Sbjct: 138 AKSIIHRDLKSNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 173 RREY 176
            ++ 
Sbjct: 196 MQDS 199

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  118 bits (298), Expect = 2e-32
 Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 21/183 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
             Y   K +G G+FGV    +  ++ ELVA+K + + ++  +N  RE+   R L H NI+
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKN--RELQIMRKLDHCNIV 110

Query: 62  RFKEVVLTPT------HLAIVMEYAAGGE-----LFDRICNAGRFSEDEGRYFFQQLISG 110
           R +    +        +L +V++Y    E                     + +  QL   
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAP 168
           + Y HS  ICHRD+K +N LLD   A  LK+CDFG +K   L     +   + +  Y AP
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEPNVSYICSRYYRAP 225

Query: 169 EVL 171
           E++
Sbjct: 226 ELI 228

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  116 bits (294), Expect = 2e-32
 Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 14/181 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----ERGRKIDENVAREIINHRSLR 56
             +++ ++ LG G +       +K T   VA+K +    E G        REI   + L+
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELK 61

Query: 57  HPNIIRFKEVVLTPTHLAIVMEY-----AAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
           H NI+R  +V+ T   L +V E+         +             +  +YF  QL+ G+
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEV 170
            +CH  +I HRDLK +N L++     +LK+ DFG +++  +     S+ V T  Y AP+V
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179

Query: 171 L 171
           L
Sbjct: 180 L 180

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  116 bits (294), Expect = 2e-32
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 13/178 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----ERGRKIDENVAREIINHRSLR 56
           ME Y  +  LG G +      + K T  LVA+K I    E G        RE+   + L+
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLK 58

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           H NI+   +++ T   L +V EY      +  D        +    + F  QL+ G+ YC
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYC 116

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           H  ++ HRDLK +N L++      LK+ DFG +++  + ++     V T  Y  P++L
Sbjct: 117 HRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDIL 172

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  115 bits (291), Expect = 4e-32
 Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 12/179 (6%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAR---EIINHRSLRHPNIIRF--- 63
           +G G+F         ET   VA   ++  +       R   E    + L+HPNI+RF   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 64  -KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ--IC 120
            +  V     + +V E    G L   +           R + +Q++ G+ + H+    I 
Sbjct: 94  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRDLK +N  + G     +KI D G +         K+ +GTP ++APE+    +YD  
Sbjct: 154 HRDLKCDNIFITGPTG-SVKIGDLGLATLKRASFA-KAVIGTPEFMAPEMY-EEKYDES 209

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  115 bits (291), Expect = 4e-32
 Identities = 58/178 (32%), Positives = 91/178 (51%), Gaps = 13/178 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLR 56
           MEKY  ++ +G G +GV    ++    E  A+K I R  K DE +     REI   + L+
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELK 58

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           H NI++  +V+ T   L +V E+      +L D     G       + F  QL++G+ YC
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYC 116

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           H  ++ HRDLK +N L++      LKI DFG +++  +  R  +  + T  Y AP+VL
Sbjct: 117 HDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  114 bits (288), Expect = 3e-31
 Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 13/180 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVA----REIINHRS 54
            ++YE +  LG G F      R K T ++VA+K I      +  + +     REI   + 
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           L HPNII   +     +++++V ++       +     N+   +    + +    + G+ 
Sbjct: 69  LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLE 126

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           Y H   I HRDLK  N LLD +    LK+ DFG +KS    +R  +  V T  Y APE+L
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 184

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  113 bits (286), Expect = 4e-31
 Identities = 56/178 (31%), Positives = 91/178 (51%), Gaps = 13/178 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLR 56
           MEKY+ ++ +G G +GV    +      +VA+K I R    DE +     REI   + L 
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAEDEGIPSTAIREISLLKELH 77

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAG--GELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           HPNI+   +V+ +   L +V E+      ++ D   N     + + + +  QL+ GV +C
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVL 171
           H  +I HRDLK +N L++      LK+ DFG +++  +  R  +  V T  Y AP+VL
Sbjct: 136 HQHRILHRDLKPQNLLINSDG--ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL 191

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  114 bits (286), Expect = 4e-31
 Identities = 31/156 (19%), Positives = 52/156 (33%), Gaps = 18/156 (11%)

Query: 40  KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI---CNAGRFS 96
              +  + +I         N +   +      +L I M+      L D +   C+     
Sbjct: 103 SPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162

Query: 97  EDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP 156
                + F Q+   V + HS  + HRDLK  N          +K+ DFG   +       
Sbjct: 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT--MDDVVKVGDFGLVTAMDQDEEE 220

Query: 157 KST-------------VGTPAYIAPEVLSRREYDGK 179
           ++              VGT  Y++PE +    Y  K
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK 256

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 59.9 bits (145), Expect = 3e-11
 Identities = 19/67 (28%), Positives = 31/67 (46%), Gaps = 2/67 (2%)

Query: 1  MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHP 58
          +  +E ++ +G G FGV    ++K      A+K I    +    E V RE+     L HP
Sbjct: 5  LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64

Query: 59 NIIRFKE 65
           I+R+  
Sbjct: 65 GIVRYFN 71

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  115 bits (288), Expect = 5e-31
 Identities = 27/210 (12%), Positives = 52/210 (24%), Gaps = 41/210 (19%)

Query: 10  LGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR--------- 56
           LG  +         +ET E   V       +      + +  E++  R LR         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 57  -------------HPNIIRFKEVVLTPTHLAIVMEYAA-----------GGELFDRICNA 92
                         P   +   V L    + ++  +             G  L       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 93  GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS--S 150
                        Q+I  +   H   + H  L+  + +LD      + +  F +     +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFEHLVRDGA 263

Query: 151 VLHSRPKSTVGTPAYIAPEVLSRREYDGKQ 180
              S        P   A  +L   ++    
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTL 293

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  112 bits (282), Expect = 5e-30
 Identities = 51/184 (27%), Positives = 86/184 (46%), Gaps = 22/184 (11%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
              Y   K +G G+FGV    +  E+ E VA+K + + ++  +N  RE+   R ++HPN+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-FKN--RELQIMRIVKHPNV 94

Query: 61  IRFKEVVLTPTH------LAIVMEYAAGGE-----LFDRICNAGRFSEDEGRYFFQQLIS 109
           +  K    +         L +V+EY    E                     + +  QL+ 
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYV--PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIA 167
            + Y HS+ ICHRD+K +N LLD  +   LK+ DFG +K  +L +   +   + +  Y A
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEPNVSYICSRYYRA 209

Query: 168 PEVL 171
           PE++
Sbjct: 210 PELI 213

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  110 bits (277), Expect = 8e-30
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 16/184 (8%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA-REIINHRSLR-HP 58
            + Y+LV+ LG G +       +    E V VK +   + + +    REI    +LR  P
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGP 91

Query: 59  NIIRFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           NII   ++V  P     A+V E+    +           ++ + R++  +++  ++YCHS
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS 148

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVL-SR 173
           M I HRD+K  N ++D     +L++ D+G ++    H   +    V +  +  PE+L   
Sbjct: 149 MGIMHRDVKPHNVMID-HEHRKLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDY 205

Query: 174 REYD 177
           + YD
Sbjct: 206 QMYD 209

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  110 bits (276), Expect = 2e-29
 Identities = 52/192 (27%), Positives = 83/192 (43%), Gaps = 28/192 (14%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENV----AREIINHRSLR 56
           + KYE +  +G G FG     RH++T + VA+K +       E       REI   + L+
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLK 74

Query: 57  HPNIIRFKEVVLTPTHLA--------IVMEYA----AGGELFDRICNAGRFSEDEGRYFF 104
           H N++   E+  T             +V ++     AG  L   +    +F+  E +   
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSEIKRVM 130

Query: 105 QQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG----YSKSSVLHSRP-KST 159
           Q L++G+ Y H  +I HRD+K  N L+       LK+ DFG    +S +         + 
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNR 188

Query: 160 VGTPAYIAPEVL 171
           V T  Y  PE+L
Sbjct: 189 VVTLWYRPPELL 200

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  107 bits (269), Expect = 8e-29
 Identities = 46/184 (25%), Positives = 70/184 (38%), Gaps = 22/184 (11%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF- 63
            L++ +G G +G       +     VAVK      +       E+ N   LRH NI+ F 
Sbjct: 11  TLLECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 64  ---KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ-- 118
                   + T L ++  Y   G L+D +                 + SG+ + H     
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 119 ------ICHRDLKLENTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIA 167
                 I HRDLK +N L+  +   +  I D G +      ++ L       VGT  Y+A
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNG--QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 168 PEVL 171
           PEVL
Sbjct: 186 PEVL 189

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  107 bits (269), Expect = 1e-28
 Identities = 47/187 (25%), Positives = 75/187 (40%), Gaps = 19/187 (10%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA------REIINHRS 54
             +YE V ++G G +G     R   +   VA+K +                 RE+   R 
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67

Query: 55  LR---HPNIIRFKEVVLTPTH-----LAIVMEYAAG--GELFDRICNAGRFSEDEGRYFF 104
           L    HPN++R  +V  T        + +V E+         D+         +  +   
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126

Query: 105 QQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPA 164
           +Q + G+++ H+  I HRDLK EN L+       +K+ DFG ++           V T  
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVKLADFGLARIYSYQMALTPVVVTLW 184

Query: 165 YIAPEVL 171
           Y APEVL
Sbjct: 185 YRAPEVL 191

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  106 bits (267), Expect = 3e-28
 Identities = 46/184 (25%), Positives = 76/184 (41%), Gaps = 22/184 (11%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFK 64
           ++VK +G G +G   + + +  K  VAVK      +       EI     +RH NI+ F 
Sbjct: 40  QMVKQIGKGRYGEVWMGKWRGEK--VAVKVFFTTEEASWFRETEIYQTVLMRHENILGFI 97

Query: 65  EVVLTP----THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ-- 118
              +      T L ++ +Y   G L+D + +                +SG+ + H+    
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 119 ------ICHRDLKLENTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIA 167
                 I HRDLK +N L+  +      I D G +      ++ +   P + VGT  Y+ 
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 168 PEVL 171
           PEVL
Sbjct: 215 PEVL 218

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  106 bits (266), Expect = 3e-28
 Identities = 51/184 (27%), Positives = 73/184 (39%), Gaps = 22/184 (11%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF- 63
            L + +G G FG     + +  +  VAVK      +       EI     LRH NI+ F 
Sbjct: 45  VLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFREAEIYQTVMLRHENILGFI 102

Query: 64  ---KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS---- 116
               +   T T L +V +Y   G LFD + N    + +          SG+ + H     
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 117 ----MQICHRDLKLENTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIA 167
                 I HRDLK +N L+  +      I D G +      +  +   P   VGT  Y+A
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 168 PEVL 171
           PEVL
Sbjct: 220 PEVL 223

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  106 bits (265), Expect = 1e-27
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 22/190 (11%)

Query: 2   EKYELVKD-LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH 57
           + +E     +G G +G    A+  +  +  +  A+K IE    I  +  REI   R L+H
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKR-KDGKDDKDYALKQIEG-TGISMSACREIALLRELKH 77

Query: 58  PNIIRFKEVVLTPTHLAI--VMEYA--------AGGELFDRICNAGRFSEDEGRYFFQQL 107
           PN+I  ++V L+     +  + +YA                     +      +    Q+
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 108 ISGVNYCHSMQICHRDLKLENTLLDGSAAPR--LKICDFGYSKSSVLHSRPKST----VG 161
           + G++Y H+  + HRDLK  N L+ G    R  +KI D G+++      +P +     V 
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197

Query: 162 TPAYIAPEVL 171
           T  Y APE+L
Sbjct: 198 TFWYRAPELL 207

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  105 bits (263), Expect = 1e-27
 Identities = 50/186 (26%), Positives = 84/186 (45%), Gaps = 19/186 (10%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHP 58
           M+++++ +  G G FG  +L + K T   VA+K +  +   +  E   + + +   L HP
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE--LQIMQDLAVLHHP 79

Query: 59  NIIRFKEVVLTPTH-------LAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQL 107
           NI++ +    T          L +VMEY     L     N  R          + F  QL
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEY-VPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138

Query: 108 ISGVNYCH--SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAY 165
           I  +   H  S+ +CHRD+K  N L++ +    LK+CDFG +K         + + +  Y
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKKLSPSEPNVAYICSRYY 197

Query: 166 IAPEVL 171
            APE++
Sbjct: 198 RAPELI 203

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  103 bits (258), Expect = 4e-27
 Identities = 47/196 (23%), Positives = 70/196 (35%), Gaps = 32/196 (16%)

Query: 1   MEKYELVKDLGAGNFG-VAR-LLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP 58
           ++  +L++ +G G +G V +  L  +     VAVK      + +    + I     + H 
Sbjct: 12  LDNLKLLELIGRGRYGAVYKGSLDERP----VAVKVFSFANRQNFINEKNIYRVPLMEHD 67

Query: 59  NIIRF-----KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           NI RF     +          +VMEY   G L   + +               +  G+ Y
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAY 126

Query: 114 CHSM---------QICHRDLKLENTLLDGSAAPRLKICDFGYSK---------SSVLHSR 155
            H+           I HRDL   N L+         I DFG S               + 
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRLVRPGEEDNA 184

Query: 156 PKSTVGTPAYIAPEVL 171
             S VGT  Y+APEVL
Sbjct: 185 AISEVGTIRYMAPEVL 200

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  103 bits (259), Expect = 4e-27
 Identities = 53/194 (27%), Positives = 88/194 (45%), Gaps = 23/194 (11%)

Query: 1   MEKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA----REI---I 50
            ++YE V ++G G +G    AR    K     VA+K + R +  +E +     RE+    
Sbjct: 10  DQQYECVAEIGEGAYGKVFKAR--DLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLR 66

Query: 51  NHRSLRHPNIIRFKEVVLTP-----THLAIVMEYAAG--GELFDRICNAGRFSEDEGRYF 103
           +  +  HPN++R  +V         T L +V E+         D+         +  +  
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDM 125

Query: 104 FQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP 163
             QL+ G+++ HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T 
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTL 183

Query: 164 AYIAPEVLSRREYD 177
            Y APEVL +  Y 
Sbjct: 184 WYRAPEVLLQSSYA 197

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  102 bits (257), Expect = 5e-27
 Identities = 50/194 (25%), Positives = 77/194 (39%), Gaps = 19/194 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
            +Y  +K LG G  G+       +  + VA+K I        ++  REI   R L H NI
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70

Query: 61  IRFKEVVLTPTHLAIVMEYAAGG--------ELFD----RICNAGRFSEDEGRYFFQQLI 108
           ++  E++            +           E  +     +   G   E+  R F  QL+
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL 130

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST----VGTPA 164
            G+ Y HS  + HRDLK  N  ++ +    LKI DFG ++    H   K      + T  
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189

Query: 165 YIAPEV-LSRREYD 177
           Y +P + LS   Y 
Sbjct: 190 YRSPRLLLSPNNYT 203

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  101 bits (254), Expect = 3e-26
 Identities = 51/188 (27%), Positives = 86/188 (45%), Gaps = 20/188 (10%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R     I  +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V      L       +V     G +L + I    + ++D  ++   Q++ G+ 
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLK 146

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++ +      + T  V T  Y APE+
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTA----DEMTGYVATRWYRAPEI 200

Query: 171 -LSRREYD 177
            L+   Y+
Sbjct: 201 MLNWMHYN 208

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  101 bits (254), Expect = 3e-26
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 20/188 (10%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLRHP 58
             Y  ++ +G+G +G         T   VA+K + R    ++  +   RE+   + +RH 
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V      L       +VM +  G +L  ++    +  ED  ++   Q++ G+ 
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGLR 142

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y H+  I HRDLK  N  ++      LKI DFG ++     +  + T  V T  Y APEV
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQ----ADSEMTGYVVTRWYRAPEV 196

Query: 171 -LSRREYD 177
            L+   Y 
Sbjct: 197 ILNWMRYT 204

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  100 bits (252), Expect = 6e-26
 Identities = 56/194 (28%), Positives = 83/194 (42%), Gaps = 28/194 (14%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVA------REIINHR 53
            +Y  +  +G G +G+         K  VA+K      KI   E+        REI    
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKILL 80

Query: 54  SLRHPNIIRFKEVVLTPTH-----LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI 108
             RH NII   +++  PT      + IV +     +L  ++      S D   YF  Q++
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQIL 138

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST----VGTPA 164
            G+ Y HS  + HRDLK  N LL+ +    LKICDFG ++ +             V T  
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRW 196

Query: 165 YIAPEV-LSRREYD 177
           Y APE+ L+ + Y 
Sbjct: 197 YRAPEIMLNSKGYT 210

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  100 bits (250), Expect = 9e-26
 Identities = 53/188 (28%), Positives = 89/188 (47%), Gaps = 21/188 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLRHP 58
           + Y     +G+G +G       K + E VA+K + R    +I  +   RE++  + ++H 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V    + L       +VM +    +L   +    +FSE++ +Y   Q++ G+ 
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGLK 140

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEV 170
           Y HS  + HRDLK  N  ++      LKI DFG ++     +  + T  V T  Y APEV
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDC--ELKILDFGLARH----ADAEMTGYVVTRWYRAPEV 194

Query: 171 -LSRREYD 177
            LS   Y+
Sbjct: 195 ILSWMHYN 202

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 99.6 bits (249), Expect = 2e-25
 Identities = 56/201 (27%), Positives = 84/201 (41%), Gaps = 35/201 (17%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVA------REIINHR 53
             ++L   LG G +GV     HK T E+VA+K      KI+  +         REI   +
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIKILK 64

Query: 54  SLRHPNIIRFKEVVLTPTHLA-----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI 108
             +H NII    +    +        I+ E     +L  R+ +    S+D  +YF  Q +
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTL 122

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--------- 159
             V   H   + HRDLK  N L++ +    LK+CDFG ++     +   S          
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNC--DLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 160 --VGTPAYIAPEV-LSRREYD 177
             V T  Y APEV L+  +Y 
Sbjct: 181 EFVATRWYRAPEVMLTSAKYS 201

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 99.8 bits (249), Expect = 2e-25
 Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 14/186 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+         +  VA+K + R    +   +   RE++  + + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 58  PNIIRFKEVVLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
            NII    V      L       IVME      L  ++        +   Y   Q++ G+
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGI 140

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198

Query: 172 SRREYD 177
               Y 
Sbjct: 199 LGMGYK 204

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  100 bits (250), Expect = 2e-25
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 11/152 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLRHP 58
           ++YE+   +G G++G       K  K +VA+K I R     ID + + REI     L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112

Query: 59  NIIRFKEVVLTPT-----HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           ++++  ++V+         L +V+E A   +           +E   +     L+ GV Y
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
            HS  I HRDLK  N L++      +K+CDFG
Sbjct: 172 VHSAGILHRDLKPANCLVNQDC--SVKVCDFG 201

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 98.7 bits (246), Expect = 5e-25
 Identities = 50/221 (22%), Positives = 77/221 (34%), Gaps = 50/221 (22%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVK--YIERGRKIDENVAREIINHRSLRHP 58
            +KY L K LG G+FG+   +   E+ +  A+K    +   K      RE+   + L H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-----RELDIMKVLDHV 60

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG------------------------- 93
           NII+  +   T                     N G                         
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 94  ----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP 137
                               +    +  QL   V + HS+ ICHRD+K +N L++     
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN- 179

Query: 138 RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV-LSRREYD 177
            LK+CDFG +K  +      + + +  Y APE+ L   EY 
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYT 220

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 97.6 bits (243), Expect = 2e-24
 Identities = 48/185 (25%), Positives = 76/185 (41%), Gaps = 14/185 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLRHP 58
           ++Y+ +K +G+G  G+            VA+K + R    +   +   RE++  + + H 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           NII    V      L       +VME      L   I        +   Y   Q++ G+ 
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGIK 178

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+ 
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 236

Query: 173 RREYD 177
              Y 
Sbjct: 237 GMGYK 241

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 96.2 bits (240), Expect = 3e-24
 Identities = 40/195 (20%), Positives = 70/195 (35%), Gaps = 23/195 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA------------REI 49
             Y + + + +G++G             VA+K +         V             REI
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 50  INHRSLRHPNIIRFKEVVLTPTH-----LAIVMEYAAGGELFDRI-CNAGRFSEDEGRYF 103
                  HPNI+  +++ +         L +V E     +L   I       S    +YF
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139

Query: 104 FQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP 163
              ++ G++  H   + HRDL   N LL  +    + ICDF  ++     +     V   
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNN--DITICDFNLAREDTADANKTHYVTHR 197

Query: 164 AYIAPEV-LSRREYD 177
            Y APE+ +  + + 
Sbjct: 198 WYRAPELVMQFKGFT 212

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 94.4 bits (235), Expect = 7e-24
 Identities = 46/188 (24%), Positives = 71/188 (37%), Gaps = 22/188 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
              +L++    G FG     +       VAVK      K       E+ +   ++H NI+
Sbjct: 24  MPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFPIQDKQSWQNEYEVYSLPGMKHENIL 81

Query: 62  RF----KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           +F    K        L ++  +   G L D +  A   S +E  +  + +  G+ Y H  
Sbjct: 82  QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLHED 140

Query: 118 Q----------ICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPA 164
                      I HRD+K +N LL  +      I DFG +    +          VGT  
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGTRR 198

Query: 165 YIAPEVLS 172
           Y+APEVL 
Sbjct: 199 YMAPEVLE 206

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 95.6 bits (238), Expect = 1e-23
 Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 11/152 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLRHP 58
           + Y +   +G G++G   L   K T++ VA+K + R     ID + + REI     L+  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85

Query: 59  NIIRFKEVVLTPTHLA-----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
            IIR  ++++    L      IV+E A   +L          +E+  +     L+ G N+
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
            H   I HRDLK  N LL+      +K+CDFG
Sbjct: 145 IHESGIIHRDLKPANCLLNQDC--SVKVCDFG 174

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 92.4 bits (230), Expect = 9e-23
 Identities = 60/205 (29%), Positives = 84/205 (40%), Gaps = 33/205 (16%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER--GRKID-ENVAREIINHRSLR-H 57
            KYELVK LG G +G+      + T E+VAVK I        D +   REI+    L  H
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68

Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            NI+    V+       + +V +Y    +L   +  A        +Y   QLI  + Y H
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYLH 126

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST---------------- 159
           S  + HRD+K  N LL+      +K+ DFG S+S V   R  +                 
Sbjct: 127 SGGLLHRDMKPSNILLNAEC--HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184

Query: 160 ------VGTPAYIAPEV-LSRREYD 177
                 V T  Y APE+ L   +Y 
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYT 209

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 86.6 bits (215), Expect = 5e-21
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 16/188 (8%)

Query: 5   ELVKDLGAGNFGVARL----LRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPN 59
           + ++ LG GNFG   +         T E+VAVK +     +   +  REI   +SL+H N
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +     L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI-----APEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P        APE L
Sbjct: 133 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESL 189

Query: 172 SRREYDGK 179
           +  ++   
Sbjct: 190 TESKFSVA 197

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 87.3 bits (217), Expect = 7e-21
 Identities = 50/183 (27%), Positives = 66/183 (36%), Gaps = 12/183 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPN 59
           E   L + +G GNFG     R +    LVAVK        D      +E    +   HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           I+R   V      + IVME   GG+    +     R              +G+ Y  S  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI-----APEVLSR 173
             HRDL   N L+       LKI DFG S+         +  G    +     APE L+ 
Sbjct: 234 CIHRDLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNY 289

Query: 174 REY 176
             Y
Sbjct: 290 GRY 292

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 86.7 bits (215), Expect = 7e-21
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 16/188 (8%)

Query: 5   ELVKDLGAGNFGVARL----LRHKETKELVAVKYI-ERGRKIDENVAREIINHRSLRHPN 59
           + ++ LG GNFG   +         T E+VAVK +     +   +  REI   +SL+H N
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I+++K V  +     L ++MEY   G L D +  +  R    +   +  Q+  G+ Y  +
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI-----APEVL 171
            +  HRDL   N L++     R+KI DFG +K  +   +    V  P        APE L
Sbjct: 164 KRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESL 220

Query: 172 SRREYDGK 179
           +  ++   
Sbjct: 221 TESKFSVA 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 87.1 bits (216), Expect = 1e-20
 Identities = 43/182 (23%), Positives = 68/182 (37%), Gaps = 6/182 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
               +   LG G +G       K+    VAVK ++      E   +E    + ++HPN++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 279

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +   V        I+ E+   G L D  R CN    S     Y   Q+ S + Y      
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAY--IAPEVLSRREYD 177
            HR+L   N L+       +K+ DFG S+     +              APE L+  ++ 
Sbjct: 340 IHRNLAARNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 178 GK 179
            K
Sbjct: 398 IK 399

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 85.1 bits (211), Expect = 2e-20
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 11/153 (7%)

Query: 5   ELVKDLGAGNFGV---ARL-LRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHP 58
           + ++DLG G+FG     R       T E VAVK +  E G     ++ +EI   R+L H 
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83

Query: 59  NIIRFKEVVLTPTH--LAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCH 115
           NI+++K +        + ++ME+   G L + +  N  + +  +   +  Q+  G++Y  
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           S Q  HRDL   N L++     ++KI DFG +K
Sbjct: 144 SRQYVHRDLAARNVLVESEH--QVKIGDFGLTK 174

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 84.7 bits (210), Expect = 3e-20
 Identities = 46/152 (30%), Positives = 68/152 (44%), Gaps = 10/152 (6%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKE-TKELVAVKYI-ERGRKIDENVAREIINHRSLRHPN 59
           + +  LG GNFG     R     + T  LVAVK +   G     +  REI   ++L    
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
           I++++ V   P    L +VMEY   G L D +  +  R        +  Q+  G+ Y  S
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            +  HRDL   N L+   +   +KI DFG +K
Sbjct: 146 RRCVHRDLAARNILV--ESEAHVKIADFGLAK 175

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 84.2 bits (209), Expect = 3e-20
 Identities = 55/172 (31%), Positives = 79/172 (45%), Gaps = 8/172 (4%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRHPN 59
           Y++V  LG G      L         VA+K I    +  E       RE+ N   L H N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I+   +V        +VMEY  G  L + I + G  S D    F  Q++ G+ + H M+I
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPE 169
            HRD+K +N L+D +    LKI DFG +K  S    ++    +GT  Y +PE
Sbjct: 133 VHRDIKPQNILIDSNK--TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 82.7 bits (205), Expect = 1e-19
 Identities = 48/152 (31%), Positives = 66/152 (43%), Gaps = 11/152 (7%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRH 57
            L++ LG G+FGV               VAVK ++           + I       SL H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
            N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y  S
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            +  HRDL   N LL  +    +KI DFG  +
Sbjct: 140 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMR 169

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 84.0 bits (208), Expect = 1e-19
 Identities = 53/187 (28%), Positives = 80/187 (42%), Gaps = 19/187 (10%)

Query: 3   KYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH---- 57
           +YE++K +G G+FG V +   HK   + VA+K +   ++     A EI   R L H    
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHK-VHQHVALKMVRNEKRFHRQAAEEI---RILEHLRKQ 153

Query: 58  -----PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISG 110
                 N+I   E      H+ +  E      L++ I       FS    R F   ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           ++  H  +I H DLK EN LL       +K+ DFG   S   H R  + + +  Y APEV
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTYIQSRFYRAPEV 270

Query: 171 LSRREYD 177
           +    Y 
Sbjct: 271 ILGARYG 277

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 82.7 bits (205), Expect = 1e-19
 Identities = 42/189 (22%), Positives = 73/189 (38%), Gaps = 22/189 (11%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVK-----------YIERGRKIDENVAREIINH 52
           Y L + +G G  G          + +VA+K           +  R +       RE    
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQ-------REARTA 88

Query: 53  RSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
             L+ P+++   +       L + M    G +L   +   G  +        +Q+ S ++
Sbjct: 89  GRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALD 148

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFG--YSKSSVLHSRPKSTVGTPAYIAPEV 170
             H+    HRD+K EN L+  SA     + DFG   + +    ++  +TVGT  Y+APE 
Sbjct: 149 AAHAAGATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206

Query: 171 LSRREYDGK 179
            S      +
Sbjct: 207 FSESHATYR 215

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 81.6 bits (202), Expect = 4e-19
 Identities = 49/152 (32%), Positives = 71/152 (46%), Gaps = 11/152 (7%)

Query: 5   ELVKDLGAGNFGVARL----LRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHP 58
           + ++DLG G+FG   L      +  T E+VAVK +  + G +      +EI   R+L H 
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93

Query: 59  NIIRFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           +II++K          L +VMEY   G L D +         +   F QQ+  G+ Y H+
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
               HRDL   N LL       +KI DFG +K
Sbjct: 153 QHYIHRDLAARNVLL--DNDRLVKIGDFGLAK 182

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 82.2 bits (203), Expect = 7e-19
 Identities = 40/177 (22%), Positives = 65/177 (36%), Gaps = 20/177 (11%)

Query: 4   YELVKDLGAGNFGVARLLRHKE-TKELVAVKYIERGRKIDENVA----REIINHRSLRHP 58
           YE+   +  G  G   L   +      V +K +      D         E      + HP
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHP 139

Query: 59  NIIRFKEVVLTPTHLA-----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           +I++    V            IVMEY  G  L        +    E   +  +++  ++Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSY 197

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
            HS+ + + DLK EN +L      +LK+ D G        +      GTP + APE+
Sbjct: 198 LHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAPEI 248

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 80.4 bits (199), Expect = 1e-18
 Identities = 43/184 (23%), Positives = 77/184 (41%), Gaps = 17/184 (9%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKETKEL-VAVKYIERGRKIDENVAREIINH----RSLR 56
           + +K LG+G FG       +   E  ++ VA+K +           +EI++      S+ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD 75

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCH 115
           +P++ R   + LT T + ++ +    G L D +  +           +  Q+  G+NY  
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGT--P-AYIAPEVLS 172
             ++ HRDL   N L+       +KI DFG +K      +     G   P  ++A E + 
Sbjct: 135 DRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 173 RREY 176
            R Y
Sbjct: 193 HRIY 196

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 78.4 bits (194), Expect = 5e-18
 Identities = 39/149 (26%), Positives = 60/149 (40%), Gaps = 4/149 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
               +   LG G +G       K+    VAVK ++      E   +E    + ++HPN++
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +   V        I+ E+   G L D  R CN    S     Y   Q+ S + Y      
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            HRDL   N L+  +    +K+ DFG S+
Sbjct: 133 IHRDLAARNCLVGENHL--VKVADFGLSR 159

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 79.4 bits (196), Expect = 5e-18
 Identities = 44/197 (22%), Positives = 75/197 (38%), Gaps = 25/197 (12%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-----INHRSLRH 57
           +Y LV+ LG G+F    L +       VA+K +   +   E    EI     +N      
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79

Query: 58  P------NIIRFKEV----VLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQ 105
                  +I++  +          H+ +V E   G  L    +            +   +
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISK 138

Query: 106 QLISGVNYCHSM-QICHRDLKLENTLLDGSAAPR----LKICDFGYSKSSVLHSRPKSTV 160
           QL+ G++Y H    I H D+K EN L++   +P     +KI D G   +        +++
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNSI 196

Query: 161 GTPAYIAPEVLSRREYD 177
            T  Y +PEVL    + 
Sbjct: 197 QTREYRSPEVLLGAPWG 213

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 77.7 bits (192), Expect = 1e-17
 Identities = 49/195 (25%), Positives = 72/195 (36%), Gaps = 48/195 (24%)

Query: 4   YELVKDLGAGNFGVA--------RLLRHKETKELVAVK-----------YIERGRKIDEN 44
           YEL + LG G  G++        R  R       VAVK           +  R R     
Sbjct: 14  YELGEILGFG--GMSEVHLARDLRDHRD------VAVKVLRADLARDPSFYLRFR----- 60

Query: 45  VAREIINHRSLRHPNIIRF----KEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEG 100
             RE  N  +L HP I+      +          IVMEY  G  L D +   G  +    
Sbjct: 61  --REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 118

Query: 101 RYFFQQLISGVNYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFG----YSKSSVLHS 154
                     +N+ H   I HRD+K  N ++         +K+ DFG     + S    +
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN----AVKVMDFGIARAIADSGNSVT 174

Query: 155 RPKSTVGTPAYIAPE 169
           +  + +GT  Y++PE
Sbjct: 175 QTAAVIGTAQYLSPE 189

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 78.4 bits (193), Expect = 1e-17
 Identities = 45/182 (24%), Positives = 68/182 (37%), Gaps = 8/182 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 325

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +   VV +   + IV EY + G L D  +          +      Q+ SG+ Y   M  
Sbjct: 326 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAY--IAPEVLSRREYD 177
            HRDL+  N L+        K+ DFG ++    +               APE      + 
Sbjct: 385 VHRDLRAANILV--GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442

Query: 178 GK 179
            K
Sbjct: 443 IK 444

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 77.0 bits (190), Expect = 2e-17
 Identities = 37/151 (24%), Positives = 67/151 (44%), Gaps = 10/151 (6%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKETKEL-VAVKYIERG--RKIDENVAREIINHRSLRHP 58
           + +K LG+G FG       +   E  ++ VA+K +      K ++ +  E     S+ +P
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           ++ R   + LT T + ++ +    G L D +  +           +  Q+  G+NY    
Sbjct: 78  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           ++ HRDL   N L+       +KI DFG +K
Sbjct: 137 RLVHRDLAARNVLV--KTPQHVKITDFGLAK 165

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 77.4 bits (191), Expect = 2e-17
 Identities = 50/188 (26%), Positives = 79/188 (42%), Gaps = 17/188 (9%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP-- 58
           ++YE+   +G G+FG V +       +E VA+K I+  +        E+     +     
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRV-EQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112

Query: 59  ----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVN 112
                I+  K   +   HL +V E      L+D + N      S +  R F QQ+ + + 
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171

Query: 113 YCHS--MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPE 169
           +  +  + I H DLK EN LL       +KI DFG   SS    +     + +  Y +PE
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPE 228

Query: 170 VLSRREYD 177
           VL    YD
Sbjct: 229 VLLGMPYD 236

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 77.5 bits (191), Expect = 2e-17
 Identities = 45/182 (24%), Positives = 68/182 (37%), Gaps = 8/182 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 242

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +   VV +   + IV EY + G L D  +          +      Q+ SG+ Y   M  
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAY--IAPEVLSRREYD 177
            HRDL+  N L+        K+ DFG ++    +               APE      + 
Sbjct: 302 VHRDLRAANILV--GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359

Query: 178 GK 179
            K
Sbjct: 360 IK 361

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 77.0 bits (190), Expect = 3e-17
 Identities = 50/197 (25%), Positives = 73/197 (37%), Gaps = 31/197 (15%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP-- 58
           E+YE+V +LG G FG V   L H   K  VA+K I    K  E    EI   + ++    
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78

Query: 59  ----NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVN 112
                 +   +      H+ I  E   G   F+ +       +     R+   QL   + 
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137

Query: 113 YCHSMQICHRDLKLENTLLDGSAA-----------------PRLKICDFGYSKSSVLHSR 155
           + H  Q+ H DLK EN L   S                     +++ DFG   S+     
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHE 194

Query: 156 PKST-VGTPAYIAPEVL 171
             +T V T  Y  PEV+
Sbjct: 195 HHTTIVATRHYRPPEVI 211

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 76.1 bits (188), Expect = 4e-17
 Identities = 40/146 (27%), Positives = 62/146 (42%), Gaps = 8/146 (5%)

Query: 8   KDLGAGNFGVAR--LLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIR 62
           K+LG+GNFG  +    + K+  + VAVK ++       + + +  E    + L +P I+R
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
              +    + + +VME A  G L   +       +        Q+  G+ Y       HR
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK 148
           DL   N LL        KI DFG SK
Sbjct: 142 DLAARNVLL--VTQHYAKISDFGLSK 165

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 75.8 bits (187), Expect = 5e-17
 Identities = 43/184 (23%), Positives = 79/184 (42%), Gaps = 17/184 (9%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKETKEL-VAVKYI--ERGRKIDENVAREIINHRSLRHP 58
             +K LG+G FG       +   E+ ++ V +K I  + GR+  + V   ++   SL H 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           +I+R   +    + L +V +Y   G L D +  + G         +  Q+  G+ Y    
Sbjct: 76  HIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI-----APEVLS 172
            + HR+L   N LL   +  ++++ DFG +   +L    K  + + A       A E + 
Sbjct: 135 GMVHRNLAARNVLL--KSPSQVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 173 RREY 176
             +Y
Sbjct: 191 FGKY 194

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 76.2 bits (188), Expect = 7e-17
 Identities = 47/181 (25%), Positives = 71/181 (39%), Gaps = 16/181 (8%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFK 64
           +L++ +G G FG   L  ++  K  VAVK I+      +    E      LRH N+++  
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLL 252

Query: 65  EVVLT-PTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
            V++     L IV EY A G L D  R         D    F   +   + Y       H
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312

Query: 122 RDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI---APEVLSRREYDG 178
           RDL   N L+        K+ DFG +K +       +       +   APE L  +++  
Sbjct: 313 RDLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFST 365

Query: 179 K 179
           K
Sbjct: 366 K 366

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 75.0 bits (185), Expect = 7e-17
 Identities = 46/160 (28%), Positives = 66/160 (41%), Gaps = 16/160 (10%)

Query: 2   EKYELVKD--------LGAGNFG-VAR-LLRHKETKELVAVKYIERGRKIDENVA--REI 49
           +K  L +D        LG GNFG V + + R ++ +  VA+K +++G +  +     RE 
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61

Query: 50  INHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLI 108
                L +P I+R   V      + +VME A GG L   +                 Q+ 
Sbjct: 62  QIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            G+ Y       HRDL   N LL        KI DFG SK
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLL--VNRHYAKISDFGLSK 158

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 75.9 bits (187), Expect = 9e-17
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E  +L K LGAG FG   +  + +  + VAVK ++ G    E    E    ++L+H  ++
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +   VV T   + I+ E+ A G L D  +     +    +   F  Q+  G+ +      
Sbjct: 247 KLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            HRDL+  N L+  SA+   KI DFG ++
Sbjct: 306 IHRDLRAANILV--SASLVCKIADFGLAR 332

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 74.5 bits (184), Expect = 1e-16
 Identities = 40/153 (26%), Positives = 64/153 (41%), Gaps = 9/153 (5%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLR 56
           E   L + LG G FG         HK  K  VAVK  ++   +D       E +  ++L 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCH 115
           HP+I++   ++       I+ME    GEL   +  N           +  Q+   + Y  
Sbjct: 72  HPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           S+   HRD+ + N L+       +K+ DFG S+
Sbjct: 131 SINCVHRDIAVRNILVASPEC--VKLGDFGLSR 161

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 74.2 bits (183), Expect = 1e-16
 Identities = 38/146 (26%), Positives = 64/146 (43%), Gaps = 6/146 (4%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFK 64
             V+++G+G FG+  L       + VA+K I  G   +E+   E      L HP +++  
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 69

Query: 65  EVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
            V L    + +V E+   G L D  R    G F+ +        +  G+ Y     + HR
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 128

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK 148
           DL   N L+  +    +K+ DFG ++
Sbjct: 129 DLAARNCLVGENQV--IKVSDFGMTR 152

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 74.2 bits (183), Expect = 1e-16
 Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           E  +LV+ LGAG FG V     +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +R   VV T   + I+ EY   G L D  +  +  + + ++      Q+  G+ +     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL+  N L+  + +   KI DFG ++
Sbjct: 130 YIHRDLRAANILVSDTLS--CKIADFGLAR 157

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 75.4 bits (185), Expect = 2e-16
 Identities = 42/144 (29%), Positives = 60/144 (41%), Gaps = 8/144 (5%)

Query: 10  LGAGNFGVAR--LLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPNIIRFKE 65
           LG GNFG  R  + R ++ +  VA+K +++G +  +     RE      L +P I+R   
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 66  VVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V      + +VME A GG L   +                 Q+  G+ Y       HR+L
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNL 462

Query: 125 KLENTLLDGSAAPRLKICDFGYSK 148
              N LL        KI DFG SK
Sbjct: 463 AARNVLL--VNRHYAKISDFGLSK 484

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 74.3 bits (183), Expect = 2e-16
 Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 10/151 (6%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPN 59
            + K +G+G+ G     RL    +    VA+K ++ G    +      E        HPN
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           IIR + VV       IV EY   G L    R  + G+F+  +     + + +G+ Y   +
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDL 170

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
              HRDL   N L+D +     K+ DFG S+
Sbjct: 171 GYVHRDLAARNVLVDSNLV--CKVSDFGLSR 199

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 73.5 bits (181), Expect = 4e-16
 Identities = 56/197 (28%), Positives = 76/197 (38%), Gaps = 31/197 (15%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRK------IDENVAREIINHRS 54
            +YE+V  LG G FG V   + HK     VAVK ++   +       +  V   +     
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP 73

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVN 112
                 ++  E      H+ IV E   G   +D I   G   F  D  R    Q+   VN
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132

Query: 113 YCHSMQICHRDLKLENTLLDGSAA-----------------PRLKICDFGYSKSSVLHSR 155
           + HS ++ H DLK EN L   S                   P +K+ DFG   S+     
Sbjct: 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDDE 189

Query: 156 PKST-VGTPAYIAPEVL 171
             ST V T  Y APEV+
Sbjct: 190 HHSTLVSTRHYRAPEVI 206

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 73.5 bits (181), Expect = 4e-16
 Identities = 39/162 (24%), Positives = 58/162 (35%), Gaps = 15/162 (9%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRS 54
           +   L++ LG G FG         + +  +   VAVK +       + +    E +    
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI------ 108
             H NI+R   V L      I+ME  AGG+L   +                 L+      
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 109 -SGVNYCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSK 148
             G  Y       HRD+   N LL      R+ KI DFG ++
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 73.0 bits (180), Expect = 4e-16
 Identities = 39/149 (26%), Positives = 66/149 (44%), Gaps = 6/149 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           +    +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  ++
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +   V      + I+ EY A G L +  R     RF   +     + +   + Y  S Q 
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            HRDL   N L++      +K+ DFG S+
Sbjct: 142 LHRDLAARNCLVNDQGV--VKVSDFGLSR 168

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 73.2 bits (180), Expect = 6e-16
 Identities = 52/188 (27%), Positives = 80/188 (42%), Gaps = 18/188 (9%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLR 56
               + K +GAG FG     RL    + +  VA+K ++ G    +      E        
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYC 114
           HPNIIR + VV     + IV EY   G L    R  +  +F+  +     + + SG+ Y 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL 163

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYI---AP 168
             M   HRDL   N L++ +     K+ DFG  +  VL   P    +T G    I   +P
Sbjct: 164 SDMGYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSP 219

Query: 169 EVLSRREY 176
           E ++ R++
Sbjct: 220 EAIAYRKF 227

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 72.7 bits (179), Expect = 6e-16
 Identities = 37/153 (24%), Positives = 62/153 (40%), Gaps = 9/153 (5%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLR 56
           E+ EL + +G G FG       +  +     VA+K  +            +E +  R   
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCH 115
           HP+I++   V+       I+ME    GEL   +              +  QL + + Y  
Sbjct: 75  HPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           S +  HRD+   N L+  S+   +K+ DFG S+
Sbjct: 134 SKRFVHRDIAARNVLV--SSNDCVKLGDFGLSR 164

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 73.7 bits (181), Expect = 6e-16
 Identities = 36/153 (23%), Positives = 61/153 (39%), Gaps = 9/153 (5%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLR 56
           E+ EL + +G G FG       +  +     VA+K  +            +E +  R   
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCH 115
           HP+I++   V+       I+ME    GEL   +              +  QL + + Y  
Sbjct: 450 HPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           S +  HRD+   N L+  +    +K+ DFG S+
Sbjct: 509 SKRFVHRDIAARNVLVSSNDC--VKLGDFGLSR 539

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 72.8 bits (179), Expect = 8e-16
 Identities = 38/162 (23%), Positives = 58/162 (35%), Gaps = 15/162 (9%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRS 54
           +   L++ LG G FG         + +  +   VAVK +       + +    E +    
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI------ 108
             H NI+R   V L      I++E  AGG+L   +                 L+      
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 109 -SGVNYCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSK 148
             G  Y       HRD+   N LL      R+ KI DFG ++
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 71.9 bits (177), Expect = 1e-15
 Identities = 42/150 (28%), Positives = 62/150 (41%), Gaps = 8/150 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           ++ +L++ +G G FG   L  ++  K  VAVK I+      +    E      LRH N++
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKND-ATAQAFLAEASVMTQLRHSNLV 77

Query: 62  RFKEVVLTPT-HLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           +   V++     L IV EY A G L D  R         D    F   +   + Y     
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             HRDL   N L+        K+ DFG +K
Sbjct: 138 FVHRDLAARNVLVSEDNV--AKVSDFGLTK 165

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 72.4 bits (178), Expect = 1e-15
 Identities = 43/202 (21%), Positives = 79/202 (39%), Gaps = 37/202 (18%)

Query: 2   EKYELVKDLGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREI-----INHRSL 55
             + +++ +G G FG V         K+  AVK +   +K   +   E      I +  +
Sbjct: 35  NAFLVIRKMGDGTFGRVLLCQHID-NKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNY 113
            + NI+++    +   H+ ++ E   G  L++ I       F  ++ + +  +++  +NY
Sbjct: 94  NNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152

Query: 114 CHSMQICHRDLKLENTLLDGSAA-----------------------PRLKICDFGYSKSS 150
              M + H DLK EN LLD                             +K+ DFG    +
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA 209

Query: 151 VLHSRPKST-VGTPAYIAPEVL 171
              S    + + T  Y APEV+
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVI 231

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 72.0 bits (177), Expect = 1e-15
 Identities = 39/168 (23%), Positives = 66/168 (39%), Gaps = 26/168 (15%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSL 55
           +++ L + LG G FG    A+L +   +   VAVK ++       ++    RE    +  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 56  RHPNIIRFKEVVL------TPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQL 107
            HP++ +   V L            +++ +   G+L  F     A R  E+      Q L
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQTL 139

Query: 108 I-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
           +        G+ Y  S    HRDL   N +L       + + DFG S+
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR 185

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 71.2 bits (175), Expect = 2e-15
 Identities = 35/164 (21%), Positives = 66/164 (40%), Gaps = 19/164 (11%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRS 54
           EK  + ++LG G+FG     VA+ +   E +  VA+K +     + E +    E    + 
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGR--------YFF 104
               +++R   VV       ++ME    G+L  + R       +                
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 105 QQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTR 186

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 70.8 bits (174), Expect = 3e-15
 Identities = 41/152 (26%), Positives = 63/152 (41%), Gaps = 11/152 (7%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPN 59
              + +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 60  IIRFKEVVLTPTH-LAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           ++    + L       +V+ Y   G+L  F R       +  +   F  Q+  G+ Y  S
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLAS 146

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            +  HRDL   N +LD      +K+ DFG ++
Sbjct: 147 KKFVHRDLAARNCMLDEKFT--VKVADFGLAR 176

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 70.3 bits (173), Expect = 3e-15
 Identities = 55/180 (30%), Positives = 86/180 (47%), Gaps = 10/180 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E+  L+K+LG+G FGV +L + K   + VAVK I+ G   ++   +E      L HP ++
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +F  V      + IV EY + G L +  R  +       +       +  G+ +  S Q 
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYI---APEVLSRREY 176
            HRDL   N L+D      +K+ DFG ++  VL  +  S+VGT   +   APEV    +Y
Sbjct: 126 IHRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKY 182

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 71.2 bits (175), Expect = 3e-15
 Identities = 44/155 (28%), Positives = 65/155 (41%), Gaps = 11/155 (7%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKEL-VAVKYIERGRKIDENVA--REIINHRSL 55
                 K +GAG FG      L      KE+ VA+K ++ G    + V    E       
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNY 113
            H NIIR + V+     + I+ EY   G L    R    G FS  +     + + +G+ Y
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKY 162

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             +M   HRDL   N L++ +     K+ DFG S+
Sbjct: 163 LANMNYVHRDLAARNILVNSNLV--CKVSDFGLSR 195

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 70.4 bits (173), Expect = 4e-15
 Identities = 27/163 (16%), Positives = 54/163 (33%), Gaps = 17/163 (10%)

Query: 2   EKYELVKDLGAGNFGV-------ARLLRHKETKELVAVKYIERG-RKIDENVAREIINHR 53
           E     + LG G F               +  +  V +K +++  R   E+         
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGV 111
            L H +++    V +      +V E+   G L    +  N    +        +QL + +
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAM 126

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRL------KICDFGYSK 148
           ++     + H ++  +N LL      +       K+ D G S 
Sbjct: 127 HFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 70.0 bits (172), Expect = 6e-15
 Identities = 38/167 (22%), Positives = 57/167 (34%), Gaps = 25/167 (14%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSL 55
               L K LG G FG      L +   T   VAVK ++        +     E    +  
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 56  RHPNIIRFKEVVL-----TPTHLAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLI 108
            HPN+IR   V +           +++ +   G+L  +       R          Q L+
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS---RLETGPKHIPLQTLL 150

Query: 109 -------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
                   G+ Y  +    HRDL   N +L       + + DFG SK
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSK 195

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 69.2 bits (170), Expect = 1e-14
 Identities = 42/170 (24%), Positives = 59/170 (34%), Gaps = 28/170 (16%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REI-INHR 53
            +    K LGAG FG      A  L   +    VAVK ++    + E  A   E+ +   
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------FDRICNAGRFSEDEGRY 102
              H NI+             ++ EY   G+L                +     +DE   
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
             + L+S       G+ +  S    HRDL   N LL        KICDFG
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFG 190

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 69.4 bits (170), Expect = 1e-14
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 11/152 (7%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPN 59
              + +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 60  IIRFKEVVLTPTH-LAIVMEYAAGGEL--FDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           ++    + L       +V+ Y   G+L  F R       +  +   F  Q+  G+ +  S
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLAS 210

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            +  HRDL   N +LD      +K+ DFG ++
Sbjct: 211 KKFVHRDLAARNCMLDEKFT--VKVADFGLAR 240

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 68.6 bits (168), Expect = 2e-14
 Identities = 22/149 (14%), Positives = 43/149 (28%), Gaps = 12/149 (8%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRHPN 59
           Y L+   G                  VA+ +++    + ++V        +    +  P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           + R  +VV T     +V E+  GG L +        S        Q L +  +  H   +
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAGV 150

Query: 120 CHRDLKLENTLL--DGSAAPRLKICDFGY 146
                      +  DG     + +     
Sbjct: 151 ALSIDHPSRVRVSIDG----DVVLAYPAT 175

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 67.3 bits (165), Expect = 5e-14
 Identities = 37/152 (24%), Positives = 67/152 (44%), Gaps = 11/152 (7%)

Query: 5   ELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRSLRHPN 59
              + +G G+FGV      +   + +   A+K + R  ++ +  A  RE +  R L HPN
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 60  IIRFKEVVLT--PTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHS 116
           ++    ++L        +++ Y   G+L   I       +  +   F  Q+  G+ Y   
Sbjct: 84  VLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
            +  HRDL   N +LD S    +K+ DFG ++
Sbjct: 143 QKFVHRDLAARNCMLDESFT--VKVADFGLAR 172

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 67.7 bits (166), Expect = 5e-14
 Identities = 40/166 (24%), Positives = 60/166 (36%), Gaps = 24/166 (14%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REI-INHR 53
              +  K LGAG FG      A  L  ++    VAVK ++     DE  A   E+ I   
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD-------RICNAGRFSEDEGRYFFQQ 106
             +H NI+           + ++ EY   G+L +        +     F+        + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 107 LIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
           L+        G+ +  S    HRD+   N LL        KI DFG
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV--AKIGDFG 209

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 67.3 bits (165), Expect = 5e-14
 Identities = 46/166 (27%), Positives = 66/166 (39%), Gaps = 24/166 (14%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDEN-VAREIINHRSL 55
               L ++LG G FG         L   + K LVAVK ++           RE     +L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD---------RICNAGRFSEDEGRYFFQQ 106
           +H +I++F  V      L +V EY   G+L            I   G+  + +G     Q
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 107 LI-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
           ++       SG+ Y  S    HRDL   N L+   A   +KI DFG
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFG 178

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 67.6 bits (165), Expect = 6e-14
 Identities = 49/238 (20%), Positives = 82/238 (34%), Gaps = 65/238 (27%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-----INHRSLR 56
            +Y +++ LG G+F    L    + K+ VA+K ++      E    EI     + +    
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96

Query: 57  HPN--IIR-----FKEVVLTPTHLAIVMEYAAGGELFDRIC--NAGRFSEDEGRYFFQQL 107
            PN  ++      FK   +  TH+ +V E   G  L   I   N         +   QQ+
Sbjct: 97  DPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQV 155

Query: 108 ISGVNYCHS-MQICHRDLKLENTLLD---------------------------------- 132
           + G++Y H+  +I H D+K EN LL                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 133 -------------GSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
                         +   ++KI D G   +  +H      + T  Y + EVL    Y+
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYN 271

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 66.9 bits (164), Expect = 1e-13
 Identities = 46/165 (27%), Positives = 63/165 (38%), Gaps = 23/165 (13%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDEN-VAREIINHRSL 55
               L  +LG G FG         L  ++ K LVAVK ++   +       RE      L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--------FDRICNAGRFSEDEGRYFFQQL 107
           +H +I+RF  V      L +V EY   G+L         D    AG      G     QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 108 I-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
           +       +G+ Y   +   HRDL   N L+       +KI DFG
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFG 203

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 65.7 bits (161), Expect = 2e-13
 Identities = 43/175 (24%), Positives = 63/175 (36%), Gaps = 33/175 (18%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRS 54
           +   L K LG G FG      A  L+ +     VAVK ++      E      E    + 
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------------FDRICNAGRFSE 97
           + HP++I+          L +++EYA  G L                      ++     
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 98  DEGRYFFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
           DE       LIS       G+ Y   M++ HRDL   N L+       +KI DFG
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFG 195

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 65.8 bits (161), Expect = 2e-13
 Identities = 40/170 (23%), Positives = 64/170 (37%), Gaps = 23/170 (13%)

Query: 2   EKYELVKDLGAGNFG-VAR-LLRHKETKELVAVKYIERGRKIDENVA--REI-INHRSLR 56
              +    +G GNFG V +  ++    +   A+K ++     D++     E+ +  +   
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFD---------RICNAGRFSEDEGRYFFQQL 107
           HPNII          +L + +EYA  G L D                 +        QQL
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 108 I-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS 150
           +        G++Y    Q  HRDL   N L+  +     KI DFG S+  
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQ 192

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 64.9 bits (159), Expect = 3e-13
 Identities = 31/167 (18%), Positives = 59/167 (35%), Gaps = 25/167 (14%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRS 54
                +++LG   FG             E  + VA+K ++   +         E +    
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD---------RICNAGRFSEDEGRYFFQ 105
           L+HPN++    VV     L+++  Y + G+L +          + +       +      
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 106 QLI-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
             +       +G+ Y  S  + H+DL   N L+       +KI D G
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--VKISDLG 173

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 65.4 bits (159), Expect = 5e-13
 Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 15/176 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNI 60
            K+ L + +G+G+FG   L  + +T E VA+K  E  +     +  E   +R L+    I
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
              +   +   +  +VM+   G  L D    C+  + S         Q+I+ V + HS  
Sbjct: 66  PNVRWFGVEGDYNVLVMDL-LGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS 123

Query: 119 ICHRDLKLENTLLD-GSAAPRLKICDFGYSK-----SSVLHSRP---KSTVGTPAY 165
             HRD+K +N L+  G  A ++ I DFG +K     S+  H      K+  GT  Y
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 64.7 bits (158), Expect = 5e-13
 Identities = 40/178 (22%), Positives = 71/178 (39%), Gaps = 17/178 (9%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH-PNI 60
             Y++ + +G G+FGV     +    + VA+K+ E  R     +  E   ++ L     I
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
                      H  +V++   G  L D   +C   +FS        +Q+++ V   H   
Sbjct: 69  PNVYYFGQEGLHNVLVIDL-LGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS 126

Query: 119 ICHRDLKLENTLL---DGSAAPRLKICDFGYSK-----SSVLH---SRPKSTVGTPAY 165
           + +RD+K +N L+   +   A  + + DFG  K      +  H      K+  GT  Y
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 64.3 bits (157), Expect = 9e-13
 Identities = 42/175 (24%), Positives = 62/175 (35%), Gaps = 33/175 (18%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REIINHRS 54
              E V+D+G G FG      A  L   E   +VAVK ++     D      RE      
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------------FDRICNAGRFSE 97
             +PNI++   V      + ++ EY A G+L                  D    A   S 
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 98  DEGRYFFQQLI-------SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
                   + +       +G+ Y    +  HRDL   N L+  +    +KI DFG
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFG 219

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 63.2 bits (154), Expect = 2e-12
 Identities = 50/180 (27%), Positives = 75/180 (41%), Gaps = 23/180 (12%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH----P 58
            + + K +G GNFG  RL ++  T E VA+K +E  +     +  E   ++ L      P
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            +  F        + A+V+E   G  L D   +C+   FS         QLIS + Y HS
Sbjct: 69  QVYYFGP---CGKYNAMVLEL-LGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHS 123

Query: 117 MQICHRDLKLENTLL---DGSAAPRLKICDFGYSK-----SSVLH---SRPKSTVGTPAY 165
             + +RD+K EN L+          + I DF  +K      +  H      KS  GT  Y
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 63.1 bits (154), Expect = 2e-12
 Identities = 43/169 (25%), Positives = 63/169 (37%), Gaps = 27/169 (15%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REI-INHR 53
           ++ +L K LG G FG      A  +    T   VAVK ++ G    E+ A   E+ I   
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 54  SLRHPNIIRFKEVVLTP-THLAIVMEYAAGGELFD---------RICNAGRFSEDEGRYF 103
              H N++        P   L +++E+   G L                      +    
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 104 FQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
            + LI        G+ +  S +  HRDL   N LL  S    +KICDFG
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFG 193

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.4 bits (152), Expect = 3e-12
 Identities = 46/176 (26%), Positives = 72/176 (40%), Gaps = 15/176 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH-PNI 60
            +Y L + +G+G+FG   L       E VA+K  E  +     +  E   ++ ++    I
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
              +       +  +VME   G  L D    C+  +FS         Q+IS + Y HS  
Sbjct: 68  PTIRWCGAEGDYNVMVMEL-LGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN 125

Query: 119 ICHRDLKLENTLL-DGSAAPRLKICDFGYSK-----SSVLH---SRPKSTVGTPAY 165
             HRD+K +N L+  G     + I DFG +K      +  H      K+  GT  Y
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 62.3 bits (152), Expect = 3e-12
 Identities = 40/179 (22%), Positives = 57/179 (31%), Gaps = 41/179 (22%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA--REI----- 49
           E  E  K LG+G FG      A  +        VAVK ++      E  A   E+     
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 50  INHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL----------------FDRICNAG 93
           +      H NI+           + ++ EY   G+L                        
Sbjct: 105 LG----SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160

Query: 94  RFSEDEGRYFFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
              ED     F+ L+        G+ +       HRDL   N L+       +KICDFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFG 217

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 62.3 bits (152), Expect = 4e-12
 Identities = 44/170 (25%), Positives = 68/170 (40%), Gaps = 28/170 (16%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKE--LVAVKYIERGRKIDENVA--REIINH 52
           +K  L K LG G FG      A  +   + KE   VAVK ++      +      E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 53  RSL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD---------RICNAGRFSEDEGRY 102
           + + +H NII           L +++EYA+ G L +            +       E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFG 202

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 61.6 bits (150), Expect = 7e-12
 Identities = 41/170 (24%), Positives = 63/170 (37%), Gaps = 28/170 (16%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKE--LVAVKYIERGRKIDENVA--REI-IN 51
           ++  L K LG G FG      A  L   +      VAVK ++      +      E+ + 
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 52  HRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD---------RICNAGRFSEDEGRY 102
               +H NII           L +++EYA+ G L +            +       E + 
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
             + L+S       G+ Y  S +  HRDL   N L+       +KI DFG
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFG 236

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 61.2 bits (149), Expect = 1e-11
 Identities = 44/170 (25%), Positives = 68/170 (40%), Gaps = 28/170 (16%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKE--LVAVKYIERGRKIDENVA--REIINH 52
           +K  L K LG G FG      A  +   + KE   VAVK ++      +      E+   
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 53  RSL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD---------RICNAGRFSEDEGRY 102
           + + +H NII           L +++EYA+ G L +            +       E + 
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 103 FFQQLIS-------GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG 145
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFG 248

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 57.6 bits (138), Expect = 2e-10
 Identities = 39/195 (20%), Positives = 58/195 (29%), Gaps = 52/195 (26%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN---------VAREIINH 52
           EK +  + +G G FG         T   VA+K I        N         +  EII  
Sbjct: 20  EKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 53  RSL---------RHPNIIRFKEVVL------------------------------TPTHL 73
           + L         R    I    V                                    L
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 74  AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH-SMQICHRDLKLENTLLD 132
            IV+E+  GG   +++      S    +    QL + +     S++  HRDL   N LL 
Sbjct: 138 FIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196

Query: 133 GSAAPRLKICDFGYS 147
            ++  +L     G S
Sbjct: 197 KTSLKKLHYTLNGKS 211

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 54.0 bits (130), Expect = 4e-09
 Identities = 31/165 (18%), Positives = 60/165 (36%), Gaps = 20/165 (12%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR 62
           ++ L K +G+G FG+  L       E  A   ++   + +  +  E+  ++ +   + I+
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97

Query: 63  FKEVVLTPTHLAI-------------------VMEYAAGGELFDRICNAGRFSEDEGRYF 103
                    +L I                   VME   G +L       G F +      
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQL 156

Query: 104 FQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
             +++  + Y H  +  H D+K  N LL      ++ + D+G S 
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.0 bits (117), Expect = 2e-07
 Identities = 28/200 (14%), Positives = 65/200 (32%), Gaps = 41/200 (20%)

Query: 2   EKYELVKDLGAGNFGV--------ARLLRHKETKELVAVKYIER--GRKIDENVAREIIN 51
            +++L       N G+                 K+  ++K ++   GR  +E    +   
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNE----QNFF 96

Query: 52  HRSLRHPNIIRFKEVVLTPT---------------HLAIVMEYAAGGELFD--RICNAGR 94
            R+ +   + ++K++  TP                +  +V+    G  L     +     
Sbjct: 97  QRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHV 155

Query: 95  FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSV 151
            SE        +L+  + + H  +  H ++  EN  +D     ++ +  +G++     S 
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215

Query: 152 LH-----SRPKSTVGTPAYI 166
            H            G   +I
Sbjct: 216 KHVAYVEGSRSPHEGDLEFI 235

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 47.6 bits (114), Expect = 5e-07
 Identities = 29/63 (46%), Positives = 35/63 (55%), Gaps = 5/63 (7%)

Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK-STV--GTPAYI 166
           G++Y H+  I HRD+K  N LLD +  P  KI DFG SK      +   STV  GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYI 208

Query: 167 APE 169
            PE
Sbjct: 209 DPE 211

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 47.1 bits (112), Expect = 7e-07
 Identities = 26/169 (15%), Positives = 53/169 (31%), Gaps = 25/169 (14%)

Query: 3   KYELVKDLGAGNFGV---ARLLRHKE--TKELVAVK---------------YIERGRKID 42
            +++   +G G FG    A +   +   +     VK               Y    +   
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 43  ENVAREIINHRSLRHPNIIRF-KEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDE 99
                     + L  P             ++  ++M+   G +L          RFS   
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKT 153

Query: 100 GRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK 148
                 +++  + Y H  +  H D+K  N LL+     ++ + D+G + 
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 45.6 bits (109), Expect = 2e-06
 Identities = 24/69 (34%), Positives = 36/69 (52%), Gaps = 17/69 (24%)

Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG-------YSKSSVLHSRPKST--V 160
           G+N+ H     HRD+K  N LLD +     KI DFG       ++++ +      ++  V
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVM------TSRIV 196

Query: 161 GTPAYIAPE 169
           GT AY+APE
Sbjct: 197 GTTAYMAPE 205

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 43.7 bits (104), Expect = 9e-06
 Identities = 52/190 (27%), Positives = 74/190 (38%), Gaps = 44/190 (23%)

Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDENVARE------IINHRSLRHPNI 60
           LG G FG     RL        LVAVK ++  R   +    +      +I+     H N+
Sbjct: 38  LGRGGFGKVYKGRL----ADGTLVAVKRLKEERT--QGGELQFQTEVEMISM--AVHRNL 89

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFF-----QQLISGV---- 111
           +R +   +TPT   +V  Y A G +   +         E +        Q++  G     
Sbjct: 90  LRLRGFCMTPTERLLVYPYMANGSVASCL-----RERPESQPPLDWPKRQRIALGSARGL 144

Query: 112 NYCH---SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-----GTP 163
            Y H     +I HRD+K  N LLD        + DFG +K   L     + V     GT 
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVRGTI 199

Query: 164 AYIAPEVLSR 173
            +IAPE LS 
Sbjct: 200 GHIAPEYLST 209

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 41.1 bits (96), Expect = 8e-05
 Identities = 31/143 (21%), Positives = 52/143 (36%), Gaps = 15/143 (10%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDENVA----REIINH 52
           ++ +L K LG G FG      A  +    T   VAVK ++ G    E+ A     +I+ H
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 53  RSLRHPNIIRFKEVVLTPTH-LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
               H N++        P   L +++E+   G L   +    R   +E   +  +     
Sbjct: 82  IG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKTKGARFR 136

Query: 112 NYCHSMQICHRDLKLENTLLDGS 134
                +     DLK     +  S
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSS 159

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	181
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.98
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.98
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.95
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.92
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.86
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.67
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.53
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.52
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.14
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.09
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	99.06
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	99.06
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.9
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.8
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.71
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.69
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.62
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.44
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.32
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.31
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	98.23
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	98.08
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	98.07
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.05
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	98.03
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	98.02
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.97
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.75
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.71
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.48
3mes_A	424	Choline kinase; malaria, structural genomics, stru	97.4
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.5
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	94.95
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	94.35
1cja_A	342	Protein (actin-fragmin kinase); transferase; HET:	89.43
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	82.36

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2e-49  Score=288.28  Aligned_cols=176  Identities=32%  Similarity=0.479  Sum_probs=158.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc----ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||+||+|.++.+++.||+|++.+.    ....+.+.+|+.+++.++||||++++++|++++.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999999999999999999753    233467899999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC---
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~---  154 (181)
                      ||+++++|.+++.+...+++..++.++.|++.||+|||++||+||||||+||+++.++.  +||+|||+|+......   
T Consensus       112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTTTCC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCCCcc
Confidence            99999999999988889999999999999999999999999999999999999976555  9999999998664333   


Q ss_pred             CCCcccCCCCccCcccccCCccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...+.+||+.|||||++.+.+|+.+
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~~  214 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACKS  214 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCHH
T ss_pred             cccCcccCcccCCHHHHcCCCCCcH
Confidence            3445689999999999999888754

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3e-48  Score=278.43  Aligned_cols=175  Identities=45%  Similarity=0.737  Sum_probs=142.4

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|+||+||+|.+..+++.||+|++.+..    ...+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            579999999999999999999999999999999987542    2235788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |||+ +++|.+.+.+...+++..++.++.|++.||+|||++||+||||||+||++++++.  +||+|||+|+........
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~~  168 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDGNFL  168 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC---------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCCCcc
Confidence            9999 6799999988889999999999999999999999999999999999999976554  999999999876666666


Q ss_pred             CcccCCCCccCcccccCCccCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      .+..||+.|||||++.+.+|..
T Consensus       169 ~~~~GT~~Y~APE~~~~~~y~~  190 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKLYAG  190 (275)
T ss_dssp             ------CTTSCHHHHSSSSCCC
T ss_pred             CCeeECcccCChhhhcCCCCCC
Confidence            6788999999999999888753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.8e-49  Score=290.52  Aligned_cols=177  Identities=32%  Similarity=0.563  Sum_probs=150.2

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      |++|++++.||+|+||.||+|.+..+++.||+|++.....   ..+.+.+|+.+++.++||||+++++++++++.+|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            5799999999999999999999999999999999976432   2357889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-
Q 030211           78 EYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-  154 (181)
Q Consensus        78 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-  154 (181)
                      ||+++++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+|||+++++.  +||+|||+|+...... 
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCHHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecCCcc
Confidence            999999999998654  36799999999999999999999999999999999999976655  9999999997654322 


Q ss_pred             CCCcccCCCCccCcccccCCccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .....+||+.|||||++.+.+|+.+
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~  205 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNK  205 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHH
T ss_pred             cccccCCCccccCHHHHCCCCCCcH
Confidence            2234579999999999999988764

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.9e-48  Score=284.34  Aligned_cols=175  Identities=27%  Similarity=0.470  Sum_probs=157.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++..... ..+.+.+|+.+++.++||||++++++|.+++.+|+||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            469999999999999999999999999999999975433 3467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCCCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~~~~  159 (181)
                      ++++|.+++.+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||+|+..... ......
T Consensus       154 ~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~  230 (346)
T 4fih_A          154 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL  230 (346)
T ss_dssp             TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCC
T ss_pred             CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCccccc
Confidence            99999998864 57999999999999999999999999999999999999976554  999999999866444 344567


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +||+.|||||++.+.+|+.+
T Consensus       231 ~GTp~YmAPEvl~~~~y~~~  250 (346)
T 4fih_A          231 VGTPYWMAPELISRLPYGPE  250 (346)
T ss_dssp             CSCGGGCCHHHHTTCCBCTH
T ss_pred             ccCcCcCCHHHHCCCCCCcH
Confidence            89999999999999999865

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.1e-47  Score=285.58  Aligned_cols=175  Identities=27%  Similarity=0.466  Sum_probs=157.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++..... ..+.+.+|+.+++.++||||++++++|.+++.+|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            469999999999999999999999999999999975433 3467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCCCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~~~~  159 (181)
                      ++++|.+++. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||+|+..... ......
T Consensus       231 ~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~  307 (423)
T 4fie_A          231 EGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL  307 (423)
T ss_dssp             TTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCCC
T ss_pred             CCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCcccccc
Confidence            9999998875 457999999999999999999999999999999999999976554  999999999866444 334567


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +||+.|||||++.+..|+++
T Consensus       308 ~GTp~YmAPEvl~~~~y~~~  327 (423)
T 4fie_A          308 VGTPYWMAPELISRLPYGPE  327 (423)
T ss_dssp             EECTTTCCHHHHTTCCBCTH
T ss_pred             ccCcCcCCHHHHCCCCCCcH
Confidence            89999999999999999865

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.3e-47  Score=280.34  Aligned_cols=173  Identities=28%  Similarity=0.420  Sum_probs=151.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      +.|++.++||+|+||.||+|.++.+|+.||+|+++....    ..+|+.+++.++|||||++++++.+++.+|+||||++
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  133 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE  133 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            568899999999999999999999999999999976432    2468999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC------
Q 030211           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR------  155 (181)
Q Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~------  155 (181)
                      +++|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++. .+||+|||+|+.......      
T Consensus       134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC-----------
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccceec
Confidence            9999999988889999999999999999999999999999999999999975432 499999999986544332      


Q ss_pred             CCcccCCCCccCcccccCCccCCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+||+.|||||++.+.+|+.+
T Consensus       213 ~~~~~GT~~YmAPE~~~~~~y~~~  236 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMGKPCDAK  236 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTTCCCCTH
T ss_pred             CCccccCccccCHHHHCCCCCCcH
Confidence            223479999999999999999875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.5e-47  Score=278.31  Aligned_cols=176  Identities=31%  Similarity=0.536  Sum_probs=149.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEc---cCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|++.+.||+|+||+||+|++.   .+++.||+|++.+..   .....+.+|+.+++.++||||+++++++++++.+|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999874   467899999987542   223467889999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-CC
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~~  154 (181)
                      ||||+++++|.+++.+...+++..++.++.|++.||+|||++||+||||||+||+++.++.  +||+|||+|+.... ..
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~  181 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEK  181 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC-----C
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCCCc
Confidence            9999999999999998889999999999999999999999999999999999999976554  99999999975433 34


Q ss_pred             CCCcccCCCCccCcccccCCccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...+..||+.|||||++.+.+|+++
T Consensus       182 ~~~~~~GT~~YmAPE~~~~~~y~~~  206 (304)
T 3ubd_A          182 KAYSFCGTVEYMAPEVVNRRGHTQS  206 (304)
T ss_dssp             CCCSCCCCGGGCCHHHHHTSCCCTH
T ss_pred             cccccccCcccCCHHHhccCCCCCC
Confidence            4556789999999999999998864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.4e-46  Score=268.04  Aligned_cols=174  Identities=26%  Similarity=0.412  Sum_probs=150.0

Q ss_pred             cc-eeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEc----CCeEE
Q 030211            3 KY-ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLT----PTHLA   74 (181)
Q Consensus         3 ~y-~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~----~~~~~   74 (181)
                      || ++.+.||+|+||.||+|.+..+++.||+|.+......   .+.+.+|+.+++.++||||++++++|++    .+.+|
T Consensus        26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence            44 7888999999999999999999999999998754322   3568899999999999999999999875    35689


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~g--i~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      +||||+++++|.+++.+...+++..++.++.|++.||+|||++|  |+||||||+|||+++ .++.+||+|||+|+. ..
T Consensus       106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~-~~g~vKl~DFGla~~-~~  183 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATL-KR  183 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS-TTSCEEECCTTGGGG-CC
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC-CCCCEEEEeCcCCEe-CC
Confidence            99999999999999988889999999999999999999999998  999999999999963 223599999999974 33


Q ss_pred             CCCCCcccCCCCccCcccccCCccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .....+..||+.|||||++.+ +|+++
T Consensus       184 ~~~~~~~~GTp~YmAPE~~~~-~y~~~  209 (290)
T 3fpq_A          184 ASFAKAVIGTPEFMAPEMYEE-KYDES  209 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CCCTH
T ss_pred             CCccCCcccCccccCHHHcCC-CCCcH
Confidence            344456689999999999865 57764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.5e-46  Score=273.38  Aligned_cols=176  Identities=28%  Similarity=0.389  Sum_probs=142.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC--------
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPT--------   71 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--------   71 (181)
                      ++|++++.||+|+||.||+|.++.+++.||+|++.....  ..+.+.+|+.+++.++||||++++++|.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            579999999999999999999999999999999875432  2357889999999999999999999987644        


Q ss_pred             ----eEEEEEeecCCCChHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeec
Q 030211           72 ----HLAIVMEYAAGGELFDRICNAGR---FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (181)
Q Consensus        72 ----~~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~df  144 (181)
                          ++|++|||+.+++|.+++.....   .++..++.++.|++.||+|||++||+||||||+||+++.++.  +||+||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DF  162 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDF  162 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccC
Confidence                47999999999999999976554   445668899999999999999999999999999999976554  999999


Q ss_pred             CCcccccCCCC-------------CCcccCCCCccCcccccCCccCCC
Q 030211          145 GYSKSSVLHSR-------------PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       145 g~a~~~~~~~~-------------~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      |+|+.......             ....+||+.|||||++.+.+|+++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~  210 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK  210 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH
Confidence            99976543322             223469999999999999999875

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1e-45  Score=268.79  Aligned_cols=176  Identities=27%  Similarity=0.385  Sum_probs=149.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|.+.+.||+|+||.||+|.+.     .++..||+|.++.... ..+.+.+|+.++++++||||+++++++.+++.+++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            47899999999999999999875     3577899999976433 24679999999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEe
Q 030211           76 VMEYAAGGELFDRICNA-------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKIC  142 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~  142 (181)
                      ||||+++++|.+++.++             ..+++..+..++.|++.||.|||+++|+||||||+||+++++..  +||+
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~Ki~  170 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIG  170 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEEC
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--EEEC
Confidence            99999999999998653             36999999999999999999999999999999999999976655  9999


Q ss_pred             ecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          143 DFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       143 dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      |||+|+.......   .....||+.|||||++.+++|+++
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k  210 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE  210 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch
Confidence            9999975433322   233468999999999999988865

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=265.99  Aligned_cols=176  Identities=27%  Similarity=0.363  Sum_probs=144.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|.+.+.||+|+||.||+|.++     .+++.||+|+++.... ..+.+.+|+.++++++|||||++++++.+++.+++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46788999999999999999865     3578899999976433 24679999999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEE
Q 030211           76 VMEYAAGGELFDRICNA---------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLK  140 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~  140 (181)
                      ||||+++++|.+++.+.               .++++..+..++.|++.||.|||+++|+||||||+||+++++.  .+|
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~--~~K  198 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL--VVK  198 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC--cEE
Confidence            99999999999988653               3589999999999999999999999999999999999997555  499


Q ss_pred             EeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          141 ICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       141 l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      |+|||+|+.......   .....||+.|||||++.+..|+.+
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~  240 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE  240 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTTCCCCHH
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc
Confidence            999999976533322   234578999999999999988764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.9e-44  Score=263.16  Aligned_cols=176  Identities=20%  Similarity=0.346  Sum_probs=150.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      +.+++.+.||+|+||.||+|...     .+++.||+|.++....  ..+.+.+|+.++++++||||+++++++.+++.++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            56889999999999999999863     4577899999975432  3468999999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCc
Q 030211           75 IVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPR  138 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~  138 (181)
                      +||||+++|+|.+++...                ..+++..+..++.|++.||+|||+++|+||||||+||+++++..  
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~--  183 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--  183 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC--
Confidence            999999999999998643                35899999999999999999999999999999999999976655  


Q ss_pred             EEEeecCCcccccCCC---CCCcccCCCCccCcccccCCccCCC
Q 030211          139 LKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       139 v~l~dfg~a~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +||+|||+|+......   ......||+.|||||++.++.|+.+
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k  227 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID  227 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc
Confidence            9999999997653322   2344578999999999999988765

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.1e-43  Score=278.98  Aligned_cols=176  Identities=28%  Similarity=0.498  Sum_probs=152.3

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHH---HHHHhhCCCCCeeEEEEeEEcCCeE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVARE---IINHRSLRHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e---~~~~~~~~~~~i~~~~~~~~~~~~~   73 (181)
                      |++|++.++||+|+||.||+|.++.+|+.||+|++.+..    .......+|   +.+++.++||||++++++|++.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            578999999999999999999999999999999987532    112233333   5666778999999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      |+||||+.||+|.+.+.+...+++..++.++.||+.||+|||++||+||||||+||+++.++.  +||+|||+|+.... 
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~~-  344 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-  344 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS-
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeecCC-
Confidence            999999999999999988889999999999999999999999999999999999999976655  99999999976543 


Q ss_pred             CCCCcccCCCCccCcccccCC-ccCCC
Q 030211          154 SRPKSTVGTPAYIAPEVLSRR-EYDGK  179 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~-~~~~~  179 (181)
                      ....+.+||+.|||||++.++ .|+.+
T Consensus       345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~  371 (689)
T 3v5w_A          345 KKPHASVGTHGYMAPEVLQKGVAYDSS  371 (689)
T ss_dssp             CCCCSCCSCGGGCCHHHHSTTCCCCTH
T ss_pred             CCCCCccCCcCccCHHHHhCCCCCCcH
Confidence            344567899999999999754 67653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.7e-43  Score=277.17  Aligned_cols=179  Identities=28%  Similarity=0.510  Sum_probs=161.6

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +++|++.+.||+|+||.||+|.++.+|+.||+|++..... ..+.+.+|+.+++.++||||++++++|.+.+.++++|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            4789999999999999999999999999999999876433 246788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           80 AAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+..+.+||+|||+|+...+......
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~  315 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  315 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEE
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceee
Confidence            999999998864 4579999999999999999999999999999999999999866666799999999987776666667


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+||+.|||||++.+.+|+.+
T Consensus       316 ~~GT~~y~APEv~~~~~y~~~  336 (573)
T 3uto_A          316 TTGTAEFAAPEVAEGKPVGYY  336 (573)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHH
T ss_pred             eEECccccCHHHhCCCCCCcH
Confidence            789999999999999888753

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-43  Score=263.19  Aligned_cols=174  Identities=29%  Similarity=0.482  Sum_probs=149.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEc------CCe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLT------PTH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~------~~~   72 (181)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++......   .+.+.+|+.+++.++||||+++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            4799999999999999999999999999999999765432   2567889999999999999999998764      367


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      +|+||||++ ++|.+++.++..+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||+|+....
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~~  210 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLCT  210 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC--
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeeccc
Confidence            999999995 579999988889999999999999999999999999999999999999975554  99999999975432


Q ss_pred             -----CCCCCcccCCCCccCcccccCCcc-CC
Q 030211          153 -----HSRPKSTVGTPAYIAPEVLSRREY-DG  178 (181)
Q Consensus       153 -----~~~~~~~~~~~~~~aPE~~~~~~~-~~  178 (181)
                           .....+.+||+.|||||++.+..+ +.
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~  242 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQ  242 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCT
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCC
Confidence                 223445689999999999887543 44

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=256.91  Aligned_cols=172  Identities=26%  Similarity=0.384  Sum_probs=141.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      +++++.++||+|+||+||+|+++.   .||+|+++....   ..+.+.+|+.++++++||||+++++++.+ +.+++|||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            578899999999999999998653   589999875432   23678999999999999999999998754 56899999


Q ss_pred             ecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC---
Q 030211           79 YAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (181)
Q Consensus        79 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~---  154 (181)
                      |+++++|.+++... .++++..+..++.|++.||+|||+++|+||||||+|||++++.  .+||+|||+|+......   
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~--~~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL--TVKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE--EEEECCCSSCBC--------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC--cEEEeeccCceecccCCcce
Confidence            99999999998654 4799999999999999999999999999999999999997655  49999999997543322   


Q ss_pred             CCCcccCCCCccCcccccCC---ccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRR---EYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~---~~~~~  179 (181)
                      ......||+.|||||++...   +|+.+
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~k  217 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQ  217 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCCHH
T ss_pred             eecccccCCCccCHHHhhccCCCCCCcH
Confidence            23445799999999999643   45543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.3e-42  Score=249.49  Aligned_cols=168  Identities=29%  Similarity=0.359  Sum_probs=137.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC----eEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPT----HLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~----~~~~v~   77 (181)
                      .+|.+.+.||+|+||.||+|++.  |+.||+|++............|+..+..++||||+++++++.+++    .+++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            47899999999999999999874  889999998765433333445666667889999999999998654    589999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM--------QICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      ||+++++|.+++.. .+++++.+..++.|++.||+|||++        +|+||||||+||+++++..  +||+|||+|+.
T Consensus        81 Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~  157 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred             cCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCcc
Confidence            99999999999865 4689999999999999999999987        9999999999999976554  99999999976


Q ss_pred             ccCCCC-----CCcccCCCCccCcccccCC
Q 030211          150 SVLHSR-----PKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       150 ~~~~~~-----~~~~~~~~~~~aPE~~~~~  174 (181)
                      ......     .....||+.|||||++.+.
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~  187 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDS  187 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTC
T ss_pred             ccCCCCceeeecccccccccccCHHHhccc
Confidence            543332     2235799999999999764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.3e-41  Score=253.24  Aligned_cols=172  Identities=23%  Similarity=0.351  Sum_probs=144.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEc---cCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||+||+|+++   .+++.||+|.+.... ....+.+|+.+++.+ .|||+++++++|.+.+.+|+||
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm   99 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM   99 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence            57999999999999999999875   357789999886543 345678899999888 6999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC---
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~---  154 (181)
                      ||+++++|.+.+.   .+++..++.++.|++.||+|||++||+||||||+||+++.+ .+.++|+|||+|+......   
T Consensus       100 E~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~-~~~~kl~DFGla~~~~~~~~~~  175 (361)
T 4f9c_A          100 PYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRR-LKKYALVDFGLAQGTHDTKIEL  175 (361)
T ss_dssp             ECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT-TTEEEECCCTTCEECTTCSCGG
T ss_pred             eCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCC-CCeEEECcCCCCcccCCccccc
Confidence            9999999999873   48999999999999999999999999999999999999743 2469999999996433211   


Q ss_pred             --------------------------CCCcccCCCCccCcccccCCc-cCC
Q 030211          155 --------------------------RPKSTVGTPAYIAPEVLSRRE-YDG  178 (181)
Q Consensus       155 --------------------------~~~~~~~~~~~~aPE~~~~~~-~~~  178 (181)
                                                ...+..||+.|+|||++.+.+ |+.
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~  226 (361)
T 4f9c_A          176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTT  226 (361)
T ss_dssp             GGGC--------------------------CCCCGGGCCHHHHTTCSCCCT
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCC
Confidence                                      123357999999999998765 554

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.5e-42  Score=257.23  Aligned_cols=176  Identities=23%  Similarity=0.337  Sum_probs=148.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC-----CcEEEEEEccccccc--cHHHHHHHHHHhhCCC-CCeeEEEEeEEcC-Ce
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET-----KELVAVKYIERGRKI--DENVAREIINHRSLRH-PNIIRFKEVVLTP-TH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~-----~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~-~~i~~~~~~~~~~-~~   72 (181)
                      ++|++.+.||+|+||.||+|.+...     ++.||+|.+......  .+.+.+|+.++.++.| ||||++++++.++ +.
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~  143 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  143 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence            5799999999999999999997643     357999998765332  3578899999999976 8999999998764 56


Q ss_pred             EEEEEeecCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCC
Q 030211           73 LAIVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA  136 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~  136 (181)
                      +++||||+++++|.+++.+.                ..+++..+..++.|++.||+|||+++|+||||||+||+++++..
T Consensus       144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~  223 (353)
T 4ase_A          144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  223 (353)
T ss_dssp             CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC
Confidence            89999999999999998653                34889999999999999999999999999999999999976655


Q ss_pred             CcEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          137 PRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       137 ~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                        +||+|||+|+.......   .....||+.|||||++.++.|+.+
T Consensus       224 --vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k  267 (353)
T 4ase_A          224 --VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ  267 (353)
T ss_dssp             --EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH
T ss_pred             --EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc
Confidence              99999999986544332   223468999999999999988764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.6e-40  Score=243.99  Aligned_cols=177  Identities=35%  Similarity=0.588  Sum_probs=157.8

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc----ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|+||.||+|.++.+++.||+|++.+.    ......+.+|..+++.++||+++++++++.+.+..+++
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            47899999999999999999999999999999998753    23346788899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~~  155 (181)
                      |||+++++|...+.....+++..++.++.|++.||+|||++||+|+||||+||+++.++  .++|+|||+++... ....
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCCTTCC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC--CEEEeeccchhhcccCCCc
Confidence            99999999999998888899999999999999999999999999999999999997555  49999999997543 3334


Q ss_pred             CCcccCCCCccCcccccCCccCCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .....||+.|+|||++.+..++.+
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~~~  185 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYGRA  185 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTT
T ss_pred             ccccccChhhCChhhhcCCCCCch
Confidence            455679999999999999888765

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6e-40  Score=244.94  Aligned_cols=177  Identities=85%  Similarity=1.386  Sum_probs=152.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.......+.+.+|+.+++.++|||++++++++.+++..+++|||+.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            68999999999999999999999999999999998877667889999999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccC
Q 030211           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVG  161 (181)
Q Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~  161 (181)
                      +++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.+..+.++|+|||+++............|
T Consensus       100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g  179 (361)
T 3uc3_A          100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG  179 (361)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcC
Confidence            99999999888889999999999999999999999999999999999999866666799999999976555556666789


Q ss_pred             CCCccCcccccCCccCC
Q 030211          162 TPAYIAPEVLSRREYDG  178 (181)
Q Consensus       162 ~~~~~aPE~~~~~~~~~  178 (181)
                      ++.|+|||++.+..++.
T Consensus       180 t~~y~aPE~~~~~~~~~  196 (361)
T 3uc3_A          180 TPAYIAPEVLLRQEYDG  196 (361)
T ss_dssp             -CTTSCHHHHHCSSCCH
T ss_pred             CCCcCChhhhcCCCCCC
Confidence            99999999998877654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.8e-40  Score=241.76  Aligned_cols=175  Identities=41%  Similarity=0.719  Sum_probs=158.1

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.....   ..+.+.+|+.+++.++|||++++++++...+..+++|
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            4789999999999999999999999999999999876432   2356788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      ||+++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.+..  ++|+|||++..........
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~  171 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLD  171 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGGG
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCccc
Confidence            99999999999988889999999999999999999999999999999999999975554  9999999998766666666


Q ss_pred             cccCCCCccCcccccCCccC
Q 030211          158 STVGTPAYIAPEVLSRREYD  177 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~  177 (181)
                      ...|++.|+|||++.+..++
T Consensus       172 ~~~gt~~y~aPE~~~~~~~~  191 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQGKKYD  191 (328)
T ss_dssp             TTSSSGGGCCHHHHHTCCCC
T ss_pred             cccCCcceeCcccccCCCcC
Confidence            67899999999999887765

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.6e-39  Score=242.50  Aligned_cols=178  Identities=33%  Similarity=0.580  Sum_probs=159.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....       ..+.+.+|+.+++.++|||++++++++.+.+.++
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            579999999999999999999999999999999876432       2357889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCC--CcEEEeecCCcccccC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA--PRLKICDFGYSKSSVL  152 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~--~~v~l~dfg~a~~~~~  152 (181)
                      ++|||+++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||++++++.  ..++|+|||++.....
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~  171 (361)
T 2yab_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (361)
T ss_dssp             EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence            99999999999999988888999999999999999999999999999999999999965442  2699999999987666


Q ss_pred             CCCCCcccCCCCccCcccccCCccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ........|++.|+|||++.+.+++.+
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~  198 (361)
T 2yab_A          172 GVEFKNIFGTPEFVAPEIVNYEPLGLE  198 (361)
T ss_dssp             TCCCCCCCSCGGGCCHHHHTTCCCCTH
T ss_pred             CCccccCCCCccEECchHHcCCCCCcc
Confidence            656666789999999999998887754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.6e-40  Score=246.28  Aligned_cols=177  Identities=28%  Similarity=0.507  Sum_probs=155.6

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +++|++.+.||+|+||.||+|.++.+++.+|+|++.+...    ..+.+..|..++..+ +|||++++++++.+.+.+++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            4689999999999999999999999999999999876432    234577788888765 89999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc-cCCC
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-VLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~-~~~~  154 (181)
                      ||||+.+++|...+.....+++..++.++.|++.||+|||++||+||||||+||+++.++.  ++|+|||+|+.. ....
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTC
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecccCCC
Confidence            9999999999999988889999999999999999999999999999999999999976554  999999999763 3444


Q ss_pred             CCCcccCCCCccCcccccCCccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ......||+.|+|||++.+..++.+
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~~~~  233 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDYGFS  233 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCBCTH
T ss_pred             ccccccCCcccCCchhhcCCCCChH
Confidence            4556789999999999999888754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-40  Score=241.72  Aligned_cols=178  Identities=25%  Similarity=0.413  Sum_probs=159.3

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      .++|++.+.||+|+||.||++.+..+++.+|+|.+.........+.+|+.+++.++|||++++++++.+.+..+++|||+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            37899999999999999999999999999999998765555567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcc
Q 030211           81 AGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~  159 (181)
                      ++++|.+.+.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.+..+.++|+|||++............
T Consensus        84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  163 (321)
T 1tki_A           84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence            9999999887654 799999999999999999999999999999999999997644567999999999876655555556


Q ss_pred             cCCCCccCcccccCCccCC
Q 030211          160 VGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~  178 (181)
                      .+++.|+|||++.+..+++
T Consensus       164 ~gt~~y~aPE~~~~~~~~~  182 (321)
T 1tki_A          164 FTAPEYYAPEVHQHDVVST  182 (321)
T ss_dssp             ESCGGGSCHHHHTTCEECH
T ss_pred             cCChhhcCcHHhcCCCCCc
Confidence            7999999999998877654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.2e-40  Score=244.51  Aligned_cols=177  Identities=34%  Similarity=0.536  Sum_probs=150.7

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +++|++.+.||+|+||.||+|.++.+++.||+|++.+..    ...+.+.+|..++..+ .|||++++++++.+.+.+++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999999999999999987532    2335677888888877 79999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCC
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~  154 (181)
                      ||||+.+++|...+.....+++..++.++.|++.||+|||++||+||||||+||+++.++.  ++|+|||+|+... ...
T Consensus       102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICNGV  179 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC---
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecccCCc
Confidence            9999999999999988889999999999999999999999999999999999999976554  9999999997533 333


Q ss_pred             CCCcccCCCCccCcccccCCccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ......||+.|+|||++.+..++++
T Consensus       180 ~~~~~~gt~~y~aPE~~~~~~~~~~  204 (353)
T 3txo_A          180 TTATFCGTPDYIAPEILQEMLYGPA  204 (353)
T ss_dssp             ------CCGGGCCHHHHHHHHCTTH
T ss_pred             cccccCCCcCeEChhhcCCCCcCCc
Confidence            3445679999999999988777653

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=243.06  Aligned_cols=171  Identities=26%  Similarity=0.504  Sum_probs=155.5

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++....    ...+.+.+|+.++..++|||++++++++.+.+..+++
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            478999999999999999999999999999999986532    2346788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |||+.+++|...+.....+++..++.++.|++.||.|||++||+|+||+|+||+++.++.  ++|+|||++.........
T Consensus        94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~  171 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRETQI  171 (384)
T ss_dssp             ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTCCB
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccCCCce
Confidence            999999999999988889999999999999999999999999999999999999975554  999999999876666666


Q ss_pred             CcccCCCCccCcccccC
Q 030211          157 KSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~  173 (181)
                      ....||+.|+|||++.+
T Consensus       172 ~~~~gt~~Y~aPE~~~~  188 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSS  188 (384)
T ss_dssp             CCCCSCGGGCCGGGTCC
T ss_pred             eccCCCccccCCeeecc
Confidence            77789999999999974

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.4e-39  Score=240.16  Aligned_cols=177  Identities=33%  Similarity=0.533  Sum_probs=155.1

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +++|++.+.||+|+||.||+|.++.+++.||+|++.+..    ...+....|..++..+ +|||++++++++.+.+.+++
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            478999999999999999999999999999999987642    2345667788888765 89999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-CC
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~~  154 (181)
                      +|||+++++|.+++.+...+++..++.++.|++.||+|||++|++|+||+|+||+++.++  .++|+|||+++.... ..
T Consensus        96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~  173 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDA  173 (345)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTC
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC--CEEEeEChhhhhcccCCC
Confidence            999999999999998878899999999999999999999999999999999999997555  499999999975432 33


Q ss_pred             CCCcccCCCCccCcccccCCccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ......||+.|+|||++.+..++.+
T Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~  198 (345)
T 1xjd_A          174 KTNTFCGTPDYIAPEILLGQKYNHS  198 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred             cccCCCCCcccCChhhhcCCCCCCh
Confidence            3455689999999999998887654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-39  Score=236.88  Aligned_cols=175  Identities=32%  Similarity=0.576  Sum_probs=156.2

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.+..    ...+.+.+|..++..++|||++++++++.+.+..+++
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            478999999999999999999999999999999987542    2345677899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |||+++++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||+++....  ..
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~Dfg~a~~~~~--~~  160 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVPD--VT  160 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEECSS--CB
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC--CEEEeecCcceecCC--cc
Confidence            99999999999998888999999999999999999999999999999999999997555  499999999975432  23


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....||+.|+|||++.+..++.+
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~  183 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNKS  183 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTT
T ss_pred             ccccCCccccCHhHhcCCCCCcc
Confidence            45679999999999999888765

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.7e-39  Score=235.97  Aligned_cols=178  Identities=35%  Similarity=0.616  Sum_probs=158.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....       ..+.+.+|+.+++.++|||++++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            479999999999999999999999999999999875432       2357889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC--CCcEEEeecCCcccccC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA--APRLKICDFGYSKSSVL  152 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~--~~~v~l~dfg~a~~~~~  152 (181)
                      ++|||+++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||++++++  ...++|+|||++.....
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            9999999999999998888899999999999999999999999999999999999996554  22699999999987665


Q ss_pred             CCCCCcccCCCCccCcccccCCccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ........+++.|+|||++.+..++++
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~  197 (326)
T 2y0a_A          171 GNEFKNIFGTPEFVAPEIVNYEPLGLE  197 (326)
T ss_dssp             TSCCCCCCSCTTTCCHHHHTTCCCCTH
T ss_pred             CCccccccCCcCcCCceeecCCCCCcH
Confidence            555566789999999999998887754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.4e-39  Score=238.92  Aligned_cols=177  Identities=28%  Similarity=0.519  Sum_probs=155.5

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +++|++.+.||+|+||.||+|.++.+++.||+|++.+....    .+.+.+|..++..+ +|||++++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            47899999999999999999999999999999999765322    24577788888877 89999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCC
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~  154 (181)
                      +|||+++++|.+.+.+...+++..++.++.|++.||+|||++||+|+||||+||+++.++  .++|+|||+++... ...
T Consensus        88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCGGGCBCSCCTTC
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEEeccccccccCCCC
Confidence            999999999999998888899999999999999999999999999999999999997555  49999999997533 333


Q ss_pred             CCCcccCCCCccCcccccCCccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ......||+.|+|||++.+..++.+
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~  190 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYGFS  190 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred             cccccCCCccccCccccCCCCCChH
Confidence            4455689999999999998887653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.8e-39  Score=238.45  Aligned_cols=178  Identities=34%  Similarity=0.557  Sum_probs=158.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++.+.||+|+||.||++.+..+++.||+|++......   .+.+.+|+.+++.++|||++++++++.+.+..+++||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            4799999999999999999999999999999998764322   3567889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-CCcEEEeecCCcccccCCCCCC
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      |+.+++|.+.+.....+++..++.++.|++.||.|||++||+|+||+|+||+++.+. ...++|+|||++..........
T Consensus       109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~  188 (362)
T 2bdw_A          109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH  188 (362)
T ss_dssp             CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCC
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccc
Confidence            999999999998888899999999999999999999999999999999999996543 3469999999998766555555


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...|++.|+|||++.+..++.+
T Consensus       189 ~~~gt~~y~aPE~~~~~~~~~~  210 (362)
T 2bdw_A          189 GFAGTPGYLSPEVLKKDPYSKP  210 (362)
T ss_dssp             CSCSCTTTCCHHHHTTCCCCTH
T ss_pred             cCCCCccccCHHHHccCCCCch
Confidence            6789999999999998887754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1e-38  Score=236.07  Aligned_cols=174  Identities=45%  Similarity=0.774  Sum_probs=156.0

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc----ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++...    ......+.+|+.+++.++|||++++++++.+++..+++
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            47899999999999999999999999999999998653    22346788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |||+ +++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++++..  ++|+|||++.........
T Consensus        88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~~  164 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFL  164 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBTT
T ss_pred             EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCccc
Confidence            9999 6789988888888999999999999999999999999999999999999975554  999999999876666666


Q ss_pred             CcccCCCCccCcccccCCccC
Q 030211          157 KSTVGTPAYIAPEVLSRREYD  177 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~  177 (181)
                      ....|++.|+|||++.+..+.
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~  185 (336)
T 3h4j_B          165 KTSCGSPNYAAPEVINGKLYA  185 (336)
T ss_dssp             CCCTTSTTTSCGGGSCCSGGG
T ss_pred             ccccCCcCcCCHHHHcCCCCC
Confidence            667899999999999887763

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.3e-39  Score=239.03  Aligned_cols=177  Identities=32%  Similarity=0.510  Sum_probs=155.6

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +++|++.+.||+|+||.||+|.++.+++.||+|++.+..    ...+.+..|..++..+ .||+++++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            478999999999999999999999989999999987542    2345677888888877 79999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCC
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~  154 (181)
                      +|||+++++|.+++.....+++..++.++.|++.||+|||++||+|+||||+||+++.++  .++|+|||+++... ...
T Consensus        99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~  176 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGV  176 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC--cEEEEeCCcccccccCCc
Confidence            999999999999998878899999999999999999999999999999999999997555  49999999997543 333


Q ss_pred             CCCcccCCCCccCcccccCCccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ......||+.|+|||++.+..++.+
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~~~~~~  201 (353)
T 2i0e_A          177 TTKTFCGTPDYIAPEIIAYQPYGKS  201 (353)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBSTH
T ss_pred             ccccccCCccccChhhhcCCCcCCc
Confidence            4455679999999999998887754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.2e-39  Score=238.89  Aligned_cols=175  Identities=32%  Similarity=0.597  Sum_probs=156.0

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.+..    ...+.+.+|+.++..++||+++++++++.+.+..+++
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            478999999999999999999999999999999986542    2346788899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |||+++++|.+++.....+++..++.++.|++.||++||++||+|+||+|+||+++.++  .++|+|||+++....  ..
T Consensus       120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFg~a~~~~~--~~  195 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVKG--RT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECSS--CB
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC--CEEEcccccceeccC--Cc
Confidence            99999999999998888899999999999999999999999999999999999997555  499999999975433  23


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....||+.|+|||++.+..++.+
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~  218 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKA  218 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTH
T ss_pred             ccccCCccccCHHHhcCCCCCCc
Confidence            45679999999999998887754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.4e-38  Score=231.54  Aligned_cols=176  Identities=32%  Similarity=0.448  Sum_probs=150.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+......    .+.+.+|+.++..++|||++++++++.+.+..+++|
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            5899999999999999999999999999999998654322    256788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--  155 (181)
                      ||+++++|.+++....++++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++........  
T Consensus        91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK--TLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCSSSTTC-------
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEEeCCCccccccccccc
Confidence            9999999999998888899999999999999999999999999999999999997555  499999999975543322  


Q ss_pred             CCcccCCCCccCcccccCCccCCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .....|++.|+|||.+.+..++++
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~~  192 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATDEC  192 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCCTT
T ss_pred             cCccccCccccCHhHhcCCCCCch
Confidence            333568999999999998887764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=231.86  Aligned_cols=176  Identities=31%  Similarity=0.513  Sum_probs=153.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc-cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.++..++|||++++++++.+.+..+++|||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            68999999999999999999999999999999876533 33467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC---
Q 030211           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP---  156 (181)
Q Consensus        81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~---  156 (181)
                      .+++|.+++.. ...+++..+..++.|++.||++||++|++|+||+|+||+++.+..  ++|+|||++.........   
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~  167 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQPEG  167 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC--------
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceecccccccccc
Confidence            99999999876 457999999999999999999999999999999999999975554  999999999754332221   


Q ss_pred             ------------CcccCCCCccCcccccCCccCCC
Q 030211          157 ------------KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ------------~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                                  ....|++.|+|||++.+..++++
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  202 (310)
T 3s95_A          168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK  202 (310)
T ss_dssp             ------------CCCCSCGGGCCHHHHTTCCCCTH
T ss_pred             cccccccccccccccCCCcceeCHHHhcCCCCCcH
Confidence                        14568999999999998887764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.7e-38  Score=230.61  Aligned_cols=175  Identities=30%  Similarity=0.516  Sum_probs=150.3

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      |++|++.+.||+|+||+||+|.+..+++.||+|++......   ...+.+|+.+++.++|||++++++++.+++..+++|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            68999999999999999999999999999999998754332   367888999999999999999999999999999999


Q ss_pred             eecCCCChHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-CCC
Q 030211           78 EYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSR  155 (181)
Q Consensus        78 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~~~  155 (181)
                      |++++ ++.+.+. .+..+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++..... ...
T Consensus        81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCSCCSC
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeecccceecCCcccc
Confidence            99976 5555444 456899999999999999999999999999999999999997555  499999999976543 233


Q ss_pred             CCcccCCCCccCcccccCCc-cCC
Q 030211          156 PKSTVGTPAYIAPEVLSRRE-YDG  178 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~-~~~  178 (181)
                      .....+++.|+|||++.+.. ++.
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~  181 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYST  181 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCT
T ss_pred             ccCCccccCCcChHHHcCCCCcCc
Confidence            44557899999999998765 454

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.9e-38  Score=231.12  Aligned_cols=175  Identities=30%  Similarity=0.501  Sum_probs=154.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+..... ..+.+.+|+.+++.++|||++++++++..++..+++|||+
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            589999999999999999999999999999999865443 3467888999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-CCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-PKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~~~~  159 (181)
                      .+++|.+++... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++........ ....
T Consensus       100 ~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~  176 (297)
T 3fxz_A          100 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTM  176 (297)
T ss_dssp             TTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCC
T ss_pred             CCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCcccccCCc
Confidence            999999988654 6899999999999999999999999999999999999975554  99999999876544333 3445


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .|++.|+|||++.+..++++
T Consensus       177 ~gt~~y~aPE~~~~~~~~~~  196 (297)
T 3fxz_A          177 VGTPYWMAPEVVTRKAYGPK  196 (297)
T ss_dssp             CSCGGGCCHHHHHCSCBCTH
T ss_pred             cCCcCccChhhhcCCCCCcH
Confidence            79999999999998888764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-39  Score=240.46  Aligned_cols=177  Identities=29%  Similarity=0.483  Sum_probs=157.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.++..++|||++++++++.+.+..+++|||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            579999999999999999999999999999999876432 2357889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcc
Q 030211           81 AGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~  159 (181)
                      .+++|.+.+.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.+..+.++|+|||++............
T Consensus       131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~  210 (387)
T 1kob_A          131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT  210 (387)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeee
Confidence            9999999886554 799999999999999999999999999999999999997655667999999999876655555566


Q ss_pred             cCCCCccCcccccCCccCC
Q 030211          160 VGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~  178 (181)
                      .+|+.|+|||++.+..++.
T Consensus       211 ~gt~~y~aPE~~~~~~~~~  229 (387)
T 1kob_A          211 TATAEFAAPEIVDREPVGF  229 (387)
T ss_dssp             CSSGGGCCHHHHTTCCBCH
T ss_pred             ccCCCccCchhccCCCCCC
Confidence            8999999999999887764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.1e-38  Score=238.74  Aligned_cols=177  Identities=32%  Similarity=0.572  Sum_probs=148.8

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHH-HhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIIN-HRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~-~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +++|++.+.||+|+||.||+|.++.+++.||+|++.+....    ...+..|..+ ++.++|||++++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            36899999999999999999999999999999999764321    2344555555 467899999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc-cCCC
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS-VLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~-~~~~  154 (181)
                      +|||+.+++|.+.+.+...+++..++.++.|++.||+|||++||+||||||+||+++.++.  ++|+|||+++.. ....
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~~~~  194 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNS  194 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBCCCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCccccccccCCC
Confidence            9999999999999988888999999999999999999999999999999999999976554  999999999753 3334


Q ss_pred             CCCcccCCCCccCcccccCCccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ......||+.|+|||++.+..++.+
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~~~  219 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQPYDRT  219 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTCCCCTH
T ss_pred             ccccccCCccccCHHHhCCCCCCch
Confidence            4556789999999999998887754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=242.54  Aligned_cols=178  Identities=31%  Similarity=0.521  Sum_probs=155.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|++.....   ..+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            579999999999999999999999999999999876442   23567899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccC-CCCcEEEeecCCcccccCCCC-C
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-AAPRLKICDFGYSKSSVLHSR-P  156 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~-~~~~v~l~dfg~a~~~~~~~~-~  156 (181)
                      |+.+++|.+.+.....+++..++.++.|++.||.|||++||+|+||||+||+++++ ..+.++|+|||++........ .
T Consensus        91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~  170 (444)
T 3soa_A           91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW  170 (444)
T ss_dssp             CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBC
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCcee
Confidence            99999999999888899999999999999999999999999999999999999743 345699999999976543332 3


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....|++.|+|||++.+.+++++
T Consensus       171 ~~~~gt~~Y~APE~l~~~~~~~~  193 (444)
T 3soa_A          171 FGFAGTPGYLSPEVLRKDPYGKP  193 (444)
T ss_dssp             CCSCSCGGGCCHHHHTTCCBCTH
T ss_pred             ecccCCcccCCHHHhcCCCCCCc
Confidence            45679999999999999888764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.1e-38  Score=243.04  Aligned_cols=175  Identities=25%  Similarity=0.485  Sum_probs=152.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.++||+|+||.||++.++.+++.||+|++.+..    .....+.+|..++..++||+++++++++.+.+.+++||
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999987532    22345788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-
Q 030211           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-  155 (181)
                      ||+++++|.+++.+ ...+++..++.++.|++.||.|||++||+||||||+||+++.++  .++|+|||+|+....... 
T Consensus       154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g--~vkL~DFGla~~~~~~~~~  231 (437)
T 4aw2_A          154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTV  231 (437)
T ss_dssp             CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTSCE
T ss_pred             ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC--CEEEcchhhhhhcccCCCc
Confidence            99999999999976 46899999999999999999999999999999999999997555  499999999976544333 


Q ss_pred             -CCcccCCCCccCccccc-----CCccCC
Q 030211          156 -PKSTVGTPAYIAPEVLS-----RREYDG  178 (181)
Q Consensus       156 -~~~~~~~~~~~aPE~~~-----~~~~~~  178 (181)
                       .....||+.|+|||++.     .+.++.
T Consensus       232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~  260 (437)
T 4aw2_A          232 QSSVAVGTPDYISPEILQAMEGGKGRYGP  260 (437)
T ss_dssp             ECCSCCSCGGGCCHHHHHHHHTSCCEECT
T ss_pred             ccccccCCcCeeChHHHhhcccCCCCCCC
Confidence             23357999999999997     445554

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1e-38  Score=241.54  Aligned_cols=171  Identities=33%  Similarity=0.498  Sum_probs=150.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc----ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++.+.    ....+.+.+|..++..++|||++++++++.+.+.+++||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999999999999999998653    223456788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--  155 (181)
                      ||+++++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.  ++|+|||+|+.......  
T Consensus       149 E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~~~~  225 (410)
T 3v8s_A          149 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVR  225 (410)
T ss_dssp             CCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSEEE
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCCccc
Confidence            99999999998864 47999999999999999999999999999999999999975554  99999999976544332  


Q ss_pred             CCcccCCCCccCcccccCCc
Q 030211          156 PKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~  175 (181)
                      .....||+.|+|||++.+..
T Consensus       226 ~~~~~gt~~Y~APE~l~~~~  245 (410)
T 3v8s_A          226 CDTAVGTPDYISPEVLKSQG  245 (410)
T ss_dssp             CCSCCSCGGGCCHHHHHTTT
T ss_pred             ccCCcCCccccCHHHhhccC
Confidence            33567999999999998765

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=239.58  Aligned_cols=169  Identities=24%  Similarity=0.435  Sum_probs=149.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||++.++.+++.||+|++.+..    ...+.+.+|..++..++||+++++++++.+.+.+|+||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999987532    22345788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-
Q 030211           78 EYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-  155 (181)
                      ||+++++|.+++.+. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.  ++|+|||+++....... 
T Consensus       141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~~~~  218 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADGTV  218 (412)
T ss_dssp             CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSCE
T ss_pred             cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCCCcc
Confidence            999999999998765 47999999999999999999999999999999999999976554  99999999976544433 


Q ss_pred             -CCcccCCCCccCccccc
Q 030211          156 -PKSTVGTPAYIAPEVLS  172 (181)
Q Consensus       156 -~~~~~~~~~~~aPE~~~  172 (181)
                       .....||+.|+|||++.
T Consensus       219 ~~~~~~Gt~~Y~APE~l~  236 (412)
T 2vd5_A          219 RSLVAVGTPDYLSPEILQ  236 (412)
T ss_dssp             ECSSCCSCGGGCCHHHHH
T ss_pred             ccceeccccCcCCHHHHh
Confidence             23457999999999997

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.6e-38  Score=241.27  Aligned_cols=175  Identities=45%  Similarity=0.762  Sum_probs=157.3

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.+++.++|||++++++++.+++..+++
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            478999999999999999999999999999999987542    2345788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |||+++++|.+++..+..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.  ++|+|||++.........
T Consensus        95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~~  172 (476)
T 2y94_A           95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFL  172 (476)
T ss_dssp             EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTCCB
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhccccccc
Confidence            999999999999988888999999999999999999999999999999999999975554  999999999876655555


Q ss_pred             CcccCCCCccCcccccCCccC
Q 030211          157 KSTVGTPAYIAPEVLSRREYD  177 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~  177 (181)
                      ....|++.|+|||++.+..+.
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~  193 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYA  193 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBC
T ss_pred             cccCCCcCeEChhhccCCCCC
Confidence            667899999999999887653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.5e-38  Score=231.23  Aligned_cols=177  Identities=27%  Similarity=0.385  Sum_probs=148.0

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC-------
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPT-------   71 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-------   71 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.....  ..+.+.+|+.+++.++|||++++++++.+.+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            3689999999999999999999999999999999875432  3467899999999999999999999986543       


Q ss_pred             --------------------------------------------------eEEEEEeecCCCChHHHHhhcC---CCCHH
Q 030211           72 --------------------------------------------------HLAIVMEYAAGGELFDRICNAG---RFSED   98 (181)
Q Consensus        72 --------------------------------------------------~~~~v~e~~~~~~l~~~~~~~~---~~~~~   98 (181)
                                                                        ..+++|||+++++|.+++....   ..++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              3899999999999999987654   35566


Q ss_pred             HHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-------------CCCcccCCCCc
Q 030211           99 EGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-------------RPKSTVGTPAY  165 (181)
Q Consensus        99 ~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-------------~~~~~~~~~~~  165 (181)
                      .++.++.|++.||.|||++|++|+||||+||+++.++  .++|+|||++.......             ......|++.|
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC--CEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            7899999999999999999999999999999997555  59999999997654432             23345689999


Q ss_pred             cCcccccCCccCCC
Q 030211          166 IAPEVLSRREYDGK  179 (181)
Q Consensus       166 ~aPE~~~~~~~~~~  179 (181)
                      +|||.+.+..++++
T Consensus       243 ~aPE~~~~~~~~~~  256 (332)
T 3qd2_B          243 MSPEQIHGNNYSHK  256 (332)
T ss_dssp             SCHHHHHCCCCCTH
T ss_pred             cChHHhcCCCCcch
Confidence            99999998887754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.7e-38  Score=231.49  Aligned_cols=174  Identities=39%  Similarity=0.635  Sum_probs=151.5

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.....  ..+.+.+|+.+++.++|||++++++++.+++..+++||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            4799999999999999999999999999999999865432  23678899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC---CC
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH---SR  155 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~---~~  155 (181)
                      |+++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++......   ..
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECEETTEECC
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC--CEEEEEeeccceeccCCcccc
Confidence            999999999998777899999999999999999999999999999999999997555  4999999999754322   22


Q ss_pred             CCcccCCCCccCcccccCCcc
Q 030211          156 PKSTVGTPAYIAPEVLSRREY  176 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~  176 (181)
                      .....|++.|+|||++.+..+
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~  184 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREF  184 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSB
T ss_pred             cCCCccCcCccCcHHhccCCC
Confidence            345678999999999987765

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.8e-38  Score=233.85  Aligned_cols=178  Identities=30%  Similarity=0.488  Sum_probs=153.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc------cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR------KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....      ...+.+.+|+.+++.++|||++++++++.+.+.+++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            47999999999999999999999999999999986421      134678899999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-CCcEEEeecCCcccc
Q 030211           76 VMEYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSS  150 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-~~~v~l~dfg~a~~~  150 (181)
                      +|||+++++|.+.+...    ..+++..++.++.|++.||.|||++|++|+||||+||+++.+. ...++|+|||++...
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            99999999998776432    3589999999999999999999999999999999999996443 346999999999765


Q ss_pred             cCCCC-CCcccCCCCccCcccccCCccCCC
Q 030211          151 VLHSR-PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       151 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..... .....|++.|+|||++.+..++.+
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  213 (351)
T 3c0i_A          184 GESGLVAGGRVGTPHFMAPEVVKREPYGKP  213 (351)
T ss_dssp             CTTSCBCCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred             cCCCeeecCCcCCcCccCHHHHcCCCCCch
Confidence            44333 345679999999999998887654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.1e-38  Score=234.75  Aligned_cols=177  Identities=37%  Similarity=0.557  Sum_probs=140.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.+++.++|||++++++++.+++..+++|||++
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            46999999999999999999999999999999987643 34567789999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc-CCCCcEEEeecCCcccccCCCCCCccc
Q 030211           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKSTV  160 (181)
Q Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~-~~~~~v~l~dfg~a~~~~~~~~~~~~~  160 (181)
                      +++|.+.+.....+++..++.++.|++.||.+||++|++|+||+|+||+++. +..+.++|+|||++.............
T Consensus       132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  211 (349)
T 2w4o_A          132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC  211 (349)
T ss_dssp             SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccccc
Confidence            9999999988888999999999999999999999999999999999999964 335569999999997655554555667


Q ss_pred             CCCCccCcccccCCccCCC
Q 030211          161 GTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       161 ~~~~~~aPE~~~~~~~~~~  179 (181)
                      |++.|+|||++.+..++++
T Consensus       212 gt~~y~aPE~~~~~~~~~~  230 (349)
T 2w4o_A          212 GTPGYCAPEILRGCAYGPE  230 (349)
T ss_dssp             -CGGGSCHHHHTTCCCCTH
T ss_pred             CCCCccCHHHhcCCCCCcc
Confidence            9999999999998887654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.1e-38  Score=229.68  Aligned_cols=178  Identities=32%  Similarity=0.561  Sum_probs=158.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....       ..+.+.+|+.+++.++|||++++++++.+.+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            579999999999999999999999999999999875432       2356889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCC--CcEEEeecCCcccccC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA--PRLKICDFGYSKSSVL  152 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~--~~v~l~dfg~a~~~~~  152 (181)
                      ++||++++++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||++++++.  ..++|+|||++.....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~  171 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence            99999999999999988888999999999999999999999999999999999999975542  2599999999987666


Q ss_pred             CCCCCcccCCCCccCcccccCCccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ........+++.|+|||.+.+.+++++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~  198 (321)
T 2a2a_A          172 GVEFKNIFGTPEFVAPEIVNYEPLGLE  198 (321)
T ss_dssp             TCCCCCCCSCGGGCCHHHHTTCCCCTH
T ss_pred             cccccccCCCCCccCcccccCCCCCCc
Confidence            555566779999999999998877654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.7e-38  Score=230.73  Aligned_cols=176  Identities=30%  Similarity=0.484  Sum_probs=145.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEc---cCCcEEEEEEccccc-----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR-----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~-----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~   73 (181)
                      ++|++.+.||+|+||.||+|.+.   .+++.||+|++.+..     .....+.+|+.+++.++|||++++++++.+.+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            68999999999999999999985   678999999987642     2235577899999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      +++|||+++++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++......
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~  174 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLCKESIHD  174 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS--CEEECCCSCC------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC--cEEEEeCCcccccccC
Confidence            99999999999999998888899999999999999999999999999999999999997555  4999999998754332


Q ss_pred             -CCCCcccCCCCccCcccccCCccCCC
Q 030211          154 -SRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 -~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                       .......|++.|+|||++.+..++.+
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~  201 (327)
T 3a62_A          175 GTVTHTFCGTIEYMAPEILMRSGHNRA  201 (327)
T ss_dssp             ----CTTSSCCTTSCHHHHTTSCCCTH
T ss_pred             CccccccCCCcCccCHhhCcCCCCCCc
Confidence             33445679999999999998877653

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.6e-38  Score=243.16  Aligned_cols=177  Identities=37%  Similarity=0.591  Sum_probs=146.8

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc----ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++...    ......+.+|+.++..++|||++++++++.+.+.+++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            36899999999999999999999999999999998753    22235677889999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHS  154 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~  154 (181)
                      |||+++++|...+.....+++..++.++.|++.||+|||+ +||+|+||||+||+++.++  .++|+|||+|+... ...
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS--CEEECCCCCCCTTCC---
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC--CEEEccCCCceeccCCCc
Confidence            9999999999999888899999999999999999999998 9999999999999997655  49999999997533 333


Q ss_pred             CCCcccCCCCccCcccccCCccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ......||+.|+|||++.+..++++
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~~~~  329 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDYGRA  329 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCCCTH
T ss_pred             ccccccCCccccCHhhcCCCCCCCc
Confidence            3455689999999999998888764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2e-37  Score=223.96  Aligned_cols=178  Identities=34%  Similarity=0.557  Sum_probs=158.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++.+.||+|++|.||+|.+..+++.|++|++......   .+.+.+|+.+++.++|||++++++++.+.+..+++||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            6899999999999999999999999999999998764322   3567789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-CCcEEEeecCCcccccCCCCCC
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      ++.+++|.+.+.....+++..++.++.|++.||.+||++|++|+||+|+||+++.+. ...++|+|||.+..........
T Consensus        86 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (284)
T 3kk8_A           86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH  165 (284)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCC
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcccc
Confidence            999999999888888899999999999999999999999999999999999996443 3459999999997766666566


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...+++.|+|||.+.+.+++++
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~  187 (284)
T 3kk8_A          166 GFAGTPGYLSPEVLKKDPYSKP  187 (284)
T ss_dssp             CSCSCGGGCCHHHHTTCCBCTH
T ss_pred             CCCCCcCCcCchhhcCCCCCcc
Confidence            6789999999999998887654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7.7e-38  Score=244.21  Aligned_cols=176  Identities=27%  Similarity=0.393  Sum_probs=156.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+..    .....+.+|..++..++|||++++++++.+.+..++||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            57999999999999999999999999999999986532    23456788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           78 EYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      ||+.+++|.+.+....  .+++..++.++.|++.||+|||++||+|+||||+||+++.++  .++|+|||++........
T Consensus       264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g--~vKL~DFGla~~~~~~~~  341 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQT  341 (576)
T ss_dssp             CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECCTTCC
T ss_pred             EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC--CeEEEecccceecccCcc
Confidence            9999999998886644  499999999999999999999999999999999999997555  499999999987655555


Q ss_pred             CCcccCCCCccCcccccCCccCCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .....||+.|+|||++.+..++.+
T Consensus       342 ~~~~~GT~~Y~APEvl~~~~~~~~  365 (576)
T 2acx_A          342 IKGRVGTVGYMAPEVVKNERYTFS  365 (576)
T ss_dssp             EECCCSCGGGCCHHHHTTCEESSH
T ss_pred             ccccCCCccccCHHHHcCCCCCcc
Confidence            556789999999999998877654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.8e-37  Score=221.37  Aligned_cols=177  Identities=34%  Similarity=0.547  Sum_probs=156.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||.||++.+..++..+++|.+..... ..+.+.+|+.+++.++|||++++++++.+.+..+++|||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            579999999999999999999999999999999876533 3467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc-CCCCcEEEeecCCcccccCCCCCCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~-~~~~~v~l~dfg~a~~~~~~~~~~~~  159 (181)
                      ++++|.+.+.....+++..++.++.|++.||.+||++|++|+||+|+||++.. +..+.++|+|||++............
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~  168 (277)
T 3f3z_A           89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK  168 (277)
T ss_dssp             CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCC
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhcc
Confidence            99999999888888999999999999999999999999999999999999932 23446999999999876666666667


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+++.|+|||.+.+. ++++
T Consensus       169 ~~t~~y~aPE~~~~~-~~~~  187 (277)
T 3f3z_A          169 VGTPYYVSPQVLEGL-YGPE  187 (277)
T ss_dssp             CSCTTTCCHHHHTTC-BCTT
T ss_pred             CCCCCccChHHhccc-CCch
Confidence            899999999998654 5543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=230.18  Aligned_cols=173  Identities=32%  Similarity=0.460  Sum_probs=155.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---------IDENVAREIINHRSLRHPNIIRFKEVVLTPTH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~   72 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....         ....+.+|+.+++.++|||++++++++.+.+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            579999999999999999999999999999999876432         22467789999999999999999999999999


Q ss_pred             EEEEEeecCCC-ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           73 LAIVMEYAAGG-ELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        73 ~~~v~e~~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      .+++||++..+ +|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++++.  .++|+|||++....
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC--cEEEeecccceECC
Confidence            99999998776 9999998888999999999999999999999999999999999999997554  49999999998766


Q ss_pred             CCCCCCcccCCCCccCcccccCCcc
Q 030211          152 LHSRPKSTVGTPAYIAPEVLSRREY  176 (181)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~  176 (181)
                      .........|++.|+|||++.+..+
T Consensus       182 ~~~~~~~~~gt~~y~aPE~~~~~~~  206 (335)
T 3dls_A          182 RGKLFYTFCGTIEYCAPEVLMGNPY  206 (335)
T ss_dssp             TTCCBCEECSCGGGCCHHHHTTCCB
T ss_pred             CCCceeccCCCccccChhhhcCCCC
Confidence            6665666789999999999988776

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.9e-37  Score=239.38  Aligned_cols=176  Identities=37%  Similarity=0.608  Sum_probs=154.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--------------cccHHHHHHHHHHhhCCCCCeeEEEEeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--------------KIDENVAREIINHRSLRHPNIIRFKEVV   67 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--------------~~~~~~~~e~~~~~~~~~~~i~~~~~~~   67 (181)
                      ++|++++.||+|+||.||+|.+..+++.+|+|++....              ...+.+.+|+.+++.++|||++++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            58999999999999999999999999999999987543              2246788999999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCC-CcEEEeecCC
Q 030211           68 LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA-PRLKICDFGY  146 (181)
Q Consensus        68 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~-~~v~l~dfg~  146 (181)
                      .+.+.+++||||+++++|.+.+.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ..++|+|||+
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  195 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL  195 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence            999999999999999999999988888999999999999999999999999999999999999975543 3699999999


Q ss_pred             cccccCCCCCCcccCCCCccCcccccCCccCC
Q 030211          147 SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       147 a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      +.............|++.|+|||++.+ .+++
T Consensus       196 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~  226 (504)
T 3q5i_A          196 SSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNE  226 (504)
T ss_dssp             CEECCTTSCBCCCCSCTTTCCHHHHTT-CBCT
T ss_pred             CEEcCCCCccccccCCcCCCCHHHhcc-CCCc
Confidence            987666666666789999999999874 4554

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.8e-37  Score=247.31  Aligned_cols=177  Identities=32%  Similarity=0.511  Sum_probs=156.1

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc----ccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +++|++.+.||+|+||.||+|.++.+++.||+|++.+.    ....+.+..|..++..+ .|++++.+++++.+.+.+|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            46899999999999999999999999999999998753    23345677888888877 78999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCC
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~  154 (181)
                      ||||+.+++|...+.....+++..++.++.|++.||+|||++||+||||||+||+++.++.  ++|+|||+|+... ...
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGV  497 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTTC
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCCc
Confidence            9999999999999988889999999999999999999999999999999999999976654  9999999997543 333


Q ss_pred             CCCcccCCCCccCcccccCCccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ......||+.|+|||++.+..|+.+
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~~~~  522 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPYGKS  522 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCBSTH
T ss_pred             ccccccCCCcccCHhhhcCCCCCcc
Confidence            4455689999999999999888764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=227.97  Aligned_cols=171  Identities=24%  Similarity=0.342  Sum_probs=149.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC--eEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPT--HLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~   77 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  ...+.+.+|+.+++.++|||++++++++...+  ..+++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            58999999999999999999999999999999987543  22467789999999999999999999998765  789999


Q ss_pred             eecCCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEe--ccCCCCcEEEeecCCcccccC
Q 030211           78 EYAAGGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i--~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ||+++++|.+++....   .+++..++.++.|++.||.+||++|++|+||+|+||++  +++....++|+|||++.....
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~  168 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence            9999999999886543   39999999999999999999999999999999999998  223444699999999987666


Q ss_pred             CCCCCcccCCCCccCccccc
Q 030211          153 HSRPKSTVGTPAYIAPEVLS  172 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~  172 (181)
                      ........+++.|+|||++.
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~  188 (319)
T 4euu_A          169 DEQFVSLYGTEEYLHPDMYE  188 (319)
T ss_dssp             TCCBCCCCSCGGGCCHHHHH
T ss_pred             CCceeecccCCCccCHHHhh
Confidence            66666678999999999987

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.5e-37  Score=224.69  Aligned_cols=175  Identities=28%  Similarity=0.456  Sum_probs=149.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc------cccHHHHHHHHHHhhC---CCCCeeEEEEeEEcCC-
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR------KIDENVAREIINHRSL---RHPNIIRFKEVVLTPT-   71 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~------~~~~~~~~e~~~~~~~---~~~~i~~~~~~~~~~~-   71 (181)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....      .......+|+.+++.+   .|||++++++++.... 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            68999999999999999999999999999999987432      1234566777776655   5999999999998765 


Q ss_pred             ----eEEEEEeecCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecC
Q 030211           72 ----HLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFG  145 (181)
Q Consensus        72 ----~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg  145 (181)
                          ..+++||++. ++|.+++.....  +++..++.++.|++.||+|||++|++|+||+|+||+++.++  .++|+|||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg  165 (308)
T 3g33_A           89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVKLADFG  165 (308)
T ss_dssp             SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS--CEEECSCS
T ss_pred             CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC--CEEEeeCc
Confidence                5899999996 599988876653  99999999999999999999999999999999999997555  49999999


Q ss_pred             CcccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          146 YSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       146 ~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.............+++.|+|||++.+..++++
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  199 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP  199 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST
T ss_pred             cccccCCCcccCCccccccccCchHHcCCCCCch
Confidence            9987666666666789999999999998888765

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.2e-37  Score=240.75  Aligned_cols=176  Identities=30%  Similarity=0.404  Sum_probs=154.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++.+..    ...+.+..|..++..++||+++++++++.+.+.++++|
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999986532    23356888999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           78 EYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        78 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      ||+.+++|.+.+...    ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.  ++|+|||++......
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELKAG  342 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeeccCC
Confidence            999999999888653    36999999999999999999999999999999999999976554  999999999865544


Q ss_pred             CCC-CcccCCCCccCcccccCCccCCC
Q 030211          154 SRP-KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ~~~-~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ... ....||+.|+|||++.+..++.+
T Consensus       343 ~~~~~~~~GT~~Y~APE~l~~~~~~~~  369 (543)
T 3c4z_A          343 QTKTKGYAGTPGFMAPELLLGEEYDFS  369 (543)
T ss_dssp             CCCBCCCCSCTTTSCHHHHTTCCBCTH
T ss_pred             CcccccccCCccccChhhhcCCCCChH
Confidence            333 34589999999999999888754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.4e-37  Score=222.70  Aligned_cols=178  Identities=35%  Similarity=0.633  Sum_probs=153.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||.||++.+..+++.+++|++.....       ..+.+.+|+.+++.++|||++++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            579999999999999999999999999999999875421       2467889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC--CCcEEEeecCCcccccC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA--APRLKICDFGYSKSSVL  152 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~--~~~v~l~dfg~a~~~~~  152 (181)
                      ++||++++++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||++++++  ...++|+|||.+.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999999999999998888899999999999999999999999999999999999997544  23699999999976655


Q ss_pred             CCCCCcccCCCCccCcccccCCccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ........+++.|+|||.+....++++
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~  191 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIVNYEPLGLE  191 (283)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTH
T ss_pred             CCcccccCCCcCccCcceecCCCCCcc
Confidence            555556678999999999988877653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.3e-37  Score=238.58  Aligned_cols=176  Identities=38%  Similarity=0.587  Sum_probs=152.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++++.||+|+||+||+|.+..++..+|+|++....   .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            47999999999999999999999999999999987542   234678899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-CCcEEEeecCCcccccCCCCCC
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      |+.+++|.+.+.....+++..++.++.|++.||.|||++|++|+||+|+||+++... ...++|+|||++..........
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~  196 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK  196 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBC
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcccc
Confidence            999999999888888899999999999999999999999999999999999996433 3469999999998766655566


Q ss_pred             cccCCCCccCcccccCCccCC
Q 030211          158 STVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ...|++.|+|||++.+ .+++
T Consensus       197 ~~~gt~~y~aPE~l~~-~~~~  216 (494)
T 3lij_A          197 ERLGTAYYIAPEVLRK-KYDE  216 (494)
T ss_dssp             CCCSCTTTCCHHHHTT-CBCT
T ss_pred             ccCCCcCeeCHHHHcc-cCCC
Confidence            6789999999999864 4654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.1e-37  Score=238.32  Aligned_cols=176  Identities=39%  Similarity=0.607  Sum_probs=153.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc---ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++...   ......+.+|+.+++.++|||++++++++.+.+.++++||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            5899999999999999999999999999999998643   2334678899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccC-CCCcEEEeecCCcccccCCCCCC
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-AAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~-~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      ++.+++|.+.+.....+++..++.++.|++.||.|||++||+|+||+|+||+++.. ..+.++|+|||++..........
T Consensus       102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  181 (486)
T 3mwu_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK  181 (486)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccC
Confidence            99999999998888889999999999999999999999999999999999999542 34469999999998666665566


Q ss_pred             cccCCCCccCcccccCCccCC
Q 030211          158 STVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ...|++.|+|||++.+ .+++
T Consensus       182 ~~~gt~~y~aPE~~~~-~~~~  201 (486)
T 3mwu_A          182 DRIGTAYYIAPEVLRG-TYDE  201 (486)
T ss_dssp             CCTTGGGGCCGGGGGS-CCCH
T ss_pred             CCcCCCCCCCHHHhCC-CCCc
Confidence            6789999999999875 3543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=231.91  Aligned_cols=176  Identities=17%  Similarity=0.167  Sum_probs=147.3

Q ss_pred             ccceeeeeeCCccceeEEEEE-----EccCCcEEEEEEccccccccHHHHHHHHHHhhCC---CCCeeEEEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLR-----HKETKELVAVKYIERGRKIDENVAREIINHRSLR---HPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~-----~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~---~~~i~~~~~~~~~~~~~   73 (181)
                      ++|++.+.||+|+||.||+|.     +..+++.||+|++...  ....+..|..++..++   |++++.+++++...+..
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~  142 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS  142 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence            579999999999999999994     6677899999998754  3456777787777776   89999999999999999


Q ss_pred             EEEEeecCCCChHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc---------CCCCcE
Q 030211           74 AIVMEYAAGGELFDRICN-----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG---------SAAPRL  139 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~---------~~~~~v  139 (181)
                      ++||||+++++|.+++..     ...+++..++.++.|++.||+|||++||+||||||+||+++.         +..+.+
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~  222 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL  222 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCE
Confidence            999999999999998863     457999999999999999999999999999999999999965         114569


Q ss_pred             EEeecCCccccc---CCCCCCcccCCCCccCcccccCCccCCC
Q 030211          140 KICDFGYSKSSV---LHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       140 ~l~dfg~a~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +|+|||+|....   .........||+.|+|||++.+..++.+
T Consensus       223 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  265 (365)
T 3e7e_A          223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ  265 (365)
T ss_dssp             EECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH
T ss_pred             EEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc
Confidence            999999996443   2223344579999999999999888764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.5e-37  Score=231.70  Aligned_cols=173  Identities=34%  Similarity=0.477  Sum_probs=147.7

Q ss_pred             eeeeeCCccceeEEEEEEccCCcEEEEEEccccc-cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCCCC
Q 030211            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAGGE   84 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   84 (181)
                      ..+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.++..++|||++++++++.+.+..+++|||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3678999999999999999999999999987643 234678899999999999999999999999999999999999999


Q ss_pred             hHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccCCC
Q 030211           85 LFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTP  163 (181)
Q Consensus        85 l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~  163 (181)
                      |.+.+... ..+++..++.++.|++.||.|||++|++|+||+|+||++.++..+.++|+|||++.............|++
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~  252 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTP  252 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSC
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCC
Confidence            98887654 46999999999999999999999999999999999999965556679999999998766666566677999


Q ss_pred             CccCcccccCCccCC
Q 030211          164 AYIAPEVLSRREYDG  178 (181)
Q Consensus       164 ~~~aPE~~~~~~~~~  178 (181)
                      .|+|||++....++.
T Consensus       253 ~y~aPE~~~~~~~~~  267 (373)
T 2x4f_A          253 EFLAPEVVNYDFVSF  267 (373)
T ss_dssp             TTCCHHHHTTCBCCH
T ss_pred             cEeChhhccCCCCCc
Confidence            999999998877654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-37  Score=226.16  Aligned_cols=176  Identities=30%  Similarity=0.471  Sum_probs=146.8

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +++|++.+.||+|++|.||+|.+..+++.||+|.+......   .+.+.+|+.+++.++|||++++++++.+.+..+++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            58999999999999999999999999999999988665432   356778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~  156 (181)
                      |++++++|..++.....+++..+..++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||.+...... ...
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  159 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS--VIKLCDFGFARLLTGPSDYY  159 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECC------
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC--CEEEeeCCCchhccCccccc
Confidence            9999988888887777899999999999999999999999999999999999997555  4999999999765432 233


Q ss_pred             CcccCCCCccCcccccC-CccCC
Q 030211          157 KSTVGTPAYIAPEVLSR-REYDG  178 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~-~~~~~  178 (181)
                      ....+++.|+|||.+.+ ..+++
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~  182 (311)
T 4agu_A          160 DDEVATRWYRSPELLVGDTQYGP  182 (311)
T ss_dssp             ------GGGCCHHHHHTCSCCCT
T ss_pred             CCCcCCccccChHHHhcCCCCCc
Confidence            44578999999999975 44554

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.6e-37  Score=222.32  Aligned_cols=176  Identities=34%  Similarity=0.617  Sum_probs=151.8

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|++|.||++.+..++..||+|++....    .....+.+|+.+++.++|||++++++++.+.+..+++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            478999999999999999999999999999999986532    2245688899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |||+++++|.+.+.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.  ++|+|||++.... ....
T Consensus        88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~-~~~~  164 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SSRR  164 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC------
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCC-cccc
Confidence            999999999999988888999999999999999999999999999999999999975554  9999999885432 2333


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+++.|+|||.+.+..++++
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~  187 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHDEK  187 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCCTT
T ss_pred             cccCCCCCccCHhHhccCCCCcc
Confidence            45678999999999998877654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.3e-37  Score=225.29  Aligned_cols=174  Identities=30%  Similarity=0.511  Sum_probs=144.7

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +++|++.+.||+|+||+||+|.+.. ++.||+|++......   .+.+.+|+.+++.++|||++++++++.+.+..+++|
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            4799999999999999999999964 889999998754322   357889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CC
Q 030211           78 EYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SR  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~  155 (181)
                      ||+++ +|.+.+... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++...... ..
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~  175 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRS  175 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSCCC-
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecCCCccc
Confidence            99975 777777554 36999999999999999999999999999999999999975554  999999999765433 33


Q ss_pred             CCcccCCCCccCcccccC-CccCC
Q 030211          156 PKSTVGTPAYIAPEVLSR-REYDG  178 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~-~~~~~  178 (181)
                      .....+++.|+|||++.+ ..++.
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~  199 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGSKKYST  199 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCT
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCc
Confidence            344578999999999876 34554

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.5e-37  Score=228.24  Aligned_cols=175  Identities=25%  Similarity=0.452  Sum_probs=153.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC-----CCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-----HPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~-----~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++............|..++..++     |||++++++++...+..+++
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv  114 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI  114 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence            6899999999999999999999999999999999865555567778899988886     99999999999999999999


Q ss_pred             EeecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccC--------------------
Q 030211           77 MEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS--------------------  134 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~--------------------  134 (181)
                      ||++ +++|.+++....  .+++..++.++.|++.||.|||++||+|+||||+||+++++                    
T Consensus       115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~  193 (360)
T 3llt_A          115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI  193 (360)
T ss_dssp             ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred             EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccc
Confidence            9999 889999887654  59999999999999999999999999999999999999641                    


Q ss_pred             ---CCCcEEEeecCCcccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          135 ---AAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       135 ---~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                         ....++|+|||++....  .......+++.|+|||++.+.+++++
T Consensus       194 ~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~  239 (360)
T 3llt_A          194 YRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVS  239 (360)
T ss_dssp             EEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTT
T ss_pred             cccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCc
Confidence               24569999999997532  23345678999999999999888765

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.9e-37  Score=229.84  Aligned_cols=173  Identities=34%  Similarity=0.547  Sum_probs=148.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||.||++.++.+++.||+|++.....   ...+|+.++..+ +|||++++++++.+.+..+++|||+
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   98 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM   98 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence            579999999999999999999999999999999976543   234577777666 7999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCC--CcEEEeecCCcccccCC-CCCC
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA--PRLKICDFGYSKSSVLH-SRPK  157 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~--~~v~l~dfg~a~~~~~~-~~~~  157 (181)
                      .+++|.+.+.....+++..++.++.|++.||.|||++|++|+||+|+||++.++..  ..++|+|||++...... ....
T Consensus        99 ~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  178 (342)
T 2qr7_A           99 KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM  178 (342)
T ss_dssp             CSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBC
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCcee
Confidence            99999999988888999999999999999999999999999999999999853322  35999999999765433 3344


Q ss_pred             cccCCCCccCcccccCCccC
Q 030211          158 STVGTPAYIAPEVLSRREYD  177 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~  177 (181)
                      ...+++.|+|||++.+..++
T Consensus       179 ~~~gt~~y~aPE~~~~~~~~  198 (342)
T 2qr7_A          179 TPCYTANFVAPEVLERQGYD  198 (342)
T ss_dssp             CSSCCSSCCCHHHHHHHHHH
T ss_pred             ccCCCccccCHHHhcCCCCC
Confidence            56789999999998776554

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-36  Score=222.96  Aligned_cols=178  Identities=22%  Similarity=0.311  Sum_probs=146.2

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|+||.||++.+..+++.||+|++......    .+.+.+|+.++..++|||++++++++.+.+..+++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            47899999999999999999999989999999998764322    25688899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC--
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--  154 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~--  154 (181)
                      ||++++++|.+++.....+++..++.++.|++.+|.+||++|++|+||+|+||+++.++  .++|+|||++.......  
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD--FAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSCCC----------
T ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC--CEEEecCccCccccccccc
Confidence            99999999999998888899999999999999999999999999999999999997555  49999999986544332  


Q ss_pred             CCCcccCCCCccCcccccCCccCCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ......+++.|+|||.+.+..++.++
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~~~~~~  216 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESHATYRA  216 (309)
T ss_dssp             ------CCGGGCCGGGTCC----CCC
T ss_pred             cccccCCCcCccCHHHHcCCCCCchH
Confidence            22345689999999999988877653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6e-37  Score=220.95  Aligned_cols=177  Identities=32%  Similarity=0.492  Sum_probs=134.6

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++....    ...+.+.+|+.++..++|||++++++++.+.+..+++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            478999999999999999999999899999999986532    2236788899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-C
Q 030211           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-S  154 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~  154 (181)
                      ||++++++|.+++... .++++..++.++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||++...... .
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~--~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM--NIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC--CEEECCCTTCEECC----
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEEEeecceeeccCCCC
Confidence            9999999999988765 5799999999999999999999999999999999999997555  4999999998755422 2


Q ss_pred             CCCcccCCCCccCcccccCCccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ......+++.|+|||.+.+..++++
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~  192 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHGLE  192 (278)
T ss_dssp             ------------------------C
T ss_pred             cceeccCCCCcCCcchhcCCCCCch
Confidence            3334578999999999988877665

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-36  Score=229.12  Aligned_cols=176  Identities=27%  Similarity=0.431  Sum_probs=151.7

Q ss_pred             ccceeeeeeCCc--cceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAG--NFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g--~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|++.+.||+|  +||.||+|.+..+++.||+|++......   .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            689999999999  9999999999999999999999765322   35677899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-
Q 030211           77 MEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-  153 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-  153 (181)
                      |||+++++|.+++...  ..+++..++.++.|++.||.|||++||+|+||||+||+++.++  .++|+|||.+...... 
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~--~~kl~dfg~~~~~~~~~  182 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMISHG  182 (389)
T ss_dssp             EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCGGGCEECEETT
T ss_pred             EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccccceeecccc
Confidence            9999999999998765  6799999999999999999999999999999999999997555  5999999987543221 


Q ss_pred             -------CCCCcccCCCCccCcccccC--CccCCC
Q 030211          154 -------SRPKSTVGTPAYIAPEVLSR--REYDGK  179 (181)
Q Consensus       154 -------~~~~~~~~~~~~~aPE~~~~--~~~~~~  179 (181)
                             .......+++.|+|||++.+  ..++++
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  217 (389)
T 3gni_B          183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK  217 (389)
T ss_dssp             EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTH
T ss_pred             ccccccccccccccccccccCHHHHhccCCCCCcH
Confidence                   22233468899999999987  456543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.7e-38  Score=229.48  Aligned_cols=176  Identities=27%  Similarity=0.400  Sum_probs=145.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCC----eE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPT----HL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~----~~   73 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......    ...+.+|+.++..++|||++++++++....    ..
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            6899999999999999999999999999999998764332    246778999999999999999999987654    35


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      +++|||+++++|.+++.....+++..++.++.|++.+|.|||++|++|+||+|+||+++.++.  ++|+|||++......
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCccccccc
Confidence            999999999999999988888999999999999999999999999999999999999976554  999999998754332


Q ss_pred             C----CCCcccCCCCccCcccccCCccCCC
Q 030211          154 S----RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ~----~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .    ......|++.|+|||.+.+..++++
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  199 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDAR  199 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHH
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCch
Confidence            2    2233468999999999988877643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1e-36  Score=220.40  Aligned_cols=176  Identities=32%  Similarity=0.627  Sum_probs=155.2

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|++|.||++.+..+++.|++|++....    ...+.+.+|+.+++.++|||++++++++.+.+..+++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            478999999999999999999999999999999986532    2246788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      ||++++++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.  ++|+|||++..... ...
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~  169 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS-LRR  169 (284)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-SCB
T ss_pred             EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-ccc
Confidence            999999999999988888999999999999999999999999999999999999975554  99999999864432 233


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+++.|+|||++.+..++++
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~  192 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGKTHDEK  192 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTT
T ss_pred             ccccCCCCcCCHHHhccCCCCcc
Confidence            44678999999999998887764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.6e-37  Score=226.99  Aligned_cols=176  Identities=37%  Similarity=0.609  Sum_probs=136.0

Q ss_pred             ccceee---eeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELV---KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~---~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.   +.||+|+||.||++.+..+++.||+|++...  ......+|+..++.+. |||++++++++.+.+..+++|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~   85 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM   85 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence            467775   7899999999999999999999999998753  3466778999999987 999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-CCcEEEeecCCcccccCCC-C
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHS-R  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-~~~v~l~dfg~a~~~~~~~-~  155 (181)
                      |++++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++ ...++|+|||++....... .
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            9999999999998888999999999999999999999999999999999999996543 2369999999997544332 2


Q ss_pred             CCcccCCCCccCcccccCCccCCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .....+++.|+|||++.+..++++
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~  189 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDES  189 (325)
T ss_dssp             ------------------CCCCHH
T ss_pred             ccccCCCcCccCHHHhcCCCCCCc
Confidence            344568999999999988877643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.5e-36  Score=219.42  Aligned_cols=176  Identities=32%  Similarity=0.494  Sum_probs=154.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||++.+..+++.+++|++.....    ..+.+.+|+.+++.++|+|++++++++.+.+..+++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            589999999999999999999999999999999875432    2356788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~  156 (181)
                      |++++++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||++++++  .++|+|||++...... ...
T Consensus        95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A           95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCSTTCCB
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC--CEEEEeccCceecccCcccc
Confidence            9999999999888878899999999999999999999999999999999999997555  4999999998765433 233


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+++.|+|||.+.+..++.+
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~  195 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHSFE  195 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBCTH
T ss_pred             ccccCCCCcCCcchhccCCCCch
Confidence            44578999999999988776653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.6e-37  Score=222.01  Aligned_cols=172  Identities=34%  Similarity=0.587  Sum_probs=144.5

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---------------------------ccHHHHHHHHHHh
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---------------------------IDENVAREIINHR   53 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---------------------------~~~~~~~e~~~~~   53 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.....                           ..+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4789999999999999999999999999999999865421                           1246889999999


Q ss_pred             hCCCCCeeEEEEeEEc--CCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEe
Q 030211           54 SLRHPNIIRFKEVVLT--PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLL  131 (181)
Q Consensus        54 ~~~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i  131 (181)
                      .++|||++++++++.+  .+..+++|||+++++|.+.. ....+++..++.++.|++.||.+||++|++|+||+|+||++
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            9999999999999987  56799999999999988754 34579999999999999999999999999999999999999


Q ss_pred             ccCCCCcEEEeecCCcccccCCC-CCCcccCCCCccCcccccCCc
Q 030211          132 DGSAAPRLKICDFGYSKSSVLHS-RPKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       132 ~~~~~~~v~l~dfg~a~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  175 (181)
                      +.++  .++|+|||++....... ......+++.|+|||.+.+..
T Consensus       171 ~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  213 (298)
T 2zv2_A          171 GEDG--HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR  213 (298)
T ss_dssp             CTTS--CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTC
T ss_pred             CCCC--CEEEecCCCccccccccccccCCcCCccccChhhhccCC
Confidence            7555  49999999997654332 233457899999999997654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.6e-37  Score=222.32  Aligned_cols=174  Identities=31%  Similarity=0.516  Sum_probs=144.8

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      |++|++.+.||+|+||.||+|.+ .+++.+|+|.+.....   ..+.+.+|+.+++.++|||++++++++.+.+..+++|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            68999999999999999999998 5688999999865432   2367889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CC
Q 030211           78 EYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SR  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~  155 (181)
                      |++++ +|.+.+... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++...... ..
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCTTHHHHHCC----
T ss_pred             EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEEeECccccccCccccc
Confidence            99975 888877654 5799999999999999999999999999999999999997555  4999999998754322 23


Q ss_pred             CCcccCCCCccCcccccCC-ccCC
Q 030211          156 PKSTVGTPAYIAPEVLSRR-EYDG  178 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~-~~~~  178 (181)
                      .....+++.|+|||++.+. .++.
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~  180 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYST  180 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCT
T ss_pred             cccccccccccCchheeCCCCCCc
Confidence            3445789999999999764 3544

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.5e-37  Score=236.65  Aligned_cols=173  Identities=27%  Similarity=0.392  Sum_probs=143.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcC------Ce
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTP------TH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~------~~   72 (181)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....   ...+.+.+|+.+++.++||||+++++++...      +.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            68999999999999999999999999999999987542   2235678899999999999999999999655      45


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      +++||||+.+ .+.+.+..  .+++..++.++.|++.||+|||++||+||||||+||+++.++  .++|+|||+|+....
T Consensus       142 ~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          142 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCCC-----
T ss_pred             EEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC--CEEEEEEEeeeecCC
Confidence            7999999966 56666543  489999999999999999999999999999999999997555  499999999987666


Q ss_pred             CCCCCcccCCCCccCcccccCCccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ........+|+.|+|||++.+..|+.+
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~  243 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILGMGYKEN  243 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTTCCCCTT
T ss_pred             CcccCCCcccccccCHHHHcCCCCCHH
Confidence            556667789999999999999888765

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-36  Score=219.63  Aligned_cols=172  Identities=34%  Similarity=0.533  Sum_probs=145.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|+||.||++.+..++..+++|.+.....  ..+.+.+|+.+++.++|||++++++++.+.+..+++||+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            579999999999999999999999999999999876532  246788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc-CCCCcEEEeecCCcccccCCC
Q 030211           80 AAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        80 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~-~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +++++|.+.+..    ...+++..++.++.|++.||.+||++|++|+||+|+||++++ +..+.++|+|||++.......
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~  181 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE  181 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence            999999887743    367999999999999999999999999999999999999954 334569999999997665555


Q ss_pred             CCCcccCCCCccCcccccC
Q 030211          155 RPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~  173 (181)
                      ......+++.|+|||.+.+
T Consensus       182 ~~~~~~~t~~y~aPE~~~~  200 (285)
T 3is5_A          182 HSTNAAGTALYMAPEVFKR  200 (285)
T ss_dssp             -----CTTGGGCCHHHHTT
T ss_pred             cCcCcccccCcCChHHhcc
Confidence            5566779999999999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.4e-36  Score=223.00  Aligned_cols=175  Identities=29%  Similarity=0.452  Sum_probs=136.2

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+....  ...+.+.+|+.+++.++|||++++++++.+++..+++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            368999999999999999999999999999999987543  234678899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           79 YAAGGELFDRICNA------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        79 ~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      |++ ++|.+++...      ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++.....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGI  160 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCSSCEETTS
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC--CEEECcCccceecCC
Confidence            997 4888877543      3589999999999999999999999999999999999997555  499999999976543


Q ss_pred             C-CCCCcccCCCCccCcccccCC-ccCC
Q 030211          153 H-SRPKSTVGTPAYIAPEVLSRR-EYDG  178 (181)
Q Consensus       153 ~-~~~~~~~~~~~~~aPE~~~~~-~~~~  178 (181)
                      . .......+++.|+|||++.+. .+++
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~  188 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMGSRTYST  188 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTTCCCCCT
T ss_pred             CcccCCCCcccccccCchHhhCCCCCCc
Confidence            2 334456789999999999764 4554

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.5e-37  Score=233.06  Aligned_cols=174  Identities=29%  Similarity=0.436  Sum_probs=146.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcC-----CeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTP-----THL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~   73 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......   .+.+.+|+.+++.++|+|++++++++...     +..
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            6899999999999999999999999999999998754322   35788999999999999999999999876     579


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      |+|||+++ ++|.+.+.....+++..++.++.|++.||.|||++|++||||||+||+++.++  .++|+|||+|+.....
T Consensus       106 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~--~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC--SVKVCDFGLARTINSE  182 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEEC---
T ss_pred             EEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC--CEEEccCCCccccccc
Confidence            99999986 59999998877899999999999999999999999999999999999997555  4999999999765433


Q ss_pred             C-----------------------CCCcccCCCCccCcccc-cCCccCC
Q 030211          154 S-----------------------RPKSTVGTPAYIAPEVL-SRREYDG  178 (181)
Q Consensus       154 ~-----------------------~~~~~~~~~~~~aPE~~-~~~~~~~  178 (181)
                      .                       ......+|+.|+|||++ ....++.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~  231 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK  231 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCT
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCc
Confidence            2                       12456789999999986 4455654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.4e-37  Score=238.74  Aligned_cols=176  Identities=39%  Similarity=0.582  Sum_probs=156.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....    ...+.+.+|+.+++.++|||++++++++.+.+..+++|
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            57999999999999999999999999999999986542    23467889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc-CCCCcEEEeecCCcccccCCCCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~-~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |++.+++|.+.+.....+++..++.++.|++.||.|||++|++|+||+|+||+++. +..+.++|+|||++.........
T Consensus       106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~  185 (484)
T 3nyv_A          106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM  185 (484)
T ss_dssp             CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSH
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccccc
Confidence            99999999999988889999999999999999999999999999999999999953 23456999999999766655555


Q ss_pred             CcccCCCCccCcccccCCccCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ....|++.|+|||++.+ .+++
T Consensus       186 ~~~~gt~~y~aPE~~~~-~~~~  206 (484)
T 3nyv_A          186 KDKIGTAYYIAPEVLHG-TYDE  206 (484)
T ss_dssp             HHHTTGGGTCCHHHHHT-CCCT
T ss_pred             ccCCCCccccCceeecC-CCCC
Confidence            56679999999999875 4554

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.3e-36  Score=224.71  Aligned_cols=176  Identities=32%  Similarity=0.494  Sum_probs=154.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||++.+..+++.+++|++.....    ..+.+.+|+.+++.++|+|++++++++.+.+..+++|
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            589999999999999999999999999999999875432    2356788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~  156 (181)
                      ||+.+++|.+++.....+++..++.++.|++.+|.+||++|++|+||+|+||+++.++  .++|+|||++...... ...
T Consensus       121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSTTCCB
T ss_pred             ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC--CEEEeeccCceecccCcccc
Confidence            9999999999988878899999999999999999999999999999999999997555  4999999999765433 233


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....+++.|+|||++.+..++.+
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~  221 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGHSFE  221 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCBCTH
T ss_pred             cccCCCccccCHHHhccCCCCch
Confidence            44578999999999988777643

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2e-36  Score=217.90  Aligned_cols=174  Identities=45%  Similarity=0.745  Sum_probs=145.7

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|++|.||++.+..+++.|++|++....    ...+.+.+|+..++.++|||++++++++.+.+..+++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            368999999999999999999999899999999986532    2345788899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      ||++++++|.+++..+..+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++.........
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~  167 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFL  167 (276)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS--CEEECCCCGGGCCCC----
T ss_pred             EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC--CEEEeecccccccCCCcce
Confidence            99999999999998888899999999999999999999999999999999999997555  4999999999766555545


Q ss_pred             CcccCCCCccCcccccCCcc
Q 030211          157 KSTVGTPAYIAPEVLSRREY  176 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~  176 (181)
                      ....+++.|+|||.+.+..+
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~  187 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGRLY  187 (276)
T ss_dssp             ---------CCTGGGTTSCC
T ss_pred             ecccCCccccCHHHHcCCCC
Confidence            55678999999999987654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=9.3e-37  Score=225.09  Aligned_cols=175  Identities=27%  Similarity=0.268  Sum_probs=151.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.+++.+ +|+|++++++++...+..+++||++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            57999999999999999999999999999999987543 345688999999999 9999999999999999999999999


Q ss_pred             CCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCC---CcEEEeecCCcccccCCCC-
Q 030211           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA---PRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~---~~v~l~dfg~a~~~~~~~~-  155 (181)
                       +++|.+++.. ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.   ..++|+|||++........ 
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~  166 (330)
T 2izr_A           88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK  166 (330)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence             8899998876 358999999999999999999999999999999999999964432   2399999999976433322 


Q ss_pred             -------CCcccCCCCccCcccccCCccCC
Q 030211          156 -------PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       156 -------~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                             .....||+.|+|||++.+..+++
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  196 (330)
T 2izr_A          167 KHIPYREHKSLTGTARYMSINTHLGKEQSR  196 (330)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCH
T ss_pred             ccccccccCCcCCCccccChHHHcCCCCCc
Confidence                   24567999999999999887764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.5e-37  Score=235.31  Aligned_cols=174  Identities=28%  Similarity=0.440  Sum_probs=136.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcC-----CeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTP-----THL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~   73 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......   .+.+.+|+.+++.++||||+++++++...     +.+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            5899999999999999999999999999999998654322   35688999999999999999999999543     569


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      |++||++ +++|...+.....+++..++.++.||+.||.|||++||+||||||+||+++.++  .++|+|||+|+.....
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~--~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC--SVKVCDFGLARTVDYP  209 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC--CEEECCCTTCBCTTSC
T ss_pred             EEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC--CEeecccccchhccCc
Confidence            9999988 568988888878899999999999999999999999999999999999997555  4999999999764322


Q ss_pred             C----------------------------CCCcccCCCCccCccccc-CCccCC
Q 030211          154 S----------------------------RPKSTVGTPAYIAPEVLS-RREYDG  178 (181)
Q Consensus       154 ~----------------------------~~~~~~~~~~~~aPE~~~-~~~~~~  178 (181)
                      .                            ......||+.|+|||++. ...++.
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~  263 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE  263 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCT
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCc
Confidence            1                            223456799999999864 555654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.1e-37  Score=220.43  Aligned_cols=174  Identities=25%  Similarity=0.416  Sum_probs=151.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|+||.||++.+.. ++.||+|++.......+.+.+|+.+++.++|||++++++++.+.+..+++|||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            589999999999999999999874 6779999998776667789999999999999999999999999999999999999


Q ss_pred             CCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC--CCCc
Q 030211           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPKS  158 (181)
Q Consensus        82 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~--~~~~  158 (181)
                      +++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||++.......  ....
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~  166 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQYTSSTG  166 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG--CEEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC--CEEeccccccccccccccccccC
Confidence            99999988654 4689999999999999999999999999999999999996555  49999999987543222  2333


Q ss_pred             ccCCCCccCcccccCCccCC
Q 030211          159 TVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ..+++.|+|||.+.+..+++
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~  186 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFSRYSS  186 (269)
T ss_dssp             TTCCGGGCCHHHHHHCCCCH
T ss_pred             cccccccCCHHHhcCCCCCc
Confidence            45677899999998777664

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-36  Score=218.67  Aligned_cols=175  Identities=29%  Similarity=0.435  Sum_probs=151.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|+||.||++.+. ++..||+|++.......+.+.+|+.++..++|||++++++++.+.+..+++||+++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            68999999999999999999887 46679999998776667789999999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--CCc
Q 030211           82 GGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PKS  158 (181)
Q Consensus        82 ~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--~~~  158 (181)
                      +++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++.+.  .++|+|||++........  ...
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~  164 (268)
T 3sxs_A           87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL--CVKVSDFGMTRYVLDDQYVSSVG  164 (268)
T ss_dssp             TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC--CEEECCTTCEEECCTTCEEECCS
T ss_pred             CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC--CEEEccCccceecchhhhhcccC
Confidence            999999887654 599999999999999999999999999999999999997555  499999999875433322  223


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..+++.|+|||.+.+..++++
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~  185 (268)
T 3sxs_A          165 TKFPVKWSAPEVFHYFKYSSK  185 (268)
T ss_dssp             CCCCGGGCCHHHHHHSEEETT
T ss_pred             CCcCcccCCHHHHhccCCchh
Confidence            345678999999988777654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1e-36  Score=223.15  Aligned_cols=174  Identities=33%  Similarity=0.529  Sum_probs=142.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++.+.||+|+||.||+|.+.  ++.||+|++......   .+.+.+|+.+++.++|||++++++++.+.+..+++||
T Consensus        37 ~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           37 CDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            68999999999999999999874  788999998765432   2467889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhcC--eeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           79 YAAGGELFDRICNAGR---FSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~g--i~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      |+.+++|.+++.....   +++..++.++.|++.||++||++|  ++|+||+|+||+++.+.  .++|+|||++......
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~--~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY--TVKVCDFGLSRLKAST  192 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC--CEEECCCC--------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC--cEEECCCCCCcccccc
Confidence            9999999998876543   999999999999999999999999  99999999999997555  4999999998744332


Q ss_pred             C-CCCcccCCCCccCcccccCCccCCC
Q 030211          154 S-RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ~-~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      . ......|++.|+|||.+.+..++++
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~  219 (309)
T 3p86_A          193 FLSSKSAAGTPEWMAPEVLRDEPSNEK  219 (309)
T ss_dssp             ---------CCTTSCHHHHTTCCCCTT
T ss_pred             ccccccCCCCccccChhhhcCCCCCch
Confidence            2 2344578999999999999888765

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.9e-37  Score=226.53  Aligned_cols=177  Identities=33%  Similarity=0.474  Sum_probs=145.3

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +++|++.+.||+|+||+||+|.+..+++.||+|++......   .+.+.+|+.+++.++|||++++++++.+++..+++|
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999998754322   356778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc---CCCCcEEEeecCCcccccCC-
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG---SAAPRLKICDFGYSKSSVLH-  153 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~---~~~~~v~l~dfg~a~~~~~~-  153 (181)
                      ||+++ +|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||+++.   +....++|+|||++...... 
T Consensus       113 e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~  191 (329)
T 3gbz_A          113 EYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI  191 (329)
T ss_dssp             ECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred             ecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence            99975 99999988888999999999999999999999999999999999999953   23346999999999754322 


Q ss_pred             CCCCcccCCCCccCcccccCCc-cCC
Q 030211          154 SRPKSTVGTPAYIAPEVLSRRE-YDG  178 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~-~~~  178 (181)
                      .......+++.|+|||++.+.. ++.
T Consensus       192 ~~~~~~~~t~~y~aPE~~~~~~~~~~  217 (329)
T 3gbz_A          192 RQFTHEIITLWYRPPEILLGSRHYST  217 (329)
T ss_dssp             --------CCTTCCHHHHTTCCCCCT
T ss_pred             cccCCCcCCccccCHHHhcCCCCCCc
Confidence            3334456899999999998744 554

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.7e-37  Score=233.37  Aligned_cols=171  Identities=37%  Similarity=0.553  Sum_probs=140.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---------IDENVAREIINHRSLRHPNIIRFKEVVLTPTH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~   72 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....         ....+.+|+.+++.++|||++++++++.. +.
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~  213 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED  213 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence            579999999999999999999999999999999875321         12357889999999999999999999754 56


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-CCcEEEeecCCccccc
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSV  151 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-~~~v~l~dfg~a~~~~  151 (181)
                      .+++|||+++++|.+.+..+..+++..++.++.|++.||.|||++|++|+||||+||+++.+. ...++|+|||+++...
T Consensus       214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  293 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  293 (419)
T ss_dssp             EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred             eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence            899999999999999988888999999999999999999999999999999999999996433 3469999999998766


Q ss_pred             CCCCCCcccCCCCccCcccccC
Q 030211          152 LHSRPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~  173 (181)
                      .........|++.|+|||++..
T Consensus       294 ~~~~~~~~~gt~~y~aPE~~~~  315 (419)
T 3i6u_A          294 ETSLMRTLCGTPTYLAPEVLVS  315 (419)
T ss_dssp             -----------CTTCCTTTTC-
T ss_pred             CCccccccCCCCCccCceeeec
Confidence            5555566789999999999863

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.3e-36  Score=225.90  Aligned_cols=170  Identities=33%  Similarity=0.511  Sum_probs=151.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---------cHHHHHHHHHHhhC-CCCCeeEEEEeEEcCC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---------DENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---------~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~   71 (181)
                      ++|++.+.||+|++|.||+|.+..+|+.||+|++......         .+.+.+|+.++..+ +|||++++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            4799999999999999999999988999999998754321         24567889999988 7999999999999999


Q ss_pred             eEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      ..+++|||+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||++++++  .++|+|||++....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~--~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEEEecCcccccC
Confidence            9999999999999999998878899999999999999999999999999999999999997555  49999999998766


Q ss_pred             CCCCCCcccCCCCccCcccccC
Q 030211          152 LHSRPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~  173 (181)
                      .........|++.|+|||++.+
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~~  273 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAPEILKC  273 (365)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHH
T ss_pred             CCcccccCCCCCCccChhhccc
Confidence            6666666789999999999863

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-36  Score=222.15  Aligned_cols=173  Identities=23%  Similarity=0.300  Sum_probs=141.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccccc---HHHHHHHHHH-hhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINH-RSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~---~~~~~e~~~~-~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.......   .....++..+ ...+|+|++++++++.+.+..+++|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999999999999999876543222   2344444444 4448999999999999999999999


Q ss_pred             eecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           78 EYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |++ +++|.+.+... ..+++..++.++.|++.||+|||++|++|+||||+||+++.+..  ++|+|||++.........
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~  213 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG  213 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC-----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCC
Confidence            999 55887776554 46999999999999999999999999999999999999976554  999999999876665556


Q ss_pred             CcccCCCCccCcccccCCccCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ....|++.|+|||++.+ .+++
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~~~  234 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SYGT  234 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CCST
T ss_pred             cccCCCccccCHhHhcC-CCCc
Confidence            66679999999999876 5554

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-36  Score=229.59  Aligned_cols=174  Identities=36%  Similarity=0.569  Sum_probs=140.8

Q ss_pred             ccceee-eeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHH-hhCCCCCeeEEEEeEEc----CCeEEE
Q 030211            2 EKYELV-KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-RSLRHPNIIRFKEVVLT----PTHLAI   75 (181)
Q Consensus         2 ~~y~~~-~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~-~~~~~~~i~~~~~~~~~----~~~~~~   75 (181)
                      ++|.+. +.||+|+||.||++.+..+++.||+|++...    ....+|+.++ +..+|||++++++++..    .+.+++
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l  136 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI  136 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence            567777 7899999999999999999999999998642    4556777776 55689999999999876    567999


Q ss_pred             EEeecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-CCcEEEeecCCcccccC
Q 030211           76 VMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVL  152 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-~~~v~l~dfg~a~~~~~  152 (181)
                      ||||+.+++|.+++....  .+++..++.++.|++.||.|||++||+|+||||+||+++.+. .+.++|+|||+++....
T Consensus       137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            999999999999987643  599999999999999999999999999999999999997532 45699999999986655


Q ss_pred             CCCCCcccCCCCccCcccccCCccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ........+|+.|+|||++.+..++.+
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~  243 (400)
T 1nxk_A          217 HNSLTTPCYTPYYVAPEVLGPEKYDKS  243 (400)
T ss_dssp             ----------CTTCCGGGSCCCCSSSH
T ss_pred             CCccccCCCCCCccCHhhcCCCCCCCc
Confidence            555566788999999999988887754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.5e-36  Score=224.04  Aligned_cols=176  Identities=31%  Similarity=0.477  Sum_probs=147.7

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +++|++.+.||+|+||.||++.+..+++.||+|++......   .+.+.+|+.+++.++|||++++++++.+.+..+++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            47999999999999999999999999999999998654332   245778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~  156 (181)
                      |++++++|..+......+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++...... ...
T Consensus       104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  181 (331)
T 4aaa_A          104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEVY  181 (331)
T ss_dssp             ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCTTC----------
T ss_pred             ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC--cEEEEeCCCceeecCCcccc
Confidence            9999888888777677899999999999999999999999999999999999997555  5999999999754332 333


Q ss_pred             CcccCCCCccCcccccCC-ccCC
Q 030211          157 KSTVGTPAYIAPEVLSRR-EYDG  178 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~-~~~~  178 (181)
                      ....+++.|+|||++.+. .+++
T Consensus       182 ~~~~~t~~y~aPE~~~~~~~~~~  204 (331)
T 4aaa_A          182 DDEVATRWYRAPELLVGDVKYGK  204 (331)
T ss_dssp             --CCCCCTTCCHHHHTTCTTCCT
T ss_pred             CCCcCCccccCcccccCCCCcch
Confidence            445789999999999875 4444

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-36  Score=227.05  Aligned_cols=176  Identities=26%  Similarity=0.337  Sum_probs=148.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-------cCCcEEEEEEcccccc--ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-------ETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-------~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~   71 (181)
                      ++|++.+.||+|+||.||+|.+.       .++..||+|++.....  ..+.+.+|+.+++.+ +|||++++++++.+.+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            58999999999999999999874       2355799999876432  235788999999999 8999999999999999


Q ss_pred             eEEEEEeecCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC
Q 030211           72 HLAIVMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~  135 (181)
                      .++++|||+++++|.+++....                .++...++.++.|++.||+|||++|++|+||||+||+++.++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~  240 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  240 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence            9999999999999999987543                478999999999999999999999999999999999997555


Q ss_pred             CCcEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          136 APRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       136 ~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                        .++|+|||++........   .....+++.|+|||++.+..++++
T Consensus       241 --~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  285 (370)
T 2psq_A          241 --VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ  285 (370)
T ss_dssp             --CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH
T ss_pred             --CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH
Confidence              499999999975443322   223456788999999988877653

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2e-36  Score=218.57  Aligned_cols=173  Identities=27%  Similarity=0.427  Sum_probs=152.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEc------------
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT------------   69 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~------------   69 (181)
                      ++|++.+.||+|++|.||+|.+..+++.|++|.+....   +.+.+|+.++..++|||++++++++..            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   87 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS   87 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence            47999999999999999999999889999999987543   467789999999999999999998864            


Q ss_pred             ----CCeEEEEEeecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEee
Q 030211           70 ----PTHLAIVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICD  143 (181)
Q Consensus        70 ----~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~d  143 (181)
                          .+..+++|||+++++|.+++...  ..+++..++.++.|++.||.+||++|++|+||+|+||+++++.  .++|+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~D  165 (284)
T 2a19_B           88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGD  165 (284)
T ss_dssp             -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECC
T ss_pred             cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC--CEEECc
Confidence                34589999999999999988653  5799999999999999999999999999999999999997555  499999


Q ss_pred             cCCcccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          144 FGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       144 fg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ||++.............+++.|+|||.+.+..++++
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  201 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE  201 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTH
T ss_pred             chhheeccccccccccCCcccccChhhhccCCCcch
Confidence            999987666655666779999999999988877654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.5e-36  Score=219.65  Aligned_cols=170  Identities=36%  Similarity=0.520  Sum_probs=151.6

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----------cccHHHHHHHHHHhhCC-CCCeeEEEEeEEc
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----------KIDENVAREIINHRSLR-HPNIIRFKEVVLT   69 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----------~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~   69 (181)
                      +++|++.+.||+|++|.||++.+..+++.||+|++....          ...+.+.+|+.++..+. |||++++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            478999999999999999999999999999999986542          11246778999999885 9999999999999


Q ss_pred             CCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           70 PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        70 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      .+..+++||++++++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.  ++|+|||++..
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~  173 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ  173 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchhh
Confidence            9999999999999999999988888999999999999999999999999999999999999975554  99999999987


Q ss_pred             ccCCCCCCcccCCCCccCccccc
Q 030211          150 SVLHSRPKSTVGTPAYIAPEVLS  172 (181)
Q Consensus       150 ~~~~~~~~~~~~~~~~~aPE~~~  172 (181)
                      ...........+++.|+|||++.
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~  196 (298)
T 1phk_A          174 LDPGEKLREVCGTPSYLAPEIIE  196 (298)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHH
T ss_pred             cCCCcccccccCCccccCHHHhc
Confidence            66655556677999999999985

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.8e-37  Score=225.88  Aligned_cols=175  Identities=25%  Similarity=0.341  Sum_probs=146.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCc---EEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKE---LVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~---~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|++.+.||+|+||.||++.+..++.   .||+|++.....  ..+.+.+|+.++..++|||++++++++.+++..+++
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            589999999999999999999975544   599999876432  235788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      |||+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.+.  .++|+|||++........
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~  206 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL--VCKVSDFGLSRVLEDDPD  206 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCSSCEECC----
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC--CEEECCCCcccccccCcc
Confidence            9999999999988654 4799999999999999999999999999999999999997555  499999999976543322


Q ss_pred             C----CcccCCCCccCcccccCCccCC
Q 030211          156 P----KSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       156 ~----~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      .    ....+++.|+|||++.+..+++
T Consensus       207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~  233 (325)
T 3kul_A          207 AAYTTTGGKIPIRWTAPEAIAFRTFSS  233 (325)
T ss_dssp             CCEECC---CCGGGSCHHHHHHCEECH
T ss_pred             ceeeccCCCCcccccCHhHhcCCCCCc
Confidence            2    1223567899999998776654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.6e-36  Score=220.24  Aligned_cols=174  Identities=29%  Similarity=0.489  Sum_probs=152.1

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      .|+..+.||+|+||.||+|.+..+++.||+|++...... .+.+.+|+.+++.++|||++++++++...+..+++|||++
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            377888999999999999999988999999998755433 4678899999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCCccc
Q 030211           82 GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKSTV  160 (181)
Q Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~~~~  160 (181)
                      +++|.+++. ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++....... ......
T Consensus       126 ~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~  202 (321)
T 2c30_A          126 GGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG--RVKLSDFGFCAQISKDVPKRKSLV  202 (321)
T ss_dssp             SCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSSSCCBCCCC
T ss_pred             CCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--cEEEeeeeeeeecccCcccccccc
Confidence            999998775 45799999999999999999999999999999999999997555  49999999987654332 234567


Q ss_pred             CCCCccCcccccCCccCCC
Q 030211          161 GTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       161 ~~~~~~aPE~~~~~~~~~~  179 (181)
                      |++.|+|||++.+..++++
T Consensus       203 gt~~y~aPE~~~~~~~~~~  221 (321)
T 2c30_A          203 GTPYWMAPEVISRSLYATE  221 (321)
T ss_dssp             SCGGGCCHHHHTTCCBCTH
T ss_pred             CCccccCHhhhcCCCCCch
Confidence            9999999999998887754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.9e-36  Score=221.03  Aligned_cols=176  Identities=35%  Similarity=0.597  Sum_probs=151.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+++.++|||++++++++.+.+..+++||++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            579999999999999999999998999999999876543 2456889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc-CCCCcEEEeecCCcccccCCCCCCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~-~~~~~v~l~dfg~a~~~~~~~~~~~~  159 (181)
                      ++++|.+.+.....+++..++.++.|++.||.+||++|++|+||+|+||++.. +..+.++|+|||++..... ......
T Consensus        89 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~  167 (304)
T 2jam_A           89 SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMSTA  167 (304)
T ss_dssp             CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-BTTHHH
T ss_pred             CCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-Cccccc
Confidence            99999999888888999999999999999999999999999999999999932 3345699999999864322 233345


Q ss_pred             cCCCCccCcccccCCccCC
Q 030211          160 VGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~  178 (181)
                      .+++.|+|||.+.+..+++
T Consensus       168 ~~~~~y~aPE~~~~~~~~~  186 (304)
T 2jam_A          168 CGTPGYVAPEVLAQKPYSK  186 (304)
T ss_dssp             HSCCCBCCTTTBSSCSCCH
T ss_pred             cCCCCccChHHhccCCCCc
Confidence            6899999999998887764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.6e-36  Score=219.20  Aligned_cols=174  Identities=24%  Similarity=0.398  Sum_probs=148.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|+||.||++.+. ++..||+|++.......+.+.+|+.++..++|||++++++++.+.+..+++||++.
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            58999999999999999999887 46789999998776667889999999999999999999999999999999999999


Q ss_pred             CCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC--CCCc
Q 030211           82 GGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPKS  158 (181)
Q Consensus        82 ~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~--~~~~  158 (181)
                      +++|.+++.. ...+++..++.++.|++.+|.+||++|++|+||+|+||+++.+.  .++|+|||++.......  ....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~  180 (283)
T 3gen_A          103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG--VVKVSDFGLSRYVLDDEYTSSVG  180 (283)
T ss_dssp             TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS--CEEECSTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC--CEEEccccccccccccccccccC
Confidence            9999998866 45799999999999999999999999999999999999997555  49999999987543221  1223


Q ss_pred             ccCCCCccCcccccCCccCC
Q 030211          159 TVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ..+++.|+|||.+.+..+++
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~  200 (283)
T 3gen_A          181 SKFPVRWSPPEVLMYSKFSS  200 (283)
T ss_dssp             TTSCGGGCCHHHHHHCCCSH
T ss_pred             CccCcccCCHHHhccCCCCc
Confidence            44678899999998777654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.5e-37  Score=226.30  Aligned_cols=177  Identities=33%  Similarity=0.532  Sum_probs=147.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc------ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG------RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~------~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...      ....+.+.+|+.+++.++|||++++++++.+.+..++
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            5799999999999999999999999999999998653      2334678899999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 030211           76 VMEYAAGGELFDRICN----------------------------------------AGRFSEDEGRYFFQQLISGVNYCH  115 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~----------------------------------------~~~~~~~~~~~~~~~i~~~l~~lh  115 (181)
                      +|||+++++|.+++..                                        ...+++..++.++.|++.||.+||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            9999999999988741                                        112357788899999999999999


Q ss_pred             hcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-----CCcccCCCCccCcccccC--CccCC
Q 030211          116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-----PKSTVGTPAYIAPEVLSR--REYDG  178 (181)
Q Consensus       116 ~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-----~~~~~~~~~~~aPE~~~~--~~~~~  178 (181)
                      ++|++|+||+|+||+++.+....++|+|||++........     .....+++.|+|||.+.+  ..+++
T Consensus       186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            9999999999999999766655799999999975433221     334578999999999975  45544

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3e-36  Score=220.93  Aligned_cols=172  Identities=28%  Similarity=0.417  Sum_probs=144.7

Q ss_pred             ccceee-eeeCCccceeEEEEEEccCCcEEEEEEccccccc-cHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELV-KDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~-~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++. +.||+|+||.||+|.+..+++.||+|++...... .+.+.+|+.++.++ +|||++++++++.+.+..+++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            578885 7899999999999999999999999999765433 46788999999884 79999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCC-CcEEEeecCCcccccCCC---
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA-PRLKICDFGYSKSSVLHS---  154 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~-~~v~l~dfg~a~~~~~~~---  154 (181)
                      ++++++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ..++|+|||++.......   
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (316)
T 2ac3_A           92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS  171 (316)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred             cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence            9999999999988888999999999999999999999999999999999999965443 359999999986543221   


Q ss_pred             -----CCCcccCCCCccCcccccC
Q 030211          155 -----RPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       155 -----~~~~~~~~~~~~aPE~~~~  173 (181)
                           ......+++.|+|||++.+
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~  195 (316)
T 2ac3_A          172 PISTPELLTPCGSAEYMAPEVVEA  195 (316)
T ss_dssp             ----------CCSGGGCCHHHHHH
T ss_pred             cccccccccccCCcCccChHHhhc
Confidence                 1223458999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.4e-37  Score=221.15  Aligned_cols=175  Identities=23%  Similarity=0.313  Sum_probs=153.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|++|.||++.+..++..|++|.+.......+.+.+|+.+++.++|||++++++++.+.+..+++||++.
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   92 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   92 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence            57999999999999999999999999999999998766666788999999999999999999999999999999999999


Q ss_pred             CCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--CC
Q 030211           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PK  157 (181)
Q Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--~~  157 (181)
                      +++|.+++...  ..+++..++.++.|++.+|.+||++|++|+||+|+||+++.+.  .++|+|||++........  ..
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~  170 (288)
T 3kfa_A           93 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHA  170 (288)
T ss_dssp             TEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG--CEEECCCCGGGTSCSSSSEEET
T ss_pred             CCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC--CEEEccCccceeccCCcccccc
Confidence            99999998764  3599999999999999999999999999999999999996555  499999999875443322  22


Q ss_pred             cccCCCCccCcccccCCccCC
Q 030211          158 STVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ...+++.|+|||.+.+..+++
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~  191 (288)
T 3kfa_A          171 GAKFPIKWTAPESLAYNKFSI  191 (288)
T ss_dssp             TEEECGGGCCHHHHHHCCCCH
T ss_pred             CCccccCcCChhhhccCCCCc
Confidence            234678899999998777654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6e-36  Score=222.39  Aligned_cols=175  Identities=30%  Similarity=0.465  Sum_probs=146.0

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcC-------
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTP-------   70 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-------   70 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.....   ....+.+|+.+++.++|||++++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            4789999999999999999999999999999998865432   235778999999999999999999999873       


Q ss_pred             -CeEEEEEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211           71 -THLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus        71 -~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                       +..+++|||+++ ++.+.+... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++.
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~a~  172 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLAR  172 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCE
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--CEEEccchhcc
Confidence             468999999976 666666543 5799999999999999999999999999999999999997555  49999999997


Q ss_pred             cccC-----CCCCCcccCCCCccCcccccCC-ccCC
Q 030211          149 SSVL-----HSRPKSTVGTPAYIAPEVLSRR-EYDG  178 (181)
Q Consensus       149 ~~~~-----~~~~~~~~~~~~~~aPE~~~~~-~~~~  178 (181)
                      ....     ........+++.|+|||++.+. .+++
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  208 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP  208 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCc
Confidence            5432     2223345689999999998763 4554

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.7e-36  Score=226.35  Aligned_cols=173  Identities=34%  Similarity=0.467  Sum_probs=135.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCC-CCCeeEEEEeEEcCC--eEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLR-HPNIIRFKEVVLTPT--HLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~--~~~~   75 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.....   ..+...+|+.++..+. |||++++++++...+  .+++
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            689999999999999999999999999999999865322   2356778999999997 999999999998654  7999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC---
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL---  152 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~---  152 (181)
                      ||||++ ++|...+.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++  .++|+|||+|+....   
T Consensus        89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC--HVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEESSSCCC
T ss_pred             EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC--CEEecCCccccccccccc
Confidence            999997 488877754 5789999999999999999999999999999999999997555  499999999975432   


Q ss_pred             -------------------CCCCCcccCCCCccCcccccC-CccCC
Q 030211          153 -------------------HSRPKSTVGTPAYIAPEVLSR-REYDG  178 (181)
Q Consensus       153 -------------------~~~~~~~~~~~~~~aPE~~~~-~~~~~  178 (181)
                                         ........+|+.|+|||++.+ ..++.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  210 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTK  210 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCT
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCC
Confidence                               111233578999999999986 45554

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.8e-36  Score=214.76  Aligned_cols=173  Identities=39%  Similarity=0.636  Sum_probs=152.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|++|.||+|.+..+++.|++|++.....  ..+.+.+|+.+++.++|||++++++++.+.+..+++||+
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            689999999999999999999998999999999865432  246788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC---CCC
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH---SRP  156 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~---~~~  156 (181)
                      +++++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||.+......   ...
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECEETTEECCB
T ss_pred             cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC--CEEEeeCCCccccCCCcchhcc
Confidence            99999999987777899999999999999999999999999999999999997555  4999999998754322   223


Q ss_pred             CcccCCCCccCcccccCCcc
Q 030211          157 KSTVGTPAYIAPEVLSRREY  176 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~  176 (181)
                      ....+++.|+|||.+.+..+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~  184 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREF  184 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSB
T ss_pred             cCCccccCccChHHHhcCCC
Confidence            44578999999999987665

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=224.31  Aligned_cols=175  Identities=29%  Similarity=0.499  Sum_probs=142.2

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      |++|++++.||+|+||.||+|.+..+++.||+|++......  ...+.+|+.+++.++|||++++++++.+.+..+++||
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            68999999999999999999999999999999998654322  2345578999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCC
Q 030211           79 YAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRP  156 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~  156 (181)
                      |+++ +|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++...... ...
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC--CEEECSSSEEECC-------
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC--CEEEccCcccccccCCcccc
Confidence            9974 8888776544 699999999999999999999999999999999999997555  4999999998754322 233


Q ss_pred             CcccCCCCccCcccccC-CccCC
Q 030211          157 KSTVGTPAYIAPEVLSR-REYDG  178 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~-~~~~~  178 (181)
                      ....+++.|+|||++.+ ..+++
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~  180 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYST  180 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCT
T ss_pred             ccccCcccccChhhhcCCCCCCc
Confidence            34578999999999876 44554

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.6e-36  Score=225.06  Aligned_cols=172  Identities=29%  Similarity=0.471  Sum_probs=144.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEc------------
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT------------   69 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~------------   69 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....   ...+|+.+++.++|||++++++++..            
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            689999999999999999999999999999998875433   23478999999999999999999844            


Q ss_pred             --------------------------CCeEEEEEeecCCCChHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHhcCe
Q 030211           70 --------------------------PTHLAIVMEYAAGGELFDRI----CNAGRFSEDEGRYFFQQLISGVNYCHSMQI  119 (181)
Q Consensus        70 --------------------------~~~~~~v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi  119 (181)
                                                ..+.+++|||+++ +|.+.+    .....+++..++.++.|++.||.|||++|+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi  162 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI  162 (383)
T ss_dssp             --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence                                      3348999999975 665544    345689999999999999999999999999


Q ss_pred             eeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccCCCCccCcccccCCc-cCC
Q 030211          120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRRE-YDG  178 (181)
Q Consensus       120 ~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~  178 (181)
                      +|+||+|+||+++. ..+.++|+|||+|.............+++.|+|||.+.+.. +++
T Consensus       163 ~H~Dikp~Nil~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  221 (383)
T 3eb0_A          163 CHRDIKPQNLLVNS-KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTP  221 (383)
T ss_dssp             ECSCCCGGGEEEET-TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCT
T ss_pred             ccCccCHHHEEEcC-CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCc
Confidence            99999999999962 23369999999998776666677778999999999988654 554

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.4e-36  Score=224.29  Aligned_cols=173  Identities=28%  Similarity=0.393  Sum_probs=139.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC------e
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPT------H   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~------~   72 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....   ..+.+.+|+.+++.++|||++++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            689999999999999999999999999999999875432   2356788999999999999999999998765      7


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      .+++||++.+ +|.+.+.  ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++.....
T Consensus       105 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGT  179 (371)
T ss_dssp             EEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCCCC------
T ss_pred             eEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC--CEEEEEeeccccccc
Confidence            8999999965 7777775  3589999999999999999999999999999999999997555  499999999976555


Q ss_pred             CCCCCcccCCCCccCcccccCCccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ........+++.|+|||++.+..++++
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~  206 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILGMGYKEN  206 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTT
T ss_pred             ccccCCceecCCccCHHHhcCCCCCch
Confidence            444556789999999999999888765

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.7e-36  Score=222.33  Aligned_cols=176  Identities=26%  Similarity=0.333  Sum_probs=147.7

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEE--EEEEcccc--ccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELV--AVKYIERG--RKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v--~~K~~~~~--~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +++|++.+.||+|+||.||+|.+..++..+  ++|.+...  ....+.+.+|+.++..+ +|||++++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            368999999999999999999998888755  89988653  22346788899999999 89999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcE
Q 030211           76 VMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL  139 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v  139 (181)
                      +||++++++|.+++....                .+++..++.++.|++.||.+||++|++|+||+|+||+++.+.  .+
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~--~~  181 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VA  181 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CE
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC--eE
Confidence            999999999999886643                699999999999999999999999999999999999997555  49


Q ss_pred             EEeecCCcccccCCCCCCcccCCCCccCcccccCCccCC
Q 030211          140 KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       140 ~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      +|+|||++.............+++.|+|||.+.+..+++
T Consensus       182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  220 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT  220 (327)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECH
T ss_pred             EEcccCcCccccccccccCCCCCccccChhhhccccCCc
Confidence            999999987544444444456788999999998766654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.4e-35  Score=214.30  Aligned_cols=170  Identities=26%  Similarity=0.416  Sum_probs=146.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++.....   ....+.+|+..+..+ +|||++++++++.+.+..+++|
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            579999999999999999999998999999999875422   235677888888888 9999999999999999999999


Q ss_pred             eecCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccC-----------------CC
Q 030211           78 EYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-----------------AA  136 (181)
Q Consensus        78 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~-----------------~~  136 (181)
                      |++++++|.+++...    ..+++..++.++.|++.||.+||++|++|+||+|+||+++.+                 ..
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            999999999988654    679999999999999999999999999999999999999643                 23


Q ss_pred             CcEEEeecCCcccccCCCCCCcccCCCCccCcccccCC
Q 030211          137 PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       137 ~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~  174 (181)
                      ..++|+|||.+......   ....+++.|+|||.+.+.
T Consensus       171 ~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~  205 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQEN  205 (289)
T ss_dssp             CCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTC
T ss_pred             eEEEEcccccccccCCc---cccCCCccccChhHhcCC
Confidence            36999999998754432   234589999999999865

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.3e-36  Score=224.25  Aligned_cols=177  Identities=16%  Similarity=0.222  Sum_probs=143.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC-----CcEEEEEEcccccc------------ccHHHHHHHHHHhhCCCCCeeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET-----KELVAVKYIERGRK------------IDENVAREIINHRSLRHPNIIRFK   64 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~-----~~~v~~K~~~~~~~------------~~~~~~~e~~~~~~~~~~~i~~~~   64 (181)
                      ++|++.+.||+|+||.||+|.+..+     ++.||+|++.....            .......++..+..++|+|+++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            4899999999999999999998764     57899999865431            112344455666778899999999


Q ss_pred             EeEEcC----CeEEEEEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcE
Q 030211           65 EVVLTP----THLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL  139 (181)
Q Consensus        65 ~~~~~~----~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v  139 (181)
                      +++...    ...+++|||+ +++|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||+++.+..+.+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~  193 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV  193 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence            998775    4589999999 88999988765 57999999999999999999999999999999999999984455669


Q ss_pred             EEeecCCcccccCCCCC--------CcccCCCCccCcccccCCccCCC
Q 030211          140 KICDFGYSKSSVLHSRP--------KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       140 ~l~dfg~a~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +|+|||+++........        ....||+.|+|||++.+..++++
T Consensus       194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  241 (364)
T 3op5_A          194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR  241 (364)
T ss_dssp             EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHH
T ss_pred             EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCch
Confidence            99999999754433221        23459999999999998877643

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.4e-36  Score=226.53  Aligned_cols=172  Identities=24%  Similarity=0.349  Sum_probs=149.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC--eEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPT--HLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~   77 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  ...+.+.+|+.+++.++|||++++++++.+.+  ..+++|
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            58999999999999999999999999999999987543  22466789999999999999999999998765  789999


Q ss_pred             eecCCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEe--ccCCCCcEEEeecCCcccccC
Q 030211           78 EYAAGGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLL--DGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i--~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ||+.+++|.+++....   .+++..++.++.|++.||.|||++|++|+||+|+||++  +++....++|+|||++.....
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~  168 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence            9999999999886543   39999999999999999999999999999999999998  223444699999999987666


Q ss_pred             CCCCCcccCCCCccCcccccC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~  173 (181)
                      ........|++.|+|||++.+
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~  189 (396)
T 4eut_A          169 DEQFVSLYGTEEYLHPDMYER  189 (396)
T ss_dssp             GGGSSCSSSCCTTCCHHHHHH
T ss_pred             CCccccccCCccccCHHHhhc
Confidence            555566779999999999865

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.5e-36  Score=226.34  Aligned_cols=174  Identities=32%  Similarity=0.478  Sum_probs=151.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....  ..+.+.+|+.+++.++|||++++++++.+++..+++|||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            589999999999999999999999999999999876432  236788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      +++++|.+++.....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++.  ++|+|||++..... .....
T Consensus       113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~~  189 (360)
T 3eqc_A          113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  189 (360)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HC---
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCccccc-ccccC
Confidence            99999999998888899999999999999999999996 9999999999999975554  99999999864422 23344


Q ss_pred             ccCCCCccCcccccCCccCC
Q 030211          159 TVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ..+++.|+|||++.+..++.
T Consensus       190 ~~gt~~y~aPE~~~~~~~~~  209 (360)
T 3eqc_A          190 FVGTRSYMSPERLQGTHYSV  209 (360)
T ss_dssp             -CCCCTTCCHHHHTTCCCSH
T ss_pred             CCCCCCeECHHHHcCCCCCc
Confidence            67899999999999887764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.4e-35  Score=215.95  Aligned_cols=175  Identities=30%  Similarity=0.494  Sum_probs=149.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.... ..+.+.+|+.++..++|||++++++++...+..+++||+++
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  107 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG  107 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence            57999999999999999999999999999999987643 35678899999999999999999999999999999999999


Q ss_pred             CCChHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCCcc
Q 030211           82 GGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKST  159 (181)
Q Consensus        82 ~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~~~  159 (181)
                      +++|.+++. ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++  .++|+|||++....... .....
T Consensus       108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~  185 (314)
T 3com_A          108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG--HAKLADFGVAGQLTDTMAKRNTV  185 (314)
T ss_dssp             TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECBTTBSCBCCC
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC--CEEEeecccchhhhhhccccCcc
Confidence            999999886 456899999999999999999999999999999999999997555  49999999987554332 23345


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+++.|+|||.+.+..++++
T Consensus       186 ~~~~~y~aPE~~~~~~~~~~  205 (314)
T 3com_A          186 IGTPFWMAPEVIQEIGYNCV  205 (314)
T ss_dssp             CSCGGGCCHHHHSSSCBCTT
T ss_pred             CCCCCccChhhcCCCCCCcc
Confidence            78999999999998887765

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.8e-36  Score=216.82  Aligned_cols=176  Identities=39%  Similarity=0.607  Sum_probs=154.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++.+.||+|++|.||+|.+..+++.|++|++....   ...+.+.+|+.+++.++|||++++++++.+.+..++++|
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            58999999999999999999999889999999986543   234678899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-CCcEEEeecCCcccccCCCCCC
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      ++.+++|.+.+.....+++..++.++.|++.||.+||++|++|+||+|+||+++.+. ...++|+|||++..........
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~  181 (287)
T 2wei_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK  181 (287)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCS
T ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccc
Confidence            999999999888778899999999999999999999999999999999999996533 3469999999987655555455


Q ss_pred             cccCCCCccCcccccCCccCC
Q 030211          158 STVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ...+++.|+|||.+.+. +++
T Consensus       182 ~~~~~~~y~aPE~~~~~-~~~  201 (287)
T 2wei_A          182 DRIGTAYYIAPEVLRGT-YDE  201 (287)
T ss_dssp             CHHHHHTTCCHHHHTTC-CCT
T ss_pred             cccCcccccChHHhcCC-CCC
Confidence            56689999999998753 443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.5e-36  Score=221.19  Aligned_cols=175  Identities=25%  Similarity=0.301  Sum_probs=149.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||.||++.+. +++.||+|.+..... ..+.+.+|+.+++.++|||++++++++.+.+..+++|||+
T Consensus        39 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  117 (321)
T 2qkw_B           39 NNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM  117 (321)
T ss_dssp             CCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred             hccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence            68999999999999999999975 588999998876533 2467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC--
Q 030211           81 AGGELFDRICNAG----RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--  154 (181)
Q Consensus        81 ~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~--  154 (181)
                      ++++|.+++....    .+++..++.++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||++.......  
T Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~  195 (321)
T 2qkw_B          118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF--VPKITDFGISKKGTELDQT  195 (321)
T ss_dssp             TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC--CEEECCCTTCEECSSSSCC
T ss_pred             CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC--CEEEeeccccccccccccc
Confidence            9999998886543    589999999999999999999999999999999999997555  59999999987543222  


Q ss_pred             -CCCcccCCCCccCcccccCCccCCC
Q 030211          155 -RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                       ......|++.|+|||++.+..++++
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~~~~  221 (321)
T 2qkw_B          196 HLSTVVKGTLGYIDPEYFIKGRLTEK  221 (321)
T ss_dssp             CCBCCCEEETTTCCHHHHHHCBCCTH
T ss_pred             ccccccCCCccccCHHHhcCCCCCcc
Confidence             1233458999999999988777654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.8e-37  Score=222.15  Aligned_cols=176  Identities=29%  Similarity=0.461  Sum_probs=145.3

Q ss_pred             ccceeeeeeCCccceeEEEEE----EccCCcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEEEEeEEcC--CeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLR----HKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTP--THLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~----~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~   74 (181)
                      ++|++.+.||+|+||.||++.    +..+++.||+|++...... .+.+.+|+.++..++|||++++++++...  ..++
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            689999999999999999998    5667899999998764332 36788999999999999999999998654  5589


Q ss_pred             EEEeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           75 IVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      ++|||+++++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||++......
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~  167 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN--RVKIGDFGLTKVLPQD  167 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCSCC-----
T ss_pred             EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC--eEEEccCcccccccCC
Confidence            9999999999999987654 599999999999999999999999999999999999997655  4999999999754333


Q ss_pred             CC----CCcccCCCCccCcccccCCccCCC
Q 030211          154 SR----PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ~~----~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..    .....+++.|+|||.+.+..++++
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  197 (295)
T 3ugc_A          168 KEFFKVKEPGESPIFWYAPESLTESKFSVA  197 (295)
T ss_dssp             --------CTTCGGGGCCHHHHHHCCCCHH
T ss_pred             cceeeeccCCCCccceeCcHHhcCCCCChH
Confidence            22    222346677999999988777643

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.7e-35  Score=215.12  Aligned_cols=176  Identities=23%  Similarity=0.257  Sum_probs=151.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++.... ..+.+.+|+..+..+ +|++++++++++.+....+++||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            57999999999999999999999899999999986543 345678899999988 7899999999999999999999999


Q ss_pred             CCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC---CCcEEEeecCCcccccCCCC-
Q 030211           81 AGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA---APRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~---~~~v~l~dfg~a~~~~~~~~-  155 (181)
                       +++|.+++.... ++++..++.++.|++.||.+||++|++|+||+|+||+++.++   ...++|+|||++........ 
T Consensus        89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~  167 (298)
T 1csn_A           89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  167 (298)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence             889999987654 699999999999999999999999999999999999996433   23599999999975543322 


Q ss_pred             -------CCcccCCCCccCcccccCCccCCC
Q 030211          156 -------PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 -------~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                             .....|++.|+|||.+.+..++++
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  198 (298)
T 1csn_A          168 QHIPYREKKNLSGTARYMSINTHLGREQSRR  198 (298)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH
T ss_pred             ccccccCccCCCCCcccCCchhhcCCCCChH
Confidence                   344568999999999998877643

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-36  Score=224.39  Aligned_cols=175  Identities=25%  Similarity=0.387  Sum_probs=148.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||.||++.+.     .+++.||+|++.....  ..+.+.+|+.+++.++|||++++++++.+.+..+
T Consensus        47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  126 (343)
T 1luf_A           47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC  126 (343)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence            68999999999999999999987     3458899999876432  2357889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEE
Q 030211           75 IVMEYAAGGELFDRICNA------------------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTL  130 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~------------------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~  130 (181)
                      ++|||+++++|.+++...                        ..+++..++.++.|++.||.+||++|++|+||+|+||+
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  206 (343)
T 1luf_A          127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  206 (343)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEE
Confidence            999999999999988663                        56899999999999999999999999999999999999


Q ss_pred             eccCCCCcEEEeecCCcccccCC---CCCCcccCCCCccCcccccCCccCC
Q 030211          131 LDGSAAPRLKICDFGYSKSSVLH---SRPKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       131 i~~~~~~~v~l~dfg~a~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ++.+.  .++|+|||++......   .......+++.|+|||.+.+..+++
T Consensus       207 ~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  255 (343)
T 1luf_A          207 VGENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT  255 (343)
T ss_dssp             ECGGG--CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred             ECCCC--eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCc
Confidence            97555  4999999998654322   2233446788999999998777654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.9e-36  Score=223.73  Aligned_cols=177  Identities=20%  Similarity=0.245  Sum_probs=144.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc---CCcEEEEEEcccccc------------ccHHHHHHHHHHhhCCCCCeeEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE---TKELVAVKYIERGRK------------IDENVAREIINHRSLRHPNIIRFKEV   66 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~v~~K~~~~~~~------------~~~~~~~e~~~~~~~~~~~i~~~~~~   66 (181)
                      ++|++.+.||+|+||.||+|.+..   ++..+|+|++.....            ....+.+|+..+..++|||+++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            579999999999999999999986   788899999875432            12346677888889999999999999


Q ss_pred             EEc----CCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEe
Q 030211           67 VLT----PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKIC  142 (181)
Q Consensus        67 ~~~----~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~  142 (181)
                      +.+    .+..+++||++ +++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.+..+.++|+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~  195 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA  195 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence            988    77899999999 8899999887778999999999999999999999999999999999999987664579999


Q ss_pred             ecCCcccccCCCCC--------CcccCCCCccCcccccCCccCCC
Q 030211          143 DFGYSKSSVLHSRP--------KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       143 dfg~a~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      |||+++........        ....+++.|+|||++.+..++++
T Consensus       196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  240 (345)
T 2v62_A          196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR  240 (345)
T ss_dssp             CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH
T ss_pred             eCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCch
Confidence            99999755332211        34468999999999998876643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=227.31  Aligned_cols=178  Identities=22%  Similarity=0.286  Sum_probs=148.4

Q ss_pred             ccceeeeeeCCccceeEEEEEE-----ccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRH-----KETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~-----~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||.||+|.+     ..+++.||+|.+.....  ....+.+|+.++..++|||++++++++.+.+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            5799999999999999999994     45677899999865322  2346888999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-CCcEEEeecCC
Q 030211           75 IVMEYAAGGELFDRICNA-------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGY  146 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-~~~v~l~dfg~  146 (181)
                      +||||+.+++|.+++...       ..+++..++.++.|++.||.|||++||+||||||+||+++.++ ...++|+|||+
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~  230 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  230 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence            999999999999988654       3589999999999999999999999999999999999996433 33599999999


Q ss_pred             ccccc---CCCCCCcccCCCCccCcccccCCccCCC
Q 030211          147 SKSSV---LHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       147 a~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ++...   .........+++.|+|||++.+..++++
T Consensus       231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  266 (367)
T 3l9p_A          231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK  266 (367)
T ss_dssp             HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHH
T ss_pred             ccccccccccccCCCcCCcccEECHHHhcCCCCCcH
Confidence            86432   2233344567899999999988777643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.7e-35  Score=218.10  Aligned_cols=171  Identities=26%  Similarity=0.455  Sum_probs=150.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC-CCCeeEEEEeEEc--CCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLT--PTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~--~~~~~~v~e   78 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...  ..+.+.+|+.++..++ |||++++++++.+  ....+++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e  113 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  113 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence            5899999999999999999999999999999998743  3467889999999997 9999999999998  567999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      ++.+++|.+.+..   +++..++.++.|++.||.+||++|++|+||+|+||+++.++ ..++|+|||++...........
T Consensus       114 ~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~~kl~Dfg~a~~~~~~~~~~~  189 (330)
T 3nsz_A          114 HVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH-RKLRLIDWGLAEFYHPGQEYNV  189 (330)
T ss_dssp             CCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT-TEEEECCCTTCEECCTTCCCCS
T ss_pred             ccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC-CEEEEEeCCCceEcCCCCcccc
Confidence            9999999887743   89999999999999999999999999999999999997443 2599999999987766666667


Q ss_pred             ccCCCCccCcccccC-CccCC
Q 030211          159 TVGTPAYIAPEVLSR-REYDG  178 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~-~~~~~  178 (181)
                      ..+++.|+|||++.+ ..++.
T Consensus       190 ~~~~~~y~aPE~~~~~~~~~~  210 (330)
T 3nsz_A          190 RVASRYFKGPELLVDYQMYDY  210 (330)
T ss_dssp             CCSCGGGCCHHHHTTCCCCCT
T ss_pred             ccccccccChhhhcCCCcCCc
Confidence            789999999999977 44554

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.1e-36  Score=221.55  Aligned_cols=170  Identities=38%  Similarity=0.556  Sum_probs=144.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---------IDENVAREIINHRSLRHPNIIRFKEVVLTPTH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~   72 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....         ....+.+|+.+++.++|||++++++++...+ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            579999999999999999999999999999999865321         1245788999999999999999999987665 


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-CCcEEEeecCCccccc
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSV  151 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-~~~v~l~dfg~a~~~~  151 (181)
                      .+++|||+++++|.+.+..+..+++..++.++.|++.||.+||++|++|+||+|+||+++.+. ...++|+|||++....
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  168 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  168 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence            899999999999999988888899999999999999999999999999999999999996443 3459999999987654


Q ss_pred             CCCCCCcccCCCCccCccccc
Q 030211          152 LHSRPKSTVGTPAYIAPEVLS  172 (181)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~  172 (181)
                      .........+++.|+|||++.
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~  189 (322)
T 2ycf_A          169 ETSLMRTLCGTPTYLAPEVLV  189 (322)
T ss_dssp             CCHHHHHHHSCCTTCCHHHHH
T ss_pred             cccccccccCCcCccCchhhc
Confidence            333333456899999999974

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.1e-36  Score=220.17  Aligned_cols=178  Identities=32%  Similarity=0.512  Sum_probs=148.7

Q ss_pred             ccceee-eeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELV-KDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~-~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|.+. +.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.++..+. |||++++++++.+.+..+++
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv  107 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI  107 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence            467787 899999999999999999999999999876432   2367888999998885 59999999999999999999


Q ss_pred             EeecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccC-CCCcEEEeecCCcccccCC
Q 030211           77 MEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-AAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~-~~~~v~l~dfg~a~~~~~~  153 (181)
                      |||+.+++|.+++...  ..+++..++.++.|++.||++||++|++|+||+|+||+++.. ..+.++|+|||++......
T Consensus       108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA  187 (327)
T ss_dssp             EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence            9999999999887543  579999999999999999999999999999999999999642 1456999999999876655


Q ss_pred             CCCCcccCCCCccCcccccCCccCCC
Q 030211          154 SRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .......+++.|+|||++.+.+++++
T Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~  213 (327)
T 3lm5_A          188 CELREIMGTPEYLAPEILNYDPITTA  213 (327)
T ss_dssp             ------CCCGGGCCHHHHTTCCCCTH
T ss_pred             cccccccCCcCccCCeeecCCCCCch
Confidence            55566789999999999998887754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.8e-36  Score=232.61  Aligned_cols=175  Identities=22%  Similarity=0.311  Sum_probs=152.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|+||.||++.+..++..||+|.+.......+.+.+|+.+++.++|||++++++++.+.+.++++|||+.
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~  299 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT  299 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence            46899999999999999999999889999999998766667889999999999999999999999999999999999999


Q ss_pred             CCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC--CCC
Q 030211           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPK  157 (181)
Q Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~--~~~  157 (181)
                      +++|.+++...  ..+++..++.++.|++.||+|||++|++|+||+|+||+++.+.  .++|+|||+++......  ...
T Consensus       300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~  377 (495)
T 1opk_A          300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHA  377 (495)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CEEECCTTCEECCTTCCEECCT
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC--cEEEeecccceeccCCceeecC
Confidence            99999998753  3689999999999999999999999999999999999997555  49999999997543222  122


Q ss_pred             cccCCCCccCcccccCCccCC
Q 030211          158 STVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ...+++.|+|||++....++.
T Consensus       378 ~~~~~~~y~aPE~~~~~~~~~  398 (495)
T 1opk_A          378 GAKFPIKWTAPESLAYNKFSI  398 (495)
T ss_dssp             TCCCCGGGCCHHHHHHCEECH
T ss_pred             CCcCCcceeCHhHHhcCCCCc
Confidence            334567899999998777654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-35  Score=218.62  Aligned_cols=168  Identities=27%  Similarity=0.340  Sum_probs=144.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC----eEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPT----HLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~----~~~~v~   77 (181)
                      ++|++.+.||+|+||.||+|.+.  ++.||+|++............|+.++..++|||++++++++.+..    .++++|
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            68999999999999999999876  789999999766554556667888899999999999999998754    479999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc----------CeeeeCCCCCCEEeccCCCCcEEEeecCCc
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM----------QICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~----------gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a  147 (181)
                      ||+++++|.+++.. ..+++..++.++.|++.||.|||+.          |++|+||||+||+++.+.  .++|+|||++
T Consensus       102 e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~--~~kL~DFg~a  178 (322)
T 3soc_A          102 AFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL--TACIADFGLA  178 (322)
T ss_dssp             ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC--CEEECCCTTC
T ss_pred             ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC--eEEEccCCcc
Confidence            99999999998865 4699999999999999999999999          999999999999997555  4999999999


Q ss_pred             ccccCCCC---CCcccCCCCccCcccccCC
Q 030211          148 KSSVLHSR---PKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       148 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~  174 (181)
                      ........   .....+++.|+|||++.+.
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  208 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGA  208 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTC
T ss_pred             cccccccCccccccCccCccccCHhhcccc
Confidence            75543322   3335789999999999863

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.1e-35  Score=215.35  Aligned_cols=175  Identities=30%  Similarity=0.505  Sum_probs=153.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|++|.||++.+..+++.||+|++....  ...+.+.+|+.+++.++|||++++++++.+.+..+++|||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            46999999999999999999999999999999987543  2346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCCc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~~  158 (181)
                      +++++|.+++.. .++++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++....... ....
T Consensus       102 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A          102 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             CTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECBTTBCCBCC
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC--CEEEeecccceecCccccccCc
Confidence            999999988754 5799999999999999999999999999999999999997555  49999999987654333 2344


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..+++.|+|||.+.+..++++
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~  199 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDSK  199 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTH
T ss_pred             cCCCcCccCHHHHhcCCCCch
Confidence            578999999999998877653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.3e-36  Score=217.26  Aligned_cols=175  Identities=32%  Similarity=0.486  Sum_probs=144.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEc------------
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT------------   69 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~------------   69 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.......+.+.+|+.+++.++|||++++++++.+            
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            57999999999999999999999899999999997655555778899999999999999999998865            


Q ss_pred             -CCeEEEEEeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCc
Q 030211           70 -PTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (181)
Q Consensus        70 -~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a  147 (181)
                       .+..+++||++++++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~  163 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLA  163 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCCCCC
T ss_pred             cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC--CEEEeeCcch
Confidence             356899999999999999987544 678899999999999999999999999999999999997555  4999999998


Q ss_pred             ccccCC---------------CCCCcccCCCCccCcccccCC-ccCC
Q 030211          148 KSSVLH---------------SRPKSTVGTPAYIAPEVLSRR-EYDG  178 (181)
Q Consensus       148 ~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~-~~~~  178 (181)
                      ......               .......+++.|+|||++.+. .++.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  210 (303)
T 1zy4_A          164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE  210 (303)
T ss_dssp             SCTTC-------------------------CTTSCHHHHTSCSCCCT
T ss_pred             hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcc
Confidence            754321               122345689999999999854 4543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.3e-36  Score=218.95  Aligned_cols=174  Identities=16%  Similarity=0.166  Sum_probs=148.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCC-------cEEEEEEccccc-cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETK-------ELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~-------~~v~~K~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~   73 (181)
                      ++|++.+.||+|+||.||++.+..++       ..|++|.+.... ...+.+.+|+.+++.++|||++++++++.+++..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            68999999999999999999998766       469999986543 3346788999999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCC------cEEEeecCC
Q 030211           74 AIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP------RLKICDFGY  146 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~------~v~l~dfg~  146 (181)
                      +++|||+.+++|.+++..... +++..++.++.|++.||.+||++|++|+||+|+||+++.+...      .++|+|||+
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~  167 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI  167 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCS
T ss_pred             EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcc
Confidence            999999999999999876654 9999999999999999999999999999999999999755532      299999998


Q ss_pred             cccccCCCCCCcccCCCCccCcccccC-CccCC
Q 030211          147 SKSSVLHSRPKSTVGTPAYIAPEVLSR-REYDG  178 (181)
Q Consensus       147 a~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~  178 (181)
                      +.....   .....+++.|+|||.+.+ ..+++
T Consensus       168 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~  197 (289)
T 4fvq_A          168 SITVLP---KDILQERIPWVPPECIENPKNLNL  197 (289)
T ss_dssp             CTTTSC---HHHHHHTTTTSCHHHHHCGGGCCH
T ss_pred             cccccC---ccccCCcCcccCHHHhCCCCCCCc
Confidence            864322   233457889999999987 44443

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.2e-35  Score=226.24  Aligned_cols=175  Identities=27%  Similarity=0.369  Sum_probs=150.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC------CCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL------RHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~------~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.........+.+|+.++..+      .|+|++++++.+...+..++
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  176 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM  176 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence            579999999999999999999999999999999987655456677777777665      57799999999999999999


Q ss_pred             EEeecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           76 VMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      +||++. ++|.+++....  .+++..++.++.|++.||.|||++||+|+||||+||+++.++...++|+|||++....  
T Consensus       177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~--  253 (429)
T 3kvw_A          177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--  253 (429)
T ss_dssp             EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT--
T ss_pred             EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC--
Confidence            999996 58888886654  5999999999999999999999999999999999999976665569999999986432  


Q ss_pred             CCCCcccCCCCccCcccccCCccCCC
Q 030211          154 SRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .......+++.|+|||++.+..++++
T Consensus       254 ~~~~~~~gt~~y~aPE~~~~~~~~~~  279 (429)
T 3kvw_A          254 QRVYTYIQSRFYRAPEVILGARYGMP  279 (429)
T ss_dssp             CCCCSSCSCGGGCCHHHHHTBCCCTH
T ss_pred             CcccccCCCCCccChHHHhCCCCCch
Confidence            33445678999999999998888764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-36  Score=228.39  Aligned_cols=175  Identities=28%  Similarity=0.366  Sum_probs=148.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.....  ..+.+.+|+.+++.++|||++++++++.+.+..+++|||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            579999999999999999999998899999999875422  235678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC---
Q 030211           80 AAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---  155 (181)
Q Consensus        80 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~---  155 (181)
                      +++++|.+++.... .++...+..++.|++.||+|||++|++|+||+|+||++++++  .++|+|||++........   
T Consensus       194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~--~~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN--VLKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCGGGCEECTTSEEECC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC--cEEECcCCCceecCCCceeec
Confidence            99999999887644 699999999999999999999999999999999999997555  499999999875332211   


Q ss_pred             CCcccCCCCccCcccccCCccCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      .....+++.|+|||.+..+.++.
T Consensus       272 ~~~~~~~~~y~aPE~~~~~~~~~  294 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNYGRYSS  294 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHHCEEEH
T ss_pred             CCCCCCCcCcCCHhHhccCCCCc
Confidence            11123467899999998776654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-35  Score=223.62  Aligned_cols=176  Identities=26%  Similarity=0.344  Sum_probs=148.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC-------CcEEEEEEccccccc--cHHHHHHHHHHhhC-CCCCeeEEEEeEEcCC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET-------KELVAVKYIERGRKI--DENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~-------~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~   71 (181)
                      ++|++.+.||+|+||.||+|.+...       +..||+|++......  .+.+.+|+.+++.+ +|||++++++++.+.+
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            5899999999999999999997532       357999998764322  35688999999999 8999999999999999


Q ss_pred             eEEEEEeecCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC
Q 030211           72 HLAIVMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~  135 (181)
                      ..+++|||+.+++|.+++....                .+++..++.++.|++.||.+||++|++|+||||+||+++.+.
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  228 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  228 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC
Confidence            9999999999999999987643                489999999999999999999999999999999999997555


Q ss_pred             CCcEEEeecCCcccccCCC---CCCcccCCCCccCcccccCCccCCC
Q 030211          136 APRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       136 ~~~v~l~dfg~a~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                        .++|+|||++.......   ......+++.|+|||++.+..++++
T Consensus       229 --~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  273 (382)
T 3tt0_A          229 --VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ  273 (382)
T ss_dssp             --CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH
T ss_pred             --cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch
Confidence              49999999997554332   2233456788999999988777643

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.3e-35  Score=220.44  Aligned_cols=171  Identities=31%  Similarity=0.497  Sum_probs=146.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......    .+.+.+|+.+++.++|||++++++++.+++..+++|
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            3589999999999999999999989999999998754322    246788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           78 EYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      ||+. +++.+.+. ....+++..++.++.|++.||.+||++|++|+||+|+||++++++  .++|+|||++.....   .
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~---~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP---A  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSSS---B
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEeeccCceecCC---C
Confidence            9997 57777664 345799999999999999999999999999999999999997554  599999999875433   2


Q ss_pred             CcccCCCCccCccccc---CCccCC
Q 030211          157 KSTVGTPAYIAPEVLS---RREYDG  178 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~---~~~~~~  178 (181)
                      ....|++.|+|||++.   ++.+++
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~~  232 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDEGQYDG  232 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSSCCBCT
T ss_pred             CcccCCcceeCHhhhccccCCCCCc
Confidence            3457899999999984   455554

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2e-36  Score=225.41  Aligned_cols=175  Identities=24%  Similarity=0.360  Sum_probs=146.2

Q ss_pred             ccceeeeeeCCccceeEEEEE-----EccCCcEEEEEEccccccc--cHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCe-
Q 030211            2 EKYELVKDLGAGNFGVARLLR-----HKETKELVAVKYIERGRKI--DENVAREIINHRSL-RHPNIIRFKEVVLTPTH-   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~-----~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~-   72 (181)
                      ++|++.+.||+|+||.||+|.     +..+++.||+|++......  .+.+.+|+.++..+ +|||++++++++.+.+. 
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            689999999999999999999     4456689999999764332  35688999999999 78999999999988654 


Q ss_pred             EEEEEeecCCCChHHHHhhcCC----------------------------------------------------------
Q 030211           73 LAIVMEYAAGGELFDRICNAGR----------------------------------------------------------   94 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~----------------------------------------------------------   94 (181)
                      .+++|||+.+++|.+++.....                                                          
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            8999999999999998865432                                                          


Q ss_pred             --------CCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC---CCcccCCC
Q 030211           95 --------FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTP  163 (181)
Q Consensus        95 --------~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~  163 (181)
                              +++..++.++.|++.||.|||++|++|+||||+||+++.+..  ++|+|||++........   .....+++
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~t~  259 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPL  259 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhccccCCCc
Confidence                    899999999999999999999999999999999999975554  99999999975433322   23345788


Q ss_pred             CccCcccccCCccCC
Q 030211          164 AYIAPEVLSRREYDG  178 (181)
Q Consensus       164 ~~~aPE~~~~~~~~~  178 (181)
                      .|+|||++.+..+++
T Consensus       260 ~y~aPE~~~~~~~~~  274 (359)
T 3vhe_A          260 KWMAPETIFDRVYTI  274 (359)
T ss_dssp             GGCCHHHHHHCCCCH
T ss_pred             eeEChhhhcCCCCCc
Confidence            999999998777664

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-35  Score=217.59  Aligned_cols=169  Identities=30%  Similarity=0.498  Sum_probs=143.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEeEEc------CCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLT------PTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~------~~~~~   74 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.......+.+.+|+.++..+ +|||++++++++..      .+..+
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~  103 (326)
T 2x7f_A           24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW  103 (326)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence            689999999999999999999998999999999987666667889999999988 79999999999987      46799


Q ss_pred             EEEeecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           75 IVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ++|||+++++|.+++...  ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.  ++|+|||++.....
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDR  181 (326)
T ss_dssp             EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTTC----
T ss_pred             EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCceecCc
Confidence            999999999999988754  47999999999999999999999999999999999999975554  99999999875433


Q ss_pred             C-CCCCcccCCCCccCccccc
Q 030211          153 H-SRPKSTVGTPAYIAPEVLS  172 (181)
Q Consensus       153 ~-~~~~~~~~~~~~~aPE~~~  172 (181)
                      . .......+++.|+|||.+.
T Consensus       182 ~~~~~~~~~~~~~y~aPE~~~  202 (326)
T 2x7f_A          182 TVGRRNTFIGTPYWMAPEVIA  202 (326)
T ss_dssp             ---------CCGGGCCHHHHC
T ss_pred             CccccccccCCccccChhhhc
Confidence            2 2334457899999999997

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.6e-36  Score=217.44  Aligned_cols=175  Identities=27%  Similarity=0.422  Sum_probs=146.9

Q ss_pred             ccceeeeeeCCccceeEEEEE----EccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcC--CeE
Q 030211            2 EKYELVKDLGAGNFGVARLLR----HKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTP--THL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~----~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~   73 (181)
                      ++|++.+.||+|+||.||+|.    +..+++.||+|++....  ...+.+.+|+.+++.++|||++++++++.+.  +.+
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            469999999999999999998    56678999999987543  2336788999999999999999999999887  668


Q ss_pred             EEEEeecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           74 AIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      +++||++++++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++.....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~  178 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIET  178 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCT
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC--CEEECcccccccccC
Confidence            999999999999999854 45799999999999999999999999999999999999997655  599999999976544


Q ss_pred             CCC----CCcccCCCCccCcccccCCccCC
Q 030211          153 HSR----PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       153 ~~~----~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ...    .....++..|+|||.+.+..+++
T Consensus       179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  208 (302)
T 4e5w_A          179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYI  208 (302)
T ss_dssp             TCCEEECCCCTTCCGGGCCHHHHHHCEEEH
T ss_pred             CCcceeccCCCCCCccccCCeeecCCCCCc
Confidence            332    33345788899999998776553

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-36  Score=222.32  Aligned_cols=172  Identities=31%  Similarity=0.554  Sum_probs=148.4

Q ss_pred             CccceeeeeeCCccceeEEEEEEc---cCCcEEEEEEccccc-----cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCC
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGR-----KIDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~-----~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~   71 (181)
                      +++|++.+.||+|+||.||++.+.   .+++.||+|++....     ...+.+.+|+.++..+ .|||++++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            368999999999999999999984   478999999987532     2335667788899888 6999999999999999


Q ss_pred             eEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      ..+++|||+.+++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.+.  .++|+|||++....
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEESCSSEEEECC
T ss_pred             eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--cEEEeeCCCCeecc
Confidence            9999999999999999998888899999999999999999999999999999999999997555  49999999987543


Q ss_pred             CCC--CCCcccCCCCccCcccccCC
Q 030211          152 LHS--RPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       152 ~~~--~~~~~~~~~~~~aPE~~~~~  174 (181)
                      ...  ......|++.|+|||++.+.
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~  235 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGG  235 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTC
T ss_pred             cCCCCcccCcccCcCccChhhhcCC
Confidence            222  23345799999999999863

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.3e-36  Score=218.90  Aligned_cols=175  Identities=24%  Similarity=0.325  Sum_probs=147.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||.||+|.+.     .+++.||+|++.....  ..+.+.+|+.+++.++|||++++++++.+.+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  102 (314)
T 2ivs_A           23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL  102 (314)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence            58999999999999999999983     3457899999875432  2357888999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEE
Q 030211           75 IVMEYAAGGELFDRICNAGR------------------------FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTL  130 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~------------------------~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~  130 (181)
                      ++|||+++++|.+++.....                        +++..++.++.|++.||.+||++|++|+||+|+||+
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl  182 (314)
T 2ivs_A          103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL  182 (314)
T ss_dssp             EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence            99999999999999876433                        889999999999999999999999999999999999


Q ss_pred             eccCCCCcEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCC
Q 030211          131 LDGSAAPRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       131 i~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ++++.  .++|+|||++........   .....+++.|+|||.+.+..+++
T Consensus       183 i~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  231 (314)
T 2ivs_A          183 VAEGR--KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTT  231 (314)
T ss_dssp             EETTT--EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECH
T ss_pred             EcCCC--CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCc
Confidence            97554  599999999875433322   22345678899999998776654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2e-35  Score=226.28  Aligned_cols=171  Identities=27%  Similarity=0.400  Sum_probs=145.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC-eEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPT-HLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||.||++.+.  ++.||+|.++... ..+.+.+|+.+++.++|||++++++++.+.+ ..+++|||+
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            67999999999999999999886  6789999987654 4678999999999999999999999987765 799999999


Q ss_pred             CCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           81 AGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      ++++|.+++....  .++...++.++.|++.||+|||++|++|+||+|+||+++.++  .++|+|||+++.....  ...
T Consensus       270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~--~~~  345 (450)
T 1k9a_A          270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASST--QDT  345 (450)
T ss_dssp             TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS--CEEECCCTTCEECC-------
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC--CEEEeeCCCccccccc--ccC
Confidence            9999999987654  379999999999999999999999999999999999997555  4999999998754322  222


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..+++.|+|||.+.+..++++
T Consensus       346 ~~~~~~y~aPE~~~~~~~~~~  366 (450)
T 1k9a_A          346 GKLPVKWTAPEALREKKFSTK  366 (450)
T ss_dssp             -CCCTTTSCHHHHHSSCCCHH
T ss_pred             CCCCcceeCHHHhcCCCCCcH
Confidence            356889999999988877654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=7.4e-36  Score=222.40  Aligned_cols=176  Identities=28%  Similarity=0.442  Sum_probs=138.6

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCe-------E
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTH-------L   73 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~-------~   73 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++...........+++..+..++|||++++++++...+.       .
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            478999999999999999999999999999999987766656677788888899999999999999976433       8


Q ss_pred             EEEEeecCCCChHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHH--hcCeeeeCCCCCCEEeccCCCCcEEEeecCCc
Q 030211           74 AIVMEYAAGGELFDRI----CNAGRFSEDEGRYFFQQLISGVNYCH--SMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lh--~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a  147 (181)
                      +++|||+++ ++...+    .....+++..++.++.|++.||.+||  ++|++|+||+|+||+++. ..+.++|+|||++
T Consensus       102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE-ADGTLKLCDFGSA  179 (360)
T ss_dssp             EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET-TTTEEEECCCTTC
T ss_pred             EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC-CCCcEEEeeCCCc
Confidence            899999976 444333    34567899999999999999999999  999999999999999974 1346999999999


Q ss_pred             ccccCCCCCCcccCCCCccCcccccCCc-cCC
Q 030211          148 KSSVLHSRPKSTVGTPAYIAPEVLSRRE-YDG  178 (181)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~  178 (181)
                      .............+++.|+|||++.+.. ++.
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  211 (360)
T 3e3p_A          180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTT  211 (360)
T ss_dssp             BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCT
T ss_pred             eecCCCCCcccccCCcceeCHHHHcCCCCCCc
Confidence            8776666666778999999999986544 554

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-35  Score=221.34  Aligned_cols=172  Identities=27%  Similarity=0.417  Sum_probs=141.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC------e
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPT------H   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~------~   72 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.....   ..+.+.+|+.+++.++|||++++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            579999999999999999999999999999999865432   2356789999999999999999999998763      4


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ++++||++ +++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++.....
T Consensus       105 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQADS  180 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCS
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC--CEEEEeeeccccccc
Confidence            69999999 7788887755 5799999999999999999999999999999999999997555  499999999976433


Q ss_pred             CCCCCcccCCCCccCcccccC-CccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSR-REYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~  179 (181)
                        ......+++.|+|||++.+ ..++.+
T Consensus       181 --~~~~~~~t~~y~aPE~~~~~~~~~~~  206 (367)
T 1cm8_A          181 --EMTGYVVTRWYRAPEVILNWMRYTQT  206 (367)
T ss_dssp             --SCCSSCSCGGGCCTHHHHTTTCCCTT
T ss_pred             --ccCcCcCCCCcCCHHHHhCCCCCChh
Confidence              2345678999999999887 556554

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.2e-35  Score=215.82  Aligned_cols=176  Identities=26%  Similarity=0.394  Sum_probs=140.5

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|.+.....    ..+.+.+|+.+++.++|||++++++++.+.+..+++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            4689999999999999999999998999999999875322    235688899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           77 MEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ||++.+++|.+++..    ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++.....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~--~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCC--------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC--CEEEEeccceeeecC
Confidence            999999999888753    45689999999999999999999999999999999999997554  599999999875433


Q ss_pred             CC-CCCcccCCCCccCcccccCCccCC
Q 030211          153 HS-RPKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       153 ~~-~~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      .. ......+++.|+|||.+.+..++.
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~  215 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERIHENGYNF  215 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCH
T ss_pred             CCccccccCCCeeEeChHHhCCCCCCc
Confidence            32 233456899999999998877654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.7e-37  Score=227.17  Aligned_cols=167  Identities=23%  Similarity=0.281  Sum_probs=138.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---------ccHHHHHHHHHHhhCC---------CCCeeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---------IDENVAREIINHRSLR---------HPNIIRF   63 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---------~~~~~~~e~~~~~~~~---------~~~i~~~   63 (181)
                      ++|++.+.||+|+||.||+|.+  +++.||+|++.....         ..+.+.+|+.+++.++         |+|++++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            5799999999999999999998  579999999976432         1267788888887775         8888887


Q ss_pred             EEeEE------------------------------cCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030211           64 KEVVL------------------------------TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY  113 (181)
Q Consensus        64 ~~~~~------------------------------~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~  113 (181)
                      .+++.                              +.+..++||||+.++++.+.+.+ ..+++..++.++.|++.||.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence            77643                              26789999999999877666643 568999999999999999999


Q ss_pred             HH-hcCeeeeCCCCCCEEeccCCC------------------CcEEEeecCCcccccCCCCCCcccCCCCccCcccccCC
Q 030211          114 CH-SMQICHRDLKLENTLLDGSAA------------------PRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       114 lh-~~gi~h~dl~p~ni~i~~~~~------------------~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~  174 (181)
                      || ++||+||||||+||+++.++.                  ..++|+|||+|+....    ....||+.|+|||++.+.
T Consensus       177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~g~  252 (336)
T 2vuw_A          177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFTGD  252 (336)
T ss_dssp             HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGCCC
T ss_pred             HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhcCC
Confidence            99 999999999999999976541                  2699999999975442    245799999999999865


Q ss_pred             c
Q 030211          175 E  175 (181)
Q Consensus       175 ~  175 (181)
                      .
T Consensus       253 ~  253 (336)
T 2vuw_A          253 G  253 (336)
T ss_dssp             S
T ss_pred             C
Confidence            4

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-35  Score=220.87  Aligned_cols=171  Identities=32%  Similarity=0.452  Sum_probs=142.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.....      ..+.+.+|+.++..++|||++++++++.+.+..++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            689999999999999999999999999999999875321      13467889999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-
Q 030211           76 VMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-  153 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-  153 (181)
                      +||++++ +|...+..+. .+++..++.++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++...... 
T Consensus        90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCCGGGSTTTSCC
T ss_pred             EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC--CEEEEecccceeccCCc
Confidence            9999976 7877776543 689999999999999999999999999999999999997555  4999999999765333 


Q ss_pred             CCCCcccCCCCccCcccccCCc
Q 030211          154 SRPKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~  175 (181)
                      .......+++.|+|||++.+..
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~~  188 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGAR  188 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCS
T ss_pred             ccCCcccccccccCchHhhCCC
Confidence            3344567899999999997543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.8e-35  Score=218.27  Aligned_cols=175  Identities=31%  Similarity=0.399  Sum_probs=149.1

Q ss_pred             ccceeeeeeCCccceeEEEEEE-ccCCcEEEEEEccccccccHHHHHHHHHHhhCCCC------CeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRH-KETKELVAVKYIERGRKIDENVAREIINHRSLRHP------NIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~-~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~------~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||.||++.+ ..+++.||+|++.......+.+.+|+.++..++|+      +++++++++...+..+
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~   93 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC   93 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence            6899999999999999999998 56788999999976554456777888888777544      5999999999999999


Q ss_pred             EEEeecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-----------------
Q 030211           75 IVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-----------------  135 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-----------------  135 (181)
                      ++||++ +++|.+++....  ++++..++.++.|++.||++||++|++|+||+|+||+++.+.                 
T Consensus        94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~  172 (339)
T 1z57_A           94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI  172 (339)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred             EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence            999999 779998887665  689999999999999999999999999999999999997533                 


Q ss_pred             CCcEEEeecCCcccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          136 APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       136 ~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+.++|+|||++....  .......+++.|+|||++.+..++.+
T Consensus       173 ~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~  214 (339)
T 1z57_A          173 NPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQP  214 (339)
T ss_dssp             CCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTH
T ss_pred             CCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcc
Confidence            4569999999987533  23345678999999999998877654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.9e-36  Score=213.29  Aligned_cols=174  Identities=25%  Similarity=0.418  Sum_probs=150.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|++|.||++.+. +++.|++|.+.......+.+.+|+.+++.++|||++++++++.+.+..+++||+++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            68999999999999999999987 46789999998776666789999999999999999999999999999999999999


Q ss_pred             CCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC--CCCCc
Q 030211           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH--SRPKS  158 (181)
Q Consensus        82 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~--~~~~~  158 (181)
                      +++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++++..  ++|+|||++......  .....
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~  164 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTG  164 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEccccccccccccccccccc
Confidence            99999988765 46899999999999999999999999999999999999975554  999999998754322  12233


Q ss_pred             ccCCCCccCcccccCCccCC
Q 030211          159 TVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ..+++.|+|||++.+..+++
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~  184 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRYSS  184 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCCCH
T ss_pred             ccccccccChhhhcCCCccc
Confidence            45678899999998776654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.4e-35  Score=214.79  Aligned_cols=167  Identities=25%  Similarity=0.369  Sum_probs=130.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccccc---HHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~---~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.......   +.+.++...++.++|||++++++++.+++..+++||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            68999999999999999999999999999999987543222   234445555788899999999999999999999999


Q ss_pred             ecCCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           79 YAAGGELFDRIC----NAGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        79 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~-gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      ++++ +|.+++.    ....+++..++.++.|++.||.+||++ |++|+||+|+||+++.+.  .++|+|||++......
T Consensus        87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~  163 (290)
T 3fme_A           87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLVDD  163 (290)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC--CEEBCCC---------
T ss_pred             hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecCCccccccc
Confidence            9975 7766553    356899999999999999999999998 999999999999997555  5999999999766655


Q ss_pred             CCCCcccCCCCccCcccc
Q 030211          154 SRPKSTVGTPAYIAPEVL  171 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~  171 (181)
                      .......+++.|+|||.+
T Consensus       164 ~~~~~~~~t~~y~aPE~~  181 (290)
T 3fme_A          164 VAKDIDAGCKPYMAPERI  181 (290)
T ss_dssp             ------CCCCCCSCHHHH
T ss_pred             ccccccCCCccccChhhc
Confidence            555556799999999997

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-36  Score=220.84  Aligned_cols=175  Identities=25%  Similarity=0.336  Sum_probs=146.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEccccc--cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGR--KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~   73 (181)
                      ++|++.+.||+|+||.||+|.+.     .++..||+|++....  ...+.+.+|+.++..+ +|||++++++++...+..
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            57999999999999999999973     356689999987532  2346788999999999 899999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEE
Q 030211           74 AIVMEYAAGGELFDRICNAG-----------------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTL  130 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~-----------------------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~  130 (181)
                      +++|||+++++|.+++....                       .+++..++.++.|++.||.+||++|++|+||+|+||+
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  204 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  204 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence            99999999999999886543                       3789999999999999999999999999999999999


Q ss_pred             eccCCCCcEEEeecCCcccccCCCCC---CcccCCCCccCcccccCCccCC
Q 030211          131 LDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       131 i~~~~~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ++.+.  .++|+|||++.........   ....+++.|+|||.+.+..+++
T Consensus       205 l~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  253 (344)
T 1rjb_A          205 VTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI  253 (344)
T ss_dssp             EETTT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred             EcCCC--cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCCh
Confidence            97554  5999999999755433322   2335678899999998777664

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-35  Score=219.02  Aligned_cols=175  Identities=22%  Similarity=0.320  Sum_probs=144.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcE----EEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKEL----VAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~----v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|++.+.||+|+||.||+|.+..++..    |++|.+....  .....+.+|+.++..++|||++++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            6899999999999999999999877765    7777765432  22356778999999999999999999886 456889


Q ss_pred             EEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +|||+.+++|.+.+... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.  ++|+|||+++......
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPDD  169 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGSCCCT
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCcccccCccc
Confidence            99999999999988664 47999999999999999999999999999999999999975554  9999999997654333


Q ss_pred             C---CCcccCCCCccCcccccCCccCCC
Q 030211          155 R---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .   .....+++.|+|||.+.+..++++
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~  197 (325)
T 3kex_A          170 KQLLYSEAKTPIKWMALESIHFGKYTHQ  197 (325)
T ss_dssp             TCCC-----CCTTTSCHHHHHHCCCCHH
T ss_pred             ccccccCCCCcccccChHHhccCCCChh
Confidence            2   233457789999999988777643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9.8e-35  Score=210.60  Aligned_cols=174  Identities=26%  Similarity=0.391  Sum_probs=147.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEc----CCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLT----PTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~----~~~~~   74 (181)
                      ..|++.+.||+|+||.||+|.+..++..|++|.+.....   ..+.+.+|+.+++.++|||++++++++..    .+.++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            358999999999999999999999999999999875432   23568889999999999999999999875    35689


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~g--i~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ++|||+++++|.+++.....+++..++.++.|++.||.+||++|  ++|+||+|+||+++. ..+.++|+|||++... .
T Consensus       106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~-~~~~~kl~Dfg~~~~~-~  183 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLK-R  183 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-TTSCEEECCTTGGGGC-C
T ss_pred             EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC-CCCCEEEeeCCCcccc-c
Confidence            99999999999999988788999999999999999999999999  999999999999962 2335999999998633 2


Q ss_pred             CCCCCcccCCCCccCcccccCCccCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ........+++.|+|||.+.+ .+++
T Consensus       184 ~~~~~~~~~t~~y~aPE~~~~-~~~~  208 (290)
T 1t4h_A          184 ASFAKAVIGTPEFMAPEMYEE-KYDE  208 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CCCT
T ss_pred             ccccccccCCcCcCCHHHHhc-cCCC
Confidence            233344578999999998874 3544

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.4e-36  Score=224.05  Aligned_cols=176  Identities=26%  Similarity=0.362  Sum_probs=139.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEc---cCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK---ETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|++.+.||+|+||.||++.+.   .++..||+|.+.....  ..+.+.+|+.++..++|||++++++++.+.+..+++
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57999999999999999999886   4567799999875432  235788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      |||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.+.  .++|+|||++........
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~  202 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL--VCKVSDFGLGRVLEDDPE  202 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC-----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC--CEEECcCccccccccCCc
Confidence            99999999999987654 799999999999999999999999999999999999997555  499999999875433222


Q ss_pred             C----CcccCCCCccCcccccCCccCCC
Q 030211          156 P----KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~----~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .    ....+++.|+|||++.+..++++
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~  230 (373)
T 2qol_A          203 AAYTTRGGKIPIRWTSPEAIAYRKFTSA  230 (373)
T ss_dssp             -----------CTTSCHHHHHHCCCCHH
T ss_pred             cceeccCCCcCCCccChhhhccCCcCch
Confidence            1    11234678999999988777643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8.2e-36  Score=218.19  Aligned_cols=175  Identities=25%  Similarity=0.318  Sum_probs=148.9

Q ss_pred             ccceeeeeeCCccceeEEEEEE-----ccCCcEEEEEEcccccc--ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRH-----KETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~-----~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~   73 (181)
                      ++|++.+.||+|+||.||+|.+     ..+++.||+|.+.....  ..+.+.+|+.++..+ +|||++++++++.+++..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            5899999999999999999985     45678899999876543  236788999999999 899999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC
Q 030211           74 AIVMEYAAGGELFDRICNAG------------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~------------------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~  135 (181)
                      +++||++++++|.+++....                  .+++..++.++.|++.||.+||++|++|+||+|+||+++++.
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  182 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC
Confidence            99999999999999887643                  489999999999999999999999999999999999997554


Q ss_pred             CCcEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCC
Q 030211          136 APRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       136 ~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                        .++|+|||++........   .....+++.|+|||.+.+..+++
T Consensus       183 --~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  226 (313)
T 1t46_A          183 --ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF  226 (313)
T ss_dssp             --EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH
T ss_pred             --CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCCh
Confidence              599999999876544332   22344678899999998776654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-35  Score=218.32  Aligned_cols=167  Identities=25%  Similarity=0.377  Sum_probs=141.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCC--CCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRH--PNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~--~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|++.+.||+|+||.||++.+. +++.||+|++......   .+.+.+|+.++..++|  +|++++++++.+.+..+++
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            47999999999999999999985 4888999998754332   2567889999999976  9999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-  155 (181)
                      || +.+++|.+++.....+++..+..++.|++.||.|||++||+|+||+|+||++++   +.++|+|||++........ 
T Consensus        88 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~---~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             EC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCCC------
T ss_pred             Ee-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC---CcEEEeecccccccCccccc
Confidence            99 557799999988889999999999999999999999999999999999999963   3599999999976543332 


Q ss_pred             --CCcccCCCCccCcccccC
Q 030211          156 --PKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       156 --~~~~~~~~~~~aPE~~~~  173 (181)
                        .....|++.|+|||++.+
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~  183 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKD  183 (343)
T ss_dssp             ------CCCCSSCCHHHHHH
T ss_pred             ccCCCCcCCcCcCCHHHHhh
Confidence              234579999999999864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-34  Score=209.93  Aligned_cols=167  Identities=28%  Similarity=0.475  Sum_probs=142.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc--------cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--------DENVAREIINHRSLRHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--------~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~   73 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......        .+.+.+|+.+++.++|||++++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            6899999999999999999999999999999998654322        157889999999999999999999998776  


Q ss_pred             EEEEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcC--eeeeCCCCCCEEeccCCC---CcEEEeecCCc
Q 030211           74 AIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAA---PRLKICDFGYS  147 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~g--i~h~dl~p~ni~i~~~~~---~~v~l~dfg~a  147 (181)
                      +++|||+.+++|.+.+... ..+++..++.++.|++.||.+||++|  ++|+||+|+||+++.+..   ..++|+|||++
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~  176 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS  176 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence            6899999999998877554 47999999999999999999999999  999999999999964332   24999999998


Q ss_pred             ccccCCCCCCcccCCCCccCccccc
Q 030211          148 KSSVLHSRPKSTVGTPAYIAPEVLS  172 (181)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~aPE~~~  172 (181)
                      .....  ......+++.|+|||++.
T Consensus       177 ~~~~~--~~~~~~g~~~y~aPE~~~  199 (287)
T 4f0f_A          177 QQSVH--SVSGLLGNFQWMAPETIG  199 (287)
T ss_dssp             BCCSS--CEECCCCCCTTSCGGGSS
T ss_pred             ccccc--cccccCCCccccCchhhc
Confidence            74322  334467899999999984

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.2e-35  Score=218.99  Aligned_cols=175  Identities=23%  Similarity=0.347  Sum_probs=141.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcE----EEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKEL----VAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~----v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|++.+.||+|+||.||+|.+..+++.    |++|.+....  ...+.+.+|+.+++.++|||++++++++.+++ .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            5899999999999999999998777665    4777775432  33467899999999999999999999998765 778


Q ss_pred             EEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +++++.+++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||++++++  .++|+|||+++......
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~~~~~~~  171 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCTTHHHHHTTTC
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC--CEEEccCcceeEccCCc
Confidence            99999999999988764 5799999999999999999999999999999999999997655  49999999997554333


Q ss_pred             CC---CcccCCCCccCcccccCCccCCC
Q 030211          155 RP---KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~---~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..   ....+++.|+|||.+.+..++++
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~  199 (327)
T 3poz_A          172 KEYHAEGGKVPIKWMALESILHRIYTHQ  199 (327)
T ss_dssp             C-------CCCGGGSCHHHHHHCCCCHH
T ss_pred             ccccccCCCccccccChHHhccCCCCch
Confidence            22   22345779999999988877653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.6e-35  Score=217.68  Aligned_cols=175  Identities=26%  Similarity=0.339  Sum_probs=146.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-------cCCcEEEEEEcccccc--ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-------ETKELVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-------~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~   71 (181)
                      ++|++.+.||+|+||.||+|.+.       .++..||+|++.....  ..+.+.+|+.+++.+ +|||++++++++.+.+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            68999999999999999999975       3567899999876432  235688899999999 8999999999999999


Q ss_pred             eEEEEEeecCCCChHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC
Q 030211           72 HLAIVMEYAAGGELFDRICNAG----------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~  135 (181)
                      ..+++|||+++++|.+++....                .+++..++.++.|++.||.+||++|++|+||+|+||+++.++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  194 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  194 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC
Confidence            9999999999999999987543                389999999999999999999999999999999999997555


Q ss_pred             CCcEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCC
Q 030211          136 APRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       136 ~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                        .++|+|||++........   .....+++.|+|||++.+..+++
T Consensus       195 --~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  238 (334)
T 2pvf_A          195 --VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  238 (334)
T ss_dssp             --CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECH
T ss_pred             --CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcCh
Confidence              499999999875443322   22335678899999988766654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.4e-36  Score=219.23  Aligned_cols=175  Identities=22%  Similarity=0.332  Sum_probs=132.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCc---EEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeE--
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKE---LVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHL--   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~---~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~--   73 (181)
                      ++|++.+.||+|+||.||+|.+..++.   .||+|++....   ...+.+.+|+.+++.++|||++++++++...+..  
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            579999999999999999999876664   79999987642   2246788999999999999999999999887655  


Q ss_pred             ----EEEEeecCCCChHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEee
Q 030211           74 ----AIVMEYAAGGELFDRICNAG------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICD  143 (181)
Q Consensus        74 ----~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~d  143 (181)
                          +++|||+.+++|.+++....      .+++..++.++.|++.||.+||++|++|+||||+||+++++.  .++|+|
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~--~~kl~D  180 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM--TVCVAD  180 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC--CEEEee
Confidence                99999999999998885432      589999999999999999999999999999999999997554  599999


Q ss_pred             cCCcccccCCCC---CCcccCCCCccCcccccCCccCC
Q 030211          144 FGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       144 fg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ||++........   .....+++.|+|||.+.+..+++
T Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  218 (323)
T 3qup_A          181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTV  218 (323)
T ss_dssp             CCC-----------------CCGGGCCHHHHHHCCCCH
T ss_pred             ccccccccccccccccccccCcccccCchhhcCCCCCC
Confidence            999975433322   22334677899999998877664

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.1e-35  Score=217.52  Aligned_cols=175  Identities=30%  Similarity=0.440  Sum_probs=147.9

Q ss_pred             ccceeeeeeCCccceeEEEEE----EccCCcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEEEEeEE--cCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLR----HKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVL--TPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~----~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~~~~~~--~~~~~~   74 (181)
                      ++|++.+.||+|+||.||++.    +..+++.||+|++...... .+.+.+|+.+++.++|+|++++++++.  +.+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            589999999999999999999    4667889999998765332 356889999999999999999999887  456799


Q ss_pred             EEEeecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           75 IVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      ++|||+++++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++......
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA--HVKIADFGLAKLLPLD  180 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCGGGCEECCTT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC--CEEEcccccceecccC
Confidence            99999999999998876 34699999999999999999999999999999999999997655  4999999999755333


Q ss_pred             CC----CCcccCCCCccCcccccCCccCC
Q 030211          154 SR----PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       154 ~~----~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ..    .....+++.|+|||.+.+..+++
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  209 (327)
T 3lxl_A          181 KDYYVVREPGQSPIFWYAPESLSDNIFSR  209 (327)
T ss_dssp             CSEEECSSCCCSCGGGSCHHHHHHCEEEH
T ss_pred             CccceeeccCCccccccCHHHhccCCCCh
Confidence            22    23345778899999988766553

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.5e-35  Score=210.91  Aligned_cols=174  Identities=33%  Similarity=0.435  Sum_probs=138.4

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-----ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-----IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +++|++.+.||+|+||.||++.+.  +..+|+|++.....     ..+.+.+|+.+++.++|||++++++++.+.+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            478999999999999999999975  78899999875432     23678889999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---eeeeCCCCCCEEeccC------CCCcEEEeecCC
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ---ICHRDLKLENTLLDGS------AAPRLKICDFGY  146 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~g---i~h~dl~p~ni~i~~~------~~~~v~l~dfg~  146 (181)
                      +|||+++++|.+++. ...+++..++.++.|++.||.+||++|   ++|+||+|+||+++.+      ..+.++|+|||+
T Consensus        84 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             EEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            999999999988774 558999999999999999999999999   8999999999999642      245699999999


Q ss_pred             cccccCCCCCCcccCCCCccCcccccCCccCC
Q 030211          147 SKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       147 a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      +...... ......+++.|+|||.+.+..+++
T Consensus       163 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  193 (271)
T 3dtc_A          163 AREWHRT-TKMSAAGAYAWMAPEVIRASMFSK  193 (271)
T ss_dssp             --------------CCGGGSCHHHHHHCCCSH
T ss_pred             ccccccc-cccCCCCccceeCHHHhccCCCCc
Confidence            8754333 233457899999999998777654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.5e-35  Score=214.71  Aligned_cols=169  Identities=31%  Similarity=0.475  Sum_probs=141.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||.||+|.+..+++.+++|++..... ..+.+.+|+.++..++|||++++++++...+..+++||++
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   98 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC   98 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence            579999999999999999999999999999999875433 3467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc-CCCCCCc
Q 030211           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSRPKS  158 (181)
Q Consensus        81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~-~~~~~~~  158 (181)
                      ++++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++.... .......
T Consensus        99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~  176 (302)
T 2j7t_A           99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG--DIRLADFGVSAKNLKTLQKRDS  176 (302)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS--CEEECCCHHHHHHHHHHHC---
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC--CEEEEECCCCcccccccccccc
Confidence            99999888765 45799999999999999999999999999999999999997555  49999999875321 1122334


Q ss_pred             ccCCCCccCccccc
Q 030211          159 TVGTPAYIAPEVLS  172 (181)
Q Consensus       159 ~~~~~~~~aPE~~~  172 (181)
                      ..+++.|+|||.+.
T Consensus       177 ~~~~~~y~aPE~~~  190 (302)
T 2j7t_A          177 FIGTPYWMAPEVVM  190 (302)
T ss_dssp             --CCGGGCCHHHHH
T ss_pred             ccCChhhcCCeeec
Confidence            57899999999984

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.6e-35  Score=213.86  Aligned_cols=174  Identities=24%  Similarity=0.326  Sum_probs=136.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC---CcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|++.+.||+|+||.||+|.+..+   +..|++|.+.....  ..+.+.+|+..++.++|||++++++++. .+..+++
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence            6899999999999999999998643   45699998875432  2357888999999999999999999984 5678899


Q ss_pred             EeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      ||++.+++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++........
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~  171 (281)
T 1mp8_A           94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTY  171 (281)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECC------------
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC--CEEECccccccccCcccc
Confidence            99999999999887654 799999999999999999999999999999999999997555  499999999875543322


Q ss_pred             --CCcccCCCCccCcccccCCccCC
Q 030211          156 --PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                        .....+++.|+|||.+....+++
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~  196 (281)
T 1mp8_A          172 YKASKGKLPIKWMAPESINFRRFTS  196 (281)
T ss_dssp             -------CCGGGCCHHHHHHCCCSH
T ss_pred             cccccCCCcccccChhhcccCCCCC
Confidence              22234677899999998776654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.8e-35  Score=220.45  Aligned_cols=167  Identities=24%  Similarity=0.379  Sum_probs=142.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCC--CCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLR--HPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~--~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|++.+.||+|+||.||++.+.. ++.||+|++.....   ..+.+.+|+.++..++  |+|++++++++...+.++++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            359999999999999999999876 88999999875432   2356888999999986  59999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-  155 (181)
                      || +.+++|.+++.....+++..++.++.|++.||.|||++||+|+||||+||++++   +.++|+|||++........ 
T Consensus       135 ~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~---~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             EE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS---SCEEECCCSSSCCC------
T ss_pred             Ee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC---CeEEEEecCccccccCCCcc
Confidence            99 567899999988888999999999999999999999999999999999999953   3599999999976543322 


Q ss_pred             --CCcccCCCCccCcccccC
Q 030211          156 --PKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       156 --~~~~~~~~~~~aPE~~~~  173 (181)
                        .....|++.|+|||++.+
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~  230 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKD  230 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHC
T ss_pred             ccCCCCCcCCCccChHHhhh
Confidence              334579999999999975

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.6e-35  Score=211.19  Aligned_cols=173  Identities=24%  Similarity=0.352  Sum_probs=147.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|++|.||++.+. ++..|++|.+.......+.+.+|+.+++.++|||++++++++.+ +..+++||+++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   90 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence            58999999999999999999976 46689999998766666789999999999999999999998864 56889999999


Q ss_pred             CCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--CC
Q 030211           82 GGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PK  157 (181)
Q Consensus        82 ~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--~~  157 (181)
                      +++|.+++....  .+++..++.++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||++........  ..
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~  168 (279)
T 1qpc_A           91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL--SCKIADFGLARLIEDNEYTARE  168 (279)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECSSSCEECCT
T ss_pred             CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC--CEEECCCcccccccCccccccc
Confidence            999999886543  699999999999999999999999999999999999997554  499999999875543321  22


Q ss_pred             cccCCCCccCcccccCCccCC
Q 030211          158 STVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ...+++.|+|||.+.++.+++
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~  189 (279)
T 1qpc_A          169 GAKFPIKWTAPEAINYGTFTI  189 (279)
T ss_dssp             TCCCCTTTSCHHHHHHCEECH
T ss_pred             CCCCccCccChhhhccCCCCc
Confidence            345678899999998766653

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.3e-35  Score=221.06  Aligned_cols=171  Identities=30%  Similarity=0.488  Sum_probs=142.9

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcC------CeEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTP------THLAIV   76 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~------~~~~~v   76 (181)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+.....   ...+|+.+++.++|+|++++++++...      .+++++
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            69999999999999999999999999999999875432   234689999999999999999988542      247799


Q ss_pred             EeecCCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           77 MEYAAGGELFDRIC----NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        77 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      |||+++ ++...+.    ....+++..++.++.|++.||.|||++||+|+||||+||+++.+. ..++|+|||+++....
T Consensus       132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT-AVLKLCDFGSAKQLVR  209 (420)
T ss_dssp             EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECCT
T ss_pred             hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC-CeEEeccchhhhhccc
Confidence            999976 5554442    346799999999999999999999999999999999999997432 3589999999987666


Q ss_pred             CCCCCcccCCCCccCcccccCC-ccCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRR-EYDG  178 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~-~~~~  178 (181)
                      ........+++.|+|||++.+. .++.
T Consensus       210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~  236 (420)
T 1j1b_A          210 GEPNVSYICSRYYRAPELIFGATDYTS  236 (420)
T ss_dssp             TCCCCSCCSCTTSCCHHHHTTCSSCCT
T ss_pred             CCCceeeeeCCCcCCHHHHcCCCCCCc
Confidence            6666667899999999999764 5554

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.9e-35  Score=222.57  Aligned_cols=175  Identities=26%  Similarity=0.394  Sum_probs=147.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC--------CCCeeEEEEeEE----c
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR--------HPNIIRFKEVVL----T   69 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~--------~~~i~~~~~~~~----~   69 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.......+.+.+|+.+++.++        |+|++++++.+.    +
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~  116 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN  116 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence            6899999999999999999999999999999999866555677888999998885        778999999998    5


Q ss_pred             CCeEEEEEeecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CeeeeCCCCCCEEeccCC-----------
Q 030211           70 PTHLAIVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSA-----------  135 (181)
Q Consensus        70 ~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~-gi~h~dl~p~ni~i~~~~-----------  135 (181)
                      ....+++||++ ++++.+.+...  ..+++..++.++.|++.||.|||++ ||+|+||||+||+++.++           
T Consensus       117 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~  195 (397)
T 1wak_A          117 GTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT  195 (397)
T ss_dssp             EEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred             CceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence            56899999999 55666666543  4699999999999999999999998 999999999999996443           


Q ss_pred             ------------------------------------CCcEEEeecCCcccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          136 ------------------------------------APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       136 ------------------------------------~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                                                          ...++|+|||.+......  .....+|+.|+|||++.+..++.+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~  273 (397)
T 1wak_A          196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGYNTP  273 (397)
T ss_dssp             ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCCCTH
T ss_pred             HHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCCCCcH
Confidence                                                126999999999754332  344578999999999998887764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.6e-35  Score=218.03  Aligned_cols=174  Identities=27%  Similarity=0.341  Sum_probs=147.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|+||.||++.+. +++.||+|++.....  ....+.+|+.++..++|||++++++++.+++..+++|||
T Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  108 (326)
T 3uim_A           30 DNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY  108 (326)
T ss_dssp             TSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred             hccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence            68999999999999999999865 588899999876432  234688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhc---CeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           80 AAGGELFDRICNAG----RFSEDEGRYFFQQLISGVNYCHSM---QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        80 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~---gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      +.+++|.+++....    .+++..++.++.|++.||.+||++   |++|+||+|+||+++++.  .++|+|||++.....
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~  186 (326)
T 3uim_A          109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF--EAVVGDFGLAKLMDY  186 (326)
T ss_dssp             CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC--CEEECCCSSCEECCS
T ss_pred             ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC--CEEeccCccccccCc
Confidence            99999999886543    499999999999999999999999   999999999999997554  499999999975543


Q ss_pred             CCC--CCcccCCCCccCcccccCCccCC
Q 030211          153 HSR--PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       153 ~~~--~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ...  .....|++.|+|||++.+..+++
T Consensus       187 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~  214 (326)
T 3uim_A          187 KDTHVTTAVRGTIGHIAPEYLSTGKSSE  214 (326)
T ss_dssp             SSSCEECCCCSCGGGCCHHHHHHSEECH
T ss_pred             ccccccccccCCcCccCHHHhccCCCCc
Confidence            322  23345899999999998776654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.4e-35  Score=217.32  Aligned_cols=171  Identities=22%  Similarity=0.415  Sum_probs=148.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccccc------------------HHHHHHHHHHhhCCCCCeeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID------------------ENVAREIINHRSLRHPNIIRF   63 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~------------------~~~~~e~~~~~~~~~~~i~~~   63 (181)
                      ++|++.+.||+|+||.||+|.+  +++.||+|.+.......                  +.+.+|+.++..++|||++++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            6899999999999999999999  78999999987542211                  788999999999999999999


Q ss_pred             EEeEEcCCeEEEEEeecCCCChHHH------Hhh--cCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccC
Q 030211           64 KEVVLTPTHLAIVMEYAAGGELFDR------ICN--AGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGS  134 (181)
Q Consensus        64 ~~~~~~~~~~~~v~e~~~~~~l~~~------~~~--~~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~  134 (181)
                      ++++.+.+..+++|||+++++|.++      +..  ...+++..++.++.|++.||.+||+ +|++|+||+|+||+++.+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence            9999999999999999999999887      655  5679999999999999999999999 999999999999999755


Q ss_pred             CCCcEEEeecCCcccccCCCCCCcccCCCCccCcccccCC-ccC
Q 030211          135 AAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR-EYD  177 (181)
Q Consensus       135 ~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~  177 (181)
                      +  .++|+|||.+...... ......+++.|+|||.+.+. .++
T Consensus       189 ~--~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  229 (348)
T 2pml_X          189 G--RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYN  229 (348)
T ss_dssp             S--CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEE
T ss_pred             C--cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCC
Confidence            5  4999999998754333 33446789999999999876 443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.4e-35  Score=219.14  Aligned_cols=173  Identities=24%  Similarity=0.376  Sum_probs=135.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc------------cHHHHHHHHHHhhCCCCCeeEEEEeEEc
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI------------DENVAREIINHRSLRHPNIIRFKEVVLT   69 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~------------~~~~~~e~~~~~~~~~~~i~~~~~~~~~   69 (181)
                      ++|++.+.||+|+||.||++.+.. ++.||+|++......            .+.+.+|+.+++.++|||++++++++..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            689999999999999999999876 889999988653221            1578899999999999999999999854


Q ss_pred             -----CCeEEEEEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEee
Q 030211           70 -----PTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICD  143 (181)
Q Consensus        70 -----~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~d  143 (181)
                           ....+++||++. ++|.+.+... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.+.  .++|+|
T Consensus       101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~D  177 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN--DITICD  177 (362)
T ss_dssp             CCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECC
T ss_pred             ccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC--CEEEEe
Confidence                 346899999997 5777777544 3799999999999999999999999999999999999996555  499999


Q ss_pred             cCCcccccCCCCCCcccCCCCccCcccccC-CccCC
Q 030211          144 FGYSKSSVLHSRPKSTVGTPAYIAPEVLSR-REYDG  178 (181)
Q Consensus       144 fg~a~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~  178 (181)
                      ||++.............+++.|+|||++.+ ..+++
T Consensus       178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  213 (362)
T 3pg1_A          178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTK  213 (362)
T ss_dssp             TTC---------------CGGGCCHHHHTTCTTCCT
T ss_pred             cCcccccccccccceecccceecCcHHhcCCCCCCc
Confidence            999976666666666788999999999886 44544

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-34  Score=214.08  Aligned_cols=171  Identities=26%  Similarity=0.400  Sum_probs=140.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHh--hCCCCCeeEEEEeEEcC----CeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR--SLRHPNIIRFKEVVLTP----THLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~--~~~~~~i~~~~~~~~~~----~~~~~   75 (181)
                      ++|++.+.||+|+||.||++.+.  ++.||+|++.....  .....+..++.  .++|||++++++++...    +..++
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  112 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL  112 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence            57999999999999999999886  88999999865433  33344444444  45999999999999887    78999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CeeeeCCCCCCEEeccCCCCcEEEeecCCc
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM--------QICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a  147 (181)
                      +|||+++++|.+++.. ..+++..++.++.|++.||.+||++        |++|+||||+||+++.+.  .++|+|||++
T Consensus       113 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kl~Dfg~a  189 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLA  189 (337)
T ss_dssp             EECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS--CEEECCCTTC
T ss_pred             EEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC--CEEEEeCCCc
Confidence            9999999999998854 4799999999999999999999998        999999999999997555  4999999999


Q ss_pred             ccccCCCCC-----CcccCCCCccCcccccCCccCCC
Q 030211          148 KSSVLHSRP-----KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       148 ~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .........     ....|++.|+|||++.+...+.+
T Consensus       190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  226 (337)
T 3mdy_A          190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNH  226 (337)
T ss_dssp             EECC---------CCSSCSCGGGCCHHHHTTCCCTTC
T ss_pred             eeeccccccccCCCCCCccCcceeChhhcccccCCcc
Confidence            654333322     24578999999999987766543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.5e-35  Score=219.02  Aligned_cols=172  Identities=27%  Similarity=0.442  Sum_probs=130.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcC------Ce
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTP------TH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~------~~   72 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....   ..+.+.+|+.+++.++|||++++++++...      +.
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            589999999999999999999999999999999875432   235678899999999999999999998764      56


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      .+++++++ +++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++.....
T Consensus       109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTAD  184 (367)
T ss_dssp             CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECC---------
T ss_pred             EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC--CEEEeeccccccccc
Confidence            89999998 6788877754 6799999999999999999999999999999999999997555  499999999875432


Q ss_pred             CCCCCcccCCCCccCcccccC-CccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSR-REYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~  179 (181)
                        ......+++.|+|||++.+ ..++.+
T Consensus       185 --~~~~~~~t~~y~aPE~~~~~~~~~~~  210 (367)
T 2fst_X          185 --EMTGYVATRWYRAPEIMLNWMHYNQT  210 (367)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTT
T ss_pred             --cCCCcCcCcCccChHHHcCCcCCCch
Confidence              2344678999999999987 556544

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3e-35  Score=225.48  Aligned_cols=174  Identities=26%  Similarity=0.355  Sum_probs=148.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|+||.||++.+.. +..||+|.+.......+.+.+|+.+++.++|||++++++++. .+..+++|||+.
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~  265 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA  265 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence            579999999999999999999864 677999999876666788999999999999999999999986 567899999999


Q ss_pred             CCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC--CCC
Q 030211           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPK  157 (181)
Q Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~--~~~  157 (181)
                      +++|.+++...  ..++...++.++.|++.||+|||++|++|+||+|+||+++.+.  .++|+|||+++......  ...
T Consensus       266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DFG~a~~~~~~~~~~~~  343 (454)
T 1qcf_A          266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTARE  343 (454)
T ss_dssp             TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC--CEEECSTTGGGGBCCHHHHTTC
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC--cEEEeeCCCceEcCCCceeccC
Confidence            99999998643  3689999999999999999999999999999999999997554  49999999997543221  122


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...+++.|+|||++..+.++.+
T Consensus       344 ~~~~~~~y~aPE~~~~~~~~~~  365 (454)
T 1qcf_A          344 GAKFPIKWTAPEAINFGSFTIK  365 (454)
T ss_dssp             SSSSCGGGSCHHHHHHCCCCHH
T ss_pred             CCcccccccCHHHhccCCCCcH
Confidence            3346778999999987777643

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=8.6e-35  Score=218.54  Aligned_cols=176  Identities=29%  Similarity=0.379  Sum_probs=149.7

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC-CC-----CeeEEEEeEEcCCeEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HP-----NIIRFKEVVLTPTHLA   74 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~-~~-----~i~~~~~~~~~~~~~~   74 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.........+..|+.++..++ |+     +++.+.+++...+..+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            36899999999999999999999999999999999865544566777888777664 44     4999999999999999


Q ss_pred             EEEeecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--hcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccc
Q 030211           75 IVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCH--SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSS  150 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh--~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~  150 (181)
                      +|||++++ +|.+++...  ..+++..++.++.|++.||.+||  +.||+|+||||+||+++++..+.++|+|||++...
T Consensus       133 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             EEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence            99999965 998888665  36899999999999999999999  57999999999999997655667999999999754


Q ss_pred             cCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          151 VLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       151 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..  ......+++.|+|||++.+.+++++
T Consensus       212 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~  238 (382)
T 2vx3_A          212 GQ--RIYQYIQSRFYRSPEVLLGMPYDLA  238 (382)
T ss_dssp             TC--CCCSSCSCGGGCCHHHHTTCCCCTH
T ss_pred             cc--ccccccCCccccChHHHcCCCCCcH
Confidence            32  3345678999999999999888764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.5e-35  Score=215.80  Aligned_cols=170  Identities=30%  Similarity=0.485  Sum_probs=128.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+....  ...+.+.+|+.++..++|||++++++++...+..+++|||
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   94 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL   94 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence            68999999999999999999998889999999886542  2345678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           80 AAGGELFDRICN--------AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        80 ~~~~~l~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      +++++|.+++..        ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.  ++|+|||++....
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~  172 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLA  172 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCHHHHHCC
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEeccchheec
Confidence            999999988753        456999999999999999999999999999999999999975554  9999999986543


Q ss_pred             CCC------CCCcccCCCCccCcccccC
Q 030211          152 LHS------RPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       152 ~~~------~~~~~~~~~~~~aPE~~~~  173 (181)
                      ...      ......+++.|+|||++.+
T Consensus       173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~  200 (303)
T 2vwi_A          173 TGGDITRNKVRKTFVGTPCWMAPEVMEQ  200 (303)
T ss_dssp             ---------------CCCTTCCHHHHHH
T ss_pred             cCCCccchhhhcccCCCccccCHHHhcc
Confidence            322      1234568999999999865

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.6e-35  Score=213.54  Aligned_cols=172  Identities=26%  Similarity=0.399  Sum_probs=143.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEE----cCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVL----TPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~----~~~~~~~v   76 (181)
                      ++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.+++.++|||++++++++.    ..+..+++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            579999999999999999999998999999998865432 3467889999999999999999999987    34578999


Q ss_pred             EeecCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           77 MEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      |||+.+++|.+++..    ...+++..++.++.|++.||.+||++|++|+||+|+||+++.+..  ++|+|||.+.....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~  186 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQACI  186 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCEESCE
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcchhccc
Confidence            999999999988865    467999999999999999999999999999999999999975554  99999998864332


Q ss_pred             CCCC----------CcccCCCCccCcccccCCc
Q 030211          153 HSRP----------KSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       153 ~~~~----------~~~~~~~~~~aPE~~~~~~  175 (181)
                      ....          ....+++.|+|||.+....
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  219 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQS  219 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCC
Confidence            1111          1234689999999987554

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.4e-35  Score=211.76  Aligned_cols=166  Identities=28%  Similarity=0.381  Sum_probs=137.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhh--CCCCCeeEEEEeEEc----CCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS--LRHPNIIRFKEVVLT----PTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~--~~~~~i~~~~~~~~~----~~~~~~   75 (181)
                      ++|++.+.||+|+||.||++.+  +++.||+|++....  ...+..|..++..  ++|||++++++++.+    .+..++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            6899999999999999999987  48899999987543  2444455555554  799999999998654    356899


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCeeeeCCCCCCEEeccCCCCcEEEeecCCc
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH--------SMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--------~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a  147 (181)
                      +|||+++++|.+++. ...+++..++.++.|++.||.|||        ++|++|+||||+||+++.+.  .++|+|||++
T Consensus        84 v~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~a  160 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG--QCCIADLGLA  160 (301)
T ss_dssp             EECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS--CEEECCCTTC
T ss_pred             ehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC--CEEEeeCCCe
Confidence            999999999999884 457999999999999999999999        99999999999999997555  4999999998


Q ss_pred             ccccCCCC-----CCcccCCCCccCcccccCC
Q 030211          148 KSSVLHSR-----PKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       148 ~~~~~~~~-----~~~~~~~~~~~aPE~~~~~  174 (181)
                      ........     .....|++.|+|||++.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  192 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET  192 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTC
T ss_pred             eecccccccccccccccccccceeChhhhcCc
Confidence            65433322     2334789999999999876

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.9e-35  Score=216.19  Aligned_cols=175  Identities=21%  Similarity=0.298  Sum_probs=147.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||.||+|.+.     .+++.||+|.+......  ...+.+|+.+++.++|||++++++++.+.+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  104 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL  104 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence            57999999999999999999876     45778999998754332  346888999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeec
Q 030211           75 IVMEYAAGGELFDRICNA----------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~df  144 (181)
                      ++||++++++|.+++...          ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+||
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~--~~kl~Df  182 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDF  182 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC--CEEECCT
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC--eEEECcC
Confidence            999999999999888642          3578999999999999999999999999999999999997555  4999999


Q ss_pred             CCcccccCCCC---CCcccCCCCccCcccccCCccCC
Q 030211          145 GYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       145 g~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      |++........   .....+++.|+|||++.+..++.
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  219 (322)
T 1p4o_A          183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT  219 (322)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH
T ss_pred             ccccccccccccccccCCCCCCCccChhhhccCCCCc
Confidence            99875433322   12234678899999998777654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-34  Score=216.50  Aligned_cols=173  Identities=30%  Similarity=0.474  Sum_probs=145.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcC-----CeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTP-----THLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~   74 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......  .+.+.+|+.++..++|||++++++++..+     ...+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            4899999999999999999999999999999998754322  36788999999999999999999999765     3689


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      ++||++.+ +|.+.+.. ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.  ++|+|||++.......
T Consensus       107 iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          107 IVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGG
T ss_pred             EEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCCCC
Confidence            99999964 88887754 57999999999999999999999999999999999999975554  9999999997554332


Q ss_pred             C----CCcccCCCCccCcccccCCc-cCC
Q 030211          155 R----PKSTVGTPAYIAPEVLSRRE-YDG  178 (181)
Q Consensus       155 ~----~~~~~~~~~~~aPE~~~~~~-~~~  178 (181)
                      .    .....+++.|+|||++.+.. +++
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  211 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTK  211 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCST
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCc
Confidence            2    23457899999999876543 554

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.5e-35  Score=213.74  Aligned_cols=176  Identities=32%  Similarity=0.572  Sum_probs=146.6

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEc--CCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLT--PTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~   75 (181)
                      +++|++.+.||+|++|.||++.+..+++.|++|.+.....   ..+.+.+|+.+++.++|||++++++++.+  .+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            3789999999999999999999999999999999875432   23568889999999999999999998754  578999


Q ss_pred             EEeecCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcC-----eeeeCCCCCCEEeccCCCCcEEEeecCC
Q 030211           76 VMEYAAGGELFDRICNA----GRFSEDEGRYFFQQLISGVNYCHSMQ-----ICHRDLKLENTLLDGSAAPRLKICDFGY  146 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~g-----i~h~dl~p~ni~i~~~~~~~v~l~dfg~  146 (181)
                      +|||+++++|.+++...    ..+++..++.++.|++.||.+||++|     ++|+||+|+||+++.+.  .++|+|||.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~--~~kl~dfg~  162 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGL  162 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS--CEEECCCCH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC--CEEEecCch
Confidence            99999999999888653    34999999999999999999999999     99999999999997555  499999999


Q ss_pred             cccccCCCC-CCcccCCCCccCcccccCCccCC
Q 030211          147 SKSSVLHSR-PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       147 a~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      +........ .....+++.|+|||.+.+..+++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  195 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNE  195 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCH
T ss_pred             heeeccccccccccCCCccccChHHhccCCCCc
Confidence            865433221 22346899999999998877654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3e-35  Score=217.09  Aligned_cols=175  Identities=24%  Similarity=0.304  Sum_probs=147.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCc-----EEEEEEcccccc--ccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKE-----LVAVKYIERGRK--IDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~-----~v~~K~~~~~~~--~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~   73 (181)
                      ++|++.+.||+|+||.||+|.+..+++     .|++|.+.....  ..+.+.+|+.++..+ +|||++++++++.+++..
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            579999999999999999999876554     799999876432  235688999999999 899999999999999999


Q ss_pred             EEEEeecCCCChHHHHhh--------------cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcE
Q 030211           74 AIVMEYAAGGELFDRICN--------------AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL  139 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v  139 (181)
                      +++|||+++++|.+++..              ...+++..++.++.|++.||.+||++|++|+||+|+||+++++.  .+
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--~~  203 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH--VA  203 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG--EE
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC--eE
Confidence            999999999999988864              23589999999999999999999999999999999999997555  49


Q ss_pred             EEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCC
Q 030211          140 KICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       140 ~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      +|+|||++........   .....+++.|+|||.+.+..+++
T Consensus       204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  245 (333)
T 2i1m_A          204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV  245 (333)
T ss_dssp             EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCH
T ss_pred             EECccccccccccccceeecCCCCCCccccCHHHhccCCCCh
Confidence            9999999975433322   22345678899999988776654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.2e-35  Score=212.23  Aligned_cols=174  Identities=25%  Similarity=0.323  Sum_probs=143.9

Q ss_pred             ccceeee-eeCCccceeEEEEEE--ccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVK-DLGAGNFGVARLLRH--KETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~-~i~~g~~~~v~~~~~--~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|++.+ .||+|+||.||++.+  ..+++.|++|++......   .+.+.+|+.+++.++|||++++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            5789998 999999999999954  556788999998764322   46788999999999999999999999 5667899


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      +||++++++|.+++..+..+++..++.++.|++.||.+||++|++|+||+|+||+++.+.  .++|+|||++........
T Consensus        95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADEN  172 (291)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCS
T ss_pred             EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC--cEEEccCCcceeeccCCC
Confidence            999999999999998888899999999999999999999999999999999999997655  599999999875543322


Q ss_pred             C----CcccCCCCccCcccccCCccCC
Q 030211          156 P----KSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       156 ~----~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      .    ....+++.|+|||.+.+..+++
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~  199 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYYKFSS  199 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEH
T ss_pred             cccccccCCCCceeeChHHhccCCCCh
Confidence            1    1234568899999987766543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.6e-34  Score=212.44  Aligned_cols=175  Identities=29%  Similarity=0.454  Sum_probs=145.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-cCCcEEEEEEcccccc---ccHHHHHHHHHHhhC---CCCCeeEEEEeEE-----c
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-ETKELVAVKYIERGRK---IDENVAREIINHRSL---RHPNIIRFKEVVL-----T   69 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~---~~~~i~~~~~~~~-----~   69 (181)
                      ++|++.+.||+|+||.||+|.+. .+++.||+|++.....   ....+.+|+.+++.+   +|||++++++++.     .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            68999999999999999999995 6788999999865332   224566677666555   8999999999987     4


Q ss_pred             CCeEEEEEeecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCc
Q 030211           70 PTHLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (181)
Q Consensus        70 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a  147 (181)
                      ....+++||++. ++|.+++....  .+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~--~~kl~Dfg~~  167 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLA  167 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECSCCSC
T ss_pred             CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC--CEEEecCccc
Confidence            567899999997 59988887643  499999999999999999999999999999999999997555  4999999999


Q ss_pred             ccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          148 KSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .............+++.|+|||++.+..++++
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  199 (326)
T 1blx_A          168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP  199 (326)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH
T ss_pred             ccccCCCCccccccccceeCHHHHhcCCCCcc
Confidence            76554444455678999999999998877654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.3e-36  Score=226.72  Aligned_cols=167  Identities=16%  Similarity=0.091  Sum_probs=136.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHH---HHHhhCCCCCeeEEE-------EeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREI---INHRSLRHPNIIRFK-------EVV   67 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~---~~~~~~~~~~i~~~~-------~~~   67 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....    ...+.+.+|+   ..++.++|||+++++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            57999999999999999999998889999999987432    2236778888   455566899999988       776


Q ss_pred             EcCCe-----------------EEEEEeecCCCChHHHHhhcCCCCH-------HHHHHHHHHHHHHHHHHHhcCeeeeC
Q 030211           68 LTPTH-----------------LAIVMEYAAGGELFDRICNAGRFSE-------DEGRYFFQQLISGVNYCHSMQICHRD  123 (181)
Q Consensus        68 ~~~~~-----------------~~~v~e~~~~~~l~~~~~~~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~h~d  123 (181)
                      .+++.                 .+++|||+ +++|.+++.....+++       ..++.++.|++.||+|||++||+|+|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD  231 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  231 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            66542                 88999999 5799998876554555       78888999999999999999999999


Q ss_pred             CCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccCCCCccCcccccCC
Q 030211          124 LKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       124 l~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~  174 (181)
                      |||+||+++.++  .++|+|||++....  .......| +.|+|||++.+.
T Consensus       232 ikp~NIll~~~~--~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~  277 (377)
T 3byv_A          232 LRPVDIVLDQRG--GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARR  277 (377)
T ss_dssp             CCGGGEEECTTC--CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHH
T ss_pred             CCHHHEEEcCCC--CEEEEechhheecC--CcccCCCC-cCccChhhhccc
Confidence            999999997555  59999999997522  22334567 999999999876

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.2e-34  Score=213.11  Aligned_cols=173  Identities=28%  Similarity=0.427  Sum_probs=148.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-------ccHHHHHHHHHHhhCC--CCCeeEEEEeEEcCCe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLR--HPNIIRFKEVVLTPTH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~~~~~~--~~~i~~~~~~~~~~~~   72 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.....       ..+.+.+|+.+++.++  |+|++++++++..++.
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~  122 (320)
T 3a99_A           43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS  122 (320)
T ss_dssp             TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence            589999999999999999999999999999999876432       1245677888888885  5999999999999999


Q ss_pred             EEEEEeecCC-CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           73 LAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        73 ~~~v~e~~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      .++++|++.+ ++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||+++. ..+.++|+|||++....
T Consensus       123 ~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~~kL~Dfg~~~~~~  201 (320)
T 3a99_A          123 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK  201 (320)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTTEEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC-CCCCEEEeeCccccccc
Confidence            9999999976 799999988888999999999999999999999999999999999999962 23359999999987544


Q ss_pred             CCCCCCcccCCCCccCcccccCCcc
Q 030211          152 LHSRPKSTVGTPAYIAPEVLSRREY  176 (181)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~  176 (181)
                      . .......+++.|+|||++.+..+
T Consensus       202 ~-~~~~~~~gt~~y~aPE~~~~~~~  225 (320)
T 3a99_A          202 D-TVYTDFDGTRVYSPPEWIRYHRY  225 (320)
T ss_dssp             S-SCBCCCCSCGGGSCHHHHHHSCB
T ss_pred             c-ccccCCCCCccCCChHHhccCCC
Confidence            3 23344578999999999876654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-35  Score=214.71  Aligned_cols=175  Identities=26%  Similarity=0.323  Sum_probs=141.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCC----cEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETK----ELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~----~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|++.+.||+|+||.||+|.+..++    ..||+|.+.....  ....+.+|+.++..++|||++++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            57899999999999999999986543    3599999875432  23568889999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +||++++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.+.  .++|+|||++.......
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~~~~  201 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDP  201 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC--------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC--cEEECCCCcchhhcccc
Confidence            99999999999988764 5799999999999999999999999999999999999997554  59999999987543322


Q ss_pred             C----CCcccCCCCccCcccccCCccCC
Q 030211          155 R----PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       155 ~----~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      .    .....+++.|+|||.+.+..+++
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~  229 (333)
T 1mqb_A          202 EATYTTSGGKIPIRWTAPEAISYRKFTS  229 (333)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCH
T ss_pred             ccccccCCCCccccccCchhcccCCCCc
Confidence            1    12234577899999998877664

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-35  Score=219.88  Aligned_cols=173  Identities=12%  Similarity=0.146  Sum_probs=144.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc--------CCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeE-----------
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE--------TKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR-----------   62 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~--------~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~-----------   62 (181)
                      ++|++.+.||+|+||.||+|.+..        .++.||+|.+...    +.+.+|+.++..++|||+++           
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence            589999999999999999999987        4789999998754    46778999999999988776           


Q ss_pred             ----EEEeEEc-CCeEEEEEeecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC
Q 030211           63 ----FKEVVLT-PTHLAIVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (181)
Q Consensus        63 ----~~~~~~~-~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~  135 (181)
                          +++++.. .+..+++|||+ +++|.+++...  ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+.
T Consensus       118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~  196 (352)
T 2jii_A          118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED  196 (352)
T ss_dssp             SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred             CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence                6777765 77899999999 88999999875  6899999999999999999999999999999999999997655


Q ss_pred             CCcEEEeecCCcccccCCCC--------CCcccCCCCccCcccccCCccCCC
Q 030211          136 APRLKICDFGYSKSSVLHSR--------PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       136 ~~~v~l~dfg~a~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...++|+|||++........        .....+++.|+|||++.+..++++
T Consensus       197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  248 (352)
T 2jii_A          197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR  248 (352)
T ss_dssp             EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH
T ss_pred             CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCch
Confidence            33699999999975443221        233478999999999998777643

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5e-35  Score=215.56  Aligned_cols=177  Identities=22%  Similarity=0.292  Sum_probs=144.0

Q ss_pred             ccceeeeeeCCccceeEEEEE-----EccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLR-----HKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~-----~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||.||++.     +..++..||+|.+....  .....+.+|+.+++.++|||++++++++.+.+..+
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            689999999999999999999     45678899999986432  22356888999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-CCcEEEeecCC
Q 030211           75 IVMEYAAGGELFDRICNA-------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGY  146 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-~~~v~l~dfg~  146 (181)
                      ++||++++++|.+++...       ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++ ...++|+|||+
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~  189 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  189 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence            999999999999998765       3488999999999999999999999999999999999996433 34699999999


Q ss_pred             cccccCC---CCCCcccCCCCccCcccccCCccCC
Q 030211          147 SKSSVLH---SRPKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       147 a~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      +......   .......+++.|+|||.+.+..+++
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  224 (327)
T 2yfx_A          190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTS  224 (327)
T ss_dssp             HHHHHC------CCGGGSCGGGCCHHHHHHCCCCH
T ss_pred             ccccccccccccCCCcCCCcceeCHhHhcCCCCCc
Confidence            8643222   2233456788999999998777654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.3e-34  Score=218.30  Aligned_cols=172  Identities=29%  Similarity=0.435  Sum_probs=140.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC------eEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPT------HLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~------~~~~   75 (181)
                      .+|++.+.||+|+||.||+|.+..++. +|+|.+......   ..+|+.+++.++|||++++++++...+      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            479999999999999999999987665 888877654322   236899999999999999999996543      3889


Q ss_pred             EEeecCCCChHHH---HhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           76 VMEYAAGGELFDR---ICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        76 v~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      +|||++++.+...   ......+++..++.++.|++.||+|||++||+|+||||+||+++. ..+.++|+|||+|+....
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~-~~~~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP-PSGVLKLIDFGSAKILIA  194 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEEEECCCTTCEECCT
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC-CCCcEEEeeCCCcccccC
Confidence            9999977433222   223567999999999999999999999999999999999999962 334599999999987766


Q ss_pred             CCCCCcccCCCCccCcccccCCc-cCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRRE-YDG  178 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~-~~~  178 (181)
                      ........+++.|+|||++.+.. ++.
T Consensus       195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~  221 (394)
T 4e7w_A          195 GEPNVSYICSRYYRAPELIFGATNYTT  221 (394)
T ss_dssp             TCCCCSSCSCGGGCCHHHHTTCSSCCT
T ss_pred             CCCCcccccCcCccCHHHHcCCCCCCc
Confidence            66667788999999999997643 554

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=213.47  Aligned_cols=175  Identities=29%  Similarity=0.463  Sum_probs=146.5

Q ss_pred             ccceeeeeeCCccceeEEEEE----EccCCcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEEEEeEEcCC--eEE
Q 030211            2 EKYELVKDLGAGNFGVARLLR----HKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPT--HLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~----~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--~~~   74 (181)
                      ++|++.+.||+|++|.||++.    +..+++.||+|.+...... .+.+.+|+.+++.++|||++++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            479999999999999999998    4567889999998764332 367889999999999999999999987654  689


Q ss_pred             EEEeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           75 IVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      ++||++++++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||++++++  .++|+|||++......
T Consensus       121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--~~kL~Dfg~~~~~~~~  198 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN--RVKIGDFGLTKVLPQD  198 (326)
T ss_dssp             EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCSS
T ss_pred             EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC--cEEEecCcchhhcccc
Confidence            9999999999999987654 699999999999999999999999999999999999997655  4999999999765433


Q ss_pred             CC----CCcccCCCCccCcccccCCccCC
Q 030211          154 SR----PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       154 ~~----~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ..    .....++..|+|||.+.+..+++
T Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  227 (326)
T 2w1i_A          199 KEYYKVKEPGESPIFWYAPESLTESKFSV  227 (326)
T ss_dssp             CSEEECSSCCSCCGGGCCHHHHHHCEEEH
T ss_pred             ccccccccCCCCceeEECchhhcCCCCCc
Confidence            22    22335677899999988766543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-34  Score=209.53  Aligned_cols=171  Identities=31%  Similarity=0.493  Sum_probs=142.3

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc-----cccHHHHHHHHHHhhCCCCCeeEEEEeEE--cCCeE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-----KIDENVAREIINHRSLRHPNIIRFKEVVL--TPTHL   73 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~--~~~~~   73 (181)
                      +++|++.+.||+|+||.||++.+..+++.+++|++....     ...+.+.+|+.+++.++|||++++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            479999999999999999999999999999999987542     23467889999999999999999999984  45679


Q ss_pred             EEEEeecCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           74 AIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      +++|||+.++ +.+.+..  ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++....
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~--~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG--TLKISALGVAEALH  160 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC--cEEeeccccccccC
Confidence            9999999775 6666654  34799999999999999999999999999999999999997555  49999999987654


Q ss_pred             CCC---CCCcccCCCCccCcccccCC
Q 030211          152 LHS---RPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       152 ~~~---~~~~~~~~~~~~aPE~~~~~  174 (181)
                      ...   ......+++.|+|||++.+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~  186 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGL  186 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCC
T ss_pred             ccccccccccCCCCCCCcChhhccCc
Confidence            322   22345689999999998764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.9e-35  Score=223.35  Aligned_cols=174  Identities=25%  Similarity=0.325  Sum_probs=144.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|+||.||++.+.. +..||+|.+.......+.+.+|+.+++.++|||++++++++.+ +..+++|||++
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~  261 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  261 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence            579999999999999999999875 4669999998766556789999999999999999999999876 67899999999


Q ss_pred             CCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--CC
Q 030211           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PK  157 (181)
Q Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--~~  157 (181)
                      +++|.+++...  ..++...+..++.|++.||+|||++|++|+||+|+||+++++.  .++|+|||++........  ..
T Consensus       262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~~  339 (452)
T 1fmk_A          262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNEYTARQ  339 (452)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCTTC-----------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC--CEEECCCccceecCCCceeccc
Confidence            99999998643  4689999999999999999999999999999999999997555  499999999975433221  22


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...+++.|+|||.+..+.++++
T Consensus       340 ~~~~~~~y~aPE~~~~~~~~~~  361 (452)
T 1fmk_A          340 GAKFPIKWTAPEAALYGRFTIK  361 (452)
T ss_dssp             ---CCGGGSCHHHHHHCCCCHH
T ss_pred             CCcccccccCHhHHhcCCCCcc
Confidence            3446788999999987777643

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7.7e-34  Score=206.23  Aligned_cols=176  Identities=25%  Similarity=0.258  Sum_probs=146.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCee-EEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII-RFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~-~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|++|.||++.+..+++.||+|++.... ..+.+.+|+.++..++|++.+ .+..++...+..+++||++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            68999999999999999999999899999999887543 345688999999999887654 4555557778899999999


Q ss_pred             CCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEec-cCCCCcEEEeecCCcccccCCCC---
Q 030211           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLD-GSAAPRLKICDFGYSKSSVLHSR---  155 (181)
Q Consensus        81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~-~~~~~~v~l~dfg~a~~~~~~~~---  155 (181)
                       +++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++ ++..+.++|+|||++........   
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (296)
T 3uzp_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  166 (296)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred             -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccc
Confidence             8899998863 45799999999999999999999999999999999999993 11233599999999975543322   


Q ss_pred             -----CCcccCCCCccCcccccCCccCCC
Q 030211          156 -----PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 -----~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                           .....+++.|+|||.+.+..++++
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  195 (296)
T 3uzp_A          167 IPYRENKNLTGTARYASINTHLGIEQSRR  195 (296)
T ss_dssp             CCCCCSCCCCSCTTTCCHHHHTTCCCCHH
T ss_pred             cccccccccccccccCChhhhcCCCCCcc
Confidence                 244578999999999998877643

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.4e-34  Score=211.83  Aligned_cols=176  Identities=25%  Similarity=0.325  Sum_probs=137.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc---CCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCC----
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE---TKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPT----   71 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~----   71 (181)
                      ++|++.+.||+|+||.||+|.+..   ++..||+|.+......   .+.+.+|+.+++.++|||++++++++.+.+    
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            589999999999999999998764   4558999998754322   356888999999999999999999998765    


Q ss_pred             -eEEEEEeecCCCChHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeec
Q 030211           72 -HLAIVMEYAAGGELFDRIC------NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (181)
Q Consensus        72 -~~~~v~e~~~~~~l~~~~~------~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~df  144 (181)
                       ..+++||++++++|.+++.      ....+++..++.++.|++.||.+||++|++|+||+|+||+++++.  .++|+||
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--~~kl~Df  191 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM--TVCVADF  191 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS--CEEECSC
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--cEEEeec
Confidence             3599999999999998873      335699999999999999999999999999999999999997555  4999999


Q ss_pred             CCcccccCCC---CCCcccCCCCccCcccccCCccCCC
Q 030211          145 GYSKSSVLHS---RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       145 g~a~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      |++.......   ......+++.|+|||.+.+..++++
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  229 (313)
T 3brb_A          192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK  229 (313)
T ss_dssp             SCC----------------CCGGGSCHHHHHSSCCCHH
T ss_pred             CcceecccccccCcccccCCCccccCchhhcCCCccch
Confidence            9987553332   1223456789999999988777643

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.1e-35  Score=215.37  Aligned_cols=175  Identities=24%  Similarity=0.358  Sum_probs=146.1

Q ss_pred             ccceeeeeeCCccceeEEEEEE-----ccCCcEEEEEEccccccc--cHHHHHHHHHHhhC-CCCCeeEEEEeEEcCC-e
Q 030211            2 EKYELVKDLGAGNFGVARLLRH-----KETKELVAVKYIERGRKI--DENVAREIINHRSL-RHPNIIRFKEVVLTPT-H   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~-----~~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~-~   72 (181)
                      ++|++.+.||+|+||.||+|.+     ..+++.||+|++......  .+.+.+|+.++..+ +|||++++++++...+ .
T Consensus        27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  106 (316)
T 2xir_A           27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  106 (316)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence            5899999999999999999985     346788999998765332  35688899999998 6899999999988754 5


Q ss_pred             EEEEEeecCCCChHHHHhhcCC----------------CCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCC
Q 030211           73 LAIVMEYAAGGELFDRICNAGR----------------FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA  136 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~----------------~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~  136 (181)
                      ++++|||+++++|.+++.....                +++..++.++.|++.||.+||++|++|+||+|+||+++.++.
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~  186 (316)
T 2xir_A          107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  186 (316)
T ss_dssp             CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC
Confidence            8999999999999999876543                889999999999999999999999999999999999975554


Q ss_pred             CcEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCC
Q 030211          137 PRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       137 ~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                        ++|+|||++........   .....+++.|+|||++.+..++.
T Consensus       187 --~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  229 (316)
T 2xir_A          187 --VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI  229 (316)
T ss_dssp             --EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred             --EEECCCccccccccCccceeccCCCcceeecCchhhccccccc
Confidence              99999999875543322   22345788999999998777654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.5e-34  Score=216.52  Aligned_cols=171  Identities=29%  Similarity=0.444  Sum_probs=142.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeE-----
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHL-----   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~-----   73 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......   .+.+.+|+.+++.++|||++++++++...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            5899999999999999999999999999999998764322   35778899999999999999999999887654     


Q ss_pred             -EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           74 -AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        74 -~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                       +++||++. ++|.+.+.  ..+++..++.++.|++.||.+||++|++|+||+|+||+++.+.  .++|+|||++.....
T Consensus       122 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC--ELKILDFGLARHADA  196 (371)
T ss_dssp             CEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECSTTCC-----
T ss_pred             EEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC--CEEEEecCccccccc
Confidence             99999996 57877663  3499999999999999999999999999999999999997555  499999999875432


Q ss_pred             CCCCCcccCCCCccCcccccC-CccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSR-REYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~  179 (181)
                        ......+++.|+|||++.+ ..++.+
T Consensus       197 --~~~~~~~t~~y~aPE~~~~~~~~~~~  222 (371)
T 4exu_A          197 --EMTGYVVTRWYRAPEVILSWMHYNQT  222 (371)
T ss_dssp             -----CTTCCCTTSCHHHHSCCSCCCTT
T ss_pred             --CcCCcccCccccCHHHhcCCCCCCcH
Confidence              2344678999999999987 556554

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.9e-34  Score=205.90  Aligned_cols=170  Identities=17%  Similarity=0.305  Sum_probs=145.2

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcC--CeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTP--THLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~   75 (181)
                      +++|++.+.||+|+||.||++.+.  ++.+|+|++......   .+.+.+|+.+++.++|||++++++++.++  +..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            478999999999999999999986  788999998764322   35688899999999999999999999887  78899


Q ss_pred             EEeecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcC--eeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           76 VMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~g--i~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      +|||+++++|.+++....  .+++..++.++.|++.||.|||++|  ++|+||+|+||++++++.  ++|.|||++..  
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~--  162 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFS--  162 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCT--
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccceee--
Confidence            999999999999997765  4899999999999999999999999  999999999999976655  77877776543  


Q ss_pred             CCCCCCcccCCCCccCcccccCCccCC
Q 030211          152 LHSRPKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                        .......+++.|+|||.+.+..++.
T Consensus       163 --~~~~~~~~t~~y~aPE~~~~~~~~~  187 (271)
T 3kmu_A          163 --FQSPGRMYAPAWVAPEALQKKPEDT  187 (271)
T ss_dssp             --TSCTTCBSCGGGSCHHHHHSCGGGS
T ss_pred             --ecccCccCCccccChhhhccCCCCC
Confidence              2223456789999999998766554

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.5e-34  Score=211.73  Aligned_cols=168  Identities=25%  Similarity=0.343  Sum_probs=124.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc--cHHHHHHHH-HHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI--DENVAREII-NHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~-~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++.+.||+|+||.||++.+..+++.||+|++......  ...+..|.. +++.++|||++++++++.+++..+++||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            6899999999999999999999989999999998764322  234445554 6777899999999999999999999999


Q ss_pred             ecCCCChHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           79 YAAGGELFDRICN-----AGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        79 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~-gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ++.+ +|.+++..     ...+++..+..++.|++.||.+||++ |++|+||+|+||+++.++  .++|+|||++.....
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~~~~~~~  178 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQLVD  178 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT--EEEECCCSSSCC---
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC--CEEEccCCCceeccc
Confidence            9975 77666642     56799999999999999999999999 999999999999997554  599999999976655


Q ss_pred             CCCCCcccCCCCccCccccc
Q 030211          153 HSRPKSTVGTPAYIAPEVLS  172 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~  172 (181)
                      ........+++.|+|||++.
T Consensus       179 ~~~~~~~~gt~~y~aPE~~~  198 (327)
T 3aln_A          179 SIAKTRDAGCRPYMAPERID  198 (327)
T ss_dssp             --------------------
T ss_pred             ccccccCCCCccccCceeec
Confidence            54455557899999999983

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.8e-34  Score=213.20  Aligned_cols=175  Identities=25%  Similarity=0.353  Sum_probs=146.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCC-cEEEEEEccccccccHHHHHHHHHHhhCCCCC------eeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETK-ELVAVKYIERGRKIDENVAREIINHRSLRHPN------IIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~-~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~------i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||.||+|.+..++ +.||+|++.......+.+.+|+.+++.++|++      ++.+.+++...+..+
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~   98 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC   98 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence            68999999999999999999998766 68999999865555567788888888776544      899999999999999


Q ss_pred             EEEeecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccC-----------------C
Q 030211           75 IVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-----------------A  135 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~-----------------~  135 (181)
                      ++||++ ++++.+.+....  .+++..++.++.|++.||.+||++|++|+||+|+||+++.+                 .
T Consensus        99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~  177 (355)
T 2eu9_A           99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK  177 (355)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred             EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccC
Confidence            999999 557776665543  69999999999999999999999999999999999999432                 3


Q ss_pred             CCcEEEeecCCcccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          136 APRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       136 ~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...++|+|||++.....  ......+++.|+|||++.+..++.+
T Consensus       178 ~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~  219 (355)
T 2eu9_A          178 NTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQP  219 (355)
T ss_dssp             CCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTH
T ss_pred             CCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCc
Confidence            45699999999875332  3344678999999999998887654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-34  Score=208.50  Aligned_cols=175  Identities=25%  Similarity=0.363  Sum_probs=145.6

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCc---EEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeE-EEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKE---LVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHL-AIV   76 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~---~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~-~~v   76 (181)
                      +|++.+.||+|+||.||+|.+..++.   .+++|.+......  .+.+.+|+.+++.++|||++++++++.+.+.. +++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46778999999999999999765544   7999998754332  35788999999999999999999999877665 999


Q ss_pred             EeecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC--
Q 030211           77 MEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH--  153 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~--  153 (181)
                      +|++.+++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||++++++  .++|+|||++......  
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF--TVKVADFGLARDILDREY  179 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECCTTSSCTTTTGGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--cEEeCcCCCcccccCCcc
Confidence            999999999998876 34789999999999999999999999999999999999997555  4999999998744322  


Q ss_pred             ---CCCCcccCCCCccCcccccCCccCCC
Q 030211          154 ---SRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ---~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                         .......+++.|+|||.+.+..++++
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  208 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTK  208 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHH
T ss_pred             cccccCcCCCCCccccChhhhccCCCChh
Confidence               22333467889999999998877653

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.9e-35  Score=210.26  Aligned_cols=171  Identities=27%  Similarity=0.400  Sum_probs=138.6

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcC-CeEEEEEee
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTP-THLAIVMEY   79 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~   79 (181)
                      +++|++.+.||+|++|.||++.+.  ++.|++|++.... ..+.+.+|+.+++.++|||++++++++.+. +..+++||+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            368999999999999999999875  7889999987543 456788999999999999999999987654 478999999


Q ss_pred             cCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           80 AAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        80 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      +++++|.+++....  .+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++......  ..
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~--~~  172 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASST--QD  172 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCCCC-----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC--cEEEeecccccccccc--cc
Confidence            99999999886654  389999999999999999999999999999999999997555  4999999998644332  22


Q ss_pred             cccCCCCccCcccccCCccCC
Q 030211          158 STVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ...+++.|+|||.+.+..+++
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~  193 (278)
T 1byg_A          173 TGKLPVKWTAPEALREKKFST  193 (278)
T ss_dssp             ---CCTTTSCHHHHHHCCCCH
T ss_pred             CCCccccccCHHHhCCCCCCc
Confidence            345788999999998776654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.2e-34  Score=212.85  Aligned_cols=174  Identities=31%  Similarity=0.428  Sum_probs=143.5

Q ss_pred             ccc-eeeeeeCCccceeEEEEEE----ccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcC--Ce
Q 030211            2 EKY-ELVKDLGAGNFGVARLLRH----KETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTP--TH   72 (181)
Q Consensus         2 ~~y-~~~~~i~~g~~~~v~~~~~----~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~   72 (181)
                      ++| ++++.||+|+||.||++..    ..+++.||+|++.....  ..+.+.+|+.+++.++|||++++++++.+.  ..
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            355 9999999999999987753    45788999999876532  235688999999999999999999999874  67


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ++++||++++++|.+++... .+++..++.++.|++.+|.+||++|++|+||+|+||+++.+.  .++|+|||++.....
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCGGGCEECCT
T ss_pred             EEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC--CEEECCccccccccc
Confidence            89999999999999988654 599999999999999999999999999999999999997555  499999999976544


Q ss_pred             CCC----CCcccCCCCccCcccccCCccCC
Q 030211          153 HSR----PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       153 ~~~----~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ...    .....+++.|+|||.+.+..++.
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  216 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYY  216 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCc
Confidence            322    23345778899999998766553

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-34  Score=208.57  Aligned_cols=174  Identities=28%  Similarity=0.404  Sum_probs=144.3

Q ss_pred             ccceeee-eeCCccceeEEEEEEc--cCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVK-DLGAGNFGVARLLRHK--ETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~-~i~~g~~~~v~~~~~~--~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|.+.+ .||+|+||.||++.+.  .++..||+|++.....  ..+.+.+|+.+++.++|||++++++++ ..+..+++
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            5688887 9999999999999864  4577899999876432  246788999999999999999999999 45678999


Q ss_pred             EeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      ||++++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||++........
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~  165 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKALGADDS  165 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEECTTCSC
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC--CEEECcccceeeeccCcc
Confidence            9999999999988644 4699999999999999999999999999999999999997555  599999999975533322


Q ss_pred             ----CCcccCCCCccCcccccCCccCC
Q 030211          156 ----PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       156 ----~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                          .....+++.|+|||.+.+..+++
T Consensus       166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~  192 (287)
T 1u59_A          166 YYTARSAGKWPLKWYAPECINFRKFSS  192 (287)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECH
T ss_pred             eeeccccccccccccCHHHhccCCCCc
Confidence                22234678899999998766554

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.8e-34  Score=207.20  Aligned_cols=174  Identities=25%  Similarity=0.247  Sum_probs=142.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeE-EEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR-FKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~-~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.... ..+.+.+|+.++..++|++++. +..++...+..+++||++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            58999999999999999999999999999999866543 2356788999999998866555 555557788899999999


Q ss_pred             CCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEe---ccCCCCcEEEeecCCcccccCCCC-
Q 030211           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLL---DGSAAPRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i---~~~~~~~v~l~dfg~a~~~~~~~~-  155 (181)
                       +++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||++   +++.  .++|+|||++........ 
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~--~~kL~Dfg~a~~~~~~~~~  164 (296)
T 4hgt_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             -CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT--CEEECCCTTCEECBCTTTC
T ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC--eEEEecCccceeccCcccC
Confidence             8899998864 4579999999999999999999999999999999999999   4444  599999999976543322 


Q ss_pred             -------CCcccCCCCccCcccccCCccCCC
Q 030211          156 -------PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 -------~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                             .....+++.|+|||.+.+..++++
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  195 (296)
T 4hgt_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRR  195 (296)
T ss_dssp             CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHH
T ss_pred             ccCCCCcccccCCCccccchHHhcCCCCCch
Confidence                   234578999999999998877643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.3e-34  Score=212.25  Aligned_cols=173  Identities=25%  Similarity=0.375  Sum_probs=130.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc-cHHHHHHHHHHhhCC-CCCeeEEEEeEE--------cCC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLR-HPNIIRFKEVVL--------TPT   71 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~-~~~i~~~~~~~~--------~~~   71 (181)
                      .+|++.+.||+|+||.||++.+..+++.||+|.+...... .+.+.+|+.++..+. |||++++++++.        ...
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            3799999999999999999999989999999988654332 456788999999986 999999999984        334


Q ss_pred             eEEEEEeecCCCChHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeeCCCCCCEEeccCCCCcEEEeecCC
Q 030211           72 HLAIVMEYAAGGELFDRICN---AGRFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGY  146 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~g--i~h~dl~p~ni~i~~~~~~~v~l~dfg~  146 (181)
                      .++++||++. ++|.+++..   ...+++..++.++.|++.||.+||+.|  ++|+||+|+||+++++.  .++|+|||+
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~  184 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGS  184 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS--CEEBCCCTT
T ss_pred             eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC--CEEEecCcc
Confidence            5899999995 588777654   457999999999999999999999999  99999999999997555  499999999


Q ss_pred             cccccCCCCC-------------CcccCCCCccCcccc---cCCccC
Q 030211          147 SKSSVLHSRP-------------KSTVGTPAYIAPEVL---SRREYD  177 (181)
Q Consensus       147 a~~~~~~~~~-------------~~~~~~~~~~aPE~~---~~~~~~  177 (181)
                      +.........             ....+++.|+|||++   .+..++
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  231 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG  231 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSS
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCC
Confidence            9755433221             134589999999998   444444

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-34  Score=212.83  Aligned_cols=175  Identities=23%  Similarity=0.345  Sum_probs=140.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEE----EEEEcccc--ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELV----AVKYIERG--RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v----~~K~~~~~--~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      ++|++.+.||+|+||.||+|.+..+++.+    ++|.+...  ....+.+.+|+.+++.++|||++++++++..++ .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            68999999999999999999998777755    66665433  233467889999999999999999999998765 788


Q ss_pred             EEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +++++.+++|.+++... ..+++..++.++.|++.||.+||++|++|+||||+||+++.++  .++|+|||++.......
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kL~DfG~a~~~~~~~  171 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCTTC--------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC--CEEEccCcceeEccCcc
Confidence            99999999999988764 4799999999999999999999999999999999999997555  49999999997653333


Q ss_pred             CC---CcccCCCCccCcccccCCccCCC
Q 030211          155 RP---KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~---~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..   ....+++.|+|||.+.+..++++
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~  199 (327)
T 3lzb_A          172 KEYHAEGGKVPIKWMALESILHRIYTHQ  199 (327)
T ss_dssp             --------CCCGGGSCHHHHHHCCCCHH
T ss_pred             ccccccCCCccccccCHHHHcCCCCChH
Confidence            22   22346778999999988777643

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-34  Score=211.84  Aligned_cols=173  Identities=31%  Similarity=0.439  Sum_probs=141.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-------ccHHHHHHHHHHhhC----CCCCeeEEEEeEEcC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSL----RHPNIIRFKEVVLTP   70 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~~~~~----~~~~i~~~~~~~~~~   70 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....       ....+.+|+.++..+    +|+|++++++++.+.
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~  110 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ  110 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence            579999999999999999999998999999999875432       123455688888777    899999999999999


Q ss_pred             CeEEEEEee-cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           71 THLAIVMEY-AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        71 ~~~~~v~e~-~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      +..++++|+ +.+++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||+++. ..+.++|+|||++..
T Consensus       111 ~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~~kl~dfg~~~~  189 (312)
T 2iwi_A          111 EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL-RRGCAKLIDFGSGAL  189 (312)
T ss_dssp             --CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET-TTTEEEECCCSSCEE
T ss_pred             CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC-CCCeEEEEEcchhhh
Confidence            999999999 778899999988888999999999999999999999999999999999999962 233599999999875


Q ss_pred             ccCCCCCCcccCCCCccCcccccCCcc
Q 030211          150 SVLHSRPKSTVGTPAYIAPEVLSRREY  176 (181)
Q Consensus       150 ~~~~~~~~~~~~~~~~~aPE~~~~~~~  176 (181)
                      .... ......+++.|+|||++.+..+
T Consensus       190 ~~~~-~~~~~~~~~~y~aPE~~~~~~~  215 (312)
T 2iwi_A          190 LHDE-PYTDFDGTRVYSPPEWISRHQY  215 (312)
T ss_dssp             CCSS-CBCCCCSCTTTSCHHHHHHSCB
T ss_pred             cccC-cccccCCcccccCceeeecCCC
Confidence            4432 3345678999999999876654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.5e-34  Score=211.54  Aligned_cols=168  Identities=27%  Similarity=0.340  Sum_probs=134.3

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEc-----CCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT-----PTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~   75 (181)
                      +++|++.+.||+|+||.||++.+  +++.||+|++............++..+..++|+|++++++.+..     ...+++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            57899999999999999999976  47899999987543322223334444556899999999875532     336789


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---------CeeeeCCCCCCEEeccCCCCcEEEeecCC
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM---------QICHRDLKLENTLLDGSAAPRLKICDFGY  146 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---------gi~h~dl~p~ni~i~~~~~~~v~l~dfg~  146 (181)
                      +|||+++++|.+++... ..++..++.++.|++.||.|||+.         |++|+||||+||++++++  .++|+|||+
T Consensus        90 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kL~DFG~  166 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGL  166 (336)
T ss_dssp             EECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS--CEEECCCTT
T ss_pred             EEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC--cEEEeeccc
Confidence            99999999999988654 458899999999999999999999         999999999999997555  599999999


Q ss_pred             cccccCCC---------CCCcccCCCCccCcccccC
Q 030211          147 SKSSVLHS---------RPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       147 a~~~~~~~---------~~~~~~~~~~~~aPE~~~~  173 (181)
                      +.......         ......|++.|+|||++.+
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  202 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG  202 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcC
Confidence            97543221         1223468999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.6e-35  Score=229.62  Aligned_cols=179  Identities=31%  Similarity=0.429  Sum_probs=153.5

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEc------CCe
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLT------PTH   72 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~------~~~   72 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.....  ..+.+.+|+.++..++|||++++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            4789999999999999999999998999999999875422  23568889999999999999999999765      667


Q ss_pred             EEEEEeecCCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCC-CcEEEeecCCcc
Q 030211           73 LAIVMEYAAGGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA-PRLKICDFGYSK  148 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~-~~v~l~dfg~a~  148 (181)
                      .+++|||+++++|.+++....   .+++..++.++.|++.||+|||++|++|+||+|+||+++.++. ..++|+|||.+.
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            899999999999999887644   5899999999999999999999999999999999999975543 358999999998


Q ss_pred             cccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          149 SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ............+++.|+|||.+.+..++++
T Consensus       173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k  203 (676)
T 3qa8_A          173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVT  203 (676)
T ss_dssp             BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTT
T ss_pred             ccccccccccccCCcccCChHHhccCCCCch
Confidence            7766666666789999999999998888765

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-34  Score=209.87  Aligned_cols=175  Identities=23%  Similarity=0.305  Sum_probs=142.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC---CcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEE-cCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVL-TPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~-~~~~~~~   75 (181)
                      .+|++.+.||+|+||.||+|.+..+   ...+++|.+......  .+.+.+|+.+++.++|||++++++++. ..+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            3689999999999999999997543   335899988754332  356889999999999999999999854 5567899


Q ss_pred             EEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +||++++++|.+++... ..++...++.++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||++.......
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSCGGGCCCSCGG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC--CEEECcccccccccccc
Confidence            99999999999998653 4689999999999999999999999999999999999996554  59999999987543322


Q ss_pred             -----CCCcccCCCCccCcccccCCccCC
Q 030211          155 -----RPKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       155 -----~~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                           ......+++.|+|||.+.+..+++
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  211 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTT  211 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCH
T ss_pred             hhccccccCCCCCccccChHHhcCCCCCh
Confidence                 223345678999999998777664

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.2e-33  Score=217.51  Aligned_cols=176  Identities=26%  Similarity=0.288  Sum_probs=148.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCC-CCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH-PNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~-~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||.||++.+..+++.||+|++..... ...+..|+.++..++| ++++.+..++...+..+++|||+
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            689999999999999999999999999999998765433 3467889999999987 66777777888889999999999


Q ss_pred             CCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc-CCCCcEEEeecCCcccccCCCC---
Q 030211           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSR---  155 (181)
Q Consensus        81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~-~~~~~v~l~dfg~a~~~~~~~~---  155 (181)
                       +++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++. +..+.++|+|||+++.......   
T Consensus        86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (483)
T 3sv0_A           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH  164 (483)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred             -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccc
Confidence             8899998864 457999999999999999999999999999999999999931 1334599999999976544332   


Q ss_pred             -----CCcccCCCCccCcccccCCccCCC
Q 030211          156 -----PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 -----~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                           .....|++.|+|||++.+..++.+
T Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~  193 (483)
T 3sv0_A          165 IPYRENKNLTGTARYASVNTHLGIEQSRR  193 (483)
T ss_dssp             CCCCCCCCCCSCTTTCCHHHHTTCCCCHH
T ss_pred             cccccccccCCCccccCHHHhcCCCCChH
Confidence                 225679999999999998877643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7e-34  Score=206.35  Aligned_cols=172  Identities=28%  Similarity=0.418  Sum_probs=143.8

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      +|.....||+|+||.||+|.+..+++.|++|.+..... ..+.+.+|+.+++.++|||++++++++.+.+..+++||+++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            44555699999999999999999999999999876533 34678899999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCC
Q 030211           82 GGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPK  157 (181)
Q Consensus        82 ~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~  157 (181)
                      +++|.+++....   .+++..++.++.|++.||.+||++|++|+||+|+||+++. ..+.++|+|||++....... ...
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~~kl~Dfg~~~~~~~~~~~~~  181 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTE  181 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTCCEEECCTTTCEESCC-----C
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC-CCCCEEEeecccccccCCCCCccc
Confidence            999999886542   5678899999999999999999999999999999999974 13359999999987554322 234


Q ss_pred             cccCCCCccCcccccCCc
Q 030211          158 STVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~  175 (181)
                      ...+++.|+|||++.+..
T Consensus       182 ~~~~~~~y~aPE~~~~~~  199 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGP  199 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGG
T ss_pred             ccCCCccccChhhhcCCC
Confidence            457899999999987653

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-34  Score=229.41  Aligned_cols=166  Identities=23%  Similarity=0.334  Sum_probs=141.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc-CCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCe-----E
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE-TKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTH-----L   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~-~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~-----~   73 (181)
                      ++|++.+.||+|+||.||++.+.. +++.|++|++.....  ....+.+|+.++..++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            689999999999999999999976 689999998865422  23567889999999999999999999987665     7


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      |+||||+++++|.+.+..  .+++..++.++.|++.+|.|||++||+|+||||+||+++++   .++|+|||+++.....
T Consensus       160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTCC
T ss_pred             EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhcccC
Confidence            999999999999887644  69999999999999999999999999999999999999754   5999999999754433


Q ss_pred             CCCCcccCCCCccCcccccCCc
Q 030211          154 SRPKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~  175 (181)
                         ....||+.|+|||++.++.
T Consensus       235 ---~~~~gt~~y~aPE~~~~~~  253 (681)
T 2pzi_A          235 ---GYLYGTPGFQAPEIVRTGP  253 (681)
T ss_dssp             ---SCCCCCTTTSCTTHHHHCS
T ss_pred             ---CccCCCccccCHHHHcCCC
Confidence               4567999999999987653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.6e-34  Score=208.40  Aligned_cols=165  Identities=27%  Similarity=0.404  Sum_probs=130.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++.+.||+|+||.||++.+..   .+++|++......   .+.+.+|+.+++.++|||+++++++. ..+..+++||
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             cceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            589999999999999999998653   4999998754332   35688999999999999999999954 5667899999


Q ss_pred             ecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC---CC
Q 030211           79 YAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL---HS  154 (181)
Q Consensus        79 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~---~~  154 (181)
                      |+.+++|.+.+... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++.....   ..
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  177 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN--TVKIGDFGLATEKSRWSGSH  177 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEEECCCC------------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC--CEEEccceeccccccccccc
Confidence            99999999888543 4799999999999999999999999999999999999997554  599999999865432   22


Q ss_pred             CCCcccCCCCccCccccc
Q 030211          155 RPKSTVGTPAYIAPEVLS  172 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~  172 (181)
                      ......+++.|+|||.+.
T Consensus       178 ~~~~~~gt~~y~aPE~~~  195 (289)
T 3og7_A          178 QFEQLSGSILWMAPEVIR  195 (289)
T ss_dssp             ------CCCTTCCHHHHC
T ss_pred             cccccCCCccccCchhhc
Confidence            233456899999999997

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.6e-34  Score=211.74  Aligned_cols=172  Identities=32%  Similarity=0.456  Sum_probs=142.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcC-----CeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTP-----THLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~   74 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.....  ....+.+|+.+++.++|||++++++++...     +..+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            689999999999999999999999999999999865332  235677899999999999999999988764     6799


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      ++||++. ++|.+.+.. ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++.......
T Consensus        91 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC--DLKVCDFGLARIIDESA  166 (353)
T ss_dssp             EEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECC---
T ss_pred             EEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC--cEEEEeccccccccccc
Confidence            9999996 588887754 5799999999999999999999999999999999999997555  49999999987543221


Q ss_pred             C-----------CCcccCCCCccCcccccC-CccC
Q 030211          155 R-----------PKSTVGTPAYIAPEVLSR-REYD  177 (181)
Q Consensus       155 ~-----------~~~~~~~~~~~aPE~~~~-~~~~  177 (181)
                      .           .....|++.|+|||++.+ ..++
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  201 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYS  201 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCC
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCcc
Confidence            1           123468999999998764 4444

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.4e-34  Score=206.91  Aligned_cols=174  Identities=24%  Similarity=0.277  Sum_probs=142.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC---CcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|++.+.||+|+||.||++.+...   +..|++|.+.....  ..+.+.+|+.+++.++|||++++++++.++ ..+++
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v   90 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWII   90 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEE
Confidence            6899999999999999999987542   34699999876432  246788899999999999999999998754 56899


Q ss_pred             EeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      ||++++++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||++........
T Consensus        91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~  168 (281)
T 3cc6_A           91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE--CVKLGDFGLSRYIEDEDY  168 (281)
T ss_dssp             EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT--EEEECCCCGGGCC-----
T ss_pred             EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC--cEEeCccCCCcccccccc
Confidence            99999999999886654 699999999999999999999999999999999999997655  599999999875443322


Q ss_pred             --CCcccCCCCccCcccccCCccCC
Q 030211          156 --PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                        .....+++.|+|||.+.+..+++
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~  193 (281)
T 3cc6_A          169 YKASVTRLPIKWMSPESINFRRFTT  193 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHCCCCH
T ss_pred             cccccCCCCcceeCchhhccCCCCc
Confidence              23345678899999998776654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.8e-34  Score=207.81  Aligned_cols=169  Identities=25%  Similarity=0.374  Sum_probs=126.5

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccccc---HHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~---~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.......   +.+.++..+++.++|||++++++++.+++..+++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            468999999999999999999999899999999987643321   23344455677889999999999999999999999


Q ss_pred             eecCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           78 EYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        78 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~-gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      |++ ++.+...... ...+++..++.++.|++.||.+||++ |++|+||+|+||+++.+.  .++|+|||++........
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~  180 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG--QIKLCDFGISGRLVDDKA  180 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS--CEEECCCTTC--------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC--CEEEEECCCchhccCCcc
Confidence            999 4455444433 46799999999999999999999995 999999999999997555  499999999976655555


Q ss_pred             CCcccCCCCccCccccc
Q 030211          156 PKSTVGTPAYIAPEVLS  172 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~  172 (181)
                      .....+++.|+|||.+.
T Consensus       181 ~~~~~~~~~y~aPE~~~  197 (318)
T 2dyl_A          181 KDRSAGCAAYMAPERID  197 (318)
T ss_dssp             ------CCTTCCHHHHC
T ss_pred             ccccCCCccccChhhcc
Confidence            55567999999999995

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.7e-34  Score=225.27  Aligned_cols=174  Identities=25%  Similarity=0.328  Sum_probs=147.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|+||.||++.+.. +..||+|++.......+.+.+|+.+++.++|+|++++++++.+ +..++||||+.
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~  344 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  344 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence            578999999999999999999875 4669999998766556789999999999999999999999876 67899999999


Q ss_pred             CCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC--CCC
Q 030211           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPK  157 (181)
Q Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~--~~~  157 (181)
                      +++|.+++...  ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+.  .++|+|||++.......  ...
T Consensus       345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~  422 (535)
T 2h8h_A          345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNEYTARQ  422 (535)
T ss_dssp             TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCTTSTTTCCCHHHHTTC
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC--cEEEcccccceecCCCceeccc
Confidence            99999998643  4689999999999999999999999999999999999997555  49999999997543211  122


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...++..|+|||++..+.++.+
T Consensus       423 ~~~~~~~y~aPE~~~~~~~~~~  444 (535)
T 2h8h_A          423 GAKFPIKWTAPEAALYGRFTIK  444 (535)
T ss_dssp             STTSCGGGSCHHHHHHCCCCHH
T ss_pred             CCcCcccccCHHHhccCCCCch
Confidence            3446788999999987776643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-33  Score=207.41  Aligned_cols=173  Identities=30%  Similarity=0.418  Sum_probs=138.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEE------------
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVL------------   68 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~------------   68 (181)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+..... ..+.+.+|+.+++.++|||++++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            689999999999999999999999999999998875432 2467889999999999999999999874            


Q ss_pred             --cCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCC
Q 030211           69 --TPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGY  146 (181)
Q Consensus        69 --~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~  146 (181)
                        +.+..+++||+++ ++|.+++. ..++++..++.++.|++.||++||++|++|+||+|+||+++.+ ...++|+|||+
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~kl~Dfg~  167 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTE-DLVLKIGDFGL  167 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TTEEEECCCTT
T ss_pred             ccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCeEEEccCcc
Confidence              3467899999997 58888775 4578999999999999999999999999999999999999632 24699999999


Q ss_pred             cccccCC----CCCCcccCCCCccCcccccC-CccC
Q 030211          147 SKSSVLH----SRPKSTVGTPAYIAPEVLSR-REYD  177 (181)
Q Consensus       147 a~~~~~~----~~~~~~~~~~~~~aPE~~~~-~~~~  177 (181)
                      +......    .......+++.|+|||.+.+ ..++
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  203 (320)
T 2i6l_A          168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT  203 (320)
T ss_dssp             CBCC--------CCCGGGSCCTTCCHHHHHCTTCCC
T ss_pred             ccccCCCcccccccccccccccccCcHHhcCcccCC
Confidence            8754322    22334567899999998865 4443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.8e-34  Score=207.61  Aligned_cols=170  Identities=33%  Similarity=0.526  Sum_probs=138.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|+||.||++.+.  ++.|++|.+... ...+.+.+|+.+++.++|||++++++++.+  ..+++|||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            68999999999999999999875  678999998753 335678899999999999999999998874  4789999999


Q ss_pred             CCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---cCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           82 GGELFDRICNAG---RFSEDEGRYFFQQLISGVNYCHS---MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        82 ~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~---~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      +++|.+++....   .++...++.++.|++.||.+||+   +|++|+||+|+||++++++. .++|+|||++......  
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC---------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEcccccccccccc--
Confidence            999999987654   47889999999999999999999   89999999999999974432 4799999998644322  


Q ss_pred             CCcccCCCCccCcccccCCccCCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .....+++.|+|||++.+..++++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~  183 (307)
T 2eva_A          160 MTNNKGSAAWMAPEVFEGSNYSEK  183 (307)
T ss_dssp             -----CCTTSSCHHHHTCCCCCTH
T ss_pred             cccCCCCCceEChhhhCCCCCCcH
Confidence            233468999999999998877654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.3e-34  Score=211.41  Aligned_cols=173  Identities=32%  Similarity=0.486  Sum_probs=125.7

Q ss_pred             ccceeee-eeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEc----CCeEEEE
Q 030211            2 EKYELVK-DLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT----PTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~-~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~----~~~~~~v   76 (181)
                      ++|++.+ .||+|+||.||+|.+..+++.||+|++.....   ...+....+..++|||++++++++..    .+..+++
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  104 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII  104 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence            6899965 69999999999999999999999999875432   22233344567799999999999876    4558999


Q ss_pred             EeecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-CCcEEEeecCCcccccCC
Q 030211           77 MEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSVLH  153 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-~~~v~l~dfg~a~~~~~~  153 (181)
                      |||+++++|.+++....  .+++..++.++.|++.||.+||++|++|+||+|+||+++.+. ...++|+|||++..... 
T Consensus       105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~-  183 (336)
T 3fhr_A          105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-  183 (336)
T ss_dssp             EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc-
Confidence            99999999999987654  699999999999999999999999999999999999996433 45699999999875432 


Q ss_pred             CCCCcccCCCCccCcccccCCccCC
Q 030211          154 SRPKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      .......+++.|+|||++....+++
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~  208 (336)
T 3fhr_A          184 NALQTPCYTPYYVAPEVLGPEKYDK  208 (336)
T ss_dssp             --------------------CHHHH
T ss_pred             cccccCCCCcCccChhhhCCCCCCc
Confidence            2334457899999999997766543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.4e-34  Score=211.65  Aligned_cols=171  Identities=28%  Similarity=0.446  Sum_probs=141.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCe------
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPTH------   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~------   72 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+......   .+.+.+|+.+++.++|||++++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            5799999999999999999999999999999998754322   3567889999999999999999999987654      


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ++++||++. ++|.+.+..  .+++..++.++.|++.||.+||++|++|+||+|+||++++++  .++|+|||++.....
T Consensus       104 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC--ELKILDFGLARHADA  178 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC--CEEECSTTCTTC---
T ss_pred             EEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC--cEEEeecccccCCCC
Confidence            599999996 578776643  599999999999999999999999999999999999997555  499999999875432


Q ss_pred             CCCCCcccCCCCccCcccccC-CccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSR-REYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~  179 (181)
                        ......+++.|+|||++.+ ..++.+
T Consensus       179 --~~~~~~~t~~y~aPE~~~~~~~~~~~  204 (353)
T 3coi_A          179 --EMTGYVVTRWYRAPEVILSWMHYNQT  204 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTT
T ss_pred             --CccccccCcCcCCHHHHhCcCCCCch
Confidence              2334578999999999887 555543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2e-34  Score=215.49  Aligned_cols=175  Identities=25%  Similarity=0.324  Sum_probs=148.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC-----------CCCeeEEEEeEEcC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-----------HPNIIRFKEVVLTP   70 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~-----------~~~i~~~~~~~~~~   70 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.......+.+.+|+.++..+.           |+|++++++++...
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~   98 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   98 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence            5899999999999999999999999999999999865545567788888887765           78999999999865


Q ss_pred             C----eEEEEEeecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CeeeeCCCCCCEEeccC----CCCcE
Q 030211           71 T----HLAIVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSM-QICHRDLKLENTLLDGS----AAPRL  139 (181)
Q Consensus        71 ~----~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~-gi~h~dl~p~ni~i~~~----~~~~v  139 (181)
                      +    ..+++||++ +++|.+++...  ..+++..++.++.|++.||.+||++ |++|+||+|+||+++.+    ....+
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~  177 (373)
T 1q8y_A           99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI  177 (373)
T ss_dssp             ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceE
Confidence            4    789999999 78999888653  4599999999999999999999998 99999999999999532    23369


Q ss_pred             EEeecCCcccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          140 KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       140 ~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +|+|||++.....  ......+++.|+|||++.+..++++
T Consensus       178 kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~  215 (373)
T 1q8y_A          178 KIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCG  215 (373)
T ss_dssp             EECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTH
T ss_pred             EEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCch
Confidence            9999999875433  2334578999999999998887754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.1e-33  Score=206.89  Aligned_cols=166  Identities=30%  Similarity=0.381  Sum_probs=142.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhh--CCCCCeeEEEEeEEcCC----eEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRS--LRHPNIIRFKEVVLTPT----HLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~--~~~~~i~~~~~~~~~~~----~~~~   75 (181)
                      ++|++.+.||+|+||.||++.+.  ++.||+|++....  ...+..|..++..  ++|||++++++++...+    ..++
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l  117 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL  117 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence            57999999999999999999984  8899999986542  3566777777776  78999999999998876    7999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCeeeeCCCCCCEEeccCCCCcEEEeecCCc
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH--------SMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--------~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a  147 (181)
                      +|||+++++|.+++.+ ..+++..++.++.|++.||.+||        +.|++|+||+|+||+++.+.  .++|+|||++
T Consensus       118 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~~  194 (342)
T 1b6c_B          118 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLA  194 (342)
T ss_dssp             EECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS--CEEECCCTTC
T ss_pred             EEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC--CEEEEECCCc
Confidence            9999999999998865 46899999999999999999999        89999999999999997555  4999999999


Q ss_pred             ccccCCC-----CCCcccCCCCccCcccccCC
Q 030211          148 KSSVLHS-----RPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       148 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~  174 (181)
                      .......     ......+++.|+|||++.+.
T Consensus       195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  226 (342)
T 1b6c_B          195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS  226 (342)
T ss_dssp             EEEETTTTEEEECCCSCCCCGGGCCHHHHTSC
T ss_pred             eeccccccccccccccCCcCcccCCHhhhccc
Confidence            7654433     23445789999999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-34  Score=214.89  Aligned_cols=175  Identities=22%  Similarity=0.284  Sum_probs=135.9

Q ss_pred             cceeeeeeCCccceeEEEEEEccCC---cEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEc-CCeEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETK---ELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLT-PTHLAIV   76 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~---~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v   76 (181)
                      +|++.+.||+|+||.||++.+..++   ..|++|.+.....  ..+.+.+|+.+++.++|||++++++++.. .+..+++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4788999999999999999976433   3589998865432  23678899999999999999999998654 5678999


Q ss_pred             EeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      |||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++++.  .++|+|||+++.......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC-----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC--CEEEeecccccccccccc
Confidence            99999999999987543 688999999999999999999999999999999999997555  499999999975433221


Q ss_pred             -----CCcccCCCCccCcccccCCccCCC
Q 030211          156 -----PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 -----~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                           .....+++.|+|||.+.+..++++
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  276 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTK  276 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHH
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcH
Confidence                 223456788999999988777643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.7e-34  Score=215.18  Aligned_cols=173  Identities=29%  Similarity=0.436  Sum_probs=129.9

Q ss_pred             ccee-eeeeCCccceeEEEEEEc--cCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEc--CCeEEEEE
Q 030211            3 KYEL-VKDLGAGNFGVARLLRHK--ETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT--PTHLAIVM   77 (181)
Q Consensus         3 ~y~~-~~~i~~g~~~~v~~~~~~--~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~   77 (181)
                      .|++ .++||+|+||.||+|.++  .+++.||+|++.... ....+.+|+.+++.++|||++++++++..  ....+++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            5676 458999999999999976  468889999987543 34678899999999999999999999954  67899999


Q ss_pred             eecCCCChHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc--CCCCcEEEeecCC
Q 030211           78 EYAAGGELFDRICNA---------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG--SAAPRLKICDFGY  146 (181)
Q Consensus        78 e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~--~~~~~v~l~dfg~  146 (181)
                      ||+.+ +|.+.+...         ..+++..++.++.|++.||.|||++||+|+||||+||++..  +..+.++|+|||+
T Consensus       100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  178 (405)
T 3rgf_A          100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  178 (405)
T ss_dssp             ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred             eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence            99965 777666421         24999999999999999999999999999999999999932  2345699999999


Q ss_pred             cccccCC----CCCCcccCCCCccCcccccCCc-cC
Q 030211          147 SKSSVLH----SRPKSTVGTPAYIAPEVLSRRE-YD  177 (181)
Q Consensus       147 a~~~~~~----~~~~~~~~~~~~~aPE~~~~~~-~~  177 (181)
                      +......    .......||+.|+|||++.+.. ++
T Consensus       179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  214 (405)
T 3rgf_A          179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT  214 (405)
T ss_dssp             CC----------------CCCTTCCHHHHTTCCSCC
T ss_pred             ceecCCCCcccccCCCceecCcccCchhhcCCCccc
Confidence            9755332    2233457899999999998743 44

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.9e-34  Score=215.90  Aligned_cols=170  Identities=19%  Similarity=0.163  Sum_probs=125.8

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc----ccHHHHHHH---HHHhhCCCCCeeEEE-------EeEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK----IDENVAREI---INHRSLRHPNIIRFK-------EVVL   68 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~---~~~~~~~~~~i~~~~-------~~~~   68 (181)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.....    ..+.+.+|+   ..+.. +|||+++++       +++.
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            59999999999999999999999999999999987542    234566664   44555 799988755       4444


Q ss_pred             cC-----------------CeEEEEEeecCCCChHHHHhhc-CCCCHHHH------HHHHHHHHHHHHHHHhcCeeeeCC
Q 030211           69 TP-----------------THLAIVMEYAAGGELFDRICNA-GRFSEDEG------RYFFQQLISGVNYCHSMQICHRDL  124 (181)
Q Consensus        69 ~~-----------------~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~------~~~~~~i~~~l~~lh~~gi~h~dl  124 (181)
                      .+                 ..+++||||++ ++|.+++... ..++....      ..++.|++.||+|||++||+|+||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            32                 34899999998 7999988753 24555555      677899999999999999999999


Q ss_pred             CCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccCCCCccCcccccC--CccCC
Q 030211          125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR--REYDG  178 (181)
Q Consensus       125 ~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~  178 (181)
                      ||+||+++.++  .++|+|||+++....  ......+++.|+|||++.+  ..+++
T Consensus       221 kp~NIll~~~~--~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~  272 (371)
T 3q60_A          221 TPDNLFIMPDG--RLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTH  272 (371)
T ss_dssp             SGGGEEECTTS--CEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCH
T ss_pred             CHHHEEECCCC--CEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCc
Confidence            99999997655  499999999975432  1224566799999999987  55554

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.6e-33  Score=202.79  Aligned_cols=166  Identities=29%  Similarity=0.386  Sum_probs=140.5

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc-----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      |...+.||+|+||.||++.+  +++.|++|.+....     ...+.+.+|+.+++.++|||++++++++.+.+..+++||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44558999999999999986  47889999986532     223678899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           79 YAAGGELFDRICN---AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        79 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      ++++++|.+++..   ...+++..++.++.|++.||.+||++|++|+||+|+||+++++.  .++|+|||++........
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF--TAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSCSS
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC--cEEEeecccccccccccc
Confidence            9999999988753   34699999999999999999999999999999999999997554  599999999875433222


Q ss_pred             ---CCcccCCCCccCcccccC
Q 030211          156 ---PKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       156 ---~~~~~~~~~~~aPE~~~~  173 (181)
                         .....+++.|+|||.+.+
T Consensus       189 ~~~~~~~~g~~~y~aPE~~~~  209 (307)
T 2nru_A          189 TVMTSRIVGTTAYMAPEALRG  209 (307)
T ss_dssp             CEECSSCCSCGGGCCHHHHTT
T ss_pred             cccccccCCCcCcCChHHhcC
Confidence               233568999999998865

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.5e-34  Score=206.56  Aligned_cols=174  Identities=32%  Similarity=0.460  Sum_probs=135.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc-CCc--EEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE-TKE--LVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~-~~~--~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|++|.||++.+.. +++  .|++|++....    ...+.+.+|+.+++.++|||++++++++..++ .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            589999999999999999998643 333  58999887542    22367889999999999999999999998765 88


Q ss_pred             EEEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           75 IVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      +++|++.+++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.+.  .++|+|||++......
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQN  174 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCC-
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC--CEEEcccccccccccc
Confidence            999999999999988654 4699999999999999999999999999999999999997555  5999999998765433


Q ss_pred             CC----CCcccCCCCccCcccccCCccCC
Q 030211          154 SR----PKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       154 ~~----~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ..    .....+++.|+|||.+.+..+++
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  203 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLKTRTFSH  203 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEH
T ss_pred             ccchhhhccCCCCceeeCchhhcCCCCCc
Confidence            32    22345677899999987766543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=7.3e-34  Score=225.27  Aligned_cols=169  Identities=26%  Similarity=0.356  Sum_probs=139.6

Q ss_pred             eeeCCccceeEEEEEE--ccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRH--KETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~--~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      +.||+|+||.||++.+  ...++.||+|+++....   ..+.+.+|+.++..++||||+++++++.. +..++||||+.+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999965  45567899999876432   23678999999999999999999999865 458899999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC----CCc
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR----PKS  158 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~----~~~  158 (181)
                      ++|.+++.....+++..++.++.|++.||+|||++||+|+||||+||+++.+.  .++|+|||+++.......    ...
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~~~  531 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENYYKAQTH  531 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCTTHHHHTTC----------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC--CEEEEEcCCccccccCccccccccC
Confidence            99999998888899999999999999999999999999999999999997655  499999999975543322    222


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..+++.|+|||++.+..++.+
T Consensus       532 ~~~t~~y~APE~~~~~~~~~~  552 (635)
T 4fl3_A          532 GKWPVKWYAPECINYYKFSSK  552 (635)
T ss_dssp             ---CGGGSCHHHHHHCCCCHH
T ss_pred             CCCceeeeChhhhcCCCCCcH
Confidence            345788999999988777653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-33  Score=222.16  Aligned_cols=174  Identities=27%  Similarity=0.390  Sum_probs=140.5

Q ss_pred             cceeee-eeCCccceeEEEEEEc--cCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            3 KYELVK-DLGAGNFGVARLLRHK--ETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         3 ~y~~~~-~i~~g~~~~v~~~~~~--~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++.+.+ .||+|+||.||++.+.  .++..||+|+++...  ...+.+.+|+.+++.++|||++++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344555 7999999999999875  345679999997643  234788999999999999999999999976 5699999


Q ss_pred             eecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           78 EYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      ||+.+++|.+++... ..+++..++.++.|++.||+|||++||+|+||+|+||+++++.  .++|+|||+++........
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~vkL~DFGla~~~~~~~~~  492 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH--YAKISDFGLSKALGADDSY  492 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCSTTTTCC-----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC--cEEEeeccCcccccCCCce
Confidence            999999999988654 4699999999999999999999999999999999999997555  5999999999765332221


Q ss_pred             ----CcccCCCCccCcccccCCccCCC
Q 030211          157 ----KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ----~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                          ....+++.|+|||++....++.+
T Consensus       493 ~~~~~~~~~~~~y~APE~~~~~~~~~~  519 (613)
T 2ozo_A          493 YTARSAGKWPLKWYAPECINFRKFSSR  519 (613)
T ss_dssp             ---------CCTTSCHHHHHHCCCCHH
T ss_pred             eeeccCCCCccceeCHhhhcCCCCCcH
Confidence                12234688999999987777653

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.8e-33  Score=205.03  Aligned_cols=167  Identities=25%  Similarity=0.383  Sum_probs=139.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCC--CCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLR--HPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~--~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|++.+.||+|+||.||++.+.. ++.||+|++.....   ..+.+.+|+.++..++  |++++++++++.+.+..+++
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            479999999999999999999864 88899999865432   2356788999999887  59999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-  155 (181)
                      || +.+++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||++++   +.++|+|||++........ 
T Consensus       107 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~---~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          107 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             EC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCC-------
T ss_pred             Ee-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC---CeEEEeeccccccccCcccc
Confidence            99 557899999988888999999999999999999999999999999999999963   4599999999875533322 


Q ss_pred             --CCcccCCCCccCcccccC
Q 030211          156 --PKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       156 --~~~~~~~~~~~aPE~~~~  173 (181)
                        .....+++.|+|||.+.+
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~  202 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKD  202 (313)
T ss_dssp             -------CCGGGCCHHHHTT
T ss_pred             ccccCCCCCCCcCCHHHHhh
Confidence              234568999999999976

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.5e-33  Score=212.14  Aligned_cols=167  Identities=31%  Similarity=0.328  Sum_probs=134.3

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      +|++.+.||+|+||+|+. ....+++.||+|++....  .....+|+.+++.+ +||||+++++++.+.+..+++||++.
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            589999999999999764 334568899999986532  24467899999988 79999999999999999999999996


Q ss_pred             CCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc---CCCCcEEEeecCCcccccCC----
Q 030211           82 GGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG---SAAPRLKICDFGYSKSSVLH----  153 (181)
Q Consensus        82 ~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~---~~~~~v~l~dfg~a~~~~~~----  153 (181)
                       ++|.+++.... ..++..++.++.|++.||.|||++||+|+||||+||+++.   ++..+++|+|||+|+.....    
T Consensus       102 -g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~  180 (432)
T 3p23_A          102 -ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF  180 (432)
T ss_dssp             -EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred             -CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce
Confidence             58988886554 4666678899999999999999999999999999999942   34456889999999765433    


Q ss_pred             CCCCcccCCCCccCcccccC
Q 030211          154 SRPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~  173 (181)
                      .......||+.|+|||++.+
T Consensus       181 ~~~~~~~gt~~y~APE~l~~  200 (432)
T 3p23_A          181 SRRSGVPGTEGWIAPEMLSE  200 (432)
T ss_dssp             -----CCSCTTSCCGGGTSC
T ss_pred             eeccccCCCcCccChhhhhc
Confidence            22334579999999999984

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.8e-33  Score=220.85  Aligned_cols=174  Identities=24%  Similarity=0.321  Sum_probs=142.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC---CcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|++.+.||+|+||.||+|.+..+   +..|++|.+.....  ..+.+.+|+.+++.++|||++++++++. .+..+++
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence            5799999999999999999998643   45699998765332  2367889999999999999999999985 4568999


Q ss_pred             EeecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           77 MEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      |||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++........
T Consensus       469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~--~vkL~DFG~a~~~~~~~~  546 (656)
T 2j0j_A          469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTY  546 (656)
T ss_dssp             EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCCCCSCCC---
T ss_pred             EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC--CEEEEecCCCeecCCCcc
Confidence            99999999999887554 789999999999999999999999999999999999997655  499999999976543322


Q ss_pred             C--CcccCCCCccCcccccCCccCC
Q 030211          156 P--KSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       156 ~--~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      .  ....+++.|+|||++....+++
T Consensus       547 ~~~~~~~~t~~y~aPE~~~~~~~~~  571 (656)
T 2j0j_A          547 YKASKGKLPIKWMAPESINFRRFTS  571 (656)
T ss_dssp             -------CCGGGCCHHHHHHCCCCH
T ss_pred             eeccCCCCCcceeCHHHhcCCCCCc
Confidence            2  2234578899999998777664

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=9.4e-34  Score=222.02  Aligned_cols=160  Identities=16%  Similarity=0.088  Sum_probs=125.2

Q ss_pred             eCCccceeEEEEEEccCCcEEEEEEccccc-----------cccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEE
Q 030211           10 LGAGNFGVARLLRHKETKELVAVKYIERGR-----------KIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus        10 i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-----------~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      .+.|+.+....+...-.|..+++|++....           ...+++.+|+.+++++ .|+|++++++++++++..|+||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            455666666666666678889999986532           1124688899999999 6899999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~  156 (181)
                      ||++|++|.+.+...++++..   .++.||+.||+|+|++||+||||||+|||+++++.  +||+|||+|+..... ...
T Consensus       322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CCS
T ss_pred             ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCccc
Confidence            999999999999888888765   48899999999999999999999999999976554  999999999765433 334


Q ss_pred             CcccCCCCccCcccccCC
Q 030211          157 KSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~  174 (181)
                      ....||+.|||||++.+.
T Consensus       397 ~t~vGTp~YmAPE~l~g~  414 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAEN  414 (569)
T ss_dssp             HHHHHHHHHHHHHHC---
T ss_pred             cCceechhhccHHHhCCC
Confidence            456799999999999765

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.98  E-value=3e-32  Score=207.81  Aligned_cols=167  Identities=30%  Similarity=0.293  Sum_probs=129.4

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      .|.+.+.||+|+||+||.+. ..+|+.||+|++....  .+.+.+|+.++..+ +||||+++++++.+.+..+++||++.
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            46667889999999998754 4568999999886532  35677889888765 89999999999999999999999996


Q ss_pred             CCChHHHHhhcCCC-------CHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccC-----------CCCcEEEee
Q 030211           82 GGELFDRICNAGRF-------SEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS-----------AAPRLKICD  143 (181)
Q Consensus        82 ~~~l~~~~~~~~~~-------~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~-----------~~~~v~l~d  143 (181)
                       ++|.+++......       ++..++.++.|++.||.|||++||+|+||||+||+++.+           ....++|+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D  171 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD  171 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence             5999988765432       233457799999999999999999999999999999643           345799999


Q ss_pred             cCCcccccCCCC-----CCcccCCCCccCcccccC
Q 030211          144 FGYSKSSVLHSR-----PKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       144 fg~a~~~~~~~~-----~~~~~~~~~~~aPE~~~~  173 (181)
                      ||++........     .....|++.|+|||++.+
T Consensus       172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  206 (434)
T 2rio_A          172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE  206 (434)
T ss_dssp             CTTCEECCC--------------CCTTSCHHHHSC
T ss_pred             cccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence            999976543322     223579999999999976

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.98  E-value=1.3e-32  Score=201.72  Aligned_cols=167  Identities=28%  Similarity=0.474  Sum_probs=139.7

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      .++|++.+.||+|+||.||++.+..   .+++|.+....   ...+.+.+|+.+++.++|+|++++++++.+++..+++|
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            3789999999999999999998864   48999887542   22356778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC----
Q 030211           78 EYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL----  152 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~----  152 (181)
                      |++.+++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||++++   +.++|+|||++.....    
T Consensus       109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~---~~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN---GKVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC--------
T ss_pred             ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC---CCEEEeecCCcccccccccc
Confidence            9999999999987655 7999999999999999999999999999999999999962   3599999999764321    


Q ss_pred             --CCCCCcccCCCCccCcccccC
Q 030211          153 --HSRPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       153 --~~~~~~~~~~~~~~aPE~~~~  173 (181)
                        ........+++.|+|||.+..
T Consensus       186 ~~~~~~~~~~g~~~y~aPE~~~~  208 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAPEIIRQ  208 (319)
T ss_dssp             --CCSCBCCSGGGGTSCHHHHSC
T ss_pred             ccccccccCCCcccccChHHhhh
Confidence              122233458899999999975

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=6.8e-31  Score=190.31  Aligned_cols=142  Identities=13%  Similarity=0.090  Sum_probs=126.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccccc----HHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.......    +.+.+|+..+..++|||++++++++.+.+..|++|
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            68999999999999999999999999999999998654332    67889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCc
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a  147 (181)
                      ||+.+++|.+++..+  .....+..++.|++.||.|||++|++|+||||+||++++++.  ++|.+++..
T Consensus       111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~~~  176 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPATM  176 (286)
T ss_dssp             ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCCCC
T ss_pred             EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEecccc
Confidence            999999999988543  466678899999999999999999999999999999976655  888876653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=3.4e-30  Score=187.60  Aligned_cols=146  Identities=35%  Similarity=0.562  Sum_probs=127.4

Q ss_pred             Cccceee-eeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHH-hhCCCCCeeEEEEeEEc----CCeEE
Q 030211            1 MEKYELV-KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-RSLRHPNIIRFKEVVLT----PTHLA   74 (181)
Q Consensus         1 ~~~y~~~-~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~-~~~~~~~i~~~~~~~~~----~~~~~   74 (181)
                      +++|.+. +.||+|+||.||++.+..+++.||+|++..    .....+|+.++ +..+|||++++++++..    .+..+
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            3678888 789999999999999999999999999864    24566777776 66799999999999887    67799


Q ss_pred             EEEeecCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-CCcEEEeecCCcccc
Q 030211           75 IVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSS  150 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-~~~v~l~dfg~a~~~  150 (181)
                      ++|||+++++|.+++....  .+++..++.++.|++.||.+||++|++|+||+|+||+++.+. .+.++|+|||++...
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  170 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  170 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence            9999999999999987654  699999999999999999999999999999999999997532 456999999998654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.97  E-value=1.7e-30  Score=197.00  Aligned_cols=163  Identities=16%  Similarity=0.072  Sum_probs=122.6

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHHhhCCC-CC------------------
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINHRSLRH-PN------------------   59 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~-~~------------------   59 (181)
                      .|+..+.||+|+||.||+|.+..+++.||+|++....    ...+.+.+|+.++..++| ++                  
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            4788899999999999999999999999999987332    224678889998888876 21                  


Q ss_pred             ---eeEEEEeEEc-----CCeEEEEEeecCCCChHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCC
Q 030211           60 ---IIRFKEVVLT-----PTHLAIVMEYAAGGELFDRICN-------AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDL  124 (181)
Q Consensus        60 ---i~~~~~~~~~-----~~~~~~v~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl  124 (181)
                         ...+..++..     ...++++|+.+ +++|.+++..       ...+++..+..++.|++.||+|||++||+||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence               1111122222     12467777765 5688877731       234778889999999999999999999999999


Q ss_pred             CCCCEEeccCCCCcEEEeecCCcccccCCCCCCcccCCCCccCcccc
Q 030211          125 KLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL  171 (181)
Q Consensus       125 ~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~  171 (181)
                      ||+||+++.++.  ++|+|||+++.....  .....| +.|+|||++
T Consensus       238 Kp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~  279 (413)
T 3dzo_A          238 RPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETT  279 (413)
T ss_dssp             CGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHH
T ss_pred             ccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhh
Confidence            999999976655  999999998754333  334567 999999999

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=2.5e-30  Score=201.67  Aligned_cols=154  Identities=21%  Similarity=0.118  Sum_probs=119.2

Q ss_pred             eeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---------cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---------DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---------~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ..+.||+|+||.||++..  .++.+++|........         .+.+.+|+.+++.++|||++++..++...+..+++
T Consensus       340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            456899999999999944  4778899976442211         23478999999999999999655555567777999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-  155 (181)
                      |||+++++|.+++..        +..++.|++.+|.|||++||+|+||||+||++++    .++|+|||+++....... 
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCcccc
Confidence            999999999998754        6689999999999999999999999999999975    599999999986544322 


Q ss_pred             -------CCcccCCCCccCcccccC
Q 030211          156 -------PKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       156 -------~~~~~~~~~~~aPE~~~~  173 (181)
                             .....||+.|||||++..
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~  510 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWER  510 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHH
Confidence                   124578999999999976

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.95  E-value=3e-28  Score=176.03  Aligned_cols=143  Identities=20%  Similarity=0.175  Sum_probs=113.2

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-------------------ccHHHHHHHHHHhhCCCCCeeEEE
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------------------IDENVAREIINHRSLRHPNIIRFK   64 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------------------~~~~~~~e~~~~~~~~~~~i~~~~   64 (181)
                      |.+.+.||+|++|.||+|.+ .+++.||+|.+.....                   ....+.+|+.+++.++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            45669999999999999999 7799999999864321                   1245788999999998  4 5555


Q ss_pred             EeEEcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeec
Q 030211           65 EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (181)
Q Consensus        65 ~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~df  144 (181)
                      +++.. +..+++|||+++++|.+ +.      ......++.|++.||.+||++|++|+||||+||+++   .+.++|+||
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~---~~~vkl~DF  236 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS---EEGIWIIDF  236 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE---TTEEEECCC
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE---CCcEEEEEC
Confidence            54433 55699999999999987 31      134557999999999999999999999999999997   445999999


Q ss_pred             CCcccccCCCCCCcccCCCCccCcccccC
Q 030211          145 GYSKSSVLHSRPKSTVGTPAYIAPEVLSR  173 (181)
Q Consensus       145 g~a~~~~~~~~~~~~~~~~~~~aPE~~~~  173 (181)
                      |+|..            +..++|||++.+
T Consensus       237 G~a~~------------~~~~~a~e~l~r  253 (282)
T 1zar_A          237 PQSVE------------VGEEGWREILER  253 (282)
T ss_dssp             TTCEE------------TTSTTHHHHHHH
T ss_pred             CCCeE------------CCCCCHHHHHHH
Confidence            99863            345688888764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.92  E-value=4e-25  Score=157.79  Aligned_cols=136  Identities=13%  Similarity=0.083  Sum_probs=105.9

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcE--EEEEEccccccc-------------------------cHHHHHHHHHHhhCC
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKEL--VAVKYIERGRKI-------------------------DENVAREIINHRSLR   56 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~--v~~K~~~~~~~~-------------------------~~~~~~e~~~~~~~~   56 (181)
                      |++.+.||+|++|.||+|.+..+|+.  ||+|++......                         ...+.+|+..+..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67899999999999999999777888  999987543111                         125788999999887


Q ss_pred             CCCe--eEEEEeEEcCCeEEEEEeecCC-C----ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-hcCeeeeCCCCCC
Q 030211           57 HPNI--IRFKEVVLTPTHLAIVMEYAAG-G----ELFDRICNAGRFSEDEGRYFFQQLISGVNYCH-SMQICHRDLKLEN  128 (181)
Q Consensus        57 ~~~i--~~~~~~~~~~~~~~~v~e~~~~-~----~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~gi~h~dl~p~n  128 (181)
                      |+++  +.+++.    +..++||||+++ +    +|.+....   .++..+..++.|++.+|.+|| ++|++|+||+|+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            7753  444442    356899999942 3    56554432   335678899999999999999 9999999999999


Q ss_pred             EEeccCCCCcEEEeecCCcccc
Q 030211          129 TLLDGSAAPRLKICDFGYSKSS  150 (181)
Q Consensus       129 i~i~~~~~~~v~l~dfg~a~~~  150 (181)
                      |++++    .++|+|||+|...
T Consensus       202 ILl~~----~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID----KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS----SEEECCCTTCEET
T ss_pred             EEEcC----cEEEEECcccccC
Confidence            99975    5999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.86  E-value=1.7e-21  Score=145.12  Aligned_cols=137  Identities=15%  Similarity=0.127  Sum_probs=98.0

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---------------c--------HHHHHHHHHHhhCCCCCe
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---------------D--------ENVAREIINHRSLRHPNI   60 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---------------~--------~~~~~e~~~~~~~~~~~i   60 (181)
                      |++.++||+|++|.||+|.+. +|+.||+|+++.+...               .        -+...|...+..+.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999986 4889999987532100               0        012345666666644443


Q ss_pred             eEEEEeEEcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCC---
Q 030211           61 IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAP---  137 (181)
Q Consensus        61 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~---  137 (181)
                      .....+...  ..++||||+++.+|....      ..+....++.|++.+|.+||++|++||||||.||++++++..   
T Consensus       176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVPEPIAQS--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCCCEEEEE--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCCeeeecc--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            222222222  237999999888876543      123456788999999999999999999999999999655422   


Q ss_pred             -----cEEEeecCCccc
Q 030211          138 -----RLKICDFGYSKS  149 (181)
Q Consensus       138 -----~v~l~dfg~a~~  149 (181)
                           .+.++||+-+..
T Consensus       248 ~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TSEEEEEEECCCTTCEE
T ss_pred             cccccceEEEEeCCccc
Confidence                 388999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.67  E-value=9.8e-16  Score=109.23  Aligned_cols=138  Identities=19%  Similarity=0.121  Sum_probs=108.5

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc-cccHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +.|++....+.++.+.||++...  ++.+++|+..... .....+.+|...+..+. +..++++++++.+.+..|++||+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            56888888888888999999754  6789999987532 22346788888888774 56788899999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-------------------------------------------  116 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-------------------------------------------  116 (181)
                      ++|.++.+.+.     +......++.++..++..||+                                           
T Consensus        92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            99988876531     222345778899999999998                                           


Q ss_pred             ----------------cCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211          117 ----------------MQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus       117 ----------------~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                                      .+++|+|++|.||+++++  ..+.|+||+.+.
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~--~~~~lIDwe~a~  212 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG--KVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT--EEEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC--cEEEEEEchhcc
Confidence                            458999999999999643  235699999874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.53  E-value=5.4e-14  Score=99.80  Aligned_cols=134  Identities=13%  Similarity=0.115  Sum_probs=94.8

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCC--eeEEEEeEEcCCeEEEEEeec
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN--IIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~--i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      .|.+....+.|..+.||++... +|..+++|+....  ....+..|...++.+.+.+  +++++.+...++..+++||++
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            4555444445666899999653 4677999987654  2345677888887775434  567888888888899999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ------------------------------------------  118 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~g------------------------------------------  118 (181)
                      +|.++.  ..   ..+   ...++.++...+..||+..                                          
T Consensus        98 ~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (264)
T 1nd4_A           98 PGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  169 (264)
T ss_dssp             SSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             CCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence            998773  21   111   2255666777777777643                                          


Q ss_pred             ----------------eeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211          119 ----------------ICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus       119 ----------------i~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                                      ++|+|++|.||+++++  ..+.|+||+.+..
T Consensus       170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~--~~~~liD~~~a~~  214 (264)
T 1nd4_A          170 LFARLKARMPDGEDLVVTHGDACLPNIMVENG--RFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETT--EEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCCCeEEECCCCCCCcEEEECC--cEEEEEcchhccc
Confidence                            9999999999999643  2356999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.52  E-value=8.8e-14  Score=103.44  Aligned_cols=140  Identities=16%  Similarity=0.225  Sum_probs=104.5

Q ss_pred             eeeeeCCccceeEEEEEEccCCcEEEEEEcc--ccc--cccHHHHHHHHHHhhCCC--CCeeEEEEeEEcC---CeEEEE
Q 030211            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIE--RGR--KIDENVAREIINHRSLRH--PNIIRFKEVVLTP---THLAIV   76 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~--~~~--~~~~~~~~e~~~~~~~~~--~~i~~~~~~~~~~---~~~~~v   76 (181)
                      .++.++.|.++.+|++...  +..+++|+..  ...  .....+.+|..+++.+..  ..+++++.++.+.   +..|++
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            4667888999999999865  4678899876  433  223567889988888864  4578888888776   458999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS----------------------------------------  116 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~----------------------------------------  116 (181)
                      ||++++..+.+..  -..++......++.++...|..||+                                        
T Consensus       120 me~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          120 MEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             EECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            9999987775322  1246788888999999999999997                                        


Q ss_pred             ------------------cCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211          117 ------------------MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus       117 ------------------~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                                        .+++|+|++|.||+++++....+.++||+.+..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              368999999999999755444468999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.09  E-value=3.1e-10  Score=82.42  Aligned_cols=135  Identities=16%  Similarity=0.118  Sum_probs=94.5

Q ss_pred             eeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC-CCC--eeEEEEeEEcCC---eEEEEEeec
Q 030211            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPN--IIRFKEVVLTPT---HLAIVMEYA   80 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~-~~~--i~~~~~~~~~~~---~~~~v~e~~   80 (181)
                      .+.++.|....+|++.     ..+++|+.... .....+.+|...+..+. +..  ++.++......+   ..|++|+++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4557788888999763     45888975432 23456788888887763 332  455555544433   347899999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS--------------------------------------------  116 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~--------------------------------------------  116 (181)
                      +|.++.....  ..++.+....++.++...+..||+                                            
T Consensus        99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A           99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence            9988765332  236777777788888888888775                                            


Q ss_pred             --------------cCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211          117 --------------MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus       117 --------------~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                                    ..++|+|++|.||+++++....+.++||+.+..
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence                          237999999999999764234578999998754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=99.06  E-value=3.6e-09  Score=76.98  Aligned_cols=135  Identities=19%  Similarity=0.154  Sum_probs=86.9

Q ss_pred             eeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCC---CeeEEEEeEE-cCCeEEEEEeecCC
Q 030211            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHP---NIIRFKEVVL-TPTHLAIVMEYAAG   82 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~---~i~~~~~~~~-~~~~~~~v~e~~~~   82 (181)
                      .+.++.|....+|++     +..+++|+... ......+..|...+..+.+.   .++.++.+.. ..+..+++|++++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            455677888889988     45688897432 22345778899999888642   3566777764 45567899999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS----------------------------------------------  116 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~----------------------------------------------  116 (181)
                      .++......  .++......++.++...|..||+                                              
T Consensus        98 ~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  175 (306)
T 3tdw_A           98 QILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR  175 (306)
T ss_dssp             EECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred             eECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence            877652211  12333333334444444333332                                              


Q ss_pred             --------------cCeeeeCCCCCCEEeccC--CCCcEEEeecCCccc
Q 030211          117 --------------MQICHRDLKLENTLLDGS--AAPRLKICDFGYSKS  149 (181)
Q Consensus       117 --------------~gi~h~dl~p~ni~i~~~--~~~~v~l~dfg~a~~  149 (181)
                                    ..++|+|++|.||+++++  ....+.|+||+.+..
T Consensus       176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          246999999999999751  122358999998754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=99.06  E-value=4.2e-09  Score=75.07  Aligned_cols=132  Identities=19%  Similarity=0.205  Sum_probs=89.3

Q ss_pred             eCCccce-eEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCeEEEEEeecCCCChHH
Q 030211           10 LGAGNFG-VARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFD   87 (181)
Q Consensus        10 i~~g~~~-~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~   87 (181)
                      +..|..+ .+|+......+..+++|+-....  ...+..|...++.+. +--+++++.++.+++..+++|+++++.++.+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~--~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSV--ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHH--HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCC--HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            3345444 68999887778889999865432  356777888877664 3347788999999999999999999987765


Q ss_pred             HHhhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------------
Q 030211           88 RICNAGRFSEDEGRYFFQQLISGVNYCHS---------------------------------------------------  116 (181)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---------------------------------------------------  116 (181)
                      .....    ......+..++...+..||.                                                   
T Consensus       110 ~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  185 (272)
T 4gkh_A          110 VLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK  185 (272)
T ss_dssp             HHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred             cccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence            43221    11222333444444444442                                                   


Q ss_pred             -------cCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211          117 -------MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus       117 -------~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                             ..++|+|++|.||+++++.  .+-|+||+.+..
T Consensus       186 ~~~~~~~~~l~HGDl~~~Nil~~~~~--~~~viDwe~a~~  223 (272)
T 4gkh_A          186 LLPFSPDSVVTHGDFSLDNLIFDEGK--LIGCIDVGRVGI  223 (272)
T ss_dssp             TCCCCCCEEEECSCCCTTSEEEETTE--EEEECCCTTCEE
T ss_pred             cccccCCcEEEcCCCCCCeEEEECCe--EEEEEECccccc
Confidence                   1278999999999997433  467999988753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.80  E-value=3.9e-08  Score=73.97  Aligned_cols=75  Identities=15%  Similarity=0.057  Sum_probs=47.2

Q ss_pred             eeeeCCccceeEEEEEEccCCcEEEEEEccccc--------cccHHHHHHHHHHhhCCC--C-CeeEEEEeEEcCCeEEE
Q 030211            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGR--------KIDENVAREIINHRSLRH--P-NIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--------~~~~~~~~e~~~~~~~~~--~-~i~~~~~~~~~~~~~~~   75 (181)
                      .+.+|.|..+.+|++....+++.+++|......        ........|...+..+..  + .++.++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            567899999999999776567789999754321        122445667777766532  2 34455543  3445679


Q ss_pred             EEeecCCC
Q 030211           76 VMEYAAGG   83 (181)
Q Consensus        76 v~e~~~~~   83 (181)
                      +||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.71  E-value=6.7e-08  Score=71.59  Aligned_cols=80  Identities=10%  Similarity=0.070  Sum_probs=53.6

Q ss_pred             eeee-CCccceeEEEEEEc--c----CCcEEEEEEccccc---c-ccHHHHHHHHHHhhCCC---CCeeEEEEeEEcC--
Q 030211            7 VKDL-GAGNFGVARLLRHK--E----TKELVAVKYIERGR---K-IDENVAREIINHRSLRH---PNIIRFKEVVLTP--   70 (181)
Q Consensus         7 ~~~i-~~g~~~~v~~~~~~--~----~~~~v~~K~~~~~~---~-~~~~~~~e~~~~~~~~~---~~i~~~~~~~~~~--   70 (181)
                      .+.| +.|....+|++...  .    ++..+++|+.....   . ....+..|...++.+..   -.+++++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 78888899988753  1    15678999865433   1 12456777777776632   3567777777655  


Q ss_pred             -CeEEEEEeecCCCChH
Q 030211           71 -THLAIVMEYAAGGELF   86 (181)
Q Consensus        71 -~~~~~v~e~~~~~~l~   86 (181)
                       +..+++||+++|.++.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999886543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.62  E-value=8.2e-07  Score=65.10  Aligned_cols=73  Identities=14%  Similarity=0.168  Sum_probs=39.7

Q ss_pred             eeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC--CCCeeEEEE------eEEcCCeEEEEEee
Q 030211            8 KDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR--HPNIIRFKE------VVLTPTHLAIVMEY   79 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~--~~~i~~~~~------~~~~~~~~~~v~e~   79 (181)
                      +.++.|..+.+|++...  +..+++|+.....   .....+...+..+.  .-.+++++.      +....+..++++++
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            34555667899998764  3358999887532   23333444443332  112344433      12346678999999


Q ss_pred             cCCCCh
Q 030211           80 AAGGEL   85 (181)
Q Consensus        80 ~~~~~l   85 (181)
                      ++|.++
T Consensus       113 i~G~~~  118 (346)
T 2q83_A          113 IEGRPF  118 (346)
T ss_dssp             CCCBCC
T ss_pred             ecCccC
Confidence            988543

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.44  E-value=4.1e-07  Score=65.85  Aligned_cols=74  Identities=15%  Similarity=0.117  Sum_probs=43.4

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCe-eEEEEeEEcCCeEEEEEeec-C
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI-IRFKEVVLTPTHLAIVMEYA-A   81 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i-~~~~~~~~~~~~~~~v~e~~-~   81 (181)
                      +.=.+.++.|....+|++      ..+++|+........-....|...+..+...++ ++++...  +..-+++++|+ +
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~   91 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG   91 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence            333677888888999998      448889876543222233456666655532222 4555543  33346799999 6


Q ss_pred             CCCh
Q 030211           82 GGEL   85 (181)
Q Consensus        82 ~~~l   85 (181)
                      +.++
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            6444

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.32  E-value=4.6e-06  Score=63.18  Aligned_cols=73  Identities=15%  Similarity=0.210  Sum_probs=43.2

Q ss_pred             eeeeeCCccceeEEEEEEccCCcEEEEEEccc-----ccc-----ccHHHHHHHHHHh-hCCCCCeeEEEEeEEcCCeEE
Q 030211            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIER-----GRK-----IDENVAREIINHR-SLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~-----~~~-----~~~~~~~e~~~~~-~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      -.+.++.|..+.+|++..  +++.+++|....     ...     ....+..|+..+. ......+++++.+.  ++..+
T Consensus        38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~  113 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL  113 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred             EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence            356788899999999964  467799994221     111     1122333332222 22224566676665  45678


Q ss_pred             EEEeec-CC
Q 030211           75 IVMEYA-AG   82 (181)
Q Consensus        75 ~v~e~~-~~   82 (181)
                      ++||++ ++
T Consensus       114 lv~e~l~~g  122 (420)
T 2pyw_A          114 IGMRYLEPP  122 (420)
T ss_dssp             EEECCCCTT
T ss_pred             EEEeecCCc
Confidence            999999 76

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.31  E-value=1.7e-05  Score=57.76  Aligned_cols=76  Identities=17%  Similarity=0.080  Sum_probs=57.8

Q ss_pred             eeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC---CCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            6 LVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR---HPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~---~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      -.+.++.|....+|++..  ++..+++|+....  ....+..|...++.+.   ...+++++.+....+..+++||++++
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            346688898899999975  3667899986643  2456777877777663   35688888888888899999999988


Q ss_pred             CCh
Q 030211           83 GEL   85 (181)
Q Consensus        83 ~~l   85 (181)
                      .++
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=98.23  E-value=8.6e-06  Score=60.90  Aligned_cols=137  Identities=15%  Similarity=0.131  Sum_probs=77.2

Q ss_pred             eeeCCccceeEEEEEEcc-------CCcEEEEEEccccccccHHHHHHHHHHhhCCCCC-eeEEEEeEEcCCeEEEEEee
Q 030211            8 KDLGAGNFGVARLLRHKE-------TKELVAVKYIERGRKIDENVAREIINHRSLRHPN-IIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~~-------~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~-i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +.+..|-...+|++...+       .++.+++|+............+|..+++.+...+ .++++.++.+    .+++||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            456567777899998642       3578999986443333455667888877664322 3556666543    289999


Q ss_pred             cCCCChHHH-----------------Hhhc-----CCCC--HHHHHHHHHHHHH-------------------HHHHH--
Q 030211           80 AAGGELFDR-----------------ICNA-----GRFS--EDEGRYFFQQLIS-------------------GVNYC--  114 (181)
Q Consensus        80 ~~~~~l~~~-----------------~~~~-----~~~~--~~~~~~~~~~i~~-------------------~l~~l--  114 (181)
                      ++|.++...                 ++..     .+..  +..+..+..++..                   .+..|  
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            988554210                 1111     1111  2344444443321                   12222  


Q ss_pred             --Hh----cCeeeeCCCCCCEEeccC--CCCcEEEeecCCcc
Q 030211          115 --HS----MQICHRDLKLENTLLDGS--AAPRLKICDFGYSK  148 (181)
Q Consensus       115 --h~----~gi~h~dl~p~ni~i~~~--~~~~v~l~dfg~a~  148 (181)
                        ..    ..++|+|+.+.||+++++  ..+.+.++||..|.
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence              21    358899999999999755  12469999999875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=98.08  E-value=2.8e-05  Score=57.82  Aligned_cols=74  Identities=14%  Similarity=0.054  Sum_probs=42.7

Q ss_pred             eeeeCCccceeEEEEEEccC--------CcEEEEEEccccccccHHHHHHHHHHhhCCCCC-eeEEEEeEEcCCeEEEEE
Q 030211            7 VKDLGAGNFGVARLLRHKET--------KELVAVKYIERGRKIDENVAREIINHRSLRHPN-IIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~--------~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~-i~~~~~~~~~~~~~~~v~   77 (181)
                      .+.++.|....+|++.....        ++.+++|+.............|...+..+...+ .++++...  ++  ++++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~  113 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE  113 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence            45566777789999986531        367899987654322222356666666553333 44566544  23  6799


Q ss_pred             eecCCCC
Q 030211           78 EYAAGGE   84 (181)
Q Consensus        78 e~~~~~~   84 (181)
                      +|+++.+
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=98.07  E-value=1.7e-05  Score=57.69  Aligned_cols=137  Identities=15%  Similarity=0.114  Sum_probs=72.1

Q ss_pred             eeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCC--eeEEEEe------EEcCCeEEEEEe
Q 030211            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN--IIRFKEV------VLTPTHLAIVME   78 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~--i~~~~~~------~~~~~~~~~v~e   78 (181)
                      .+.|+.|....+|++...+ + .+++|+.... .....+..|...+..+...+  +++++..      ....+..+.+++
T Consensus        27 ~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTK-D-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEECC---EEEEEEEESS-C-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eeccCCCcccceEEEEeCC-c-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            4456678788999987642 3 5889988752 12234455666655442212  3333321      123456789999


Q ss_pred             ecCCCChHH--------------HHhhc-CCC--------CHHHHHHH---------------HHHHHHHHHHHH-----
Q 030211           79 YAAGGELFD--------------RICNA-GRF--------SEDEGRYF---------------FQQLISGVNYCH-----  115 (181)
Q Consensus        79 ~~~~~~l~~--------------~~~~~-~~~--------~~~~~~~~---------------~~~i~~~l~~lh-----  115 (181)
                      +++|.++..              .++.. ..+        ........               ...+...++.+.     
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            998864310              01110 011        10000000               011233344444     


Q ss_pred             --hcCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211          116 --SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus       116 --~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                        ..+++|+|++|.||+++++.  .+.++||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~--~~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDE--LSGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEEeCCc--eEEEecchhcc
Confidence              24799999999999997442  35799998774

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.05  E-value=8.9e-05  Score=53.17  Aligned_cols=76  Identities=12%  Similarity=0.030  Sum_probs=51.7

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc-cHHHHHHHHHHhhCCCC---CeeEEEEeEEcCCeEEEEEee
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHP---NIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~---~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ..-++.+|.|..+.||++... +|+.+++|+....... ...+..|...++.+...   -+++++..  ..  -+++||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~   91 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEW   91 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEEC
T ss_pred             eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEe
Confidence            345677889999999999875 4788999986644332 34567788888776432   34455543  22  3678999


Q ss_pred             cCCCC
Q 030211           80 AAGGE   84 (181)
Q Consensus        80 ~~~~~   84 (181)
                      +.+..
T Consensus        92 l~~~~   96 (288)
T 3f7w_A           92 VDERP   96 (288)
T ss_dssp             CCCCC
T ss_pred             ecccC
Confidence            87754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=98.03  E-value=9.6e-05  Score=54.06  Aligned_cols=33  Identities=30%  Similarity=0.392  Sum_probs=26.2

Q ss_pred             cCeeeeCCCCCCEEeccCC--CCcEEEeecCCccc
Q 030211          117 MQICHRDLKLENTLLDGSA--APRLKICDFGYSKS  149 (181)
Q Consensus       117 ~gi~h~dl~p~ni~i~~~~--~~~v~l~dfg~a~~  149 (181)
                      ..++|||++|.||+++++.  ...+.++||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            4799999999999996531  14589999998754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=98.02  E-value=6.1e-05  Score=54.91  Aligned_cols=74  Identities=11%  Similarity=0.064  Sum_probs=45.6

Q ss_pred             eeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCC--eeEEEEe-----EEcCCeEEEEEeecC
Q 030211            9 DLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN--IIRFKEV-----VLTPTHLAIVMEYAA   81 (181)
Q Consensus         9 ~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~--i~~~~~~-----~~~~~~~~~v~e~~~   81 (181)
                      .++ |....+|++... +|+.+++|+..........+..|...+..+...+  +++++..     ....+..+.++++++
T Consensus        33 ~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             eec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            455 777789988654 3557999998744333455666776666553222  3444432     122456788999998


Q ss_pred             CCC
Q 030211           82 GGE   84 (181)
Q Consensus        82 ~~~   84 (181)
                      |.+
T Consensus       111 G~~  113 (328)
T 1zyl_A          111 GRQ  113 (328)
T ss_dssp             CEE
T ss_pred             CCC
Confidence            754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.97  E-value=3.7e-05  Score=58.46  Aligned_cols=73  Identities=12%  Similarity=0.144  Sum_probs=47.0

Q ss_pred             eeeeCCccceeEEEEEEcc-------CCcEEEEEEccccccccHHHHHHHHHHhhCCCCCe-eEEEEeEEcCCeEEEEEe
Q 030211            7 VKDLGAGNFGVARLLRHKE-------TKELVAVKYIERGRKIDENVAREIINHRSLRHPNI-IRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~-------~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i-~~~~~~~~~~~~~~~v~e   78 (181)
                      ++.|+.|....+|++....       .++.+++|+.... .....+..|...+..+...++ +++++.+.  +  .++++
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e  152 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE  152 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence            4567778888999998653       2567899987432 221455578877776643333 56666553  2  27899


Q ss_pred             ecCCCC
Q 030211           79 YAAGGE   84 (181)
Q Consensus        79 ~~~~~~   84 (181)
                      |+++.+
T Consensus       153 ~l~G~~  158 (429)
T 1nw1_A          153 YIPSRP  158 (429)
T ss_dssp             CCCEEE
T ss_pred             EeCCcc
Confidence            997643

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.75  E-value=0.00098  Score=48.98  Aligned_cols=31  Identities=23%  Similarity=0.440  Sum_probs=25.2

Q ss_pred             cCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211          117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus       117 ~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      .+++|+|+.|.||+++++.  .+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~--~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEE--SIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGG--CEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCC--eEEEEECCCCee
Confidence            4699999999999996443  489999987653

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.71  E-value=0.00099  Score=51.05  Aligned_cols=75  Identities=13%  Similarity=0.061  Sum_probs=46.6

Q ss_pred             eeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCe-eEEEEeEEcCCeEEEEEeecCCCCh
Q 030211            7 VKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI-IRFKEVVLTPTHLAIVMEYAAGGEL   85 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i-~~~~~~~~~~~~~~~v~e~~~~~~l   85 (181)
                      .+.|+.|-...+|++...+.+..+++|+........-....|...+..+...++ ++++.++.  +.  .+++|+++.++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~l  188 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYAL  188 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCccC
Confidence            456777888899999876445778999875432222223577777777754444 55676662  32  49999987443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=97.40  E-value=0.0011  Score=50.38  Aligned_cols=75  Identities=15%  Similarity=0.075  Sum_probs=46.6

Q ss_pred             eeeeCCccceeEEEEEEccC-------CcEEEEEEccccccccHHHHHHHHHHhhCCCCC-eeEEEEeEEcCCeEEEEEe
Q 030211            7 VKDLGAGNFGVARLLRHKET-------KELVAVKYIERGRKIDENVAREIINHRSLRHPN-IIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~-------~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~-i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++.+..|-...+|++.....       ++.+++|+........-...+|...++.+...+ .+++++.+  ++  +.+++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e  150 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE  150 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence            45566677789999987531       577999987554332223456777766653222 45555533  33  67999


Q ss_pred             ecCCCCh
Q 030211           79 YAAGGEL   85 (181)
Q Consensus        79 ~~~~~~l   85 (181)
                      |+++.++
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9988653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.50  E-value=0.017  Score=43.45  Aligned_cols=31  Identities=39%  Similarity=0.581  Sum_probs=24.8

Q ss_pred             eeeeCCCCCCEEecc----CCCCcEEEeecCCccc
Q 030211          119 ICHRDLKLENTLLDG----SAAPRLKICDFGYSKS  149 (181)
Q Consensus       119 i~h~dl~p~ni~i~~----~~~~~v~l~dfg~a~~  149 (181)
                      +.|+|+.+.||++.+    +....+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            679999999999943    3345699999998753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=94.95  E-value=0.35  Score=33.15  Aligned_cols=90  Identities=13%  Similarity=0.059  Sum_probs=64.1

Q ss_pred             CCCCeeEEEEeEEcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHH-HHHhcCeeeeCCCCCCEEeccC
Q 030211           56 RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN-YCHSMQICHRDLKLENTLLDGS  134 (181)
Q Consensus        56 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~-~lh~~gi~h~dl~p~ni~i~~~  134 (181)
                      .+|++  ...+-.+.+.+.+.++..++..-...+.   ..+....++++.+++.... ++  ..-+|--++|+|++++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            57777  5555577888888888765543333342   3788999999999888776 43  456788999999999766


Q ss_pred             CCCcEEEeecCCcccccCCC
Q 030211          135 AAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus       135 ~~~~v~l~dfg~a~~~~~~~  154 (181)
                      ..  +++.-.|+-....|..
T Consensus       121 ~~--p~i~hRGi~~~lpP~e  138 (219)
T 4ano_A          121 LE--PFFLHVGVKESLPPDE  138 (219)
T ss_dssp             CC--EEESCCEETTTBSSCS
T ss_pred             Cc--EEEEEcCCcccCCCCC
Confidence            65  8888888654444443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=94.35  E-value=0.36  Score=32.95  Aligned_cols=90  Identities=12%  Similarity=0.063  Sum_probs=62.5

Q ss_pred             CCCCeeEEEEeEEcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC
Q 030211           56 RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (181)
Q Consensus        56 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~  135 (181)
                      .+|++++. .+-.+.+.+.+.++..+...-...+.   ..+....++++.+|+....++  ..-+|--++|+|++++.+.
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~  116 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDG  116 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTS
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCC
Confidence            67888877 56666777877777654332222232   368889999999998888444  4457889999999997655


Q ss_pred             CCcEEEeecCCcccccCC
Q 030211          136 APRLKICDFGYSKSSVLH  153 (181)
Q Consensus       136 ~~~v~l~dfg~a~~~~~~  153 (181)
                      .  +++.--|+.....|.
T Consensus       117 ~--p~i~~RGik~~l~P~  132 (215)
T 4ann_A          117 L--PIAKTRGLQNVVDPL  132 (215)
T ss_dssp             C--EEESCCEETTTBSCC
T ss_pred             C--EEEEEccCccCCCCC
Confidence            5  888877765434343

>1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3

Probab=89.43  E-value=3.2  Score=30.41  Aligned_cols=138  Identities=12%  Similarity=0.070  Sum_probs=71.3

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEe-----------------
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEV-----------------   66 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~-----------------   66 (181)
                      ++.++....|..|..+-+.   ++..+++|-..  ....+.+-.++...-.++-|...-+...                 
T Consensus        71 v~~I~~s~~Gstgvff~~t---d~~~~VVK~s~--~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~~~~~  145 (342)
T 1cja_A           71 FKGIERSEKGTEGLFFVET---ESGVFIVKRST--NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAIDKS  145 (342)
T ss_dssp             EEEEEECCSTTSCEEEEEE---SSCEEEEECCT--THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHHCSS
T ss_pred             eeEEEeccCCCCCeEEEEe---CCCEEEEeCcH--HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHHhhhh
Confidence            5566666666655554444   36678999442  2223344445555555555554333211                 


Q ss_pred             -----EEcCCeEEEEEeecCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC-ee----eeCCCCCCEEeccC
Q 030211           67 -----VLTPTHLAIVMEYAAGGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQ-IC----HRDLKLENTLLDGS  134 (181)
Q Consensus        67 -----~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~g-i~----h~dl~p~ni~i~~~  134 (181)
                           -...+..+++|+|.+|..|...-..  ...+..+....+.+  +-++..+..++ =.    +..-+|.||++.++
T Consensus       146 ~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG~--Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~  223 (342)
T 1cja_A          146 FRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLGS--LMALDVIVNNSDRLPIAWTNEGNLDNIMLSER  223 (342)
T ss_dssp             SCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHHH--HHHHHHHHTCCSSSCSSSCSCCCGGGEEEESB
T ss_pred             hHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHhhch--hheehhhhcCCccCcccccCCCChhheEEeCC
Confidence                 0012357799999987666542211  01133333222111  22334444332 11    12358999999754


Q ss_pred             CCCcEEEeecCCccc
Q 030211          135 AAPRLKICDFGYSKS  149 (181)
Q Consensus       135 ~~~~v~l~dfg~a~~  149 (181)
                      . .++.++|-+++..
T Consensus       224 n-~~~~~IDhn~af~  237 (342)
T 1cja_A          224 G-ATVVPIDSKIIPL  237 (342)
T ss_dssp             T-TCEEECSCCCCCC
T ss_pred             C-CeEEEEcCCcccc
Confidence            3 3799999988854

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=82.36  E-value=4.4  Score=27.84  Aligned_cols=58  Identities=12%  Similarity=-0.004  Sum_probs=41.0

Q ss_pred             CChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCCCcEEEe
Q 030211           83 GELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKIC  142 (181)
Q Consensus        83 ~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~~~v~l~  142 (181)
                      .+|.+.+.. +.+++++++|.+..|++.+|..+-. +.-...=..|..|++..+++  |.+.
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~   92 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLA   92 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEEC
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eecc
Confidence            367887754 5599999999999999999887632 22223445568888866665  6554

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	181
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-54
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-54
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-54
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-53
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-50
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-50
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-50
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-50
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-49
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-48
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-47
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-47
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-47
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-47
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-43
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-43
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-43
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-42
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-42
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-42
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-41
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-41
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-40
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-40
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-38
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-38
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-38
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-37
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-37
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	8e-37
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-36
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-36
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-36
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-36
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-36
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-35
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-34
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-33
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-33
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-32
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-31
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-30
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-14

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 1e-54
 Identities = 70/183 (38%), Positives = 105/183 (57%), Gaps = 7/183 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRSLRHPN 59
           E ++LV+ LG G +G  +L  ++ T+E VAVK ++  R +D  EN+ +EI  ++ L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +++F           + +EY +GGELFDRI       E + + FF QL++GV Y H + I
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST---VGTPAYIAPEVLSRREY 176
            HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE+
Sbjct: 125 THRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 177 DGK 179
             +
Sbjct: 183 HAE 185

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  174 bits (442), Expect = 1e-54
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 2/178 (1%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           + Y+++++LG+G FGV      K T  +   K+I     +D   V  EI     L HP +
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQI 119
           I   +       + +++E+ +GGELFDRI     + SE E   + +Q   G+ + H   I
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            H D+K EN + +   A  +KI DFG +         K T  T  + APE++ R    
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  174 bits (441), Expect = 2e-54
 Identities = 51/181 (28%), Positives = 87/181 (48%), Gaps = 2/181 (1%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPN 59
           ++ Y++ ++LG G FGV   +  + T    A K++    + D E V +EI     LRHP 
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 84

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQ 118
           ++   +       + ++ E+ +GGELF+++ +   + SEDE   + +Q+  G+ + H   
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
             H DLK EN +     +  LK+ DFG +         K T GT  + APEV   +    
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 204

Query: 179 K 179
            
Sbjct: 205 Y 205

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 6e-54
 Identities = 60/183 (32%), Positives = 98/183 (53%), Gaps = 7/183 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLR 56
           +E +E+ + LG G FG   L R K++K ++A+K + + +     V     RE+     LR
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + ++YCHS
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL  +    LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 125 KRVIHRDIKPENLLLGSA--GELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 181

Query: 177 DGK 179
           D K
Sbjct: 182 DEK 184

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 1e-53
 Identities = 56/181 (30%), Positives = 85/181 (46%), Gaps = 6/181 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
           + +E + +LGAGN GV   + HK +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ- 118
           I+ F     +   ++I ME+  GG L   +  AGR  E         +I G+ Y      
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y  
Sbjct: 126 IMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSV 182

Query: 179 K 179
           +
Sbjct: 183 Q 183

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 1e-50
 Identities = 57/185 (30%), Positives = 82/185 (44%), Gaps = 9/185 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH----RSLRH 57
           E ++  K LG G+F    L R   T    A+K +E+   I EN    +         L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P  ++          L   + YA  GEL   I   G F E   R++  +++S + Y H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K     S   R  S VGT  Y++PE+L+ +
Sbjct: 128 GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 175 EYDGK 179
                
Sbjct: 186 SACKS 190

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (408), Expect = 5e-50
 Identities = 62/181 (34%), Positives = 94/181 (51%), Gaps = 3/181 (1%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPN 59
           + Y+    LG G F    L   K T++LVA+K I +      + ++  EI     ++HPN
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           I+   ++  +  HL ++M+  +GGELFDRI   G ++E +      Q++  V Y H + I
Sbjct: 69  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128

Query: 120 CHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRDLK EN L        ++ I DFG SK     S   +  GTP Y+APEVL+++ Y  
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 188

Query: 179 K 179
            
Sbjct: 189 A 189

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (408), Expect = 5e-50
 Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 12/185 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLRH 57
           + +  ++++G G+FG     R     E+VA+K +    K      +++ +E+   + LRH
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           PN I+++   L      +VMEY  G        +     E E        + G+ Y HS 
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL---SRR 174
            + HRD+K  N LL       +K+ DFG +    + +   S VGTP ++APEV+      
Sbjct: 135 NMIHRDVKAGNILLSEPG--LVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDEG 189

Query: 175 EYDGK 179
           +YDGK
Sbjct: 190 QYDGK 194

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 6e-50
 Identities = 46/179 (25%), Positives = 79/179 (44%), Gaps = 1/179 (0%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           EKY + +DLG G FG+        +K+    K+++        V +EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
              E   +   L ++ E+ +G ++F+RI  +A   +E E   +  Q+   + + HS  I 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           H D++ EN +     +  +KI +FG ++        +     P Y APEV         
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-49
 Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 5/181 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           + +E++ +LG G FG     ++KET  L A K I+   + + E+   EI    S  HPNI
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 71

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-FSEDEGRYFFQQLISGVNYCHSMQI 119
           ++  +      +L I++E+ AGG +   +    R  +E + +   +Q +  +NY H  +I
Sbjct: 72  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 131

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSKSSV-LHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRDLK  N L        +K+ DFG S  +     R  S +GTP ++APEV+       
Sbjct: 132 IHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189

Query: 179 K 179
           +
Sbjct: 190 R 190

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-49
 Identities = 54/180 (30%), Positives = 90/180 (50%), Gaps = 5/180 (2%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-ENVAREIINHRSLRHPNI 60
           +KY   + +G G  G         T + VA++ +   ++   E +  EI+  R  ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           + + +  L    L +VMEY AGG L D +       E +     ++ +  + + HS Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRREYDGK 179
           HRD+K +N LL       +K+ DFG+          +ST VGTP ++APEV++R+ Y  K
Sbjct: 139 HRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  155 bits (394), Expect = 3e-48
 Identities = 64/191 (33%), Positives = 90/191 (47%), Gaps = 13/191 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI----------ERGRKIDENVAREIIN 51
           E YE  + LG G   V R   HK T +  AVK I          E  +++ E   +E+  
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 52  HRSLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISG 110
            R +  HPNII+ K+   T T   +V +    GELFD +      SE E R   + L+  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 111 VNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 171 LSRREYDGKQG 181
           +     D   G
Sbjct: 181 IECSMNDNHPG 191

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 3e-47
 Identities = 62/188 (32%), Positives = 95/188 (50%), Gaps = 13/188 (6%)

Query: 1   MEKYELVKD-LGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREI-INHRSLRHP 58
           ++ Y++    LG G  G    + +K T+E  A+K ++   K      RE+ ++ R+ + P
Sbjct: 10  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR----REVELHWRASQCP 65

Query: 59  NIIRFKEVVLTP----THLAIVMEYAAGGELFDRICNAG--RFSEDEGRYFFQQLISGVN 112
           +I+R  +V          L IVME   GGELF RI + G   F+E E     + +   + 
Sbjct: 66  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125

Query: 113 YCHSMQICHRDLKLENTLLDGSAAP-RLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
           Y HS+ I HRD+K EN L         LK+ DFG++K +  H+   +   TP Y+APEVL
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185

Query: 172 SRREYDGK 179
              +YD  
Sbjct: 186 GPEKYDKS 193

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 7e-47
 Identities = 63/185 (34%), Positives = 101/185 (54%), Gaps = 9/185 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID-------ENVAREIINHRS 54
           + Y+  ++LG+G F V +  R K T    A K+I++ R          E++ RE+   + 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           ++HPN+I   EV    T + +++E  AGGELFD +      +E+E   F +Q+++GV Y 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129

Query: 115 HSMQICHRDLKLENTLLD--GSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           HS+QI H DLK EN +L       PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189

Query: 173 RREYD 177
                
Sbjct: 190 YEPLG 194

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 8e-47
 Identities = 57/193 (29%), Positives = 94/193 (48%), Gaps = 17/193 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           E YE++  +G G++G  + +R K   +++  K ++ G   +   + +  E+   R L+HP
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 59  NIIRFKEVVL--TPTHLAIVMEYAAGGELFDRICNAGR----FSEDEGRYFFQQLISGVN 112
           NI+R+ + ++  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 113 YCH-----SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTV-GTPAYI 166
            CH        + HRDLK  N  LDG     +K+ DFG ++     +       GTP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 167 APEVLSRREYDGK 179
           +PE ++R  Y+ K
Sbjct: 182 SPEQMNRMSYNEK 194

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 9e-47
 Identities = 58/185 (31%), Positives = 95/185 (51%), Gaps = 8/185 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-----VAREIINHRSL 55
           +E + L K LG G+FG   L   K+T +  A+K +++   + ++     +  + +   + 
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
            HP +        T  +L  VMEY  GG+L   I +  +F      ++  ++I G+ + H
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRR 174
           S  I +RDLKL+N LLD      +KI DFG  K ++L     +T  GTP YIAPE+L  +
Sbjct: 121 SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178

Query: 175 EYDGK 179
           +Y+  
Sbjct: 179 KYNHS 183

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  148 bits (375), Expect = 6e-45
 Identities = 55/183 (30%), Positives = 95/183 (51%), Gaps = 8/183 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR 56
           ++ +++++ LG G+FG   L+R +      A+K +++   +     E+   E +    + 
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP IIR          + ++M+Y  GGELF  +  + RF     +++  ++   + Y HS
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
             I +RDLK EN LLD +    +KI DFG++K   +     +  GTP YIAPEV+S + Y
Sbjct: 123 KDIIYRDLKPENILLDKNG--HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPY 178

Query: 177 DGK 179
           +  
Sbjct: 179 NKS 181

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  144 bits (365), Expect = 6e-44
 Identities = 46/188 (24%), Positives = 72/188 (38%), Gaps = 10/188 (5%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA----REIINHRSLRH 57
           ++YEL + LG G      L R       VAVK +      D +      RE  N  +L H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 58  PNIIRFKEVVLTPTH----LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           P I+   +     T       IVMEY  G  L D +   G  +              +N+
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFG--YSKSSVLHSRPKSTVGTPAYIAPEVL 171
            H   I HRD+K  N ++  + A ++         + S    ++  + +GT  Y++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 172 SRREYDGK 179
                D +
Sbjct: 187 RGDSVDAR 194

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  146 bits (368), Expect = 2e-43
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 10/187 (5%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHR------- 53
           M  + + + +G G FG     R  +T ++ A+K +++ R   +      +N R       
Sbjct: 3   MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 54  SLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           +   P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G+ +
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            H+  + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL +
Sbjct: 123 MHNRFVVYRDLKPANILLD--EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQK 179

Query: 174 REYDGKQ 180
                  
Sbjct: 180 GVAYDSS 186

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-43
 Identities = 44/181 (24%), Positives = 76/181 (41%), Gaps = 6/181 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           +    +K+LG G FGV +  + +   + VA+K I+ G   ++    E     +L H  ++
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +   V      + I+ EY A G L + +     RF   +     + +   + Y  S Q  
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVLSRREYDG 178
           HRDL   N L++      +K+ DFG S+  +      S        +  PEVL   ++  
Sbjct: 123 HRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 179 K 179
           K
Sbjct: 181 K 181

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 5e-43
 Identities = 45/185 (24%), Positives = 78/185 (42%), Gaps = 12/185 (6%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHPNI 60
            +   ++G G+F         ET   VA   ++  +      +    E    + L+HPNI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 61  IRFKEVVLTPT----HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           +RF +   +       + +V E    G L   +           R + +Q++ G+ + H+
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 117 M--QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
               I HRDLK +N  + G     +KI D G +      S  K+ +GTP ++APE+    
Sbjct: 131 RTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMY-EE 187

Query: 175 EYDGK 179
           +YD  
Sbjct: 188 KYDES 192

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 2e-42
 Identities = 63/184 (34%), Positives = 94/184 (51%), Gaps = 7/184 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN----VAREIINHRSLR 56
           M  ++ +K LG G FG   L+R K T    A+K + +   I ++       E    ++ R
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+  R++  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 176 YDGK 179
           Y   
Sbjct: 182 YGRA 185

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 7e-42
 Identities = 50/182 (27%), Positives = 77/182 (42%), Gaps = 10/182 (5%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNI 60
           M++ +L++ +G G FG   L  ++  K  VAVK I +     +    E      LRH N+
Sbjct: 6   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSNL 62

Query: 61  IRFKEVVL-TPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSM 117
           ++   V++     L IV EY A G L D + + GR     D    F   +   + Y    
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
              HRDL   N L+        K+ DFG +K     S   +      + APE L  +++ 
Sbjct: 123 NFVHRDLAARNVLVSEDN--VAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKFS 178

Query: 178 GK 179
            K
Sbjct: 179 TK 180

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (356), Expect = 8e-42
 Identities = 55/183 (30%), Positives = 103/183 (56%), Gaps = 8/183 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRSLR 56
           +++++ +K LG G+FG   L++HKE+    A+K +++ + +     E+   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE   R++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K      R  +  GTP  +APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGY 215

Query: 177 DGK 179
           +  
Sbjct: 216 NKA 218

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-41
 Identities = 51/187 (27%), Positives = 83/187 (44%), Gaps = 12/187 (6%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDEN-------VAREIINHRSL 55
           +Y++   LG+G FG             VA+K++E+ R  D         V  E++  + +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAGG-ELFDRICNAGRFSEDEGRYFFQQLISGVN 112
                 +IR  +    P    +++E      +LFD I   G   E+  R FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG     +  +      GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLN-RGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIR 182

Query: 173 RREYDGK 179
              Y G+
Sbjct: 183 YHRYHGR 189

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 4e-41
 Identities = 45/184 (24%), Positives = 78/184 (42%), Gaps = 13/184 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVA---REIINHRSLRHP 58
            +  + + +G+G+FG     +       VAVK +       + +     E+   R  RH 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSM 117
           NI+ F     T   LAIV ++  G  L+  +     +F   +     +Q   G++Y H+ 
Sbjct: 65  NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK  N  L       +KI DFG +          + +   G+  ++APEV+  +
Sbjct: 124 SIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 175 EYDG 178
           + + 
Sbjct: 182 DKNP 185

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (344), Expect = 1e-40
 Identities = 42/182 (23%), Positives = 71/182 (39%), Gaps = 6/182 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
               +   LG G +G       K+    VAVK ++      E   +E    + ++HPN++
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR--FSEDEGRYFFQQLISGVNYCHSMQI 119
           +   V        I+ E+   G L D +    R   S     Y   Q+ S + Y      
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 136

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL   N L+  +    +K+ DFG S+  +   ++          + APE L+  ++ 
Sbjct: 137 IHRDLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194

Query: 178 GK 179
            K
Sbjct: 195 IK 196

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  136 bits (343), Expect = 4e-40
 Identities = 45/183 (24%), Positives = 84/183 (45%), Gaps = 9/183 (4%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPN 59
            + Y+LV+ LG G +       +    E V VK ++  +K  + + REI    +LR  PN
Sbjct: 34  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPN 91

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           II   ++V  P     A+V E+    +           ++ + R++  +++  ++YCHSM
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 148

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +  
Sbjct: 149 GIMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207

Query: 178 GKQ 180
              
Sbjct: 208 DYS 210

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 4e-40
 Identities = 53/182 (29%), Positives = 80/182 (43%), Gaps = 9/182 (4%)

Query: 5   ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK------IDENVAREIINHRSLRHP 58
           E +  LG G F      R K T ++VA+K I+ G +      I+    REI   + L HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ 118
           NII   +     +++++V ++           N+   +    + +    + G+ Y H   
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 119 ICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK  N LLD +    LK+ DFG +KS    +      V T  Y APE+L      
Sbjct: 121 ILHRDLKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 178 GK 179
           G 
Sbjct: 179 GV 180

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 4e-39
 Identities = 45/181 (24%), Positives = 76/181 (41%), Gaps = 6/181 (3%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
            +   V+++G+G FG+  L      K+ VA+K I  G   +E+   E      L HP ++
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
           +   V L    + +V E+   G L D      G F+ +        +  G+ Y     + 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123

Query: 121 HRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           HRDL   N L+  +    +K+ DFG ++      ++    T     + +PEV S   Y  
Sbjct: 124 HRDLAARNCLVGEN--QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181

Query: 179 K 179
           K
Sbjct: 182 K 182

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 5e-39
 Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 13/185 (7%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRF 63
           Y   K +G G+FGV    +  ++ ELVA+K + + ++      RE+   R L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78

Query: 64  KEVVLTP------THLAIVMEYAAGG---ELFDRICNAGRFSEDEGRYFFQQLISGVNYC 114
           +    +        +L +V++Y                        + +  QL   + Y 
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  ICHRD+K +N LLD   A   K+CDFG +K  V      S + +  Y APE++   
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197

Query: 175 EYDGK 179
                
Sbjct: 198 TDYTS 202

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-38
 Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 18/195 (9%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           + KYE +  +G G FG     RH++T + VA+K +              REI   + L+H
Sbjct: 9   VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68

Query: 58  PNIIRFKEVVLTPT--------HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLIS 109
            N++   E+  T           + +V ++              +F+  E +   Q L++
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 110 GVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPA 164
           G+ Y H  +I HRD+K  N L+       LK+ DFG ++      +   +R  + V T  
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 165 YIAPEVLSRREYDGK 179
           Y  PE+L      G 
Sbjct: 187 YRPPELLLGERDYGP 201

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 1e-38
 Identities = 52/183 (28%), Positives = 92/183 (50%), Gaps = 6/183 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           M+KYE ++ +G G +G     +++ET E+VA+K +   +    +  +  REI   + L+H
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
            NI+R  +V+ +   L +V E+             G    +  + F  QL+ G+ +CHS 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS-TVGTPAYIAPEVLSRREY 176
            + HRDLK +N L++ +    LK+ +FG +++  +  R  S  V T  Y  P+VL   + 
Sbjct: 121 NVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 177 DGK 179
              
Sbjct: 179 YST 181

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 4e-38
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 8/182 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E  +LV+ LGAG FG   +  +    + VAVK +++G    +    E    + L+H  ++
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRI--CNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           R   VV T   + I+ EY   G L D +   +  + + ++      Q+  G+ +      
Sbjct: 72  RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  +     KI DFG ++      ++  +       + APE ++   + 
Sbjct: 131 IHRDLRAANILVSDT--LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 178 GK 179
            K
Sbjct: 189 IK 190

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 5e-38
 Identities = 45/182 (24%), Positives = 72/182 (39%), Gaps = 8/182 (4%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
           E   L   LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFD--RICNAGRFSEDEGRYFFQQLISGVNYCHSMQI 119
           +   VV +   + IV EY + G L D  +          +      Q+ SG+ Y   M  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134

Query: 120 CHRDLKLENTLLDGSAAPRLKICDFGYSK--SSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 135 VHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192

Query: 178 GK 179
            K
Sbjct: 193 IK 194

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 6e-38
 Identities = 55/184 (29%), Positives = 91/184 (49%), Gaps = 7/184 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           ME ++ V+ +G G +GV    R+K T E+VA+K I        +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAA-GGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS 116
           PNI++  +V+ T   L +V E+     + F              + +  QL+ G+ +CHS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST-VGTPAYIAPEVLSRRE 175
            ++ HRDLK +N L++      +K+ DFG +++  +  R  +  V T  Y APE+L   +
Sbjct: 121 HRVLHRDLKPQNLLINTE--GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 176 YDGK 179
           Y   
Sbjct: 179 YYST 182

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 6e-38
 Identities = 52/189 (27%), Positives = 80/189 (42%), Gaps = 13/189 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYI--ERGRKIDENVAREIINHRSLRHPN 59
            +Y  +  +G G +G+         K  VA+K I     +   +   REI      RH N
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67

Query: 60  IIRFKEVVLTPTH----LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCH 115
           II   +++  PT        ++ +  G +L+  +      S D   YF  Q++ G+ Y H
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSK----SSVLHSRPKSTVGTPAYIAPEVL 171
           S  + HRDLK  N LL+ +    LKICDFG ++               V T  Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 172 SRREYDGKQ 180
              +   K 
Sbjct: 185 LNSKGYTKS 193

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  128 bits (322), Expect = 2e-37
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 7/184 (3%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYI---ERGRKIDENVAREIINHRSLRH 57
           MEKY  ++ +G G +GV    ++    E  A+K I   +    I     REI   + L+H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
            NI++  +V+ T   L +V E+             G       + F  QL++G+ YCH  
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSKS-SVLHSRPKSTVGTPAYIAPEVLSRREY 176
           ++ HRDLK +N L++      LKI DFG +++  +   +    + T  Y AP+VL   + 
Sbjct: 120 RVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 177 DGKQ 180
               
Sbjct: 178 YSTT 181

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (321), Expect = 4e-37
 Identities = 42/187 (22%), Positives = 72/187 (38%), Gaps = 11/187 (5%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR 62
           +Y L + +G+G+FG   L       E VA+K +E  +     +  E   ++ ++    I 
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIYKMMQGGVGIP 66

Query: 63  -FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICH 121
             +       +  +VME             + +FS         Q+IS + Y HS    H
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126

Query: 122 RDLKLENTLL-DGSAAPRLKICDFGYSK--------SSVLHSRPKSTVGTPAYIAPEVLS 172
           RD+K +N L+  G     + I DFG +K          + +   K+  GT  Y +     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 173 RREYDGK 179
             E   +
Sbjct: 187 GIEQSRR 193

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 5e-37
 Identities = 55/190 (28%), Positives = 80/190 (42%), Gaps = 15/190 (7%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGRKID----ENVAREIINHRS 54
           +   L++ LG G+FGV               VAVK ++          ++  RE+    S
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNY 113
           L H N+IR   VVLTP  + +V E A  G L DR+  + G F       +  Q+  G+ Y
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK----SSVLHSRPKSTVGTPAYIAPE 169
             S +  HRDL   N LL       +KI DFG  +    +   +   +      A+ APE
Sbjct: 127 LESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 170 VLSRREYDGK 179
            L  R +   
Sbjct: 185 SLKTRTFSHA 194

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 8e-37
 Identities = 44/181 (24%), Positives = 73/181 (40%), Gaps = 12/181 (6%)

Query: 8   KDLGAGNFGVARL--LRHKETKELVAVKYIERG---RKIDENVAREIINHRSLRHPNIIR 62
           K+LG+GNFG  +    + K+  + VAVK ++       + + +  E    + L +P I+R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
              +    + + +VME A  G L   +       +        Q+  G+ Y       HR
Sbjct: 73  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSKS----SVLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           DL   N LL        KI DFG SK+       +           + APE ++  ++  
Sbjct: 132 DLAARNVLLVTQ--HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189

Query: 179 K 179
           K
Sbjct: 190 K 190

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  126 bits (318), Expect = 1e-36
 Identities = 45/191 (23%), Positives = 78/191 (40%), Gaps = 14/191 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKE---LVAVKYIERG--RKIDENVAREIINHRSL 55
           +   ++ + +GAG FG       K   +    VA+K ++ G   K   +   E       
Sbjct: 25  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGRYFFQQLISGVNYC 114
            HPN+I  + VV   T + I+ E+   G L      N G+F+  +     + + +G+ Y 
Sbjct: 85  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK------SSVLHSRPKSTVGTPAYIAP 168
             M   HRDL   N L++ +     K+ DFG S+      S   ++          + AP
Sbjct: 145 ADMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202

Query: 169 EVLSRREYDGK 179
           E +  R++   
Sbjct: 203 EAIQYRKFTSA 213

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-36
 Identities = 43/186 (23%), Positives = 78/186 (41%), Gaps = 11/186 (5%)

Query: 2   EKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLR 56
           E+ EL + +G G FG       +  +     VA+K  +      + E   +E +  R   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCH 115
           HP+I++   V+ T   + I+ME    GEL   +              +  QL + + Y  
Sbjct: 67  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 116 SMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST--VGTPAYIAPEVLSR 173
           S +  HRD+   N L+  +    +K+ DFG S+     +  K++       ++APE ++ 
Sbjct: 126 SKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 174 REYDGK 179
           R +   
Sbjct: 184 RRFTSA 189

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 3e-36
 Identities = 44/212 (20%), Positives = 72/212 (33%), Gaps = 36/212 (16%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKEL-----VAVKYIERGRKIDE--NVAREIINHRS 54
           E  E  K LG+G FG           +      VAVK ++      E   +  E+     
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI-----------------------C 90
           L  H NI+           + ++ EY   G+L + +                        
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 91  NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK-- 148
           +    + ++   F  Q+  G+ +       HRDL   N L+       +KICDFG ++  
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLARDI 214

Query: 149 -SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            S   +    +      ++APE L    Y  K
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  125 bits (314), Expect = 3e-36
 Identities = 36/190 (18%), Positives = 70/190 (36%), Gaps = 13/190 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
             Y++ + +G G+FGV     +    + VA+K+  R R     +  E   ++ L     I
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63

Query: 62  -RFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQIC 120
                      H  +V++               +FS        +Q+++ V   H   + 
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123

Query: 121 HRDLKLENTLLDGSAAP---RLKICDFGYSK--------SSVLHSRPKSTVGTPAYIAPE 169
           +RD+K +N L+    +     + + DFG  K          + +   K+  GT  Y++  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 170 VLSRREYDGK 179
               RE   +
Sbjct: 184 THLGREQSRR 193

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 5e-36
 Identities = 47/187 (25%), Positives = 77/187 (41%), Gaps = 15/187 (8%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIER---GRKIDENVAREIINHRSLRHP 58
             Y  ++ +G+G +G         T   VA+K + R        +   RE+   + +RH 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 59  NIIRFKEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVN 112
           N+I   +V          T   +VM +   G    ++    +  ED  ++   Q++ G+ 
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135

Query: 113 YCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLS 172
           Y H+  I HRDLK  N  ++      LKI DFG ++     S     V T  Y APEV+ 
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191

Query: 173 RREYDGK 179
                 +
Sbjct: 192 NWMRYTQ 198

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 5e-36
 Identities = 39/185 (21%), Positives = 67/185 (36%), Gaps = 11/185 (5%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYI------ERGRKIDENVAREIINHRSLRH 57
           ++ +K LG+G FG           E V +             K ++ +  E     S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSM 117
           P++ R   + LT T   I      G  L     +           +  Q+  G+NY    
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 118 QICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVGTPAYIAPEVLSRR 174
           ++ HRDL   N L+       +KI DFG +K   +       +       ++A E +  R
Sbjct: 131 RLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188

Query: 175 EYDGK 179
            Y  +
Sbjct: 189 IYTHQ 193

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 5e-36
 Identities = 49/179 (27%), Positives = 73/179 (40%), Gaps = 12/179 (6%)

Query: 10  LGAGNFGVARLLRHKETKE--LVAVKYIERGRKID--ENVAREIINHRSLRHPNIIRFKE 65
           LG GNFG  R   ++  K+   VA+K +++G +    E + RE      L +P I+R   
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 66  VVLTPTHLAIVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDL 124
           V      L +VME A GG L   +                 Q+  G+ Y       HRDL
Sbjct: 77  VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135

Query: 125 KLENTLLDGSAAPRLKICDFGYSK----SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
              N LL        KI DFG SK        ++   +      + APE ++ R++  +
Sbjct: 136 AARNVLLVNR--HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-35
 Identities = 47/200 (23%), Positives = 73/200 (36%), Gaps = 23/200 (11%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKEL--VAVKYIERGRKID--ENVAREIINHRSL- 55
               +    +G GNFG     R K+       A+K ++     D   + A E+     L 
Sbjct: 9   WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI----------------CNAGRFSEDE 99
            HPNII          +L + +EYA  G L D +                  A   S  +
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 100 GRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST 159
             +F   +  G++Y    Q  HRDL   N L+  +     KI DFG S+   ++ +    
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTMG 186

Query: 160 VGTPAYIAPEVLSRREYDGK 179
                ++A E L+   Y   
Sbjct: 187 RLPVRWMAIESLNYSVYTTN 206

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 4e-35
 Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 15/191 (7%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKET-KELVAVKYI---ERGRKIDENVAREIINHRSL-- 55
           ++YE V ++G G +G     R  +     VA+K +        +  +  RE+   R L  
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 56  -RHPNIIRFKEVVLTP-----THLAIVMEYAAGGEL-FDRICNAGRFSEDEGRYFFQQLI 108
             HPN++R  +V         T L +V E+       +           +  +    QL+
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAP 168
            G+++ HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 169 EVLSRREYDGK 179
           EVL +  Y   
Sbjct: 185 EVLLQSSYATP 195

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 4e-34
 Identities = 55/196 (28%), Positives = 72/196 (36%), Gaps = 22/196 (11%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII 61
               L + +G G FG     R K   E VAVK      +       EI     LRH NI+
Sbjct: 3   RTIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60

Query: 62  RFKEVV----LTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS- 116
            F         T T L +V +Y   G LFD + N    + +          SG+ + H  
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHME 119

Query: 117 -------MQICHRDLKLENTLLDGSAAPRLKICDFG-----YSKSSVLHSRPKSTVGTPA 164
                    I HRDLK +N L+  +      I D G      S +  +   P   VGT  
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 165 YIAPEVLSRREYDGKQ 180
           Y+APEVL         
Sbjct: 178 YMAPEVLDDSINMKHF 193

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  119 bits (299), Expect = 6e-34
 Identities = 46/212 (21%), Positives = 78/212 (36%), Gaps = 36/212 (16%)

Query: 2   EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRKID--ENVAREIINHRS 54
              E V+D+G G FG     R       E   +VAVK ++     D   +  RE      
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGR-------------------- 94
             +PNI++   V      + ++ EY A G+L + + +                       
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 95  ----FSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK-- 148
                S  E     +Q+ +G+ Y    +  HRDL   N L+  +    +KI DFG S+  
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNI 190

Query: 149 -SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            S+  +    +      ++ PE +    Y  +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTE 222

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 2e-33
 Identities = 45/188 (23%), Positives = 75/188 (39%), Gaps = 14/188 (7%)

Query: 1   MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRH 57
           +++Y+ +K +G+G  G+            VA+K + R  +     +   RE++  + + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 58  PNIIRFKEVVLTP------THLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
            NII    V            + +VME                   +   Y   Q++ G+
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGI 132

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 172 SRREYDGK 179
               Y   
Sbjct: 191 LGMGYKEN 198

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 3e-33
 Identities = 45/207 (21%), Positives = 70/207 (33%), Gaps = 31/207 (14%)

Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKID--ENVAREIINHRS 54
            +    K LGAG FG      A  L   +    VAVK ++    +   E +  E+     
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRIC------------------NAGRF 95
           L  H NI+             ++ EY   G+L + +                   +    
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 96  SEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR 155
             ++   F  Q+  G+ +  S    HRDL   N LL        KICDFG ++     S 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKNDSN 200

Query: 156 PKST---VGTPAYIAPEVLSRREYDGK 179
                       ++APE +    Y  +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFE 227

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 5e-33
 Identities = 49/185 (26%), Positives = 87/185 (47%), Gaps = 9/185 (4%)

Query: 1   MEKYELVKDLGAGNFGV---ARLLRHKETKELVAVKYIERGR-----KIDENVAREIINH 52
           +E +EL+K LG G +G     R +   +T +L A+K +++       K  E+   E    
Sbjct: 23  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 53  RSLRH-PNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGV 111
             +R  P ++       T T L ++++Y  GGELF  +    RF+E E + +  +++  +
Sbjct: 83  EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142

Query: 112 NYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVL 171
            + H + I +RD+KLEN LLD +    L          +    R     GT  Y+AP+++
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 172 SRREY 176
              + 
Sbjct: 203 RGGDS 207

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 2e-32
 Identities = 46/189 (24%), Positives = 72/189 (38%), Gaps = 13/189 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKE----LVAVKYIERGRKIDENVA--REIINHRSL 55
                 K +GAG FG       K +       VA+K ++ G    + V    E       
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYC 114
            H NIIR + V+     + I+ EY   G L   +    G FS  +     + + +G+ Y 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 115 HSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK----SSVLHSRPKSTVGTPAYIAPEV 170
            +M   HRDL   N L++ +     K+ DFG S+                    + APE 
Sbjct: 127 ANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 171 LSRREYDGK 179
           +S R++   
Sbjct: 185 ISYRKFTSA 193

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 3e-32
 Identities = 45/186 (24%), Positives = 81/186 (43%), Gaps = 13/186 (6%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKID---ENVAREIINHRSLRHP 58
           E+Y+ +  +G+G +G        +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 59  NIIRFKEVVLTPTHLA-----IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNY 113
           N+I   +V      L       ++ +  G    + I    + ++D  ++   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 114 CHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSR 173
            HS  I HRDLK  N  ++      LKI DFG ++           V T  Y APE++  
Sbjct: 137 IHSADIIHRDLKPSNLAVNED--CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLN 192

Query: 174 REYDGK 179
             +  +
Sbjct: 193 WMHYNQ 198

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 6e-32
 Identities = 42/182 (23%), Positives = 71/182 (39%), Gaps = 14/182 (7%)

Query: 10  LGAGNFGV---ARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRSLRHPNIIRFK 64
           +G G+FG      LL +   K   AVK + R   I E      E I  +   HPN++   
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94

Query: 65  EVVL-TPTHLAIVMEYAAGGELFD-RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHR 122
            + L +     +V+ Y   G+L +         +  +   F  Q+  G+ +  S +  HR
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 154

Query: 123 DLKLENTLLDGSAAPRLKICDFGYSK-----SSVLHSRPKSTVGTPAYIAPEVLSRREYD 177
           DL   N +LD      +K+ DFG ++                     ++A E L  +++ 
Sbjct: 155 DLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212

Query: 178 GK 179
            K
Sbjct: 213 TK 214

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 2e-31
 Identities = 38/199 (19%), Positives = 77/199 (38%), Gaps = 22/199 (11%)

Query: 2   EKYELVKDLGAGNFG-----VARLLRHKETKELVAVKYIERGRKIDE--NVAREIINHRS 54
           EK  + ++LG G+FG     VA+ +   E +  VA+K +     + E      E    + 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRICNAGRF----------SEDEGRYFF 104
               +++R   VV       ++ME    G+L   + +              S  +     
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 105 QQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLHSRPKSTVG 161
            ++  G+ Y ++ +  HRDL   N ++       +KI DFG ++    +  + +    + 
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 162 TPAYIAPEVLSRREYDGKQ 180
              +++PE L    +    
Sbjct: 198 PVRWMSPESLKDGVFTTYS 216

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 3e-30
 Identities = 41/205 (20%), Positives = 72/205 (35%), Gaps = 27/205 (13%)

Query: 2   EKYELVKDLGAGNFGVARLLRHKETKE-------LVAVKYI--ERGRKIDENVAREIINH 52
           ++  L K LG G FG   L       +        VAVK +  +   K   ++  E+   
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 53  RSL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFDRI----------------CNAGRF 95
           + + +H NII           L +++EYA+ G L + +                    + 
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 96  SEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL-KICDFGYSKSSVLHS 154
           S  +      Q+  G+ Y  S +  HRDL   N L+      ++              + 
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 155 RPKSTVGTPAYIAPEVLSRREYDGK 179
           +  +      ++APE L  R Y  +
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQ 217

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 5e-30
 Identities = 45/206 (21%), Positives = 77/206 (37%), Gaps = 30/206 (14%)

Query: 2   EKYELVKDLGAGNFGV-----ARLLRHKETKELVAVKYIERGRKIDEN---VAREIINHR 53
           ++ +L K LG G FG      A  +    T   VAVK ++ G    E+   ++   I   
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 54  SLRHPNIIRFKEVVLTP-THLAIVMEYAAGGELFDRICNAGR----------------FS 96
              H N++        P   L +++E+   G L   + +                    +
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 97  EDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK---SSVLH 153
            +    +  Q+  G+ +  S +  HRDL   N LL       +KICDFG ++       +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDPDY 190

Query: 154 SRPKSTVGTPAYIAPEVLSRREYDGK 179
            R         ++APE +  R Y  +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQ 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 97.0 bits (240), Expect = 6e-25
 Identities = 39/196 (19%), Positives = 69/196 (35%), Gaps = 19/196 (9%)

Query: 3   KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIR 62
           +Y LV+ LG G+F    L +       VA+K +   +   E    EI   + +   +  +
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 63  ---------------FKEVVLTPTHLAIVMEYAAGGEL-FDRICNAGRFSEDEGRYFFQQ 106
                          F        H+ +V E      L   +            +   +Q
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 107 LISGVNYCHSMQ-ICHRDLKLENTLLD--GSAAPRLKICDFGYSKSSVLHSRPKSTVGTP 163
           L+ G++Y H    I H D+K EN L++   S    ++I       +        +++ T 
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 164 AYIAPEVLSRREYDGK 179
            Y +PEVL    +   
Sbjct: 194 EYRSPEVLLGAPWGCG 209

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 64.4 bits (156), Expect = 6e-14
 Identities = 24/161 (14%), Positives = 46/161 (28%), Gaps = 26/161 (16%)

Query: 4   YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-----------KIDENVAREIINH 52
             + K +G G          ++  E   VK+ + G              D + +   I  
Sbjct: 2   DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 53  RSLRHPNIIRFKEVVLTPTH----LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLI 108
                  + + + + +   +     A++ME               R   +        ++
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMEL-------IDAKELYRVRVENPDEVLDMIL 113

Query: 109 SGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS 149
             V   +   I H DL   N L+       + I DF  S  
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFPQSVE 151

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	181
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.95
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	99.07
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.69
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.5
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	98.24
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.91
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.76

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-47  Score=271.73  Aligned_cols=176  Identities=34%  Similarity=0.615  Sum_probs=158.7

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc----ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      +++|++.+.||+|+||+||+|.++.+++.||+|++.+.    ....+.+.+|+.+++.++||||+++++++.+++.+++|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            57999999999999999999999999999999998643    23346788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |||+++++|.+++.+...+++..++.++.|++.||+|||++||+||||||+||++++++.  ++|+|||+|.... ....
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~-~~~~  161 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SSRR  161 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCC-CCCC
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecC-CCcc
Confidence            999999999999988889999999999999999999999999999999999999976554  9999999997443 3344


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....||+.|+|||++.+.+++++
T Consensus       162 ~~~~Gt~~Y~APE~~~~~~~~~~  184 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEGRMHDEK  184 (263)
T ss_dssp             EETTEEGGGCCHHHHTTCCCCTT
T ss_pred             cccCCCCcccCHHHHcCCCCCch
Confidence            55689999999999999999876

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-47  Score=271.91  Aligned_cols=175  Identities=39%  Similarity=0.634  Sum_probs=154.2

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      +++|++.+.||+|+||+||+|.++.+++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            578999999999999999999999999999999987543  234678899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC---CC
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH---SR  155 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~---~~  155 (181)
                      |+++++|.+++.++..+++..++.++.|++.||.|||++||+||||||+||++++++  .+||+|||+|+.....   ..
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~--~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECEETTEECC
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC--CEEEccchhheeeccCCcccc
Confidence            999999999998888899999999999999999999999999999999999997555  4999999999765332   23


Q ss_pred             CCcccCCCCccCcccccCCccC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYD  177 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~  177 (181)
                      .....||+.|||||++.+.++.
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~  183 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFH  183 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBC
T ss_pred             ccceeeCcCccCHhHhcCCCCC
Confidence            4456799999999999888764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-46  Score=268.86  Aligned_cols=175  Identities=30%  Similarity=0.503  Sum_probs=156.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||+||+|.+..+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++.+++.+|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            479999999999999999999999999999999876543 3467899999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCCcc
Q 030211           81 AGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~~~  159 (181)
                      ++++|.+++.+ ..+++..++.++.|++.||.|||++||+||||||+||+++.++.  ++|+|||+|+...... .....
T Consensus       100 ~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~~~  176 (293)
T d1yhwa1         100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTM  176 (293)
T ss_dssp             TTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCC
T ss_pred             CCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--Eeeccchhheeecccccccccc
Confidence            99999987754 57999999999999999999999999999999999999976554  9999999998765443 34456


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .||+.|+|||++.+++|+++
T Consensus       177 ~gt~~Y~aPE~~~~~~~~~~  196 (293)
T d1yhwa1         177 VGTPYWMAPEVVTRKAYGPK  196 (293)
T ss_dssp             CSCGGGCCHHHHSSSCBCTH
T ss_pred             ccCCCccChhhhcCCCCCch
Confidence            79999999999999998764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-46  Score=273.14  Aligned_cols=178  Identities=35%  Similarity=0.602  Sum_probs=142.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|+||+||+|.++.+++.||+|++.....  ....+.+|+.+++.++||||+++++++.+++.+|++|||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            469999999999999999999999999999999876432  235677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc-CCCCcEEEeecCCcccccCCCCCCc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~-~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      +++++|.+++.....+++..++.++.|++.||+|||++|++||||||+||++.. +..+.++|+|||+|+..........
T Consensus        89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  168 (307)
T d1a06a_          89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST  168 (307)
T ss_dssp             CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred             cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeee
Confidence            999999999988889999999999999999999999999999999999999953 3345699999999987666666667


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..||+.|||||++.+.+|+++
T Consensus       169 ~~GT~~y~APE~~~~~~~~~~  189 (307)
T d1a06a_         169 ACGTPGYVAPEVLAQKPYSKA  189 (307)
T ss_dssp             ----CTTSCHHHHTTCCCCTH
T ss_pred             eeeCccccCcHHHcCCCCCcH
Confidence            789999999999999998865

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-46  Score=272.56  Aligned_cols=177  Identities=35%  Similarity=0.592  Sum_probs=160.4

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc----ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      |++|++++.||+|+||.||+|+++.+++.||+|++.+.    ....+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            57999999999999999999999999999999998753    22346788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-CCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~~~  155 (181)
                      |||+++++|..++.+...++++.++.++.|++.||+|||++||+||||||+||+++.++  .++|+|||+|+.... ...
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g--~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCCTTCC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC--CEEEeecccccccccCCcc
Confidence            99999999999999888999999999999999999999999999999999999997655  499999999986543 344


Q ss_pred             CCcccCCCCccCcccccCCccCCC
Q 030211          156 PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .....||+.|+|||++.+.+|+++
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~~~  185 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYGRA  185 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTT
T ss_pred             cccceeCHHHhhhhhccCCCCChh
Confidence            455789999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-46  Score=277.57  Aligned_cols=179  Identities=28%  Similarity=0.514  Sum_probs=161.1

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            47899999999999999999999999999999998765332 46788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           80 AAGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      +++++|.+.+.+ ...+++..++.++.||+.||.|||++|++||||||+||+++.+..+.++|+|||+|+..........
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  184 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  184 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccce
Confidence            999999998854 4579999999999999999999999999999999999999766566799999999987776666667


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..||+.|||||++.+.+++.+
T Consensus       185 ~~gT~~Y~aPEv~~~~~~~~~  205 (350)
T d1koaa2         185 TTGTAEFAAPEVAEGKPVGYY  205 (350)
T ss_dssp             ECSCTTTCCHHHHHTCCBCHH
T ss_pred             ecCcccccCHHHHcCCCCChh
Confidence            789999999999999888753

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-46  Score=267.70  Aligned_cols=176  Identities=32%  Similarity=0.479  Sum_probs=154.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc----ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      ++|++.+.||+|+||+||+|.++.+++.||+|++.+.    ....+.+.+|+.+++.++||||+++++++.+.+.+|++|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999999999999999998753    233467889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC---
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~---  154 (181)
                      ||+++++|.+++.....+++..++.++.|++.||+|||++||+||||||+||++++++.  ++|+|||+|+......   
T Consensus        88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC------
T ss_pred             EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCccc
Confidence            99999999999988889999999999999999999999999999999999999976655  9999999998654332   


Q ss_pred             CCCcccCCCCccCcccccCCccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ......||+.|+|||++.+..|+.+
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~  190 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKS  190 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHH
T ss_pred             ccccccCCccccCceeeccCCCCcc
Confidence            2334579999999999999888754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-46  Score=273.04  Aligned_cols=176  Identities=31%  Similarity=0.469  Sum_probs=156.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      ++|++.+.||+|+||+||+|.+..+++.||+|+++...  ...+.+.+|+.+++.++||||++++++|.+++.+++||||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy   85 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   85 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            68999999999999999999999999999999987543  2246788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           80 AAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      +++++|.+++.++..+++..++.++.|++.||.|||+ +||+||||||+||++++++.  +||+|||+|+.... ....+
T Consensus        86 ~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~-~~~~~  162 (322)
T d1s9ja_          86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  162 (322)
T ss_dssp             CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HTC--
T ss_pred             CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCC-Ccccc
Confidence            9999999999888899999999999999999999997 59999999999999976554  99999999975433 23345


Q ss_pred             ccCCCCccCcccccCCccCCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGKQ  180 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~  180 (181)
                      ..||+.|+|||++.+.+|++++
T Consensus       163 ~~GT~~Y~APEvl~~~~y~~~~  184 (322)
T d1s9ja_         163 FVGTRSYMSPERLQGTHYSVQS  184 (322)
T ss_dssp             -CCSSCCCCHHHHHCSCCCTTH
T ss_pred             ccCCccccCchHHcCCCCCcHH
Confidence            7899999999999999998763

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.3e-46  Score=272.99  Aligned_cols=178  Identities=29%  Similarity=0.489  Sum_probs=160.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc-cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++...... .+.+.+|+.+++.++||||++++++|.+++.+|+||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            6799999999999999999999999999999998765432 356788999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcc
Q 030211           81 AGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~  159 (181)
                      ++++|.+.+.... ++++..++.++.|++.||.|||++||+||||||+||+++....+.++|+|||+|............
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~  188 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT  188 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeec
Confidence            9999988776544 799999999999999999999999999999999999997555667999999999887776666677


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+++.|+|||++.+.+|+++
T Consensus       189 ~gt~~y~aPE~~~~~~~~~~  208 (352)
T d1koba_         189 TATAEFAAPEIVDREPVGFY  208 (352)
T ss_dssp             CSSGGGCCHHHHTTCCBCHH
T ss_pred             cCcccccCHHHHcCCCCCCc
Confidence            89999999999999888754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-45  Score=263.94  Aligned_cols=178  Identities=35%  Similarity=0.617  Sum_probs=160.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++.+...       ..+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            579999999999999999999999999999999865321       2367889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCC--CcEEEeecCCcccccC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA--PRLKICDFGYSKSSVL  152 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~--~~v~l~dfg~a~~~~~  152 (181)
                      ++|||+++++|.+++.....+++..++.++.|++.||+|||++|++||||||+||+++.++.  ..++|+|||+|.....
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            99999999999999988889999999999999999999999999999999999999965443  3599999999987766


Q ss_pred             CCCCCcccCCCCccCcccccCCccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ........+++.|+|||++.+..++++
T Consensus       170 ~~~~~~~~~t~~y~APE~~~~~~~~~~  196 (293)
T d1jksa_         170 GNEFKNIFGTPEFVAPEIVNYEPLGLE  196 (293)
T ss_dssp             SCBCSCCCCCGGGCCHHHHTTCCBCTH
T ss_pred             CccccccCCCCcccCHHHHcCCCCCCc
Confidence            666777789999999999999888765

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-46  Score=270.34  Aligned_cols=179  Identities=25%  Similarity=0.410  Sum_probs=162.7

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      +++|++.+.||+|+||+||+|.++.+++.||+|+++........+.+|+.+++.++||||+++++++.+++.+|+||||+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            58999999999999999999999999999999999876555567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCcc
Q 030211           81 AGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKST  159 (181)
Q Consensus        81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~~  159 (181)
                      .+++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||+++.+....++|+|||++............
T Consensus        84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~  163 (321)
T d1tkia_          84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccccc
Confidence            9999999997665 799999999999999999999999999999999999998767678999999999876555555667


Q ss_pred             cCCCCccCcccccCCccCCC
Q 030211          160 VGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       160 ~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .+++.|+|||.+.+..++++
T Consensus       164 ~~t~~y~ape~~~~~~~~~~  183 (321)
T d1tkia_         164 FTAPEYYAPEVHQHDVVSTA  183 (321)
T ss_dssp             ESCGGGSCHHHHTTCEECHH
T ss_pred             ccccccccchhccCCCCCch
Confidence            89999999999998887754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.2e-45  Score=266.15  Aligned_cols=175  Identities=32%  Similarity=0.577  Sum_probs=157.9

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc----ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      |++|++.+.||+|+||+||+|.++.+|+.||+|++.+.    ....+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            57899999999999999999999999999999998753    23346788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      |||+.++++...+.....+++..++.++.|++.||.|||++||+||||||+||+++.++  .++|+|||+|+....  ..
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g--~vkL~DFG~a~~~~~--~~  158 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVPD--VT  158 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEECSS--CB
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC--CEEEecCccceEecc--cc
Confidence            99999999999998888999999999999999999999999999999999999997555  499999999976432  33


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....||+.|||||++.+.+|+++
T Consensus       159 ~~~~Gt~~Y~APE~l~~~~y~~~  181 (316)
T d1fota_         159 YTLCGTPDYIAPEVVSTKPYNKS  181 (316)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTT
T ss_pred             ccccCcccccCHHHHcCCCCCch
Confidence            45689999999999999999875

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-45  Score=263.96  Aligned_cols=169  Identities=32%  Similarity=0.486  Sum_probs=149.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc-cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR-KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      +.|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46999999999999999999999999999999987643 33478899999999999999999999999999999999999


Q ss_pred             CCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCCCc
Q 030211           81 AGGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRPKS  158 (181)
Q Consensus        81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~~~  158 (181)
                      ++++|.+++.+ ..++++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||+|...... .....
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcccccc
Confidence            99999988765 457999999999999999999999999999999999999976554  999999998654322 22335


Q ss_pred             ccCCCCccCccccc
Q 030211          159 TVGTPAYIAPEVLS  172 (181)
Q Consensus       159 ~~~~~~~~aPE~~~  172 (181)
                      ..||+.|+|||++.
T Consensus       170 ~~Gt~~y~APE~l~  183 (288)
T d2jfla1         170 FIGTPYWMAPEVVM  183 (288)
T ss_dssp             CCSCCTTCCHHHHT
T ss_pred             cccccccCCHHHHh
Confidence            67999999999984

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-45  Score=264.32  Aligned_cols=176  Identities=23%  Similarity=0.322  Sum_probs=156.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|+||+||+|.++.+++.||+|+++......+.+.+|+.++++++||||+++++++.+++.++++|||++
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~   96 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   96 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence            57899999999999999999999999999999998777667889999999999999999999999999999999999999


Q ss_pred             CCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC--C
Q 030211           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--K  157 (181)
Q Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~--~  157 (181)
                      +++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+||+++++..  +||+|||+|+........  .
T Consensus        97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~~~~  174 (287)
T d1opja_          97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHA  174 (287)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSEEET
T ss_pred             CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCceeec
Confidence            99999988654  47899999999999999999999999999999999999976554  999999999765433222  2


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...+++.|+|||++.++.|+++
T Consensus       175 ~~~g~~~y~aPE~~~~~~~~~k  196 (287)
T d1opja_         175 GAKFPIKWTAPESLAYNKFSIK  196 (287)
T ss_dssp             TEEECGGGCCHHHHHHCCCSHH
T ss_pred             cccccccccChHHHcCCCCCch
Confidence            3457899999999999888764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-44  Score=266.66  Aligned_cols=175  Identities=32%  Similarity=0.588  Sum_probs=157.8

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccc----ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERG----RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      |++|++++.||+|+||.||+|.++.+|+.||+|++.+.    ....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            57899999999999999999999999999999998643    23346788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC
Q 030211           77 MEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP  156 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~  156 (181)
                      ||++.+++|...+.+...+++..++.++.||+.||.|||++||+||||||+||+++.++  .++|+|||+|+....  ..
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g--~ikL~DFG~a~~~~~--~~  195 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVKG--RT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECSS--CB
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC--CEEeeeceeeeeccc--cc
Confidence            99999999999998888999999999999999999999999999999999999997555  499999999986543  33


Q ss_pred             CcccCCCCccCcccccCCccCCC
Q 030211          157 KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ....||+.|||||++.+..++++
T Consensus       196 ~~~~Gt~~Y~APE~~~~~~~~~~  218 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILSKGYNKA  218 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTH
T ss_pred             ccccCccccCCHHHHcCCCCCcc
Confidence            45689999999999999988865

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-44  Score=262.61  Aligned_cols=172  Identities=31%  Similarity=0.470  Sum_probs=150.8

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      +|+..+.||+|+||.||+|.+..+++.||+|++......    .+.+.+|+.++++++||||+++++++.+++.+|++||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            599999999999999999999999999999998765432    2468889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      |+.++++........++++..++.++.|++.||.|||++||+||||||+||++++++  .++|+|||+|.....   ...
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~--~~Kl~DFG~a~~~~~---~~~  170 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP---ANS  170 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSSS---BCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC--CEEEeecccccccCC---CCc
Confidence            999988877777777899999999999999999999999999999999999997555  499999999975433   345


Q ss_pred             ccCCCCccCcccccC---CccCCC
Q 030211          159 TVGTPAYIAPEVLSR---REYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~---~~~~~~  179 (181)
                      ..||+.|||||++.+   ++|+.+
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~  194 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGK  194 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTH
T ss_pred             cccCccccCHHHHhccCCCCcCch
Confidence            679999999999864   446553

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-44  Score=258.78  Aligned_cols=176  Identities=33%  Similarity=0.574  Sum_probs=142.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEc--CCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLT--PTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v   76 (181)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|.+......   .+.+.+|+.+++.++||||+++++++.+  ++.+|++
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            6899999999999999999999999999999998765432   3568889999999999999999999865  4568999


Q ss_pred             EeecCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcC-----eeeeCCCCCCEEeccCCCCcEEEeecCCc
Q 030211           77 MEYAAGGELFDRICN----AGRFSEDEGRYFFQQLISGVNYCHSMQ-----ICHRDLKLENTLLDGSAAPRLKICDFGYS  147 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~g-----i~h~dl~p~ni~i~~~~~~~v~l~dfg~a  147 (181)
                      |||+++++|.+++.+    +..+++..++.++.|++.||.|||+.|     |+||||||+||++++++.  ++|+|||+|
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~a  161 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLA  161 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccce
Confidence            999999999988753    457999999999999999999999976     999999999999976554  999999999


Q ss_pred             ccccCCC-CCCcccCCCCccCcccccCCccCCC
Q 030211          148 KSSVLHS-RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       148 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      +...... ......||+.|+|||++.+.+|+++
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~  194 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK  194 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCHH
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCChH
Confidence            8654433 3445679999999999999888764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-44  Score=253.76  Aligned_cols=174  Identities=26%  Similarity=0.412  Sum_probs=148.8

Q ss_pred             cc-eeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEc----CCeEE
Q 030211            3 KY-ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLT----PTHLA   74 (181)
Q Consensus         3 ~y-~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~----~~~~~   74 (181)
                      || ++.+.||+|+||+||+|.+..+++.||+|.+......   .+.+.+|+.++++++||||+++++++.+    .+.++
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            45 7888999999999999999999999999998754322   3568899999999999999999999875    35689


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQ--ICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~g--i~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ++|||+++++|.+++.+...+++..++.++.|++.||.|||+++  |+||||||+||++++ .++.+||+|||+|+. ..
T Consensus        89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~-~~~~~Kl~DFGla~~-~~  166 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATL-KR  166 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-TTSCEEECCTTGGGG-CC
T ss_pred             EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC-CCCCEEEeecCccee-cc
Confidence            99999999999999988889999999999999999999999998  999999999999963 223599999999964 33


Q ss_pred             CCCCCcccCCCCccCcccccCCccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ........||+.|||||++.+ +++++
T Consensus       167 ~~~~~~~~GT~~Y~aPE~~~~-~~~~~  192 (270)
T d1t4ha_         167 ASFAKAVIGTPEFMAPEMYEE-KYDES  192 (270)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CCCTH
T ss_pred             CCccCCcccCccccCHHHhCC-CCCCc
Confidence            334455689999999999865 46654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-44  Score=259.41  Aligned_cols=177  Identities=33%  Similarity=0.532  Sum_probs=154.9

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHHHHHHH-hhCCCCCeeEEEEeEEcCCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAREIINH-RSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~~-~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      |++|++.+.||+|+||+||+|+++.+++.||+|++.+..    ...+.+..|..++ ..++||||+++++++.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            689999999999999999999999999999999997532    2234455566555 57899999999999999999999


Q ss_pred             EEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-
Q 030211           76 VMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-  154 (181)
                      ||||+++++|.+++..+..+++..++.++.|++.||+|||++|++||||||+||++++++  .++|+|||+|+...... 
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~--~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTC
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC--ceeccccchhhhcccccc
Confidence            999999999999998888999999999999999999999999999999999999997555  49999999998654433 


Q ss_pred             CCCcccCCCCccCcccccCCccCCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ......||+.|+|||++.+.+|+++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~  183 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHS  183 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred             cccccCCCCCcCCHHHHcCCCCCch
Confidence            3444679999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-44  Score=255.37  Aligned_cols=175  Identities=26%  Similarity=0.421  Sum_probs=146.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|+||+||+|.+.+ ++.||+|.+.......+++.+|+.++.+++||||+++++++.+++..+++|||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            589999999999999999999874 6679999998776667889999999999999999999999999999999999999


Q ss_pred             CCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--CCc
Q 030211           82 GGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PKS  158 (181)
Q Consensus        82 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--~~~  158 (181)
                      +++|.+++.+. ..+++..++.++.|++.||.|||+++|+||||||+||+++++..  +||+|||+++.......  ...
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~  161 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTG  161 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC---------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCceeecc
Confidence            99999987654 46899999999999999999999999999999999999976655  99999999976544333  233


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..||+.|+|||++.++.++++
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~k  182 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSSK  182 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCHH
T ss_pred             eecCcccCChHHhcCCCCCch
Confidence            568999999999999988765

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-43  Score=253.30  Aligned_cols=174  Identities=35%  Similarity=0.479  Sum_probs=156.1

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----------cHHHHHHHHHHhhCC-CCCeeEEEEeEEc
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----------DENVAREIINHRSLR-HPNIIRFKEVVLT   69 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----------~~~~~~e~~~~~~~~-~~~i~~~~~~~~~   69 (181)
                      .++|++.+.||+|+||+||+|++..+++.||+|++......          .+.+.+|+.+++.+. |||++++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            37999999999999999999999999999999998764321          135778999999996 9999999999999


Q ss_pred             CCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           70 PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        70 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      ++.+|++|||+++++|.+++..+..+++..++.++.|++.||+|||++||+||||+|+||++++++.  ++|+|||+++.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~  159 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ  159 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeE
Confidence            9999999999999999999988889999999999999999999999999999999999999975554  99999999987


Q ss_pred             ccCCCCCCcccCCCCccCcccccCCcc
Q 030211          150 SVLHSRPKSTVGTPAYIAPEVLSRREY  176 (181)
Q Consensus       150 ~~~~~~~~~~~~~~~~~aPE~~~~~~~  176 (181)
                      ...........||+.|+|||.+.....
T Consensus       160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~  186 (277)
T d1phka_         160 LDPGEKLREVCGTPSYLAPEIIECSMN  186 (277)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHC
T ss_pred             ccCCCceeeeeccCCCCCHHHhhcccc
Confidence            777666677889999999999975443

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.4e-43  Score=261.21  Aligned_cols=176  Identities=28%  Similarity=0.488  Sum_probs=151.6

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc----cccHHHHH---HHHHHhhCCCCCeeEEEEeEEcCCeE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR----KIDENVAR---EIINHRSLRHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~---e~~~~~~~~~~~i~~~~~~~~~~~~~   73 (181)
                      |++|++.++||+|+||.||+|.+..+|+.||+|++.+..    .....+.+   ++.+++.++||||+++++++.+++.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            689999999999999999999999999999999986432    11223333   36667778899999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      |+||||+++++|.+++.++..+++..++.++.||+.||+|||++|++||||||+||+++.++.  +||+|||+|+.....
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~~  160 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK  160 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSSS
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCCC
Confidence            999999999999999988889999999999999999999999999999999999999975554  999999999755433


Q ss_pred             CCCCcccCCCCccCcccccCC-ccCCC
Q 030211          154 SRPKSTVGTPAYIAPEVLSRR-EYDGK  179 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~-~~~~~  179 (181)
                       ......||+.|+|||++.++ .|+++
T Consensus       161 -~~~~~~GT~~y~APE~~~~~~~~~~~  186 (364)
T d1omwa3         161 -KPHASVGTHGYMAPEVLQKGVAYDSS  186 (364)
T ss_dssp             -CCCSCCSCGGGCCHHHHSTTCCCCTH
T ss_pred             -cccccccccccchhHHhhcCCCCCcc
Confidence             34556899999999999754 56654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-43  Score=256.59  Aligned_cols=175  Identities=35%  Similarity=0.554  Sum_probs=152.5

Q ss_pred             Cccceeee-eeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHH-hhCCCCCeeEEEEeEEc----CCeEE
Q 030211            1 MEKYELVK-DLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINH-RSLRHPNIIRFKEVVLT----PTHLA   74 (181)
Q Consensus         1 ~~~y~~~~-~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~-~~~~~~~i~~~~~~~~~----~~~~~   74 (181)
                      +++|++.+ +||+|+||+||+|.+..+++.||+|+++..    +.+.+|+.++ +..+|||+++++++|++    .+.+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            47899875 599999999999999999999999998653    4566788775 45689999999999976    46689


Q ss_pred             EEEeecCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC-CCcEEEeecCCccccc
Q 030211           75 IVMEYAAGGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA-APRLKICDFGYSKSSV  151 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~-~~~v~l~dfg~a~~~~  151 (181)
                      ++|||+++++|.+++.+.  ..+++..++.++.|++.||+|||++||+||||||+||+++++. .+.++|+|||+|+...
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~  165 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  165 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence            999999999999998764  3699999999999999999999999999999999999996433 4569999999998777


Q ss_pred             CCCCCCcccCCCCccCcccccCCccCCC
Q 030211          152 LHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .........||+.|+|||++.+..|+++
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~y~~~  193 (335)
T d2ozaa1         166 SHNSLTTPCYTPYYVAPEVLGPEKYDKS  193 (335)
T ss_dssp             CCCCCCCCSCCCSSCCCCCCCGGGGSHH
T ss_pred             CCCccccccCCcccCCcHHHcCCCCCHH
Confidence            7777777889999999999999888764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6e-43  Score=250.86  Aligned_cols=176  Identities=27%  Similarity=0.397  Sum_probs=146.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc----cHHHHHHHHHHhhCCCCCeeEEEEeEEcCC----eE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI----DENVAREIINHRSLRHPNIIRFKEVVLTPT----HL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~----~~   73 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++.....    .+.+.+|+.+++.++|||++++++++...+    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            5799999999999999999999999999999998764322    246888999999999999999999997643    48


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      |+||||+++++|.+.+....++++..++.++.|++.||+|||++|++||||||+||+++.+..  +++.|||.+......
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADS  164 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC--
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhccc
Confidence            999999999999999988889999999999999999999999999999999999999976655  999999988644322


Q ss_pred             C----CCCcccCCCCccCcccccCCccCCC
Q 030211          154 S----RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ~----~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .    ......||+.|+|||++.+.+++++
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~  194 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSVDAR  194 (277)
T ss_dssp             --------------TTCCHHHHTTCCCCHH
T ss_pred             cccccccccccCcccccCHHHHcCCCCCcc
Confidence            2    3344579999999999999888764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-43  Score=247.60  Aligned_cols=175  Identities=25%  Similarity=0.403  Sum_probs=154.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|+++++||+|+||+||+++++ +++.||+|.++......+++.+|+.++.+++||||+++++++.+++.++++|||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            68999999999999999999986 57789999999877777899999999999999999999999999999999999999


Q ss_pred             CCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC--CCc
Q 030211           82 GGELFDRICN-AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR--PKS  158 (181)
Q Consensus        82 ~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~--~~~  158 (181)
                      +++|..++.. ...+++..+..++.|++.||+|||++||+|+||+|+||+++++..  +||+|||+++.......  ...
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~  160 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVG  160 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceeecc
Confidence            9999887654 457899999999999999999999999999999999999976554  99999999975443332  223


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..+++.|+|||.+.++.++.+
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~k  181 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFSSK  181 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCCHH
T ss_pred             cCCCCCcCCcHHhcCCCCCcc
Confidence            568899999999998888764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-43  Score=249.94  Aligned_cols=174  Identities=25%  Similarity=0.352  Sum_probs=150.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|+||.||+|.++ +++.||+|++.......+.+.+|+.++.+++||||+++++++.+ +..++||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            58999999999999999999986 46789999998776667889999999999999999999998754 56789999999


Q ss_pred             CCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC--CCC
Q 030211           82 GGELFDRICNA--GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPK  157 (181)
Q Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~--~~~  157 (181)
                      +++|.+.+...  ..+++..+..++.|++.||.|||+++|+||||||+||+++++..  +||+|||+|+......  ...
T Consensus        91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~~~~~  168 (272)
T d1qpca_          91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTARE  168 (272)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEECCT
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCCcccccc
Confidence            99998866433  36999999999999999999999999999999999999976554  9999999998654332  233


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...+++.|+|||++.++.++++
T Consensus       169 ~~~gt~~y~APE~~~~~~~~~~  190 (272)
T d1qpca_         169 GAKFPIKWTAPEAINYGTFTIK  190 (272)
T ss_dssp             TCCCCTTTSCHHHHHHCEECHH
T ss_pred             ccCCcccccChHHHhCCCCCch
Confidence            4568899999999998887754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-42  Score=251.87  Aligned_cols=176  Identities=24%  Similarity=0.356  Sum_probs=139.9

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCc---EEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKE---LVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~---~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|++.+.||+|+||+||+|.++.+++   .||+|.+.....  ..+.+.+|+.++++++||||+++++++.+++.++++
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            579999999999999999999876654   588888765432  235789999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      |||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.+..  +||+|||+|+.......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccCCCC
Confidence            9999999999887664 47999999999999999999999999999999999999975554  99999999976543332


Q ss_pred             CC------cccCCCCccCcccccCCccCCC
Q 030211          156 PK------STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ~~------~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..      ...+++.|||||++.++.++++
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  213 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSA  213 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCCHH
T ss_pred             cceeeecccccCCccccCHHHHhcCCCCcc
Confidence            21      2346889999999999888754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=246.44  Aligned_cols=175  Identities=31%  Similarity=0.475  Sum_probs=148.8

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      |++|++++.||+|+||+||+|.+..+++.||+|+++...   ...+.+.+|+.++++++||||+++++++.+++.++++|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            689999999999999999999999999999999986543   23467889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC-CC
Q 030211           78 EYAAGGELFDRIC--NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL-HS  154 (181)
Q Consensus        78 e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~-~~  154 (181)
                      |++.++ +.+.+.  ....+++..++.++.|++.||.|||++||+||||||+||+++.+.  .++|+|||+|+.... ..
T Consensus        81 e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~--~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          81 EFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             ECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSTTHHHHHCCCSB
T ss_pred             eecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC--cceeccCCcceeccCCcc
Confidence            999664 444432  344799999999999999999999999999999999999997555  499999999976543 33


Q ss_pred             CCCcccCCCCccCcccccCCccCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRREYDG  178 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~  178 (181)
                      ......|++.|+|||.+....+.+
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~  181 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYS  181 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCC
T ss_pred             cceeecccceeeehhhhccccCCC
Confidence            444567999999999988877643

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-42  Score=251.83  Aligned_cols=176  Identities=25%  Similarity=0.350  Sum_probs=147.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCc-----EEEEEEcccc--ccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKE-----LVAVKYIERG--RKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~-----~v~~K~~~~~--~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~   73 (181)
                      ++|++.+.||+|+||+||+|.+...++     .||+|.+...  ......+.+|+.++.++ +||||+++++++.+++..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            579999999999999999999875443     5899988643  23346788999999887 899999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEE
Q 030211           74 AIVMEYAAGGELFDRICNA-----------------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTL  130 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~-----------------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~  130 (181)
                      +++|||+++++|.+++.+.                       ..+++..++.++.|++.||+|||++||+||||||+||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil  196 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  196 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence            9999999999999998654                       24889999999999999999999999999999999999


Q ss_pred             eccCCCCcEEEeecCCcccccCCCCC---CcccCCCCccCcccccCCccCCC
Q 030211          131 LDGSAAPRLKICDFGYSKSSVLHSRP---KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       131 i~~~~~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.+.  .+||+|||+|+........   ....+|+.|||||++.++.++++
T Consensus       197 l~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~  246 (325)
T d1rjba_         197 VTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK  246 (325)
T ss_dssp             EETTT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH
T ss_pred             cccCC--eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc
Confidence            97554  5999999999765544432   23457999999999998888764

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-41  Score=243.65  Aligned_cols=174  Identities=28%  Similarity=0.436  Sum_probs=149.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-------ccHHHHHHHHHHhhCC--CCCeeEEEEeEEcCCe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-------IDENVAREIINHRSLR--HPNIIRFKEVVLTPTH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~~~~~~--~~~i~~~~~~~~~~~~   72 (181)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.+...       ....+.+|+.+++++.  |||++++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            589999999999999999999999999999999875321       1234678999998875  8999999999999999


Q ss_pred             EEEEEeecCC-CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           73 LAIVMEYAAG-GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        73 ~~~v~e~~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      .+++||++.+ +++.+.+..+..++++.++.++.|++.||+|||++||+||||||+||+++.+ .+.++|+|||+|+...
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~-~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT-TTEEEECCCTTCEECC
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecC-CCeEEECccccceecc
Confidence            9999999976 5777888778899999999999999999999999999999999999999743 2369999999997533


Q ss_pred             CCCCCCcccCCCCccCcccccCCccC
Q 030211          152 LHSRPKSTVGTPAYIAPEVLSRREYD  177 (181)
Q Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~  177 (181)
                       ........||+.|+|||++.+.++.
T Consensus       163 -~~~~~~~~GT~~y~aPE~~~~~~~~  187 (273)
T d1xwsa_         163 -DTVYTDFDGTRVYSPPEWIRYHRYH  187 (273)
T ss_dssp             -SSCBCCCCSCGGGSCHHHHHHSCBC
T ss_pred             -cccccccccCCCcCCHHHHcCCCCC
Confidence             3344557899999999999876653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-42  Score=245.98  Aligned_cols=174  Identities=26%  Similarity=0.337  Sum_probs=145.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (181)
                      ++|++.+.||+|+||.||+|.++++ +.||+|++.......+.+.+|+.++++++|+||+++++++.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            6899999999999999999998764 569999998776666889999999999999999999999854 56889999999


Q ss_pred             CCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC--CCC
Q 030211           82 GGELFDRICN--AGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS--RPK  157 (181)
Q Consensus        82 ~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~--~~~  157 (181)
                      +++|..++..  ...+++..++.++.|++.||+|||++|++|+||||+||+++++..  ++|+|||+|+......  ...
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~  172 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQ  172 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC-----------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCceeec
Confidence            9999887754  346999999999999999999999999999999999999976554  9999999997653332  223


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...+++.|+|||++.++.++++
T Consensus       173 ~~~gt~~y~aPE~~~~~~~~~k  194 (285)
T d1fmka3         173 GAKFPIKWTAPEAALYGRFTIK  194 (285)
T ss_dssp             ---CCGGGSCHHHHHHCCCCHH
T ss_pred             cccccccccChHHHhCCCCCcH
Confidence            3568999999999999888764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-41  Score=242.96  Aligned_cols=175  Identities=27%  Similarity=0.386  Sum_probs=145.9

Q ss_pred             ccceeeee-eCCccceeEEEEEEcc--CCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKD-LGAGNFGVARLLRHKE--TKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~-i~~g~~~~v~~~~~~~--~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|.+.+. ||+|+||.||+|.++.  ++..||+|+++....  ..+.+.+|+.++.+++||||+++++++.+ +.+++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            46788885 9999999999998754  345799999875432  23678899999999999999999999875 468899


Q ss_pred             EeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      |||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.+.  .+||+|||+|+.......
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~--~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKALGADDS  164 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEECTTCSC
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC--ceeeccchhhhccccccc
Confidence            9999999999987543 5799999999999999999999999999999999999997655  499999999976543322


Q ss_pred             ----CCcccCCCCccCcccccCCccCCC
Q 030211          156 ----PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 ----~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                          .....+++.|+|||++..+.++++
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k  192 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKFSSR  192 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHH
T ss_pred             ccccccccccCccccChHHHhCCCCCcc
Confidence                223457899999999988887754

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-41  Score=242.01  Aligned_cols=167  Identities=27%  Similarity=0.374  Sum_probs=138.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++|++.+.||+|+||+||+|+.+   ..||+|+++....   ..+.+.+|+.++.+++||||+++++++. .+.++++||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E   83 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   83 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence            57999999999999999999764   3599999875432   2367889999999999999999999865 456899999


Q ss_pred             ecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC---
Q 030211           79 YAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS---  154 (181)
Q Consensus        79 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~---  154 (181)
                      |+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.+..  +||+|||+|+......   
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC--------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccCCcc
Confidence            99999999988654 47999999999999999999999999999999999999976654  9999999997554322   


Q ss_pred             CCCcccCCCCccCcccccCC
Q 030211          155 RPKSTVGTPAYIAPEVLSRR  174 (181)
Q Consensus       155 ~~~~~~~~~~~~aPE~~~~~  174 (181)
                      ......||+.|||||++...
T Consensus       162 ~~~~~~gt~~y~APE~l~~~  181 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQ  181 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTC
T ss_pred             cccccccCcccCCHHHHhcc
Confidence            23345789999999999743

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-41  Score=243.17  Aligned_cols=176  Identities=26%  Similarity=0.321  Sum_probs=143.1

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCC----cEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETK----ELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~----~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +.|++.++||+|+||.||+|.++.++    ..||+|.+.....  ....+.+|+.++.+++||||+++++++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            56899999999999999999987544    4699999865432  23568899999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +||++.++++.+.+... ..+++..+..++.|++.||+|||+++|+||||||+||+++.+.  .+||+|||+|+......
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~--~~Kl~DFGla~~~~~~~  164 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDP  164 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC--------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC--eEEEcccchhhcccCCC
Confidence            99999999988877654 5799999999999999999999999999999999999997655  49999999997543322


Q ss_pred             C----CCcccCCCCccCcccccCCccCCC
Q 030211          155 R----PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~----~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .    .....||+.|+|||++.++.++++
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~  193 (283)
T d1mqba_         165 EATYTTSGGKIPIRWTAPEAISYRKFTSA  193 (283)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCHH
T ss_pred             ccceEeccCCCCccccCHHHHccCCCCCc
Confidence            2    223457899999999999888764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-41  Score=244.27  Aligned_cols=172  Identities=31%  Similarity=0.403  Sum_probs=145.1

Q ss_pred             eeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc------ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEe
Q 030211            5 ELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK------IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         5 ~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (181)
                      +.++.||+|+||+||+|.++.+++.||+|++.....      ..+.+.+|+.+++.++||||+++++++.+++.+++|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            357899999999999999999999999999865432      13568899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC-CCC
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS-RPK  157 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~-~~~  157 (181)
                      |+.++++......+..+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||+|+...... ...
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~  158 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYT  158 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCccccc
Confidence            9988877766666678999999999999999999999999999999999999975554  9999999997654433 344


Q ss_pred             cccCCCCccCcccccCC-ccCC
Q 030211          158 STVGTPAYIAPEVLSRR-EYDG  178 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~-~~~~  178 (181)
                      ...+|+.|+|||++.+. .|+.
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~  180 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGV  180 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCH
T ss_pred             ceecChhhccHHHHccCCCCCh
Confidence            56799999999998755 4454

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-41  Score=242.41  Aligned_cols=169  Identities=25%  Similarity=0.352  Sum_probs=140.4

Q ss_pred             eeeCCccceeEEEEEEc--cCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEEeecCC
Q 030211            8 KDLGAGNFGVARLLRHK--ETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (181)
Q Consensus         8 ~~i~~g~~~~v~~~~~~--~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (181)
                      ++||+|+||+||+|.++  .+++.||+|+++....   ..+.+.+|+.++++++||||+++++++..+ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            36999999999999865  3457899999865432   235789999999999999999999998654 57899999999


Q ss_pred             CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC----CCc
Q 030211           83 GELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR----PKS  158 (181)
Q Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~----~~~  158 (181)
                      ++|.+++.....+++..+..++.|++.||+|||++|++||||||+||+++.++  .++|+|||+|+.......    ...
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~--~~kl~DFGla~~~~~~~~~~~~~~~  169 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENYYKAQTH  169 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCSEEEC---
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC--cccccchhhhhhccccccccccccc
Confidence            99999998888999999999999999999999999999999999999997555  499999999976543332    223


Q ss_pred             ccCCCCccCcccccCCccCCC
Q 030211          159 TVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..||+.|+|||++.+..++++
T Consensus       170 ~~gt~~y~APE~l~~~~~~~~  190 (277)
T d1xbba_         170 GKWPVKWYAPECINYYKFSSK  190 (277)
T ss_dssp             -CCCGGGCCHHHHHHCEEEHH
T ss_pred             cCCCceecCchhhcCCCCCch
Confidence            468899999999988877654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.4e-40  Score=238.21  Aligned_cols=175  Identities=30%  Similarity=0.471  Sum_probs=147.5

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      |+||++.+.||+|+||+||+|.++ +++.||+|++....   ...+.+.+|+.+++.++|||++++++.+.+++..++++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            689999999999999999999987 67899999986542   23468889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC-CCC
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH-SRP  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~-~~~  156 (181)
                      +++.++.+..+......+++..++.++.|++.||+|||++||+|+||||+||+++.++.  ++|+|||.|...... ...
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~  157 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY  157 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCcccc
Confidence            99988776666666778999999999999999999999999999999999999976554  999999999765433 334


Q ss_pred             CcccCCCCccCcccccCCc-cCC
Q 030211          157 KSTVGTPAYIAPEVLSRRE-YDG  178 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~-~~~  178 (181)
                      ....+++.|+|||.+.+.. +++
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~  180 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYST  180 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCT
T ss_pred             ceecccchhhhHHHHhCCCCCCc
Confidence            4557899999999997654 344

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-40  Score=241.63  Aligned_cols=177  Identities=25%  Similarity=0.336  Sum_probs=150.2

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcE--EEEEEcccc--ccccHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKEL--VAVKYIERG--RKIDENVAREIINHRSL-RHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~--v~~K~~~~~--~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +++|++.++||+|+||.||+|.++.++..  ||+|.+...  ....+.+.+|+.++..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            46899999999999999999999887764  677776532  22346789999999998 79999999999999999999


Q ss_pred             EEeecCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcE
Q 030211           76 VMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRL  139 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v  139 (181)
                      ||||+++++|.+++..+                ..+++..+..++.|++.||.|||+++++||||||+||+++.+..  +
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~--~  166 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--A  166 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--E
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--e
Confidence            99999999999988643                46899999999999999999999999999999999999976554  9


Q ss_pred             EEeecCCcccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          140 KICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       140 ~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ||+|||+|+............+++.|+|||.+.++.++++
T Consensus       167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~  206 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN  206 (309)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH
T ss_pred             EEccccccccccccccccceecCCcccchHHhccCCCCcc
Confidence            9999999987666666666778999999999998888754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-40  Score=241.89  Aligned_cols=175  Identities=23%  Similarity=0.340  Sum_probs=143.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCc----EEEEEEcccc--ccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKE----LVAVKYIERG--RKIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~----~v~~K~~~~~--~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   75 (181)
                      +.|++++.||+|+||+||+|.+..+|+    .||+|.+...  ....+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            469999999999999999999987765    5888887643  23457899999999999999999999999875 4667


Q ss_pred             EEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           76 VMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        76 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      +++++.+++|.+.+... ..+++..++.++.|++.||.|||++||+||||||+||+++.+.  .+||+|||+|+......
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~--~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCCSHHHHTTTTC
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC--CeEeeccccceeccccc
Confidence            78888899998877654 5899999999999999999999999999999999999997655  49999999998654433


Q ss_pred             CC---CcccCCCCccCcccccCCccCCC
Q 030211          155 RP---KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ~~---~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ..   ....||+.|+|||++.++.++.+
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~  193 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQ  193 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHH
T ss_pred             ccccccccccCccccChHHHhcCCCChh
Confidence            32   22357999999999999888754

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-39  Score=238.90  Aligned_cols=171  Identities=27%  Similarity=0.481  Sum_probs=149.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC-CCCeeEEEEeEEcC--CeEEEEEe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-HPNIIRFKEVVLTP--THLAIVME   78 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~--~~~~~v~e   78 (181)
                      ++|+++++||+|+||+||+|.+..+++.||+|+++...  .+.+.+|+.+++.+. |||++++++++...  ..++++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            68999999999999999999999999999999987543  467889999999885 99999999999854  56999999


Q ss_pred             ecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCCc
Q 030211           79 YAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPKS  158 (181)
Q Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~~  158 (181)
                      |+.+++|....   ..+++..++.++.|++.||.|||++||+|+||||+||+++.++ ..++|+|||+|...........
T Consensus       113 ~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~-~~vkl~DFG~a~~~~~~~~~~~  188 (328)
T d3bqca1         113 HVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH-RKLRLIDWGLAEFYHPGQEYNV  188 (328)
T ss_dssp             CCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT-TEEEECCGGGCEECCTTCCCCS
T ss_pred             ecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCC-CeeeecccccceeccCCCcccc
Confidence            99999987653   4599999999999999999999999999999999999997433 3589999999987777777777


Q ss_pred             ccCCCCccCcccccCCc-cCC
Q 030211          159 TVGTPAYIAPEVLSRRE-YDG  178 (181)
Q Consensus       159 ~~~~~~~~aPE~~~~~~-~~~  178 (181)
                      ..+|+.|+|||.+.+.. ++.
T Consensus       189 ~~~t~~y~aPE~~~~~~~~~~  209 (328)
T d3bqca1         189 RVASRYFKGPELLVDYQMYDY  209 (328)
T ss_dssp             CCSCGGGCCHHHHTTCCCCCT
T ss_pred             cccCccccCcccccCCCCCCc
Confidence            88999999999988754 443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.4e-39  Score=234.82  Aligned_cols=176  Identities=22%  Similarity=0.246  Sum_probs=150.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCC-CCeeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH-PNIIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~-~~i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|++.+..++| ++++.+++++.++...+++||++
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            58999999999999999999999999999999886543 34567788899988876 89999999999999999999998


Q ss_pred             CCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccC---CCCcEEEeecCCcccccCC---
Q 030211           81 AGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGS---AAPRLKICDFGYSKSSVLH---  153 (181)
Q Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~---~~~~v~l~dfg~a~~~~~~---  153 (181)
                       +++|.+.+... ..++..++..++.|++.+|++||++||+||||||+||+++.+   ..+.++|+|||+|+.....   
T Consensus        84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (293)
T d1csna_          84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  162 (293)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence             67888877654 479999999999999999999999999999999999999632   2456999999999754322   


Q ss_pred             -----CCCCcccCCCCccCcccccCCccCCC
Q 030211          154 -----SRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 -----~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                           .......||+.|||||.+.+.+++++
T Consensus       163 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~  193 (293)
T d1csna_         163 QHIPYREKKNLSGTARYMSINTHLGREQSRR  193 (293)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH
T ss_pred             cceeecccCceEEchhhcCHHHhcCCCCChH
Confidence                 22334579999999999999888754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-40  Score=237.23  Aligned_cols=175  Identities=23%  Similarity=0.310  Sum_probs=137.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC---CcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET---KELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIV   76 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   76 (181)
                      ++|++.+.||+|+||.||+|.+..+   +..||+|.+......  .+.+.+|+.++++++||||+++++++. .+.++++
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            6899999999999999999998644   346888888654322  357889999999999999999999986 4678999


Q ss_pred             EeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC
Q 030211           77 MEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR  155 (181)
Q Consensus        77 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~  155 (181)
                      |||++++++.+++... .++++..++.++.|++.||.|||++|++||||||+||+++++..  +||+|||+|+.......
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC------------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCCcc
Confidence            9999999998876554 47999999999999999999999999999999999999976554  99999999976543322


Q ss_pred             --CCcccCCCCccCcccccCCccCCC
Q 030211          156 --PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                        .....+++.|+|||++.+++++++
T Consensus       164 ~~~~~~~gt~~y~apE~l~~~~~~~~  189 (273)
T d1mp8a_         164 YKASKGKLPIKWMAPESINFRRFTSA  189 (273)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHH
T ss_pred             eeccceecCcccchhhHhccCCCCCc
Confidence              233467899999999998888754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-40  Score=238.29  Aligned_cols=176  Identities=28%  Similarity=0.408  Sum_probs=144.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccC-CcEEEEEEccccc---cccHHHHHHHHHHhh---CCCCCeeEEEEeEEc-----
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKET-KELVAVKYIERGR---KIDENVAREIINHRS---LRHPNIIRFKEVVLT-----   69 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~-~~~v~~K~~~~~~---~~~~~~~~e~~~~~~---~~~~~i~~~~~~~~~-----   69 (181)
                      ++|++++.||+|+||+||+|.+..+ ++.||+|++....   .....+.+|+.+++.   .+|||++++++++..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            6899999999999999999999654 6679999986532   223455666666554   489999999999864     


Q ss_pred             CCeEEEEEeecCCCChHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211           70 PTHLAIVMEYAAGGELFDRIC-NAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus        70 ~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      ....+++||++.++.+..... ....+++..++.++.|++.||+|||++||+||||||+||++++++.  ++|+|||++.
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~~  164 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLAR  164 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhhhh
Confidence            346899999998876643333 3457999999999999999999999999999999999999975554  9999999998


Q ss_pred             cccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          149 SSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ............||+.|+|||++.+.+|+++
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~  195 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATP  195 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH
T ss_pred             hhcccccCCCcccChhhcCcchhcCCCCChh
Confidence            7666666667789999999999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-39  Score=236.84  Aligned_cols=177  Identities=28%  Similarity=0.400  Sum_probs=146.0

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccc---cccHHHHHHHHHHhhCCCCCeeEEEEeEEc--------
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGR---KIDENVAREIINHRSLRHPNIIRFKEVVLT--------   69 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--------   69 (181)
                      ++||++++.||+|+||+||+|.+..+|+.||+|++....   .....+.+|+.+++.++|+|++++++.+..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            579999999999999999999999999999999986542   234678899999999999999999998865        


Q ss_pred             CCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           70 PTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        70 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      .+.++++||+++++.+.........+++..++.++.|++.||.|||++||+||||||+||+++.++.  ++|.|||++..
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~  166 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARA  166 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeecceeee
Confidence            3458999999987766665566668999999999999999999999999999999999999976554  99999999965


Q ss_pred             ccCC-----CCCCcccCCCCccCcccccCC-ccCCC
Q 030211          150 SVLH-----SRPKSTVGTPAYIAPEVLSRR-EYDGK  179 (181)
Q Consensus       150 ~~~~-----~~~~~~~~~~~~~aPE~~~~~-~~~~~  179 (181)
                      ....     .......||+.|+|||++.+. .|+++
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k  202 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP  202 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTH
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcH
Confidence            4322     223345689999999999765 56654

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-39  Score=239.37  Aligned_cols=173  Identities=30%  Similarity=0.451  Sum_probs=145.2

Q ss_pred             cceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcC------CeEEEE
Q 030211            3 KYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTP------THLAIV   76 (181)
Q Consensus         3 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~------~~~~~v   76 (181)
                      +|+.+++||+|+||+||+|++..+++.||+|++.....   ...+|+.+++.++|+|+++++++|...      .+++++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            68999999999999999999999999999999876543   234789999999999999999998643      358999


Q ss_pred             EeecCCCChHH---HHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           77 MEYAAGGELFD---RICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        77 ~e~~~~~~l~~---~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      |||++++.+..   .......+++..++.++.|++.||+|||++||+||||||+||+++.++ ..++|+|||++......
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~-~~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT-AVLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT-CCEEECCCTTCEECCTT
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCC-CceeEecccchhhccCC
Confidence            99997653322   233455799999999999999999999999999999999999997443 25999999999877777


Q ss_pred             CCCCcccCCCCccCcccccCC-ccCCC
Q 030211          154 SRPKSTVGTPAYIAPEVLSRR-EYDGK  179 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~-~~~~~  179 (181)
                      .......|++.|+|||.+.+. .++++
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~  203 (350)
T d1q5ka_         177 EPNVSYICSRYYRAPELIFGATDYTSS  203 (350)
T ss_dssp             SCCCSCCSCTTSCCHHHHTTCSSCCTH
T ss_pred             cccccccccccccChHHhhcccCCCcc
Confidence            777778899999999998754 55553

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-39  Score=231.05  Aligned_cols=174  Identities=29%  Similarity=0.498  Sum_probs=153.3

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc---ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEEEEE
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK---IDENVAREIINHRSLRHPNIIRFKEVVLTPTHLAIVM   77 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   77 (181)
                      |++|++++.||+|+||+||+|++..+++.||+|+++....   ....+.+|+.+++.++|||++++++++.+++..++++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            6899999999999999999999999999999999865432   2467889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCC-C
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSR-P  156 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~-~  156 (181)
                      +++.++++..+...+..+++..++.++.|++.||+|||++||+|+||||+||+++.+.  .++|+|||.|........ .
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~--~~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSCCSCC
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC--ceeeeecchhhcccCCCccc
Confidence            9999988888888888999999999999999999999999999999999999996554  599999999986654433 3


Q ss_pred             CcccCCCCccCcccccCCcc
Q 030211          157 KSTVGTPAYIAPEVLSRREY  176 (181)
Q Consensus       157 ~~~~~~~~~~aPE~~~~~~~  176 (181)
                      ....+++.|+|||++....+
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~  178 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFGAKL  178 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSC
T ss_pred             eeeccccchhhhhHhccCCC
Confidence            34467788999999887654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-40  Score=238.75  Aligned_cols=176  Identities=25%  Similarity=0.385  Sum_probs=149.4

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||+||+|+++     .+++.||+|++......  .+.+.+|+.++++++|||++++++++.+.+..+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            57999999999999999999975     35678999998754322  367899999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEE
Q 030211           75 IVMEYAAGGELFDRICNA------------------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTL  130 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~------------------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~  130 (181)
                      ++||++++++|.+++...                        ..+++..+..++.|++.||+|||+++++||||||+||+
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL  172 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  172 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence            999999999999988542                        24888999999999999999999999999999999999


Q ss_pred             eccCCCCcEEEeecCCcccccCCC---CCCcccCCCCccCcccccCCccCCC
Q 030211          131 LDGSAAPRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       131 i~~~~~~~v~l~dfg~a~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ++.+..  +||+|||+|+......   ......+++.|+|||.+.+.+++++
T Consensus       173 ld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~k  222 (301)
T d1lufa_         173 VGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE  222 (301)
T ss_dssp             ECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH
T ss_pred             ECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChh
Confidence            976554  9999999997543332   2334568899999999999888865

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-40  Score=235.23  Aligned_cols=172  Identities=27%  Similarity=0.409  Sum_probs=141.3

Q ss_pred             CccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEc-CCeEEEEEee
Q 030211            1 MEKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLT-PTHLAIVMEY   79 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~   79 (181)
                      +++|++.+.||+|+||.||+|.++  |+.||+|.++.. ...+.+.+|+.+++.++||||+++++++.+ .+.+++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            478999999999999999999985  778999999754 345789999999999999999999999865 4568999999


Q ss_pred             cCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCCC
Q 030211           80 AAGGELFDRICNAG--RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRPK  157 (181)
Q Consensus        80 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~~  157 (181)
                      +++++|.+++.+..  .+++..++.++.|++.||.|||+++++|+||+|+||+++.++.  ++|+|||+++....  ...
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~~--~~~  158 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS--TQD  158 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC-----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecCC--CCc
Confidence            99999999986543  5899999999999999999999999999999999999976555  99999999875432  233


Q ss_pred             cccCCCCccCcccccCCccCCC
Q 030211          158 STVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...+++.|+|||++.++.++++
T Consensus       159 ~~~~~~~y~aPE~l~~~~~t~~  180 (262)
T d1byga_         159 TGKLPVKWTAPEALREKKFSTK  180 (262)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHH
T ss_pred             cccccccCCChHHHhCCCCChH
Confidence            3567899999999998888764

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-39  Score=233.03  Aligned_cols=176  Identities=24%  Similarity=0.235  Sum_probs=145.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCC-eeEEEEeEEcCCeEEEEEeec
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPN-IIRFKEVVLTPTHLAIVMEYA   80 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~-i~~~~~~~~~~~~~~~v~e~~   80 (181)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+..|+.+++.++|++ ++.+..++.+++..+++||++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~   85 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   85 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence            47999999999999999999999999999999877643 3456788999999998755 666777788889999999999


Q ss_pred             CCCChHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEecc-CCCCcEEEeecCCcccccCCC----
Q 030211           81 AGGELFDRI-CNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDG-SAAPRLKICDFGYSKSSVLHS----  154 (181)
Q Consensus        81 ~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~-~~~~~v~l~dfg~a~~~~~~~----  154 (181)
                      ++ ++...+ .....+++..+..++.|++.||+|||++||+||||||+||+++. +....++|+|||+|+......    
T Consensus        86 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  164 (299)
T d1ckia_          86 GP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  164 (299)
T ss_dssp             CC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred             CC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence            54 555544 44558999999999999999999999999999999999999842 334469999999997654322    


Q ss_pred             ----CCCcccCCCCccCcccccCCccCCC
Q 030211          155 ----RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       155 ----~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                          ......||+.|+|||.+.+.+++++
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  193 (299)
T d1ckia_         165 IPYRENKNLTGTARYASINTHLGIEQSRR  193 (299)
T ss_dssp             CCCCBCCSCCCCSSSCCHHHHTTBCCCHH
T ss_pred             eeccccCCcCCCccccCHHHHhCCCCCCh
Confidence                2334579999999999999888754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-39  Score=238.60  Aligned_cols=173  Identities=27%  Similarity=0.384  Sum_probs=137.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEc------CCe
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLT------PTH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~------~~~   72 (181)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++......   ...+.+|+.++++++|||+++++++|..      .+.
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            6899999999999999999999999999999999764322   2467899999999999999999999964      468


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      +|++|||+.++ +.+.+.  ..+++..++.++.|++.||.|||++||+|+||||+||+++.+..  ++++|||.++....
T Consensus        97 ~~iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~  171 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT  171 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC------
T ss_pred             eEEEEeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhcccc
Confidence            99999999664 544443  45999999999999999999999999999999999999976555  99999999887776


Q ss_pred             CCCCCcccCCCCccCcccccCCccCCC
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ........+|+.|+|||++.+..++++
T Consensus       172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~  198 (355)
T d2b1pa1         172 SFMMTPYVVTRYYRAPEVILGMGYKEN  198 (355)
T ss_dssp             ---------CCTTCCHHHHTTCCCCTT
T ss_pred             ccccccccccccccChhhhcCCCCCCC
Confidence            666777789999999999999888875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-39  Score=234.80  Aligned_cols=176  Identities=26%  Similarity=0.344  Sum_probs=144.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCC-------cEEEEEEccccccc--cHHHHHHHHHHhhC-CCCCeeEEEEeEEcCC
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETK-------ELVAVKYIERGRKI--DENVAREIINHRSL-RHPNIIRFKEVVLTPT   71 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~-------~~v~~K~~~~~~~~--~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~   71 (181)
                      ++|++.+.||+|+||.||+|.....+       ..||+|.+......  ...+.+|...+..+ +||||+++++++.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            78999999999999999999876443       36999998765432  35677788888777 8999999999999999


Q ss_pred             eEEEEEeecCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC
Q 030211           72 HLAIVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~  135 (181)
                      ..+++|||+.+++|.+++...                ..+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~  172 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  172 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence            999999999999999988644                3589999999999999999999999999999999999997655


Q ss_pred             CCcEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          136 APRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       136 ~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      .  ++|+|||++........   .....+++.|+|||++.+++|+++
T Consensus       173 ~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k  217 (299)
T d1fgka_         173 V--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ  217 (299)
T ss_dssp             C--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH
T ss_pred             C--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch
Confidence            4  99999999976544332   333568899999999999988865

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-39  Score=236.07  Aligned_cols=169  Identities=27%  Similarity=0.400  Sum_probs=138.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcCC------e
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTPT------H   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~------~   72 (181)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++......   .+.+.+|+.+++.++|||+++++++|...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            5899999999999999999999999999999999754322   357889999999999999999999998764      4


Q ss_pred             EEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccC
Q 030211           73 LAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVL  152 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~  152 (181)
                      ++++|||+ +.+|.... ++..+++..++.++.|++.||.|||++||+|+||||+||+++.++.  ++|+|||+|.....
T Consensus        98 ~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQADS  173 (346)
T ss_dssp             CEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCS
T ss_pred             EEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceeccCC
Confidence            79999999 54666554 5568999999999999999999999999999999999999976555  99999999975433


Q ss_pred             CCCCCcccCCCCccCcccccCCcc
Q 030211          153 HSRPKSTVGTPAYIAPEVLSRREY  176 (181)
Q Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~  176 (181)
                        ......+++.|+|||++.+..+
T Consensus       174 --~~~~~~~t~~y~aPE~~~~~~~  195 (346)
T d1cm8a_         174 --EMTGYVVTRWYRAPEVILNWMR  195 (346)
T ss_dssp             --SCCSSCSCGGGCCTHHHHTTTC
T ss_pred             --ccccccccccccCHHHHcCCCC
Confidence              3445679999999999876543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=235.83  Aligned_cols=176  Identities=24%  Similarity=0.355  Sum_probs=136.3

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc-----CCcEEEEEEccccccc--cHHHHHHHHHHhhC-CCCCeeEEEEeEEcC-Ce
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRKI--DENVAREIINHRSL-RHPNIIRFKEVVLTP-TH   72 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~-~~   72 (181)
                      ++|++.+.||+|+||.||+|.+..     +++.||+|.+......  .+.+.+|...+.++ +|+|++.+++++.+. +.
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            679999999999999999999754     3467999998754322  34566677766665 689999999987764 56


Q ss_pred             EEEEEeecCCCChHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCC
Q 030211           73 LAIVMEYAAGGELFDRICNA----------------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAA  136 (181)
Q Consensus        73 ~~~v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~  136 (181)
                      ++++|||+++++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+||+++++..
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~  172 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  172 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence            89999999999999988643                24889999999999999999999999999999999999976554


Q ss_pred             CcEEEeecCCcccccCCC---CCCcccCCCCccCcccccCCccCCC
Q 030211          137 PRLKICDFGYSKSSVLHS---RPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       137 ~~v~l~dfg~a~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                        +||+|||+|+......   ......||+.|+|||++.++.++++
T Consensus       173 --~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~  216 (299)
T d1ywna1         173 --VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ  216 (299)
T ss_dssp             --EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH
T ss_pred             --EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc
Confidence              9999999997543332   2334568999999999998888754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-38  Score=234.85  Aligned_cols=173  Identities=31%  Similarity=0.486  Sum_probs=140.7

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc--ccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC-----eEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK--IDENVAREIINHRSLRHPNIIRFKEVVLTPT-----HLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-----~~~   74 (181)
                      +||++++.||+|+||+||+|.+..+|+.||+|++.....  ..+.+.+|+.++++++|||++++++++..+.     .++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            579999999999999999999999999999999875432  2357889999999999999999999987653     345


Q ss_pred             EEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCC
Q 030211           75 IVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHS  154 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~  154 (181)
                      ++ +++.+++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||++++++  .++|+|||+|.......
T Consensus        88 l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~--~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          88 LV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDH  163 (345)
T ss_dssp             EE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCGGG
T ss_pred             EE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC--CEEEcccCceeeccCCC
Confidence            55 55668899988854 4799999999999999999999999999999999999997555  49999999997543332


Q ss_pred             C----CCcccCCCCccCcccccCCc-cCC
Q 030211          155 R----PKSTVGTPAYIAPEVLSRRE-YDG  178 (181)
Q Consensus       155 ~----~~~~~~~~~~~aPE~~~~~~-~~~  178 (181)
                      .    .....|++.|+|||++..+. +++
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~  192 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTK  192 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCST
T ss_pred             ccceeeccccccceechHHHhhcCCCCCc
Confidence            2    34456899999999986553 443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-39  Score=230.19  Aligned_cols=175  Identities=32%  Similarity=0.447  Sum_probs=136.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc-CC--cEEEEEEccccc----cccHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE-TK--ELVAVKYIERGR----KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~-~~--~~v~~K~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||.||+|.... ++  ..||+|.+.+..    ...+.+.+|+.++.+++||||+++++++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            579999999999999999998653 22  368999887542    2235789999999999999999999999764 678


Q ss_pred             EEEeecCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           75 IVMEYAAGGELFDRICNA-GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      ++|||+.++++.+.+..+ ..+++..++.++.|++.||.|||++||+||||||+||+++.+.  .++|+|||+++.....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~--~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCC-
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc--ceeeccchhhhhcccC
Confidence            999999999998877554 4699999999999999999999999999999999999997655  5999999999865443


Q ss_pred             CCC----CcccCCCCccCcccccCCccCCC
Q 030211          154 SRP----KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       154 ~~~----~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ...    ....++..|+|||++.+..++++
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  194 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHA  194 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHH
T ss_pred             CCcceecCccccCcccCCHHHHhCCCCCcc
Confidence            332    22346789999999998877653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-38  Score=231.73  Aligned_cols=176  Identities=24%  Similarity=0.324  Sum_probs=149.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEc-----cCCcEEEEEEccccccc--cHHHHHHHHHHhhC-CCCCeeEEEEeEEcCCeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHK-----ETKELVAVKYIERGRKI--DENVAREIINHRSL-RHPNIIRFKEVVLTPTHL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~   73 (181)
                      ++|++.+.||+|+||.||+|++.     .+++.||+|.++.....  ...+.+|+.+++.+ +||||+++++++.+++..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            67899999999999999999863     45678999998754332  34688899999988 699999999999999999


Q ss_pred             EEEEeecCCCChHHHHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCC
Q 030211           74 AIVMEYAAGGELFDRICNAG------------------RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSA  135 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~------------------~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~  135 (181)
                      +++|||+++++|.+++....                  .+++..+..++.|++.||+|||++|++||||||+||+++.+.
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~  182 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence            99999999999998886532                  589999999999999999999999999999999999997554


Q ss_pred             CCcEEEeecCCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          136 APRLKICDFGYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       136 ~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                        .++++|||.++.......   .....+++.|+|||++.++.++.+
T Consensus       183 --~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  227 (311)
T d1t46a_         183 --ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE  227 (311)
T ss_dssp             --EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH
T ss_pred             --cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc
Confidence              599999999976543322   223468999999999998887754

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-38  Score=231.33  Aligned_cols=176  Identities=20%  Similarity=0.285  Sum_probs=149.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEcc-----CCcEEEEEEccccccc--cHHHHHHHHHHhhCCCCCeeEEEEeEEcCCeEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKE-----TKELVAVKYIERGRKI--DENVAREIINHRSLRHPNIIRFKEVVLTPTHLA   74 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~~--~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (181)
                      ++|++.+.||+|+||.||+|.++.     ++..||+|++......  ...+.+|+.++++++|||++++++++...+..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            689999999999999999998752     3568999999754332  245889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeec
Q 030211           75 IVMEYAAGGELFDRICNA----------GRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (181)
Q Consensus        75 ~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~df  144 (181)
                      ++|||+.+++|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+||+++.+.  .+||+||
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~--~~Kl~DF  177 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDF  177 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC--CEEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc--eEEEeec
Confidence            999999999999887542          2478899999999999999999999999999999999997555  4999999


Q ss_pred             CCcccccCCCC---CCcccCCCCccCcccccCCccCCC
Q 030211          145 GYSKSSVLHSR---PKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       145 g~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      |+|+.......   .....+++.|+|||.+.++.++++
T Consensus       178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~  215 (308)
T d1p4oa_         178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY  215 (308)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH
T ss_pred             ccceeccCCcceeeccceecccccCCHHHHccCCCCcc
Confidence            99975543332   223358999999999998888754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-38  Score=227.29  Aligned_cols=169  Identities=29%  Similarity=0.347  Sum_probs=137.6

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCeeEEEEeEEcCC----eEEEEE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNIIRFKEVVLTPT----HLAIVM   77 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~----~~~~v~   77 (181)
                      .+|.+.+.||+|+||+||+|+.  +|+.||+|.+............|+..+..++||||+++++++.+.+    .+++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4789999999999999999986  4789999998765432233334555556789999999999998653    589999


Q ss_pred             eecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh--------cCeeeeCCCCCCEEeccCCCCcEEEeecCCccc
Q 030211           78 EYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHS--------MQICHRDLKLENTLLDGSAAPRLKICDFGYSKS  149 (181)
Q Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~--------~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~  149 (181)
                      ||+++++|.+++.+. ++++...+.++.|++.+|.+||+        +||+|+||||+||+++++.  .+||+|||+++.
T Consensus        81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~--~~Kl~DFGl~~~  157 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS--CEEECCCTTCEE
T ss_pred             ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC--CeEEEecCcccc
Confidence            999999999999654 68999999999999999999996        6999999999999997555  599999999976


Q ss_pred             ccCCC-----CCCcccCCCCccCcccccCCc
Q 030211          150 SVLHS-----RPKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       150 ~~~~~-----~~~~~~~~~~~~aPE~~~~~~  175 (181)
                      .....     ......||+.|+|||++....
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  188 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSI  188 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCS
T ss_pred             ccCCCcceeccccceecccCcCChhhccccc
Confidence            54433     233457899999999987653

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-38  Score=231.36  Aligned_cols=173  Identities=32%  Similarity=0.568  Sum_probs=151.0

Q ss_pred             CccceeeeeeCCccceeEEEEEE---ccCCcEEEEEEccccc-----cccHHHHHHHHHHhhCCC-CCeeEEEEeEEcCC
Q 030211            1 MEKYELVKDLGAGNFGVARLLRH---KETKELVAVKYIERGR-----KIDENVAREIINHRSLRH-PNIIRFKEVVLTPT   71 (181)
Q Consensus         1 ~~~y~~~~~i~~g~~~~v~~~~~---~~~~~~v~~K~~~~~~-----~~~~~~~~e~~~~~~~~~-~~i~~~~~~~~~~~   71 (181)
                      +++|++++.||+|+||+||+|.+   +.+|+.||+|.+.+..     ...+.+.+|+.++++++| |||+++++++.+.+
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            47899999999999999999987   4468899999986532     234678889999999977 89999999999999


Q ss_pred             eEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCccccc
Q 030211           72 HLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSV  151 (181)
Q Consensus        72 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~  151 (181)
                      ..+++||++.+++|.+.+.....+++..+..++.|++.||.|||++|++|+||||+||+++.++  .++|+|||+|+...
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~--~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEESCSSEEEECC
T ss_pred             ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC--CEEEeeccchhhhc
Confidence            9999999999999999998888999999999999999999999999999999999999997655  59999999997543


Q ss_pred             C--CCCCCcccCCCCccCcccccCCc
Q 030211          152 L--HSRPKSTVGTPAYIAPEVLSRRE  175 (181)
Q Consensus       152 ~--~~~~~~~~~~~~~~aPE~~~~~~  175 (181)
                      .  ........+++.|+|||.+....
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~  206 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGD  206 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC
T ss_pred             ccccccccccccccccchhHHhhcCC
Confidence            3  33344567999999999997654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-38  Score=227.65  Aligned_cols=172  Identities=23%  Similarity=0.291  Sum_probs=142.1

Q ss_pred             eeeeeCCccceeEEEEEEccCC---cEEEEEEccccc--cccHHHHHHHHHHhhCCCCCeeEEEEeEEc-CCeEEEEEee
Q 030211            6 LVKDLGAGNFGVARLLRHKETK---ELVAVKYIERGR--KIDENVAREIINHRSLRHPNIIRFKEVVLT-PTHLAIVMEY   79 (181)
Q Consensus         6 ~~~~i~~g~~~~v~~~~~~~~~---~~v~~K~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~   79 (181)
                      +.++||+|+||+||+|.+.+++   ..||+|.++...  ...+.+.+|+.++.+++|||++++++++.+ ++..++||||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            4678999999999999986543   368999986432  223679999999999999999999999765 5689999999


Q ss_pred             cCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCCCCC--
Q 030211           80 AAGGELFDRICNAG-RFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLHSRP--  156 (181)
Q Consensus        80 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~~~~--  156 (181)
                      +++++|.+++.... ..++..+..++.|++.||.|||+.+|+||||||+||+++++.  .++|+|||+++........  
T Consensus       111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~--~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSSGGGCCTTTTTCCCT
T ss_pred             eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC--CEEEecccchhhccccccccc
Confidence            99999998876543 677888999999999999999999999999999999997555  4999999999765433322  


Q ss_pred             ---CcccCCCCccCcccccCCccCCC
Q 030211          157 ---KSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       157 ---~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                         ....+++.|+|||.+.++.++.+
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~k  214 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTK  214 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHH
T ss_pred             eecccccccccccChHHHhcCCCCCh
Confidence               22457899999999998887754

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-37  Score=227.75  Aligned_cols=170  Identities=26%  Similarity=0.404  Sum_probs=140.0

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc---cHHHHHHHHHHhhCCCCCeeEEEEeEEcC-----CeE
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI---DENVAREIINHRSLRHPNIIRFKEVVLTP-----THL   73 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~   73 (181)
                      +||++.+.||+|+||+||+|.+..+|+.||+|++......   .+.+.+|+.+++.++|||++++++++...     ...
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            6899999999999999999999999999999999765332   24678999999999999999999998643     234


Q ss_pred             EEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeecCCcccccCC
Q 030211           74 AIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSVLH  153 (181)
Q Consensus        74 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~~~~~~  153 (181)
                      +++++++.+++|.+++. ...+++..++.++.|++.||+|||++||+||||||+||+++.++.  ++++|||.+....  
T Consensus        98 ~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~--  172 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD--  172 (348)
T ss_dssp             CEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCT--
T ss_pred             EEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccC--
Confidence            56667777889998774 457999999999999999999999999999999999999975554  9999999986432  


Q ss_pred             CCCCcccCCCCccCcccccCCcc
Q 030211          154 SRPKSTVGTPAYIAPEVLSRREY  176 (181)
Q Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~  176 (181)
                      .......|++.|+|||.+.+..+
T Consensus       173 ~~~~~~~g~~~y~apE~~~~~~~  195 (348)
T d2gfsa1         173 DEMTGYVATRWYRAPEIMLNWMH  195 (348)
T ss_dssp             GGGSSSCHHHHTSCHHHHTTCSC
T ss_pred             cccccccccccccCchhhcCCcc
Confidence            23344678899999999877654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.6e-33  Score=205.97  Aligned_cols=176  Identities=24%  Similarity=0.327  Sum_probs=140.2

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCC-----------CCCeeEEEEeEEc-
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLR-----------HPNIIRFKEVVLT-   69 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~-----------~~~i~~~~~~~~~-   69 (181)
                      +||++++.||+|+||+||+|++..+|+.||+|++.+.....+.+.+|+.+++.+.           |+|++++++++.. 
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            3799999999999999999999999999999999876544566777888777664           5789999888764 


Q ss_pred             -CCeEEEEEeecCCCChH-HH--HhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeeCCCCCCEEeccCCC----CcEE
Q 030211           70 -PTHLAIVMEYAAGGELF-DR--ICNAGRFSEDEGRYFFQQLISGVNYCHS-MQICHRDLKLENTLLDGSAA----PRLK  140 (181)
Q Consensus        70 -~~~~~~v~e~~~~~~l~-~~--~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~gi~h~dl~p~ni~i~~~~~----~~v~  140 (181)
                       ....++++.+....... ..  ......+++..+..++.|++.|+++||+ .||+||||||+||+++.++.    ..++
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k  172 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK  172 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence             45666777766554332 22  2334579999999999999999999998 89999999999999964433    2599


Q ss_pred             EeecCCcccccCCCCCCcccCCCCccCcccccCCccCCC
Q 030211          141 ICDFGYSKSSVLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (181)
Q Consensus       141 l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  179 (181)
                      ++|||.+....  .......+++.|+|||++....++++
T Consensus       173 l~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~  209 (362)
T d1q8ya_         173 IADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCG  209 (362)
T ss_dssp             ECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTH
T ss_pred             Eeecccccccc--cccccccccccccChhhccccCCCcc
Confidence            99999986433  23345679999999999999888764

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.95  E-value=2.7e-27  Score=160.32  Aligned_cols=132  Identities=18%  Similarity=0.142  Sum_probs=103.9

Q ss_pred             ceeeeeeCCccceeEEEEEEccCCcEEEEEEccccccc-------------------cHHHHHHHHHHhhCCCCCeeEEE
Q 030211            4 YELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRKI-------------------DENVAREIINHRSLRHPNIIRFK   64 (181)
Q Consensus         4 y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-------------------~~~~~~e~~~~~~~~~~~i~~~~   64 (181)
                      +.+.++||+|+||+||+|.+. +|+.||+|+++.+...                   ......|...+..+.+.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            468899999999999999986 5889999987532110                   12344577788889999998887


Q ss_pred             EeEEcCCeEEEEEeecCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeeCCCCCCEEeccCCCCcEEEeec
Q 030211           65 EVVLTPTHLAIVMEYAAGGELFDRICNAGRFSEDEGRYFFQQLISGVNYCHSMQICHRDLKLENTLLDGSAAPRLKICDF  144 (181)
Q Consensus        65 ~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~gi~h~dl~p~ni~i~~~~~~~v~l~df  144 (181)
                      ++..    .+++||++++..+.+       ++......++.|++.++.+||++|++|+||||+||+++++   .++|+||
T Consensus        81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~---~~~liDF  146 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE---GIWIIDF  146 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT---EEEECCC
T ss_pred             EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC---CEEEEEC
Confidence            6532    268999998765543       4556677899999999999999999999999999999743   3899999


Q ss_pred             CCcccc
Q 030211          145 GYSKSS  150 (181)
Q Consensus       145 g~a~~~  150 (181)
                      |.|...
T Consensus       147 G~a~~~  152 (191)
T d1zara2         147 PQSVEV  152 (191)
T ss_dssp             TTCEET
T ss_pred             CCcccC
Confidence            998653

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=99.07  E-value=1.4e-09  Score=75.51  Aligned_cols=85  Identities=20%  Similarity=0.073  Sum_probs=58.8

Q ss_pred             ccceeeeeeCCccceeEEEEEEccCCcEEEEEEcccccc-ccHHHHHHHHHHhhCC-CCCeeEEEEeEEcCCeEEEEEee
Q 030211            2 EKYELVKDLGAGNFGVARLLRHKETKELVAVKYIERGRK-IDENVAREIINHRSLR-HPNIIRFKEVVLTPTHLAIVMEY   79 (181)
Q Consensus         2 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e~   79 (181)
                      +.|++++..+-+..+.+|++..  +++.+++|+...... ....+.+|...+..+. +--+++++.+..+++..+++|++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~   91 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence            5677777654444568998864  356688898765432 2345677777776553 33367788888888999999999


Q ss_pred             cCCCChHHH
Q 030211           80 AAGGELFDR   88 (181)
Q Consensus        80 ~~~~~l~~~   88 (181)
                      +++.++.+.
T Consensus        92 l~G~~~~~~  100 (263)
T d1j7la_          92 ADGVLCSEE  100 (263)
T ss_dssp             CSSEEHHHH
T ss_pred             ccccccccc
Confidence            988776543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.69  E-value=1.1e-07  Score=69.78  Aligned_cols=77  Identities=16%  Similarity=0.110  Sum_probs=45.8

Q ss_pred             eeeeCCccceeEEEEEEccCCcEEEEEEccc-----cc---cccHHHHHHHHHHhhCC-C--CCeeEEEEeEEcCCeEEE
Q 030211            7 VKDLGAGNFGVARLLRHKETKELVAVKYIER-----GR---KIDENVAREIINHRSLR-H--PNIIRFKEVVLTPTHLAI   75 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~~~~~v~~K~~~~-----~~---~~~~~~~~e~~~~~~~~-~--~~i~~~~~~~~~~~~~~~   75 (181)
                      .+.||.|....||++.+.++++.+++|.-..     ++   ........|...+..+. +  ..+++++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4568888999999999887788899996432     11   11233455666665442 2  235555543  4445578


Q ss_pred             EEeecCCCCh
Q 030211           76 VMEYAAGGEL   85 (181)
Q Consensus        76 v~e~~~~~~l   85 (181)
                      +||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.50  E-value=1.4e-06  Score=59.53  Aligned_cols=74  Identities=15%  Similarity=0.067  Sum_probs=49.9

Q ss_pred             eeCCccc-eeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCC--CCeeEEEEeEEcCCeEEEEEeecCCCCh
Q 030211            9 DLGAGNF-GVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRH--PNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (181)
Q Consensus         9 ~i~~g~~-~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~--~~i~~~~~~~~~~~~~~~v~e~~~~~~l   85 (181)
                      .+..|.. ..||++... ++..+++|......  ...+..|...++.+..  -.+++++.+..+++..+++|+++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3344443 578988865 35568889765443  2345667766665532  3367788888888899999999987654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=98.24  E-value=2.7e-06  Score=60.56  Aligned_cols=69  Identities=10%  Similarity=0.054  Sum_probs=45.2

Q ss_pred             ceeEEEEEEccCCcEEEEEEccccccccHHHHHHHHHHhhCCCCCee--EEE-----EeEEcCCeEEEEEeecCCCC
Q 030211           15 FGVARLLRHKETKELVAVKYIERGRKIDENVAREIINHRSLRHPNII--RFK-----EVVLTPTHLAIVMEYAAGGE   84 (181)
Q Consensus        15 ~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~i~--~~~-----~~~~~~~~~~~v~e~~~~~~   84 (181)
                      --.||++... +|..+++|+...+....+++.+|...+..+...+++  .+.     ..+...+..+.++++++|..
T Consensus        35 EN~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          35 ENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             cceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            3479999875 477899999877665667788888777665322221  111     12234567888999987743

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.91  E-value=4.5e-05  Score=55.50  Aligned_cols=74  Identities=14%  Similarity=0.130  Sum_probs=47.3

Q ss_pred             eeeeCCccceeEEEEEEcc-------CCcEEEEEEccccccccHHHHHHHHHHhhCCCCC-eeEEEEeEEcCCeEEEEEe
Q 030211            7 VKDLGAGNFGVARLLRHKE-------TKELVAVKYIERGRKIDENVAREIINHRSLRHPN-IIRFKEVVLTPTHLAIVME   78 (181)
Q Consensus         7 ~~~i~~g~~~~v~~~~~~~-------~~~~v~~K~~~~~~~~~~~~~~e~~~~~~~~~~~-i~~~~~~~~~~~~~~~v~e   78 (181)
                      ++.|+-|-.-.+|++...+       ..+.+++++... ........+|..+++.+...+ .+++++++.+    +.+++
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            3567667777999998653       245678887663 333345567777777664333 4567776642    56899


Q ss_pred             ecCCCCh
Q 030211           79 YAAGGEL   85 (181)
Q Consensus        79 ~~~~~~l   85 (181)
                      |+++.++
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9977543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.76  E-value=2.8e-05  Score=54.73  Aligned_cols=30  Identities=23%  Similarity=0.340  Sum_probs=25.1

Q ss_pred             cCeeeeCCCCCCEEeccCCCCcEEEeecCCcc
Q 030211          117 MQICHRDLKLENTLLDGSAAPRLKICDFGYSK  148 (181)
Q Consensus       117 ~gi~h~dl~p~ni~i~~~~~~~v~l~dfg~a~  148 (181)
                      .|++|+|+.++|++++.+.  ..-++||+.|.
T Consensus       183 ~giIHgDl~~dNvl~~~~~--v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDE--LSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred             cccccCCcchhhhhccccc--ceeEecccccc
Confidence            5799999999999997443  36899999875